DrugA,DrugB,Interaction,Mechanism,risk_level
Enokizumab,Quinestrol,Quinestrol may increase the thrombogenic activities of Enokizumab.,increase,no risk
Enokizumab,Ublituximab,The risk or severity of adverse effects can be increased when Enokizumab is combined with Ublituximab.,increase,risk
Enokizumab,Ustekinumab,The risk or severity of adverse effects can be increased when Enokizumab is combined with Ustekinumab.,increase,risk
Enokizumab,Vedolizumab,The risk or severity of adverse effects can be increased when Enokizumab is combined with Vedolizumab.,increase,risk
Tralokinumab,Natalizumab,The risk or severity of adverse effects can be increased when Natalizumab is combined with Tralokinumab.,increase,risk
Tralokinumab,Necitumumab,The risk or severity of adverse effects can be increased when Necitumumab is combined with Tralokinumab.,increase,risk
Tralokinumab,Nivolumab,The risk or severity of adverse effects can be increased when Nivolumab is combined with Tralokinumab.,increase,risk
Tralokinumab,Obiltoxaximab,The risk or severity of adverse effects can be increased when Obiltoxaximab is combined with Tralokinumab.,increase,risk
Tralokinumab,Obinutuzumab,The risk or severity of adverse effects can be increased when Obinutuzumab is combined with Tralokinumab.,increase,risk
Tralokinumab,Ocrelizumab,The risk or severity of adverse effects can be increased when Ocrelizumab is combined with Tralokinumab.,increase,risk
Tralokinumab,Odesivimab,The risk or severity of adverse effects can be increased when Tralokinumab is combined with Odesivimab.,increase,risk
Tralokinumab,Ofatumumab,The risk or severity of adverse effects can be increased when Ofatumumab is combined with Tralokinumab.,increase,risk
Tralokinumab,Olaratumab,The risk or severity of adverse effects can be increased when Olaratumab is combined with Tralokinumab.,increase,risk
Tralokinumab,Omalizumab,The risk or severity of adverse effects can be increased when Omalizumab is combined with Tralokinumab.,increase,risk
Tralokinumab,Quinestrol,Quinestrol may increase the thrombogenic activities of Tralokinumab.,increase,no risk
Tralokinumab,Ublituximab,The risk or severity of adverse effects can be increased when Ublituximab is combined with Tralokinumab.,increase,risk
Tralokinumab,Ustekinumab,The risk or severity of adverse effects can be increased when Ustekinumab is combined with Tralokinumab.,increase,risk
Tralokinumab,Vedolizumab,The risk or severity of adverse effects can be increased when Vedolizumab is combined with Tralokinumab.,increase,risk
Naluzotan,Gabapentin,The risk or severity of CNS depression can be increased when Gabapentin is combined with Naluzotan.,increase,risk
Naluzotan,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Naluzotan is combined with Gabapentin enacarbil.,increase,risk
Naluzotan,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with Naluzotan.,increase,risk
Naluzotan,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Naluzotan is combined with Ganaxolone.",increase,risk
Naluzotan,Gepirone,The risk or severity of CNS depression can be increased when Naluzotan is combined with Gepirone.,increase,risk
Naluzotan,Gilteritinib,The therapeutic efficacy of Naluzotan can be decreased when used in combination with Gilteritinib.,decrease,no risk
Naluzotan,Glutethimide,The risk or severity of CNS depression can be increased when Glutethimide is combined with Naluzotan.,increase,risk
Naluzotan,Granisetron,The risk or severity of CNS depression can be increased when Granisetron is combined with Naluzotan.,increase,risk
Naluzotan,Guanabenz,Naluzotan may decrease the antihypertensive activities of Guanabenz.,decrease,no risk
Naluzotan,Guanadrel,Naluzotan may decrease the antihypertensive activities of Guanadrel.,decrease,no risk
Naluzotan,Guanethidine,Naluzotan may decrease the antihypertensive activities of Guanethidine.,decrease,no risk
Naluzotan,Guanfacine,The risk or severity of CNS depression can be increased when Guanfacine is combined with Naluzotan.,increase,risk
Naluzotan,Guanoxan,Naluzotan may decrease the antihypertensive activities of Guanoxan.,decrease,no risk
Naluzotan,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with Naluzotan.,increase,risk
Naluzotan,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Naluzotan.,increase,risk
Naluzotan,Halothane,The risk or severity of CNS depression can be increased when Halothane is combined with Naluzotan.,increase,risk
Naluzotan,Hexafluronium,The risk or severity of CNS depression can be increased when Hexafluronium is combined with Naluzotan.,increase,risk
Naluzotan,Hydralazine,Naluzotan may decrease the antihypertensive activities of Hydralazine.,decrease,no risk
Naluzotan,Hydrochlorothiazide,Naluzotan may decrease the antihypertensive activities of Hydrochlorothiazide.,decrease,no risk
Naluzotan,Hydrocodone,Naluzotan may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Naluzotan,Hydroflumethiazide,Naluzotan may decrease the antihypertensive activities of Hydroflumethiazide.,decrease,no risk
Naluzotan,Hydromorphone,The risk or severity of CNS depression can be increased when Hydromorphone is combined with Naluzotan.,increase,risk
Naluzotan,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Naluzotan.,increase,no risk
Naluzotan,Ketamine,The risk or severity of CNS depression can be increased when Ketamine is combined with Naluzotan.,increase,risk
Naluzotan,Ketazolam,The risk or severity of CNS depression can be increased when Ketazolam is combined with Naluzotan.,increase,risk
Naluzotan,Ketoprofen,The risk or severity of hypertension can be increased when Ketoprofen is combined with Naluzotan.,increase,risk
Naluzotan,Ketorolac,The risk or severity of hypertension can be increased when Ketorolac is combined with Naluzotan.,increase,risk
Naluzotan,Nabilone,Nabilone may increase the central nervous system depressant (CNS depressant) activities of Naluzotan.,increase,no risk
Naluzotan,Nabumetone,The risk or severity of hypertension can be increased when Nabumetone is combined with Naluzotan.,increase,risk
Naluzotan,Nadolol,Naluzotan may decrease the antihypertensive activities of Nadolol.,decrease,no risk
Naluzotan,Nalbuphine,The risk or severity of CNS depression can be increased when Nalbuphine is combined with Naluzotan.,increase,risk
Naluzotan,Naphazoline,The risk or severity of hypertension can be increased when Naluzotan is combined with Naphazoline.,increase,risk
Naluzotan,Naproxen,The risk or severity of hypertension can be increased when Naproxen is combined with Naluzotan.,increase,risk
Naluzotan,Naratriptan,The risk or severity of CNS depression can be increased when Naratriptan is combined with Naluzotan.,increase,risk
Naluzotan,Naxitamab,The risk or severity of hypertension can be increased when Naluzotan is combined with Naxitamab.,increase,risk
Naluzotan,Nebivolol,Naluzotan may decrease the antihypertensive activities of Nebivolol.,decrease,no risk
Naluzotan,Nefazodone,The risk or severity of adverse effects can be increased when Naluzotan is combined with Nefazodone.,increase,risk
Naluzotan,Nialamide,The metabolism of Naluzotan can be decreased when combined with Nialamide.,decrease,no risk
Naluzotan,Nicardipine,Naluzotan may decrease the antihypertensive activities of Nicardipine.,decrease,no risk
Naluzotan,Nicergoline,Nicergoline may increase the vasoconstricting activities of Naluzotan.,increase,no risk
Naluzotan,Nicorandil,Naluzotan may decrease the antihypertensive activities of Nicorandil.,decrease,no risk
Naluzotan,Nilvadipine,Naluzotan may decrease the antihypertensive activities of Nilvadipine.,decrease,no risk
Naluzotan,Nimesulide,The risk or severity of hypertension can be increased when Nimesulide is combined with Naluzotan.,increase,risk
Naluzotan,Nimodipine,Naluzotan may decrease the antihypertensive activities of Nimodipine.,decrease,no risk
Naluzotan,Nisoldipine,Naluzotan may decrease the antihypertensive activities of Nisoldipine.,decrease,no risk
Naluzotan,Nitrazepam,The risk or severity of CNS depression can be increased when Nitrazepam is combined with Naluzotan.,increase,risk
Naluzotan,Nitrendipine,Naluzotan may decrease the antihypertensive activities of Nitrendipine.,decrease,no risk
Naluzotan,Nitroglycerin,Naluzotan may decrease the antihypertensive activities of Nitroglycerin.,decrease,no risk
Naluzotan,Nitroprusside,Naluzotan may decrease the antihypertensive activities of Nitroprusside.,decrease,no risk
Naluzotan,Nitrous oxide,The risk or severity of CNS depression can be increased when Naluzotan is combined with Nitrous oxide.,increase,risk
Naluzotan,Nomifensine,The risk or severity of CNS depression can be increased when Nomifensine is combined with Naluzotan.,increase,risk
Naluzotan,Norepinephrine,The risk or severity of hypertension can be increased when Norepinephrine is combined with Naluzotan.,increase,risk
Naluzotan,Normethadone,The risk or severity of CNS depression can be increased when Naluzotan is combined with Normethadone.,increase,risk
Naluzotan,Nortriptyline,The risk or severity of CNS depression can be increased when Nortriptyline is combined with Naluzotan.,increase,risk
Naluzotan,Nylidrin,The risk or severity of hypertension can be increased when Naluzotan is combined with Nylidrin.,increase,risk
Naluzotan,Olanzapine,The risk or severity of CNS depression can be increased when Olanzapine is combined with Naluzotan.,increase,risk
Naluzotan,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Naluzotan is combined with Oliceridine.",increase,risk
Naluzotan,Olmesartan,Naluzotan may decrease the antihypertensive activities of Olmesartan.,decrease,no risk
Naluzotan,Olodaterol,The risk or severity of hypertension can be increased when Naluzotan is combined with Olodaterol.,increase,risk
Naluzotan,Ondansetron,The risk or severity of CNS depression can be increased when Ondansetron is combined with Naluzotan.,increase,risk
Naluzotan,Opium,The risk or severity of CNS depression can be increased when Naluzotan is combined with Opium.,increase,risk
Naluzotan,Orciprenaline,The risk or severity of hypertension can be increased when Orciprenaline is combined with Naluzotan.,increase,risk
Naluzotan,Orphenadrine,Naluzotan may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Naluzotan,Oxaprozin,The risk or severity of hypertension can be increased when Oxaprozin is combined with Naluzotan.,increase,risk
Naluzotan,Oxazepam,The risk or severity of CNS depression can be increased when Oxazepam is combined with Naluzotan.,increase,risk
Naluzotan,Oxcarbazepine,The risk or severity of CNS depression can be increased when Oxcarbazepine is combined with Naluzotan.,increase,risk
Naluzotan,Oxitriptan,The risk or severity of CNS depression can be increased when Oxitriptan is combined with Naluzotan.,increase,risk
Naluzotan,Oxprenolol,The risk or severity of CNS depression can be increased when Oxprenolol is combined with Naluzotan.,increase,risk
Naluzotan,Oxybuprocaine,The risk or severity of CNS depression can be increased when Oxybuprocaine is combined with Naluzotan.,increase,risk
Naluzotan,Oxycodone,The risk or severity of CNS depression can be increased when Oxycodone is combined with Naluzotan.,increase,risk
Naluzotan,Oxymetazoline,The risk or severity of hypertension can be increased when Oxymetazoline is combined with Naluzotan.,increase,risk
Naluzotan,Oxymorphone,The risk or severity of CNS depression can be increased when Oxymorphone is combined with Naluzotan.,increase,risk
Naluzotan,Oxyphenbutazone,The risk or severity of hypertension can be increased when Oxyphenbutazone is combined with Naluzotan.,increase,risk
Naluzotan,Quazepam,The risk or severity of CNS depression can be increased when Quazepam is combined with Naluzotan.,increase,risk
Naluzotan,Quetiapine,The risk or severity of CNS depression can be increased when Quetiapine is combined with Naluzotan.,increase,risk
Naluzotan,Quinapril,Naluzotan may decrease the antihypertensive activities of Quinapril.,decrease,no risk
Naluzotan,Quinidine,The risk or severity of hypertension can be increased when Quinidine is combined with Naluzotan.,increase,risk
Naluzotan,Quinine,The risk or severity of CNS depression can be increased when Quinine is combined with Naluzotan.,increase,risk
Naluzotan,Quinupramine,The risk or severity of CNS depression can be increased when Naluzotan is combined with Quinupramine.,increase,risk
Naluzotan,Urethane,The risk or severity of CNS depression can be increased when Urethane is combined with Naluzotan.,increase,risk
Naluzotan,Valdecoxib,The risk or severity of hypertension can be increased when Valdecoxib is combined with Naluzotan.,increase,risk
Naluzotan,Valproic acid,The risk or severity of CNS depression can be increased when Valproic acid is combined with Naluzotan.,increase,risk
Naluzotan,Valsartan,Naluzotan may decrease the antihypertensive activities of Valsartan.,decrease,no risk
Naluzotan,Vecuronium,The risk or severity of CNS depression can be increased when Vecuronium is combined with Naluzotan.,increase,risk
Naluzotan,Venlafaxine,The risk or severity of CNS depression can be increased when Venlafaxine is combined with Naluzotan.,increase,risk
Naluzotan,Vigabatrin,The risk or severity of CNS depression can be increased when Vigabatrin is combined with Naluzotan.,increase,risk
Naluzotan,Vilanterol,The risk or severity of hypertension can be increased when Naluzotan is combined with Vilanterol.,increase,risk
Naluzotan,Vilazodone,The risk or severity of CNS depression can be increased when Naluzotan is combined with Vilazodone.,increase,risk
Naluzotan,Viloxazine,The risk or severity of CNS depression can be increased when Naluzotan is combined with Viloxazine.,increase,risk
Naluzotan,Vortioxetine,The risk or severity of CNS depression can be increased when Naluzotan is combined with Vortioxetine.,increase,risk
Naluzotan,Warfarin,The risk or severity of adverse effects can be increased when Naluzotan is combined with Warfarin.,increase,risk
Naluzotan,Xamoterol,The risk or severity of hypertension can be increased when Naluzotan is combined with Xamoterol.,increase,risk
Naluzotan,Xylometazoline,The risk or severity of hypertension can be increased when Naluzotan is combined with Xylometazoline.,increase,risk
Naluzotan,Yohimbine,The risk or severity of CNS depression can be increased when Yohimbine is combined with Naluzotan.,increase,risk
Naluzotan,Zaleplon,The risk or severity of CNS depression can be increased when Zaleplon is combined with Naluzotan.,increase,risk
Naluzotan,Ziconotide,The risk or severity of CNS depression can be increased when Naluzotan is combined with Ziconotide.,increase,risk
Naluzotan,Zimelidine,The risk or severity of adverse effects can be increased when Naluzotan is combined with Zimelidine.,increase,risk
Naluzotan,Ziprasidone,The risk or severity of adverse effects can be increased when Naluzotan is combined with Ziprasidone.,increase,risk
Naluzotan,Zofenopril,Naluzotan may decrease the antihypertensive activities of Zofenopril.,decrease,no risk
Naluzotan,Zolmitriptan,The risk or severity of vasospastic reactions can be increased when Naluzotan is combined with Zolmitriptan.,increase,risk
Naluzotan,Zolpidem,Naluzotan may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Naluzotan,Zonisamide,The risk or severity of CNS depression can be increased when Zonisamide is combined with Naluzotan.,increase,risk
Naluzotan,Zopiclone,The risk or severity of adverse effects can be increased when Naluzotan is combined with Zopiclone.,increase,risk
Naluzotan,Zotepine,The risk or severity of CNS depression can be increased when Naluzotan is combined with Zotepine.,increase,risk
Naluzotan,Zuclopenthixol,The risk or severity of CNS depression can be increased when Zuclopenthixol is combined with Naluzotan.,increase,risk
Naluzotan,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Naluzotan.,increase,risk
Linaclotide,Gallamine triethiodide,The therapeutic efficacy of Linaclotide can be decreased when used in combination with Gallamine triethiodide.,decrease,no risk
Linaclotide,Glycerin,The risk or severity of adverse effects can be increased when Linaclotide is combined with Glycerin.,increase,risk
Linaclotide,Glycopyrronium,The therapeutic efficacy of Linaclotide can be decreased when used in combination with Glycopyrronium.,decrease,no risk
Linaclotide,Hexafluronium,The therapeutic efficacy of Linaclotide can be decreased when used in combination with Hexafluronium.,decrease,no risk
Linaclotide,Hexocyclium,The therapeutic efficacy of Linaclotide can be decreased when used in combination with Hexocyclium.,decrease,no risk
Linaclotide,Homatropine,The therapeutic efficacy of Linaclotide can be decreased when used in combination with Homatropine.,decrease,no risk
Linaclotide,Homatropine methylbromide,The therapeutic efficacy of Linaclotide can be decreased when used in combination with Homatropine methylbromide.,decrease,no risk
Linaclotide,Hydrochlorothiazide,The risk or severity of dehydration can be increased when Hydrochlorothiazide is combined with Linaclotide.,increase,risk
Linaclotide,Hydrocodone,The therapeutic efficacy of Linaclotide can be decreased when used in combination with Hydrocodone.,decrease,no risk
Linaclotide,Hydroflumethiazide,The risk or severity of dehydration can be increased when Hydroflumethiazide is combined with Linaclotide.,increase,risk
Linaclotide,Hydromorphone,The therapeutic efficacy of Linaclotide can be decreased when used in combination with Hydromorphone.,decrease,no risk
Linaclotide,Hyoscyamine,The therapeutic efficacy of Linaclotide can be decreased when used in combination with Hyoscyamine.,decrease,no risk
Linaclotide,Nalbuphine,The therapeutic efficacy of Linaclotide can be decreased when used in combination with Nalbuphine.,decrease,no risk
Linaclotide,Naloxegol,The therapeutic efficacy of Linaclotide can be decreased when used in combination with Naloxegol.,decrease,no risk
Linaclotide,Naltrexone,The therapeutic efficacy of Linaclotide can be decreased when used in combination with Naltrexone.,decrease,no risk
Linaclotide,Nicardipine,The therapeutic efficacy of Linaclotide can be decreased when used in combination with Nicardipine.,decrease,no risk
Linaclotide,Nifedipine,The therapeutic efficacy of Linaclotide can be decreased when used in combination with Nifedipine.,decrease,no risk
Linaclotide,Nilvadipine,The therapeutic efficacy of Linaclotide can be decreased when used in combination with Nilvadipine.,decrease,no risk
Linaclotide,Nimesulide,The therapeutic efficacy of Linaclotide can be decreased when used in combination with Nimesulide.,decrease,no risk
Linaclotide,Nimodipine,The therapeutic efficacy of Linaclotide can be decreased when used in combination with Nimodipine.,decrease,no risk
Linaclotide,Nisoldipine,The therapeutic efficacy of Linaclotide can be decreased when used in combination with Nisoldipine.,decrease,no risk
Linaclotide,Nitrendipine,The therapeutic efficacy of Linaclotide can be decreased when used in combination with Nitrendipine.,decrease,no risk
Linaclotide,Normethadone,The therapeutic efficacy of Linaclotide can be decreased when used in combination with Normethadone.,decrease,no risk
Linaclotide,Nortriptyline,The therapeutic efficacy of Linaclotide can be decreased when used in combination with Nortriptyline.,decrease,no risk
Linaclotide,Nylidrin,The therapeutic efficacy of Linaclotide can be decreased when used in combination with Nylidrin.,decrease,no risk
Linaclotide,Olanzapine,The therapeutic efficacy of Linaclotide can be decreased when used in combination with Olanzapine.,decrease,no risk
Linaclotide,Oliceridine,The therapeutic efficacy of Linaclotide can be decreased when used in combination with Oliceridine.,decrease,no risk
Linaclotide,Opium,The therapeutic efficacy of Linaclotide can be decreased when used in combination with Opium.,decrease,no risk
Linaclotide,Orphenadrine,The therapeutic efficacy of Linaclotide can be decreased when used in combination with Orphenadrine.,decrease,no risk
Linaclotide,Oxybutynin,The therapeutic efficacy of Linaclotide can be decreased when used in combination with Oxybutynin.,decrease,no risk
Linaclotide,Oxycodone,The therapeutic efficacy of Linaclotide can be decreased when used in combination with Oxycodone.,decrease,no risk
Linaclotide,Oxymorphone,The therapeutic efficacy of Linaclotide can be decreased when used in combination with Oxymorphone.,decrease,no risk
Linaclotide,Oxyphencyclimine,The therapeutic efficacy of Linaclotide can be decreased when used in combination with Oxyphencyclimine.,decrease,no risk
Linaclotide,Oxyphenisatin acetate,The risk or severity of adverse effects can be increased when Linaclotide is combined with Oxyphenisatin acetate.,increase,risk
Linaclotide,Oxyphenonium,The therapeutic efficacy of Linaclotide can be decreased when used in combination with Oxyphenonium.,decrease,no risk
Linaclotide,Quetiapine,The therapeutic efficacy of Linaclotide can be decreased when used in combination with Quetiapine.,decrease,no risk
Linaclotide,Quinethazone,The risk or severity of dehydration can be increased when Quinethazone is combined with Linaclotide.,increase,risk
Linaclotide,Quinidine,The therapeutic efficacy of Linaclotide can be decreased when used in combination with Quinidine.,decrease,no risk
Linaclotide,Umeclidinium,The therapeutic efficacy of Linaclotide can be decreased when used in combination with Umeclidinium.,decrease,no risk
Linaclotide,Vecuronium,The therapeutic efficacy of Linaclotide can be decreased when used in combination with Vecuronium.,decrease,no risk
Linaclotide,Verapamil,The therapeutic efficacy of Linaclotide can be decreased when used in combination with Verapamil.,decrease,no risk
Linaclotide,Xylometazoline,The therapeutic efficacy of Linaclotide can be decreased when used in combination with Xylometazoline.,decrease,no risk
Linaclotide,Ziconotide,The therapeutic efficacy of Linaclotide can be decreased when used in combination with Ziconotide.,decrease,no risk
Linaclotide,Ziprasidone,The therapeutic efficacy of Linaclotide can be decreased when used in combination with Ziprasidone.,decrease,no risk
Linaclotide,Zonisamide,The risk or severity of dehydration can be increased when Zonisamide is combined with Linaclotide.,increase,risk
Motesanib,Voriconazole,The serum concentration of Motesanib can be increased when it is combined with Voriconazole.,increase,no risk
Ramucirumab,Human cytomegalovirus immune globulin,The risk or severity of adverse effects can be increased when Ramucirumab is combined with Human cytomegalovirus immune globulin.,increase,risk
Ramucirumab,Human immunoglobulin G,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Ramucirumab.,increase,risk
Ramucirumab,Human Rho(D) immune globulin,The risk or severity of adverse effects can be increased when Ramucirumab is combined with Human Rho(D) immune globulin.,increase,risk
Ramucirumab,Human varicella-zoster immune globulin,The risk or severity of adverse effects can be increased when Ramucirumab is combined with Human varicella-zoster immune globulin.,increase,risk
Ramucirumab,Natalizumab,The risk or severity of adverse effects can be increased when Natalizumab is combined with Ramucirumab.,increase,risk
Ramucirumab,Necitumumab,The risk or severity of adverse effects can be increased when Ramucirumab is combined with Necitumumab.,increase,risk
Ramucirumab,Nivolumab,The risk or severity of adverse effects can be increased when Ramucirumab is combined with Nivolumab.,increase,risk
Ramucirumab,Obiltoxaximab,The risk or severity of adverse effects can be increased when Obiltoxaximab is combined with Ramucirumab.,increase,risk
Ramucirumab,Obinutuzumab,The risk or severity of adverse effects can be increased when Ramucirumab is combined with Obinutuzumab.,increase,risk
Ramucirumab,Ocrelizumab,The risk or severity of adverse effects can be increased when Ramucirumab is combined with Ocrelizumab.,increase,risk
Ramucirumab,Odesivimab,The risk or severity of adverse effects can be increased when Ramucirumab is combined with Odesivimab.,increase,risk
Ramucirumab,Ofatumumab,The risk or severity of adverse effects can be increased when Ramucirumab is combined with Ofatumumab.,increase,risk
Ramucirumab,Olaratumab,The risk or severity of adverse effects can be increased when Ramucirumab is combined with Olaratumab.,increase,risk
Ramucirumab,Omalizumab,The risk or severity of adverse effects can be increased when Omalizumab is combined with Ramucirumab.,increase,risk
Ramucirumab,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Ramucirumab is combined with Oxetacaine.,increase,risk
Ramucirumab,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Ramucirumab is combined with Oxybuprocaine.,increase,risk
Ramucirumab,Quinestrol,Quinestrol may increase the thrombogenic activities of Ramucirumab.,increase,no risk
Ramucirumab,Ublituximab,The risk or severity of adverse effects can be increased when Ramucirumab is combined with Ublituximab.,increase,risk
Ramucirumab,Ustekinumab,The risk or severity of adverse effects can be increased when Ramucirumab is combined with Ustekinumab.,increase,risk
Ramucirumab,Vedolizumab,The risk or severity of adverse effects can be increased when Ramucirumab is combined with Vedolizumab.,increase,risk
Ramucirumab,Zoledronic acid,The risk or severity of jaw osteonecrosis and anti-angiogenesis can be increased when Ramucirumab is combined with Zoledronic acid.,increase,risk
Teriparatide,Quizartinib,The therapeutic efficacy of Teriparatide can be decreased when used in combination with Quizartinib.,decrease,no risk
Teriparatide,Vandetanib,The therapeutic efficacy of Teriparatide can be decreased when used in combination with Vandetanib.,decrease,no risk
Teriparatide,Vemurafenib,The therapeutic efficacy of Teriparatide can be decreased when used in combination with Vemurafenib.,decrease,no risk
Teriparatide,Zanubrutinib,The therapeutic efficacy of Teriparatide can be decreased when used in combination with Zanubrutinib.,decrease,no risk
Teriparatide,Zimelidine,The therapeutic efficacy of Teriparatide can be decreased when used in combination with Zimelidine.,decrease,no risk
Farletuzumab,Human varicella-zoster immune globulin,The risk or severity of adverse effects can be increased when Farletuzumab is combined with Human varicella-zoster immune globulin.,increase,risk
Farletuzumab,Natalizumab,The risk or severity of adverse effects can be increased when Natalizumab is combined with Farletuzumab.,increase,risk
Farletuzumab,Necitumumab,The risk or severity of adverse effects can be increased when Farletuzumab is combined with Necitumumab.,increase,risk
Farletuzumab,Nelarabine,The risk or severity of adverse effects can be increased when Nelarabine is combined with Farletuzumab.,increase,risk
Farletuzumab,Nivolumab,The risk or severity of adverse effects can be increased when Farletuzumab is combined with Nivolumab.,increase,risk
Farletuzumab,Obiltoxaximab,The risk or severity of adverse effects can be increased when Obiltoxaximab is combined with Farletuzumab.,increase,risk
Farletuzumab,Obinutuzumab,The risk or severity of adverse effects can be increased when Farletuzumab is combined with Obinutuzumab.,increase,risk
Farletuzumab,Ocrelizumab,The risk or severity of adverse effects can be increased when Farletuzumab is combined with Ocrelizumab.,increase,risk
Farletuzumab,Odesivimab,The risk or severity of adverse effects can be increased when Farletuzumab is combined with Odesivimab.,increase,risk
Farletuzumab,Ofatumumab,The risk or severity of adverse effects can be increased when Farletuzumab is combined with Ofatumumab.,increase,risk
Farletuzumab,Olaratumab,The risk or severity of adverse effects can be increased when Farletuzumab is combined with Olaratumab.,increase,risk
Farletuzumab,Omalizumab,The risk or severity of adverse effects can be increased when Omalizumab is combined with Farletuzumab.,increase,risk
Farletuzumab,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Farletuzumab is combined with Oxetacaine.,increase,risk
Farletuzumab,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Farletuzumab is combined with Oxybuprocaine.,increase,risk
Farletuzumab,Quinestrol,Quinestrol may increase the thrombogenic activities of Farletuzumab.,increase,no risk
Farletuzumab,Ublituximab,The risk or severity of adverse effects can be increased when Farletuzumab is combined with Ublituximab.,increase,risk
Farletuzumab,Ustekinumab,The risk or severity of adverse effects can be increased when Farletuzumab is combined with Ustekinumab.,increase,risk
Farletuzumab,Vedolizumab,The risk or severity of adverse effects can be increased when Farletuzumab is combined with Vedolizumab.,increase,risk
PRX-08066,Gabapentin,The risk or severity of CNS depression can be increased when Gabapentin is combined with PRX-08066.,increase,risk
PRX-08066,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when PRX-08066 is combined with Gabapentin enacarbil.,increase,risk
PRX-08066,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with PRX-08066.,increase,risk
PRX-08066,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when PRX-08066 is combined with Ganaxolone.",increase,risk
PRX-08066,Gepirone,The risk or severity of CNS depression can be increased when PRX-08066 is combined with Gepirone.,increase,risk
PRX-08066,Gilteritinib,The therapeutic efficacy of PRX-08066 can be decreased when used in combination with Gilteritinib.,decrease,no risk
PRX-08066,Glutethimide,The risk or severity of CNS depression can be increased when Glutethimide is combined with PRX-08066.,increase,risk
PRX-08066,Granisetron,The risk or severity of CNS depression can be increased when Granisetron is combined with PRX-08066.,increase,risk
PRX-08066,Guanfacine,The risk or severity of CNS depression can be increased when Guanfacine is combined with PRX-08066.,increase,risk
PRX-08066,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with PRX-08066.,increase,risk
PRX-08066,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with PRX-08066.,increase,risk
PRX-08066,Halothane,The risk or severity of CNS depression can be increased when Halothane is combined with PRX-08066.,increase,risk
PRX-08066,Hexafluronium,The risk or severity of CNS depression can be increased when Hexafluronium is combined with PRX-08066.,increase,risk
PRX-08066,Hydrocodone,PRX-08066 may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
PRX-08066,Hydromorphone,The risk or severity of CNS depression can be increased when Hydromorphone is combined with PRX-08066.,increase,risk
PRX-08066,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of PRX-08066.,increase,no risk
PRX-08066,Ketamine,The risk or severity of CNS depression can be increased when Ketamine is combined with PRX-08066.,increase,risk
PRX-08066,Ketazolam,The risk or severity of CNS depression can be increased when Ketazolam is combined with PRX-08066.,increase,risk
PRX-08066,Nabilone,Nabilone may increase the central nervous system depressant (CNS depressant) activities of PRX-08066.,increase,no risk
PRX-08066,Nalbuphine,The risk or severity of CNS depression can be increased when Nalbuphine is combined with PRX-08066.,increase,risk
PRX-08066,Naratriptan,The risk or severity of CNS depression can be increased when Naratriptan is combined with PRX-08066.,increase,risk
PRX-08066,Nefazodone,The risk or severity of adverse effects can be increased when PRX-08066 is combined with Nefazodone.,increase,risk
PRX-08066,Nialamide,The risk or severity of CNS depression can be increased when Nialamide is combined with PRX-08066.,increase,risk
PRX-08066,Nitrazepam,The risk or severity of CNS depression can be increased when Nitrazepam is combined with PRX-08066.,increase,risk
PRX-08066,Nitrous oxide,The risk or severity of CNS depression can be increased when PRX-08066 is combined with Nitrous oxide.,increase,risk
PRX-08066,Nomifensine,The risk or severity of CNS depression can be increased when Nomifensine is combined with PRX-08066.,increase,risk
PRX-08066,Normethadone,The risk or severity of CNS depression can be increased when PRX-08066 is combined with Normethadone.,increase,risk
PRX-08066,Nortriptyline,The risk or severity of CNS depression can be increased when Nortriptyline is combined with PRX-08066.,increase,risk
PRX-08066,Olanzapine,The risk or severity of CNS depression can be increased when Olanzapine is combined with PRX-08066.,increase,risk
PRX-08066,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when PRX-08066 is combined with Oliceridine.",increase,risk
PRX-08066,Ondansetron,The risk or severity of CNS depression can be increased when Ondansetron is combined with PRX-08066.,increase,risk
PRX-08066,Opium,The risk or severity of CNS depression can be increased when PRX-08066 is combined with Opium.,increase,risk
PRX-08066,Orphenadrine,PRX-08066 may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
PRX-08066,Oxazepam,The risk or severity of CNS depression can be increased when Oxazepam is combined with PRX-08066.,increase,risk
PRX-08066,Oxcarbazepine,The risk or severity of CNS depression can be increased when Oxcarbazepine is combined with PRX-08066.,increase,risk
PRX-08066,Oxitriptan,The risk or severity of CNS depression can be increased when Oxitriptan is combined with PRX-08066.,increase,risk
PRX-08066,Oxprenolol,The risk or severity of CNS depression can be increased when Oxprenolol is combined with PRX-08066.,increase,risk
PRX-08066,Oxybuprocaine,The risk or severity of CNS depression can be increased when Oxybuprocaine is combined with PRX-08066.,increase,risk
PRX-08066,Oxycodone,The risk or severity of CNS depression can be increased when Oxycodone is combined with PRX-08066.,increase,risk
PRX-08066,Oxymorphone,The risk or severity of CNS depression can be increased when Oxymorphone is combined with PRX-08066.,increase,risk
PRX-08066,Quazepam,The risk or severity of CNS depression can be increased when Quazepam is combined with PRX-08066.,increase,risk
PRX-08066,Quetiapine,The risk or severity of CNS depression can be increased when Quetiapine is combined with PRX-08066.,increase,risk
PRX-08066,Quinine,The risk or severity of CNS depression can be increased when Quinine is combined with PRX-08066.,increase,risk
PRX-08066,Quinupramine,The risk or severity of CNS depression can be increased when PRX-08066 is combined with Quinupramine.,increase,risk
PRX-08066,Urethane,The risk or severity of CNS depression can be increased when Urethane is combined with PRX-08066.,increase,risk
PRX-08066,Valproic acid,The risk or severity of CNS depression can be increased when Valproic acid is combined with PRX-08066.,increase,risk
PRX-08066,Vecuronium,The risk or severity of CNS depression can be increased when Vecuronium is combined with PRX-08066.,increase,risk
PRX-08066,Venlafaxine,The risk or severity of CNS depression can be increased when Venlafaxine is combined with PRX-08066.,increase,risk
PRX-08066,Vigabatrin,The risk or severity of CNS depression can be increased when Vigabatrin is combined with PRX-08066.,increase,risk
PRX-08066,Vilazodone,The risk or severity of CNS depression can be increased when PRX-08066 is combined with Vilazodone.,increase,risk
PRX-08066,Viloxazine,The risk or severity of CNS depression can be increased when PRX-08066 is combined with Viloxazine.,increase,risk
PRX-08066,Vortioxetine,The risk or severity of CNS depression can be increased when PRX-08066 is combined with Vortioxetine.,increase,risk
PRX-08066,Warfarin,The risk or severity of adverse effects can be increased when PRX-08066 is combined with Warfarin.,increase,risk
PRX-08066,Yohimbine,The risk or severity of CNS depression can be increased when Yohimbine is combined with PRX-08066.,increase,risk
PRX-08066,Zaleplon,The risk or severity of CNS depression can be increased when Zaleplon is combined with PRX-08066.,increase,risk
PRX-08066,Ziconotide,The risk or severity of CNS depression can be increased when PRX-08066 is combined with Ziconotide.,increase,risk
PRX-08066,Zimelidine,The risk or severity of adverse effects can be increased when PRX-08066 is combined with Zimelidine.,increase,risk
PRX-08066,Ziprasidone,The risk or severity of adverse effects can be increased when PRX-08066 is combined with Ziprasidone.,increase,risk
PRX-08066,Zolmitriptan,The risk or severity of CNS depression can be increased when Zolmitriptan is combined with PRX-08066.,increase,risk
PRX-08066,Zolpidem,PRX-08066 may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
PRX-08066,Zonisamide,The risk or severity of CNS depression can be increased when Zonisamide is combined with PRX-08066.,increase,risk
PRX-08066,Zopiclone,The risk or severity of adverse effects can be increased when PRX-08066 is combined with Zopiclone.,increase,risk
PRX-08066,Zotepine,The risk or severity of CNS depression can be increased when PRX-08066 is combined with Zotepine.,increase,risk
PRX-08066,Zuclopenthixol,The risk or severity of CNS depression can be increased when Zuclopenthixol is combined with PRX-08066.,increase,risk
PRX-08066,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with PRX-08066.,increase,risk
Elvitegravir,Galantamine,The metabolism of Galantamine can be decreased when combined with Elvitegravir.,decrease,no risk
Elvitegravir,Gefitinib,The metabolism of Gefitinib can be decreased when combined with Elvitegravir.,decrease,no risk
Elvitegravir,Gemfibrozil,The metabolism of Gemfibrozil can be decreased when combined with Elvitegravir.,decrease,no risk
Elvitegravir,Gepirone,The serum concentration of Gepirone can be increased when it is combined with Elvitegravir.,increase,no risk
Elvitegravir,Gestrinone,The serum concentration of Gestrinone can be decreased when it is combined with Elvitegravir.,decrease,no risk
Elvitegravir,Gilteritinib,The metabolism of Gilteritinib can be decreased when combined with Elvitegravir.,decrease,no risk
Elvitegravir,Glasdegib,The serum concentration of Glasdegib can be increased when it is combined with Elvitegravir.,increase,no risk
Elvitegravir,Glecaprevir,The metabolism of Elvitegravir can be decreased when combined with Glecaprevir.,decrease,no risk
Elvitegravir,Glofitamab,The serum concentration of Elvitegravir can be increased when it is combined with Glofitamab.,increase,no risk
Elvitegravir,Glyburide,The metabolism of Glyburide can be decreased when combined with Elvitegravir.,decrease,no risk
Elvitegravir,Granisetron,The metabolism of Granisetron can be decreased when combined with Elvitegravir.,decrease,no risk
Elvitegravir,Grazoprevir,The metabolism of Grazoprevir can be decreased when combined with Elvitegravir.,decrease,no risk
Elvitegravir,Grepafloxacin,The metabolism of Grepafloxacin can be decreased when combined with Elvitegravir.,decrease,no risk
Elvitegravir,Guanfacine,The metabolism of Guanfacine can be decreased when combined with Elvitegravir.,decrease,no risk
Elvitegravir,Halofantrine,The metabolism of Halofantrine can be decreased when combined with Elvitegravir.,decrease,no risk
Elvitegravir,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Elvitegravir.,increase,no risk
Elvitegravir,Human adenovirus e serotype 4 strain cl-68578 antigen,The therapeutic efficacy of Human adenovirus e serotype 4 strain cl-68578 antigen can be decreased when used in combination with Elvitegravir.,decrease,no risk
Elvitegravir,Hydrocodone,The metabolism of Hydrocodone can be decreased when combined with Elvitegravir.,decrease,no risk
Elvitegravir,Hydrocortisone,The metabolism of Hydrocortisone can be decreased when combined with Elvitegravir.,decrease,no risk
Elvitegravir,Hydrocortisone acetate,The metabolism of Hydrocortisone acetate can be decreased when combined with Elvitegravir.,decrease,no risk
Elvitegravir,Hydrocortisone butyrate,The metabolism of Hydrocortisone butyrate can be decreased when combined with Elvitegravir.,decrease,no risk
Elvitegravir,Hydrocortisone cypionate,The metabolism of Hydrocortisone cypionate can be decreased when combined with Elvitegravir.,decrease,no risk
Elvitegravir,Hydrocortisone phosphate,The metabolism of Hydrocortisone phosphate can be decreased when combined with Elvitegravir.,decrease,no risk
Elvitegravir,Hydrocortisone succinate,The metabolism of Hydrocortisone succinate can be decreased when combined with Elvitegravir.,decrease,no risk
Elvitegravir,Hydrotalcite,Hydrotalcite can cause a decrease in the absorption of Elvitegravir resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Elvitegravir,Hydroxychloroquine,The metabolism of Hydroxychloroquine can be decreased when combined with Elvitegravir.,decrease,no risk
Elvitegravir,Hydroxyprogesterone caproate,The serum concentration of Hydroxyprogesterone caproate can be decreased when it is combined with Elvitegravir.,decrease,no risk
Elvitegravir,Hydroxyzine,The metabolism of Hydroxyzine can be decreased when combined with Elvitegravir.,decrease,no risk
Elvitegravir,Ketamine,The metabolism of Ketamine can be decreased when combined with Elvitegravir.,decrease,no risk
Elvitegravir,Ketazolam,The metabolism of Ketazolam can be decreased when combined with Elvitegravir.,decrease,no risk
Elvitegravir,Ketoconazole,The serum concentration of Elvitegravir can be increased when it is combined with Ketoconazole.,increase,no risk
Elvitegravir,Nabilone,The metabolism of Nabilone can be decreased when combined with Elvitegravir.,decrease,no risk
Elvitegravir,Naloxegol,The metabolism of Naloxegol can be decreased when combined with Elvitegravir.,decrease,no risk
Elvitegravir,Nateglinide,The metabolism of Nateglinide can be decreased when combined with Elvitegravir.,decrease,no risk
Elvitegravir,Nebivolol,The metabolism of Nebivolol can be decreased when combined with Elvitegravir.,decrease,no risk
Elvitegravir,Nefazodone,The metabolism of Elvitegravir can be decreased when combined with Nefazodone.,decrease,no risk
Elvitegravir,Nelfinavir,The metabolism of Elvitegravir can be decreased when combined with Nelfinavir.,decrease,no risk
Elvitegravir,Neratinib,The serum concentration of Neratinib can be increased when it is combined with Elvitegravir.,increase,no risk
Elvitegravir,Netupitant,The metabolism of Netupitant can be decreased when combined with Elvitegravir.,decrease,no risk
Elvitegravir,Nevirapine,The metabolism of Nevirapine can be decreased when combined with Elvitegravir.,decrease,no risk
Elvitegravir,Nicardipine,The metabolism of Nicardipine can be decreased when combined with Elvitegravir.,decrease,no risk
Elvitegravir,Nicergoline,The serum concentration of Nicergoline can be increased when it is combined with Elvitegravir.,increase,no risk
Elvitegravir,Nifedipine,The metabolism of Nifedipine can be decreased when combined with Elvitegravir.,decrease,no risk
Elvitegravir,Nilotinib,The metabolism of Nilotinib can be decreased when combined with Elvitegravir.,decrease,no risk
Elvitegravir,Nilvadipine,The metabolism of Nilvadipine can be decreased when combined with Elvitegravir.,decrease,no risk
Elvitegravir,Nimesulide,The metabolism of Nimesulide can be decreased when combined with Elvitegravir.,decrease,no risk
Elvitegravir,Nimodipine,The metabolism of Nimodipine can be decreased when combined with Elvitegravir.,decrease,no risk
Elvitegravir,Nintedanib,The metabolism of Nintedanib can be decreased when combined with Elvitegravir.,decrease,no risk
Elvitegravir,Nirmatrelvir,The metabolism of Nirmatrelvir can be decreased when combined with Elvitegravir.,decrease,no risk
Elvitegravir,Nirogacestat,The serum concentration of Nirogacestat can be increased when it is combined with Elvitegravir.,increase,no risk
Elvitegravir,Nisoldipine,The metabolism of Nisoldipine can be decreased when combined with Elvitegravir.,decrease,no risk
Elvitegravir,Nitrazepam,The metabolism of Nitrazepam can be decreased when combined with Elvitegravir.,decrease,no risk
Elvitegravir,Nitrendipine,The metabolism of Nitrendipine can be decreased when combined with Elvitegravir.,decrease,no risk
Elvitegravir,Nomegestrol,The serum concentration of Nomegestrol can be decreased when it is combined with Elvitegravir.,decrease,no risk
Elvitegravir,Nomegestrol acetate,The serum concentration of Nomegestrol acetate can be decreased when it is combined with Elvitegravir.,decrease,no risk
Elvitegravir,Norelgestromin,The serum concentration of Norelgestromin can be decreased when it is combined with Elvitegravir.,decrease,no risk
Elvitegravir,Norethisterone,The serum concentration of Norethisterone can be decreased when it is combined with Elvitegravir.,decrease,no risk
Elvitegravir,Norethynodrel,The serum concentration of Norethynodrel can be decreased when it is combined with Elvitegravir.,decrease,no risk
Elvitegravir,Norgestimate,The serum concentration of Norgestimate can be decreased when it is combined with Elvitegravir.,decrease,no risk
Elvitegravir,Norgestrel,The serum concentration of Norgestrel can be decreased when it is combined with Elvitegravir.,decrease,no risk
Elvitegravir,Nortriptyline,The metabolism of Nortriptyline can be decreased when combined with Elvitegravir.,decrease,no risk
Elvitegravir,Nylidrin,The metabolism of Nylidrin can be decreased when combined with Elvitegravir.,decrease,no risk
Elvitegravir,Olaparib,The metabolism of Olaparib can be decreased when combined with Elvitegravir.,decrease,no risk
Elvitegravir,Oliceridine,The serum concentration of Oliceridine can be increased when it is combined with Elvitegravir.,increase,no risk
Elvitegravir,Olutasidenib,The metabolism of Olutasidenib can be decreased when combined with Elvitegravir.,decrease,no risk
Elvitegravir,Omaveloxolone,The serum concentration of Omaveloxolone can be increased when it is combined with Elvitegravir.,increase,no risk
Elvitegravir,Ombitasvir,The metabolism of Elvitegravir can be decreased when combined with Ombitasvir.,decrease,no risk
Elvitegravir,Ondansetron,The metabolism of Ondansetron can be decreased when combined with Elvitegravir.,decrease,no risk
Elvitegravir,Opium,The metabolism of Opium can be decreased when combined with Elvitegravir.,decrease,no risk
Elvitegravir,Orphenadrine,The metabolism of Orphenadrine can be decreased when combined with Elvitegravir.,decrease,no risk
Elvitegravir,Osilodrostat,The serum concentration of Osilodrostat can be increased when it is combined with Elvitegravir.,increase,no risk
Elvitegravir,Osimertinib,The metabolism of Osimertinib can be decreased when combined with Elvitegravir.,decrease,no risk
Elvitegravir,Ospemifene,The metabolism of Ospemifene can be decreased when combined with Elvitegravir.,decrease,no risk
Elvitegravir,Oxybutynin,The metabolism of Oxybutynin can be decreased when combined with Elvitegravir.,decrease,no risk
Elvitegravir,Oxycodone,The metabolism of Oxycodone can be decreased when combined with Elvitegravir.,decrease,no risk
Elvitegravir,Oxymorphone,The metabolism of Oxymorphone can be decreased when combined with Elvitegravir.,decrease,no risk
Elvitegravir,Quazepam,The metabolism of Quazepam can be decreased when combined with Elvitegravir.,decrease,no risk
Elvitegravir,Quetiapine,The serum concentration of Quetiapine can be increased when it is combined with Elvitegravir.,increase,no risk
Elvitegravir,Quinidine,The metabolism of Quinidine can be decreased when combined with Elvitegravir.,decrease,no risk
Elvitegravir,Quinine,The metabolism of Quinine can be decreased when combined with Elvitegravir.,decrease,no risk
Elvitegravir,Quizartinib,The serum concentration of Quizartinib can be increased when it is combined with Elvitegravir.,increase,no risk
Elvitegravir,Ubrogepant,The serum concentration of Ubrogepant can be increased when it is combined with Elvitegravir.,increase,no risk
Elvitegravir,Udenafil,The metabolism of Udenafil can be decreased when combined with Elvitegravir.,decrease,no risk
Elvitegravir,Ulipristal,The serum concentration of Ulipristal can be decreased when it is combined with Elvitegravir.,decrease,no risk
Elvitegravir,Upadacitinib,The metabolism of Upadacitinib can be decreased when combined with Elvitegravir.,decrease,no risk
Elvitegravir,Vadadustat,The serum concentration of Elvitegravir can be increased when it is combined with Vadadustat.,increase,no risk
Elvitegravir,Valbenazine,The serum concentration of Valbenazine can be increased when it is combined with Elvitegravir.,increase,no risk
Elvitegravir,Valdecoxib,The metabolism of Valdecoxib can be decreased when combined with Elvitegravir.,decrease,no risk
Elvitegravir,Valproic acid,The metabolism of Elvitegravir can be decreased when combined with Valproic acid.,decrease,no risk
Elvitegravir,Vamorolone,The serum concentration of Vamorolone can be increased when it is combined with Elvitegravir.,increase,no risk
Elvitegravir,Vandetanib,The metabolism of Vandetanib can be decreased when combined with Elvitegravir.,decrease,no risk
Elvitegravir,Vardenafil,The metabolism of Vardenafil can be decreased when combined with Elvitegravir.,decrease,no risk
Elvitegravir,Varicella zoster vaccine (live/attenuated),The therapeutic efficacy of Varicella zoster vaccine (live/attenuated) can be decreased when used in combination with Elvitegravir.,decrease,no risk
Elvitegravir,Velpatasvir,The metabolism of Velpatasvir can be decreased when combined with Elvitegravir.,decrease,no risk
Elvitegravir,Vemurafenib,The metabolism of Vemurafenib can be decreased when combined with Elvitegravir.,decrease,no risk
Elvitegravir,Venetoclax,The metabolism of Venetoclax can be decreased when combined with Elvitegravir.,decrease,no risk
Elvitegravir,Venlafaxine,The metabolism of Venlafaxine can be decreased when combined with Elvitegravir.,decrease,no risk
Elvitegravir,Verapamil,The metabolism of Verapamil can be decreased when combined with Elvitegravir.,decrease,no risk
Elvitegravir,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Elvitegravir.,decrease,no risk
Elvitegravir,Vilanterol,The serum concentration of Vilanterol can be increased when it is combined with Elvitegravir.,increase,no risk
Elvitegravir,Vilazodone,The metabolism of Vilazodone can be decreased when combined with Elvitegravir.,decrease,no risk
Elvitegravir,Viloxazine,The metabolism of Elvitegravir can be decreased when combined with Viloxazine.,decrease,no risk
Elvitegravir,Vinblastine,The metabolism of Vinblastine can be decreased when combined with Elvitegravir.,decrease,no risk
Elvitegravir,Vincristine,The metabolism of Vincristine can be decreased when combined with Elvitegravir.,decrease,no risk
Elvitegravir,Vindesine,The metabolism of Vindesine can be decreased when combined with Elvitegravir.,decrease,no risk
Elvitegravir,Vinflunine,The metabolism of Vinflunine can be decreased when combined with Elvitegravir.,decrease,no risk
Elvitegravir,Vinorelbine,The metabolism of Vinorelbine can be decreased when combined with Elvitegravir.,decrease,no risk
Elvitegravir,Vitamin D,The metabolism of Vitamin D can be decreased when combined with Elvitegravir.,decrease,no risk
Elvitegravir,Vitamin E,The metabolism of Vitamin E can be decreased when combined with Elvitegravir.,decrease,no risk
Elvitegravir,Voclosporin,The metabolism of Voclosporin can be decreased when combined with Elvitegravir.,decrease,no risk
Elvitegravir,Vonoprazan,The metabolism of Vonoprazan can be decreased when combined with Elvitegravir.,decrease,no risk
Elvitegravir,Vorapaxar,The metabolism of Vorapaxar can be decreased when combined with Elvitegravir.,decrease,no risk
Elvitegravir,Voriconazole,The metabolism of Elvitegravir can be decreased when combined with Voriconazole.,decrease,no risk
Elvitegravir,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Elvitegravir.,decrease,no risk
Elvitegravir,Voxelotor,The serum concentration of Voxelotor can be increased when it is combined with Elvitegravir.,increase,no risk
Elvitegravir,Voxilaprevir,The metabolism of Voxilaprevir can be decreased when combined with Elvitegravir.,decrease,no risk
Elvitegravir,Warfarin,The serum concentration of Warfarin can be decreased when it is combined with Elvitegravir.,decrease,no risk
Elvitegravir,Yellow fever vaccine,The therapeutic efficacy of Yellow fever vaccine can be decreased when used in combination with Elvitegravir.,decrease,no risk
Elvitegravir,Yohimbine,The metabolism of Yohimbine can be decreased when combined with Elvitegravir.,decrease,no risk
Elvitegravir,Zaleplon,The metabolism of Zaleplon can be decreased when combined with Elvitegravir.,decrease,no risk
Elvitegravir,Zanubrutinib,The metabolism of Zanubrutinib can be decreased when combined with Elvitegravir.,decrease,no risk
Elvitegravir,Zidovudine,The metabolism of Zidovudine can be decreased when combined with Elvitegravir.,decrease,no risk
Elvitegravir,Zileuton,The metabolism of Zileuton can be decreased when combined with Elvitegravir.,decrease,no risk
Elvitegravir,Zimelidine,The metabolism of Elvitegravir can be decreased when combined with Zimelidine.,decrease,no risk
Elvitegravir,Ziprasidone,The metabolism of Ziprasidone can be decreased when combined with Elvitegravir.,decrease,no risk
Elvitegravir,Zolpidem,The metabolism of Zolpidem can be decreased when combined with Elvitegravir.,decrease,no risk
Elvitegravir,Zonisamide,The metabolism of Zonisamide can be decreased when combined with Elvitegravir.,decrease,no risk
Elvitegravir,Zopiclone,The metabolism of Zopiclone can be decreased when combined with Elvitegravir.,decrease,no risk
Elvitegravir,Zotepine,The metabolism of Zotepine can be decreased when combined with Elvitegravir.,decrease,no risk
Elvitegravir,Zuclopenthixol,The metabolism of Zuclopenthixol can be decreased when combined with Elvitegravir.,decrease,no risk
Elvitegravir,Zuranolone,The serum concentration of Zuranolone can be increased when it is combined with Elvitegravir.,increase,no risk
Mocetinostat,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Gadobenic acid is combined with Mocetinostat.,increase,risk
Mocetinostat,Galantamine,The risk or severity of QTc prolongation can be increased when Galantamine is combined with Mocetinostat.,increase,risk
Mocetinostat,Gatifloxacin,The risk or severity of QTc prolongation can be increased when Gatifloxacin is combined with Mocetinostat.,increase,risk
Mocetinostat,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Gemifloxacin is combined with Mocetinostat.,increase,risk
Mocetinostat,Gepirone,The risk or severity of QTc prolongation can be increased when Gepirone is combined with Mocetinostat.,increase,risk
Mocetinostat,Gilteritinib,The risk or severity of QTc prolongation can be increased when Mocetinostat is combined with Gilteritinib.,increase,risk
Mocetinostat,Glasdegib,The risk or severity of QTc prolongation can be increased when Mocetinostat is combined with Glasdegib.,increase,risk
Mocetinostat,Goserelin,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Mocetinostat.,increase,risk
Mocetinostat,Granisetron,The risk or severity of QTc prolongation can be increased when Granisetron is combined with Mocetinostat.,increase,risk
Mocetinostat,Grepafloxacin,The risk or severity of QTc prolongation can be increased when Mocetinostat is combined with Grepafloxacin.,increase,risk
Mocetinostat,Halofantrine,The risk or severity of QTc prolongation can be increased when Mocetinostat is combined with Halofantrine.,increase,risk
Mocetinostat,Haloperidol,The risk or severity of QTc prolongation can be increased when Mocetinostat is combined with Haloperidol.,increase,risk
Mocetinostat,Histrelin,The risk or severity of QTc prolongation can be increased when Histrelin is combined with Mocetinostat.,increase,risk
Mocetinostat,Hydrochlorothiazide,The risk or severity of QTc prolongation can be increased when Hydrochlorothiazide is combined with Mocetinostat.,increase,risk
Mocetinostat,Hydroxychloroquine,The risk or severity of QTc prolongation can be increased when Hydroxychloroquine is combined with Mocetinostat.,increase,risk
Mocetinostat,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Mocetinostat is combined with Hydroxyzine.,increase,risk
Mocetinostat,Hyoscyamine,The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Mocetinostat.,increase,risk
Mocetinostat,Ketoconazole,The risk or severity of QTc prolongation can be increased when Ketoconazole is combined with Mocetinostat.,increase,risk
Mocetinostat,Nalidixic acid,The risk or severity of QTc prolongation can be increased when Nalidixic acid is combined with Mocetinostat.,increase,risk
Mocetinostat,Nelarabine,The risk or severity of adverse effects can be increased when Nelarabine is combined with Mocetinostat.,increase,risk
Mocetinostat,Nelfinavir,The risk or severity of QTc prolongation can be increased when Nelfinavir is combined with Mocetinostat.,increase,risk
Mocetinostat,Nicardipine,The risk or severity of QTc prolongation can be increased when Nicardipine is combined with Mocetinostat.,increase,risk
Mocetinostat,Nifedipine,The risk or severity of QTc prolongation can be increased when Nifedipine is combined with Mocetinostat.,increase,risk
Mocetinostat,Nilotinib,The risk or severity of QTc prolongation can be increased when Mocetinostat is combined with Nilotinib.,increase,risk
Mocetinostat,Nilvadipine,The risk or severity of QTc prolongation can be increased when Nilvadipine is combined with Mocetinostat.,increase,risk
Mocetinostat,Nimodipine,The risk or severity of QTc prolongation can be increased when Nimodipine is combined with Mocetinostat.,increase,risk
Mocetinostat,Nitrendipine,The risk or severity of QTc prolongation can be increased when Nitrendipine is combined with Mocetinostat.,increase,risk
Mocetinostat,Norfloxacin,The risk or severity of QTc prolongation can be increased when Norfloxacin is combined with Mocetinostat.,increase,risk
Mocetinostat,Nortriptyline,The risk or severity of QTc prolongation can be increased when Nortriptyline is combined with Mocetinostat.,increase,risk
Mocetinostat,Octreotide,The risk or severity of QTc prolongation can be increased when Octreotide is combined with Mocetinostat.,increase,risk
Mocetinostat,Ofloxacin,The risk or severity of QTc prolongation can be increased when Ofloxacin is combined with Mocetinostat.,increase,risk
Mocetinostat,Olanzapine,The risk or severity of QTc prolongation can be increased when Olanzapine is combined with Mocetinostat.,increase,risk
Mocetinostat,Olodaterol,The risk or severity of QTc prolongation can be increased when Olodaterol is combined with Mocetinostat.,increase,risk
Mocetinostat,Ondansetron,The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Mocetinostat.,increase,risk
Mocetinostat,Orphenadrine,The risk or severity of QTc prolongation can be increased when Orphenadrine is combined with Mocetinostat.,increase,risk
Mocetinostat,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Mocetinostat.,increase,risk
Mocetinostat,Oxatomide,The risk or severity of QTc prolongation can be increased when Mocetinostat is combined with Oxatomide.,increase,risk
Mocetinostat,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Mocetinostat is combined with Oxetacaine.,increase,risk
Mocetinostat,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Mocetinostat is combined with Oxybuprocaine.,increase,risk
Mocetinostat,Oxytocin,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Mocetinostat.,increase,risk
Mocetinostat,Quetiapine,The risk or severity of QTc prolongation can be increased when Quetiapine is combined with Mocetinostat.,increase,risk
Mocetinostat,Quinidine,The risk or severity of QTc prolongation can be increased when Mocetinostat is combined with Quinidine.,increase,risk
Mocetinostat,Quinine,The risk or severity of QTc prolongation can be increased when Mocetinostat is combined with Quinine.,increase,risk
Mocetinostat,Quizartinib,The risk or severity of QTc prolongation can be increased when Mocetinostat is combined with Quizartinib.,increase,risk
Mocetinostat,Valproic acid,The risk or severity of QTc prolongation can be increased when Mocetinostat is combined with Valproic acid.,increase,risk
Mocetinostat,Vandetanib,The risk or severity of QTc prolongation can be increased when Mocetinostat is combined with Vandetanib.,increase,risk
Mocetinostat,Vardenafil,The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Mocetinostat.,increase,risk
Mocetinostat,Vemurafenib,The risk or severity of QTc prolongation can be increased when Mocetinostat is combined with Vemurafenib.,increase,risk
Mocetinostat,Vernakalant,The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Mocetinostat.,increase,risk
Mocetinostat,Vilanterol,The risk or severity of QTc prolongation and ventricular arrhythmias can be increased when Vilanterol is combined with Mocetinostat.,increase,risk
Mocetinostat,Voriconazole,The risk or severity of QTc prolongation can be increased when Voriconazole is combined with Mocetinostat.,increase,risk
Mocetinostat,Vorinostat,The risk or severity of gastrointestinal bleeding and thrombocytopenia can be increased when Mocetinostat is combined with Vorinostat.,increase,risk
Mocetinostat,Ziprasidone,The risk or severity of QTc prolongation can be increased when Mocetinostat is combined with Ziprasidone.,increase,risk
Mocetinostat,Zonisamide,The risk or severity of QTc prolongation can be increased when Zonisamide is combined with Mocetinostat.,increase,risk
Mocetinostat,Zuclopenthixol,The risk or severity of QTc prolongation can be increased when Mocetinostat is combined with Zuclopenthixol.,increase,risk
Sagopilone,Gepirone,The serum concentration of Gepirone can be increased when it is combined with Sagopilone.,increase,no risk
Sagopilone,Gilteritinib,The metabolism of Gilteritinib can be decreased when combined with Sagopilone.,decrease,no risk
Sagopilone,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Sagopilone.,increase,no risk
Sagopilone,Hydrocortisone,The serum concentration of Hydrocortisone can be increased when it is combined with Sagopilone.,increase,no risk
Sagopilone,Nelarabine,The risk or severity of adverse effects can be increased when Nelarabine is combined with Sagopilone.,increase,risk
Sagopilone,Neratinib,The serum concentration of Neratinib can be increased when it is combined with Sagopilone.,increase,no risk
Sagopilone,Netupitant,The metabolism of Netupitant can be decreased when combined with Sagopilone.,decrease,no risk
Sagopilone,Nicergoline,The serum concentration of Nicergoline can be increased when it is combined with Sagopilone.,increase,no risk
Sagopilone,Nilotinib,The serum concentration of Nilotinib can be increased when it is combined with Sagopilone.,increase,no risk
Sagopilone,Nintedanib,The metabolism of Nintedanib can be decreased when combined with Sagopilone.,decrease,no risk
Sagopilone,Norethisterone,The metabolism of Norethisterone can be decreased when combined with Sagopilone.,decrease,no risk
Sagopilone,Nortriptyline,The serum concentration of Nortriptyline can be increased when it is combined with Sagopilone.,increase,no risk
Sagopilone,Olaparib,The serum concentration of Olaparib can be increased when it is combined with Sagopilone.,increase,no risk
Sagopilone,Osimertinib,The serum concentration of Osimertinib can be increased when it is combined with Sagopilone.,increase,no risk
Sagopilone,Ouabain,The serum concentration of Ouabain can be increased when it is combined with Sagopilone.,increase,no risk
Sagopilone,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Sagopilone is combined with Oxetacaine.,increase,risk
Sagopilone,Oxtriphylline,The metabolism of Oxtriphylline can be decreased when combined with Sagopilone.,decrease,no risk
Sagopilone,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Sagopilone is combined with Oxybuprocaine.,increase,risk
Sagopilone,Quinidine,The serum concentration of Quinidine can be increased when it is combined with Sagopilone.,increase,no risk
Sagopilone,Quinine,The serum concentration of Quinine can be increased when it is combined with Sagopilone.,increase,no risk
Sagopilone,Vandetanib,The serum concentration of Vandetanib can be increased when it is combined with Sagopilone.,increase,no risk
Sagopilone,Vardenafil,The metabolism of Vardenafil can be decreased when combined with Sagopilone.,decrease,no risk
Sagopilone,Vemurafenib,The serum concentration of Vemurafenib can be increased when it is combined with Sagopilone.,increase,no risk
Sagopilone,Venetoclax,The serum concentration of Venetoclax can be increased when it is combined with Sagopilone.,increase,no risk
Sagopilone,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Sagopilone.,decrease,no risk
Sagopilone,Vinblastine,The serum concentration of Vinblastine can be increased when it is combined with Sagopilone.,increase,no risk
Sagopilone,Vincristine,The serum concentration of Vincristine can be increased when it is combined with Sagopilone.,increase,no risk
Sagopilone,Vindesine,The serum concentration of Vindesine can be increased when it is combined with Sagopilone.,increase,no risk
Sagopilone,Vinflunine,The serum concentration of Vinflunine can be increased when it is combined with Sagopilone.,increase,no risk
Sagopilone,Vinorelbine,The serum concentration of Vinorelbine can be increased when it is combined with Sagopilone.,increase,no risk
Sagopilone,Vorapaxar,The metabolism of Vorapaxar can be decreased when combined with Sagopilone.,decrease,no risk
Sagopilone,Voxelotor,The serum concentration of Voxelotor can be increased when it is combined with Sagopilone.,increase,no risk
Sagopilone,Warfarin,The serum concentration of Warfarin can be increased when it is combined with Sagopilone.,increase,no risk
Sagopilone,Zanubrutinib,The serum concentration of Zanubrutinib can be increased when it is combined with Sagopilone.,increase,no risk
Sagopilone,Ziprasidone,The metabolism of Ziprasidone can be decreased when combined with Sagopilone.,decrease,no risk
Sagopilone,Zopiclone,The metabolism of Zopiclone can be decreased when combined with Sagopilone.,decrease,no risk
Sagopilone,Zuclopenthixol,The metabolism of Zuclopenthixol can be decreased when combined with Sagopilone.,decrease,no risk
Veltuzumab,Human varicella-zoster immune globulin,The risk or severity of adverse effects can be increased when Veltuzumab is combined with Human varicella-zoster immune globulin.,increase,risk
Veltuzumab,Natalizumab,The risk or severity of adverse effects can be increased when Natalizumab is combined with Veltuzumab.,increase,risk
Veltuzumab,Necitumumab,The risk or severity of adverse effects can be increased when Veltuzumab is combined with Necitumumab.,increase,risk
Veltuzumab,Nelarabine,The risk or severity of adverse effects can be increased when Nelarabine is combined with Veltuzumab.,increase,risk
Veltuzumab,Nivolumab,The risk or severity of adverse effects can be increased when Veltuzumab is combined with Nivolumab.,increase,risk
Veltuzumab,Obiltoxaximab,The risk or severity of adverse effects can be increased when Obiltoxaximab is combined with Veltuzumab.,increase,risk
Veltuzumab,Obinutuzumab,The risk or severity of adverse effects can be increased when Veltuzumab is combined with Obinutuzumab.,increase,risk
Veltuzumab,Ocrelizumab,The risk or severity of adverse effects can be increased when Veltuzumab is combined with Ocrelizumab.,increase,risk
Veltuzumab,Odesivimab,The risk or severity of adverse effects can be increased when Veltuzumab is combined with Odesivimab.,increase,risk
Veltuzumab,Ofatumumab,The risk or severity of adverse effects can be increased when Veltuzumab is combined with Ofatumumab.,increase,risk
Veltuzumab,Olaratumab,The risk or severity of adverse effects can be increased when Veltuzumab is combined with Olaratumab.,increase,risk
Veltuzumab,Omalizumab,The risk or severity of adverse effects can be increased when Omalizumab is combined with Veltuzumab.,increase,risk
Veltuzumab,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Veltuzumab is combined with Oxetacaine.,increase,risk
Veltuzumab,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Veltuzumab is combined with Oxybuprocaine.,increase,risk
Veltuzumab,Quinestrol,Quinestrol may increase the thrombogenic activities of Veltuzumab.,increase,no risk
Veltuzumab,Ublituximab,The risk or severity of adverse effects can be increased when Veltuzumab is combined with Ublituximab.,increase,risk
Veltuzumab,Ustekinumab,The risk or severity of adverse effects can be increased when Veltuzumab is combined with Ustekinumab.,increase,risk
Veltuzumab,Vedolizumab,The risk or severity of adverse effects can be increased when Veltuzumab is combined with Vedolizumab.,increase,risk
Boceprevir,Galantamine,The metabolism of Galantamine can be decreased when combined with Boceprevir.,decrease,no risk
Boceprevir,Gefitinib,The metabolism of Gefitinib can be decreased when combined with Boceprevir.,decrease,no risk
Boceprevir,Gemfibrozil,The metabolism of Gemfibrozil can be decreased when combined with Boceprevir.,decrease,no risk
Boceprevir,Gepirone,The serum concentration of Gepirone can be increased when it is combined with Boceprevir.,increase,no risk
Boceprevir,Gestrinone,The serum concentration of Gestrinone can be increased when it is combined with Boceprevir.,increase,no risk
Boceprevir,Gilteritinib,The metabolism of Gilteritinib can be decreased when combined with Boceprevir.,decrease,no risk
Boceprevir,Glasdegib,The serum concentration of Glasdegib can be increased when it is combined with Boceprevir.,increase,no risk
Boceprevir,Glofitamab,The serum concentration of Boceprevir can be increased when it is combined with Glofitamab.,increase,no risk
Boceprevir,Glyburide,The metabolism of Glyburide can be decreased when combined with Boceprevir.,decrease,no risk
Boceprevir,Golimumab,The metabolism of Boceprevir can be increased when combined with Golimumab.,increase,no risk
Boceprevir,Granisetron,The metabolism of Granisetron can be decreased when combined with Boceprevir.,decrease,no risk
Boceprevir,Grazoprevir,The metabolism of Grazoprevir can be decreased when combined with Boceprevir.,decrease,no risk
Boceprevir,Grepafloxacin,The metabolism of Grepafloxacin can be decreased when combined with Boceprevir.,decrease,no risk
Boceprevir,Guanfacine,The metabolism of Guanfacine can be decreased when combined with Boceprevir.,decrease,no risk
Boceprevir,Halofantrine,The metabolism of Halofantrine can be decreased when combined with Boceprevir.,decrease,no risk
Boceprevir,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Boceprevir.,increase,no risk
Boceprevir,Human adenovirus e serotype 4 strain cl-68578 antigen,The therapeutic efficacy of Human adenovirus e serotype 4 strain cl-68578 antigen can be decreased when used in combination with Boceprevir.,decrease,no risk
Boceprevir,Hydrocodone,The metabolism of Hydrocodone can be decreased when combined with Boceprevir.,decrease,no risk
Boceprevir,Hydrocortisone,The metabolism of Hydrocortisone can be decreased when combined with Boceprevir.,decrease,no risk
Boceprevir,Hydrocortisone acetate,The metabolism of Hydrocortisone acetate can be decreased when combined with Boceprevir.,decrease,no risk
Boceprevir,Hydrocortisone butyrate,The metabolism of Hydrocortisone butyrate can be decreased when combined with Boceprevir.,decrease,no risk
Boceprevir,Hydrocortisone cypionate,The metabolism of Hydrocortisone cypionate can be decreased when combined with Boceprevir.,decrease,no risk
Boceprevir,Hydrocortisone phosphate,The metabolism of Hydrocortisone phosphate can be decreased when combined with Boceprevir.,decrease,no risk
Boceprevir,Hydrocortisone succinate,The metabolism of Hydrocortisone succinate can be decreased when combined with Boceprevir.,decrease,no risk
Boceprevir,Hydroxychloroquine,The metabolism of Hydroxychloroquine can be decreased when combined with Boceprevir.,decrease,no risk
Boceprevir,Hydroxyprogesterone caproate,The serum concentration of Hydroxyprogesterone caproate can be increased when it is combined with Boceprevir.,increase,no risk
Boceprevir,Hydroxyzine,The metabolism of Hydroxyzine can be decreased when combined with Boceprevir.,decrease,no risk
Boceprevir,Ketamine,The metabolism of Ketamine can be decreased when combined with Boceprevir.,decrease,no risk
Boceprevir,Ketazolam,The metabolism of Ketazolam can be decreased when combined with Boceprevir.,decrease,no risk
Boceprevir,Ketoconazole,The serum concentration of Boceprevir can be increased when it is combined with Ketoconazole.,increase,no risk
Boceprevir,Nabilone,The metabolism of Nabilone can be decreased when combined with Boceprevir.,decrease,no risk
Boceprevir,Naloxegol,The metabolism of Naloxegol can be decreased when combined with Boceprevir.,decrease,no risk
Boceprevir,Nateglinide,The metabolism of Nateglinide can be decreased when combined with Boceprevir.,decrease,no risk
Boceprevir,Nebivolol,The metabolism of Nebivolol can be decreased when combined with Boceprevir.,decrease,no risk
Boceprevir,Nefazodone,The metabolism of Boceprevir can be decreased when combined with Nefazodone.,decrease,no risk
Boceprevir,Nelfinavir,The metabolism of Boceprevir can be decreased when combined with Nelfinavir.,decrease,no risk
Boceprevir,Neratinib,The serum concentration of Neratinib can be increased when it is combined with Boceprevir.,increase,no risk
Boceprevir,Netupitant,The metabolism of Netupitant can be decreased when combined with Boceprevir.,decrease,no risk
Boceprevir,Nevirapine,The metabolism of Nevirapine can be decreased when combined with Boceprevir.,decrease,no risk
Boceprevir,Nicardipine,The serum concentration of Nicardipine can be increased when it is combined with Boceprevir.,increase,no risk
Boceprevir,Nicergoline,The risk or severity of adverse effects can be increased when Boceprevir is combined with Nicergoline.,increase,risk
Boceprevir,Nifedipine,The serum concentration of Nifedipine can be increased when it is combined with Boceprevir.,increase,no risk
Boceprevir,Nilotinib,The metabolism of Nilotinib can be decreased when combined with Boceprevir.,decrease,no risk
Boceprevir,Nilvadipine,The serum concentration of Nilvadipine can be increased when it is combined with Boceprevir.,increase,no risk
Boceprevir,Nimesulide,The serum concentration of Nimesulide can be increased when it is combined with Boceprevir.,increase,no risk
Boceprevir,Nimodipine,The serum concentration of Nimodipine can be increased when it is combined with Boceprevir.,increase,no risk
Boceprevir,Nintedanib,The metabolism of Nintedanib can be decreased when combined with Boceprevir.,decrease,no risk
Boceprevir,Nirmatrelvir,The metabolism of Nirmatrelvir can be decreased when combined with Boceprevir.,decrease,no risk
Boceprevir,Nirogacestat,The serum concentration of Nirogacestat can be increased when it is combined with Boceprevir.,increase,no risk
Boceprevir,Nisoldipine,The serum concentration of Nisoldipine can be increased when it is combined with Boceprevir.,increase,no risk
Boceprevir,Nitrazepam,The metabolism of Nitrazepam can be decreased when combined with Boceprevir.,decrease,no risk
Boceprevir,Nitrendipine,The serum concentration of Nitrendipine can be increased when it is combined with Boceprevir.,increase,no risk
Boceprevir,Nomegestrol,The serum concentration of Nomegestrol can be increased when it is combined with Boceprevir.,increase,no risk
Boceprevir,Nomegestrol acetate,The serum concentration of Nomegestrol acetate can be increased when it is combined with Boceprevir.,increase,no risk
Boceprevir,Norelgestromin,The serum concentration of Norelgestromin can be increased when it is combined with Boceprevir.,increase,no risk
Boceprevir,Norethisterone,The serum concentration of Norethisterone can be increased when it is combined with Boceprevir.,increase,no risk
Boceprevir,Norethynodrel,The serum concentration of Norethynodrel can be increased when it is combined with Boceprevir.,increase,no risk
Boceprevir,Norgestimate,The serum concentration of Norgestimate can be increased when it is combined with Boceprevir.,increase,no risk
Boceprevir,Norgestrel,The serum concentration of Norgestrel can be increased when it is combined with Boceprevir.,increase,no risk
Boceprevir,Nortriptyline,The metabolism of Nortriptyline can be decreased when combined with Boceprevir.,decrease,no risk
Boceprevir,Nylidrin,The serum concentration of Nylidrin can be increased when it is combined with Boceprevir.,increase,no risk
Boceprevir,Olaparib,The metabolism of Olaparib can be decreased when combined with Boceprevir.,decrease,no risk
Boceprevir,Oliceridine,The serum concentration of Oliceridine can be increased when it is combined with Boceprevir.,increase,no risk
Boceprevir,Olutasidenib,The metabolism of Olutasidenib can be decreased when combined with Boceprevir.,decrease,no risk
Boceprevir,Omaveloxolone,The serum concentration of Omaveloxolone can be increased when it is combined with Boceprevir.,increase,no risk
Boceprevir,Ondansetron,The metabolism of Ondansetron can be decreased when combined with Boceprevir.,decrease,no risk
Boceprevir,Opium,The metabolism of Opium can be decreased when combined with Boceprevir.,decrease,no risk
Boceprevir,Orphenadrine,The metabolism of Orphenadrine can be decreased when combined with Boceprevir.,decrease,no risk
Boceprevir,Osilodrostat,The serum concentration of Osilodrostat can be increased when it is combined with Boceprevir.,increase,no risk
Boceprevir,Osimertinib,The metabolism of Osimertinib can be decreased when combined with Boceprevir.,decrease,no risk
Boceprevir,Ospemifene,The metabolism of Ospemifene can be decreased when combined with Boceprevir.,decrease,no risk
Boceprevir,Oxcarbazepine,The metabolism of Boceprevir can be increased when combined with Oxcarbazepine.,increase,no risk
Boceprevir,Oxybutynin,The metabolism of Oxybutynin can be decreased when combined with Boceprevir.,decrease,no risk
Boceprevir,Oxycodone,The metabolism of Oxycodone can be decreased when combined with Boceprevir.,decrease,no risk
Boceprevir,Oxymorphone,The metabolism of Oxymorphone can be decreased when combined with Boceprevir.,decrease,no risk
Boceprevir,Quazepam,The metabolism of Quazepam can be decreased when combined with Boceprevir.,decrease,no risk
Boceprevir,Quetiapine,The serum concentration of Quetiapine can be increased when it is combined with Boceprevir.,increase,no risk
Boceprevir,Quinidine,The metabolism of Quinidine can be decreased when combined with Boceprevir.,decrease,no risk
Boceprevir,Quinine,The metabolism of Quinine can be decreased when combined with Boceprevir.,decrease,no risk
Boceprevir,Quizartinib,The serum concentration of Quizartinib can be increased when it is combined with Boceprevir.,increase,no risk
Boceprevir,Ubrogepant,The serum concentration of Ubrogepant can be increased when it is combined with Boceprevir.,increase,no risk
Boceprevir,Udenafil,The metabolism of Udenafil can be decreased when combined with Boceprevir.,decrease,no risk
Boceprevir,Ulipristal,The serum concentration of Ulipristal can be increased when it is combined with Boceprevir.,increase,no risk
Boceprevir,Upadacitinib,The metabolism of Upadacitinib can be decreased when combined with Boceprevir.,decrease,no risk
Boceprevir,Vadadustat,The serum concentration of Boceprevir can be increased when it is combined with Vadadustat.,increase,no risk
Boceprevir,Valbenazine,The serum concentration of Valbenazine can be increased when it is combined with Boceprevir.,increase,no risk
Boceprevir,Valdecoxib,The metabolism of Valdecoxib can be decreased when combined with Boceprevir.,decrease,no risk
Boceprevir,Vamorolone,The serum concentration of Vamorolone can be increased when it is combined with Boceprevir.,increase,no risk
Boceprevir,Vandetanib,The metabolism of Vandetanib can be decreased when combined with Boceprevir.,decrease,no risk
Boceprevir,Vardenafil,The metabolism of Vardenafil can be decreased when combined with Boceprevir.,decrease,no risk
Boceprevir,Varicella zoster vaccine (live/attenuated),The therapeutic efficacy of Varicella zoster vaccine (live/attenuated) can be decreased when used in combination with Boceprevir.,decrease,no risk
Boceprevir,Velpatasvir,The metabolism of Velpatasvir can be decreased when combined with Boceprevir.,decrease,no risk
Boceprevir,Vemurafenib,The metabolism of Vemurafenib can be decreased when combined with Boceprevir.,decrease,no risk
Boceprevir,Venetoclax,The metabolism of Venetoclax can be decreased when combined with Boceprevir.,decrease,no risk
Boceprevir,Venlafaxine,The metabolism of Venlafaxine can be decreased when combined with Boceprevir.,decrease,no risk
Boceprevir,Verapamil,The serum concentration of Verapamil can be increased when it is combined with Boceprevir.,increase,no risk
Boceprevir,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Boceprevir.,decrease,no risk
Boceprevir,Vilanterol,The serum concentration of Vilanterol can be increased when it is combined with Boceprevir.,increase,no risk
Boceprevir,Vilazodone,The metabolism of Vilazodone can be decreased when combined with Boceprevir.,decrease,no risk
Boceprevir,Viloxazine,The metabolism of Boceprevir can be decreased when combined with Viloxazine.,decrease,no risk
Boceprevir,Vinblastine,The metabolism of Vinblastine can be decreased when combined with Boceprevir.,decrease,no risk
Boceprevir,Vincristine,The metabolism of Vincristine can be decreased when combined with Boceprevir.,decrease,no risk
Boceprevir,Vindesine,The metabolism of Vindesine can be decreased when combined with Boceprevir.,decrease,no risk
Boceprevir,Vinflunine,The metabolism of Vinflunine can be decreased when combined with Boceprevir.,decrease,no risk
Boceprevir,Vinorelbine,The metabolism of Vinorelbine can be decreased when combined with Boceprevir.,decrease,no risk
Boceprevir,Vitamin D,The metabolism of Vitamin D can be decreased when combined with Boceprevir.,decrease,no risk
Boceprevir,Vitamin E,The metabolism of Vitamin E can be decreased when combined with Boceprevir.,decrease,no risk
Boceprevir,Voclosporin,The metabolism of Voclosporin can be decreased when combined with Boceprevir.,decrease,no risk
Boceprevir,Vonoprazan,The metabolism of Vonoprazan can be decreased when combined with Boceprevir.,decrease,no risk
Boceprevir,Vorapaxar,The metabolism of Vorapaxar can be decreased when combined with Boceprevir.,decrease,no risk
Boceprevir,Voriconazole,The metabolism of Boceprevir can be decreased when combined with Voriconazole.,decrease,no risk
Boceprevir,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Boceprevir.,decrease,no risk
Boceprevir,Voxelotor,The serum concentration of Voxelotor can be increased when it is combined with Boceprevir.,increase,no risk
Boceprevir,Voxilaprevir,The metabolism of Voxilaprevir can be decreased when combined with Boceprevir.,decrease,no risk
Boceprevir,Warfarin,The metabolism of Warfarin can be decreased when combined with Boceprevir.,decrease,no risk
Boceprevir,Yellow fever vaccine,The therapeutic efficacy of Yellow fever vaccine can be decreased when used in combination with Boceprevir.,decrease,no risk
Boceprevir,Yohimbine,The metabolism of Yohimbine can be decreased when combined with Boceprevir.,decrease,no risk
Boceprevir,Zaleplon,The metabolism of Zaleplon can be decreased when combined with Boceprevir.,decrease,no risk
Boceprevir,Zanubrutinib,The metabolism of Zanubrutinib can be decreased when combined with Boceprevir.,decrease,no risk
Boceprevir,Zidovudine,The metabolism of Zidovudine can be decreased when combined with Boceprevir.,decrease,no risk
Boceprevir,Zileuton,The metabolism of Zileuton can be decreased when combined with Boceprevir.,decrease,no risk
Boceprevir,Zimelidine,The metabolism of Boceprevir can be decreased when combined with Zimelidine.,decrease,no risk
Boceprevir,Ziprasidone,The metabolism of Ziprasidone can be decreased when combined with Boceprevir.,decrease,no risk
Boceprevir,Zolpidem,The metabolism of Zolpidem can be decreased when combined with Boceprevir.,decrease,no risk
Boceprevir,Zonisamide,The serum concentration of Zonisamide can be increased when it is combined with Boceprevir.,increase,no risk
Boceprevir,Zopiclone,The metabolism of Zopiclone can be decreased when combined with Boceprevir.,decrease,no risk
Boceprevir,Zotepine,The metabolism of Zotepine can be decreased when combined with Boceprevir.,decrease,no risk
Boceprevir,Zuclopenthixol,The metabolism of Zuclopenthixol can be decreased when combined with Boceprevir.,decrease,no risk
Boceprevir,Zuranolone,The serum concentration of Zuranolone can be increased when it is combined with Boceprevir.,increase,no risk
Levoketoconazole,Galantamine,The metabolism of Galantamine can be decreased when combined with Levoketoconazole.,decrease,no risk
Levoketoconazole,Ganciclovir,The excretion of Ganciclovir can be decreased when combined with Levoketoconazole.,decrease,no risk
Levoketoconazole,Gefitinib,The metabolism of Gefitinib can be decreased when combined with Levoketoconazole.,decrease,no risk
Levoketoconazole,Gemcitabine,The serum concentration of Gemcitabine can be increased when it is combined with Levoketoconazole.,increase,no risk
Levoketoconazole,Gemfibrozil,The metabolism of Gemfibrozil can be decreased when combined with Levoketoconazole.,decrease,no risk
Levoketoconazole,Gentamicin,The serum concentration of Gentamicin can be increased when it is combined with Levoketoconazole.,increase,no risk
Levoketoconazole,Gepirone,The serum concentration of Gepirone can be increased when it is combined with Levoketoconazole.,increase,no risk
Levoketoconazole,Gestrinone,The metabolism of Gestrinone can be decreased when combined with Levoketoconazole.,decrease,no risk
Levoketoconazole,Gilteritinib,The metabolism of Gilteritinib can be decreased when combined with Levoketoconazole.,decrease,no risk
Levoketoconazole,Glasdegib,The serum concentration of Glasdegib can be increased when it is combined with Levoketoconazole.,increase,no risk
Levoketoconazole,Glecaprevir,The serum concentration of Glecaprevir can be increased when it is combined with Levoketoconazole.,increase,no risk
Levoketoconazole,Glofitamab,The serum concentration of Levoketoconazole can be increased when it is combined with Glofitamab.,increase,no risk
Levoketoconazole,Glyburide,The metabolism of Glyburide can be decreased when combined with Levoketoconazole.,decrease,no risk
Levoketoconazole,Granisetron,The metabolism of Granisetron can be decreased when combined with Levoketoconazole.,decrease,no risk
Levoketoconazole,Grazoprevir,The metabolism of Grazoprevir can be decreased when combined with Levoketoconazole.,decrease,no risk
Levoketoconazole,Grepafloxacin,The metabolism of Grepafloxacin can be decreased when combined with Levoketoconazole.,decrease,no risk
Levoketoconazole,Guanfacine,The metabolism of Guanfacine can be decreased when combined with Levoketoconazole.,decrease,no risk
Levoketoconazole,Guanidine,The excretion of Guanidine can be decreased when combined with Levoketoconazole.,decrease,no risk
Levoketoconazole,Halofantrine,The metabolism of Halofantrine can be decreased when combined with Levoketoconazole.,decrease,no risk
Levoketoconazole,Haloperidol,The risk or severity of QTc prolongation can be increased when Levoketoconazole is combined with Haloperidol.,increase,risk
Levoketoconazole,Halothane,The metabolism of Halothane can be decreased when combined with Levoketoconazole.,decrease,no risk
Levoketoconazole,Histamine,The serum concentration of Histamine can be increased when it is combined with Levoketoconazole.,increase,no risk
Levoketoconazole,Hydrocodone,The metabolism of Hydrocodone can be decreased when combined with Levoketoconazole.,decrease,no risk
Levoketoconazole,Hydrocortisone,The metabolism of Hydrocortisone can be decreased when combined with Levoketoconazole.,decrease,no risk
Levoketoconazole,Hydrocortisone acetate,The metabolism of Hydrocortisone acetate can be decreased when combined with Levoketoconazole.,decrease,no risk
Levoketoconazole,Hydrocortisone butyrate,The metabolism of Hydrocortisone butyrate can be decreased when combined with Levoketoconazole.,decrease,no risk
Levoketoconazole,Hydrocortisone cypionate,The metabolism of Hydrocortisone cypionate can be decreased when combined with Levoketoconazole.,decrease,no risk
Levoketoconazole,Hydrocortisone phosphate,The metabolism of Hydrocortisone phosphate can be decreased when combined with Levoketoconazole.,decrease,no risk
Levoketoconazole,Hydrocortisone succinate,The metabolism of Hydrocortisone succinate can be decreased when combined with Levoketoconazole.,decrease,no risk
Levoketoconazole,Hydrotalcite,Hydrotalcite can cause a decrease in the absorption of Levoketoconazole resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Levoketoconazole,Hydroxychloroquine,The metabolism of Hydroxychloroquine can be decreased when combined with Levoketoconazole.,decrease,no risk
Levoketoconazole,Hydroxyprogesterone caproate,The metabolism of Hydroxyprogesterone caproate can be decreased when combined with Levoketoconazole.,decrease,no risk
Levoketoconazole,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Levoketoconazole is combined with Hydroxyzine.,increase,risk
Levoketoconazole,Ketamine,The metabolism of Ketamine can be decreased when combined with Levoketoconazole.,decrease,no risk
Levoketoconazole,Ketazolam,The metabolism of Ketazolam can be decreased when combined with Levoketoconazole.,decrease,no risk
Levoketoconazole,Ketoconazole,The metabolism of Levoketoconazole can be decreased when combined with Ketoconazole.,decrease,no risk
Levoketoconazole,Ketorolac,The metabolism of Ketorolac can be decreased when combined with Levoketoconazole.,decrease,no risk
Levoketoconazole,Nabilone,The metabolism of Nabilone can be decreased when combined with Levoketoconazole.,decrease,no risk
Levoketoconazole,Nadolol,The excretion of Nadolol can be decreased when combined with Levoketoconazole.,decrease,no risk
Levoketoconazole,Naloxegol,The serum concentration of Naloxegol can be increased when it is combined with Levoketoconazole.,increase,no risk
Levoketoconazole,Naproxen,The metabolism of Naproxen can be decreased when combined with Levoketoconazole.,decrease,no risk
Levoketoconazole,Nateglinide,The metabolism of Nateglinide can be decreased when combined with Levoketoconazole.,decrease,no risk
Levoketoconazole,Nebivolol,The metabolism of Nebivolol can be decreased when combined with Levoketoconazole.,decrease,no risk
Levoketoconazole,Nefazodone,The metabolism of Levoketoconazole can be decreased when combined with Nefazodone.,decrease,no risk
Levoketoconazole,Nelfinavir,The metabolism of Levoketoconazole can be decreased when combined with Nelfinavir.,decrease,no risk
Levoketoconazole,Neratinib,The serum concentration of Neratinib can be increased when it is combined with Levoketoconazole.,increase,no risk
Levoketoconazole,Netupitant,The metabolism of Netupitant can be decreased when combined with Levoketoconazole.,decrease,no risk
Levoketoconazole,Nevirapine,The metabolism of Nevirapine can be decreased when combined with Levoketoconazole.,decrease,no risk
Levoketoconazole,Nicardipine,The metabolism of Nicardipine can be decreased when combined with Levoketoconazole.,decrease,no risk
Levoketoconazole,Nicergoline,The serum concentration of Nicergoline can be increased when it is combined with Levoketoconazole.,increase,no risk
Levoketoconazole,Nicotine,The metabolism of Nicotine can be decreased when combined with Levoketoconazole.,decrease,no risk
Levoketoconazole,Nifedipine,The metabolism of Nifedipine can be decreased when combined with Levoketoconazole.,decrease,no risk
Levoketoconazole,Nilotinib,The metabolism of Nilotinib can be decreased when combined with Levoketoconazole.,decrease,no risk
Levoketoconazole,Nilvadipine,The metabolism of Nilvadipine can be decreased when combined with Levoketoconazole.,decrease,no risk
Levoketoconazole,Nimesulide,The metabolism of Nimesulide can be decreased when combined with Levoketoconazole.,decrease,no risk
Levoketoconazole,Nimodipine,The metabolism of Nimodipine can be decreased when combined with Levoketoconazole.,decrease,no risk
Levoketoconazole,Nintedanib,The metabolism of Nintedanib can be decreased when combined with Levoketoconazole.,decrease,no risk
Levoketoconazole,Nirmatrelvir,The metabolism of Nirmatrelvir can be decreased when combined with Levoketoconazole.,decrease,no risk
Levoketoconazole,Nirogacestat,The serum concentration of Nirogacestat can be increased when it is combined with Levoketoconazole.,increase,no risk
Levoketoconazole,Nisoldipine,The metabolism of Nisoldipine can be decreased when combined with Levoketoconazole.,decrease,no risk
Levoketoconazole,Nitrazepam,The metabolism of Nitrazepam can be decreased when combined with Levoketoconazole.,decrease,no risk
Levoketoconazole,Nitrendipine,The metabolism of Nitrendipine can be decreased when combined with Levoketoconazole.,decrease,no risk
Levoketoconazole,Nizatidine,Nizatidine can cause a decrease in the absorption of Levoketoconazole resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Levoketoconazole,Nomegestrol,The metabolism of Nomegestrol can be decreased when combined with Levoketoconazole.,decrease,no risk
Levoketoconazole,Nomegestrol acetate,The metabolism of Nomegestrol acetate can be decreased when combined with Levoketoconazole.,decrease,no risk
Levoketoconazole,Norelgestromin,The metabolism of Norelgestromin can be decreased when combined with Levoketoconazole.,decrease,no risk
Levoketoconazole,Norepinephrine,The serum concentration of Norepinephrine can be increased when it is combined with Levoketoconazole.,increase,no risk
Levoketoconazole,Norethisterone,The metabolism of Norethisterone can be decreased when combined with Levoketoconazole.,decrease,no risk
Levoketoconazole,Norethynodrel,The metabolism of Norethynodrel can be decreased when combined with Levoketoconazole.,decrease,no risk
Levoketoconazole,Norgestimate,The metabolism of Norgestimate can be decreased when combined with Levoketoconazole.,decrease,no risk
Levoketoconazole,Norgestrel,The metabolism of Norgestrel can be decreased when combined with Levoketoconazole.,decrease,no risk
Levoketoconazole,Nortriptyline,The metabolism of Nortriptyline can be decreased when combined with Levoketoconazole.,decrease,no risk
Levoketoconazole,Nylidrin,The metabolism of Nylidrin can be decreased when combined with Levoketoconazole.,decrease,no risk
Levoketoconazole,Olanzapine,Olanzapine can cause a decrease in the absorption of Levoketoconazole resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Levoketoconazole,Olaparib,The metabolism of Olaparib can be decreased when combined with Levoketoconazole.,decrease,no risk
Levoketoconazole,Oliceridine,The serum concentration of Oliceridine can be increased when it is combined with Levoketoconazole.,increase,no risk
Levoketoconazole,Olodaterol,The metabolism of Olodaterol can be decreased when combined with Levoketoconazole.,decrease,no risk
Levoketoconazole,Olutasidenib,The metabolism of Olutasidenib can be decreased when combined with Levoketoconazole.,decrease,no risk
Levoketoconazole,Omadacycline,The serum concentration of Omadacycline can be increased when it is combined with Levoketoconazole.,increase,no risk
Levoketoconazole,Omaveloxolone,The serum concentration of Omaveloxolone can be increased when it is combined with Levoketoconazole.,increase,no risk
Levoketoconazole,Ombitasvir,The serum concentration of Ombitasvir can be increased when it is combined with Levoketoconazole.,increase,no risk
Levoketoconazole,Omeprazole,Omeprazole can cause a decrease in the absorption of Levoketoconazole resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Levoketoconazole,Ondansetron,The metabolism of Ondansetron can be decreased when combined with Levoketoconazole.,decrease,no risk
Levoketoconazole,Opium,The metabolism of Opium can be decreased when combined with Levoketoconazole.,decrease,no risk
Levoketoconazole,Orphenadrine,The metabolism of Orphenadrine can be decreased when combined with Levoketoconazole.,decrease,no risk
Levoketoconazole,Osilodrostat,The serum concentration of Osilodrostat can be increased when it is combined with Levoketoconazole.,increase,no risk
Levoketoconazole,Osimertinib,The metabolism of Osimertinib can be decreased when combined with Levoketoconazole.,decrease,no risk
Levoketoconazole,Ospemifene,The metabolism of Ospemifene can be decreased when combined with Levoketoconazole.,decrease,no risk
Levoketoconazole,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Levoketoconazole.,increase,risk
Levoketoconazole,Oxybutynin,The metabolism of Oxybutynin can be decreased when combined with Levoketoconazole.,decrease,no risk
Levoketoconazole,Oxycodone,The metabolism of Oxycodone can be decreased when combined with Levoketoconazole.,decrease,no risk
Levoketoconazole,Oxymorphone,The metabolism of Oxymorphone can be decreased when combined with Levoketoconazole.,decrease,no risk
Levoketoconazole,Ozanimod,The metabolism of Ozanimod can be decreased when combined with Levoketoconazole.,decrease,no risk
Levoketoconazole,Quazepam,The metabolism of Quazepam can be decreased when combined with Levoketoconazole.,decrease,no risk
Levoketoconazole,Quetiapine,The serum concentration of Quetiapine can be increased when it is combined with Levoketoconazole.,increase,no risk
Levoketoconazole,Quinidine,The metabolism of Quinidine can be decreased when combined with Levoketoconazole.,decrease,no risk
Levoketoconazole,Quinine,The metabolism of Quinine can be decreased when combined with Levoketoconazole.,decrease,no risk
Levoketoconazole,Quizartinib,The serum concentration of Quizartinib can be increased when it is combined with Levoketoconazole.,increase,no risk
Levoketoconazole,Ubrogepant,The serum concentration of Ubrogepant can be increased when it is combined with Levoketoconazole.,increase,no risk
Levoketoconazole,Udenafil,The metabolism of Udenafil can be decreased when combined with Levoketoconazole.,decrease,no risk
Levoketoconazole,Ulipristal,The metabolism of Ulipristal can be decreased when combined with Levoketoconazole.,decrease,no risk
Levoketoconazole,Umeclidinium,The serum concentration of Umeclidinium can be increased when it is combined with Levoketoconazole.,increase,no risk
Levoketoconazole,Upadacitinib,The metabolism of Upadacitinib can be decreased when combined with Levoketoconazole.,decrease,no risk
Levoketoconazole,Vadadustat,The serum concentration of Levoketoconazole can be increased when it is combined with Vadadustat.,increase,no risk
Levoketoconazole,Valbenazine,The serum concentration of Valbenazine can be increased when it is combined with Levoketoconazole.,increase,no risk
Levoketoconazole,Valdecoxib,The metabolism of Valdecoxib can be decreased when combined with Levoketoconazole.,decrease,no risk
Levoketoconazole,Valproic acid,The metabolism of Valproic acid can be decreased when combined with Levoketoconazole.,decrease,no risk
Levoketoconazole,Vamorolone,The serum concentration of Vamorolone can be increased when it is combined with Levoketoconazole.,increase,no risk
Levoketoconazole,Vandetanib,The metabolism of Vandetanib can be decreased when combined with Levoketoconazole.,decrease,no risk
Levoketoconazole,Vardenafil,The metabolism of Vardenafil can be decreased when combined with Levoketoconazole.,decrease,no risk
Levoketoconazole,Varenicline,The excretion of Varenicline can be decreased when combined with Levoketoconazole.,decrease,no risk
Levoketoconazole,Velpatasvir,The metabolism of Velpatasvir can be decreased when combined with Levoketoconazole.,decrease,no risk
Levoketoconazole,Vemurafenib,The metabolism of Vemurafenib can be decreased when combined with Levoketoconazole.,decrease,no risk
Levoketoconazole,Venetoclax,The metabolism of Venetoclax can be decreased when combined with Levoketoconazole.,decrease,no risk
Levoketoconazole,Venlafaxine,The metabolism of Venlafaxine can be decreased when combined with Levoketoconazole.,decrease,no risk
Levoketoconazole,Verapamil,The metabolism of Verapamil can be decreased when combined with Levoketoconazole.,decrease,no risk
Levoketoconazole,Vilanterol,The serum concentration of Vilanterol can be increased when it is combined with Levoketoconazole.,increase,no risk
Levoketoconazole,Vilazodone,The metabolism of Vilazodone can be decreased when combined with Levoketoconazole.,decrease,no risk
Levoketoconazole,Viloxazine,The metabolism of Levoketoconazole can be decreased when combined with Viloxazine.,decrease,no risk
Levoketoconazole,Vinblastine,The metabolism of Vinblastine can be decreased when combined with Levoketoconazole.,decrease,no risk
Levoketoconazole,Vincristine,The excretion of Vincristine can be decreased when combined with Levoketoconazole.,decrease,no risk
Levoketoconazole,Vindesine,The metabolism of Vindesine can be decreased when combined with Levoketoconazole.,decrease,no risk
Levoketoconazole,Vinflunine,The metabolism of Vinflunine can be decreased when combined with Levoketoconazole.,decrease,no risk
Levoketoconazole,Vinorelbine,The metabolism of Vinorelbine can be decreased when combined with Levoketoconazole.,decrease,no risk
Levoketoconazole,Vitamin D,The metabolism of Vitamin D can be decreased when combined with Levoketoconazole.,decrease,no risk
Levoketoconazole,Vitamin E,The metabolism of Vitamin E can be decreased when combined with Levoketoconazole.,decrease,no risk
Levoketoconazole,Voclosporin,The metabolism of Voclosporin can be decreased when combined with Levoketoconazole.,decrease,no risk
Levoketoconazole,Vonoprazan,Vonoprazan can cause a decrease in the absorption of Levoketoconazole resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Levoketoconazole,Vorapaxar,The metabolism of Vorapaxar can be decreased when combined with Levoketoconazole.,decrease,no risk
Levoketoconazole,Voriconazole,The metabolism of Levoketoconazole can be decreased when combined with Voriconazole.,decrease,no risk
Levoketoconazole,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Levoketoconazole.,decrease,no risk
Levoketoconazole,Voxelotor,The serum concentration of Voxelotor can be increased when it is combined with Levoketoconazole.,increase,no risk
Levoketoconazole,Voxilaprevir,The metabolism of Voxilaprevir can be decreased when combined with Levoketoconazole.,decrease,no risk
Levoketoconazole,Warfarin,The metabolism of Warfarin can be decreased when combined with Levoketoconazole.,decrease,no risk
Levoketoconazole,Xylometazoline,The therapeutic efficacy of Levoketoconazole can be increased when used in combination with Xylometazoline.,increase,no risk
Levoketoconazole,Yohimbine,The metabolism of Yohimbine can be decreased when combined with Levoketoconazole.,decrease,no risk
Levoketoconazole,Zaleplon,The metabolism of Zaleplon can be decreased when combined with Levoketoconazole.,decrease,no risk
Levoketoconazole,Zanubrutinib,The metabolism of Zanubrutinib can be decreased when combined with Levoketoconazole.,decrease,no risk
Levoketoconazole,Ziconotide,The therapeutic efficacy of Levoketoconazole can be increased when used in combination with Ziconotide.,increase,no risk
Levoketoconazole,Zidovudine,The metabolism of Zidovudine can be decreased when combined with Levoketoconazole.,decrease,no risk
Levoketoconazole,Zileuton,The metabolism of Zileuton can be decreased when combined with Levoketoconazole.,decrease,no risk
Levoketoconazole,Zimelidine,The metabolism of Levoketoconazole can be decreased when combined with Zimelidine.,decrease,no risk
Levoketoconazole,Ziprasidone,The risk or severity of QTc prolongation can be increased when Levoketoconazole is combined with Ziprasidone.,increase,risk
Levoketoconazole,Zolpidem,The metabolism of Zolpidem can be decreased when combined with Levoketoconazole.,decrease,no risk
Levoketoconazole,Zonisamide,The metabolism of Zonisamide can be decreased when combined with Levoketoconazole.,decrease,no risk
Levoketoconazole,Zopiclone,The metabolism of Zopiclone can be decreased when combined with Levoketoconazole.,decrease,no risk
Levoketoconazole,Zotepine,The metabolism of Zotepine can be decreased when combined with Levoketoconazole.,decrease,no risk
Levoketoconazole,Zuclopenthixol,The metabolism of Zuclopenthixol can be decreased when combined with Levoketoconazole.,decrease,no risk
Levoketoconazole,Zuranolone,The serum concentration of Zuranolone can be increased when it is combined with Levoketoconazole.,increase,no risk
Palifosfamide,Benzocaine,The risk or severity of methemoglobinemia can be increased when Palifosfamide is combined with Benzocaine.,increase,risk
Palifosfamide,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Palifosfamide is combined with Benzyl alcohol.,increase,risk
Palifosfamide,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Palifosfamide is combined with Bupivacaine.,increase,risk
Palifosfamide,Butacaine,The risk or severity of methemoglobinemia can be increased when Palifosfamide is combined with Butacaine.,increase,risk
Palifosfamide,Butamben,The risk or severity of methemoglobinemia can be increased when Palifosfamide is combined with Butamben.,increase,risk
Palifosfamide,Nelarabine,The risk or severity of adverse effects can be increased when Nelarabine is combined with Palifosfamide.,increase,risk
Palifosfamide,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Palifosfamide is combined with Oxetacaine.,increase,risk
Palifosfamide,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Palifosfamide is combined with Oxybuprocaine.,increase,risk
Apremilast,Bacillus calmette-guerin substrain connaught live antigen,The risk or severity of infection can be increased when Bacillus calmette-guerin substrain connaught live antigen is combined with Apremilast.,increase,risk
Apremilast,Bacillus calmette-guerin substrain russian BCG-I live antigen,The therapeutic efficacy of Bacillus calmette-guerin substrain russian BCG-I live antigen can be decreased when used in combination with Apremilast.,decrease,no risk
Apremilast,Bacillus calmette-guerin substrain tice live antigen,The risk or severity of infection can be increased when Bacillus calmette-guerin substrain tice live antigen is combined with Apremilast.,increase,risk
Apremilast,Bacitracin,Bacitracin may decrease the excretion rate of Apremilast which could result in a higher serum level.,decrease,no risk
Apremilast,Baclofen,Baclofen may decrease the excretion rate of Apremilast which could result in a higher serum level.,decrease,no risk
Apremilast,Balsalazide,Balsalazide may decrease the excretion rate of Apremilast which could result in a higher serum level.,decrease,no risk
Apremilast,Baricitinib,The risk or severity of adverse effects can be increased when Apremilast is combined with Baricitinib.,increase,risk
Apremilast,Basiliximab,The risk or severity of adverse effects can be increased when Basiliximab is combined with Apremilast.,increase,risk
Apremilast,BCG vaccine,The risk or severity of infection can be increased when BCG vaccine is combined with Apremilast.,increase,risk
Apremilast,Beclomethasone dipropionate,The risk or severity of adverse effects can be increased when Beclomethasone dipropionate is combined with Apremilast.,increase,risk
Apremilast,Belatacept,The risk or severity of adverse effects can be increased when Apremilast is combined with Belatacept.,increase,risk
Apremilast,Belimumab,The risk or severity of adverse effects can be increased when Apremilast is combined with Belimumab.,increase,risk
Apremilast,Belinostat,The risk or severity of adverse effects can be increased when Belinostat is combined with Apremilast.,increase,risk
Apremilast,Belumosudil,The risk or severity of adverse effects can be increased when Apremilast is combined with Belumosudil.,increase,risk
Apremilast,Belzutifan,The metabolism of Belzutifan can be increased when combined with Apremilast.,increase,no risk
Apremilast,Bendamustine,The metabolism of Bendamustine can be increased when combined with Apremilast.,increase,no risk
Apremilast,Bendroflumethiazide,Bendroflumethiazide may increase the excretion rate of Apremilast which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Apremilast,Benorilate,Benorilate may decrease the excretion rate of Apremilast which could result in a higher serum level.,decrease,no risk
Apremilast,Benoxaprofen,Benoxaprofen may decrease the excretion rate of Apremilast which could result in a higher serum level.,decrease,no risk
Apremilast,Benserazide,Apremilast may decrease the excretion rate of Benserazide which could result in a higher serum level.,decrease,no risk
Apremilast,Benzatropine,The metabolism of Benzatropine can be increased when combined with Apremilast.,increase,no risk
Apremilast,Benznidazole,Apremilast may decrease the excretion rate of Benznidazole which could result in a higher serum level.,decrease,no risk
Apremilast,Benzocaine,The metabolism of Benzocaine can be increased when combined with Apremilast.,increase,no risk
Apremilast,Benzphetamine,The metabolism of Benzphetamine can be increased when combined with Apremilast.,increase,no risk
Apremilast,Benzthiazide,Benzthiazide may increase the excretion rate of Apremilast which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Apremilast,Benzydamine,Benzydamine may decrease the excretion rate of Apremilast which could result in a higher serum level.,decrease,no risk
Apremilast,Benzyl alcohol,The metabolism of Benzyl alcohol can be increased when combined with Apremilast.,increase,no risk
Apremilast,Bepotastine,Bepotastine may decrease the excretion rate of Apremilast which could result in a higher serum level.,decrease,no risk
Apremilast,Bepridil,The metabolism of Bepridil can be increased when combined with Apremilast.,increase,no risk
Apremilast,Berotralstat,The metabolism of Apremilast can be decreased when combined with Berotralstat.,decrease,no risk
Apremilast,Betamethasone,The risk or severity of adverse effects can be increased when Betamethasone is combined with Apremilast.,increase,risk
Apremilast,Betaxolol,The metabolism of Betaxolol can be increased when combined with Apremilast.,increase,no risk
Apremilast,Bexarotene,The metabolism of Bexarotene can be increased when combined with Apremilast.,increase,no risk
Apremilast,Bicalutamide,The metabolism of Bicalutamide can be increased when combined with Apremilast.,increase,no risk
Apremilast,Bicisate,Apremilast may decrease the excretion rate of Bicisate which could result in a higher serum level.,decrease,no risk
Apremilast,Bimekizumab,The metabolism of Apremilast can be increased when combined with Bimekizumab.,increase,no risk
Apremilast,Binimetinib,The metabolism of Binimetinib can be increased when combined with Apremilast.,increase,no risk
Apremilast,Bismuth subgallate,Apremilast may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Apremilast,Bisoprolol,Bisoprolol may decrease the excretion rate of Apremilast which could result in a higher serum level.,decrease,no risk
Apremilast,Bisoxatin,Apremilast may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,decrease,no risk
Apremilast,Bleomycin,The risk or severity of adverse effects can be increased when Bleomycin is combined with Apremilast.,increase,risk
Apremilast,Blinatumomab,The risk or severity of adverse effects can be increased when Apremilast is combined with Blinatumomab.,increase,risk
Apremilast,Boceprevir,The metabolism of Apremilast can be decreased when combined with Boceprevir.,decrease,no risk
Apremilast,"Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated)","The therapeutic efficacy of Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated) can be decreased when used in combination with Apremilast.",decrease,no risk
Apremilast,Bortezomib,The metabolism of Bortezomib can be increased when combined with Apremilast.,increase,no risk
Apremilast,Bosentan,The metabolism of Bosentan can be increased when combined with Apremilast.,increase,no risk
Apremilast,Bosutinib,The metabolism of Bosutinib can be increased when combined with Apremilast.,increase,no risk
Apremilast,Brentuximab vedotin,The metabolism of Brentuximab vedotin can be increased when combined with Apremilast.,increase,no risk
Apremilast,Brexpiprazole,The metabolism of Brexpiprazole can be increased when combined with Apremilast.,increase,no risk
Apremilast,Brigatinib,The metabolism of Brigatinib can be increased when combined with Apremilast.,increase,no risk
Apremilast,Brivaracetam,The metabolism of Brivaracetam can be increased when combined with Apremilast.,increase,no risk
Apremilast,Brodalumab,The risk or severity of adverse effects can be increased when Apremilast is combined with Brodalumab.,increase,risk
Apremilast,Bromazepam,The metabolism of Bromazepam can be increased when combined with Apremilast.,increase,no risk
Apremilast,Bromotheophylline,The metabolism of Bromotheophylline can be increased when combined with Apremilast.,increase,no risk
Apremilast,Brompheniramine,The metabolism of Brompheniramine can be increased when combined with Apremilast.,increase,no risk
Apremilast,Budesonide,The risk or severity of adverse effects can be increased when Budesonide is combined with Apremilast.,increase,risk
Apremilast,Bumadizone,Bumadizone may decrease the excretion rate of Apremilast which could result in a higher serum level.,decrease,no risk
Apremilast,Bumetanide,Bumetanide may increase the excretion rate of Apremilast which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Apremilast,Bupivacaine,The metabolism of Bupivacaine can be increased when combined with Apremilast.,increase,no risk
Apremilast,Buprenorphine,The metabolism of Buprenorphine can be increased when combined with Apremilast.,increase,no risk
Apremilast,Bupropion,The metabolism of Bupropion can be increased when combined with Apremilast.,increase,no risk
Apremilast,Buspirone,The metabolism of Buspirone can be increased when combined with Apremilast.,increase,no risk
Apremilast,Busulfan,The metabolism of Busulfan can be increased when combined with Apremilast.,increase,no risk
Apremilast,Butabarbital,Butabarbital may decrease the excretion rate of Apremilast which could result in a higher serum level.,decrease,no risk
Apremilast,Gabapentin enacarbil,Apremilast may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Apremilast,Gadobenic acid,Gadobenic acid may decrease the excretion rate of Apremilast which could result in a higher serum level.,decrease,no risk
Apremilast,Gadodiamide,Gadodiamide may decrease the excretion rate of Apremilast which could result in a higher serum level.,decrease,no risk
Apremilast,Gadofosveset trisodium,Apremilast may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Apremilast,Gadopentetic acid,Gadopentetic acid may decrease the excretion rate of Apremilast which could result in a higher serum level.,decrease,no risk
Apremilast,Gadoteric acid,Apremilast may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Apremilast,Gadoteridol,Gadoteridol may decrease the excretion rate of Apremilast which could result in a higher serum level.,decrease,no risk
Apremilast,Galantamine,The metabolism of Galantamine can be increased when combined with Apremilast.,increase,no risk
Apremilast,Ganciclovir,Ganciclovir may decrease the excretion rate of Apremilast which could result in a higher serum level.,decrease,no risk
Apremilast,Gatifloxacin,The metabolism of Apremilast can be decreased when combined with Gatifloxacin.,decrease,no risk
Apremilast,Gefitinib,The metabolism of Gefitinib can be increased when combined with Apremilast.,increase,no risk
Apremilast,Gemcitabine,The risk or severity of adverse effects can be increased when Gemcitabine is combined with Apremilast.,increase,risk
Apremilast,Gemfibrozil,The metabolism of Apremilast can be decreased when combined with Gemfibrozil.,decrease,no risk
Apremilast,Gemifloxacin,The metabolism of Apremilast can be decreased when combined with Gemifloxacin.,decrease,no risk
Apremilast,Gemtuzumab ozogamicin,The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Apremilast.,increase,risk
Apremilast,Gentamicin,Apremilast may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Apremilast,Gilteritinib,The metabolism of Gilteritinib can be increased when combined with Apremilast.,increase,no risk
Apremilast,Gimeracil,Apremilast may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Apremilast,Givosiran,The serum concentration of Apremilast can be increased when it is combined with Givosiran.,increase,no risk
Apremilast,Glasdegib,The metabolism of Glasdegib can be increased when combined with Apremilast.,increase,no risk
Apremilast,Glatiramer,The risk or severity of adverse effects can be increased when Glatiramer is combined with Apremilast.,increase,risk
Apremilast,Gliclazide,The metabolism of Gliclazide can be increased when combined with Apremilast.,increase,no risk
Apremilast,Glimepiride,The metabolism of Glimepiride can be increased when combined with Apremilast.,increase,no risk
Apremilast,Glipizide,The metabolism of Glipizide can be increased when combined with Apremilast.,increase,no risk
Apremilast,Gliquidone,The metabolism of Gliquidone can be increased when combined with Apremilast.,increase,no risk
Apremilast,Glofitamab,The serum concentration of Apremilast can be increased when it is combined with Glofitamab.,increase,no risk
Apremilast,Glyburide,The metabolism of Glyburide can be increased when combined with Apremilast.,increase,no risk
Apremilast,Glycerol phenylbutyrate,Apremilast may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Apremilast,Golimumab,The therapeutic efficacy of Apremilast can be decreased when used in combination with Golimumab.,decrease,no risk
Apremilast,Golodirsen,Apremilast may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Apremilast,Goserelin,Goserelin may decrease the excretion rate of Apremilast which could result in a higher serum level.,decrease,no risk
Apremilast,Grepafloxacin,The metabolism of Grepafloxacin can be increased when combined with Apremilast.,increase,no risk
Apremilast,Guanabenz,The metabolism of Guanabenz can be increased when combined with Apremilast.,increase,no risk
Apremilast,Guanethidine,Guanethidine may decrease the excretion rate of Apremilast which could result in a higher serum level.,decrease,no risk
Apremilast,Guanfacine,Guanfacine may decrease the excretion rate of Apremilast which could result in a higher serum level.,decrease,no risk
Apremilast,Guselkumab,The risk or severity of adverse effects can be increased when Apremilast is combined with Guselkumab.,increase,risk
Apremilast,Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Apremilast.,decrease,no risk
Apremilast,Halofantrine,The metabolism of Halofantrine can be increased when combined with Apremilast.,increase,no risk
Apremilast,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Apremilast.,increase,no risk
Apremilast,Halothane,The metabolism of Halothane can be increased when combined with Apremilast.,increase,no risk
Apremilast,Hepatitis A Vaccine,The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Apremilast.,decrease,no risk
Apremilast,Hepatitis B Vaccine (Recombinant),The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Apremilast.,decrease,no risk
Apremilast,Human adenovirus e serotype 4 strain cl-68578 antigen,The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Apremilast.,increase,risk
Apremilast,Hydralazine,Hydralazine may decrease the excretion rate of Apremilast which could result in a higher serum level.,decrease,no risk
Apremilast,Hydrochlorothiazide,Hydrochlorothiazide may increase the excretion rate of Apremilast which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Apremilast,Hydrocodone,The metabolism of Hydrocodone can be increased when combined with Apremilast.,increase,no risk
Apremilast,Hydrocortisone,The metabolism of Hydrocortisone can be increased when combined with Apremilast.,increase,no risk
Apremilast,Hydrocortisone acetate,The metabolism of Hydrocortisone acetate can be increased when combined with Apremilast.,increase,no risk
Apremilast,Hydrocortisone butyrate,The metabolism of Hydrocortisone butyrate can be increased when combined with Apremilast.,increase,no risk
Apremilast,Hydrocortisone cypionate,The metabolism of Hydrocortisone cypionate can be increased when combined with Apremilast.,increase,no risk
Apremilast,Hydrocortisone phosphate,The metabolism of Hydrocortisone phosphate can be increased when combined with Apremilast.,increase,no risk
Apremilast,Hydrocortisone succinate,The risk or severity of adverse effects can be increased when Apremilast is combined with Hydrocortisone succinate.,increase,risk
Apremilast,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of Apremilast which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Apremilast,Hydromorphone,The metabolism of Hydromorphone can be increased when combined with Apremilast.,increase,no risk
Apremilast,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Apremilast which could result in a higher serum level.,decrease,no risk
Apremilast,Hydroxychloroquine,The metabolism of Hydroxychloroquine can be increased when combined with Apremilast.,increase,no risk
Apremilast,Hydroxyethyl Starch,Apremilast may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Apremilast,Hydroxyprogesterone caproate,The metabolism of Hydroxyprogesterone caproate can be increased when combined with Apremilast.,increase,no risk
Apremilast,Hydroxyurea,The risk or severity of adverse effects can be increased when Hydroxyurea is combined with Apremilast.,increase,risk
Apremilast,Hydroxyzine,The metabolism of Hydroxyzine can be increased when combined with Apremilast.,increase,no risk
Apremilast,Janssen COVID-19 Vaccine,The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Apremilast.,decrease,no risk
Apremilast,Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated),The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Apremilast.,decrease,no risk
Apremilast,Kanamycin,Apremilast may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Apremilast,Ketamine,The metabolism of Ketamine can be increased when combined with Apremilast.,increase,no risk
Apremilast,Ketazolam,Ketazolam may decrease the excretion rate of Apremilast which could result in a higher serum level.,decrease,no risk
Apremilast,Ketoprofen,Ketoprofen may decrease the excretion rate of Apremilast which could result in a higher serum level.,decrease,no risk
Apremilast,Ketorolac,The metabolism of Ketorolac can be increased when combined with Apremilast.,increase,no risk
Apremilast,N-acetyltyrosine,Apremilast may decrease the excretion rate of N-acetyltyrosine which could result in a higher serum level.,decrease,no risk
Apremilast,Nabilone,The metabolism of Nabilone can be increased when combined with Apremilast.,increase,no risk
Apremilast,Nabumetone,The metabolism of Nabumetone can be increased when combined with Apremilast.,increase,no risk
Apremilast,Nadolol,The metabolism of Nadolol can be increased when combined with Apremilast.,increase,no risk
Apremilast,Nafcillin,The metabolism of Apremilast can be increased when combined with Nafcillin.,increase,no risk
Apremilast,Naldemedine,Apremilast may decrease the excretion rate of Naldemedine which could result in a higher serum level.,decrease,no risk
Apremilast,Nalidixic acid,The metabolism of Apremilast can be decreased when combined with Nalidixic acid.,decrease,no risk
Apremilast,Nalmefene,Apremilast may decrease the excretion rate of Nalmefene which could result in a higher serum level.,decrease,no risk
Apremilast,Naloxone,Naloxone may decrease the excretion rate of Apremilast which could result in a higher serum level.,decrease,no risk
Apremilast,Naproxen,The metabolism of Naproxen can be increased when combined with Apremilast.,increase,no risk
Apremilast,Natalizumab,The risk or severity of immunosuppression can be increased when Apremilast is combined with Natalizumab.,increase,risk
Apremilast,Nateglinide,The metabolism of Nateglinide can be increased when combined with Apremilast.,increase,no risk
Apremilast,Nebivolol,The metabolism of Nebivolol can be increased when combined with Apremilast.,increase,no risk
Apremilast,Nedaplatin,Apremilast may decrease the excretion rate of Nedaplatin which could result in a higher serum level.,decrease,no risk
Apremilast,Nedocromil,Nedocromil may decrease the excretion rate of Apremilast which could result in a higher serum level.,decrease,no risk
Apremilast,Nefazodone,The metabolism of Apremilast can be decreased when combined with Nefazodone.,decrease,no risk
Apremilast,Nelarabine,The risk or severity of adverse effects can be increased when Nelarabine is combined with Apremilast.,increase,risk
Apremilast,Nelfinavir,The metabolism of Apremilast can be decreased when combined with Nelfinavir.,decrease,no risk
Apremilast,Neomycin,Apremilast may decrease the excretion rate of Neomycin which could result in a higher serum level.,decrease,no risk
Apremilast,Neratinib,The metabolism of Neratinib can be increased when combined with Apremilast.,increase,no risk
Apremilast,Netilmicin,Apremilast may decrease the excretion rate of Netilmicin which could result in a higher serum level.,decrease,no risk
Apremilast,Netupitant,The metabolism of Netupitant can be increased when combined with Apremilast.,increase,no risk
Apremilast,Nevirapine,The metabolism of Nevirapine can be increased when combined with Apremilast.,increase,no risk
Apremilast,Nicardipine,The metabolism of Apremilast can be decreased when combined with Nicardipine.,decrease,no risk
Apremilast,Nicergoline,The metabolism of Nicergoline can be increased when combined with Apremilast.,increase,no risk
Apremilast,Niclosamide,The metabolism of Niclosamide can be increased when combined with Apremilast.,increase,no risk
Apremilast,Nicorandil,Apremilast may decrease the excretion rate of Nicorandil which could result in a higher serum level.,decrease,no risk
Apremilast,Nicotine,The metabolism of Nicotine can be increased when combined with Apremilast.,increase,no risk
Apremilast,Nifedipine,The metabolism of Nifedipine can be increased when combined with Apremilast.,increase,no risk
Apremilast,Nilotinib,The metabolism of Apremilast can be decreased when combined with Nilotinib.,decrease,no risk
Apremilast,Nilutamide,The metabolism of Nilutamide can be increased when combined with Apremilast.,increase,no risk
Apremilast,Nilvadipine,The metabolism of Nilvadipine can be increased when combined with Apremilast.,increase,no risk
Apremilast,Nimesulide,Nimesulide may decrease the excretion rate of Apremilast which could result in a higher serum level.,decrease,no risk
Apremilast,Nintedanib,The metabolism of Nintedanib can be increased when combined with Apremilast.,increase,no risk
Apremilast,Nirogacestat,The metabolism of Nirogacestat can be increased when combined with Apremilast.,increase,no risk
Apremilast,Nisoldipine,The metabolism of Nisoldipine can be increased when combined with Apremilast.,increase,no risk
Apremilast,Nitrendipine,The metabolism of Nitrendipine can be increased when combined with Apremilast.,increase,no risk
Apremilast,Nitric Oxide,Nitric Oxide may decrease the excretion rate of Apremilast which could result in a higher serum level.,decrease,no risk
Apremilast,Nitrofurantoin,Nitrofurantoin may decrease the excretion rate of Apremilast which could result in a higher serum level.,decrease,no risk
Apremilast,Nitroprusside,Nitroprusside may decrease the excretion rate of Apremilast which could result in a higher serum level.,decrease,no risk
Apremilast,Norethisterone,The metabolism of Norethisterone can be increased when combined with Apremilast.,increase,no risk
Apremilast,Norfloxacin,The metabolism of Apremilast can be decreased when combined with Norfloxacin.,decrease,no risk
Apremilast,Norgestimate,The metabolism of Norgestimate can be increased when combined with Apremilast.,increase,no risk
Apremilast,Nortriptyline,The metabolism of Nortriptyline can be increased when combined with Apremilast.,increase,no risk
Apremilast,Nuvaxovid,The therapeutic efficacy of Nuvaxovid can be decreased when used in combination with Apremilast.,decrease,no risk
Apremilast,Obeticholic acid,The metabolism of Apremilast can be decreased when combined with Obeticholic acid.,decrease,no risk
Apremilast,Obinutuzumab,The risk or severity of adverse effects can be increased when Apremilast is combined with Obinutuzumab.,increase,risk
Apremilast,Ocrelizumab,The risk or severity of adverse effects can be increased when Apremilast is combined with Ocrelizumab.,increase,risk
Apremilast,Octinoxate,Apremilast may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Apremilast,Ofatumumab,The risk or severity of adverse effects can be increased when Apremilast is combined with Ofatumumab.,increase,risk
Apremilast,Olanzapine,The metabolism of Olanzapine can be increased when combined with Apremilast.,increase,no risk
Apremilast,Olaparib,The metabolism of Olaparib can be increased when combined with Apremilast.,increase,no risk
Apremilast,Oliceridine,The metabolism of Oliceridine can be increased when combined with Apremilast.,increase,no risk
Apremilast,Olodaterol,The metabolism of Olodaterol can be increased when combined with Apremilast.,increase,no risk
Apremilast,Olsalazine,Olsalazine may decrease the excretion rate of Apremilast which could result in a higher serum level.,decrease,no risk
Apremilast,Omaveloxolone,The serum concentration of Apremilast can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Apremilast,Ombitasvir,The metabolism of Ombitasvir can be increased when combined with Apremilast.,increase,no risk
Apremilast,Omeprazole,The metabolism of Omeprazole can be increased when combined with Apremilast.,increase,no risk
Apremilast,Ondansetron,The metabolism of Ondansetron can be increased when combined with Apremilast.,increase,no risk
Apremilast,Opium,The metabolism of Opium can be increased when combined with Apremilast.,increase,no risk
Apremilast,Orphenadrine,The metabolism of Apremilast can be decreased when combined with Orphenadrine.,decrease,no risk
Apremilast,Oseltamivir,Oseltamivir may decrease the excretion rate of Apremilast which could result in a higher serum level.,decrease,no risk
Apremilast,Osilodrostat,The metabolism of Osilodrostat can be increased when combined with Apremilast.,increase,no risk
Apremilast,Osimertinib,The serum concentration of Apremilast can be decreased when it is combined with Osimertinib.,decrease,no risk
Apremilast,Ospemifene,The metabolism of Ospemifene can be increased when combined with Apremilast.,increase,no risk
Apremilast,Oxacillin,Oxacillin may decrease the excretion rate of Apremilast which could result in a higher serum level.,decrease,no risk
Apremilast,Oxaliplatin,The risk or severity of adverse effects can be increased when Oxaliplatin is combined with Apremilast.,increase,risk
Apremilast,Oxaprozin,Oxaprozin may decrease the excretion rate of Apremilast which could result in a higher serum level.,decrease,no risk
Apremilast,Oxazepam,Oxazepam may decrease the excretion rate of Apremilast which could result in a higher serum level.,decrease,no risk
Apremilast,Oxprenolol,The metabolism of Oxprenolol can be increased when combined with Apremilast.,increase,no risk
Apremilast,Oxtriphylline,The metabolism of Oxtriphylline can be increased when combined with Apremilast.,increase,no risk
Apremilast,Oxybenzone,Oxybenzone may decrease the excretion rate of Apremilast which could result in a higher serum level.,decrease,no risk
Apremilast,Oxybutynin,The metabolism of Oxybutynin can be increased when combined with Apremilast.,increase,no risk
Apremilast,Oxycodone,The metabolism of Oxycodone can be increased when combined with Apremilast.,increase,no risk
Apremilast,Oxymorphone,The metabolism of Oxymorphone can be increased when combined with Apremilast.,increase,no risk
Apremilast,Oxyphenbutazone,Oxyphenbutazone may decrease the excretion rate of Apremilast which could result in a higher serum level.,decrease,no risk
Apremilast,Oxyquinoline,Apremilast may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Apremilast,Ozanimod,The risk or severity of adverse effects can be increased when Apremilast is combined with Ozanimod.,increase,risk
Apremilast,Quetiapine,The metabolism of Quetiapine can be increased when combined with Apremilast.,increase,no risk
Apremilast,Quinethazone,Quinethazone may increase the excretion rate of Apremilast which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Apremilast,Quinidine,The metabolism of Quinidine can be increased when combined with Apremilast.,increase,no risk
Apremilast,Quinine,The metabolism of Quinine can be increased when combined with Apremilast.,increase,no risk
Apremilast,Quizartinib,The metabolism of Quizartinib can be increased when combined with Apremilast.,increase,no risk
Apremilast,Ublituximab,The risk or severity of infection can be increased when Ublituximab is combined with Apremilast.,increase,risk
Apremilast,Udenafil,The metabolism of Udenafil can be increased when combined with Apremilast.,increase,no risk
Apremilast,Umeclidinium,The metabolism of Umeclidinium can be increased when combined with Apremilast.,increase,no risk
Apremilast,Upadacitinib,The risk or severity of adverse effects can be increased when Apremilast is combined with Upadacitinib.,increase,risk
Apremilast,Ustekinumab,The therapeutic efficacy of Apremilast can be decreased when used in combination with Ustekinumab.,decrease,no risk
Apremilast,Vaborbactam,Apremilast may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Apremilast,Vadadustat,The serum concentration of Apremilast can be increased when it is combined with Vadadustat.,increase,no risk
Apremilast,Valaciclovir,Valaciclovir may decrease the excretion rate of Apremilast which could result in a higher serum level.,decrease,no risk
Apremilast,Valbenazine,The metabolism of Valbenazine can be increased when combined with Apremilast.,increase,no risk
Apremilast,Valdecoxib,The metabolism of Valdecoxib can be increased when combined with Apremilast.,increase,no risk
Apremilast,Valganciclovir,Valganciclovir may decrease the excretion rate of Apremilast which could result in a higher serum level.,decrease,no risk
Apremilast,Valproic acid,The metabolism of Valproic acid can be increased when combined with Apremilast.,increase,no risk
Apremilast,Valsartan,The metabolism of Valsartan can be increased when combined with Apremilast.,increase,no risk
Apremilast,Vancomycin,Apremilast may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Apremilast,Vandetanib,The metabolism of Vandetanib can be increased when combined with Apremilast.,increase,no risk
Apremilast,Vardenafil,The metabolism of Vardenafil can be increased when combined with Apremilast.,increase,no risk
Apremilast,Varenicline,Varenicline may decrease the excretion rate of Apremilast which could result in a higher serum level.,decrease,no risk
Apremilast,Varicella zoster vaccine (live/attenuated),The risk or severity of infection can be increased when Varicella zoster vaccine (live/attenuated) is combined with Apremilast.,increase,risk
Apremilast,Varicella zoster vaccine (recombinant),The therapeutic efficacy of Varicella zoster vaccine (recombinant) can be decreased when used in combination with Apremilast.,decrease,no risk
Apremilast,Vedolizumab,The risk or severity of adverse effects can be increased when Apremilast is combined with Vedolizumab.,increase,risk
Apremilast,Velpatasvir,The metabolism of Velpatasvir can be increased when combined with Apremilast.,increase,no risk
Apremilast,Vemurafenib,The serum concentration of Apremilast can be increased when it is combined with Vemurafenib.,increase,no risk
Apremilast,Venetoclax,The metabolism of Venetoclax can be increased when combined with Apremilast.,increase,no risk
Apremilast,Venlafaxine,The metabolism of Venlafaxine can be increased when combined with Apremilast.,increase,no risk
Apremilast,Verapamil,The metabolism of Verapamil can be increased when combined with Apremilast.,increase,no risk
Apremilast,Vernakalant,The metabolism of Vernakalant can be increased when combined with Apremilast.,increase,no risk
Apremilast,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Apremilast.,decrease,no risk
Apremilast,Vilanterol,The risk or severity of adverse effects can be increased when Apremilast is combined with Vilanterol.,increase,risk
Apremilast,Vilazodone,The metabolism of Vilazodone can be increased when combined with Apremilast.,increase,no risk
Apremilast,Viloxazine,The metabolism of Apremilast can be decreased when combined with Viloxazine.,decrease,no risk
Apremilast,Vinblastine,The metabolism of Vinblastine can be increased when combined with Apremilast.,increase,no risk
Apremilast,Vincristine,The metabolism of Vincristine can be increased when combined with Apremilast.,increase,no risk
Apremilast,Vindesine,The metabolism of Vindesine can be increased when combined with Apremilast.,increase,no risk
Apremilast,Vinflunine,The metabolism of Vinflunine can be increased when combined with Apremilast.,increase,no risk
Apremilast,Vinorelbine,The metabolism of Vinorelbine can be increased when combined with Apremilast.,increase,no risk
Apremilast,Voclosporin,The risk or severity of adverse effects can be increased when Apremilast is combined with Voclosporin.,increase,risk
Apremilast,Vonoprazan,The metabolism of Vonoprazan can be increased when combined with Apremilast.,increase,no risk
Apremilast,Vorapaxar,The metabolism of Vorapaxar can be increased when combined with Apremilast.,increase,no risk
Apremilast,Voriconazole,The metabolism of Apremilast can be decreased when combined with Voriconazole.,decrease,no risk
Apremilast,Vorinostat,The risk or severity of adverse effects can be increased when Vorinostat is combined with Apremilast.,increase,risk
Apremilast,Vortioxetine,The metabolism of Vortioxetine can be increased when combined with Apremilast.,increase,no risk
Apremilast,Voxelotor,The metabolism of Voxelotor can be increased when combined with Apremilast.,increase,no risk
Apremilast,Voxilaprevir,The metabolism of Voxilaprevir can be increased when combined with Apremilast.,increase,no risk
Apremilast,Warfarin,The metabolism of Warfarin can be increased when combined with Apremilast.,increase,no risk
Apremilast,Ximelagatran,The metabolism of Ximelagatran can be increased when combined with Apremilast.,increase,no risk
Apremilast,Yellow fever vaccine,The risk or severity of infection can be increased when Yellow fever vaccine is combined with Apremilast.,increase,risk
Apremilast,Yohimbine,The metabolism of Yohimbine can be increased when combined with Apremilast.,increase,no risk
Apremilast,Zafirlukast,The metabolism of Zafirlukast can be increased when combined with Apremilast.,increase,no risk
Apremilast,Zaleplon,The metabolism of Zaleplon can be increased when combined with Apremilast.,increase,no risk
Apremilast,Zanamivir,Zanamivir may decrease the excretion rate of Apremilast which could result in a higher serum level.,decrease,no risk
Apremilast,Zanubrutinib,The metabolism of Zanubrutinib can be increased when combined with Apremilast.,increase,no risk
Apremilast,Zidovudine,The metabolism of Zidovudine can be increased when combined with Apremilast.,increase,no risk
Apremilast,Zileuton,The metabolism of Zileuton can be increased when combined with Apremilast.,increase,no risk
Apremilast,Zimelidine,The metabolism of Apremilast can be decreased when combined with Zimelidine.,decrease,no risk
Apremilast,Ziprasidone,The metabolism of Ziprasidone can be increased when combined with Apremilast.,increase,no risk
Apremilast,Zolmitriptan,The metabolism of Zolmitriptan can be increased when combined with Apremilast.,increase,no risk
Apremilast,Zolpidem,The metabolism of Zolpidem can be increased when combined with Apremilast.,increase,no risk
Apremilast,Zonisamide,The metabolism of Zonisamide can be increased when combined with Apremilast.,increase,no risk
Apremilast,Zopiclone,The metabolism of Zopiclone can be increased when combined with Apremilast.,increase,no risk
Apremilast,Zotepine,The metabolism of Zotepine can be increased when combined with Apremilast.,increase,no risk
Apremilast,Zuclopenthixol,The metabolism of Zuclopenthixol can be increased when combined with Apremilast.,increase,no risk
Radium Ra 223 dichloride,Benzocaine,The risk or severity of methemoglobinemia can be increased when Radium Ra 223 dichloride is combined with Benzocaine.,increase,risk
Radium Ra 223 dichloride,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Radium Ra 223 dichloride is combined with Benzyl alcohol.,increase,risk
Radium Ra 223 dichloride,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Radium Ra 223 dichloride is combined with Bupivacaine.,increase,risk
Radium Ra 223 dichloride,Butacaine,The risk or severity of methemoglobinemia can be increased when Radium Ra 223 dichloride is combined with Butacaine.,increase,risk
Radium Ra 223 dichloride,Butamben,The risk or severity of methemoglobinemia can be increased when Radium Ra 223 dichloride is combined with Butamben.,increase,risk
Radium Ra 223 dichloride,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Radium Ra 223 dichloride is combined with Oxetacaine.,increase,risk
Radium Ra 223 dichloride,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Radium Ra 223 dichloride is combined with Oxybuprocaine.,increase,risk
Ustekinumab,Natalizumab,The risk or severity of adverse effects can be increased when Natalizumab is combined with Ustekinumab.,increase,risk
Ustekinumab,Necitumumab,The risk or severity of adverse effects can be increased when Ustekinumab is combined with Necitumumab.,increase,risk
Ustekinumab,Nivolumab,The risk or severity of adverse effects can be increased when Ustekinumab is combined with Nivolumab.,increase,risk
Ustekinumab,Obiltoxaximab,The risk or severity of adverse effects can be increased when Obiltoxaximab is combined with Ustekinumab.,increase,risk
Ustekinumab,Obinutuzumab,The risk or severity of adverse effects can be increased when Ustekinumab is combined with Obinutuzumab.,increase,risk
Ustekinumab,Ocrelizumab,The risk or severity of adverse effects can be increased when Ustekinumab is combined with Ocrelizumab.,increase,risk
Ustekinumab,Odesivimab,The risk or severity of adverse effects can be increased when Ustekinumab is combined with Odesivimab.,increase,risk
Ustekinumab,Ofatumumab,The risk or severity of adverse effects can be increased when Ustekinumab is combined with Ofatumumab.,increase,risk
Ustekinumab,Olaratumab,The risk or severity of adverse effects can be increased when Ustekinumab is combined with Olaratumab.,increase,risk
Ustekinumab,Omalizumab,The risk or severity of adverse effects can be increased when Omalizumab is combined with Ustekinumab.,increase,risk
Ustekinumab,Quinestrol,Quinestrol may increase the thrombogenic activities of Ustekinumab.,increase,no risk
Ustekinumab,Ublituximab,The risk or severity of adverse effects can be increased when Ustekinumab is combined with Ublituximab.,increase,risk
Ustekinumab,Vedolizumab,The risk or severity of adverse effects can be increased when Ustekinumab is combined with Vedolizumab.,increase,risk
BL-1020,Gabapentin,The risk or severity of CNS depression can be increased when Gabapentin is combined with BL-1020.,increase,risk
BL-1020,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when BL-1020 is combined with Gabapentin enacarbil.,increase,risk
BL-1020,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with BL-1020.,increase,risk
BL-1020,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when BL-1020 is combined with Ganaxolone.",increase,risk
BL-1020,Gepirone,The risk or severity of CNS depression can be increased when BL-1020 is combined with Gepirone.,increase,risk
BL-1020,Gliclazide,The therapeutic efficacy of Gliclazide can be decreased when used in combination with BL-1020.,decrease,no risk
BL-1020,Glimepiride,The therapeutic efficacy of Glimepiride can be decreased when used in combination with BL-1020.,decrease,no risk
BL-1020,Glipizide,The therapeutic efficacy of Glipizide can be decreased when used in combination with BL-1020.,decrease,no risk
BL-1020,Gliquidone,The therapeutic efficacy of Gliquidone can be decreased when used in combination with BL-1020.,decrease,no risk
BL-1020,Glutethimide,The risk or severity of CNS depression can be increased when Glutethimide is combined with BL-1020.,increase,risk
BL-1020,Glyburide,The therapeutic efficacy of Glyburide can be decreased when used in combination with BL-1020.,decrease,no risk
BL-1020,Granisetron,The risk or severity of CNS depression can be increased when Granisetron is combined with BL-1020.,increase,risk
BL-1020,Guanfacine,The risk or severity of CNS depression can be increased when Guanfacine is combined with BL-1020.,increase,risk
BL-1020,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with BL-1020.,increase,risk
BL-1020,Halofantrine,The risk or severity of QTc prolongation can be increased when Halofantrine is combined with BL-1020.,increase,risk
BL-1020,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with BL-1020.,increase,risk
BL-1020,Halothane,The risk or severity of CNS depression can be increased when Halothane is combined with BL-1020.,increase,risk
BL-1020,Hexafluronium,The risk or severity of CNS depression can be increased when Hexafluronium is combined with BL-1020.,increase,risk
BL-1020,Hydrocodone,BL-1020 may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
BL-1020,Hydromorphone,The risk or severity of hypotension and CNS depression can be increased when BL-1020 is combined with Hydromorphone.,increase,risk
BL-1020,Hydrotalcite,Hydrotalcite can cause a decrease in the absorption of BL-1020 resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
BL-1020,Hydroxychloroquine,The risk or severity of QTc prolongation can be increased when Hydroxychloroquine is combined with BL-1020.,increase,risk
BL-1020,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of BL-1020.,increase,no risk
BL-1020,Hyoscyamine,BL-1020 may increase the anticholinergic activities of Hyoscyamine.,increase,no risk
BL-1020,Ketamine,The risk or severity of CNS depression can be increased when Ketamine is combined with BL-1020.,increase,risk
BL-1020,Ketazolam,The risk or severity of CNS depression can be increased when Ketazolam is combined with BL-1020.,increase,risk
BL-1020,Nabilone,Nabilone may increase the central nervous system depressant (CNS depressant) activities of BL-1020.,increase,no risk
BL-1020,Nadolol,The serum concentration of Nadolol can be increased when it is combined with BL-1020.,increase,no risk
BL-1020,Nalbuphine,The risk or severity of hypotension and CNS depression can be increased when BL-1020 is combined with Nalbuphine.,increase,risk
BL-1020,Naloxegol,The risk or severity of hypotension and CNS depression can be increased when BL-1020 is combined with Naloxegol.,increase,risk
BL-1020,Naltrexone,The risk or severity of hypotension and CNS depression can be increased when BL-1020 is combined with Naltrexone.,increase,risk
BL-1020,Naratriptan,The risk or severity of adverse effects can be increased when Naratriptan is combined with BL-1020.,increase,risk
BL-1020,Naxitamab,BL-1020 may increase the neurotoxic activities of Naxitamab.,increase,no risk
BL-1020,Nebivolol,The serum concentration of Nebivolol can be increased when it is combined with BL-1020.,increase,no risk
BL-1020,Nefazodone,The risk or severity of adverse effects can be increased when BL-1020 is combined with Nefazodone.,increase,risk
BL-1020,Neomycin,Neomycin may increase the neurotoxic activities of BL-1020.,increase,no risk
BL-1020,Nialamide,The risk or severity of extrapyramidal symptoms can be increased when Nialamide is combined with BL-1020.,increase,risk
BL-1020,Nitrazepam,The risk or severity of CNS depression can be increased when Nitrazepam is combined with BL-1020.,increase,risk
BL-1020,Nitrous oxide,The risk or severity of CNS depression can be increased when BL-1020 is combined with Nitrous oxide.,increase,risk
BL-1020,Nomifensine,The risk or severity of CNS depression can be increased when Nomifensine is combined with BL-1020.,increase,risk
BL-1020,Normethadone,The risk or severity of hypotension and CNS depression can be increased when BL-1020 is combined with Normethadone.,increase,risk
BL-1020,Nortriptyline,The serum concentration of Nortriptyline can be increased when it is combined with BL-1020.,increase,no risk
BL-1020,Olanzapine,The risk or severity of CNS depression can be increased when Olanzapine is combined with BL-1020.,increase,risk
BL-1020,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when BL-1020 is combined with Oliceridine.",increase,risk
BL-1020,Ondansetron,The risk or severity of CNS depression can be increased when Ondansetron is combined with BL-1020.,increase,risk
BL-1020,Opium,The risk or severity of hypotension and CNS depression can be increased when BL-1020 is combined with Opium.,increase,risk
BL-1020,Orphenadrine,BL-1020 may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
BL-1020,Oxazepam,The risk or severity of CNS depression can be increased when Oxazepam is combined with BL-1020.,increase,risk
BL-1020,Oxcarbazepine,The risk or severity of CNS depression can be increased when Oxcarbazepine is combined with BL-1020.,increase,risk
BL-1020,Oxitriptan,The risk or severity of CNS depression can be increased when Oxitriptan is combined with BL-1020.,increase,risk
BL-1020,Oxprenolol,The serum concentration of Oxprenolol can be increased when it is combined with BL-1020.,increase,no risk
BL-1020,Oxybuprocaine,The risk or severity of CNS depression can be increased when Oxybuprocaine is combined with BL-1020.,increase,risk
BL-1020,Oxycodone,The risk or severity of hypotension and CNS depression can be increased when BL-1020 is combined with Oxycodone.,increase,risk
BL-1020,Oxymorphone,The risk or severity of hypotension and CNS depression can be increased when BL-1020 is combined with Oxymorphone.,increase,risk
BL-1020,Quazepam,The risk or severity of CNS depression can be increased when Quazepam is combined with BL-1020.,increase,risk
BL-1020,Quetiapine,The risk or severity of CNS depression can be increased when Quetiapine is combined with BL-1020.,increase,risk
BL-1020,Quinagolide,The therapeutic efficacy of Quinagolide can be decreased when used in combination with BL-1020.,decrease,no risk
BL-1020,Quinidine,The risk or severity of QTc prolongation can be increased when Quinidine is combined with BL-1020.,increase,risk
BL-1020,Quinine,The risk or severity of QTc prolongation can be increased when Quinine is combined with BL-1020.,increase,risk
Vorapaxar,Butalbital,The metabolism of Vorapaxar can be increased when combined with Butalbital.,increase,no risk
Vorapaxar,Gemcitabine,The serum concentration of Gemcitabine can be increased when it is combined with Vorapaxar.,increase,no risk
Vorapaxar,Gemtuzumab ozogamicin,The risk or severity of bleeding can be increased when Vorapaxar is combined with Gemtuzumab ozogamicin.,increase,risk
Vorapaxar,Gestrinone,The risk or severity of adverse effects can be increased when Gestrinone is combined with Vorapaxar.,increase,risk
Vorapaxar,Gilteritinib,The serum concentration of Gilteritinib can be increased when it is combined with Vorapaxar.,increase,no risk
Vorapaxar,Ginkgo biloba,Ginkgo biloba may increase the anticoagulant activities of Vorapaxar.,increase,no risk
Vorapaxar,Glasdegib,The serum concentration of Glasdegib can be increased when it is combined with Vorapaxar.,increase,no risk
Vorapaxar,Glecaprevir,The serum concentration of Glecaprevir can be increased when it is combined with Vorapaxar.,increase,no risk
Vorapaxar,Glofitamab,The serum concentration of Vorapaxar can be increased when it is combined with Glofitamab.,increase,no risk
Vorapaxar,Glucosamine,Glucosamine may increase the antiplatelet activities of Vorapaxar.,increase,no risk
Vorapaxar,Glyburide,The metabolism of Vorapaxar can be decreased when combined with Glyburide.,decrease,no risk
Vorapaxar,Glycerol phenylbutyrate,The metabolism of Vorapaxar can be increased when combined with Glycerol phenylbutyrate.,increase,no risk
Vorapaxar,Glycol salicylate,The risk or severity of bleeding and hemorrhage can be increased when Glycol salicylate is combined with Vorapaxar.,increase,risk
Vorapaxar,Golimumab,The metabolism of Vorapaxar can be increased when combined with Golimumab.,increase,no risk
Vorapaxar,Grapefruit,The metabolism of Vorapaxar can be decreased when combined with Grapefruit.,decrease,no risk
Vorapaxar,Grazoprevir,The serum concentration of Grazoprevir can be increased when it is combined with Vorapaxar.,increase,no risk
Vorapaxar,Griseofulvin,The metabolism of Vorapaxar can be increased when combined with Griseofulvin.,increase,no risk
Vorapaxar,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Vorapaxar.,increase,no risk
Vorapaxar,Hemin,Hemin may increase the anticoagulant activities of Vorapaxar.,increase,no risk
Vorapaxar,Heparin,The risk or severity of bleeding and hemorrhage can be increased when Vorapaxar is combined with Heparin.,increase,risk
Vorapaxar,Hydralazine,The metabolism of Vorapaxar can be decreased when combined with Hydralazine.,decrease,no risk
Vorapaxar,Hydrochlorothiazide,The therapeutic efficacy of Vorapaxar can be decreased when used in combination with Hydrochlorothiazide.,decrease,no risk
Vorapaxar,Hydrocortamate,The metabolism of Vorapaxar can be increased when combined with Hydrocortamate.,increase,no risk
Vorapaxar,Hydrocortisone,The metabolism of Vorapaxar can be increased when combined with Hydrocortisone.,increase,no risk
Vorapaxar,Hydrocortisone acetate,The metabolism of Vorapaxar can be increased when combined with Hydrocortisone acetate.,increase,no risk
Vorapaxar,Hydrocortisone butyrate,The metabolism of Vorapaxar can be increased when combined with Hydrocortisone butyrate.,increase,no risk
Vorapaxar,Hydrocortisone succinate,The metabolism of Vorapaxar can be increased when combined with Hydrocortisone succinate.,increase,no risk
Vorapaxar,Hydroflumethiazide,The therapeutic efficacy of Vorapaxar can be decreased when used in combination with Hydroflumethiazide.,decrease,no risk
Vorapaxar,Hydroxyprogesterone caproate,The therapeutic efficacy of Vorapaxar can be decreased when used in combination with Hydroxyprogesterone caproate.,decrease,no risk
Vorapaxar,Hydroxyurea,The risk or severity of bleeding can be increased when Vorapaxar is combined with Hydroxyurea.,increase,risk
Vorapaxar,Ketazolam,The metabolism of Vorapaxar can be decreased when combined with Ketazolam.,decrease,no risk
Vorapaxar,Ketoconazole,The metabolism of Vorapaxar can be decreased when combined with Ketoconazole.,decrease,no risk
Vorapaxar,Ketoprofen,The risk or severity of bleeding and hemorrhage can be increased when Ketoprofen is combined with Vorapaxar.,increase,risk
Vorapaxar,Ketorolac,The risk or severity of bleeding and hemorrhage can be increased when Ketorolac is combined with Vorapaxar.,increase,risk
Vorapaxar,Nabumetone,The risk or severity of bleeding and hemorrhage can be increased when Nabumetone is combined with Vorapaxar.,increase,risk
Vorapaxar,Nadroparin,The risk or severity of bleeding and hemorrhage can be increased when Vorapaxar is combined with Nadroparin.,increase,risk
Vorapaxar,Nafcillin,The metabolism of Vorapaxar can be increased when combined with Nafcillin.,increase,no risk
Vorapaxar,Naloxegol,The serum concentration of Naloxegol can be increased when it is combined with Vorapaxar.,increase,no risk
Vorapaxar,Naproxen,The risk or severity of bleeding and hemorrhage can be increased when Naproxen is combined with Vorapaxar.,increase,risk
Vorapaxar,Nefazodone,The metabolism of Vorapaxar can be decreased when combined with Nefazodone.,decrease,no risk
Vorapaxar,Nelarabine,The risk or severity of bleeding can be increased when Vorapaxar is combined with Nelarabine.,increase,risk
Vorapaxar,Nelfinavir,The metabolism of Vorapaxar can be decreased when combined with Nelfinavir.,decrease,no risk
Vorapaxar,Neratinib,The metabolism of Neratinib can be decreased when combined with Vorapaxar.,decrease,no risk
Vorapaxar,Netupitant,The metabolism of Vorapaxar can be decreased when combined with Netupitant.,decrease,no risk
Vorapaxar,Niacin,The metabolism of Vorapaxar can be decreased when combined with Niacin.,decrease,no risk
Vorapaxar,Nialamide,The risk or severity of bleeding and hemorrhage can be increased when Nialamide is combined with Vorapaxar.,increase,risk
Vorapaxar,Nicardipine,The metabolism of Vorapaxar can be decreased when combined with Nicardipine.,decrease,no risk
Vorapaxar,Nilotinib,The metabolism of Vorapaxar can be decreased when combined with Nilotinib.,decrease,no risk
Vorapaxar,Nilvadipine,The metabolism of Vorapaxar can be decreased when combined with Nilvadipine.,decrease,no risk
Vorapaxar,Nimesulide,The risk or severity of bleeding and hemorrhage can be increased when Nimesulide is combined with Vorapaxar.,increase,risk
Vorapaxar,Nintedanib,The risk or severity of bleeding can be increased when Nintedanib is combined with Vorapaxar.,increase,risk
Vorapaxar,Nirogacestat,The serum concentration of Nirogacestat can be increased when it is combined with Vorapaxar.,increase,no risk
Vorapaxar,Nomegestrol,The therapeutic efficacy of Vorapaxar can be decreased when used in combination with Nomegestrol.,decrease,no risk
Vorapaxar,Nomegestrol acetate,The risk or severity of adverse effects can be increased when Nomegestrol acetate is combined with Vorapaxar.,increase,risk
Vorapaxar,Nonacog beta pegol,The therapeutic efficacy of Nonacog beta pegol can be decreased when used in combination with Vorapaxar.,decrease,no risk
Vorapaxar,Norelgestromin,The therapeutic efficacy of Vorapaxar can be decreased when used in combination with Norelgestromin.,decrease,no risk
Vorapaxar,Norethisterone,The risk or severity of adverse effects can be increased when Norethisterone is combined with Vorapaxar.,increase,risk
Vorapaxar,Norethynodrel,The risk or severity of adverse effects can be increased when Norethynodrel is combined with Vorapaxar.,increase,risk
Vorapaxar,Norgestimate,The risk or severity of adverse effects can be increased when Norgestimate is combined with Vorapaxar.,increase,risk
Vorapaxar,Norgestrel,The risk or severity of adverse effects can be increased when Norgestrel is combined with Vorapaxar.,increase,risk
Vorapaxar,Nortriptyline,The serum concentration of Nortriptyline can be increased when it is combined with Vorapaxar.,increase,no risk
Vorapaxar,Noscapine,The metabolism of Vorapaxar can be decreased when combined with Noscapine.,decrease,no risk
Vorapaxar,Obeticholic acid,The risk or severity of adverse effects can be increased when Vorapaxar is combined with Obeticholic acid.,increase,risk
Vorapaxar,Obinutuzumab,The risk or severity of adverse effects can be increased when Vorapaxar is combined with Obinutuzumab.,increase,risk
Vorapaxar,Octreotide,The metabolism of Vorapaxar can be decreased when combined with Octreotide.,decrease,no risk
Vorapaxar,Olaparib,The metabolism of Olaparib can be decreased when combined with Vorapaxar.,decrease,no risk
Vorapaxar,Olive oil,The therapeutic efficacy of Vorapaxar can be decreased when used in combination with Olive oil.,decrease,no risk
Vorapaxar,Olsalazine,The risk or severity of bleeding can be increased when Olsalazine is combined with Vorapaxar.,increase,risk
Vorapaxar,Olutasidenib,The metabolism of Vorapaxar can be increased when combined with Olutasidenib.,increase,no risk
Vorapaxar,Omacetaxine mepesuccinate,The risk or severity of bleeding can be increased when Vorapaxar is combined with Omacetaxine mepesuccinate.,increase,risk
Vorapaxar,Omadacycline,The serum concentration of Omadacycline can be increased when it is combined with Vorapaxar.,increase,no risk
Vorapaxar,Omaveloxolone,The serum concentration of Vorapaxar can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Vorapaxar,Ombitasvir,The serum concentration of Ombitasvir can be increased when it is combined with Vorapaxar.,increase,no risk
Vorapaxar,Omega-3 fatty acids,Omega-3 fatty acids may increase the antiplatelet activities of Vorapaxar.,increase,no risk
Vorapaxar,Omega-3-acid ethyl esters,The risk or severity of bleeding can be increased when Omega-3-acid ethyl esters is combined with Vorapaxar.,increase,risk
Vorapaxar,Omega-3-carboxylic acids,The therapeutic efficacy of Vorapaxar can be increased when used in combination with Omega-3-carboxylic acids.,increase,no risk
Vorapaxar,Oritavancin,The metabolism of Vorapaxar can be increased when combined with Oritavancin.,increase,no risk
Vorapaxar,Orphenadrine,The metabolism of Vorapaxar can be decreased when combined with Orphenadrine.,decrease,no risk
Vorapaxar,Osilodrostat,The metabolism of Vorapaxar can be decreased when combined with Osilodrostat.,decrease,no risk
Vorapaxar,Osimertinib,The serum concentration of Osimertinib can be increased when it is combined with Vorapaxar.,increase,no risk
Vorapaxar,Oxaliplatin,The risk or severity of hemorrhage can be increased when Oxaliplatin is combined with Vorapaxar.,increase,risk
Vorapaxar,Oxaprozin,The risk or severity of bleeding and hemorrhage can be increased when Oxaprozin is combined with Vorapaxar.,increase,risk
Vorapaxar,Oxcarbazepine,The metabolism of Vorapaxar can be increased when combined with Oxcarbazepine.,increase,no risk
Vorapaxar,Oxybutynin,The metabolism of Vorapaxar can be decreased when combined with Oxybutynin.,decrease,no risk
Vorapaxar,Oxyphenbutazone,The risk or severity of bleeding and hemorrhage can be increased when Oxyphenbutazone is combined with Vorapaxar.,increase,risk
Vorapaxar,Quinestrol,Quinestrol may decrease the anticoagulant activities of Vorapaxar.,decrease,no risk
Vorapaxar,Quinidine,The therapeutic efficacy of Vorapaxar can be increased when used in combination with Quinidine.,increase,no risk
Vorapaxar,Quinine,The therapeutic efficacy of Vorapaxar can be increased when used in combination with Quinine.,increase,no risk
Vorapaxar,Quinupristin,The metabolism of Vorapaxar can be decreased when combined with Quinupristin.,decrease,no risk
Vorapaxar,Quizartinib,The serum concentration of Quizartinib can be increased when it is combined with Vorapaxar.,increase,no risk
Vorapaxar,Ubrogepant,The serum concentration of Ubrogepant can be increased when it is combined with Vorapaxar.,increase,no risk
Vorapaxar,Ulipristal,The therapeutic efficacy of Vorapaxar can be decreased when used in combination with Ulipristal.,decrease,no risk
Vorapaxar,Umeclidinium,The serum concentration of Umeclidinium can be increased when it is combined with Vorapaxar.,increase,no risk
Vorapaxar,Urokinase,Urokinase may increase the anticoagulant activities of Vorapaxar.,increase,no risk
Vorapaxar,Ursodeoxycholic acid,The risk or severity of adverse effects can be increased when Vorapaxar is combined with Ursodeoxycholic acid.,increase,risk
Vorapaxar,Vadadustat,The serum concentration of Vorapaxar can be increased when it is combined with Vadadustat.,increase,no risk
Vorapaxar,Valdecoxib,The risk or severity of bleeding and hemorrhage can be increased when Valdecoxib is combined with Vorapaxar.,increase,risk
Vorapaxar,Valproic acid,The metabolism of Vorapaxar can be decreased when combined with Valproic acid.,decrease,no risk
Vorapaxar,Vandetanib,The metabolism of Vandetanib can be decreased when combined with Vorapaxar.,decrease,no risk
Vorapaxar,Vardenafil,The serum concentration of Vardenafil can be increased when it is combined with Vorapaxar.,increase,no risk
Vorapaxar,Velpatasvir,The serum concentration of Velpatasvir can be increased when it is combined with Vorapaxar.,increase,no risk
Vorapaxar,Vemurafenib,The serum concentration of Vemurafenib can be increased when it is combined with Vorapaxar.,increase,no risk
Vorapaxar,Venetoclax,The serum concentration of Venetoclax can be increased when it is combined with Vorapaxar.,increase,no risk
Vorapaxar,Venlafaxine,The risk or severity of bleeding can be increased when Vorapaxar is combined with Venlafaxine.,increase,risk
Vorapaxar,Verapamil,The metabolism of Vorapaxar can be decreased when combined with Verapamil.,decrease,no risk
Vorapaxar,Viloxazine,The metabolism of Vorapaxar can be decreased when combined with Viloxazine.,decrease,no risk
Vorapaxar,Vinblastine,The serum concentration of Vinblastine can be increased when it is combined with Vorapaxar.,increase,no risk
Vorapaxar,Vincristine,The excretion of Vincristine can be decreased when combined with Vorapaxar.,decrease,no risk
Vorapaxar,Vindesine,The metabolism of Vindesine can be decreased when combined with Vorapaxar.,decrease,no risk
Vorapaxar,Vinflunine,The serum concentration of Vinflunine can be increased when it is combined with Vorapaxar.,increase,no risk
Vorapaxar,Vinorelbine,The metabolism of Vinorelbine can be decreased when combined with Vorapaxar.,decrease,no risk
Vorapaxar,Vitamin E,Vitamin E may increase the antiplatelet activities of Vorapaxar.,increase,no risk
Vorapaxar,Voclosporin,The serum concentration of Voclosporin can be increased when it is combined with Vorapaxar.,increase,no risk
Vorapaxar,Von Willebrand factor human,The therapeutic efficacy of Von Willebrand factor human can be decreased when used in combination with Vorapaxar.,decrease,no risk
Vorapaxar,Voriconazole,The metabolism of Vorapaxar can be decreased when combined with Voriconazole.,decrease,no risk
Vorapaxar,Vorinostat,The risk or severity of bleeding can be increased when Vorapaxar is combined with Vorinostat.,increase,risk
Vorapaxar,Vortioxetine,The risk or severity of bleeding can be increased when Vortioxetine is combined with Vorapaxar.,increase,risk
Vorapaxar,Voxilaprevir,The serum concentration of Voxilaprevir can be increased when it is combined with Vorapaxar.,increase,no risk
Vorapaxar,Warfarin,The risk or severity of bleeding and hemorrhage can be increased when Vorapaxar is combined with Warfarin.,increase,risk
Vorapaxar,Ximelagatran,The risk or severity of bleeding and hemorrhage can be increased when Vorapaxar is combined with Ximelagatran.,increase,risk
Vorapaxar,Zafirlukast,The metabolism of Vorapaxar can be decreased when combined with Zafirlukast.,decrease,no risk
Vorapaxar,Zanubrutinib,The metabolism of Zanubrutinib can be decreased when combined with Vorapaxar.,decrease,no risk
Vorapaxar,Zidovudine,The risk or severity of bleeding can be increased when Vorapaxar is combined with Zidovudine.,increase,risk
Vorapaxar,Zimelidine,The risk or severity of hemorrhage can be increased when Zimelidine is combined with Vorapaxar.,increase,risk
Vorapaxar,Ziprasidone,The metabolism of Vorapaxar can be decreased when combined with Ziprasidone.,decrease,no risk
Vorapaxar,Zuclopenthixol,The metabolism of Vorapaxar can be decreased when combined with Zuclopenthixol.,decrease,no risk
Elagolix,Galantamine,The metabolism of Elagolix can be decreased when combined with Galantamine.,decrease,no risk
Elagolix,Gefitinib,The metabolism of Elagolix can be decreased when combined with Gefitinib.,decrease,no risk
Elagolix,Gemcitabine,The serum concentration of Gemcitabine can be increased when it is combined with Elagolix.,increase,no risk
Elagolix,Gemfibrozil,The metabolism of Elagolix can be decreased when combined with Gemfibrozil.,decrease,no risk
Elagolix,Gilteritinib,The serum concentration of Gilteritinib can be increased when it is combined with Elagolix.,increase,no risk
Elagolix,Givosiran,The serum concentration of Elagolix can be increased when it is combined with Givosiran.,increase,no risk
Elagolix,Glasdegib,The serum concentration of Elagolix can be increased when it is combined with Glasdegib.,increase,no risk
Elagolix,Glecaprevir,The serum concentration of Glecaprevir can be increased when it is combined with Elagolix.,increase,no risk
Elagolix,Glycerol phenylbutyrate,The metabolism of Elagolix can be decreased when combined with Glycerol phenylbutyrate.,decrease,no risk
Elagolix,Golimumab,The metabolism of Elagolix can be increased when combined with Golimumab.,increase,no risk
Elagolix,Grazoprevir,The serum concentration of Grazoprevir can be increased when it is combined with Elagolix.,increase,no risk
Elagolix,Halofantrine,The metabolism of Elagolix can be decreased when combined with Halofantrine.,decrease,no risk
Elagolix,Haloperidol,The serum concentration of Elagolix can be increased when it is combined with Haloperidol.,increase,no risk
Elagolix,Hydrocortisone,The metabolism of Elagolix can be increased when combined with Hydrocortisone.,increase,no risk
Elagolix,Hydroxychloroquine,The metabolism of Elagolix can be decreased when combined with Hydroxychloroquine.,decrease,no risk
Elagolix,Hydroxyzine,The metabolism of Elagolix can be decreased when combined with Hydroxyzine.,decrease,no risk
Elagolix,Ketamine,The metabolism of Elagolix can be decreased when combined with Ketamine.,decrease,no risk
Elagolix,Ketoconazole,The metabolism of Elagolix can be decreased when combined with Ketoconazole.,decrease,no risk
Elagolix,Ketoprofen,The metabolism of Elagolix can be decreased when combined with Ketoprofen.,decrease,no risk
Elagolix,Ketorolac,The metabolism of Elagolix can be decreased when combined with Ketorolac.,decrease,no risk
Elagolix,Nadolol,The metabolism of Elagolix can be decreased when combined with Nadolol.,decrease,no risk
Elagolix,Naloxegol,The serum concentration of Naloxegol can be increased when it is combined with Elagolix.,increase,no risk
Elagolix,Naproxen,The metabolism of Elagolix can be decreased when combined with Naproxen.,decrease,no risk
Elagolix,Nateglinide,The metabolism of Elagolix can be decreased when combined with Nateglinide.,decrease,no risk
Elagolix,Nebivolol,The metabolism of Elagolix can be decreased when combined with Nebivolol.,decrease,no risk
Elagolix,Nefazodone,The metabolism of Elagolix can be decreased when combined with Nefazodone.,decrease,no risk
Elagolix,Nelfinavir,The metabolism of Elagolix can be increased when combined with Nelfinavir.,increase,no risk
Elagolix,Neratinib,The serum concentration of Elagolix can be increased when it is combined with Neratinib.,increase,no risk
Elagolix,Netupitant,The serum concentration of Elagolix can be increased when it is combined with Netupitant.,increase,no risk
Elagolix,Nevirapine,The metabolism of Elagolix can be decreased when combined with Nevirapine.,decrease,no risk
Elagolix,Niacin,The metabolism of Elagolix can be decreased when combined with Niacin.,decrease,no risk
Elagolix,Nicardipine,The metabolism of Elagolix can be decreased when combined with Nicardipine.,decrease,no risk
Elagolix,Nicergoline,The metabolism of Elagolix can be decreased when combined with Nicergoline.,decrease,no risk
Elagolix,Nifedipine,The metabolism of Elagolix can be decreased when combined with Nifedipine.,decrease,no risk
Elagolix,Nilotinib,The serum concentration of Elagolix can be increased when it is combined with Nilotinib.,increase,no risk
Elagolix,Nilutamide,The metabolism of Elagolix can be decreased when combined with Nilutamide.,decrease,no risk
Elagolix,Nilvadipine,The metabolism of Elagolix can be decreased when combined with Nilvadipine.,decrease,no risk
Elagolix,Nintedanib,The serum concentration of Nintedanib can be increased when it is combined with Elagolix.,increase,no risk
Elagolix,Nirogacestat,The serum concentration of Nirogacestat can be increased when it is combined with Elagolix.,increase,no risk
Elagolix,Norgestimate,The serum concentration of Elagolix can be increased when it is combined with Norgestimate.,increase,no risk
Elagolix,Nortriptyline,The serum concentration of Nortriptyline can be increased when it is combined with Elagolix.,increase,no risk
Elagolix,Novobiocin,The excretion of Elagolix can be decreased when combined with Novobiocin.,decrease,no risk
Elagolix,Nystatin,The excretion of Elagolix can be decreased when combined with Nystatin.,decrease,no risk
Elagolix,Olanzapine,The metabolism of Elagolix can be decreased when combined with Olanzapine.,decrease,no risk
Elagolix,Oliceridine,The metabolism of Oliceridine can be decreased when combined with Elagolix.,decrease,no risk
Elagolix,Olodaterol,The metabolism of Elagolix can be decreased when combined with Olodaterol.,decrease,no risk
Elagolix,Omadacycline,The serum concentration of Omadacycline can be increased when it is combined with Elagolix.,increase,no risk
Elagolix,Omaveloxolone,The serum concentration of Elagolix can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Elagolix,Ombitasvir,The serum concentration of Ombitasvir can be increased when it is combined with Elagolix.,increase,no risk
Elagolix,Ondansetron,The metabolism of Elagolix can be decreased when combined with Ondansetron.,decrease,no risk
Elagolix,Opium,The metabolism of Elagolix can be decreased when combined with Opium.,decrease,no risk
Elagolix,Oritavancin,The metabolism of Elagolix can be decreased when combined with Oritavancin.,decrease,no risk
Elagolix,Orphenadrine,The metabolism of Elagolix can be decreased when combined with Orphenadrine.,decrease,no risk
Elagolix,Osilodrostat,The metabolism of Elagolix can be decreased when combined with Osilodrostat.,decrease,no risk
Elagolix,Osimertinib,The serum concentration of Osimertinib can be increased when it is combined with Elagolix.,increase,no risk
Elagolix,Ospemifene,The metabolism of Elagolix can be decreased when combined with Ospemifene.,decrease,no risk
Elagolix,Ouabain,The excretion of Elagolix can be decreased when combined with Ouabain.,decrease,no risk
Elagolix,Oxamniquine,The metabolism of Elagolix can be decreased when combined with Oxamniquine.,decrease,no risk
Elagolix,Oxprenolol,The metabolism of Elagolix can be decreased when combined with Oxprenolol.,decrease,no risk
Elagolix,Oxybutynin,The metabolism of Elagolix can be decreased when combined with Oxybutynin.,decrease,no risk
Elagolix,Oxycodone,The metabolism of Elagolix can be decreased when combined with Oxycodone.,decrease,no risk
Elagolix,Oxymorphone,The metabolism of Elagolix can be decreased when combined with Oxymorphone.,decrease,no risk
Elagolix,Ozanimod,The metabolism of Ozanimod can be decreased when combined with Elagolix.,decrease,no risk
Elagolix,Quetiapine,The metabolism of Elagolix can be decreased when combined with Quetiapine.,decrease,no risk
Elagolix,Quinidine,The serum concentration of Quinidine can be increased when it is combined with Elagolix.,increase,no risk
Elagolix,Quinine,The metabolism of Elagolix can be decreased when combined with Quinine.,decrease,no risk
Elagolix,Quizartinib,The serum concentration of Quizartinib can be increased when it is combined with Elagolix.,increase,no risk
Elagolix,Ubrogepant,The serum concentration of Ubrogepant can be increased when it is combined with Elagolix.,increase,no risk
Elagolix,Umbralisib,The serum concentration of Elagolix can be increased when it is combined with Umbralisib.,increase,no risk
Elagolix,Umeclidinium,The serum concentration of Umeclidinium can be increased when it is combined with Elagolix.,increase,no risk
Elagolix,Vadadustat,The serum concentration of Elagolix can be increased when it is combined with Vadadustat.,increase,no risk
Elagolix,Valbenazine,The metabolism of Elagolix can be decreased when combined with Valbenazine.,decrease,no risk
Elagolix,Valproic acid,The metabolism of Elagolix can be decreased when combined with Valproic acid.,decrease,no risk
Elagolix,Valsartan,The excretion of Elagolix can be decreased when combined with Valsartan.,decrease,no risk
Elagolix,Vandetanib,The serum concentration of Elagolix can be increased when it is combined with Vandetanib.,increase,no risk
Elagolix,Vardenafil,The serum concentration of Elagolix can be increased when it is combined with Vardenafil.,increase,no risk
Elagolix,Velpatasvir,The serum concentration of Elagolix can be increased when it is combined with Velpatasvir.,increase,no risk
Elagolix,Vemurafenib,The serum concentration of Elagolix can be increased when it is combined with Vemurafenib.,increase,no risk
Elagolix,Venetoclax,The serum concentration of Venetoclax can be increased when it is combined with Elagolix.,increase,no risk
Elagolix,Venlafaxine,The metabolism of Elagolix can be decreased when combined with Venlafaxine.,decrease,no risk
Elagolix,Verapamil,The serum concentration of Elagolix can be increased when it is combined with Verapamil.,increase,no risk
Elagolix,Vernakalant,The metabolism of Elagolix can be decreased when combined with Vernakalant.,decrease,no risk
Elagolix,Vilazodone,The metabolism of Elagolix can be decreased when combined with Vilazodone.,decrease,no risk
Elagolix,Viloxazine,The metabolism of Elagolix can be decreased when combined with Viloxazine.,decrease,no risk
Elagolix,Vinblastine,The serum concentration of Vinblastine can be increased when it is combined with Elagolix.,increase,no risk
Elagolix,Vincristine,The excretion of Vincristine can be decreased when combined with Elagolix.,decrease,no risk
Elagolix,Vinflunine,The serum concentration of Vinflunine can be increased when it is combined with Elagolix.,increase,no risk
Elagolix,Vinorelbine,The metabolism of Elagolix can be decreased when combined with Vinorelbine.,decrease,no risk
Elagolix,Voclosporin,The serum concentration of Elagolix can be increased when it is combined with Voclosporin.,increase,no risk
Elagolix,Vorapaxar,The serum concentration of Elagolix can be increased when it is combined with Vorapaxar.,increase,no risk
Elagolix,Vortioxetine,The metabolism of Elagolix can be decreased when combined with Vortioxetine.,decrease,no risk
Elagolix,Voxilaprevir,The serum concentration of Voxilaprevir can be increased when it is combined with Elagolix.,increase,no risk
Elagolix,Yohimbine,The metabolism of Elagolix can be decreased when combined with Yohimbine.,decrease,no risk
Elagolix,Zidovudine,The metabolism of Elagolix can be increased when combined with Zidovudine.,increase,no risk
Elagolix,Zolpidem,The metabolism of Elagolix can be decreased when combined with Zolpidem.,decrease,no risk
Elagolix,Zonisamide,The serum concentration of Elagolix can be increased when it is combined with Zonisamide.,increase,no risk
Elagolix,Zopiclone,The metabolism of Elagolix can be decreased when combined with Zopiclone.,decrease,no risk
Elagolix,Zuclopenthixol,The metabolism of Elagolix can be decreased when combined with Zuclopenthixol.,decrease,no risk
Trabedersen,Benzocaine,The risk or severity of methemoglobinemia can be increased when Trabedersen is combined with Benzocaine.,increase,risk
Trabedersen,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Trabedersen is combined with Benzyl alcohol.,increase,risk
Trabedersen,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Trabedersen is combined with Bupivacaine.,increase,risk
Trabedersen,Butacaine,The risk or severity of methemoglobinemia can be increased when Trabedersen is combined with Butacaine.,increase,risk
Trabedersen,Butamben,The risk or severity of methemoglobinemia can be increased when Trabedersen is combined with Butamben.,increase,risk
Trabedersen,Nelarabine,The risk or severity of adverse effects can be increased when Nelarabine is combined with Trabedersen.,increase,risk
Trabedersen,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Trabedersen is combined with Oxetacaine.,increase,risk
Trabedersen,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Trabedersen is combined with Oxybuprocaine.,increase,risk
Vortioxetine,Bacitracin,Bacitracin may decrease the excretion rate of Vortioxetine which could result in a higher serum level.,decrease,no risk
Vortioxetine,Baclofen,Baclofen may increase the central nervous system depressant (CNS depressant) activities of Vortioxetine.,increase,no risk
Vortioxetine,Balsalazide,The risk or severity of hypertension can be increased when Balsalazide is combined with Vortioxetine.,increase,risk
Vortioxetine,Baricitinib,Vortioxetine may decrease the excretion rate of Baricitinib which could result in a higher serum level.,decrease,no risk
Vortioxetine,Beclomethasone dipropionate,The metabolism of Vortioxetine can be increased when combined with Beclomethasone dipropionate.,increase,no risk
Vortioxetine,Belzutifan,The metabolism of Belzutifan can be decreased when combined with Vortioxetine.,decrease,no risk
Vortioxetine,Benazepril,Vortioxetine may decrease the antihypertensive activities of Benazepril.,decrease,no risk
Vortioxetine,Bendroflumethiazide,Bendroflumethiazide may increase the excretion rate of Vortioxetine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Vortioxetine,Benorilate,The risk or severity of hypertension can be increased when Vortioxetine is combined with Benorilate.,increase,risk
Vortioxetine,Benoxaprofen,The risk or severity of hypertension can be increased when Benoxaprofen is combined with Vortioxetine.,increase,risk
Vortioxetine,Benperidol,The risk or severity of adverse effects can be increased when Vortioxetine is combined with Benperidol.,increase,risk
Vortioxetine,Benserazide,Vortioxetine may decrease the excretion rate of Benserazide which could result in a higher serum level.,decrease,no risk
Vortioxetine,Benzatropine,Benzatropine may decrease the excretion rate of Vortioxetine which could result in a higher serum level.,decrease,no risk
Vortioxetine,Benznidazole,Vortioxetine may decrease the excretion rate of Benznidazole which could result in a higher serum level.,decrease,no risk
Vortioxetine,Benzocaine,The risk or severity of CNS depression can be increased when Benzocaine is combined with Vortioxetine.,increase,risk
Vortioxetine,Benzphetamine,The risk or severity of CNS depression can be increased when Benzphetamine is combined with Vortioxetine.,increase,risk
Vortioxetine,Benzthiazide,Benzthiazide may increase the excretion rate of Vortioxetine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Vortioxetine,Benzydamine,The risk or severity of hypertension can be increased when Vortioxetine is combined with Benzydamine.,increase,risk
Vortioxetine,Benzyl alcohol,The risk or severity of CNS depression can be increased when Benzyl alcohol is combined with Vortioxetine.,increase,risk
Vortioxetine,Bepotastine,Bepotastine may decrease the excretion rate of Vortioxetine which could result in a higher serum level.,decrease,no risk
Vortioxetine,Bepridil,The metabolism of Vortioxetine can be decreased when combined with Bepridil.,decrease,no risk
Vortioxetine,Berotralstat,The metabolism of Vortioxetine can be decreased when combined with Berotralstat.,decrease,no risk
Vortioxetine,Betamethasone,The metabolism of Vortioxetine can be increased when combined with Betamethasone.,increase,no risk
Vortioxetine,Betamethasone phosphate,The metabolism of Vortioxetine can be increased when combined with Betamethasone phosphate.,increase,no risk
Vortioxetine,Betaxolol,Vortioxetine may decrease the antihypertensive activities of Betaxolol.,decrease,no risk
Vortioxetine,Bethanidine,Vortioxetine may decrease the antihypertensive activities of Bethanidine.,decrease,no risk
Vortioxetine,Bexarotene,The metabolism of Vortioxetine can be decreased when combined with Bexarotene.,decrease,no risk
Vortioxetine,Bezafibrate,The metabolism of Vortioxetine can be decreased when combined with Bezafibrate.,decrease,no risk
Vortioxetine,Bicisate,Vortioxetine may decrease the excretion rate of Bicisate which could result in a higher serum level.,decrease,no risk
Vortioxetine,Bimekizumab,The metabolism of Vortioxetine can be increased when combined with Bimekizumab.,increase,no risk
Vortioxetine,Biperiden,The metabolism of Vortioxetine can be decreased when combined with Biperiden.,decrease,no risk
Vortioxetine,Bismuth subgallate,Vortioxetine may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Vortioxetine,Bisoprolol,Vortioxetine may decrease the antihypertensive activities of Bisoprolol.,decrease,no risk
Vortioxetine,Bisoxatin,Vortioxetine may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,decrease,no risk
Vortioxetine,Bleomycin,Bleomycin may decrease the excretion rate of Vortioxetine which could result in a higher serum level.,decrease,no risk
Vortioxetine,Boceprevir,The metabolism of Vortioxetine can be decreased when combined with Boceprevir.,decrease,no risk
Vortioxetine,Bortezomib,The metabolism of Vortioxetine can be decreased when combined with Bortezomib.,decrease,no risk
Vortioxetine,Bosentan,The metabolism of Vortioxetine can be increased when combined with Bosentan.,increase,no risk
Vortioxetine,Bosutinib,The metabolism of Vortioxetine can be decreased when combined with Bosutinib.,decrease,no risk
Vortioxetine,Botulinum toxin type A,The risk or severity of CNS depression can be increased when Botulinum toxin type A is combined with Vortioxetine.,increase,risk
Vortioxetine,Botulinum toxin type B,The risk or severity of CNS depression can be increased when Botulinum toxin type B is combined with Vortioxetine.,increase,risk
Vortioxetine,Bretylium,Vortioxetine may decrease the antihypertensive activities of Bretylium.,decrease,no risk
Vortioxetine,Brexanolone,The risk or severity of CNS depression can be increased when Vortioxetine is combined with Brexanolone.,increase,risk
Vortioxetine,Brexpiprazole,The risk or severity of adverse effects can be increased when Vortioxetine is combined with Brexpiprazole.,increase,risk
Vortioxetine,Brigatinib,The metabolism of Brigatinib can be decreased when combined with Vortioxetine.,decrease,no risk
Vortioxetine,Brimonidine,Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Vortioxetine.,increase,no risk
Vortioxetine,Brivaracetam,The risk or severity of CNS depression can be increased when Brivaracetam is combined with Vortioxetine.,increase,risk
Vortioxetine,Bromazepam,The risk or severity of CNS depression can be increased when Bromazepam is combined with Vortioxetine.,increase,risk
Vortioxetine,Bromocriptine,Bromocriptine may increase the vasoconstricting activities of Vortioxetine.,increase,no risk
Vortioxetine,Bromotheophylline,Bromotheophylline may increase the excretion rate of Vortioxetine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Vortioxetine,Bromperidol,The risk or severity of adverse effects can be increased when Vortioxetine is combined with Bromperidol.,increase,risk
Vortioxetine,Brompheniramine,The risk or severity of CNS depression can be increased when Brompheniramine is combined with Vortioxetine.,increase,risk
Vortioxetine,Budesonide,The metabolism of Vortioxetine can be increased when combined with Budesonide.,increase,no risk
Vortioxetine,Bumadizone,The risk or severity of hypertension can be increased when Vortioxetine is combined with Bumadizone.,increase,risk
Vortioxetine,Bumetanide,Bumetanide may increase the excretion rate of Vortioxetine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Vortioxetine,Bupivacaine,The risk or severity of CNS depression can be increased when Bupivacaine is combined with Vortioxetine.,increase,risk
Vortioxetine,Buprenorphine,Vortioxetine may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Vortioxetine,Bupropion,The risk or severity of adverse effects can be increased when Bupropion is combined with Vortioxetine.,increase,risk
Vortioxetine,Buspirone,The risk or severity of CNS depression can be increased when Buspirone is combined with Vortioxetine.,increase,risk
Vortioxetine,Butabarbital,The risk or severity of CNS depression can be increased when Butabarbital is combined with Vortioxetine.,increase,risk
Vortioxetine,Butalbital,The risk or severity of CNS depression can be increased when Butalbital is combined with Vortioxetine.,increase,risk
Vortioxetine,Butaperazine,The risk or severity of adverse effects can be increased when Vortioxetine is combined with Butaperazine.,increase,risk
Vortioxetine,Butobarbital,The risk or severity of CNS depression can be increased when Butobarbital is combined with Vortioxetine.,increase,risk
Vortioxetine,Butorphanol,The risk or severity of CNS depression can be increased when Butorphanol is combined with Vortioxetine.,increase,risk
Vortioxetine,Butriptyline,The risk or severity of CNS depression can be increased when Butriptyline is combined with Vortioxetine.,increase,risk
Vortioxetine,Gabapentin,The risk or severity of CNS depression can be increased when Gabapentin is combined with Vortioxetine.,increase,risk
Vortioxetine,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Gabapentin enacarbil is combined with Vortioxetine.,increase,risk
Vortioxetine,Gadobenic acid,Gadobenic acid may decrease the excretion rate of Vortioxetine which could result in a higher serum level.,decrease,no risk
Vortioxetine,Gadodiamide,Gadodiamide may decrease the excretion rate of Vortioxetine which could result in a higher serum level.,decrease,no risk
Vortioxetine,Gadofosveset trisodium,Gadofosveset trisodium may decrease the excretion rate of Vortioxetine which could result in a higher serum level.,decrease,no risk
Vortioxetine,Gadopentetic acid,Gadopentetic acid may decrease the excretion rate of Vortioxetine which could result in a higher serum level.,decrease,no risk
Vortioxetine,Gadoteric acid,Vortioxetine may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Vortioxetine,Gadoteridol,Gadoteridol may decrease the excretion rate of Vortioxetine which could result in a higher serum level.,decrease,no risk
Vortioxetine,Galantamine,The metabolism of Vortioxetine can be decreased when combined with Galantamine.,decrease,no risk
Vortioxetine,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with Vortioxetine.,increase,risk
Vortioxetine,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Vortioxetine is combined with Ganaxolone.",increase,risk
Vortioxetine,Ganciclovir,Ganciclovir may decrease the excretion rate of Vortioxetine which could result in a higher serum level.,decrease,no risk
Vortioxetine,Gefitinib,The metabolism of Vortioxetine can be decreased when combined with Gefitinib.,decrease,no risk
Vortioxetine,Gemcitabine,Gemcitabine may decrease the excretion rate of Vortioxetine which could result in a higher serum level.,decrease,no risk
Vortioxetine,Gemfibrozil,The metabolism of Vortioxetine can be decreased when combined with Gemfibrozil.,decrease,no risk
Vortioxetine,Gentamicin,Vortioxetine may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Vortioxetine,Gepirone,The risk or severity of serotonin syndrome can be increased when Gepirone is combined with Vortioxetine.,increase,risk
Vortioxetine,Gilteritinib,The therapeutic efficacy of Vortioxetine can be decreased when used in combination with Gilteritinib.,decrease,no risk
Vortioxetine,Gimeracil,Vortioxetine may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Vortioxetine,Ginkgo biloba,The metabolism of Vortioxetine can be decreased when combined with Ginkgo biloba.,decrease,no risk
Vortioxetine,Givosiran,The serum concentration of Vortioxetine can be increased when it is combined with Givosiran.,increase,no risk
Vortioxetine,Glasdegib,The metabolism of Glasdegib can be decreased when combined with Vortioxetine.,decrease,no risk
Vortioxetine,Gliclazide,The metabolism of Vortioxetine can be decreased when combined with Gliclazide.,decrease,no risk
Vortioxetine,Glimepiride,The metabolism of Vortioxetine can be decreased when combined with Glimepiride.,decrease,no risk
Vortioxetine,Glipizide,Glipizide may decrease the excretion rate of Vortioxetine which could result in a higher serum level.,decrease,no risk
Vortioxetine,Gliquidone,The metabolism of Vortioxetine can be decreased when combined with Gliquidone.,decrease,no risk
Vortioxetine,Glofitamab,The serum concentration of Vortioxetine can be increased when it is combined with Glofitamab.,increase,no risk
Vortioxetine,Glutethimide,The risk or severity of CNS depression can be increased when Glutethimide is combined with Vortioxetine.,increase,risk
Vortioxetine,Glyburide,The metabolism of Vortioxetine can be decreased when combined with Glyburide.,decrease,no risk
Vortioxetine,Glycerol phenylbutyrate,The metabolism of Vortioxetine can be decreased when combined with Glycerol phenylbutyrate.,decrease,no risk
Vortioxetine,Golimumab,The metabolism of Vortioxetine can be increased when combined with Golimumab.,increase,no risk
Vortioxetine,Golodirsen,Vortioxetine may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Vortioxetine,Goserelin,Goserelin may decrease the excretion rate of Vortioxetine which could result in a higher serum level.,decrease,no risk
Vortioxetine,Granisetron,The risk or severity of CNS depression can be increased when Granisetron is combined with Vortioxetine.,increase,risk
Vortioxetine,Guanabenz,Vortioxetine may decrease the antihypertensive activities of Guanabenz.,decrease,no risk
Vortioxetine,Guanadrel,Vortioxetine may decrease the antihypertensive activities of Guanadrel.,decrease,no risk
Vortioxetine,Guanethidine,Vortioxetine may decrease the antihypertensive activities of Guanethidine.,decrease,no risk
Vortioxetine,Guanfacine,The risk or severity of CNS depression can be increased when Guanfacine is combined with Vortioxetine.,increase,risk
Vortioxetine,Guanoxan,Vortioxetine may decrease the antihypertensive activities of Guanoxan.,decrease,no risk
Vortioxetine,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with Vortioxetine.,increase,risk
Vortioxetine,Halofantrine,The metabolism of Vortioxetine can be decreased when combined with Halofantrine.,decrease,no risk
Vortioxetine,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Vortioxetine.,increase,risk
Vortioxetine,Halothane,The risk or severity of CNS depression can be increased when Halothane is combined with Vortioxetine.,increase,risk
Vortioxetine,Hexafluronium,The risk or severity of CNS depression can be increased when Hexafluronium is combined with Vortioxetine.,increase,risk
Vortioxetine,Hydralazine,Vortioxetine may decrease the antihypertensive activities of Hydralazine.,decrease,no risk
Vortioxetine,Hydrochlorothiazide,Hydrochlorothiazide may increase the excretion rate of Vortioxetine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Vortioxetine,Hydrocodone,Vortioxetine may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Vortioxetine,Hydrocortisone,The metabolism of Vortioxetine can be increased when combined with Hydrocortisone.,increase,no risk
Vortioxetine,Hydrocortisone acetate,The metabolism of Hydrocortisone acetate can be decreased when combined with Vortioxetine.,decrease,no risk
Vortioxetine,Hydrocortisone butyrate,The metabolism of Hydrocortisone butyrate can be decreased when combined with Vortioxetine.,decrease,no risk
Vortioxetine,Hydrocortisone cypionate,The metabolism of Hydrocortisone cypionate can be decreased when combined with Vortioxetine.,decrease,no risk
Vortioxetine,Hydrocortisone phosphate,The metabolism of Hydrocortisone phosphate can be decreased when combined with Vortioxetine.,decrease,no risk
Vortioxetine,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of Vortioxetine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Vortioxetine,Hydromorphone,The risk or severity of CNS depression can be increased when Hydromorphone is combined with Vortioxetine.,increase,risk
Vortioxetine,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Vortioxetine which could result in a higher serum level.,decrease,no risk
Vortioxetine,Hydroxychloroquine,The metabolism of Vortioxetine can be decreased when combined with Hydroxychloroquine.,decrease,no risk
Vortioxetine,Hydroxyethyl Starch,Vortioxetine may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Vortioxetine,Hydroxyprogesterone caproate,The metabolism of Vortioxetine can be decreased when combined with Hydroxyprogesterone caproate.,decrease,no risk
Vortioxetine,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Vortioxetine.,increase,no risk
Vortioxetine,Kanamycin,Vortioxetine may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Vortioxetine,Ketamine,The risk or severity of CNS depression can be increased when Ketamine is combined with Vortioxetine.,increase,risk
Vortioxetine,Ketazolam,The risk or severity of CNS depression can be increased when Ketazolam is combined with Vortioxetine.,increase,risk
Vortioxetine,Ketoconazole,The metabolism of Vortioxetine can be decreased when combined with Ketoconazole.,decrease,no risk
Vortioxetine,Ketoprofen,The risk or severity of hypertension can be increased when Ketoprofen is combined with Vortioxetine.,increase,risk
Vortioxetine,Ketorolac,The metabolism of Vortioxetine can be decreased when combined with Ketorolac.,decrease,no risk
Vortioxetine,N-acetyltyrosine,Vortioxetine may decrease the excretion rate of N-acetyltyrosine which could result in a higher serum level.,decrease,no risk
Vortioxetine,Nabilone,Nabilone may increase the central nervous system depressant (CNS depressant) activities of Vortioxetine.,increase,no risk
Vortioxetine,Nabumetone,The risk or severity of hypertension can be increased when Nabumetone is combined with Vortioxetine.,increase,risk
Vortioxetine,Nadolol,Vortioxetine may decrease the antihypertensive activities of Nadolol.,decrease,no risk
Vortioxetine,Nalbuphine,The risk or severity of CNS depression can be increased when Nalbuphine is combined with Vortioxetine.,increase,risk
Vortioxetine,Naldemedine,Vortioxetine may decrease the excretion rate of Naldemedine which could result in a higher serum level.,decrease,no risk
Vortioxetine,Nalmefene,Nalmefene may decrease the excretion rate of Vortioxetine which could result in a higher serum level.,decrease,no risk
Vortioxetine,Naloxone,Naloxone may decrease the excretion rate of Vortioxetine which could result in a higher serum level.,decrease,no risk
Vortioxetine,Naltrexone,The risk or severity of serotonin syndrome can be increased when Naltrexone is combined with Vortioxetine.,increase,risk
Vortioxetine,Naphazoline,The risk or severity of CNS depression can be increased when Naphazoline is combined with Vortioxetine.,increase,risk
Vortioxetine,Naproxen,The metabolism of Vortioxetine can be decreased when combined with Naproxen.,decrease,no risk
Vortioxetine,Naratriptan,The risk or severity of adverse effects can be increased when Naratriptan is combined with Vortioxetine.,increase,risk
Vortioxetine,Nateglinide,Nateglinide may decrease the excretion rate of Vortioxetine which could result in a higher serum level.,decrease,no risk
Vortioxetine,Naxitamab,The risk or severity of hypertension can be increased when Vortioxetine is combined with Naxitamab.,increase,risk
Vortioxetine,Nebivolol,The metabolism of Vortioxetine can be decreased when combined with Nebivolol.,decrease,no risk
Vortioxetine,Nedaplatin,Vortioxetine may decrease the excretion rate of Nedaplatin which could result in a higher serum level.,decrease,no risk
Vortioxetine,Nedocromil,Nedocromil may decrease the excretion rate of Vortioxetine which could result in a higher serum level.,decrease,no risk
Vortioxetine,Nefazodone,The metabolism of Vortioxetine can be decreased when combined with Nefazodone.,decrease,no risk
Vortioxetine,Nelfinavir,The metabolism of Vortioxetine can be decreased when combined with Nelfinavir.,decrease,no risk
Vortioxetine,Neomycin,Vortioxetine may decrease the excretion rate of Neomycin which could result in a higher serum level.,decrease,no risk
Vortioxetine,Netilmicin,Vortioxetine may decrease the excretion rate of Netilmicin which could result in a higher serum level.,decrease,no risk
Vortioxetine,Netupitant,The metabolism of Vortioxetine can be decreased when combined with Netupitant.,decrease,no risk
Vortioxetine,Nevirapine,The metabolism of Vortioxetine can be increased when combined with Nevirapine.,increase,no risk
Vortioxetine,Niacin,The metabolism of Vortioxetine can be decreased when combined with Niacin.,decrease,no risk
Vortioxetine,Nialamide,The metabolism of Vortioxetine can be decreased when combined with Nialamide.,decrease,no risk
Vortioxetine,Nicardipine,The metabolism of Vortioxetine can be decreased when combined with Nicardipine.,decrease,no risk
Vortioxetine,Nicergoline,Nicergoline may increase the vasoconstricting activities of Vortioxetine.,increase,no risk
Vortioxetine,Niclosamide,The metabolism of Vortioxetine can be decreased when combined with Niclosamide.,decrease,no risk
Vortioxetine,Nicorandil,Vortioxetine may decrease the antihypertensive activities of Nicorandil.,decrease,no risk
Vortioxetine,Nicotine,The metabolism of Vortioxetine can be decreased when combined with Nicotine.,decrease,no risk
Vortioxetine,Nifedipine,The metabolism of Vortioxetine can be decreased when combined with Nifedipine.,decrease,no risk
Vortioxetine,Nilotinib,The metabolism of Vortioxetine can be decreased when combined with Nilotinib.,decrease,no risk
Vortioxetine,Nilutamide,The metabolism of Vortioxetine can be decreased when combined with Nilutamide.,decrease,no risk
Vortioxetine,Nilvadipine,The metabolism of Vortioxetine can be decreased when combined with Nilvadipine.,decrease,no risk
Vortioxetine,Nimesulide,The risk or severity of bleeding can be increased when Vortioxetine is combined with Nimesulide.,increase,risk
Vortioxetine,Nimodipine,Vortioxetine may decrease the antihypertensive activities of Nimodipine.,decrease,no risk
Vortioxetine,Nirogacestat,The metabolism of Vortioxetine can be increased when combined with Nirogacestat.,increase,no risk
Vortioxetine,Nisoldipine,Vortioxetine may decrease the antihypertensive activities of Nisoldipine.,decrease,no risk
Vortioxetine,Nitrazepam,The risk or severity of CNS depression can be increased when Nitrazepam is combined with Vortioxetine.,increase,risk
Vortioxetine,Nitrendipine,Vortioxetine may decrease the antihypertensive activities of Nitrendipine.,decrease,no risk
Vortioxetine,Nitric Oxide,Nitric Oxide may decrease the excretion rate of Vortioxetine which could result in a higher serum level.,decrease,no risk
Vortioxetine,Nitrofurantoin,Nitrofurantoin may decrease the excretion rate of Vortioxetine which could result in a higher serum level.,decrease,no risk
Vortioxetine,Nitroglycerin,Vortioxetine may decrease the antihypertensive activities of Nitroglycerin.,decrease,no risk
Vortioxetine,Nitroprusside,Vortioxetine may decrease the antihypertensive activities of Nitroprusside.,decrease,no risk
Vortioxetine,Nitrous oxide,The risk or severity of CNS depression can be increased when Nitrous oxide is combined with Vortioxetine.,increase,risk
Mirabegron,Baricitinib,Mirabegron may decrease the excretion rate of Baricitinib which could result in a higher serum level.,decrease,no risk
Mirabegron,Bedaquiline,The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Bedaquiline.,increase,risk
Mirabegron,Belantamab mafodotin,The serum concentration of Belantamab mafodotin can be increased when it is combined with Mirabegron.,increase,no risk
Mirabegron,Belinostat,The serum concentration of Belinostat can be increased when it is combined with Mirabegron.,increase,no risk
Mirabegron,Belladonna,The risk or severity of urinary retention can be increased when Belladonna is combined with Mirabegron.,increase,risk
Mirabegron,Belumosudil,The serum concentration of Mirabegron can be increased when it is combined with Belumosudil.,increase,no risk
Mirabegron,Benazepril,Mirabegron may decrease the antihypertensive activities of Benazepril.,decrease,no risk
Mirabegron,Bendamustine,The serum concentration of Bendamustine can be increased when it is combined with Mirabegron.,increase,no risk
Mirabegron,Bendroflumethiazide,Bendroflumethiazide may increase the excretion rate of Mirabegron which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Mirabegron,Benorilate,The risk or severity of hypertension can be increased when Mirabegron is combined with Benorilate.,increase,risk
Mirabegron,Benoxaprofen,The risk or severity of hypertension can be increased when Benoxaprofen is combined with Mirabegron.,increase,risk
Mirabegron,Benserazide,Mirabegron may decrease the excretion rate of Benserazide which could result in a higher serum level.,decrease,no risk
Mirabegron,Benzatropine,The risk or severity of urinary retention can be increased when Benzatropine is combined with Mirabegron.,increase,risk
Mirabegron,Benznidazole,Mirabegron may decrease the excretion rate of Benznidazole which could result in a higher serum level.,decrease,no risk
Mirabegron,Benzocaine,The serum concentration of Benzocaine can be increased when it is combined with Mirabegron.,increase,no risk
Mirabegron,Benzonatate,The serum concentration of Mirabegron can be increased when it is combined with Benzonatate.,increase,no risk
Mirabegron,Benzphetamine,The risk or severity of hypertension can be increased when Benzphetamine is combined with Mirabegron.,increase,risk
Mirabegron,Benzthiazide,Benzthiazide may increase the excretion rate of Mirabegron which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Mirabegron,Benzydamine,The risk or severity of hypertension can be increased when Mirabegron is combined with Benzydamine.,increase,risk
Mirabegron,Benzyl alcohol,The serum concentration of Benzyl alcohol can be increased when it is combined with Mirabegron.,increase,no risk
Mirabegron,Benzylpenicilloyl polylysine,Mirabegron may decrease effectiveness of Benzylpenicilloyl polylysine as a diagnostic agent.,decrease,no risk
Mirabegron,Bepotastine,Bepotastine may decrease the excretion rate of Mirabegron which could result in a higher serum level.,decrease,no risk
Mirabegron,Bepridil,The serum concentration of Bepridil can be increased when it is combined with Mirabegron.,increase,no risk
Mirabegron,Berotralstat,The serum concentration of Berotralstat can be increased when it is combined with Mirabegron.,increase,no risk
Mirabegron,Betaine,Betaine may increase the neuromuscular blocking activities of Mirabegron.,increase,no risk
Mirabegron,Betaxolol,The serum concentration of Betaxolol can be increased when it is combined with Mirabegron.,increase,no risk
Mirabegron,Bethanidine,Mirabegron may decrease the antihypertensive activities of Bethanidine.,decrease,no risk
Mirabegron,Betrixaban,The serum concentration of Betrixaban can be increased when it is combined with Mirabegron.,increase,no risk
Mirabegron,Bicisate,Mirabegron may decrease the excretion rate of Bicisate which could result in a higher serum level.,decrease,no risk
Mirabegron,Bilastine,The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Bilastine.,increase,risk
Mirabegron,Bimekizumab,The metabolism of Mirabegron can be increased when combined with Bimekizumab.,increase,no risk
Mirabegron,Binimetinib,The serum concentration of Binimetinib can be increased when it is combined with Mirabegron.,increase,no risk
Mirabegron,Biperiden,The risk or severity of urinary retention can be increased when Biperiden is combined with Mirabegron.,increase,risk
Mirabegron,Bismuth subgallate,Mirabegron may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Mirabegron,Bisoprolol,The therapeutic efficacy of Mirabegron can be decreased when used in combination with Bisoprolol.,decrease,no risk
Mirabegron,Bisoxatin,Mirabegron may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,decrease,no risk
Mirabegron,Bleomycin,Bleomycin may decrease the excretion rate of Mirabegron which could result in a higher serum level.,decrease,no risk
Mirabegron,Boceprevir,The metabolism of Mirabegron can be decreased when combined with Boceprevir.,decrease,no risk
Mirabegron,Bortezomib,The serum concentration of Bortezomib can be increased when it is combined with Mirabegron.,increase,no risk
Mirabegron,Bosentan,Mirabegron may decrease the antihypertensive activities of Bosentan.,decrease,no risk
Mirabegron,Bosutinib,The serum concentration of Bosutinib can be increased when it is combined with Mirabegron.,increase,no risk
Mirabegron,Brentuximab vedotin,The serum concentration of Brentuximab vedotin can be increased when it is combined with Mirabegron.,increase,no risk
Mirabegron,Bretylium,Mirabegron may decrease the antihypertensive activities of Bretylium.,decrease,no risk
Mirabegron,Brexpiprazole,The metabolism of Brexpiprazole can be decreased when combined with Mirabegron.,decrease,no risk
Mirabegron,Brivaracetam,Brivaracetam may decrease the excretion rate of Mirabegron which could result in a higher serum level.,decrease,no risk
Mirabegron,Bromazepam,Bromazepam may decrease the excretion rate of Mirabegron which could result in a higher serum level.,decrease,no risk
Mirabegron,Bromocriptine,Bromocriptine may increase the hypertensive and vasoconstricting activities of Mirabegron.,increase,no risk
Mirabegron,Bromotheophylline,Bromotheophylline may increase the excretion rate of Mirabegron which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Mirabegron,Brompheniramine,The risk or severity of urinary retention can be increased when Brompheniramine is combined with Mirabegron.,increase,risk
Mirabegron,Buclizine,The risk or severity of urinary retention can be increased when Buclizine is combined with Mirabegron.,increase,risk
Mirabegron,Budesonide,Budesonide may decrease the excretion rate of Mirabegron which could result in a higher serum level.,decrease,no risk
Mirabegron,Bumadizone,The risk or severity of hypertension can be increased when Mirabegron is combined with Bumadizone.,increase,risk
Mirabegron,Bumetanide,Bumetanide may increase the excretion rate of Mirabegron which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Mirabegron,Bupivacaine,The serum concentration of Bupivacaine can be increased when it is combined with Mirabegron.,increase,no risk
Mirabegron,Buprenorphine,The serum concentration of Buprenorphine can be increased when it is combined with Mirabegron.,increase,no risk
Mirabegron,Bupropion,The metabolism of Mirabegron can be decreased when combined with Bupropion.,decrease,no risk
Mirabegron,Buserelin,The risk or severity of QTc prolongation can be increased when Buserelin is combined with Mirabegron.,increase,risk
Mirabegron,Buspirone,The serum concentration of Buspirone can be increased when it is combined with Mirabegron.,increase,no risk
Mirabegron,Butabarbital,Butabarbital may decrease the excretion rate of Mirabegron which could result in a higher serum level.,decrease,no risk
Mirabegron,Butriptyline,The risk or severity of hypertension can be increased when Butriptyline is combined with Mirabegron.,increase,risk
Mirabegron,Butylscopolamine,The risk or severity of urinary retention can be increased when Butylscopolamine is combined with Mirabegron.,increase,risk
Isosorbide,Gabapentin enacarbil,Isosorbide may increase the excretion rate of Gabapentin enacarbil which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Isosorbide,Gadobenic acid,Isosorbide may increase the excretion rate of Gadobenic acid which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Isosorbide,Gadodiamide,Isosorbide may increase the excretion rate of Gadodiamide which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Isosorbide,Gadofosveset trisodium,Isosorbide may increase the excretion rate of Gadofosveset trisodium which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Isosorbide,Gadopentetic acid,Isosorbide may increase the excretion rate of Gadopentetic acid which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Isosorbide,Gadoteric acid,Isosorbide may increase the excretion rate of Gadoteric acid which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Isosorbide,Gadoteridol,Isosorbide may increase the excretion rate of Gadoteridol which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Isosorbide,Ganciclovir,Isosorbide may increase the excretion rate of Ganciclovir which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Isosorbide,Gemcitabine,Isosorbide may increase the excretion rate of Gemcitabine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Isosorbide,Gemfibrozil,Isosorbide may increase the excretion rate of Gemfibrozil which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Isosorbide,Gimeracil,Isosorbide may increase the excretion rate of Gimeracil which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Isosorbide,Glipizide,Isosorbide may increase the excretion rate of Glipizide which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Isosorbide,Gluconic Acid,The risk or severity of dehydration can be increased when Isosorbide is combined with Gluconic Acid.,increase,risk
Isosorbide,Glycerin,The risk or severity of dehydration can be increased when Isosorbide is combined with Glycerin.,increase,risk
Isosorbide,Glycerol phenylbutyrate,Isosorbide may increase the excretion rate of Glycerol phenylbutyrate which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Isosorbide,Golodirsen,Isosorbide may increase the excretion rate of Golodirsen which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Isosorbide,Goserelin,Isosorbide may increase the excretion rate of Goserelin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Isosorbide,Guanethidine,Isosorbide may increase the excretion rate of Guanethidine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Isosorbide,Guanfacine,Isosorbide may increase the excretion rate of Guanfacine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Isosorbide,Haloperidol,Isosorbide may increase the excretion rate of Haloperidol which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Isosorbide,Hydralazine,Isosorbide may increase the excretion rate of Hydralazine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Isosorbide,Hydrocodone,The therapeutic efficacy of Isosorbide can be decreased when used in combination with Hydrocodone.,decrease,no risk
Isosorbide,Hydromorphone,Isosorbide may increase the excretion rate of Hydromorphone which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Isosorbide,Hydroxocobalamin,Isosorbide may increase the excretion rate of Hydroxocobalamin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Isosorbide,Hydroxyethyl Starch,Isosorbide may increase the excretion rate of Hydroxyethyl Starch which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Isosorbide,Ketamine,Isosorbide may increase the excretion rate of Ketamine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Isosorbide,Ketazolam,Isosorbide may increase the excretion rate of Ketazolam which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Isosorbide,Ketoprofen,Isosorbide may increase the excretion rate of Ketoprofen which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Isosorbide,N-acetyltyrosine,Isosorbide may increase the excretion rate of N-acetyltyrosine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Isosorbide,Nadolol,Isosorbide may increase the excretion rate of Nadolol which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Isosorbide,Nalbuphine,The therapeutic efficacy of Isosorbide can be decreased when used in combination with Nalbuphine.,decrease,no risk
Isosorbide,Naldemedine,Isosorbide may increase the excretion rate of Naldemedine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Isosorbide,Nalmefene,Isosorbide may increase the excretion rate of Nalmefene which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Isosorbide,Naloxegol,The therapeutic efficacy of Isosorbide can be decreased when used in combination with Naloxegol.,decrease,no risk
Isosorbide,Naloxone,Isosorbide may increase the excretion rate of Naloxone which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Isosorbide,Naltrexone,The therapeutic efficacy of Isosorbide can be decreased when used in combination with Naltrexone.,decrease,no risk
Isosorbide,Nateglinide,Isosorbide may increase the excretion rate of Nateglinide which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Isosorbide,Nedaplatin,Isosorbide may increase the excretion rate of Nedaplatin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Isosorbide,Nedocromil,Isosorbide may increase the excretion rate of Nedocromil which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Isosorbide,Nefazodone,Isosorbide may increase the excretion rate of Nefazodone which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Isosorbide,Nicardipine,Nicardipine may increase the vasodilatory activities of Isosorbide.,increase,no risk
Isosorbide,Nicorandil,Isosorbide may increase the excretion rate of Nicorandil which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Isosorbide,Nifedipine,Nifedipine may increase the vasodilatory activities of Isosorbide.,increase,no risk
Isosorbide,Nilutamide,Isosorbide may increase the excretion rate of Nilutamide which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Isosorbide,Nilvadipine,Nilvadipine may increase the vasodilatory activities of Isosorbide.,increase,no risk
Isosorbide,Nimesulide,Nimesulide may increase the vasodilatory activities of Isosorbide.,increase,no risk
Isosorbide,Nimodipine,Nimodipine may increase the vasodilatory activities of Isosorbide.,increase,no risk
Isosorbide,Nisoldipine,Nisoldipine may increase the vasodilatory activities of Isosorbide.,increase,no risk
Isosorbide,Nitrendipine,Nitrendipine may increase the vasodilatory activities of Isosorbide.,increase,no risk
GTS-21,Galantamine,The risk or severity of adverse effects can be increased when Galantamine is combined with GTS-21.,increase,risk
GTS-21,Gallamine triethiodide,The risk or severity of adverse effects can be increased when Gallamine triethiodide is combined with GTS-21.,increase,risk
GTS-21,Gatifloxacin,The metabolism of GTS-21 can be decreased when combined with Gatifloxacin.,decrease,no risk
GTS-21,Gemfibrozil,The metabolism of GTS-21 can be decreased when combined with Gemfibrozil.,decrease,no risk
GTS-21,Gemifloxacin,The metabolism of GTS-21 can be decreased when combined with Gemifloxacin.,decrease,no risk
GTS-21,Gentamicin,The therapeutic efficacy of GTS-21 can be decreased when used in combination with Gentamicin.,decrease,no risk
GTS-21,Ginkgo biloba,The risk or severity of adverse effects can be increased when Ginkgo biloba is combined with GTS-21.,increase,risk
GTS-21,Givosiran,The serum concentration of GTS-21 can be increased when it is combined with Givosiran.,increase,no risk
GTS-21,Glofitamab,The serum concentration of GTS-21 can be increased when it is combined with Glofitamab.,increase,no risk
GTS-21,Golimumab,The metabolism of GTS-21 can be increased when combined with Golimumab.,increase,no risk
GTS-21,Grepafloxacin,The metabolism of GTS-21 can be decreased when combined with Grepafloxacin.,decrease,no risk
GTS-21,Guanabenz,The metabolism of GTS-21 can be decreased when combined with Guanabenz.,decrease,no risk
GTS-21,Haloperidol,The metabolism of GTS-21 can be decreased when combined with Haloperidol.,decrease,no risk
GTS-21,Hexafluronium,The risk or severity of adverse effects can be increased when Hexafluronium is combined with GTS-21.,increase,risk
GTS-21,Huperzine A,The risk or severity of adverse effects can be increased when Huperzine A is combined with GTS-21.,increase,risk
GTS-21,Kanamycin,The therapeutic efficacy of GTS-21 can be decreased when used in combination with Kanamycin.,decrease,no risk
GTS-21,Ketamine,The risk or severity of adverse effects can be increased when Ketamine is combined with GTS-21.,increase,risk
GTS-21,Ketoconazole,The metabolism of GTS-21 can be decreased when combined with Ketoconazole.,decrease,no risk
GTS-21,Nabumetone,The metabolism of GTS-21 can be decreased when combined with Nabumetone.,decrease,no risk
GTS-21,Nadolol,The risk or severity of adverse effects can be increased when Nadolol is combined with GTS-21.,increase,risk
GTS-21,Nafcillin,The metabolism of GTS-21 can be increased when combined with Nafcillin.,increase,no risk
GTS-21,Nalidixic acid,The metabolism of GTS-21 can be decreased when combined with Nalidixic acid.,decrease,no risk
GTS-21,Naproxen,The metabolism of GTS-21 can be decreased when combined with Naproxen.,decrease,no risk
GTS-21,Nebivolol,The risk or severity of adverse effects can be increased when Nebivolol is combined with GTS-21.,increase,risk
GTS-21,Neomycin,The therapeutic efficacy of GTS-21 can be decreased when used in combination with Neomycin.,decrease,no risk
GTS-21,Neostigmine,The risk or severity of adverse effects can be increased when Neostigmine is combined with GTS-21.,increase,risk
GTS-21,Netilmicin,The therapeutic efficacy of GTS-21 can be decreased when used in combination with Netilmicin.,decrease,no risk
GTS-21,Nevirapine,The metabolism of GTS-21 can be decreased when combined with Nevirapine.,decrease,no risk
GTS-21,Niclosamide,The metabolism of GTS-21 can be decreased when combined with Niclosamide.,decrease,no risk
GTS-21,Nifedipine,The metabolism of GTS-21 can be decreased when combined with Nifedipine.,decrease,no risk
GTS-21,Nizatidine,The risk or severity of adverse effects can be increased when Nizatidine is combined with GTS-21.,increase,risk
GTS-21,Norfloxacin,The metabolism of GTS-21 can be decreased when combined with Norfloxacin.,decrease,no risk
GTS-21,Obeticholic acid,The metabolism of GTS-21 can be decreased when combined with Obeticholic acid.,decrease,no risk
GTS-21,Olanzapine,The metabolism of GTS-21 can be decreased when combined with Olanzapine.,decrease,no risk
GTS-21,Ondansetron,The metabolism of GTS-21 can be decreased when combined with Ondansetron.,decrease,no risk
GTS-21,Orphenadrine,The metabolism of GTS-21 can be decreased when combined with Orphenadrine.,decrease,no risk
GTS-21,Osilodrostat,The metabolism of GTS-21 can be decreased when combined with Osilodrostat.,decrease,no risk
GTS-21,Osimertinib,The serum concentration of GTS-21 can be decreased when it is combined with Osimertinib.,decrease,no risk
GTS-21,Oxprenolol,The risk or severity of adverse effects can be increased when Oxprenolol is combined with GTS-21.,increase,risk
GTS-21,Oxtriphylline,The metabolism of GTS-21 can be decreased when combined with Oxtriphylline.,decrease,no risk
GTS-21,Quinidine,The metabolism of GTS-21 can be decreased when combined with Quinidine.,decrease,no risk
GTS-21,Quinine,The metabolism of GTS-21 can be decreased when combined with Quinine.,decrease,no risk
GTS-21,Valproic acid,The metabolism of GTS-21 can be decreased when combined with Valproic acid.,decrease,no risk
GTS-21,Vemurafenib,The serum concentration of GTS-21 can be increased when it is combined with Vemurafenib.,increase,no risk
GTS-21,Verapamil,The metabolism of GTS-21 can be decreased when combined with Verapamil.,decrease,no risk
GTS-21,Viloxazine,The metabolism of GTS-21 can be decreased when combined with Viloxazine.,decrease,no risk
GTS-21,Voxilaprevir,The metabolism of Voxilaprevir can be decreased when combined with GTS-21.,decrease,no risk
GTS-21,Warfarin,The metabolism of GTS-21 can be decreased when combined with Warfarin.,decrease,no risk
GTS-21,Zileuton,The metabolism of GTS-21 can be decreased when combined with Zileuton.,decrease,no risk
GTS-21,Zolmitriptan,The metabolism of GTS-21 can be decreased when combined with Zolmitriptan.,decrease,no risk
GTS-21,Zolpidem,The metabolism of GTS-21 can be decreased when combined with Zolpidem.,decrease,no risk
GTS-21,Zotepine,The metabolism of Zotepine can be decreased when combined with GTS-21.,decrease,no risk
Meclocycline,Benzocaine,The risk or severity of methemoglobinemia can be increased when Meclocycline is combined with Benzocaine.,increase,risk
Meclocycline,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Meclocycline is combined with Benzyl alcohol.,increase,risk
Meclocycline,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Meclocycline is combined with Bupivacaine.,increase,risk
Meclocycline,Butacaine,The risk or severity of methemoglobinemia can be increased when Meclocycline is combined with Butacaine.,increase,risk
Meclocycline,Butamben,The risk or severity of methemoglobinemia can be increased when Meclocycline is combined with Butamben.,increase,risk
Meclocycline,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Meclocycline is combined with Oxetacaine.,increase,risk
Meclocycline,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Meclocycline is combined with Oxybuprocaine.,increase,risk
Meclocycline,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Meclocycline.,decrease,no risk
Gantacurium,Gabapentin,The risk or severity of CNS depression can be increased when Gabapentin is combined with Gantacurium.,increase,risk
Gantacurium,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Gantacurium is combined with Gabapentin enacarbil.,increase,risk
Gantacurium,Galantamine,The therapeutic efficacy of Gantacurium can be decreased when used in combination with Galantamine.,decrease,no risk
Gantacurium,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with Gantacurium.,increase,risk
Gantacurium,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Gantacurium is combined with Ganaxolone.",increase,risk
Gantacurium,Gepirone,The risk or severity of CNS depression can be increased when Gantacurium is combined with Gepirone.,increase,risk
Gantacurium,Ginkgo biloba,The therapeutic efficacy of Gantacurium can be decreased when used in combination with Ginkgo biloba.,decrease,no risk
Gantacurium,Glutethimide,The risk or severity of CNS depression can be increased when Glutethimide is combined with Gantacurium.,increase,risk
Gantacurium,Glycerin,The therapeutic efficacy of Glycerin can be decreased when used in combination with Gantacurium.,decrease,no risk
Gantacurium,Glycopyrronium,The risk or severity of adverse effects can be increased when Glycopyrronium is combined with Gantacurium.,increase,risk
Gantacurium,Granisetron,The risk or severity of CNS depression can be increased when Granisetron is combined with Gantacurium.,increase,risk
Gantacurium,Guanfacine,The risk or severity of CNS depression can be increased when Guanfacine is combined with Gantacurium.,increase,risk
Gantacurium,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with Gantacurium.,increase,risk
Gantacurium,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Gantacurium.,increase,risk
Gantacurium,Halothane,The risk or severity of CNS depression can be increased when Halothane is combined with Gantacurium.,increase,risk
Gantacurium,Hexafluronium,The risk or severity of CNS depression can be increased when Hexafluronium is combined with Gantacurium.,increase,risk
Gantacurium,Hexocyclium,The risk or severity of adverse effects can be increased when Gantacurium is combined with Hexocyclium.,increase,risk
Gantacurium,Homatropine,The risk or severity of adverse effects can be increased when Gantacurium is combined with Homatropine.,increase,risk
Gantacurium,Homatropine methylbromide,The risk or severity of adverse effects can be increased when Homatropine methylbromide is combined with Gantacurium.,increase,risk
Gantacurium,Huperzine A,The therapeutic efficacy of Gantacurium can be decreased when used in combination with Huperzine A.,decrease,no risk
Gantacurium,Hydrochlorothiazide,The serum concentration of Hydrochlorothiazide can be increased when it is combined with Gantacurium.,increase,no risk
Gantacurium,Hydrocodone,Gantacurium may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Gantacurium,Hydroflumethiazide,The serum concentration of Hydroflumethiazide can be increased when it is combined with Gantacurium.,increase,no risk
Gantacurium,Hydromorphone,The risk or severity of adverse effects can be increased when Gantacurium is combined with Hydromorphone.,increase,risk
Gantacurium,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Gantacurium.,increase,no risk
Gantacurium,Hyoscyamine,The risk or severity of adverse effects can be increased when Hyoscyamine is combined with Gantacurium.,increase,risk
Gantacurium,Ketamine,The risk or severity of CNS depression can be increased when Ketamine is combined with Gantacurium.,increase,risk
Gantacurium,Ketazolam,The risk or severity of CNS depression can be increased when Ketazolam is combined with Gantacurium.,increase,risk
Gantacurium,Nabilone,Nabilone may increase the central nervous system depressant (CNS depressant) activities of Gantacurium.,increase,no risk
Gantacurium,Nalbuphine,The risk or severity of adverse effects can be increased when Gantacurium is combined with Nalbuphine.,increase,risk
Gantacurium,Naloxegol,The risk or severity of adverse effects can be increased when Gantacurium is combined with Naloxegol.,increase,risk
Gantacurium,Naltrexone,The risk or severity of adverse effects can be increased when Gantacurium is combined with Naltrexone.,increase,risk
Gantacurium,Naratriptan,The risk or severity of CNS depression can be increased when Naratriptan is combined with Gantacurium.,increase,risk
Gantacurium,Nefazodone,The risk or severity of adverse effects can be increased when Gantacurium is combined with Nefazodone.,increase,risk
Gantacurium,Neostigmine,The therapeutic efficacy of Gantacurium can be decreased when used in combination with Neostigmine.,decrease,no risk
Gantacurium,Nialamide,The risk or severity of CNS depression can be increased when Nialamide is combined with Gantacurium.,increase,risk
Gantacurium,Nicardipine,The risk or severity of adverse effects can be increased when Nicardipine is combined with Gantacurium.,increase,risk
Gantacurium,Nitrazepam,The risk or severity of CNS depression can be increased when Nitrazepam is combined with Gantacurium.,increase,risk
Gantacurium,Nitrous oxide,The risk or severity of CNS depression can be increased when Gantacurium is combined with Nitrous oxide.,increase,risk
Gantacurium,Nizatidine,The therapeutic efficacy of Gantacurium can be decreased when used in combination with Nizatidine.,decrease,no risk
Gantacurium,Nomifensine,The risk or severity of CNS depression can be increased when Nomifensine is combined with Gantacurium.,increase,risk
Gantacurium,Normethadone,The risk or severity of adverse effects can be increased when Gantacurium is combined with Normethadone.,increase,risk
Gantacurium,Nortriptyline,The risk or severity of CNS depression can be increased when Nortriptyline is combined with Gantacurium.,increase,risk
Gantacurium,Olanzapine,The risk or severity of CNS depression can be increased when Olanzapine is combined with Gantacurium.,increase,risk
Gantacurium,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Gantacurium is combined with Oliceridine.",increase,risk
Gantacurium,Ondansetron,The risk or severity of CNS depression can be increased when Ondansetron is combined with Gantacurium.,increase,risk
Gantacurium,Opium,The risk or severity of adverse effects can be increased when Gantacurium is combined with Opium.,increase,risk
Gantacurium,Orphenadrine,Gantacurium may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Gantacurium,Oxazepam,The risk or severity of CNS depression can be increased when Oxazepam is combined with Gantacurium.,increase,risk
Gantacurium,Oxcarbazepine,The risk or severity of CNS depression can be increased when Oxcarbazepine is combined with Gantacurium.,increase,risk
Gantacurium,Oxitriptan,The risk or severity of CNS depression can be increased when Oxitriptan is combined with Gantacurium.,increase,risk
Gantacurium,Oxprenolol,The risk or severity of CNS depression can be increased when Oxprenolol is combined with Gantacurium.,increase,risk
Gantacurium,Oxybuprocaine,The risk or severity of CNS depression can be increased when Oxybuprocaine is combined with Gantacurium.,increase,risk
Gantacurium,Oxybutynin,The risk or severity of adverse effects can be increased when Oxybutynin is combined with Gantacurium.,increase,risk
Gantacurium,Oxycodone,The risk or severity of adverse effects can be increased when Gantacurium is combined with Oxycodone.,increase,risk
Gantacurium,Oxymorphone,The risk or severity of adverse effects can be increased when Gantacurium is combined with Oxymorphone.,increase,risk
Gantacurium,Oxyphencyclimine,The risk or severity of adverse effects can be increased when Oxyphencyclimine is combined with Gantacurium.,increase,risk
Gantacurium,Oxyphenisatin acetate,The therapeutic efficacy of Oxyphenisatin acetate can be decreased when used in combination with Gantacurium.,decrease,no risk
Gantacurium,Oxyphenonium,The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Gantacurium.,increase,risk
Gantacurium,Quazepam,The risk or severity of CNS depression can be increased when Quazepam is combined with Gantacurium.,increase,risk
Gantacurium,Quetiapine,The risk or severity of CNS depression can be increased when Quetiapine is combined with Gantacurium.,increase,risk
Gantacurium,Quinethazone,The serum concentration of Quinethazone can be increased when it is combined with Gantacurium.,increase,no risk
Gantacurium,Quinidine,The risk or severity of adverse effects can be increased when Quinidine is combined with Gantacurium.,increase,risk
Gantacurium,Quinine,The risk or severity of CNS depression can be increased when Quinine is combined with Gantacurium.,increase,risk
Gantacurium,Quinupramine,The risk or severity of CNS depression can be increased when Gantacurium is combined with Quinupramine.,increase,risk
Gantacurium,Umeclidinium,The risk or severity of adverse effects can be increased when Gantacurium is combined with Umeclidinium.,increase,risk
Gantacurium,Urethane,The risk or severity of CNS depression can be increased when Urethane is combined with Gantacurium.,increase,risk
Gantacurium,Valproic acid,The risk or severity of CNS depression can be increased when Valproic acid is combined with Gantacurium.,increase,risk
Gantacurium,Vecuronium,The risk or severity of CNS depression can be increased when Vecuronium is combined with Gantacurium.,increase,risk
Gantacurium,Venlafaxine,The risk or severity of CNS depression can be increased when Venlafaxine is combined with Gantacurium.,increase,risk
Gantacurium,Vigabatrin,The risk or severity of CNS depression can be increased when Vigabatrin is combined with Gantacurium.,increase,risk
Gantacurium,Vilazodone,The risk or severity of CNS depression can be increased when Gantacurium is combined with Vilazodone.,increase,risk
Gantacurium,Viloxazine,The risk or severity of CNS depression can be increased when Gantacurium is combined with Viloxazine.,increase,risk
Gantacurium,Vortioxetine,The risk or severity of CNS depression can be increased when Gantacurium is combined with Vortioxetine.,increase,risk
Gantacurium,Yohimbine,The risk or severity of CNS depression can be increased when Yohimbine is combined with Gantacurium.,increase,risk
Gantacurium,Zaleplon,The risk or severity of CNS depression can be increased when Zaleplon is combined with Gantacurium.,increase,risk
Gantacurium,Ziconotide,The risk or severity of CNS depression can be increased when Gantacurium is combined with Ziconotide.,increase,risk
Gantacurium,Zimelidine,The risk or severity of adverse effects can be increased when Gantacurium is combined with Zimelidine.,increase,risk
Gantacurium,Ziprasidone,The risk or severity of adverse effects can be increased when Gantacurium is combined with Ziprasidone.,increase,risk
Gantacurium,Zolmitriptan,The risk or severity of CNS depression can be increased when Zolmitriptan is combined with Gantacurium.,increase,risk
Gantacurium,Zolpidem,Gantacurium may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Gantacurium,Zonisamide,The risk or severity of CNS depression can be increased when Zonisamide is combined with Gantacurium.,increase,risk
Gantacurium,Zopiclone,The risk or severity of adverse effects can be increased when Gantacurium is combined with Zopiclone.,increase,risk
Gantacurium,Zotepine,The risk or severity of CNS depression can be increased when Gantacurium is combined with Zotepine.,increase,risk
Gantacurium,Zuclopenthixol,The risk or severity of CNS depression can be increased when Zuclopenthixol is combined with Gantacurium.,increase,risk
Gantacurium,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Gantacurium.,increase,risk
Eliglustat,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Gadobenic acid is combined with Eliglustat.,increase,risk
Eliglustat,Galantamine,The metabolism of Galantamine can be decreased when combined with Eliglustat.,decrease,no risk
Eliglustat,Gatifloxacin,The risk or severity of QTc prolongation can be increased when Gatifloxacin is combined with Eliglustat.,increase,risk
Eliglustat,Gefitinib,The metabolism of Gefitinib can be decreased when combined with Eliglustat.,decrease,no risk
Eliglustat,Gemcitabine,The serum concentration of Gemcitabine can be increased when it is combined with Eliglustat.,increase,no risk
Eliglustat,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Gemifloxacin is combined with Eliglustat.,increase,risk
Eliglustat,Gepirone,The risk or severity of QTc prolongation can be increased when Gepirone is combined with Eliglustat.,increase,risk
Eliglustat,Gilteritinib,The serum concentration of Gilteritinib can be increased when it is combined with Eliglustat.,increase,no risk
Eliglustat,Givosiran,The serum concentration of Eliglustat can be increased when it is combined with Givosiran.,increase,no risk
Eliglustat,Glasdegib,The serum concentration of Glasdegib can be increased when it is combined with Eliglustat.,increase,no risk
Eliglustat,Glecaprevir,The serum concentration of Glecaprevir can be increased when it is combined with Eliglustat.,increase,no risk
Eliglustat,Glofitamab,The serum concentration of Eliglustat can be increased when it is combined with Glofitamab.,increase,no risk
Eliglustat,Glyburide,The metabolism of Eliglustat can be decreased when combined with Glyburide.,decrease,no risk
Eliglustat,Glycerol phenylbutyrate,The metabolism of Eliglustat can be decreased when combined with Glycerol phenylbutyrate.,decrease,no risk
Eliglustat,Golimumab,The metabolism of Eliglustat can be increased when combined with Golimumab.,increase,no risk
Eliglustat,Goserelin,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Eliglustat.,increase,risk
Eliglustat,Granisetron,The risk or severity of QTc prolongation can be increased when Granisetron is combined with Eliglustat.,increase,risk
Eliglustat,Grazoprevir,The serum concentration of Grazoprevir can be increased when it is combined with Eliglustat.,increase,no risk
Eliglustat,Grepafloxacin,The risk or severity of QTc prolongation can be increased when Grepafloxacin is combined with Eliglustat.,increase,risk
Eliglustat,Halofantrine,The metabolism of Eliglustat can be decreased when combined with Halofantrine.,decrease,no risk
Eliglustat,Haloperidol,The metabolism of Eliglustat can be decreased when combined with Haloperidol.,decrease,no risk
Eliglustat,Histrelin,The risk or severity of QTc prolongation can be increased when Histrelin is combined with Eliglustat.,increase,risk
Eliglustat,Hydralazine,The metabolism of Eliglustat can be decreased when combined with Hydralazine.,decrease,no risk
Eliglustat,Hydrochlorothiazide,The risk or severity of QTc prolongation can be increased when Hydrochlorothiazide is combined with Eliglustat.,increase,risk
Eliglustat,Hydrocodone,The metabolism of Hydrocodone can be decreased when combined with Eliglustat.,decrease,no risk
Eliglustat,Hydroxychloroquine,The metabolism of Hydroxychloroquine can be decreased when combined with Eliglustat.,decrease,no risk
Eliglustat,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Eliglustat is combined with Hydroxyzine.,increase,risk
Eliglustat,Hyoscyamine,The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Eliglustat.,increase,risk
Eliglustat,Ketazolam,The metabolism of Eliglustat can be decreased when combined with Ketazolam.,decrease,no risk
Eliglustat,Ketoconazole,The metabolism of Eliglustat can be decreased when combined with Ketoconazole.,decrease,no risk
Eliglustat,Nadolol,The metabolism of Nadolol can be decreased when combined with Eliglustat.,decrease,no risk
Eliglustat,Nalidixic acid,The risk or severity of QTc prolongation can be increased when Nalidixic acid is combined with Eliglustat.,increase,risk
Eliglustat,Naloxegol,The serum concentration of Naloxegol can be increased when it is combined with Eliglustat.,increase,no risk
Eliglustat,Nateglinide,The metabolism of Nateglinide can be decreased when combined with Eliglustat.,decrease,no risk
Eliglustat,Nebivolol,The metabolism of Nebivolol can be decreased when combined with Eliglustat.,decrease,no risk
Eliglustat,Nefazodone,The metabolism of Eliglustat can be decreased when combined with Nefazodone.,decrease,no risk
Eliglustat,Nelfinavir,The metabolism of Eliglustat can be decreased when combined with Nelfinavir.,decrease,no risk
Eliglustat,Netupitant,The metabolism of Eliglustat can be decreased when combined with Netupitant.,decrease,no risk
Eliglustat,Nevirapine,The metabolism of Nevirapine can be decreased when combined with Eliglustat.,decrease,no risk
Eliglustat,Niacin,The metabolism of Eliglustat can be decreased when combined with Niacin.,decrease,no risk
Eliglustat,Nicardipine,The metabolism of Eliglustat can be decreased when combined with Nicardipine.,decrease,no risk
Eliglustat,Nicergoline,The metabolism of Nicergoline can be decreased when combined with Eliglustat.,decrease,no risk
Eliglustat,Nifedipine,The metabolism of Nifedipine can be decreased when combined with Eliglustat.,decrease,no risk
Eliglustat,Nilotinib,The metabolism of Eliglustat can be decreased when combined with Nilotinib.,decrease,no risk
Eliglustat,Nilvadipine,The metabolism of Eliglustat can be decreased when combined with Nilvadipine.,decrease,no risk
Eliglustat,Nimodipine,The risk or severity of QTc prolongation can be increased when Nimodipine is combined with Eliglustat.,increase,risk
Eliglustat,Nintedanib,The serum concentration of Nintedanib can be increased when it is combined with Eliglustat.,increase,no risk
Eliglustat,Nirogacestat,The metabolism of Nirogacestat can be decreased when combined with Eliglustat.,decrease,no risk
Eliglustat,Nitrendipine,The risk or severity of QTc prolongation can be increased when Nitrendipine is combined with Eliglustat.,increase,risk
Eliglustat,Nitric Oxide,The metabolism of Eliglustat can be decreased when combined with Nitric Oxide.,decrease,no risk
Eliglustat,Norfloxacin,The metabolism of Eliglustat can be decreased when combined with Norfloxacin.,decrease,no risk
Eliglustat,Nortriptyline,The metabolism of Nortriptyline can be decreased when combined with Eliglustat.,decrease,no risk
Eliglustat,Noscapine,The metabolism of Eliglustat can be decreased when combined with Noscapine.,decrease,no risk
Eliglustat,Octreotide,The metabolism of Eliglustat can be decreased when combined with Octreotide.,decrease,no risk
Eliglustat,Ofloxacin,The risk or severity of QTc prolongation can be increased when Ofloxacin is combined with Eliglustat.,increase,risk
Eliglustat,Olanzapine,The metabolism of Olanzapine can be decreased when combined with Eliglustat.,decrease,no risk
Eliglustat,Olaparib,The metabolism of Eliglustat can be decreased when combined with Olaparib.,decrease,no risk
Eliglustat,Oliceridine,The metabolism of Oliceridine can be decreased when combined with Eliglustat.,decrease,no risk
Eliglustat,Olodaterol,The risk or severity of QTc prolongation can be increased when Olodaterol is combined with Eliglustat.,increase,risk
Eliglustat,Olutasidenib,The therapeutic efficacy of Eliglustat can be decreased when used in combination with Olutasidenib.,decrease,no risk
Eliglustat,Omadacycline,The serum concentration of Omadacycline can be increased when it is combined with Eliglustat.,increase,no risk
Eliglustat,Omaveloxolone,The serum concentration of Eliglustat can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Eliglustat,Ombitasvir,The serum concentration of Ombitasvir can be increased when it is combined with Eliglustat.,increase,no risk
Eliglustat,Ondansetron,The metabolism of Ondansetron can be decreased when combined with Eliglustat.,decrease,no risk
Eliglustat,Opium,The metabolism of Opium can be decreased when combined with Eliglustat.,decrease,no risk
Eliglustat,Oritavancin,The metabolism of Eliglustat can be decreased when combined with Oritavancin.,decrease,no risk
Eliglustat,Orphenadrine,The metabolism of Eliglustat can be decreased when combined with Orphenadrine.,decrease,no risk
Eliglustat,Osilodrostat,The metabolism of Eliglustat can be decreased when combined with Osilodrostat.,decrease,no risk
Eliglustat,Osimertinib,The serum concentration of Osimertinib can be increased when it is combined with Eliglustat.,increase,no risk
Eliglustat,Ospemifene,The metabolism of Eliglustat can be decreased when combined with Ospemifene.,decrease,no risk
Eliglustat,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Eliglustat.,increase,risk
Eliglustat,Oxamniquine,The metabolism of Eliglustat can be decreased when combined with Oxamniquine.,decrease,no risk
Eliglustat,Oxatomide,The risk or severity of QTc prolongation can be increased when Oxatomide is combined with Eliglustat.,increase,risk
Eliglustat,Oxetacaine,The metabolism of Eliglustat can be decreased when combined with Oxetacaine.,decrease,no risk
Eliglustat,Oxprenolol,The metabolism of Oxprenolol can be decreased when combined with Eliglustat.,decrease,no risk
Eliglustat,Oxybutynin,The metabolism of Eliglustat can be decreased when combined with Oxybutynin.,decrease,no risk
Eliglustat,Oxycodone,The metabolism of Oxycodone can be decreased when combined with Eliglustat.,decrease,no risk
Eliglustat,Oxymetholone,The metabolism of Eliglustat can be decreased when combined with Oxymetholone.,decrease,no risk
Eliglustat,Oxymorphone,The metabolism of Oxymorphone can be decreased when combined with Eliglustat.,decrease,no risk
Eliglustat,Oxytocin,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Eliglustat.,increase,risk
Eliglustat,Quetiapine,The metabolism of Quetiapine can be decreased when combined with Eliglustat.,decrease,no risk
Eliglustat,Quinidine,The metabolism of Eliglustat can be decreased when combined with Quinidine.,decrease,no risk
Eliglustat,Quinine,The metabolism of Eliglustat can be decreased when combined with Quinine.,decrease,no risk
Eliglustat,Quinupristin,The metabolism of Eliglustat can be decreased when combined with Quinupristin.,decrease,no risk
Eliglustat,Quizartinib,The serum concentration of Quizartinib can be increased when it is combined with Eliglustat.,increase,no risk
Eliglustat,Ubrogepant,The serum concentration of Ubrogepant can be increased when it is combined with Eliglustat.,increase,no risk
Eliglustat,Umeclidinium,The metabolism of Umeclidinium can be decreased when combined with Eliglustat.,decrease,no risk
Eliglustat,Vadadustat,The serum concentration of Eliglustat can be increased when it is combined with Vadadustat.,increase,no risk
Eliglustat,Valbenazine,The metabolism of Valbenazine can be decreased when combined with Eliglustat.,decrease,no risk
Eliglustat,Valproic acid,The metabolism of Eliglustat can be decreased when combined with Valproic acid.,decrease,no risk
Eliglustat,Vandetanib,The risk or severity of QTc prolongation can be increased when Vandetanib is combined with Eliglustat.,increase,risk
Eliglustat,Vardenafil,The serum concentration of Vardenafil can be increased when it is combined with Eliglustat.,increase,no risk
Eliglustat,Velpatasvir,The serum concentration of Velpatasvir can be increased when it is combined with Eliglustat.,increase,no risk
Eliglustat,Vemurafenib,The serum concentration of Vemurafenib can be increased when it is combined with Eliglustat.,increase,no risk
Eliglustat,Venetoclax,The metabolism of Eliglustat can be decreased when combined with Venetoclax.,decrease,no risk
Eliglustat,Venlafaxine,The metabolism of Venlafaxine can be decreased when combined with Eliglustat.,decrease,no risk
Eliglustat,Verapamil,The metabolism of Eliglustat can be decreased when combined with Verapamil.,decrease,no risk
Eliglustat,Vernakalant,The risk or severity of Cardiac Arrhythmia can be increased when Eliglustat is combined with Vernakalant.,increase,risk
Eliglustat,Vilanterol,The risk or severity of QTc prolongation and ventricular arrhythmias can be increased when Vilanterol is combined with Eliglustat.,increase,risk
Eliglustat,Vilazodone,The metabolism of Vilazodone can be decreased when combined with Eliglustat.,decrease,no risk
Eliglustat,Viloxazine,The metabolism of Eliglustat can be decreased when combined with Viloxazine.,decrease,no risk
Eliglustat,Vinblastine,The metabolism of Eliglustat can be decreased when combined with Vinblastine.,decrease,no risk
Eliglustat,Vincristine,The serum concentration of Vincristine can be increased when it is combined with Eliglustat.,increase,no risk
Eliglustat,Vinflunine,The serum concentration of Vinflunine can be increased when it is combined with Eliglustat.,increase,no risk
Eliglustat,Vinorelbine,The metabolism of Eliglustat can be decreased when combined with Vinorelbine.,decrease,no risk
Eliglustat,Voclosporin,The serum concentration of Voclosporin can be increased when it is combined with Eliglustat.,increase,no risk
Eliglustat,Voriconazole,The metabolism of Eliglustat can be decreased when combined with Voriconazole.,decrease,no risk
Eliglustat,Vorinostat,The risk or severity of QTc prolongation can be increased when Vorinostat is combined with Eliglustat.,increase,risk
Eliglustat,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Eliglustat.,decrease,no risk
Eliglustat,Voxilaprevir,The serum concentration of Voxilaprevir can be increased when it is combined with Eliglustat.,increase,no risk
Eliglustat,Yohimbine,The metabolism of Yohimbine can be decreased when combined with Eliglustat.,decrease,no risk
Eliglustat,Zafirlukast,The metabolism of Eliglustat can be decreased when combined with Zafirlukast.,decrease,no risk
Eliglustat,Zimelidine,The metabolism of Eliglustat can be decreased when combined with Zimelidine.,decrease,no risk
Eliglustat,Ziprasidone,The metabolism of Eliglustat can be decreased when combined with Ziprasidone.,decrease,no risk
Eliglustat,Zolpidem,The metabolism of Zolpidem can be decreased when combined with Eliglustat.,decrease,no risk
Eliglustat,Zonisamide,The risk or severity of QTc prolongation can be increased when Zonisamide is combined with Eliglustat.,increase,risk
Eliglustat,Zuclopenthixol,The metabolism of Zuclopenthixol can be decreased when combined with Eliglustat.,decrease,no risk
Maxy-G34,Vinblastine,The risk or severity of peripheral neuropathy can be increased when Maxy-G34 is combined with Vinblastine.,increase,risk
Maxy-G34,Vincristine,The risk or severity of peripheral neuropathy can be increased when Maxy-G34 is combined with Vincristine.,increase,risk
Maxy-G34,Vindesine,The risk or severity of peripheral neuropathy can be increased when Maxy-G34 is combined with Vindesine.,increase,risk
Maxy-G34,Vinflunine,The risk or severity of peripheral neuropathy can be increased when Maxy-G34 is combined with Vinflunine.,increase,risk
Maxy-G34,Vinorelbine,The risk or severity of peripheral neuropathy can be increased when Maxy-G34 is combined with Vinorelbine.,increase,risk
Cixutumumab,Natalizumab,The risk or severity of adverse effects can be increased when Natalizumab is combined with Cixutumumab.,increase,risk
Cixutumumab,Necitumumab,The risk or severity of adverse effects can be increased when Necitumumab is combined with Cixutumumab.,increase,risk
Cixutumumab,Nivolumab,The risk or severity of adverse effects can be increased when Nivolumab is combined with Cixutumumab.,increase,risk
Cixutumumab,Obiltoxaximab,The risk or severity of adverse effects can be increased when Obiltoxaximab is combined with Cixutumumab.,increase,risk
Cixutumumab,Obinutuzumab,The risk or severity of adverse effects can be increased when Obinutuzumab is combined with Cixutumumab.,increase,risk
Cixutumumab,Ocrelizumab,The risk or severity of adverse effects can be increased when Ocrelizumab is combined with Cixutumumab.,increase,risk
Cixutumumab,Odesivimab,The risk or severity of adverse effects can be increased when Cixutumumab is combined with Odesivimab.,increase,risk
Cixutumumab,Ofatumumab,The risk or severity of adverse effects can be increased when Ofatumumab is combined with Cixutumumab.,increase,risk
Cixutumumab,Olaratumab,The risk or severity of adverse effects can be increased when Olaratumab is combined with Cixutumumab.,increase,risk
Cixutumumab,Omalizumab,The risk or severity of adverse effects can be increased when Omalizumab is combined with Cixutumumab.,increase,risk
Cixutumumab,Quinestrol,Quinestrol may increase the thrombogenic activities of Cixutumumab.,increase,no risk
Cixutumumab,Ublituximab,The risk or severity of adverse effects can be increased when Ublituximab is combined with Cixutumumab.,increase,risk
Cixutumumab,Ustekinumab,The risk or severity of adverse effects can be increased when Ustekinumab is combined with Cixutumumab.,increase,risk
Cixutumumab,Vedolizumab,The risk or severity of adverse effects can be increased when Vedolizumab is combined with Cixutumumab.,increase,risk
Levosalbutamol,Biperiden,The risk or severity of Tachycardia can be increased when Biperiden is combined with Levosalbutamol.,increase,risk
Levosalbutamol,Bismuth subgallate,Levosalbutamol may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Levosalbutamol,Bisoprolol,The therapeutic efficacy of Levosalbutamol can be decreased when used in combination with Bisoprolol.,decrease,no risk
Levosalbutamol,Bisoxatin,Bisoxatin may decrease the excretion rate of Levosalbutamol which could result in a higher serum level.,decrease,no risk
Levosalbutamol,Bleomycin,Bleomycin may decrease the excretion rate of Levosalbutamol which could result in a higher serum level.,decrease,no risk
Levosalbutamol,Bosentan,Levosalbutamol may decrease the antihypertensive activities of Bosentan.,decrease,no risk
Levosalbutamol,Bretylium,Levosalbutamol may decrease the antihypertensive activities of Bretylium.,decrease,no risk
Levosalbutamol,Brexpiprazole,The therapeutic efficacy of Levosalbutamol can be decreased when used in combination with Brexpiprazole.,decrease,no risk
Levosalbutamol,Brivaracetam,Brivaracetam may decrease the excretion rate of Levosalbutamol which could result in a higher serum level.,decrease,no risk
Levosalbutamol,Bromazepam,Bromazepam may decrease the excretion rate of Levosalbutamol which could result in a higher serum level.,decrease,no risk
Levosalbutamol,Bromocriptine,Bromocriptine may increase the hypertensive and vasoconstricting activities of Levosalbutamol.,increase,no risk
Levosalbutamol,Bromotheophylline,Bromotheophylline may increase the excretion rate of Levosalbutamol which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Levosalbutamol,Brompheniramine,The risk or severity of Tachycardia can be increased when Brompheniramine is combined with Levosalbutamol.,increase,risk
Levosalbutamol,Buclizine,The risk or severity of Tachycardia can be increased when Buclizine is combined with Levosalbutamol.,increase,risk
Levosalbutamol,Budesonide,The risk or severity of hypokalemia can be increased when Budesonide is combined with Levosalbutamol.,increase,risk
Levosalbutamol,Bumadizone,The risk or severity of hypertension can be increased when Levosalbutamol is combined with Bumadizone.,increase,risk
Levosalbutamol,Bumetanide,The risk or severity of hypokalemia can be increased when Levosalbutamol is combined with Bumetanide.,increase,risk
Levosalbutamol,Bupropion,Bupropion may decrease the excretion rate of Levosalbutamol which could result in a higher serum level.,decrease,no risk
Levosalbutamol,Buspirone,The risk or severity of hypertension can be increased when Buspirone is combined with Levosalbutamol.,increase,risk
Levosalbutamol,Butabarbital,Butabarbital may decrease the excretion rate of Levosalbutamol which could result in a higher serum level.,decrease,no risk
Levosalbutamol,Butriptyline,The risk or severity of hypertension can be increased when Butriptyline is combined with Levosalbutamol.,increase,risk
Levosalbutamol,Butylscopolamine,The risk or severity of Tachycardia can be increased when Butylscopolamine is combined with Levosalbutamol.,increase,risk
Levosalbutamol,Gabapentin enacarbil,The excretion of Levosalbutamol can be decreased when combined with Fusidic acid.,decrease,no risk
Levosalbutamol,Gadobenic acid,Gabapentin enacarbil may decrease the excretion rate of Levosalbutamol which could result in a higher serum level.,decrease,no risk
Levosalbutamol,Gadodiamide,Gadobenic acid may decrease the excretion rate of Levosalbutamol which could result in a higher serum level.,decrease,no risk
Levosalbutamol,Gadofosveset trisodium,Gadodiamide may decrease the excretion rate of Levosalbutamol which could result in a higher serum level.,decrease,no risk
Levosalbutamol,Gadopentetic acid,Gadofosveset trisodium may decrease the excretion rate of Levosalbutamol which could result in a higher serum level.,decrease,no risk
Levosalbutamol,Gadoteric acid,Gadopentetic acid may decrease the excretion rate of Levosalbutamol which could result in a higher serum level.,decrease,no risk
Levosalbutamol,Gadoteridol,Gadoteric acid may decrease the excretion rate of Levosalbutamol which could result in a higher serum level.,decrease,no risk
Levosalbutamol,Gallamine triethiodide,Gadoteridol may decrease the excretion rate of Levosalbutamol which could result in a higher serum level.,decrease,no risk
Levosalbutamol,Ganciclovir,The risk or severity of Tachycardia can be increased when Gallamine triethiodide is combined with Levosalbutamol.,increase,risk
Levosalbutamol,Gemcitabine,Ganciclovir may decrease the excretion rate of Levosalbutamol which could result in a higher serum level.,decrease,no risk
Levosalbutamol,Gemfibrozil,Gemcitabine may decrease the excretion rate of Levosalbutamol which could result in a higher serum level.,decrease,no risk
Levosalbutamol,Gentamicin,The excretion of Levosalbutamol can be decreased when combined with Gemfibrozil.,decrease,no risk
Levosalbutamol,Gimeracil,Levosalbutamol may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Levosalbutamol,Givosiran,Gimeracil may decrease the excretion rate of Levosalbutamol which could result in a higher serum level.,decrease,no risk
Levosalbutamol,Glecaprevir,Givosiran may decrease the excretion rate of Levosalbutamol which could result in a higher serum level.,decrease,no risk
Levosalbutamol,Glipizide,The excretion of Levosalbutamol can be decreased when combined with Glecaprevir.,decrease,no risk
Levosalbutamol,Glycerol phenylbutyrate,Glipizide may decrease the excretion rate of Levosalbutamol which could result in a higher serum level.,decrease,no risk
Levosalbutamol,Glycopyrronium,Glycerol phenylbutyrate may decrease the excretion rate of Levosalbutamol which could result in a higher serum level.,decrease,no risk
Levosalbutamol,Golodirsen,The risk or severity of Tachycardia can be increased when Glycopyrronium is combined with Levosalbutamol.,increase,risk
Levosalbutamol,Goserelin,Levosalbutamol may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Levosalbutamol,Guanabenz,Goserelin may decrease the excretion rate of Levosalbutamol which could result in a higher serum level.,decrease,no risk
Levosalbutamol,Guanadrel,Levosalbutamol may decrease the antihypertensive activities of Guanabenz.,decrease,no risk
Levosalbutamol,Guanethidine,Levosalbutamol may decrease the antihypertensive activities of Guanadrel.,decrease,no risk
Levosalbutamol,Guanfacine,Levosalbutamol may decrease the antihypertensive activities of Guanethidine.,decrease,no risk
Levosalbutamol,Guanoxan,Levosalbutamol may decrease the antihypertensive activities of Guanfacine.,decrease,no risk
Levosalbutamol,Haloperidol,Levosalbutamol may decrease the antihypertensive activities of Guanoxan.,decrease,no risk
Levosalbutamol,Halothane,Haloperidol may decrease the excretion rate of Levosalbutamol which could result in a higher serum level.,decrease,no risk
Levosalbutamol,Hexocyclium,The risk or severity of hypertension can be increased when Halothane is combined with Levosalbutamol.,increase,risk
Levosalbutamol,Homatropine methylbromide,The risk or severity of Tachycardia can be increased when Hexocyclium is combined with Levosalbutamol.,increase,risk
Levosalbutamol,Hydralazine,The risk or severity of Tachycardia can be increased when Homatropine methylbromide is combined with Levosalbutamol.,increase,risk
Levosalbutamol,Hydrochlorothiazide,Levosalbutamol may decrease the antihypertensive activities of Hydralazine.,decrease,no risk
Levosalbutamol,Hydrocortisone,The risk or severity of hypokalemia can be increased when Levosalbutamol is combined with Hydrochlorothiazide.,increase,risk
Levosalbutamol,Hydrocortisone acetate,The risk or severity of hypokalemia can be increased when Hydrocortisone is combined with Levosalbutamol.,increase,risk
Levosalbutamol,Hydrocortisone butyrate,The risk or severity of hypokalemia can be increased when Hydrocortisone acetate is combined with Levosalbutamol.,increase,risk
Levosalbutamol,Hydrocortisone cypionate,The risk or severity of hypokalemia can be increased when Hydrocortisone butyrate is combined with Levosalbutamol.,increase,risk
Levosalbutamol,Hydrocortisone succinate,The risk or severity of hypokalemia can be increased when Hydrocortisone cypionate is combined with Levosalbutamol.,increase,risk
Levosalbutamol,Hydroflumethiazide,The risk or severity of hypokalemia can be increased when Hydrocortisone succinate is combined with Levosalbutamol.,increase,risk
Levosalbutamol,Hydromorphone,The risk or severity of hypokalemia can be increased when Levosalbutamol is combined with Hydroflumethiazide.,increase,risk
Levosalbutamol,Hydroxocobalamin,Hydromorphone may decrease the excretion rate of Levosalbutamol which could result in a higher serum level.,decrease,no risk
Levosalbutamol,Hydroxyethyl Starch,Hydroxocobalamin may decrease the excretion rate of Levosalbutamol which could result in a higher serum level.,decrease,no risk
Levosalbutamol,Hyoscyamine,Hydroxyethyl Starch may decrease the excretion rate of Levosalbutamol which could result in a higher serum level.,decrease,no risk
Levosalbutamol,Kanamycin,Ixazomib may decrease the excretion rate of Levosalbutamol which could result in a higher serum level.,decrease,no risk
Levosalbutamol,Ketamine,Levosalbutamol may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Levosalbutamol,Ketazolam,Ketamine may decrease the excretion rate of Levosalbutamol which could result in a higher serum level.,decrease,no risk
Levosalbutamol,Ketoconazole,Ketazolam may decrease the excretion rate of Levosalbutamol which could result in a higher serum level.,decrease,no risk
Levosalbutamol,Ketoprofen,The excretion of Levosalbutamol can be decreased when combined with Ketoconazole.,decrease,no risk
Levosalbutamol,Ketorolac,The risk or severity of hypertension can be increased when Ketoprofen is combined with Levosalbutamol.,increase,risk
Levosalbutamol,N-acetyltyrosine,Mycophenolic acid may decrease the excretion rate of Levosalbutamol which could result in a higher serum level.,decrease,no risk
Levosalbutamol,Nabilone,N-acetyltyrosine may decrease the excretion rate of Levosalbutamol which could result in a higher serum level.,decrease,no risk
Levosalbutamol,Nabumetone,The risk or severity of Tachycardia can be increased when Nabilone is combined with Levosalbutamol.,increase,risk
Levosalbutamol,Nadolol,The risk or severity of hypertension can be increased when Nabumetone is combined with Levosalbutamol.,increase,risk
Levosalbutamol,Naldemedine,Nadolol may decrease the bronchodilatory activities of Levosalbutamol.,decrease,no risk
Levosalbutamol,Nalmefene,Naldemedine may decrease the excretion rate of Levosalbutamol which could result in a higher serum level.,decrease,no risk
Levosalbutamol,Naloxone,Nalmefene may decrease the excretion rate of Levosalbutamol which could result in a higher serum level.,decrease,no risk
Levosalbutamol,Naphazoline,Naloxone may decrease the excretion rate of Levosalbutamol which could result in a higher serum level.,decrease,no risk
Levosalbutamol,Naproxen,The risk or severity of hypertension can be increased when Naphazoline is combined with Levosalbutamol.,increase,risk
Levosalbutamol,Naratriptan,The risk or severity of hypertension can be increased when Naproxen is combined with Levosalbutamol.,increase,risk
Levosalbutamol,Nateglinide,The risk or severity of hypertension can be increased when Naratriptan is combined with Levosalbutamol.,increase,risk
Levosalbutamol,Naxitamab,Nateglinide may decrease the excretion rate of Levosalbutamol which could result in a higher serum level.,decrease,no risk
Levosalbutamol,Nebivolol,The risk or severity of hypertension can be increased when Levosalbutamol is combined with Naxitamab.,increase,risk
Levosalbutamol,Nedaplatin,The therapeutic efficacy of Levosalbutamol can be decreased when used in combination with Nebivolol.,decrease,no risk
Levosalbutamol,Nedocromil,Levosalbutamol may decrease the excretion rate of Nedaplatin which could result in a higher serum level.,decrease,no risk
Levosalbutamol,Nefazodone,Nedocromil may decrease the excretion rate of Levosalbutamol which could result in a higher serum level.,decrease,no risk
Levosalbutamol,Nelfinavir,Nefazodone may increase the tachycardic activities of Levosalbutamol.,increase,no risk
Levosalbutamol,Neomycin,The excretion of Levosalbutamol can be decreased when combined with Nelfinavir.,decrease,no risk
Levosalbutamol,Netilmicin,Levosalbutamol may decrease the excretion rate of Neomycin which could result in a higher serum level.,decrease,no risk
Levosalbutamol,Nialamide,Levosalbutamol may decrease the excretion rate of Netilmicin which could result in a higher serum level.,decrease,no risk
Levosalbutamol,Nicardipine,The risk or severity of hypertension can be increased when Nialamide is combined with Levosalbutamol.,increase,risk
Levosalbutamol,Nicergoline,The therapeutic efficacy of Levosalbutamol can be decreased when used in combination with Nicardipine.,decrease,no risk
Levosalbutamol,Nicorandil,Nicergoline may increase the hypertensive and vasoconstricting activities of Levosalbutamol.,increase,no risk
Levosalbutamol,Nicotine,Levosalbutamol may decrease the antihypertensive activities of Nicorandil.,decrease,no risk
Levosalbutamol,Nifedipine,The risk or severity of Tachycardia can be increased when Nicotine is combined with Levosalbutamol.,increase,risk
Levosalbutamol,Nilotinib,Nifedipine may decrease the excretion rate of Levosalbutamol which could result in a higher serum level.,decrease,no risk
Levosalbutamol,Nilutamide,The excretion of Levosalbutamol can be decreased when combined with Nilotinib.,decrease,no risk
Levosalbutamol,Nilvadipine,Nilutamide may decrease the excretion rate of Levosalbutamol which could result in a higher serum level.,decrease,no risk
Levosalbutamol,Nimesulide,Levosalbutamol may decrease the antihypertensive activities of Nilvadipine.,decrease,no risk
Levosalbutamol,Nimodipine,The risk or severity of hypertension can be increased when Nimesulide is combined with Levosalbutamol.,increase,risk
Levosalbutamol,Nisoldipine,Levosalbutamol may decrease the antihypertensive activities of Nimodipine.,decrease,no risk
Levosalbutamol,Nitrendipine,Levosalbutamol may decrease the antihypertensive activities of Nisoldipine.,decrease,no risk
Levosalbutamol,Nitric Oxide,Levosalbutamol may decrease the antihypertensive activities of Nitrendipine.,decrease,no risk
Levosalbutamol,Nitrofurantoin,Nitric Oxide may decrease the excretion rate of Levosalbutamol which could result in a higher serum level.,decrease,no risk
Levosalbutamol,Nitroglycerin,Nitrofurantoin may decrease the excretion rate of Levosalbutamol which could result in a higher serum level.,decrease,no risk
Levosalbutamol,Nitroprusside,Levosalbutamol may decrease the antihypertensive activities of Nitroglycerin.,decrease,no risk
Levosalbutamol,Nitrous oxide,Levosalbutamol may decrease the antihypertensive activities of Nitroprusside.,decrease,no risk
Levosalbutamol,Norepinephrine,The risk or severity of hypertension can be increased when Nitrous oxide is combined with Levosalbutamol.,increase,risk
Levosalbutamol,Nortriptyline,The risk or severity of adverse effects can be increased when Norepinephrine is combined with Levosalbutamol.,increase,risk
Levosalbutamol,Novobiocin,The therapeutic efficacy of Levosalbutamol can be decreased when used in combination with Nortriptyline.,decrease,no risk
Levosalbutamol,Nylidrin,The excretion of Levosalbutamol can be decreased when combined with Novobiocin.,decrease,no risk
Levosalbutamol,Nystatin,The risk or severity of hypertension can be increased when Nylidrin is combined with Levosalbutamol.,increase,risk
Levosalbutamol,Octinoxate,The excretion of Levosalbutamol can be decreased when combined with Nystatin.,decrease,no risk
Levosalbutamol,Olanzapine,Octinoxate may decrease the excretion rate of Levosalbutamol which could result in a higher serum level.,decrease,no risk
Levosalbutamol,Olmesartan,The therapeutic efficacy of Levosalbutamol can be decreased when used in combination with Olanzapine.,decrease,no risk
Levosalbutamol,Olodaterol,Levosalbutamol may decrease the antihypertensive activities of Olmesartan.,decrease,no risk
Levosalbutamol,Olsalazine,The risk or severity of adverse effects can be increased when Olodaterol is combined with Levosalbutamol.,increase,risk
Levosalbutamol,Opium,Olsalazine may decrease the excretion rate of Levosalbutamol which could result in a higher serum level.,decrease,no risk
Levosalbutamol,Orciprenaline,Opium may decrease the excretion rate of Levosalbutamol which could result in a higher serum level.,decrease,no risk
Levosalbutamol,Orphenadrine,The risk or severity of adverse effects can be increased when Orciprenaline is combined with Levosalbutamol.,increase,risk
Levosalbutamol,Oseltamivir,The risk or severity of Tachycardia can be increased when Orphenadrine is combined with Levosalbutamol.,increase,risk
Levosalbutamol,Ouabain,Oseltamivir may decrease the excretion rate of Levosalbutamol which could result in a higher serum level.,decrease,no risk
Levosalbutamol,Oxacillin,The excretion of Levosalbutamol can be decreased when combined with Ouabain.,decrease,no risk
Levosalbutamol,Oxaprozin,Oxacillin may decrease the excretion rate of Levosalbutamol which could result in a higher serum level.,decrease,no risk
Levosalbutamol,Oxazepam,The risk or severity of hypertension can be increased when Oxaprozin is combined with Levosalbutamol.,increase,risk
Levosalbutamol,Oxprenolol,Oxazepam may decrease the excretion rate of Levosalbutamol which could result in a higher serum level.,decrease,no risk
Levosalbutamol,Oxtriphylline,Oxprenolol may decrease the bronchodilatory activities of Levosalbutamol.,decrease,no risk
Levosalbutamol,Oxybenzone,The risk or severity of hypokalemia can be increased when Oxtriphylline is combined with Levosalbutamol.,increase,risk
Levosalbutamol,Oxybutynin,Oxybenzone may decrease the excretion rate of Levosalbutamol which could result in a higher serum level.,decrease,no risk
Levosalbutamol,Oxymetazoline,The risk or severity of Tachycardia can be increased when Oxybutynin is combined with Levosalbutamol.,increase,risk
Levosalbutamol,Oxyphenbutazone,The risk or severity of hypertension can be increased when Oxymetazoline is combined with Levosalbutamol.,increase,risk
Levosalbutamol,Oxyphencyclimine,The risk or severity of hypertension can be increased when Oxyphenbutazone is combined with Levosalbutamol.,increase,risk
Levosalbutamol,Oxyphenonium,The risk or severity of Tachycardia can be increased when Oxyphencyclimine is combined with Levosalbutamol.,increase,risk
Levosalbutamol,Oxyquinoline,The risk or severity of Tachycardia can be increased when Oxyphenonium is combined with Levosalbutamol.,increase,risk
Navitoclax,Benzocaine,The risk or severity of methemoglobinemia can be increased when Navitoclax is combined with Benzocaine.,increase,risk
Navitoclax,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Navitoclax is combined with Benzyl alcohol.,increase,risk
Navitoclax,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Navitoclax is combined with Bupivacaine.,increase,risk
Navitoclax,Butacaine,The risk or severity of methemoglobinemia can be increased when Navitoclax is combined with Butacaine.,increase,risk
Navitoclax,Butamben,The risk or severity of methemoglobinemia can be increased when Navitoclax is combined with Butamben.,increase,risk
Navitoclax,Nelarabine,The risk or severity of adverse effects can be increased when Nelarabine is combined with Navitoclax.,increase,risk
Navitoclax,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Navitoclax is combined with Oxetacaine.,increase,risk
Navitoclax,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Navitoclax is combined with Oxybuprocaine.,increase,risk
Andrographolide,Gemcitabine,The risk or severity of bleeding can be increased when Andrographolide is combined with Gemcitabine.,increase,risk
Andrographolide,Gemtuzumab ozogamicin,The risk or severity of bleeding can be increased when Andrographolide is combined with Gemtuzumab ozogamicin.,increase,risk
Andrographolide,Ginkgo biloba,Ginkgo biloba may increase the antiplatelet activities of Andrographolide.,increase,no risk
Andrographolide,Glucosamine,Glucosamine may increase the antiplatelet activities of Andrographolide.,increase,no risk
Andrographolide,Glycol salicylate,The risk or severity of bleeding can be increased when Glycol salicylate is combined with Andrographolide.,increase,risk
Andrographolide,Heparin,The risk or severity of bleeding can be increased when Andrographolide is combined with Heparin.,increase,risk
Andrographolide,Hydroxyurea,The risk or severity of bleeding can be increased when Andrographolide is combined with Hydroxyurea.,increase,risk
Andrographolide,Ketoprofen,The risk or severity of bleeding can be increased when Ketoprofen is combined with Andrographolide.,increase,risk
Andrographolide,Ketorolac,The risk or severity of bleeding can be increased when Ketorolac is combined with Andrographolide.,increase,risk
Andrographolide,Nabumetone,The risk or severity of bleeding can be increased when Nabumetone is combined with Andrographolide.,increase,risk
Andrographolide,Nadroparin,The risk or severity of bleeding can be increased when Andrographolide is combined with Nadroparin.,increase,risk
Andrographolide,Naproxen,The risk or severity of bleeding can be increased when Naproxen is combined with Andrographolide.,increase,risk
Andrographolide,Nefazodone,The risk or severity of hemorrhage can be increased when Nefazodone is combined with Andrographolide.,increase,risk
Andrographolide,Nelarabine,The risk or severity of bleeding can be increased when Andrographolide is combined with Nelarabine.,increase,risk
Andrographolide,Nialamide,The risk or severity of bleeding and hemorrhage can be increased when Nialamide is combined with Andrographolide.,increase,risk
Andrographolide,Nilotinib,The risk or severity of bleeding can be increased when Andrographolide is combined with Nilotinib.,increase,risk
Andrographolide,Nimesulide,The risk or severity of bleeding can be increased when Nimesulide is combined with Andrographolide.,increase,risk
Andrographolide,Obeticholic acid,The risk or severity of adverse effects can be increased when Andrographolide is combined with Obeticholic acid.,increase,risk
Andrographolide,Obinutuzumab,The risk or severity of adverse effects can be increased when Andrographolide is combined with Obinutuzumab.,increase,risk
Andrographolide,Olaparib,The risk or severity of bleeding can be increased when Andrographolide is combined with Olaparib.,increase,risk
Andrographolide,Olsalazine,The risk or severity of bleeding can be increased when Andrographolide is combined with Olsalazine.,increase,risk
Andrographolide,Omega-3 fatty acids,Omega-3 fatty acids may increase the antiplatelet activities of Andrographolide.,increase,no risk
Andrographolide,Omega-3-acid ethyl esters,The risk or severity of bleeding can be increased when Omega-3-acid ethyl esters is combined with Andrographolide.,increase,risk
Andrographolide,Oxaliplatin,The risk or severity of bleeding can be increased when Andrographolide is combined with Oxaliplatin.,increase,risk
Andrographolide,Oxaprozin,The risk or severity of bleeding can be increased when Oxaprozin is combined with Andrographolide.,increase,risk
Andrographolide,Oxyphenbutazone,The risk or severity of bleeding can be increased when Oxyphenbutazone is combined with Andrographolide.,increase,risk
Andrographolide,Urokinase,Andrographolide may increase the anticoagulant activities of Urokinase.,increase,no risk
Andrographolide,Ursodeoxycholic acid,The risk or severity of adverse effects can be increased when Andrographolide is combined with Ursodeoxycholic acid.,increase,risk
Andrographolide,Valdecoxib,The risk or severity of bleeding can be increased when Valdecoxib is combined with Andrographolide.,increase,risk
Andrographolide,Venlafaxine,The risk or severity of bleeding can be increased when Andrographolide is combined with Venlafaxine.,increase,risk
Andrographolide,Vinblastine,The risk or severity of bleeding can be increased when Andrographolide is combined with Vinblastine.,increase,risk
Andrographolide,Vindesine,The risk or severity of bleeding can be increased when Andrographolide is combined with Vindesine.,increase,risk
Andrographolide,Vinorelbine,The risk or severity of bleeding can be increased when Andrographolide is combined with Vinorelbine.,increase,risk
Andrographolide,Vitamin E,Vitamin E may increase the antiplatelet activities of Andrographolide.,increase,no risk
Andrographolide,Vorapaxar,The risk or severity of bleeding can be increased when Andrographolide is combined with Vorapaxar.,increase,risk
Andrographolide,Vorinostat,The risk or severity of bleeding can be increased when Andrographolide is combined with Vorinostat.,increase,risk
Andrographolide,Vortioxetine,The risk or severity of bleeding can be increased when Vortioxetine is combined with Andrographolide.,increase,risk
Andrographolide,Warfarin,The risk or severity of bleeding can be increased when Andrographolide is combined with Warfarin.,increase,risk
Andrographolide,Ximelagatran,The risk or severity of bleeding can be increased when Andrographolide is combined with Ximelagatran.,increase,risk
Andrographolide,Zidovudine,The risk or severity of bleeding can be increased when Andrographolide is combined with Zidovudine.,increase,risk
Andrographolide,Zimelidine,The risk or severity of hemorrhage can be increased when Zimelidine is combined with Andrographolide.,increase,risk
Trastuzumab emtansine,Berotralstat,The serum concentration of Trastuzumab emtansine can be increased when it is combined with Berotralstat.,increase,no risk
Trastuzumab emtansine,Besilesomab,The risk or severity of adverse effects can be increased when Trastuzumab emtansine is combined with Besilesomab.,increase,risk
Trastuzumab emtansine,Betamethasone,The metabolism of Trastuzumab emtansine can be increased when combined with Betamethasone.,increase,no risk
Trastuzumab emtansine,Betamethasone phosphate,The metabolism of Trastuzumab emtansine can be increased when combined with Betamethasone phosphate.,increase,no risk
Trastuzumab emtansine,Betrixaban,The serum concentration of Trastuzumab emtansine can be increased when it is combined with Betrixaban.,increase,no risk
Trastuzumab emtansine,Bevacizumab,The risk or severity of adverse effects can be increased when Bevacizumab is combined with Trastuzumab emtansine.,increase,risk
Trastuzumab emtansine,Bexarotene,The metabolism of Trastuzumab emtansine can be increased when combined with Bexarotene.,increase,no risk
Trastuzumab emtansine,Bezlotoxumab,The risk or severity of adverse effects can be increased when Trastuzumab emtansine is combined with Bezlotoxumab.,increase,risk
Trastuzumab emtansine,Bicalutamide,The metabolism of Trastuzumab emtansine can be decreased when combined with Bicalutamide.,decrease,no risk
Trastuzumab emtansine,Bifonazole,The metabolism of Trastuzumab emtansine can be decreased when combined with Bifonazole.,decrease,no risk
Trastuzumab emtansine,Bimekizumab,The metabolism of Trastuzumab emtansine can be increased when combined with Bimekizumab.,increase,no risk
Trastuzumab emtansine,Binimetinib,The serum concentration of Binimetinib can be increased when it is combined with Trastuzumab emtansine.,increase,no risk
Trastuzumab emtansine,Bisoprolol,The serum concentration of Trastuzumab emtansine can be increased when it is combined with Bisoprolol.,increase,no risk
Trastuzumab emtansine,Bivalirudin,The risk or severity of bleeding can be increased when Bivalirudin is combined with Trastuzumab emtansine.,increase,risk
Trastuzumab emtansine,Bleomycin,The risk or severity of adverse effects can be increased when Bleomycin is combined with Trastuzumab emtansine.,increase,risk
Trastuzumab emtansine,Blinatumomab,The risk or severity of adverse effects can be increased when Trastuzumab emtansine is combined with Blinatumomab.,increase,risk
Trastuzumab emtansine,Boceprevir,The metabolism of Trastuzumab emtansine can be decreased when combined with Boceprevir.,decrease,no risk
Trastuzumab emtansine,"Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated)","The therapeutic efficacy of Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated) can be decreased when used in combination with Trastuzumab emtansine.",decrease,no risk
Trastuzumab emtansine,Bortezomib,The risk or severity of adverse effects can be increased when Bortezomib is combined with Trastuzumab emtansine.,increase,risk
Trastuzumab emtansine,Bosentan,The metabolism of Trastuzumab emtansine can be increased when combined with Bosentan.,increase,no risk
Trastuzumab emtansine,Bosutinib,The metabolism of Trastuzumab emtansine can be decreased when combined with Bosutinib.,decrease,no risk
Trastuzumab emtansine,Brentuximab vedotin,The serum concentration of Trastuzumab emtansine can be increased when it is combined with Brentuximab vedotin.,increase,no risk
Trastuzumab emtansine,Brodalumab,The risk or severity of adverse effects can be increased when Trastuzumab emtansine is combined with Brodalumab.,increase,risk
Trastuzumab emtansine,Brolucizumab,The risk or severity of adverse effects can be increased when Trastuzumab emtansine is combined with Brolucizumab.,increase,risk
Trastuzumab emtansine,Budesonide,The metabolism of Trastuzumab emtansine can be increased when combined with Budesonide.,increase,no risk
Trastuzumab emtansine,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Trastuzumab emtansine is combined with Bupivacaine.,increase,risk
Trastuzumab emtansine,Buprenorphine,The metabolism of Trastuzumab emtansine can be decreased when combined with Buprenorphine.,decrease,no risk
Trastuzumab emtansine,Burosumab,The risk or severity of adverse effects can be increased when Trastuzumab emtansine is combined with Burosumab.,increase,risk
Trastuzumab emtansine,Buspirone,The metabolism of Trastuzumab emtansine can be decreased when combined with Buspirone.,decrease,no risk
Trastuzumab emtansine,Busulfan,The risk or severity of adverse effects can be increased when Busulfan is combined with Trastuzumab emtansine.,increase,risk
Trastuzumab emtansine,Butacaine,The risk or severity of methemoglobinemia can be increased when Trastuzumab emtansine is combined with Butacaine.,increase,risk
Trastuzumab emtansine,Butalbital,The metabolism of Trastuzumab emtansine can be increased when combined with Butalbital.,increase,no risk
Trastuzumab emtansine,Butamben,The risk or severity of methemoglobinemia can be increased when Trastuzumab emtansine is combined with Butamben.,increase,risk
Necitumumab,Human varicella-zoster immune globulin,The risk or severity of adverse effects can be increased when Necitumumab is combined with Human varicella-zoster immune globulin.,increase,risk
Necitumumab,Natalizumab,The risk or severity of adverse effects can be increased when Natalizumab is combined with Necitumumab.,increase,risk
Necitumumab,Nivolumab,The risk or severity of adverse effects can be increased when Nivolumab is combined with Necitumumab.,increase,risk
Necitumumab,Obiltoxaximab,The risk or severity of adverse effects can be increased when Obiltoxaximab is combined with Necitumumab.,increase,risk
Necitumumab,Obinutuzumab,The risk or severity of adverse effects can be increased when Obinutuzumab is combined with Necitumumab.,increase,risk
Necitumumab,Ocrelizumab,The risk or severity of adverse effects can be increased when Necitumumab is combined with Ocrelizumab.,increase,risk
Necitumumab,Odesivimab,The risk or severity of adverse effects can be increased when Necitumumab is combined with Odesivimab.,increase,risk
Necitumumab,Ofatumumab,The risk or severity of adverse effects can be increased when Ofatumumab is combined with Necitumumab.,increase,risk
Necitumumab,Olaratumab,The risk or severity of adverse effects can be increased when Olaratumab is combined with Necitumumab.,increase,risk
Necitumumab,Omalizumab,The risk or severity of adverse effects can be increased when Omalizumab is combined with Necitumumab.,increase,risk
Necitumumab,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Necitumumab is combined with Oxetacaine.,increase,risk
Necitumumab,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Necitumumab is combined with Oxybuprocaine.,increase,risk
Necitumumab,Quinestrol,Quinestrol may increase the thrombogenic activities of Necitumumab.,increase,no risk
Necitumumab,Ublituximab,The risk or severity of adverse effects can be increased when Necitumumab is combined with Ublituximab.,increase,risk
Necitumumab,Ustekinumab,The risk or severity of adverse effects can be increased when Ustekinumab is combined with Necitumumab.,increase,risk
Necitumumab,Vedolizumab,The risk or severity of adverse effects can be increased when Vedolizumab is combined with Necitumumab.,increase,risk
Oglufanide,Benzocaine,The risk or severity of methemoglobinemia can be increased when Oglufanide is combined with Benzocaine.,increase,risk
Oglufanide,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Oglufanide is combined with Benzyl alcohol.,increase,risk
Oglufanide,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Oglufanide is combined with Bupivacaine.,increase,risk
Oglufanide,Butacaine,The risk or severity of methemoglobinemia can be increased when Oglufanide is combined with Butacaine.,increase,risk
Oglufanide,Butamben,The risk or severity of methemoglobinemia can be increased when Oglufanide is combined with Butamben.,increase,risk
Oglufanide,Nelarabine,The risk or severity of adverse effects can be increased when Nelarabine is combined with Oglufanide.,increase,risk
Oglufanide,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Oglufanide is combined with Oxetacaine.,increase,risk
Oglufanide,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Oglufanide is combined with Oxybuprocaine.,increase,risk
Irofulven,Benzocaine,The risk or severity of methemoglobinemia can be increased when Irofulven is combined with Benzocaine.,increase,risk
Irofulven,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Irofulven is combined with Benzyl alcohol.,increase,risk
Irofulven,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Irofulven is combined with Bupivacaine.,increase,risk
Irofulven,Butacaine,The risk or severity of methemoglobinemia can be increased when Irofulven is combined with Butacaine.,increase,risk
Irofulven,Butamben,The risk or severity of methemoglobinemia can be increased when Irofulven is combined with Butamben.,increase,risk
Irofulven,Nelarabine,The risk or severity of adverse effects can be increased when Nelarabine is combined with Irofulven.,increase,risk
Irofulven,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Irofulven is combined with Oxetacaine.,increase,risk
Irofulven,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Irofulven is combined with Oxybuprocaine.,increase,risk
PRO-542,Natalizumab,The risk or severity of adverse effects can be increased when Natalizumab is combined with PRO-542.,increase,risk
PRO-542,Necitumumab,The risk or severity of adverse effects can be increased when PRO-542 is combined with Necitumumab.,increase,risk
PRO-542,Nivolumab,The risk or severity of adverse effects can be increased when PRO-542 is combined with Nivolumab.,increase,risk
PRO-542,Obiltoxaximab,The risk or severity of adverse effects can be increased when Obiltoxaximab is combined with PRO-542.,increase,risk
PRO-542,Obinutuzumab,The risk or severity of adverse effects can be increased when PRO-542 is combined with Obinutuzumab.,increase,risk
PRO-542,Ocrelizumab,The risk or severity of adverse effects can be increased when PRO-542 is combined with Ocrelizumab.,increase,risk
PRO-542,Odesivimab,The risk or severity of adverse effects can be increased when PRO-542 is combined with Odesivimab.,increase,risk
PRO-542,Ofatumumab,The risk or severity of adverse effects can be increased when PRO-542 is combined with Ofatumumab.,increase,risk
PRO-542,Olaratumab,The risk or severity of adverse effects can be increased when PRO-542 is combined with Olaratumab.,increase,risk
PRO-542,Omalizumab,The risk or severity of adverse effects can be increased when Omalizumab is combined with PRO-542.,increase,risk
PRO-542,Quinestrol,Quinestrol may increase the thrombogenic activities of PRO-542.,increase,no risk
PRO-542,Ublituximab,The risk or severity of adverse effects can be increased when PRO-542 is combined with Ublituximab.,increase,risk
PRO-542,Ustekinumab,The risk or severity of adverse effects can be increased when Ustekinumab is combined with PRO-542.,increase,risk
PRO-542,Vedolizumab,The risk or severity of adverse effects can be increased when PRO-542 is combined with Vedolizumab.,increase,risk
Solriamfetol,Betaxolol,Solriamfetol may decrease the antihypertensive activities of Betaxolol.,decrease,no risk
Solriamfetol,Bethanidine,The risk or severity of hypertension can be increased when Solriamfetol is combined with Bethanidine.,increase,risk
Solriamfetol,Bicisate,Bicisate may decrease the excretion rate of Solriamfetol which could result in a higher serum level.,decrease,no risk
Solriamfetol,Bictegravir,The excretion of Solriamfetol can be decreased when combined with Bictegravir.,decrease,no risk
Solriamfetol,Biperiden,The risk or severity of Tachycardia can be increased when Solriamfetol is combined with Biperiden.,increase,risk
Solriamfetol,Bismuth subgallate,Bismuth subgallate may decrease the excretion rate of Solriamfetol which could result in a higher serum level.,decrease,no risk
Solriamfetol,Bisoprolol,Solriamfetol may decrease the antihypertensive activities of Bisoprolol.,decrease,no risk
Solriamfetol,Bisoxatin,Bisoxatin may decrease the excretion rate of Solriamfetol which could result in a higher serum level.,decrease,no risk
Solriamfetol,Bleomycin,Bleomycin may decrease the excretion rate of Solriamfetol which could result in a higher serum level.,decrease,no risk
Solriamfetol,Bosentan,Solriamfetol may decrease the antihypertensive activities of Bosentan.,decrease,no risk
Solriamfetol,Botulinum toxin type A,The risk or severity of CNS depression can be increased when Botulinum toxin type A is combined with Solriamfetol.,increase,risk
Solriamfetol,Botulinum toxin type B,The risk or severity of CNS depression can be increased when Botulinum toxin type B is combined with Solriamfetol.,increase,risk
Solriamfetol,Bretylium,Solriamfetol may decrease the antihypertensive activities of Bretylium.,decrease,no risk
Solriamfetol,Brexanolone,The risk or severity of CNS depression can be increased when Brexanolone is combined with Solriamfetol.,increase,risk
Solriamfetol,Brexpiprazole,The risk or severity of hypertension can be increased when Solriamfetol is combined with Brexpiprazole.,increase,risk
Solriamfetol,Brigatinib,The excretion of Solriamfetol can be decreased when combined with Brigatinib.,decrease,no risk
Solriamfetol,Brimonidine,Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Solriamfetol.,increase,no risk
Solriamfetol,Brivaracetam,The risk or severity of CNS depression can be increased when Brivaracetam is combined with Solriamfetol.,increase,risk
Solriamfetol,Bromazepam,The risk or severity of CNS depression can be increased when Bromazepam is combined with Solriamfetol.,increase,risk
Solriamfetol,Bromocriptine,The risk or severity of hypertension can be increased when Solriamfetol is combined with Bromocriptine.,increase,risk
Solriamfetol,Bromotheophylline,Bromotheophylline may increase the excretion rate of Solriamfetol which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Solriamfetol,Bromperidol,The risk or severity of CNS depression can be increased when Bromperidol is combined with Solriamfetol.,increase,risk
Solriamfetol,Brompheniramine,The risk or severity of Tachycardia can be increased when Solriamfetol is combined with Brompheniramine.,increase,risk
Solriamfetol,Buclizine,The risk or severity of Tachycardia can be increased when Solriamfetol is combined with Buclizine.,increase,risk
Solriamfetol,Budesonide,Budesonide may decrease the excretion rate of Solriamfetol which could result in a higher serum level.,decrease,no risk
Solriamfetol,Bumadizone,The risk or severity of hypertension can be increased when Solriamfetol is combined with Bumadizone.,increase,risk
Solriamfetol,Bumetanide,Bumetanide may increase the excretion rate of Solriamfetol which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Solriamfetol,Bupivacaine,The risk or severity of CNS depression can be increased when Bupivacaine is combined with Solriamfetol.,increase,risk
Solriamfetol,Buprenorphine,Solriamfetol may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Solriamfetol,Bupropion,The excretion of Solriamfetol can be decreased when combined with Bupropion.,decrease,no risk
Solriamfetol,Buspirone,The risk or severity of hypertension can be increased when Solriamfetol is combined with Buspirone.,increase,risk
Solriamfetol,Butabarbital,The risk or severity of CNS depression can be increased when Butabarbital is combined with Solriamfetol.,increase,risk
Solriamfetol,Butalbital,The risk or severity of CNS depression can be increased when Butalbital is combined with Solriamfetol.,increase,risk
Solriamfetol,Butaperazine,The risk or severity of CNS depression can be increased when Butaperazine is combined with Solriamfetol.,increase,risk
Solriamfetol,Butobarbital,The risk or severity of CNS depression can be increased when Butobarbital is combined with Solriamfetol.,increase,risk
Solriamfetol,Butorphanol,The risk or severity of CNS depression can be increased when Butorphanol is combined with Solriamfetol.,increase,risk
Solriamfetol,Butriptyline,The risk or severity of hypertension can be increased when Solriamfetol is combined with Butriptyline.,increase,risk
Solriamfetol,Butylscopolamine,The risk or severity of Tachycardia can be increased when Solriamfetol is combined with Butylscopolamine.,increase,risk
Solriamfetol,Gabapentin,The risk or severity of CNS depression can be increased when Gabapentin is combined with Solriamfetol.,increase,risk
Solriamfetol,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Gabapentin enacarbil is combined with Solriamfetol.,increase,risk
Solriamfetol,Gadobenic acid,Gadobenic acid may decrease the excretion rate of Solriamfetol which could result in a higher serum level.,decrease,no risk
Solriamfetol,Gadodiamide,Gadodiamide may decrease the excretion rate of Solriamfetol which could result in a higher serum level.,decrease,no risk
Solriamfetol,Gadofosveset trisodium,Gadofosveset trisodium may decrease the excretion rate of Solriamfetol which could result in a higher serum level.,decrease,no risk
Solriamfetol,Gadopentetic acid,Gadopentetic acid may decrease the excretion rate of Solriamfetol which could result in a higher serum level.,decrease,no risk
Solriamfetol,Gadoteric acid,Gadoteric acid may decrease the excretion rate of Solriamfetol which could result in a higher serum level.,decrease,no risk
Solriamfetol,Gadoteridol,Gadoteridol may decrease the excretion rate of Solriamfetol which could result in a higher serum level.,decrease,no risk
Solriamfetol,Gallamine triethiodide,The risk or severity of Tachycardia can be increased when Solriamfetol is combined with Gallamine triethiodide.,increase,risk
Solriamfetol,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Solriamfetol is combined with Ganaxolone.",increase,risk
Solriamfetol,Ganciclovir,Ganciclovir may decrease the excretion rate of Solriamfetol which could result in a higher serum level.,decrease,no risk
Solriamfetol,Gemcitabine,Gemcitabine may decrease the excretion rate of Solriamfetol which could result in a higher serum level.,decrease,no risk
Solriamfetol,Gemfibrozil,Gemfibrozil may decrease the excretion rate of Solriamfetol which could result in a higher serum level.,decrease,no risk
Solriamfetol,Gentamicin,Solriamfetol may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Solriamfetol,Gepirone,The risk or severity of CNS depression can be increased when Gepirone is combined with Solriamfetol.,increase,risk
Solriamfetol,Gilteritinib,The excretion of Solriamfetol can be decreased when combined with Gilteritinib.,decrease,no risk
Solriamfetol,Gimeracil,Gimeracil may decrease the excretion rate of Solriamfetol which could result in a higher serum level.,decrease,no risk
Solriamfetol,Givosiran,Givosiran may decrease the excretion rate of Solriamfetol which could result in a higher serum level.,decrease,no risk
Solriamfetol,Glasdegib,The excretion of Solriamfetol can be decreased when combined with Glasdegib.,decrease,no risk
Solriamfetol,Glipizide,Glipizide may decrease the excretion rate of Solriamfetol which could result in a higher serum level.,decrease,no risk
Solriamfetol,Glutethimide,The risk or severity of CNS depression can be increased when Glutethimide is combined with Solriamfetol.,increase,risk
Solriamfetol,Glycerol phenylbutyrate,Glycerol phenylbutyrate may decrease the excretion rate of Solriamfetol which could result in a higher serum level.,decrease,no risk
Solriamfetol,Glycopyrronium,The risk or severity of Tachycardia can be increased when Solriamfetol is combined with Glycopyrronium.,increase,risk
Solriamfetol,Golodirsen,Solriamfetol may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Solriamfetol,Goserelin,Goserelin may decrease the excretion rate of Solriamfetol which could result in a higher serum level.,decrease,no risk
Solriamfetol,Granisetron,The risk or severity of CNS depression can be increased when Granisetron is combined with Solriamfetol.,increase,risk
Solriamfetol,Grepafloxacin,The serum concentration of Solriamfetol can be increased when it is combined with Grepafloxacin.,increase,no risk
Solriamfetol,Guanabenz,The risk or severity of hypertension can be increased when Solriamfetol is combined with Guanabenz.,increase,risk
Solriamfetol,Guanadrel,Solriamfetol may decrease the antihypertensive activities of Guanadrel.,decrease,no risk
Solriamfetol,Guanethidine,Solriamfetol may decrease the antihypertensive activities of Guanethidine.,decrease,no risk
Solriamfetol,Guanfacine,The risk or severity of hypertension can be increased when Solriamfetol is combined with Guanfacine.,increase,risk
Solriamfetol,Guanidine,The serum concentration of Solriamfetol can be increased when it is combined with Guanidine.,increase,no risk
Solriamfetol,Guanoxan,Solriamfetol may decrease the antihypertensive activities of Guanoxan.,decrease,no risk
Solriamfetol,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with Solriamfetol.,increase,risk
Solriamfetol,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Solriamfetol.,increase,risk
Solriamfetol,Halothane,The risk or severity of hypertension can be increased when Solriamfetol is combined with Halothane.,increase,risk
Solriamfetol,Hexafluronium,The risk or severity of CNS depression can be increased when Hexafluronium is combined with Solriamfetol.,increase,risk
Solriamfetol,Hexocyclium,The risk or severity of Tachycardia can be increased when Solriamfetol is combined with Hexocyclium.,increase,risk
Solriamfetol,Histamine,The serum concentration of Solriamfetol can be increased when it is combined with Histamine.,increase,no risk
Solriamfetol,Homatropine methylbromide,The risk or severity of Tachycardia can be increased when Solriamfetol is combined with Homatropine methylbromide.,increase,risk
Solriamfetol,Hydralazine,Solriamfetol may decrease the antihypertensive activities of Hydralazine.,decrease,no risk
Solriamfetol,Hydrochlorothiazide,Hydrochlorothiazide may increase the excretion rate of Solriamfetol which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Solriamfetol,Hydrocodone,Solriamfetol may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Solriamfetol,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of Solriamfetol which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Solriamfetol,Hydromorphone,The risk or severity of CNS depression can be increased when Hydromorphone is combined with Solriamfetol.,increase,risk
Solriamfetol,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Solriamfetol which could result in a higher serum level.,decrease,no risk
Solriamfetol,Hydroxyethyl Starch,Hydroxyethyl Starch may decrease the excretion rate of Solriamfetol which could result in a higher serum level.,decrease,no risk
Solriamfetol,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Solriamfetol.,increase,no risk
Solriamfetol,Hyoscyamine,The risk or severity of Tachycardia can be increased when Solriamfetol is combined with Hyoscyamine.,increase,risk
Solriamfetol,Kanamycin,Solriamfetol may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Solriamfetol,Ketamine,The risk or severity of Tachycardia can be increased when Solriamfetol is combined with Ketamine.,increase,risk
Solriamfetol,Ketazolam,The risk or severity of CNS depression can be increased when Ketazolam is combined with Solriamfetol.,increase,risk
Solriamfetol,Ketoprofen,The risk or severity of hypertension can be increased when Solriamfetol is combined with Ketoprofen.,increase,risk
Solriamfetol,Ketorolac,The risk or severity of hypertension can be increased when Solriamfetol is combined with Ketorolac.,increase,risk
Solriamfetol,N-acetyltyrosine,N-acetyltyrosine may decrease the excretion rate of Solriamfetol which could result in a higher serum level.,decrease,no risk
Solriamfetol,Nabilone,The risk or severity of Tachycardia can be increased when Solriamfetol is combined with Nabilone.,increase,risk
Solriamfetol,Nabumetone,The risk or severity of hypertension can be increased when Solriamfetol is combined with Nabumetone.,increase,risk
Solriamfetol,Nadolol,Solriamfetol may decrease the antihypertensive activities of Nadolol.,decrease,no risk
Solriamfetol,Nalbuphine,The risk or severity of CNS depression can be increased when Nalbuphine is combined with Solriamfetol.,increase,risk
Solriamfetol,Naldemedine,Naldemedine may decrease the excretion rate of Solriamfetol which could result in a higher serum level.,decrease,no risk
Solriamfetol,Nalmefene,Nalmefene may decrease the excretion rate of Solriamfetol which could result in a higher serum level.,decrease,no risk
Solriamfetol,Naloxone,Naloxone may decrease the excretion rate of Solriamfetol which could result in a higher serum level.,decrease,no risk
Solriamfetol,Naphazoline,The risk or severity of hypertension can be increased when Solriamfetol is combined with Naphazoline.,increase,risk
Solriamfetol,Naproxen,The risk or severity of hypertension can be increased when Solriamfetol is combined with Naproxen.,increase,risk
Solriamfetol,Naratriptan,The risk or severity of hypertension can be increased when Solriamfetol is combined with Naratriptan.,increase,risk
Solriamfetol,Nateglinide,Nateglinide may decrease the excretion rate of Solriamfetol which could result in a higher serum level.,decrease,no risk
Solriamfetol,Naxitamab,The risk or severity of hypertension can be increased when Solriamfetol is combined with Naxitamab.,increase,risk
Solriamfetol,Nebivolol,Solriamfetol may decrease the antihypertensive activities of Nebivolol.,decrease,no risk
Solriamfetol,Nedaplatin,Solriamfetol may decrease the excretion rate of Nedaplatin which could result in a higher serum level.,decrease,no risk
Solriamfetol,Nedocromil,Nedocromil may decrease the excretion rate of Solriamfetol which could result in a higher serum level.,decrease,no risk
Solriamfetol,Nefazodone,The risk or severity of hypertension can be increased when Solriamfetol is combined with Nefazodone.,increase,risk
Solriamfetol,Neomycin,Solriamfetol may decrease the excretion rate of Neomycin which could result in a higher serum level.,decrease,no risk
Solriamfetol,Netilmicin,Solriamfetol may decrease the excretion rate of Netilmicin which could result in a higher serum level.,decrease,no risk
Solriamfetol,Nialamide,The risk or severity of hypertension can be increased when Solriamfetol is combined with Nialamide.,increase,risk
Solriamfetol,Nicardipine,The risk or severity of Tachycardia can be increased when Solriamfetol is combined with Nicardipine.,increase,risk
Solriamfetol,Nicergoline,The risk or severity of hypertension can be increased when Solriamfetol is combined with Nicergoline.,increase,risk
Solriamfetol,Nicorandil,Solriamfetol may decrease the antihypertensive activities of Nicorandil.,decrease,no risk
Solriamfetol,Nicotine,The risk or severity of Tachycardia can be increased when Solriamfetol is combined with Nicotine.,increase,risk
Solriamfetol,Nifedipine,Nifedipine may decrease the excretion rate of Solriamfetol which could result in a higher serum level.,decrease,no risk
Solriamfetol,Nilutamide,Nilutamide may decrease the excretion rate of Solriamfetol which could result in a higher serum level.,decrease,no risk
Solriamfetol,Nilvadipine,Solriamfetol may decrease the antihypertensive activities of Nilvadipine.,decrease,no risk
Solriamfetol,Nimesulide,The risk or severity of hypertension can be increased when Solriamfetol is combined with Nimesulide.,increase,risk
Solriamfetol,Nimodipine,Solriamfetol may decrease the antihypertensive activities of Nimodipine.,decrease,no risk
Solriamfetol,Nisoldipine,Solriamfetol may decrease the antihypertensive activities of Nisoldipine.,decrease,no risk
Solriamfetol,Nitrazepam,The risk or severity of CNS depression can be increased when Nitrazepam is combined with Solriamfetol.,increase,risk
Solriamfetol,Nitrendipine,Solriamfetol may decrease the antihypertensive activities of Nitrendipine.,decrease,no risk
Solriamfetol,Nitric Oxide,Nitric Oxide may decrease the excretion rate of Solriamfetol which could result in a higher serum level.,decrease,no risk
Solriamfetol,Nitrofurantoin,Nitrofurantoin may decrease the excretion rate of Solriamfetol which could result in a higher serum level.,decrease,no risk
Solriamfetol,Nitroglycerin,Solriamfetol may decrease the antihypertensive activities of Nitroglycerin.,decrease,no risk
Solriamfetol,Nitroprusside,Solriamfetol may decrease the antihypertensive activities of Nitroprusside.,decrease,no risk
Solriamfetol,Nitrous oxide,The risk or severity of hypertension can be increased when Solriamfetol is combined with Nitrous oxide.,increase,risk
Solriamfetol,Nomifensine,The risk or severity of adverse effects can be increased when Solriamfetol is combined with Nomifensine.,increase,risk
Solriamfetol,Norepinephrine,The risk or severity of hypertension can be increased when Solriamfetol is combined with Norepinephrine.,increase,risk
Solriamfetol,Normethadone,The risk or severity of CNS depression can be increased when Normethadone is combined with Solriamfetol.,increase,risk
Solriamfetol,Nortriptyline,The risk or severity of hypertension can be increased when Solriamfetol is combined with Nortriptyline.,increase,risk
Solriamfetol,Nylidrin,The risk or severity of hypertension can be increased when Solriamfetol is combined with Nylidrin.,increase,risk
Solriamfetol,Octinoxate,Octinoxate may decrease the excretion rate of Solriamfetol which could result in a higher serum level.,decrease,no risk
Solriamfetol,Olanzapine,The risk or severity of Tachycardia can be increased when Solriamfetol is combined with Olanzapine.,increase,risk
Solriamfetol,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Solriamfetol is combined with Oliceridine.",increase,risk
Solriamfetol,Olmesartan,Solriamfetol may decrease the antihypertensive activities of Olmesartan.,decrease,no risk
Solriamfetol,Olodaterol,The risk or severity of hypertension can be increased when Solriamfetol is combined with Olodaterol.,increase,risk
Solriamfetol,Olsalazine,Olsalazine may decrease the excretion rate of Solriamfetol which could result in a higher serum level.,decrease,no risk
Solriamfetol,Ondansetron,The risk or severity of CNS depression can be increased when Ondansetron is combined with Solriamfetol.,increase,risk
Solriamfetol,Opium,The risk or severity of CNS depression can be increased when Opium is combined with Solriamfetol.,increase,risk
Solriamfetol,Orciprenaline,The risk or severity of hypertension can be increased when Solriamfetol is combined with Orciprenaline.,increase,risk
Solriamfetol,Orphenadrine,The risk or severity of Tachycardia can be increased when Solriamfetol is combined with Orphenadrine.,increase,risk
Solriamfetol,Oseltamivir,Oseltamivir may decrease the excretion rate of Solriamfetol which could result in a higher serum level.,decrease,no risk
Solriamfetol,Oxacillin,Oxacillin may decrease the excretion rate of Solriamfetol which could result in a higher serum level.,decrease,no risk
Solriamfetol,Oxaprozin,The risk or severity of hypertension can be increased when Solriamfetol is combined with Oxaprozin.,increase,risk
Solriamfetol,Oxazepam,The risk or severity of CNS depression can be increased when Oxazepam is combined with Solriamfetol.,increase,risk
Solriamfetol,Oxcarbazepine,The risk or severity of CNS depression can be increased when Oxcarbazepine is combined with Solriamfetol.,increase,risk
Solriamfetol,Oxitriptan,The risk or severity of CNS depression can be increased when Oxitriptan is combined with Solriamfetol.,increase,risk
Solriamfetol,Oxprenolol,The risk or severity of CNS depression can be increased when Oxprenolol is combined with Solriamfetol.,increase,risk
Solriamfetol,Oxybenzone,Oxybenzone may decrease the excretion rate of Solriamfetol which could result in a higher serum level.,decrease,no risk
Solriamfetol,Oxybuprocaine,The risk or severity of CNS depression can be increased when Oxybuprocaine is combined with Solriamfetol.,increase,risk
Solriamfetol,Oxybutynin,The risk or severity of Tachycardia can be increased when Solriamfetol is combined with Oxybutynin.,increase,risk
Solriamfetol,Oxycodone,The risk or severity of CNS depression can be increased when Oxycodone is combined with Solriamfetol.,increase,risk
Solriamfetol,Oxymetazoline,The risk or severity of hypertension can be increased when Solriamfetol is combined with Oxymetazoline.,increase,risk
Solriamfetol,Oxymorphone,The risk or severity of CNS depression can be increased when Oxymorphone is combined with Solriamfetol.,increase,risk
Solriamfetol,Oxyphenbutazone,The risk or severity of hypertension can be increased when Solriamfetol is combined with Oxyphenbutazone.,increase,risk
Solriamfetol,Oxyphencyclimine,The risk or severity of Tachycardia can be increased when Solriamfetol is combined with Oxyphencyclimine.,increase,risk
Solriamfetol,Oxyphenonium,The risk or severity of Tachycardia can be increased when Solriamfetol is combined with Oxyphenonium.,increase,risk
Solriamfetol,Oxyquinoline,Oxyquinoline may decrease the excretion rate of Solriamfetol which could result in a higher serum level.,decrease,no risk
TNX-901,Natalizumab,The risk or severity of adverse effects can be increased when Natalizumab is combined with TNX-901.,increase,risk
TNX-901,Necitumumab,The risk or severity of adverse effects can be increased when TNX-901 is combined with Necitumumab.,increase,risk
TNX-901,Nivolumab,The risk or severity of adverse effects can be increased when TNX-901 is combined with Nivolumab.,increase,risk
TNX-901,Obiltoxaximab,The risk or severity of adverse effects can be increased when Obiltoxaximab is combined with TNX-901.,increase,risk
TNX-901,Obinutuzumab,The risk or severity of adverse effects can be increased when TNX-901 is combined with Obinutuzumab.,increase,risk
TNX-901,Ocrelizumab,The risk or severity of adverse effects can be increased when TNX-901 is combined with Ocrelizumab.,increase,risk
TNX-901,Odesivimab,The risk or severity of adverse effects can be increased when TNX-901 is combined with Odesivimab.,increase,risk
TNX-901,Ofatumumab,The risk or severity of adverse effects can be increased when TNX-901 is combined with Ofatumumab.,increase,risk
TNX-901,Olaratumab,The risk or severity of adverse effects can be increased when TNX-901 is combined with Olaratumab.,increase,risk
TNX-901,Omalizumab,The risk or severity of adverse effects can be increased when Omalizumab is combined with TNX-901.,increase,risk
TNX-901,Quinestrol,Quinestrol may increase the thrombogenic activities of TNX-901.,increase,no risk
TNX-901,Ublituximab,The risk or severity of adverse effects can be increased when TNX-901 is combined with Ublituximab.,increase,risk
TNX-901,Ustekinumab,The risk or severity of adverse effects can be increased when Ustekinumab is combined with TNX-901.,increase,risk
TNX-901,Vedolizumab,The risk or severity of adverse effects can be increased when TNX-901 is combined with Vedolizumab.,increase,risk
Vedolizumab,Galcanezumab,The risk or severity of adverse effects can be increased when Vedolizumab is combined with Galcanezumab.,increase,risk
Vedolizumab,Gemcitabine,The risk or severity of adverse effects can be increased when Gemcitabine is combined with Vedolizumab.,increase,risk
Vedolizumab,Gemtuzumab ozogamicin,The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Vedolizumab.,increase,risk
Vedolizumab,Glatiramer,The risk or severity of adverse effects can be increased when Glatiramer is combined with Vedolizumab.,increase,risk
Vedolizumab,Glofitamab,The risk or severity of adverse effects can be increased when Vedolizumab is combined with Glofitamab.,increase,risk
Vedolizumab,Golimumab,The risk or severity of infection can be increased when Golimumab is combined with Vedolizumab.,increase,risk
Vedolizumab,Guselkumab,The risk or severity of adverse effects can be increased when Vedolizumab is combined with Guselkumab.,increase,risk
Vedolizumab,Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Vedolizumab.,decrease,no risk
Vedolizumab,Hepatitis A Vaccine,The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Vedolizumab.,decrease,no risk
Vedolizumab,Hepatitis B immune globulin,The risk or severity of adverse effects can be increased when Hepatitis B immune globulin is combined with Vedolizumab.,increase,risk
Vedolizumab,Hepatitis B Vaccine (Recombinant),The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Vedolizumab.,decrease,no risk
Vedolizumab,Human adenovirus e serotype 4 strain cl-68578 antigen,The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Vedolizumab.,increase,risk
Vedolizumab,Human cytomegalovirus immune globulin,The risk or severity of adverse effects can be increased when Vedolizumab is combined with Human cytomegalovirus immune globulin.,increase,risk
Vedolizumab,Human immunoglobulin G,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Vedolizumab.,increase,risk
Vedolizumab,Human Rho(D) immune globulin,The risk or severity of adverse effects can be increased when Vedolizumab is combined with Human Rho(D) immune globulin.,increase,risk
Vedolizumab,Human varicella-zoster immune globulin,The risk or severity of adverse effects can be increased when Vedolizumab is combined with Human varicella-zoster immune globulin.,increase,risk
Vedolizumab,Hydrocortisone acetate,The risk or severity of adverse effects can be increased when Vedolizumab is combined with Hydrocortisone acetate.,increase,risk
Vedolizumab,Hydrocortisone butyrate,The risk or severity of adverse effects can be increased when Vedolizumab is combined with Hydrocortisone butyrate.,increase,risk
Vedolizumab,Hydrocortisone succinate,The risk or severity of adverse effects can be increased when Vedolizumab is combined with Hydrocortisone succinate.,increase,risk
Vedolizumab,Hydroxychloroquine,The risk or severity of adverse effects can be increased when Hydroxychloroquine is combined with Vedolizumab.,increase,risk
Vedolizumab,Hydroxyurea,The risk or severity of adverse effects can be increased when Hydroxyurea is combined with Vedolizumab.,increase,risk
Vedolizumab,Janssen COVID-19 Vaccine,The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Vedolizumab.,decrease,no risk
Vedolizumab,Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated),The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Vedolizumab.,decrease,no risk
Vedolizumab,Natalizumab,The risk or severity of progressive multifocal leukoencephalopathy and immunosuppression can be increased when Vedolizumab is combined with Natalizumab.,increase,risk
Vedolizumab,Necitumumab,The risk or severity of adverse effects can be increased when Vedolizumab is combined with Necitumumab.,increase,risk
Vedolizumab,Nelarabine,The risk or severity of adverse effects can be increased when Nelarabine is combined with Vedolizumab.,increase,risk
Vedolizumab,Nilotinib,The risk or severity of adverse effects can be increased when Nilotinib is combined with Vedolizumab.,increase,risk
Vedolizumab,Nivolumab,The risk or severity of adverse effects can be increased when Vedolizumab is combined with Nivolumab.,increase,risk
Vedolizumab,Nuvaxovid,The therapeutic efficacy of Nuvaxovid can be decreased when used in combination with Vedolizumab.,decrease,no risk
Vedolizumab,Obiltoxaximab,The risk or severity of adverse effects can be increased when Obiltoxaximab is combined with Vedolizumab.,increase,risk
Vedolizumab,Obinutuzumab,The risk or severity of adverse effects can be increased when Obinutuzumab is combined with Vedolizumab.,increase,risk
Vedolizumab,Ocrelizumab,Ocrelizumab may increase the immunosuppressive activities of Vedolizumab.,increase,no risk
Vedolizumab,Odesivimab,The risk or severity of adverse effects can be increased when Vedolizumab is combined with Odesivimab.,increase,risk
Vedolizumab,Ofatumumab,The risk or severity of adverse effects can be increased when Ofatumumab is combined with Vedolizumab.,increase,risk
Vedolizumab,Olaparib,The risk or severity of adverse effects can be increased when Vedolizumab is combined with Olaparib.,increase,risk
Vedolizumab,Olaratumab,The risk or severity of adverse effects can be increased when Olaratumab is combined with Vedolizumab.,increase,risk
Vedolizumab,Omalizumab,The risk or severity of adverse effects can be increased when Omalizumab is combined with Vedolizumab.,increase,risk
Vedolizumab,Oxaliplatin,The risk or severity of adverse effects can be increased when Oxaliplatin is combined with Vedolizumab.,increase,risk
Vedolizumab,Ozanimod,The risk or severity of adverse effects can be increased when Vedolizumab is combined with Ozanimod.,increase,risk
Vedolizumab,Quinestrol,Quinestrol may increase the thrombogenic activities of Vedolizumab.,increase,no risk
Vedolizumab,Ublituximab,The risk or severity of infection can be increased when Ublituximab is combined with Vedolizumab.,increase,risk
Vedolizumab,Upadacitinib,The risk or severity of adverse effects can be increased when Vedolizumab is combined with Upadacitinib.,increase,risk
Vedolizumab,Ustekinumab,The risk or severity of adverse effects can be increased when Ustekinumab is combined with Vedolizumab.,increase,risk
Vedolizumab,Varicella zoster vaccine (live/attenuated),The risk or severity of infection can be increased when Varicella zoster vaccine (live/attenuated) is combined with Vedolizumab.,increase,risk
Vedolizumab,Varicella zoster vaccine (recombinant),The therapeutic efficacy of Varicella zoster vaccine (recombinant) can be decreased when used in combination with Vedolizumab.,decrease,no risk
Vedolizumab,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Vedolizumab.,decrease,no risk
Vedolizumab,Vilanterol,The risk or severity of adverse effects can be increased when Vedolizumab is combined with Vilanterol.,increase,risk
Vedolizumab,Vinblastine,The risk or severity of adverse effects can be increased when Vinblastine is combined with Vedolizumab.,increase,risk
Vedolizumab,Vincristine,The risk or severity of adverse effects can be increased when Vincristine is combined with Vedolizumab.,increase,risk
Vedolizumab,Vindesine,The risk or severity of adverse effects can be increased when Vindesine is combined with Vedolizumab.,increase,risk
Vedolizumab,Vinorelbine,The risk or severity of adverse effects can be increased when Vinorelbine is combined with Vedolizumab.,increase,risk
Vedolizumab,Voclosporin,The risk or severity of adverse effects can be increased when Vedolizumab is combined with Voclosporin.,increase,risk
Vedolizumab,Vorinostat,The risk or severity of adverse effects can be increased when Vorinostat is combined with Vedolizumab.,increase,risk
Vedolizumab,Yellow fever vaccine,The risk or severity of infection can be increased when Yellow fever vaccine is combined with Vedolizumab.,increase,risk
Vedolizumab,Zidovudine,The risk or severity of adverse effects can be increased when Zidovudine is combined with Vedolizumab.,increase,risk
Prasterone sulfate,Glimepiride,Glimepiride may decrease the excretion rate of Prasterone sulfate which could result in a higher serum level.,decrease,no risk
Prasterone sulfate,Glipizide,Glipizide may decrease the excretion rate of Prasterone sulfate which could result in a higher serum level.,decrease,no risk
Prasterone sulfate,Glyburide,Glyburide may decrease the excretion rate of Prasterone sulfate which could result in a higher serum level.,decrease,no risk
Prasterone sulfate,Glycyrrhizic acid,Prasterone sulfate may decrease the excretion rate of Glycyrrhizic acid which could result in a higher serum level.,decrease,no risk
Prasterone sulfate,Golimumab,The metabolism of Prasterone sulfate can be increased when combined with Golimumab.,increase,no risk
Prasterone sulfate,Haloperidol,The metabolism of Prasterone sulfate can be decreased when combined with Haloperidol.,decrease,no risk
Prasterone sulfate,Hydrocortisone,The risk or severity of edema formation can be increased when Prasterone sulfate is combined with Hydrocortisone.,increase,risk
Prasterone sulfate,Hydrocortisone acetate,The risk or severity of edema formation can be increased when Prasterone sulfate is combined with Hydrocortisone acetate.,increase,risk
Prasterone sulfate,Hydrocortisone butyrate,The risk or severity of edema formation can be increased when Prasterone sulfate is combined with Hydrocortisone butyrate.,increase,risk
Prasterone sulfate,Hydrocortisone cypionate,The risk or severity of edema formation can be increased when Prasterone sulfate is combined with Hydrocortisone cypionate.,increase,risk
Prasterone sulfate,Hydrocortisone phosphate,The metabolism of Hydrocortisone phosphate can be decreased when combined with Prasterone sulfate.,decrease,no risk
Prasterone sulfate,Hydrocortisone succinate,The risk or severity of edema formation can be increased when Prasterone sulfate is combined with Hydrocortisone succinate.,increase,risk
Prasterone sulfate,Ketoconazole,The metabolism of Prasterone sulfate can be decreased when combined with Ketoconazole.,decrease,no risk
Prasterone sulfate,Naproxen,Naproxen may decrease the excretion rate of Prasterone sulfate which could result in a higher serum level.,decrease,no risk
Prasterone sulfate,Nateglinide,The metabolism of Prasterone sulfate can be decreased when combined with Nateglinide.,decrease,no risk
Prasterone sulfate,Nefazodone,Nefazodone may decrease the excretion rate of Prasterone sulfate which could result in a higher serum level.,decrease,no risk
Prasterone sulfate,Nelfinavir,The metabolism of Prasterone sulfate can be decreased when combined with Nelfinavir.,decrease,no risk
Prasterone sulfate,Nevirapine,The metabolism of Prasterone sulfate can be decreased when combined with Nevirapine.,decrease,no risk
Prasterone sulfate,Nicardipine,Nicardipine may decrease the excretion rate of Prasterone sulfate which could result in a higher serum level.,decrease,no risk
Prasterone sulfate,Nifedipine,Nifedipine may decrease the excretion rate of Prasterone sulfate which could result in a higher serum level.,decrease,no risk
Prasterone sulfate,Nisoldipine,The metabolism of Prasterone sulfate can be decreased when combined with Nisoldipine.,decrease,no risk
Prasterone sulfate,Nitrendipine,Nitrendipine may decrease the excretion rate of Prasterone sulfate which could result in a higher serum level.,decrease,no risk
Prasterone sulfate,Nitrofurantoin,Nitrofurantoin may decrease the excretion rate of Prasterone sulfate which could result in a higher serum level.,decrease,no risk
Prasterone sulfate,Norethisterone,The metabolism of Prasterone sulfate can be decreased when combined with Norethisterone.,decrease,no risk
Prasterone sulfate,Ofloxacin,Ofloxacin may decrease the excretion rate of Prasterone sulfate which could result in a higher serum level.,decrease,no risk
Prasterone sulfate,Olmesartan,Olmesartan may decrease the excretion rate of Prasterone sulfate which could result in a higher serum level.,decrease,no risk
Prasterone sulfate,Ondansetron,The metabolism of Prasterone sulfate can be decreased when combined with Ondansetron.,decrease,no risk
Prasterone sulfate,Quetiapine,The metabolism of Prasterone sulfate can be decreased when combined with Quetiapine.,decrease,no risk
Prasterone sulfate,Quinidine,The metabolism of Quinidine can be decreased when combined with Prasterone sulfate.,decrease,no risk
Prasterone sulfate,Quinine,The metabolism of Prasterone sulfate can be decreased when combined with Quinine.,decrease,no risk
Prasterone sulfate,Ursodeoxycholic acid,Ursodeoxycholic acid may decrease the excretion rate of Prasterone sulfate which could result in a higher serum level.,decrease,no risk
Prasterone sulfate,Vamorolone,The risk or severity of edema formation can be increased when Prasterone sulfate is combined with Vamorolone.,increase,risk
Prasterone sulfate,Vinblastine,Vinblastine may decrease the excretion rate of Prasterone sulfate which could result in a higher serum level.,decrease,no risk
Prasterone sulfate,Vincristine,The metabolism of Vincristine can be decreased when combined with Prasterone sulfate.,decrease,no risk
Prasterone sulfate,Voriconazole,The metabolism of Prasterone sulfate can be decreased when combined with Voriconazole.,decrease,no risk
Prasterone sulfate,Zaleplon,The metabolism of Prasterone sulfate can be decreased when combined with Zaleplon.,decrease,no risk
Abiraterone,Galantamine,The metabolism of Galantamine can be decreased when combined with Abiraterone.,decrease,no risk
Abiraterone,Gefitinib,The metabolism of Gefitinib can be decreased when combined with Abiraterone.,decrease,no risk
Abiraterone,Glasdegib,The metabolism of Glasdegib can be decreased when combined with Abiraterone.,decrease,no risk
Abiraterone,Glofitamab,The serum concentration of Abiraterone can be increased when it is combined with Glofitamab.,increase,no risk
Abiraterone,Grepafloxacin,The serum concentration of Grepafloxacin can be increased when it is combined with Abiraterone.,increase,no risk
Abiraterone,Guanabenz,The serum concentration of Guanabenz can be increased when it is combined with Abiraterone.,increase,no risk
Abiraterone,Halofantrine,The metabolism of Halofantrine can be decreased when combined with Abiraterone.,decrease,no risk
Abiraterone,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Abiraterone.,increase,no risk
Abiraterone,Hydrocodone,The metabolism of Hydrocodone can be decreased when combined with Abiraterone.,decrease,no risk
Abiraterone,Hydroxychloroquine,The metabolism of Hydroxychloroquine can be decreased when combined with Abiraterone.,decrease,no risk
Abiraterone,Ketamine,The metabolism of Ketamine can be decreased when combined with Abiraterone.,decrease,no risk
Abiraterone,Ketoconazole,The metabolism of Abiraterone can be decreased when combined with Ketoconazole.,decrease,no risk
Abiraterone,Ketorolac,The metabolism of Ketorolac can be decreased when combined with Abiraterone.,decrease,no risk
Abiraterone,Nabumetone,The serum concentration of Nabumetone can be increased when it is combined with Abiraterone.,increase,no risk
Abiraterone,Nadolol,The metabolism of Nadolol can be decreased when combined with Abiraterone.,decrease,no risk
Abiraterone,Naproxen,The serum concentration of Naproxen can be increased when it is combined with Abiraterone.,increase,no risk
Abiraterone,Nateglinide,The metabolism of Nateglinide can be decreased when combined with Abiraterone.,decrease,no risk
Abiraterone,Nebivolol,The metabolism of Nebivolol can be decreased when combined with Abiraterone.,decrease,no risk
Abiraterone,Nefazodone,The metabolism of Abiraterone can be decreased when combined with Nefazodone.,decrease,no risk
Abiraterone,Nelfinavir,The metabolism of Abiraterone can be decreased when combined with Nelfinavir.,decrease,no risk
Abiraterone,Netupitant,The metabolism of Netupitant can be decreased when combined with Abiraterone.,decrease,no risk
Abiraterone,Nevirapine,The metabolism of Nevirapine can be decreased when combined with Abiraterone.,decrease,no risk
Abiraterone,Nicardipine,The metabolism of Abiraterone can be decreased when combined with Nicardipine.,decrease,no risk
Abiraterone,Nicergoline,The metabolism of Nicergoline can be decreased when combined with Abiraterone.,decrease,no risk
Abiraterone,Nifedipine,The serum concentration of Nifedipine can be increased when it is combined with Abiraterone.,increase,no risk
Abiraterone,Nilotinib,The metabolism of Abiraterone can be decreased when combined with Nilotinib.,decrease,no risk
Abiraterone,Nilvadipine,The metabolism of Nilvadipine can be decreased when combined with Abiraterone.,decrease,no risk
Abiraterone,Nirogacestat,The metabolism of Nirogacestat can be decreased when combined with Abiraterone.,decrease,no risk
Abiraterone,Nortriptyline,The metabolism of Nortriptyline can be decreased when combined with Abiraterone.,decrease,no risk
Abiraterone,Olanzapine,The serum concentration of Olanzapine can be increased when it is combined with Abiraterone.,increase,no risk
Abiraterone,Oliceridine,The serum concentration of Oliceridine can be increased when it is combined with Abiraterone.,increase,no risk
Abiraterone,Olodaterol,The metabolism of Olodaterol can be decreased when combined with Abiraterone.,decrease,no risk
Abiraterone,Omaveloxolone,The serum concentration of Abiraterone can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Abiraterone,Ombitasvir,The metabolism of Ombitasvir can be decreased when combined with Abiraterone.,decrease,no risk
Abiraterone,Ondansetron,The serum concentration of Ondansetron can be increased when it is combined with Abiraterone.,increase,no risk
Abiraterone,Opium,The metabolism of Opium can be decreased when combined with Abiraterone.,decrease,no risk
Abiraterone,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Abiraterone is combined with Oxetacaine.,increase,risk
Abiraterone,Oxprenolol,The metabolism of Oxprenolol can be decreased when combined with Abiraterone.,decrease,no risk
Abiraterone,Oxtriphylline,The serum concentration of Oxtriphylline can be increased when it is combined with Abiraterone.,increase,no risk
Abiraterone,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Abiraterone is combined with Oxybuprocaine.,increase,risk
Abiraterone,Oxycodone,The metabolism of Oxycodone can be decreased when combined with Abiraterone.,decrease,no risk
Abiraterone,Oxymorphone,The metabolism of Oxymorphone can be decreased when combined with Abiraterone.,decrease,no risk
Abiraterone,Ozanimod,The metabolism of Ozanimod can be decreased when combined with Abiraterone.,decrease,no risk
Abiraterone,Quetiapine,The metabolism of Quetiapine can be decreased when combined with Abiraterone.,decrease,no risk
Abiraterone,Quinine,The serum concentration of Quinine can be increased when it is combined with Abiraterone.,increase,no risk
Abiraterone,Umeclidinium,The metabolism of Umeclidinium can be decreased when combined with Abiraterone.,decrease,no risk
Abiraterone,Vadadustat,The serum concentration of Abiraterone can be increased when it is combined with Vadadustat.,increase,no risk
Abiraterone,Valbenazine,The metabolism of Valbenazine can be decreased when combined with Abiraterone.,decrease,no risk
Abiraterone,Velpatasvir,The metabolism of Velpatasvir can be decreased when combined with Abiraterone.,decrease,no risk
Abiraterone,Venetoclax,The metabolism of Abiraterone can be decreased when combined with Venetoclax.,decrease,no risk
Abiraterone,Venlafaxine,The metabolism of Venlafaxine can be decreased when combined with Abiraterone.,decrease,no risk
Abiraterone,Verapamil,The serum concentration of Verapamil can be increased when it is combined with Abiraterone.,increase,no risk
Abiraterone,Vernakalant,The metabolism of Vernakalant can be decreased when combined with Abiraterone.,decrease,no risk
Abiraterone,Vilazodone,The metabolism of Vilazodone can be decreased when combined with Abiraterone.,decrease,no risk
Abiraterone,Viloxazine,The metabolism of Abiraterone can be decreased when combined with Viloxazine.,decrease,no risk
Abiraterone,Voriconazole,The metabolism of Abiraterone can be decreased when combined with Voriconazole.,decrease,no risk
Abiraterone,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Abiraterone.,decrease,no risk
Abiraterone,Voxilaprevir,The serum concentration of Voxilaprevir can be increased when it is combined with Abiraterone.,increase,no risk
Abiraterone,Warfarin,The serum concentration of Warfarin can be increased when it is combined with Abiraterone.,increase,no risk
Abiraterone,Yohimbine,The metabolism of Yohimbine can be decreased when combined with Abiraterone.,decrease,no risk
Abiraterone,Zidovudine,The metabolism of Zidovudine can be decreased when combined with Abiraterone.,decrease,no risk
Abiraterone,Zileuton,The serum concentration of Zileuton can be increased when it is combined with Abiraterone.,increase,no risk
Abiraterone,Zimelidine,The metabolism of Abiraterone can be decreased when combined with Zimelidine.,decrease,no risk
Abiraterone,Ziprasidone,The metabolism of Abiraterone can be decreased when combined with Ziprasidone.,decrease,no risk
Abiraterone,Zolmitriptan,The serum concentration of Zolmitriptan can be increased when it is combined with Abiraterone.,increase,no risk
Abiraterone,Zolpidem,The serum concentration of Zolpidem can be increased when it is combined with Abiraterone.,increase,no risk
Abiraterone,Zopiclone,The metabolism of Zopiclone can be decreased when combined with Abiraterone.,decrease,no risk
Abiraterone,Zotepine,The serum concentration of Zotepine can be increased when it is combined with Abiraterone.,increase,no risk
Abiraterone,Zuclopenthixol,The metabolism of Zuclopenthixol can be decreased when combined with Abiraterone.,decrease,no risk
GPI-1485,Neratinib,The serum concentration of Neratinib can be increased when it is combined with GPI-1485.,increase,no risk
GPI-1485,Netupitant,The metabolism of Netupitant can be decreased when combined with GPI-1485.,decrease,no risk
GPI-1485,Nilotinib,The serum concentration of Nilotinib can be increased when it is combined with GPI-1485.,increase,no risk
GPI-1485,Nintedanib,The metabolism of Nintedanib can be decreased when combined with GPI-1485.,decrease,no risk
GPI-1485,Norethisterone,The metabolism of Norethisterone can be decreased when combined with GPI-1485.,decrease,no risk
GPI-1485,Nortriptyline,The serum concentration of Nortriptyline can be increased when it is combined with GPI-1485.,increase,no risk
GPI-1485,Olaparib,The serum concentration of Olaparib can be increased when it is combined with GPI-1485.,increase,no risk
GPI-1485,Osimertinib,The serum concentration of Osimertinib can be increased when it is combined with GPI-1485.,increase,no risk
GPI-1485,Quinidine,The serum concentration of Quinidine can be increased when it is combined with GPI-1485.,increase,no risk
GPI-1485,Vandetanib,The serum concentration of Vandetanib can be increased when it is combined with GPI-1485.,increase,no risk
GPI-1485,Vardenafil,The metabolism of Vardenafil can be decreased when combined with GPI-1485.,decrease,no risk
GPI-1485,Vemurafenib,The serum concentration of Vemurafenib can be increased when it is combined with GPI-1485.,increase,no risk
GPI-1485,Venetoclax,The serum concentration of Venetoclax can be increased when it is combined with GPI-1485.,increase,no risk
GPI-1485,Vinblastine,The serum concentration of Vinblastine can be increased when it is combined with GPI-1485.,increase,no risk
GPI-1485,Vincristine,The serum concentration of Vincristine can be increased when it is combined with GPI-1485.,increase,no risk
GPI-1485,Vindesine,The serum concentration of Vindesine can be increased when it is combined with GPI-1485.,increase,no risk
GPI-1485,Vinflunine,The serum concentration of Vinflunine can be increased when it is combined with GPI-1485.,increase,no risk
GPI-1485,Vinorelbine,The serum concentration of Vinorelbine can be increased when it is combined with GPI-1485.,increase,no risk
GPI-1485,Vorapaxar,The metabolism of Vorapaxar can be decreased when combined with GPI-1485.,decrease,no risk
GPI-1485,Voxelotor,The serum concentration of Voxelotor can be increased when it is combined with GPI-1485.,increase,no risk
GPI-1485,Warfarin,The serum concentration of Warfarin can be increased when it is combined with GPI-1485.,increase,no risk
GPI-1485,Zanubrutinib,The serum concentration of Zanubrutinib can be increased when it is combined with GPI-1485.,increase,no risk
GPI-1485,Ziprasidone,The metabolism of Ziprasidone can be decreased when combined with GPI-1485.,decrease,no risk
GPI-1485,Zopiclone,The metabolism of Zopiclone can be decreased when combined with GPI-1485.,decrease,no risk
GPI-1485,Zuclopenthixol,The metabolism of Zuclopenthixol can be decreased when combined with GPI-1485.,decrease,no risk
Apomorphine,Bosentan,Apomorphine may increase the hypotensive activities of Bosentan.,increase,no risk
Apomorphine,Bosutinib,The metabolism of Apomorphine can be decreased when combined with Bosutinib.,decrease,no risk
Apomorphine,Botulinum toxin type A,The risk or severity of CNS depression can be increased when Botulinum toxin type A is combined with Apomorphine.,increase,risk
Apomorphine,Botulinum toxin type B,The risk or severity of CNS depression can be increased when Botulinum toxin type B is combined with Apomorphine.,increase,risk
Apomorphine,Bretylium,The risk or severity of adverse effects can be increased when Apomorphine is combined with Bretylium.,increase,risk
Apomorphine,Brexanolone,The risk or severity of CNS depression can be increased when Apomorphine is combined with Brexanolone.,increase,risk
Apomorphine,Brexpiprazole,The risk or severity of adverse effects can be decreased when Apomorphine is combined with Brexpiprazole.,decrease,risk
Apomorphine,Brigatinib,The metabolism of Brigatinib can be decreased when combined with Apomorphine.,decrease,no risk
Apomorphine,Brimonidine,Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Apomorphine.,increase,no risk
Apomorphine,Brivaracetam,The risk or severity of CNS depression can be increased when Apomorphine is combined with Brivaracetam.,increase,risk
Apomorphine,Bromazepam,The risk or severity of CNS depression can be increased when Apomorphine is combined with Bromazepam.,increase,risk
Apomorphine,Bromocriptine,The risk or severity of adverse effects can be decreased when Apomorphine is combined with Bromocriptine.,decrease,risk
Apomorphine,Bromperidol,The risk or severity of CNS depression can be increased when Apomorphine is combined with Bromperidol.,increase,risk
Apomorphine,Brompheniramine,The risk or severity of CNS depression can be increased when Apomorphine is combined with Brompheniramine.,increase,risk
Apomorphine,Buclizine,The risk or severity of QTc prolongation can be increased when Buclizine is combined with Apomorphine.,increase,risk
Apomorphine,Budesonide,The metabolism of Apomorphine can be increased when combined with Budesonide.,increase,no risk
Apomorphine,Bumetanide,The risk or severity of adverse effects can be increased when Apomorphine is combined with Bumetanide.,increase,risk
Apomorphine,Bupivacaine,The risk or severity of CNS depression can be increased when Bupivacaine is combined with Apomorphine.,increase,risk
Apomorphine,Buprenorphine,Apomorphine may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Apomorphine,Bupropion,The risk or severity of adverse effects can be increased when Bupropion is combined with Apomorphine.,increase,risk
Apomorphine,Buserelin,The risk or severity of QTc prolongation can be increased when Apomorphine is combined with Buserelin.,increase,risk
Apomorphine,Buspirone,The risk or severity of CNS depression can be increased when Buspirone is combined with Apomorphine.,increase,risk
Apomorphine,Butabarbital,Butabarbital may increase the hypotensive activities of Apomorphine.,increase,no risk
Apomorphine,Butalbital,Butalbital may increase the hypotensive activities of Apomorphine.,increase,no risk
Apomorphine,Butaperazine,The risk or severity of CNS depression can be increased when Apomorphine is combined with Butaperazine.,increase,risk
Apomorphine,Butobarbital,The risk or severity of CNS depression can be increased when Apomorphine is combined with Butobarbital.,increase,risk
Apomorphine,Butorphanol,The risk or severity of CNS depression can be increased when Butorphanol is combined with Apomorphine.,increase,risk
Apomorphine,Butriptyline,The risk or severity of CNS depression can be increased when Apomorphine is combined with Butriptyline.,increase,risk
Apomorphine,Gabapentin,The risk or severity of CNS depression can be increased when Apomorphine is combined with Gabapentin.,increase,risk
Apomorphine,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Apomorphine is combined with Gabapentin enacarbil.,increase,risk
Apomorphine,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Apomorphine is combined with Gadobenic acid.,increase,risk
Apomorphine,Galantamine,The risk or severity of QTc prolongation can be increased when Galantamine is combined with Apomorphine.,increase,risk
Apomorphine,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with Apomorphine.,increase,risk
Apomorphine,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Apomorphine is combined with Ganaxolone.",increase,risk
Apomorphine,Gatifloxacin,The risk or severity of QTc prolongation can be increased when Apomorphine is combined with Gatifloxacin.,increase,risk
Apomorphine,Gefitinib,The metabolism of Apomorphine can be decreased when combined with Gefitinib.,decrease,no risk
Apomorphine,Gemfibrozil,The metabolism of Apomorphine can be decreased when combined with Gemfibrozil.,decrease,no risk
Apomorphine,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Apomorphine is combined with Gemifloxacin.,increase,risk
Apomorphine,Gepirone,The risk or severity of QTc prolongation can be increased when Gepirone is combined with Apomorphine.,increase,risk
Apomorphine,Gilteritinib,The therapeutic efficacy of Apomorphine can be decreased when used in combination with Gilteritinib.,decrease,no risk
Apomorphine,Glasdegib,The risk or severity of QTc prolongation can be increased when Apomorphine is combined with Glasdegib.,increase,risk
Apomorphine,Glutethimide,The risk or severity of CNS depression can be increased when Apomorphine is combined with Glutethimide.,increase,risk
Apomorphine,Glyburide,The metabolism of Glyburide can be decreased when combined with Apomorphine.,decrease,no risk
Apomorphine,Golimumab,The metabolism of Apomorphine can be increased when combined with Golimumab.,increase,no risk
Apomorphine,Goserelin,The risk or severity of QTc prolongation can be increased when Apomorphine is combined with Goserelin.,increase,risk
Apomorphine,Granisetron,The risk or severity of hypotension can be increased when Granisetron is combined with Apomorphine.,increase,risk
Apomorphine,Grepafloxacin,The risk or severity of QTc prolongation can be increased when Apomorphine is combined with Grepafloxacin.,increase,risk
Apomorphine,Guanabenz,Apomorphine may increase the hypotensive activities of Guanabenz.,increase,no risk
Apomorphine,Guanadrel,Apomorphine may increase the hypotensive activities of Guanadrel.,increase,no risk
Apomorphine,Guanethidine,Apomorphine may increase the hypotensive activities of Guanethidine.,increase,no risk
Apomorphine,Guanfacine,The risk or severity of CNS depression can be increased when Apomorphine is combined with Guanfacine.,increase,risk
Apomorphine,Guanoxan,Apomorphine may increase the hypotensive activities of Guanoxan.,increase,no risk
Apomorphine,Halazepam,The risk or severity of CNS depression can be increased when Apomorphine is combined with Halazepam.,increase,risk
Apomorphine,Halofantrine,The risk or severity of QTc prolongation can be increased when Apomorphine is combined with Halofantrine.,increase,risk
Apomorphine,Haloperidol,The risk or severity of QTc prolongation can be increased when Apomorphine is combined with Haloperidol.,increase,risk
Apomorphine,Halothane,The risk or severity of CNS depression can be increased when Apomorphine is combined with Halothane.,increase,risk
Apomorphine,Hexafluronium,The risk or severity of CNS depression can be increased when Apomorphine is combined with Hexafluronium.,increase,risk
Apomorphine,Histrelin,The risk or severity of QTc prolongation can be increased when Apomorphine is combined with Histrelin.,increase,risk
Apomorphine,Hydralazine,The risk or severity of adverse effects can be increased when Apomorphine is combined with Hydralazine.,increase,risk
Apomorphine,Hydrochlorothiazide,The risk or severity of adverse effects can be increased when Apomorphine is combined with Hydrochlorothiazide.,increase,risk
Apomorphine,Hydrocodone,Apomorphine may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Apomorphine,Hydrocortisone,The metabolism of Apomorphine can be increased when combined with Hydrocortisone.,increase,no risk
Apomorphine,Hydrocortisone acetate,The metabolism of Hydrocortisone acetate can be decreased when combined with Apomorphine.,decrease,no risk
Apomorphine,Hydrocortisone butyrate,The metabolism of Hydrocortisone butyrate can be decreased when combined with Apomorphine.,decrease,no risk
Apomorphine,Hydrocortisone cypionate,The metabolism of Hydrocortisone cypionate can be decreased when combined with Apomorphine.,decrease,no risk
Apomorphine,Hydrocortisone phosphate,The metabolism of Hydrocortisone phosphate can be decreased when combined with Apomorphine.,decrease,no risk
Apomorphine,Hydroflumethiazide,The risk or severity of adverse effects can be increased when Apomorphine is combined with Hydroflumethiazide.,increase,risk
Apomorphine,Hydromorphone,The risk or severity of CNS depression can be increased when Hydromorphone is combined with Apomorphine.,increase,risk
Apomorphine,Hydroxychloroquine,The metabolism of Hydroxychloroquine can be decreased when combined with Apomorphine.,decrease,no risk
Apomorphine,Hydroxyprogesterone caproate,The metabolism of Hydroxyprogesterone caproate can be decreased when combined with Apomorphine.,decrease,no risk
Apomorphine,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Apomorphine is combined with Hydroxyzine.,increase,risk
Apomorphine,Hyoscyamine,The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Apomorphine.,increase,risk
Apomorphine,Ketamine,The risk or severity of CNS depression can be increased when Apomorphine is combined with Ketamine.,increase,risk
Apomorphine,Ketazolam,The risk or severity of CNS depression can be increased when Apomorphine is combined with Ketazolam.,increase,risk
Apomorphine,Ketoconazole,The metabolism of Apomorphine can be decreased when combined with Ketoconazole.,decrease,no risk
Apomorphine,Ketoprofen,The metabolism of Apomorphine can be decreased when combined with Ketoprofen.,decrease,no risk
Apomorphine,Ketorolac,The metabolism of Apomorphine can be decreased when combined with Ketorolac.,decrease,no risk
Apomorphine,Nabilone,Nabilone may increase the central nervous system depressant (CNS depressant) activities of Apomorphine.,increase,no risk
Apomorphine,Nadolol,The risk or severity of adverse effects can be increased when Apomorphine is combined with Nadolol.,increase,risk
Apomorphine,Nalbuphine,The risk or severity of CNS depression can be increased when Apomorphine is combined with Nalbuphine.,increase,risk
Apomorphine,Nalidixic acid,The risk or severity of QTc prolongation can be increased when Apomorphine is combined with Nalidixic acid.,increase,risk
Apomorphine,Naltrexone,The risk or severity of serotonin syndrome can be increased when Naltrexone is combined with Apomorphine.,increase,risk
Apomorphine,Naproxen,The metabolism of Naproxen can be decreased when combined with Apomorphine.,decrease,no risk
Apomorphine,Naratriptan,The risk or severity of CNS depression can be increased when Apomorphine is combined with Naratriptan.,increase,risk
Apomorphine,Nateglinide,The metabolism of Nateglinide can be decreased when combined with Apomorphine.,decrease,no risk
Apomorphine,Nebivolol,The risk or severity of adverse effects can be increased when Apomorphine is combined with Nebivolol.,increase,risk
Apomorphine,Nefazodone,The risk or severity of adverse effects can be increased when Apomorphine is combined with Nefazodone.,increase,risk
Apomorphine,Nelfinavir,The metabolism of Apomorphine can be decreased when combined with Nelfinavir.,decrease,no risk
Apomorphine,Nesiritide,The risk or severity of adverse effects can be increased when Apomorphine is combined with Nesiritide.,increase,risk
Apomorphine,Nevirapine,The metabolism of Apomorphine can be increased when combined with Nevirapine.,increase,no risk
Apomorphine,Nialamide,Nialamide may increase the orthostatic hypotensive activities of Apomorphine.,increase,no risk
Apomorphine,Nicardipine,The metabolism of Apomorphine can be decreased when combined with Nicardipine.,decrease,no risk
Apomorphine,Nicorandil,Nicorandil may increase the hypotensive activities of Apomorphine.,increase,no risk
Apomorphine,Nicotine,The metabolism of Apomorphine can be decreased when combined with Nicotine.,decrease,no risk
Apomorphine,Nifedipine,The risk or severity of QTc prolongation can be increased when Apomorphine is combined with Nifedipine.,increase,risk
Apomorphine,Nilotinib,The risk or severity of QTc prolongation can be increased when Apomorphine is combined with Nilotinib.,increase,risk
Apomorphine,Nilutamide,The metabolism of Apomorphine can be decreased when combined with Nilutamide.,decrease,no risk
Apomorphine,Nilvadipine,The metabolism of Apomorphine can be decreased when combined with Nilvadipine.,decrease,no risk
Apomorphine,Nimodipine,The risk or severity of QTc prolongation can be increased when Apomorphine is combined with Nimodipine.,increase,risk
Apomorphine,Nirogacestat,The metabolism of Apomorphine can be increased when combined with Nirogacestat.,increase,no risk
Apomorphine,Nisoldipine,The risk or severity of adverse effects can be increased when Nisoldipine is combined with Apomorphine.,increase,risk
Apomorphine,Nitrazepam,The risk or severity of CNS depression can be increased when Apomorphine is combined with Nitrazepam.,increase,risk
Apomorphine,Nitrendipine,The risk or severity of adverse effects can be increased when Apomorphine is combined with Nitrendipine.,increase,risk
Apomorphine,Nitric Oxide,The risk or severity of adverse effects can be increased when Nitric Oxide is combined with Apomorphine.,increase,risk
Apomorphine,Nitroglycerin,The risk or severity of adverse effects can be increased when Apomorphine is combined with Nitroglycerin.,increase,risk
Apomorphine,Nitroprusside,The risk or severity of adverse effects can be increased when Nitroprusside is combined with Apomorphine.,increase,risk
Apomorphine,Nitrous acid,The risk or severity of adverse effects can be increased when Apomorphine is combined with Nitrous acid.,increase,risk
Apomorphine,Nitrous oxide,The risk or severity of CNS depression can be increased when Apomorphine is combined with Nitrous oxide.,increase,risk
Apomorphine,Nomifensine,The risk or severity of CNS depression can be increased when Apomorphine is combined with Nomifensine.,increase,risk
Apomorphine,Norethisterone,The metabolism of Norethisterone can be decreased when combined with Apomorphine.,decrease,no risk
Apomorphine,Norfloxacin,The risk or severity of QTc prolongation can be increased when Apomorphine is combined with Norfloxacin.,increase,risk
Apomorphine,Norgestimate,The metabolism of Norgestimate can be decreased when combined with Apomorphine.,decrease,no risk
Apomorphine,Normethadone,The risk or severity of CNS depression can be increased when Apomorphine is combined with Normethadone.,increase,risk
Apomorphine,Nortriptyline,The risk or severity of CNS depression can be increased when Nortriptyline is combined with Apomorphine.,increase,risk
Apomorphine,Obinutuzumab,The risk or severity of adverse effects can be increased when Apomorphine is combined with Obinutuzumab.,increase,risk
Apomorphine,Octreotide,The risk or severity of QTc prolongation can be increased when Octreotide is combined with Apomorphine.,increase,risk
Apomorphine,Ofloxacin,The risk or severity of QTc prolongation can be increased when Apomorphine is combined with Ofloxacin.,increase,risk
Apomorphine,Olanzapine,The therapeutic efficacy of Apomorphine can be decreased when used in combination with Olanzapine.,decrease,no risk
Apomorphine,Olaparib,The metabolism of Olaparib can be decreased when combined with Apomorphine.,decrease,no risk
Apomorphine,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Apomorphine is combined with Oliceridine.",increase,risk
Apomorphine,Olmesartan,The risk or severity of adverse effects can be increased when Olmesartan is combined with Apomorphine.,increase,risk
Apomorphine,Olodaterol,The metabolism of Olodaterol can be decreased when combined with Apomorphine.,decrease,no risk
Apomorphine,Omaveloxolone,The serum concentration of Apomorphine can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Apomorphine,Ombitasvir,The metabolism of Ombitasvir can be decreased when combined with Apomorphine.,decrease,no risk
Apomorphine,Ondansetron,The risk or severity of adverse effects can be increased when Ondansetron is combined with Apomorphine.,increase,risk
Apomorphine,Opicapone,The metabolism of Apomorphine can be decreased when combined with Opicapone.,decrease,no risk
Apomorphine,Opium,The risk or severity of CNS depression can be increased when Apomorphine is combined with Opium.,increase,risk
Apomorphine,Orphenadrine,Apomorphine may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Apomorphine,Osilodrostat,The metabolism of Osilodrostat can be decreased when combined with Apomorphine.,decrease,no risk
Apomorphine,Ospemifene,The metabolism of Ospemifene can be decreased when combined with Apomorphine.,decrease,no risk
Apomorphine,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Apomorphine.,increase,risk
Apomorphine,Oxatomide,The risk or severity of QTc prolongation can be increased when Apomorphine is combined with Oxatomide.,increase,risk
Apomorphine,Oxazepam,The risk or severity of CNS depression can be increased when Apomorphine is combined with Oxazepam.,increase,risk
Apomorphine,Oxcarbazepine,The risk or severity of CNS depression can be increased when Apomorphine is combined with Oxcarbazepine.,increase,risk
Apomorphine,Oxitriptan,The risk or severity of CNS depression can be increased when Apomorphine is combined with Oxitriptan.,increase,risk
Apomorphine,Oxprenolol,The risk or severity of CNS depression can be increased when Apomorphine is combined with Oxprenolol.,increase,risk
Apomorphine,Oxybuprocaine,The risk or severity of CNS depression can be increased when Apomorphine is combined with Oxybuprocaine.,increase,risk
Apomorphine,Oxybutynin,The metabolism of Apomorphine can be decreased when combined with Oxybutynin.,decrease,no risk
Apomorphine,Oxycodone,The risk or severity of CNS depression can be increased when Oxycodone is combined with Apomorphine.,increase,risk
Apomorphine,Oxymorphone,The risk or severity of CNS depression can be increased when Apomorphine is combined with Oxymorphone.,increase,risk
Apomorphine,Oxytocin,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Apomorphine.,increase,risk
Apomorphine,Ozanimod,The metabolism of Ozanimod can be decreased when combined with Apomorphine.,decrease,no risk
Apomorphine,Quazepam,The risk or severity of CNS depression can be increased when Apomorphine is combined with Quazepam.,increase,risk
Apomorphine,Quetiapine,The therapeutic efficacy of Apomorphine can be decreased when used in combination with Quetiapine.,decrease,no risk
Apomorphine,Quinagolide,The risk or severity of adverse effects can be decreased when Apomorphine is combined with Quinagolide.,decrease,risk
Apomorphine,Quinapril,The risk or severity of adverse effects can be increased when Apomorphine is combined with Quinapril.,increase,risk
Apomorphine,Quinidine,The risk or severity of QTc prolongation can be increased when Apomorphine is combined with Quinidine.,increase,risk
Apomorphine,Quinine,The risk or severity of QTc prolongation can be increased when Apomorphine is combined with Quinine.,increase,risk
Apomorphine,Quinupramine,The risk or severity of CNS depression can be increased when Apomorphine is combined with Quinupramine.,increase,risk
Apomorphine,Quizartinib,The risk or severity of QTc prolongation can be increased when Apomorphine is combined with Quizartinib.,increase,risk
Nitroaspirin,Benzydamine,The risk or severity of adverse effects can be increased when Benzydamine is combined with Nitroaspirin.,increase,risk
Nitroaspirin,Bepotastine,Nitroaspirin may decrease the excretion rate of Bepotastine which could result in a higher serum level.,decrease,no risk
Nitroaspirin,Bepridil,The therapeutic efficacy of Bepridil can be decreased when used in combination with Nitroaspirin.,decrease,no risk
Nitroaspirin,Betamethasone,The risk or severity of gastrointestinal irritation can be increased when Betamethasone is combined with Nitroaspirin.,increase,risk
Nitroaspirin,Betamethasone phosphate,The risk or severity of gastrointestinal irritation can be increased when Betamethasone phosphate is combined with Nitroaspirin.,increase,risk
Nitroaspirin,Betaxolol,Nitroaspirin may decrease the antihypertensive activities of Betaxolol.,decrease,no risk
Nitroaspirin,Bethanidine,The therapeutic efficacy of Bethanidine can be decreased when used in combination with Nitroaspirin.,decrease,no risk
Nitroaspirin,Betrixaban,The risk or severity of bleeding can be increased when Betrixaban is combined with Nitroaspirin.,increase,risk
Nitroaspirin,Betulinic Acid,The risk or severity of adverse effects can be increased when Nitroaspirin is combined with Betulinic Acid.,increase,risk
Nitroaspirin,Bexagliflozin,Nitroaspirin may increase the hypoglycemic activities of Bexagliflozin.,increase,no risk
Nitroaspirin,Bexarotene,The risk or severity of bleeding can be increased when Nitroaspirin is combined with Bexarotene.,increase,risk
Nitroaspirin,Bicisate,Nitroaspirin may decrease the excretion rate of Bicisate which could result in a higher serum level.,decrease,no risk
Nitroaspirin,Bimatoprost,The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Nitroaspirin.,decrease,no risk
Nitroaspirin,Bismuth subgallate,Nitroaspirin may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Nitroaspirin,Bismuth subsalicylate,"The risk or severity of bleeding, nephrotoxicity, and gastrointestinal bleeding can be increased when Bismuth subsalicylate is combined with Nitroaspirin.",increase,risk
Nitroaspirin,Bisoprolol,Nitroaspirin may decrease the antihypertensive activities of Bisoprolol.,decrease,no risk
Nitroaspirin,Bisoxatin,Nitroaspirin may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,decrease,no risk
Nitroaspirin,Bivalirudin,The risk or severity of bleeding and hemorrhage can be increased when Nitroaspirin is combined with Bivalirudin.,increase,risk
Nitroaspirin,Bleomycin,Nitroaspirin may decrease the excretion rate of Bleomycin which could result in a higher serum level.,decrease,no risk
Nitroaspirin,Blinatumomab,The risk or severity of bleeding can be increased when Nitroaspirin is combined with Blinatumomab.,increase,risk
Nitroaspirin,Bortezomib,The risk or severity of bleeding can be increased when Nitroaspirin is combined with Bortezomib.,increase,risk
Nitroaspirin,Bosentan,The therapeutic efficacy of Bosentan can be decreased when used in combination with Nitroaspirin.,decrease,no risk
Nitroaspirin,Bosutinib,The risk or severity of bleeding can be increased when Nitroaspirin is combined with Bosutinib.,increase,risk
Nitroaspirin,Bretylium,The therapeutic efficacy of Bretylium can be decreased when used in combination with Nitroaspirin.,decrease,no risk
Nitroaspirin,Brexpiprazole,The risk or severity of hypertension can be increased when Brexpiprazole is combined with Nitroaspirin.,increase,risk
Nitroaspirin,Brinzolamide,The risk or severity of electrolyte abnormality can be increased when Brinzolamide is combined with Nitroaspirin.,increase,risk
Nitroaspirin,Brivaracetam,Nitroaspirin may decrease the excretion rate of Brivaracetam which could result in a higher serum level.,decrease,no risk
Nitroaspirin,Bromazepam,Nitroaspirin may decrease the excretion rate of Bromazepam which could result in a higher serum level.,decrease,no risk
Nitroaspirin,Bromfenac,The therapeutic efficacy of Nitroaspirin can be decreased when used in combination with Bromfenac.,decrease,no risk
Nitroaspirin,Bromocriptine,Nitroaspirin may increase the hypoglycemic activities of Bromocriptine.,increase,no risk
Nitroaspirin,Budesonide,The risk or severity of gastrointestinal irritation can be increased when Budesonide is combined with Nitroaspirin.,increase,risk
Nitroaspirin,Bufexamac,The therapeutic efficacy of Nitroaspirin can be decreased when used in combination with Bufexamac.,decrease,no risk
Nitroaspirin,Bumadizone,The risk or severity of adverse effects can be increased when Nitroaspirin is combined with Bumadizone.,increase,risk
Nitroaspirin,Bumetanide,The therapeutic efficacy of Bumetanide can be decreased when used in combination with Nitroaspirin.,decrease,no risk
Nitroaspirin,Bupropion,Nitroaspirin may decrease the excretion rate of Bupropion which could result in a higher serum level.,decrease,no risk
Nitroaspirin,Buspirone,The risk or severity of hypertension can be increased when Buspirone is combined with Nitroaspirin.,increase,risk
Nitroaspirin,Busulfan,The risk or severity of bleeding can be increased when Nitroaspirin is combined with Busulfan.,increase,risk
Nitroaspirin,Butabarbital,Nitroaspirin may decrease the excretion rate of Butabarbital which could result in a higher serum level.,decrease,no risk
Nitroaspirin,Butriptyline,The risk or severity of gastrointestinal bleeding can be increased when Butriptyline is combined with Nitroaspirin.,increase,risk
Nitroaspirin,Gabapentin enacarbil,The risk or severity of adverse effects can be increased when Furosemide is combined with Nitroaspirin.,increase,risk
Nitroaspirin,Gadobenic acid,Nitroaspirin may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Nitroaspirin,Gadodiamide,Nitroaspirin may decrease the excretion rate of Gadobenic acid which could result in a higher serum level.,decrease,no risk
Nitroaspirin,Gadofosveset trisodium,Nitroaspirin may decrease the excretion rate of Gadodiamide which could result in a higher serum level.,decrease,no risk
Nitroaspirin,Gadopentetic acid,Nitroaspirin may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Nitroaspirin,Gadoteric acid,Nitroaspirin may decrease the excretion rate of Gadopentetic acid which could result in a higher serum level.,decrease,no risk
Nitroaspirin,Gadoteridol,Nitroaspirin may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Nitroaspirin,Ganciclovir,Nitroaspirin may decrease the excretion rate of Gadoteridol which could result in a higher serum level.,decrease,no risk
Nitroaspirin,Gatifloxacin,Nitroaspirin may decrease the excretion rate of Ganciclovir which could result in a higher serum level.,decrease,no risk
Nitroaspirin,Gemcitabine,Nitroaspirin may increase the neuroexcitatory activities of Gatifloxacin.,increase,no risk
Nitroaspirin,Gemfibrozil,The risk or severity of bleeding can be increased when Nitroaspirin is combined with Gemcitabine.,increase,risk
Nitroaspirin,Gemifloxacin,Nitroaspirin may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Nitroaspirin,Gemtuzumab ozogamicin,Nitroaspirin may increase the neuroexcitatory activities of Gemifloxacin.,increase,no risk
Nitroaspirin,Gentamicin,The risk or severity of bleeding can be increased when Nitroaspirin is combined with Gemtuzumab ozogamicin.,increase,risk
Nitroaspirin,Gimeracil,Nitroaspirin may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Nitroaspirin,Ginkgo biloba,Nitroaspirin may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Nitroaspirin,Givosiran,The risk or severity of bleeding can be increased when Ginkgo biloba is combined with Nitroaspirin.,increase,risk
Nitroaspirin,Gliclazide,The risk or severity of nephrotoxicity can be increased when Nitroaspirin is combined with Givosiran.,increase,risk
Nitroaspirin,Glimepiride,Nitroaspirin may increase the hypoglycemic activities of Gliclazide.,increase,no risk
Nitroaspirin,Glipizide,Nitroaspirin may increase the hypoglycemic activities of Glimepiride.,increase,no risk
Nitroaspirin,Gliquidone,Nitroaspirin may increase the hypoglycemic activities of Glipizide.,increase,no risk
Nitroaspirin,Glucosamine,Nitroaspirin may increase the hypoglycemic activities of Gliquidone.,increase,no risk
Nitroaspirin,Glyburide,Glucosamine may increase the antiplatelet activities of Nitroaspirin.,increase,no risk
Nitroaspirin,Glycerol phenylbutyrate,Nitroaspirin may increase the hypoglycemic activities of Glyburide.,increase,no risk
Nitroaspirin,Glycol salicylate,Nitroaspirin may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Nitroaspirin,Glymidine,The risk or severity of adverse effects can be increased when Glycol salicylate is combined with Nitroaspirin.,increase,risk
Nitroaspirin,Golodirsen,Nitroaspirin may increase the hypoglycemic activities of Glymidine.,increase,no risk
Nitroaspirin,Goserelin,Nitroaspirin may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Nitroaspirin,Grepafloxacin,Nitroaspirin may decrease the excretion rate of Goserelin which could result in a higher serum level.,decrease,no risk
Nitroaspirin,Guanabenz,Nitroaspirin may increase the neuroexcitatory activities of Grepafloxacin.,increase,no risk
Nitroaspirin,Guanadrel,The therapeutic efficacy of Guanabenz can be decreased when used in combination with Nitroaspirin.,decrease,no risk
Nitroaspirin,Guanethidine,The therapeutic efficacy of Guanadrel can be decreased when used in combination with Nitroaspirin.,decrease,no risk
Nitroaspirin,Guanfacine,The therapeutic efficacy of Guanethidine can be decreased when used in combination with Nitroaspirin.,decrease,no risk
Nitroaspirin,Guanoxan,The therapeutic efficacy of Guanfacine can be decreased when used in combination with Nitroaspirin.,decrease,no risk
Nitroaspirin,Haloperidol,The therapeutic efficacy of Guanoxan can be decreased when used in combination with Nitroaspirin.,decrease,no risk
Nitroaspirin,Halothane,The therapeutic efficacy of Haloperidol can be increased when used in combination with Nitroaspirin.,increase,no risk
Nitroaspirin,Heparin,The risk or severity of hypertension can be increased when Halothane is combined with Nitroaspirin.,increase,risk
Nitroaspirin,Hyaluronidase,The risk or severity of bleeding and hemorrhage can be increased when Nitroaspirin is combined with Heparin.,increase,risk
Nitroaspirin,Hyaluronidase (human recombinant),The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Nitroaspirin.,decrease,no risk
Nitroaspirin,Hyaluronidase (ovine),The therapeutic efficacy of Hyaluronidase (human recombinant) can be decreased when used in combination with Nitroaspirin.,decrease,no risk
Nitroaspirin,Hydralazine,The therapeutic efficacy of Hyaluronidase (ovine) can be decreased when used in combination with Nitroaspirin.,decrease,no risk
Nitroaspirin,Hydrochlorothiazide,Nitroaspirin may decrease the antihypertensive activities of Hydralazine.,decrease,no risk
Nitroaspirin,Hydrocortisone,The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with Nitroaspirin.,decrease,no risk
Nitroaspirin,Hydrocortisone acetate,The risk or severity of gastrointestinal irritation can be increased when Hydrocortisone is combined with Nitroaspirin.,increase,risk
Nitroaspirin,Hydrocortisone butyrate,The risk or severity of gastrointestinal irritation can be increased when Hydrocortisone acetate is combined with Nitroaspirin.,increase,risk
Nitroaspirin,Hydrocortisone cypionate,The risk or severity of gastrointestinal irritation can be increased when Hydrocortisone butyrate is combined with Nitroaspirin.,increase,risk
Nitroaspirin,Hydrocortisone succinate,The risk or severity of gastrointestinal irritation can be increased when Hydrocortisone cypionate is combined with Nitroaspirin.,increase,risk
Nitroaspirin,Hydroflumethiazide,The risk or severity of gastrointestinal irritation can be increased when Hydrocortisone succinate is combined with Nitroaspirin.,increase,risk
Nitroaspirin,Hydromorphone,The therapeutic efficacy of Hydroflumethiazide can be decreased when used in combination with Nitroaspirin.,decrease,no risk
Nitroaspirin,Hydroxocobalamin,Nitroaspirin may decrease the excretion rate of Hydromorphone which could result in a higher serum level.,decrease,no risk
Nitroaspirin,Hydroxyethyl Starch,Nitroaspirin may decrease the excretion rate of Hydroxocobalamin which could result in a higher serum level.,decrease,no risk
Nitroaspirin,Hydroxyurea,Nitroaspirin may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Nitroaspirin,Kanamycin,Nitroaspirin may decrease the excretion rate of Ixazomib which could result in a higher serum level.,decrease,no risk
Nitroaspirin,Ketamine,Nitroaspirin may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Nitroaspirin,Ketazolam,Nitroaspirin may decrease the excretion rate of Ketamine which could result in a higher serum level.,decrease,no risk
Nitroaspirin,Ketoconazole,Nitroaspirin may decrease the excretion rate of Ketazolam which could result in a higher serum level.,decrease,no risk
Nitroaspirin,Ketoprofen,The risk or severity of hyperkalemia can be increased when Ketoconazole is combined with Nitroaspirin.,increase,risk
Nitroaspirin,Ketorolac,The risk or severity of bleeding and gastrointestinal bleeding can be increased when Nitroaspirin is combined with Ketoprofen.,increase,risk
Parathyroid hormone,Orciprenaline,The risk or severity of adverse effects can be increased when Orciprenaline is combined with Parathyroid hormone.,increase,risk
Parathyroid hormone,Osimertinib,The therapeutic efficacy of Parathyroid hormone can be decreased when used in combination with Osimertinib.,decrease,no risk
Parathyroid hormone,Ouabain,The risk or severity of adverse effects can be increased when Parathyroid hormone is combined with Ouabain.,increase,risk
Parathyroid hormone,Oxymetazoline,The risk or severity of adverse effects can be increased when Oxymetazoline is combined with Parathyroid hormone.,increase,risk
Parathyroid hormone,Quizartinib,The therapeutic efficacy of Parathyroid hormone can be decreased when used in combination with Quizartinib.,decrease,no risk
Parathyroid hormone,Vandetanib,The therapeutic efficacy of Parathyroid hormone can be decreased when used in combination with Vandetanib.,decrease,no risk
Parathyroid hormone,Vemurafenib,The therapeutic efficacy of Parathyroid hormone can be decreased when used in combination with Vemurafenib.,decrease,no risk
Parathyroid hormone,Zanubrutinib,The therapeutic efficacy of Parathyroid hormone can be decreased when used in combination with Zanubrutinib.,decrease,no risk
Parathyroid hormone,Zimelidine,The therapeutic efficacy of Parathyroid hormone can be decreased when used in combination with Zimelidine.,decrease,no risk
Parathyroid hormone,Zoledronic acid,The therapeutic efficacy of Parathyroid hormone can be decreased when used in combination with Zoledronic acid.,decrease,no risk
Trestolone,Gabapentin,The metabolism of Trestolone can be increased when combined with Gabapentin.,increase,no risk
Trestolone,Ganaxolone,The metabolism of Trestolone can be increased when combined with Ganaxolone.,increase,no risk
Trestolone,Gliclazide,The therapeutic efficacy of Gliclazide can be decreased when used in combination with Trestolone.,decrease,no risk
Trestolone,Glimepiride,The therapeutic efficacy of Glimepiride can be decreased when used in combination with Trestolone.,decrease,no risk
Trestolone,Glipizide,The therapeutic efficacy of Glipizide can be decreased when used in combination with Trestolone.,decrease,no risk
Trestolone,Gliquidone,The therapeutic efficacy of Gliquidone can be decreased when used in combination with Trestolone.,decrease,no risk
Trestolone,Glyburide,The therapeutic efficacy of Glyburide can be decreased when used in combination with Trestolone.,decrease,no risk
Trestolone,Glycerol phenylbutyrate,The metabolism of Trestolone can be increased when combined with Glycerol phenylbutyrate.,increase,no risk
Trestolone,Griseofulvin,The metabolism of Trestolone can be increased when combined with Griseofulvin.,increase,no risk
Trestolone,Heparin,The therapeutic efficacy of Heparin can be decreased when used in combination with Trestolone.,decrease,no risk
Trestolone,Hetacillin,The therapeutic efficacy of Trestolone can be decreased when used in combination with Hetacillin.,decrease,no risk
Trestolone,Hydrocortamate,The metabolism of Trestolone can be increased when combined with Hydrocortamate.,increase,no risk
Trestolone,Hydrocortisone,The serum concentration of Hydrocortisone can be increased when it is combined with Trestolone.,increase,no risk
Trestolone,Hydrocortisone acetate,The serum concentration of Hydrocortisone acetate can be increased when it is combined with Trestolone.,increase,no risk
Trestolone,Hydrocortisone butyrate,The serum concentration of Hydrocortisone butyrate can be increased when it is combined with Trestolone.,increase,no risk
Trestolone,Hydrocortisone cypionate,The serum concentration of Hydrocortisone cypionate can be increased when it is combined with Trestolone.,increase,no risk
Trestolone,Hydrocortisone succinate,The serum concentration of Hydrocortisone succinate can be increased when it is combined with Trestolone.,increase,no risk
Trestolone,Nadroparin,The therapeutic efficacy of Nadroparin can be decreased when used in combination with Trestolone.,decrease,no risk
Trestolone,Nafcillin,The metabolism of Trestolone can be increased when combined with Nafcillin.,increase,no risk
Trestolone,Nitrazepam,The metabolism of Trestolone can be increased when combined with Nitrazepam.,increase,no risk
Trestolone,Norgestimate,The metabolism of Trestolone can be increased when combined with Norgestimate.,increase,no risk
Trestolone,Olutasidenib,The metabolism of Trestolone can be increased when combined with Olutasidenib.,increase,no risk
Trestolone,Omadacycline,The serum concentration of Trestolone can be decreased when it is combined with Omadacycline.,decrease,no risk
Trestolone,Omaveloxolone,The therapeutic efficacy of Trestolone can be decreased when used in combination with Omaveloxolone.,decrease,no risk
Trestolone,Oritavancin,The metabolism of Trestolone can be increased when combined with Oritavancin.,increase,no risk
Trestolone,Oxacillin,The therapeutic efficacy of Trestolone can be decreased when used in combination with Oxacillin.,decrease,no risk
Trestolone,Oxcarbazepine,The metabolism of Trestolone can be increased when combined with Oxcarbazepine.,increase,no risk
Trestolone,Oxytetracycline,The serum concentration of Trestolone can be decreased when it is combined with Oxytetracycline.,decrease,no risk
Trestolone,Quinine,The metabolism of Trestolone can be increased when combined with Quinine.,increase,no risk
Trestolone,Urokinase,The therapeutic efficacy of Urokinase can be decreased when used in combination with Trestolone.,decrease,no risk
Trestolone,Valproic acid,The metabolism of Trestolone can be increased when combined with Valproic acid.,increase,no risk
Trestolone,Vamorolone,The serum concentration of Vamorolone can be increased when it is combined with Trestolone.,increase,no risk
Trestolone,Vemurafenib,The metabolism of Trestolone can be increased when combined with Vemurafenib.,increase,no risk
Trestolone,Vigabatrin,The metabolism of Trestolone can be increased when combined with Vigabatrin.,increase,no risk
Trestolone,Vinblastine,The metabolism of Trestolone can be increased when combined with Vinblastine.,increase,no risk
Trestolone,Vitamin E,The metabolism of Trestolone can be increased when combined with Vitamin E.,increase,no risk
Trestolone,Vorapaxar,The therapeutic efficacy of Vorapaxar can be decreased when used in combination with Trestolone.,decrease,no risk
Trestolone,Warfarin,The therapeutic efficacy of Warfarin can be decreased when used in combination with Trestolone.,decrease,no risk
Trestolone,Ximelagatran,The therapeutic efficacy of Ximelagatran can be decreased when used in combination with Trestolone.,decrease,no risk
Trestolone,Zaleplon,The metabolism of Trestolone can be increased when combined with Zaleplon.,increase,no risk
Trestolone,Zonisamide,The metabolism of Trestolone can be increased when combined with Zonisamide.,increase,no risk
Peginterferon alfacon-1,Nonacog beta pegol,The therapeutic efficacy of Nonacog beta pegol can be decreased when used in combination with Peginterferon alfacon-1.,decrease,no risk
Besifloxacin,Bedaquiline,The risk or severity of QTc prolongation can be increased when Besifloxacin is combined with Bedaquiline.,increase,risk
Besifloxacin,Benzocaine,The risk or severity of methemoglobinemia can be increased when Besifloxacin is combined with Benzocaine.,increase,risk
Besifloxacin,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Besifloxacin is combined with Benzyl alcohol.,increase,risk
Besifloxacin,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Besifloxacin is combined with Bupivacaine.,increase,risk
Besifloxacin,Butacaine,The risk or severity of methemoglobinemia can be increased when Besifloxacin is combined with Butacaine.,increase,risk
Besifloxacin,Butamben,The risk or severity of methemoglobinemia can be increased when Besifloxacin is combined with Butamben.,increase,risk
Besifloxacin,Gepirone,The risk or severity of QTc prolongation can be increased when Gepirone is combined with Besifloxacin.,increase,risk
Besifloxacin,Glasdegib,The risk or severity of QTc prolongation can be increased when Besifloxacin is combined with Glasdegib.,increase,risk
Besifloxacin,Haloperidol,The risk or severity of QTc prolongation can be increased when Besifloxacin is combined with Haloperidol.,increase,risk
Besifloxacin,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Besifloxacin is combined with Hydroxyzine.,increase,risk
Besifloxacin,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Besifloxacin.,increase,risk
Besifloxacin,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Besifloxacin is combined with Oxetacaine.,increase,risk
Besifloxacin,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Besifloxacin is combined with Oxybuprocaine.,increase,risk
Besifloxacin,Quizartinib,The risk or severity of QTc prolongation can be increased when Besifloxacin is combined with Quizartinib.,increase,risk
Besifloxacin,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Besifloxacin.,decrease,no risk
Besifloxacin,Vilanterol,The risk or severity of QTc prolongation and ventricular arrhythmias can be increased when Vilanterol is combined with Besifloxacin.,increase,risk
Besifloxacin,Ziprasidone,The risk or severity of QTc prolongation can be increased when Besifloxacin is combined with Ziprasidone.,increase,risk
UC-781,Bacillus calmette-guerin substrain connaught live antigen,The therapeutic efficacy of Bacillus calmette-guerin substrain connaught live antigen can be decreased when used in combination with UC-781.,decrease,no risk
UC-781,Bacillus calmette-guerin substrain russian BCG-I live antigen,The therapeutic efficacy of Bacillus calmette-guerin substrain russian BCG-I live antigen can be decreased when used in combination with UC-781.,decrease,no risk
UC-781,Bacillus calmette-guerin substrain tice live antigen,The therapeutic efficacy of Bacillus calmette-guerin substrain tice live antigen can be decreased when used in combination with UC-781.,decrease,no risk
UC-781,BCG vaccine,The therapeutic efficacy of BCG vaccine can be decreased when used in combination with UC-781.,decrease,no risk
UC-781,Human adenovirus e serotype 4 strain cl-68578 antigen,The therapeutic efficacy of Human adenovirus e serotype 4 strain cl-68578 antigen can be decreased when used in combination with UC-781.,decrease,no risk
UC-781,Varicella zoster vaccine (live/attenuated),The therapeutic efficacy of Varicella zoster vaccine (live/attenuated) can be decreased when used in combination with UC-781.,decrease,no risk
UC-781,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with UC-781.,decrease,no risk
UC-781,Yellow fever vaccine,The therapeutic efficacy of Yellow fever vaccine can be decreased when used in combination with UC-781.,decrease,no risk
Raxibacumab,Natalizumab,The risk or severity of adverse effects can be increased when Natalizumab is combined with Raxibacumab.,increase,risk
Raxibacumab,Necitumumab,The risk or severity of adverse effects can be increased when Raxibacumab is combined with Necitumumab.,increase,risk
Raxibacumab,Nivolumab,The risk or severity of adverse effects can be increased when Raxibacumab is combined with Nivolumab.,increase,risk
Raxibacumab,Obiltoxaximab,The risk or severity of adverse effects can be increased when Obiltoxaximab is combined with Raxibacumab.,increase,risk
Raxibacumab,Obinutuzumab,The risk or severity of adverse effects can be increased when Raxibacumab is combined with Obinutuzumab.,increase,risk
Raxibacumab,Ocrelizumab,The risk or severity of adverse effects can be increased when Raxibacumab is combined with Ocrelizumab.,increase,risk
Raxibacumab,Odesivimab,The risk or severity of adverse effects can be increased when Raxibacumab is combined with Odesivimab.,increase,risk
Raxibacumab,Ofatumumab,The risk or severity of adverse effects can be increased when Ofatumumab is combined with Raxibacumab.,increase,risk
Raxibacumab,Olaratumab,The risk or severity of adverse effects can be increased when Olaratumab is combined with Raxibacumab.,increase,risk
Raxibacumab,Omalizumab,The risk or severity of adverse effects can be increased when Omalizumab is combined with Raxibacumab.,increase,risk
Raxibacumab,Quinestrol,Quinestrol may increase the thrombogenic activities of Raxibacumab.,increase,no risk
Raxibacumab,Ublituximab,The risk or severity of adverse effects can be increased when Raxibacumab is combined with Ublituximab.,increase,risk
Raxibacumab,Ustekinumab,The risk or severity of adverse effects can be increased when Ustekinumab is combined with Raxibacumab.,increase,risk
Raxibacumab,Vedolizumab,The risk or severity of adverse effects can be increased when Raxibacumab is combined with Vedolizumab.,increase,risk
"Sar9, Met (O2)11-Substance P",Benzonatate,"The serum concentration of Sar9, Met (O2)11-Substance P can be increased when it is combined with Benzonatate.",increase,no risk
"Sar9, Met (O2)11-Substance P",Betaine,"Betaine may increase the neuromuscular blocking activities of Sar9, Met (O2)11-Substance P.",increase,no risk
"Sar9, Met (O2)11-Substance P",Galantamine,"Galantamine may increase the neuromuscular blocking activities of Sar9, Met (O2)11-Substance P.",increase,no risk
"Sar9, Met (O2)11-Substance P",Gallamine triethiodide,"Gallamine triethiodide may increase the neuromuscular blocking activities of Sar9, Met (O2)11-Substance P.",increase,no risk
"Sar9, Met (O2)11-Substance P",Ginkgo biloba,"Ginkgo biloba may increase the neuromuscular blocking activities of Sar9, Met (O2)11-Substance P.",increase,no risk
"Sar9, Met (O2)11-Substance P",Hexafluronium,"Hexafluronium may increase the neuromuscular blocking activities of Sar9, Met (O2)11-Substance P.",increase,no risk
"Sar9, Met (O2)11-Substance P",Huperzine A,"Huperzine A may increase the neuromuscular blocking activities of Sar9, Met (O2)11-Substance P.",increase,no risk
"Sar9, Met (O2)11-Substance P",Ketamine,"Ketamine may increase the neuromuscular blocking activities of Sar9, Met (O2)11-Substance P.",increase,no risk
"Sar9, Met (O2)11-Substance P",Neostigmine,"Neostigmine may increase the neuromuscular blocking activities of Sar9, Met (O2)11-Substance P.",increase,no risk
"Sar9, Met (O2)11-Substance P",Nizatidine,"Nizatidine may increase the neuromuscular blocking activities of Sar9, Met (O2)11-Substance P.",increase,no risk
"Sar9, Met (O2)11-Substance P",Oxybuprocaine,"The serum concentration of Sar9, Met (O2)11-Substance P can be increased when it is combined with Oxybuprocaine.",increase,no risk
Seletracetam,Galantamine,Galantamine may increase the bradycardic activities of Seletracetam.,increase,no risk
Seletracetam,Gallamine triethiodide,Seletracetam may increase the neuromuscular blocking activities of Gallamine triethiodide.,increase,no risk
Seletracetam,Gliclazide,The risk or severity of hypoglycemia can be increased when Seletracetam is combined with Gliclazide.,increase,risk
Seletracetam,Glimepiride,The risk or severity of hypoglycemia can be increased when Seletracetam is combined with Glimepiride.,increase,risk
Seletracetam,Glipizide,The risk or severity of hypoglycemia can be increased when Seletracetam is combined with Glipizide.,increase,risk
Seletracetam,Gliquidone,The risk or severity of hypoglycemia can be increased when Seletracetam is combined with Gliquidone.,increase,risk
Seletracetam,Glofitamab,The serum concentration of Seletracetam can be increased when it is combined with Glofitamab.,increase,no risk
Seletracetam,Gluconic Acid,The therapeutic efficacy of Gluconic Acid can be decreased when used in combination with Seletracetam.,decrease,no risk
Seletracetam,Glyburide,The risk or severity of hypoglycemia can be increased when Seletracetam is combined with Glyburide.,increase,risk
Seletracetam,Glycerin,The therapeutic efficacy of Glycerin can be decreased when used in combination with Seletracetam.,decrease,no risk
Seletracetam,Glymidine,The risk or severity of hypoglycemia can be increased when Seletracetam is combined with Glymidine.,increase,risk
Seletracetam,Guanfacine,Guanfacine may increase the bradycardic activities of Seletracetam.,increase,no risk
Seletracetam,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Seletracetam.,increase,no risk
Inotuzumab ozogamicin,Galcanezumab,The risk or severity of adverse effects can be increased when Inotuzumab ozogamicin is combined with Galcanezumab.,increase,risk
Inotuzumab ozogamicin,Gemcitabine,The serum concentration of Inotuzumab ozogamicin can be increased when it is combined with Gemcitabine.,increase,no risk
Inotuzumab ozogamicin,Gemtuzumab ozogamicin,The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Inotuzumab ozogamicin.,increase,risk
Inotuzumab ozogamicin,Gilteritinib,The serum concentration of Inotuzumab ozogamicin can be increased when it is combined with Gilteritinib.,increase,no risk
Inotuzumab ozogamicin,Glasdegib,The serum concentration of Inotuzumab ozogamicin can be increased when it is combined with Glasdegib.,increase,no risk
Inotuzumab ozogamicin,Glecaprevir,The serum concentration of Inotuzumab ozogamicin can be increased when it is combined with Glecaprevir.,increase,no risk
Inotuzumab ozogamicin,Glofitamab,The risk or severity of adverse effects can be increased when Inotuzumab ozogamicin is combined with Glofitamab.,increase,risk
Inotuzumab ozogamicin,Golimumab,The risk or severity of adverse effects can be increased when Inotuzumab ozogamicin is combined with Golimumab.,increase,risk
Inotuzumab ozogamicin,Grazoprevir,The serum concentration of Inotuzumab ozogamicin can be increased when it is combined with Grazoprevir.,increase,no risk
Inotuzumab ozogamicin,Guselkumab,The risk or severity of adverse effects can be increased when Inotuzumab ozogamicin is combined with Guselkumab.,increase,risk
Inotuzumab ozogamicin,Hepatitis B immune globulin,The risk or severity of adverse effects can be increased when Hepatitis B immune globulin is combined with Inotuzumab ozogamicin.,increase,risk
Inotuzumab ozogamicin,Human cytomegalovirus immune globulin,The risk or severity of adverse effects can be increased when Inotuzumab ozogamicin is combined with Human cytomegalovirus immune globulin.,increase,risk
Inotuzumab ozogamicin,Human immunoglobulin G,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Inotuzumab ozogamicin.,increase,risk
Inotuzumab ozogamicin,Human Rho(D) immune globulin,The risk or severity of adverse effects can be increased when Inotuzumab ozogamicin is combined with Human Rho(D) immune globulin.,increase,risk
Inotuzumab ozogamicin,Human varicella-zoster immune globulin,The risk or severity of adverse effects can be increased when Inotuzumab ozogamicin is combined with Human varicella-zoster immune globulin.,increase,risk
Inotuzumab ozogamicin,Ketoconazole,The serum concentration of Inotuzumab ozogamicin can be increased when it is combined with Ketoconazole.,increase,no risk
Inotuzumab ozogamicin,Natalizumab,The risk or severity of adverse effects can be increased when Natalizumab is combined with Inotuzumab ozogamicin.,increase,risk
Inotuzumab ozogamicin,Necitumumab,The risk or severity of adverse effects can be increased when Inotuzumab ozogamicin is combined with Necitumumab.,increase,risk
Inotuzumab ozogamicin,Neratinib,The serum concentration of Inotuzumab ozogamicin can be increased when it is combined with Neratinib.,increase,no risk
Inotuzumab ozogamicin,Netupitant,The serum concentration of Inotuzumab ozogamicin can be increased when it is combined with Netupitant.,increase,no risk
Inotuzumab ozogamicin,Nilotinib,The serum concentration of Inotuzumab ozogamicin can be increased when it is combined with Nilotinib.,increase,no risk
Inotuzumab ozogamicin,Nintedanib,The serum concentration of Inotuzumab ozogamicin can be increased when it is combined with Nintedanib.,increase,no risk
Inotuzumab ozogamicin,Nirogacestat,The serum concentration of Inotuzumab ozogamicin can be increased when it is combined with Nirogacestat.,increase,no risk
Inotuzumab ozogamicin,Nivolumab,The risk or severity of adverse effects can be increased when Inotuzumab ozogamicin is combined with Nivolumab.,increase,risk
Inotuzumab ozogamicin,Norgestimate,The serum concentration of Inotuzumab ozogamicin can be increased when it is combined with Norgestimate.,increase,no risk
Inotuzumab ozogamicin,Nortriptyline,The serum concentration of Nortriptyline can be increased when it is combined with Inotuzumab ozogamicin.,increase,no risk
Inotuzumab ozogamicin,Obiltoxaximab,The risk or severity of adverse effects can be increased when Obiltoxaximab is combined with Inotuzumab ozogamicin.,increase,risk
Inotuzumab ozogamicin,Obinutuzumab,The risk or severity of adverse effects can be increased when Inotuzumab ozogamicin is combined with Obinutuzumab.,increase,risk
Inotuzumab ozogamicin,Ocrelizumab,The risk or severity of adverse effects can be increased when Inotuzumab ozogamicin is combined with Ocrelizumab.,increase,risk
Inotuzumab ozogamicin,Odesivimab,The risk or severity of adverse effects can be increased when Inotuzumab ozogamicin is combined with Odesivimab.,increase,risk
Inotuzumab ozogamicin,Ofatumumab,The risk or severity of adverse effects can be increased when Inotuzumab ozogamicin is combined with Ofatumumab.,increase,risk
Inotuzumab ozogamicin,Olaratumab,The risk or severity of adverse effects can be increased when Inotuzumab ozogamicin is combined with Olaratumab.,increase,risk
Inotuzumab ozogamicin,Omadacycline,The serum concentration of Inotuzumab ozogamicin can be increased when it is combined with Omadacycline.,increase,no risk
Inotuzumab ozogamicin,Omalizumab,The risk or severity of adverse effects can be increased when Omalizumab is combined with Inotuzumab ozogamicin.,increase,risk
Inotuzumab ozogamicin,Ombitasvir,The serum concentration of Inotuzumab ozogamicin can be increased when it is combined with Ombitasvir.,increase,no risk
Inotuzumab ozogamicin,Osimertinib,The serum concentration of Osimertinib can be increased when it is combined with Inotuzumab ozogamicin.,increase,no risk
Inotuzumab ozogamicin,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Inotuzumab ozogamicin is combined with Oxetacaine.,increase,risk
Inotuzumab ozogamicin,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Inotuzumab ozogamicin is combined with Oxybuprocaine.,increase,risk
Inotuzumab ozogamicin,Quinestrol,Quinestrol may increase the thrombogenic activities of Inotuzumab ozogamicin.,increase,no risk
Inotuzumab ozogamicin,Quinidine,The serum concentration of Inotuzumab ozogamicin can be increased when it is combined with Quinidine.,increase,no risk
Inotuzumab ozogamicin,Quinine,The serum concentration of Inotuzumab ozogamicin can be increased when it is combined with Quinine.,increase,no risk
Inotuzumab ozogamicin,Quizartinib,The serum concentration of Inotuzumab ozogamicin can be increased when it is combined with Quizartinib.,increase,no risk
Inotuzumab ozogamicin,Ublituximab,The risk or severity of adverse effects can be increased when Inotuzumab ozogamicin is combined with Ublituximab.,increase,risk
Inotuzumab ozogamicin,Ubrogepant,The serum concentration of Inotuzumab ozogamicin can be increased when it is combined with Ubrogepant.,increase,no risk
Inotuzumab ozogamicin,Umbralisib,The serum concentration of Inotuzumab ozogamicin can be increased when it is combined with Umbralisib.,increase,no risk
Inotuzumab ozogamicin,Umeclidinium,The serum concentration of Inotuzumab ozogamicin can be increased when it is combined with Umeclidinium.,increase,no risk
Inotuzumab ozogamicin,Ustekinumab,The risk or severity of adverse effects can be increased when Ustekinumab is combined with Inotuzumab ozogamicin.,increase,risk
Inotuzumab ozogamicin,Valoctocogene roxaparvovec,The therapeutic efficacy of Valoctocogene roxaparvovec can be decreased when used in combination with Inotuzumab ozogamicin.,decrease,no risk
Inotuzumab ozogamicin,Vandetanib,The serum concentration of Inotuzumab ozogamicin can be increased when it is combined with Vandetanib.,increase,no risk
Inotuzumab ozogamicin,Vardenafil,The serum concentration of Inotuzumab ozogamicin can be increased when it is combined with Vardenafil.,increase,no risk
Inotuzumab ozogamicin,Vedolizumab,The risk or severity of adverse effects can be increased when Inotuzumab ozogamicin is combined with Vedolizumab.,increase,risk
Inotuzumab ozogamicin,Velpatasvir,The serum concentration of Inotuzumab ozogamicin can be increased when it is combined with Velpatasvir.,increase,no risk
Inotuzumab ozogamicin,Vemurafenib,The serum concentration of Inotuzumab ozogamicin can be increased when it is combined with Vemurafenib.,increase,no risk
Inotuzumab ozogamicin,Venetoclax,The serum concentration of Inotuzumab ozogamicin can be increased when it is combined with Venetoclax.,increase,no risk
Inotuzumab ozogamicin,Verapamil,The serum concentration of Inotuzumab ozogamicin can be increased when it is combined with Verapamil.,increase,no risk
Inotuzumab ozogamicin,Vinblastine,The serum concentration of Inotuzumab ozogamicin can be increased when it is combined with Vinblastine.,increase,no risk
Inotuzumab ozogamicin,Vincristine,The serum concentration of Inotuzumab ozogamicin can be increased when it is combined with Vincristine.,increase,no risk
Inotuzumab ozogamicin,Vinflunine,The serum concentration of Vinflunine can be increased when it is combined with Inotuzumab ozogamicin.,increase,no risk
Inotuzumab ozogamicin,Voclosporin,The serum concentration of Inotuzumab ozogamicin can be increased when it is combined with Voclosporin.,increase,no risk
Inotuzumab ozogamicin,Vorapaxar,The serum concentration of Inotuzumab ozogamicin can be increased when it is combined with Vorapaxar.,increase,no risk
Inotuzumab ozogamicin,Voxilaprevir,The serum concentration of Inotuzumab ozogamicin can be increased when it is combined with Voxilaprevir.,increase,no risk
Inotuzumab ozogamicin,Zonisamide,The serum concentration of Inotuzumab ozogamicin can be increased when it is combined with Zonisamide.,increase,no risk
RI 624,Natalizumab,The risk or severity of adverse effects can be increased when Natalizumab is combined with RI 624.,increase,risk
RI 624,Necitumumab,The risk or severity of adverse effects can be increased when RI 624 is combined with Necitumumab.,increase,risk
RI 624,Nivolumab,The risk or severity of adverse effects can be increased when RI 624 is combined with Nivolumab.,increase,risk
RI 624,Obiltoxaximab,The risk or severity of adverse effects can be increased when Obiltoxaximab is combined with RI 624.,increase,risk
RI 624,Obinutuzumab,The risk or severity of adverse effects can be increased when RI 624 is combined with Obinutuzumab.,increase,risk
RI 624,Ocrelizumab,The risk or severity of adverse effects can be increased when RI 624 is combined with Ocrelizumab.,increase,risk
RI 624,Odesivimab,The risk or severity of adverse effects can be increased when RI 624 is combined with Odesivimab.,increase,risk
RI 624,Ofatumumab,The risk or severity of adverse effects can be increased when RI 624 is combined with Ofatumumab.,increase,risk
RI 624,Olaratumab,The risk or severity of adverse effects can be increased when RI 624 is combined with Olaratumab.,increase,risk
RI 624,Omalizumab,The risk or severity of adverse effects can be increased when Omalizumab is combined with RI 624.,increase,risk
RI 624,Quinestrol,Quinestrol may increase the thrombogenic activities of RI 624.,increase,no risk
RI 624,Ublituximab,The risk or severity of adverse effects can be increased when RI 624 is combined with Ublituximab.,increase,risk
RI 624,Ustekinumab,The risk or severity of adverse effects can be increased when Ustekinumab is combined with RI 624.,increase,risk
RI 624,Vedolizumab,The risk or severity of adverse effects can be increased when RI 624 is combined with Vedolizumab.,increase,risk
KOS-1584,Gepirone,The serum concentration of Gepirone can be increased when it is combined with KOS-1584.,increase,no risk
KOS-1584,Gilteritinib,The metabolism of Gilteritinib can be decreased when combined with KOS-1584.,decrease,no risk
KOS-1584,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with KOS-1584.,increase,no risk
KOS-1584,Hydrocortisone,The serum concentration of Hydrocortisone can be increased when it is combined with KOS-1584.,increase,no risk
KOS-1584,Nelarabine,The risk or severity of adverse effects can be increased when Nelarabine is combined with KOS-1584.,increase,risk
KOS-1584,Neratinib,The serum concentration of Neratinib can be increased when it is combined with KOS-1584.,increase,no risk
KOS-1584,Netupitant,The metabolism of Netupitant can be decreased when combined with KOS-1584.,decrease,no risk
KOS-1584,Nicergoline,The serum concentration of Nicergoline can be increased when it is combined with KOS-1584.,increase,no risk
KOS-1584,Nilotinib,The serum concentration of Nilotinib can be increased when it is combined with KOS-1584.,increase,no risk
KOS-1584,Nintedanib,The metabolism of Nintedanib can be decreased when combined with KOS-1584.,decrease,no risk
KOS-1584,Norethisterone,The metabolism of Norethisterone can be decreased when combined with KOS-1584.,decrease,no risk
KOS-1584,Nortriptyline,The serum concentration of Nortriptyline can be increased when it is combined with KOS-1584.,increase,no risk
KOS-1584,Olaparib,The serum concentration of Olaparib can be increased when it is combined with KOS-1584.,increase,no risk
KOS-1584,Osimertinib,The serum concentration of Osimertinib can be increased when it is combined with KOS-1584.,increase,no risk
KOS-1584,Ouabain,The serum concentration of Ouabain can be increased when it is combined with KOS-1584.,increase,no risk
KOS-1584,Oxetacaine,The risk or severity of methemoglobinemia can be increased when KOS-1584 is combined with Oxetacaine.,increase,risk
KOS-1584,Oxtriphylline,The metabolism of Oxtriphylline can be decreased when combined with KOS-1584.,decrease,no risk
KOS-1584,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when KOS-1584 is combined with Oxybuprocaine.,increase,risk
KOS-1584,Quinidine,The serum concentration of Quinidine can be increased when it is combined with KOS-1584.,increase,no risk
KOS-1584,Quinine,The serum concentration of Quinine can be increased when it is combined with KOS-1584.,increase,no risk
KOS-1584,Vandetanib,The serum concentration of Vandetanib can be increased when it is combined with KOS-1584.,increase,no risk
KOS-1584,Vardenafil,The metabolism of Vardenafil can be decreased when combined with KOS-1584.,decrease,no risk
KOS-1584,Vemurafenib,The serum concentration of Vemurafenib can be increased when it is combined with KOS-1584.,increase,no risk
KOS-1584,Venetoclax,The serum concentration of Venetoclax can be increased when it is combined with KOS-1584.,increase,no risk
KOS-1584,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with KOS-1584.,decrease,no risk
KOS-1584,Vinblastine,The serum concentration of Vinblastine can be increased when it is combined with KOS-1584.,increase,no risk
KOS-1584,Vincristine,The serum concentration of Vincristine can be increased when it is combined with KOS-1584.,increase,no risk
KOS-1584,Vindesine,The serum concentration of Vindesine can be increased when it is combined with KOS-1584.,increase,no risk
KOS-1584,Vinflunine,The serum concentration of Vinflunine can be increased when it is combined with KOS-1584.,increase,no risk
KOS-1584,Vinorelbine,The serum concentration of Vinorelbine can be increased when it is combined with KOS-1584.,increase,no risk
KOS-1584,Vorapaxar,The metabolism of Vorapaxar can be decreased when combined with KOS-1584.,decrease,no risk
KOS-1584,Voxelotor,The serum concentration of Voxelotor can be increased when it is combined with KOS-1584.,increase,no risk
KOS-1584,Warfarin,The serum concentration of Warfarin can be increased when it is combined with KOS-1584.,increase,no risk
KOS-1584,Zanubrutinib,The serum concentration of Zanubrutinib can be increased when it is combined with KOS-1584.,increase,no risk
KOS-1584,Ziprasidone,The metabolism of Ziprasidone can be decreased when combined with KOS-1584.,decrease,no risk
KOS-1584,Zopiclone,The metabolism of Zopiclone can be decreased when combined with KOS-1584.,decrease,no risk
KOS-1584,Zuclopenthixol,The metabolism of Zuclopenthixol can be decreased when combined with KOS-1584.,decrease,no risk
Betulinic Acid,Balsalazide,The risk or severity of adverse effects can be increased when Balsalazide is combined with Betulinic Acid.,increase,risk
Betulinic Acid,Bendazac,The risk or severity of adverse effects can be increased when Betulinic Acid is combined with Bendazac.,increase,risk
Betulinic Acid,Benorilate,The risk or severity of adverse effects can be increased when Betulinic Acid is combined with Benorilate.,increase,risk
Betulinic Acid,Benoxaprofen,The risk or severity of adverse effects can be increased when Benoxaprofen is combined with Betulinic Acid.,increase,risk
Betulinic Acid,Benzydamine,The risk or severity of adverse effects can be increased when Benzydamine is combined with Betulinic Acid.,increase,risk
Betulinic Acid,Bromfenac,The risk or severity of adverse effects can be increased when Bromfenac is combined with Betulinic Acid.,increase,risk
Betulinic Acid,Bufexamac,The risk or severity of adverse effects can be increased when Betulinic Acid is combined with Bufexamac.,increase,risk
Betulinic Acid,Bumadizone,The risk or severity of adverse effects can be increased when Betulinic Acid is combined with Bumadizone.,increase,risk
Betulinic Acid,Butriptyline,The risk or severity of gastrointestinal bleeding can be increased when Butriptyline is combined with Betulinic Acid.,increase,risk
Betulinic Acid,Glycol salicylate,The risk or severity of adverse effects can be increased when Glycol salicylate is combined with Betulinic Acid.,increase,risk
Betulinic Acid,Ketoprofen,The risk or severity of adverse effects can be increased when Ketoprofen is combined with Betulinic Acid.,increase,risk
Betulinic Acid,Ketorolac,The risk or severity of adverse effects can be increased when Ketorolac is combined with Betulinic Acid.,increase,risk
Betulinic Acid,Nabumetone,The risk or severity of adverse effects can be increased when Nabumetone is combined with Betulinic Acid.,increase,risk
Betulinic Acid,Naproxen,The risk or severity of adverse effects can be increased when Naproxen is combined with Betulinic Acid.,increase,risk
Betulinic Acid,Nepafenac,The risk or severity of adverse effects can be increased when Nepafenac is combined with Betulinic Acid.,increase,risk
Betulinic Acid,Nimesulide,The risk or severity of adverse effects can be increased when Nimesulide is combined with Betulinic Acid.,increase,risk
Betulinic Acid,Nortriptyline,The risk or severity of gastrointestinal bleeding can be increased when Nortriptyline is combined with Betulinic Acid.,increase,risk
Betulinic Acid,Oxaprozin,The risk or severity of adverse effects can be increased when Oxaprozin is combined with Betulinic Acid.,increase,risk
Betulinic Acid,Oxyphenbutazone,The risk or severity of adverse effects can be increased when Oxyphenbutazone is combined with Betulinic Acid.,increase,risk
Betulinic Acid,Quinupramine,The risk or severity of gastrointestinal bleeding can be increased when Quinupramine is combined with Betulinic Acid.,increase,risk
Betulinic Acid,Valdecoxib,The risk or severity of adverse effects can be increased when Valdecoxib is combined with Betulinic Acid.,increase,risk
Betulinic Acid,Valproic acid,The protein binding of Valproic acid can be decreased when combined with Betulinic Acid.,decrease,no risk
Betulinic Acid,Voriconazole,The serum concentration of Betulinic Acid can be increased when it is combined with Voriconazole.,increase,no risk
Stamulumab,Natalizumab,The risk or severity of adverse effects can be increased when Natalizumab is combined with MYO-029.,increase,risk
Stamulumab,Necitumumab,The risk or severity of adverse effects can be increased when MYO-029 is combined with Necitumumab.,increase,risk
Stamulumab,Nivolumab,The risk or severity of adverse effects can be increased when MYO-029 is combined with Nivolumab.,increase,risk
Stamulumab,Obiltoxaximab,The risk or severity of adverse effects can be increased when Obiltoxaximab is combined with MYO-029.,increase,risk
Stamulumab,Obinutuzumab,The risk or severity of adverse effects can be increased when MYO-029 is combined with Obinutuzumab.,increase,risk
Stamulumab,Ocrelizumab,The risk or severity of adverse effects can be increased when MYO-029 is combined with Ocrelizumab.,increase,risk
Stamulumab,Odesivimab,The risk or severity of adverse effects can be increased when MYO-029 is combined with Odesivimab.,increase,risk
Stamulumab,Ofatumumab,The risk or severity of adverse effects can be increased when MYO-029 is combined with Ofatumumab.,increase,risk
Stamulumab,Olaratumab,The risk or severity of adverse effects can be increased when MYO-029 is combined with Olaratumab.,increase,risk
Stamulumab,Omalizumab,The risk or severity of adverse effects can be increased when Omalizumab is combined with MYO-029.,increase,risk
Stamulumab,Quinestrol,Quinestrol may increase the thrombogenic activities of MYO-029.,increase,no risk
Stamulumab,Ublituximab,The risk or severity of adverse effects can be increased when MYO-029 is combined with Ublituximab.,increase,risk
Stamulumab,Ustekinumab,The risk or severity of adverse effects can be increased when Ustekinumab is combined with MYO-029.,increase,risk
Stamulumab,Vedolizumab,The risk or severity of adverse effects can be increased when MYO-029 is combined with Vedolizumab.,increase,risk
CT-011,Human varicella-zoster immune globulin,The risk or severity of adverse effects can be increased when CT-011 is combined with Human varicella-zoster immune globulin.,increase,risk
CT-011,Natalizumab,The risk or severity of adverse effects can be increased when Natalizumab is combined with CT-011.,increase,risk
CT-011,Necitumumab,The risk or severity of adverse effects can be increased when CT-011 is combined with Necitumumab.,increase,risk
CT-011,Nelarabine,The risk or severity of adverse effects can be increased when Nelarabine is combined with CT-011.,increase,risk
CT-011,Nivolumab,The risk or severity of adverse effects can be increased when CT-011 is combined with Nivolumab.,increase,risk
CT-011,Obiltoxaximab,The risk or severity of adverse effects can be increased when Obiltoxaximab is combined with CT-011.,increase,risk
CT-011,Obinutuzumab,The risk or severity of adverse effects can be increased when CT-011 is combined with Obinutuzumab.,increase,risk
CT-011,Ocrelizumab,The risk or severity of adverse effects can be increased when CT-011 is combined with Ocrelizumab.,increase,risk
CT-011,Odesivimab,The risk or severity of adverse effects can be increased when CT-011 is combined with Odesivimab.,increase,risk
CT-011,Ofatumumab,The risk or severity of adverse effects can be increased when CT-011 is combined with Ofatumumab.,increase,risk
CT-011,Olaratumab,The risk or severity of adverse effects can be increased when CT-011 is combined with Olaratumab.,increase,risk
CT-011,Omalizumab,The risk or severity of adverse effects can be increased when Omalizumab is combined with CT-011.,increase,risk
CT-011,Oxetacaine,The risk or severity of methemoglobinemia can be increased when CT-011 is combined with Oxetacaine.,increase,risk
CT-011,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when CT-011 is combined with Oxybuprocaine.,increase,risk
CT-011,Quinestrol,Quinestrol may increase the thrombogenic activities of CT-011.,increase,no risk
CT-011,Ublituximab,The risk or severity of adverse effects can be increased when CT-011 is combined with Ublituximab.,increase,risk
CT-011,Ustekinumab,The risk or severity of adverse effects can be increased when Ustekinumab is combined with CT-011.,increase,risk
CT-011,Vedolizumab,The risk or severity of adverse effects can be increased when CT-011 is combined with Vedolizumab.,increase,risk
Macimorelin,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Gadobenic acid is combined with Macimorelin.,increase,risk
Macimorelin,Galantamine,The risk or severity of QTc prolongation can be increased when Galantamine is combined with Macimorelin.,increase,risk
Macimorelin,Gallamine triethiodide,The therapeutic efficacy of Macimorelin can be decreased when used in combination with Gallamine triethiodide.,decrease,no risk
Macimorelin,Gatifloxacin,The risk or severity of QTc prolongation can be increased when Gatifloxacin is combined with Macimorelin.,increase,risk
Macimorelin,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Gemifloxacin is combined with Macimorelin.,increase,risk
Macimorelin,Gepirone,The risk or severity of QTc prolongation can be increased when Gepirone is combined with Macimorelin.,increase,risk
Macimorelin,Gilteritinib,The risk or severity of QTc prolongation can be increased when Gilteritinib is combined with Macimorelin.,increase,risk
Macimorelin,Glasdegib,The risk or severity of QTc prolongation can be increased when Macimorelin is combined with Glasdegib.,increase,risk
Macimorelin,Glofitamab,The serum concentration of Macimorelin can be increased when it is combined with Glofitamab.,increase,no risk
Macimorelin,Glycol salicylate,The therapeutic efficacy of Macimorelin can be decreased when used in combination with Glycol salicylate.,decrease,no risk
Macimorelin,Glycopyrronium,The therapeutic efficacy of Macimorelin can be decreased when used in combination with Glycopyrronium.,decrease,no risk
Macimorelin,Goserelin,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Macimorelin.,increase,risk
Macimorelin,Granisetron,The risk or severity of QTc prolongation can be increased when Granisetron is combined with Macimorelin.,increase,risk
Macimorelin,Grepafloxacin,The risk or severity of QTc prolongation can be increased when Grepafloxacin is combined with Macimorelin.,increase,risk
Macimorelin,Halofantrine,The risk or severity of QTc prolongation can be increased when Halofantrine is combined with Macimorelin.,increase,risk
Macimorelin,Haloperidol,The risk or severity of QTc prolongation can be increased when Macimorelin is combined with Haloperidol.,increase,risk
Macimorelin,Hexocyclium,The therapeutic efficacy of Macimorelin can be decreased when used in combination with Hexocyclium.,decrease,no risk
Macimorelin,Histrelin,The risk or severity of QTc prolongation can be increased when Histrelin is combined with Macimorelin.,increase,risk
Macimorelin,Homatropine methylbromide,The therapeutic efficacy of Macimorelin can be decreased when used in combination with Homatropine methylbromide.,decrease,no risk
Macimorelin,Hydrochlorothiazide,The risk or severity of QTc prolongation can be increased when Hydrochlorothiazide is combined with Macimorelin.,increase,risk
Macimorelin,Hydroxychloroquine,The risk or severity of QTc prolongation can be increased when Hydroxychloroquine is combined with Macimorelin.,increase,risk
Macimorelin,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Macimorelin is combined with Hydroxyzine.,increase,risk
Macimorelin,Hyoscyamine,The therapeutic efficacy of Macimorelin can be decreased when used in combination with Hyoscyamine.,decrease,no risk
Macimorelin,Ketoconazole,The metabolism of Macimorelin can be decreased when combined with Ketoconazole.,decrease,no risk
Macimorelin,Ketoprofen,The therapeutic efficacy of Macimorelin can be decreased when used in combination with Ketoprofen.,decrease,no risk
Macimorelin,Ketorolac,The therapeutic efficacy of Macimorelin can be decreased when used in combination with Ketorolac.,decrease,no risk
Macimorelin,Nabumetone,The therapeutic efficacy of Macimorelin can be decreased when used in combination with Nabumetone.,decrease,no risk
Macimorelin,Nalidixic acid,The risk or severity of QTc prolongation can be increased when Nalidixic acid is combined with Macimorelin.,increase,risk
Macimorelin,Naproxen,The therapeutic efficacy of Macimorelin can be decreased when used in combination with Naproxen.,decrease,no risk
Macimorelin,Nefazodone,The metabolism of Macimorelin can be decreased when combined with Nefazodone.,decrease,no risk
Macimorelin,Nelfinavir,The metabolism of Macimorelin can be decreased when combined with Nelfinavir.,decrease,no risk
Macimorelin,Netupitant,The metabolism of Macimorelin can be decreased when combined with Netupitant.,decrease,no risk
Macimorelin,Nicardipine,The therapeutic efficacy of Macimorelin can be decreased when used in combination with Nicardipine.,decrease,no risk
Macimorelin,Nifedipine,The risk or severity of QTc prolongation can be increased when Nifedipine is combined with Macimorelin.,increase,risk
Macimorelin,Nilotinib,The metabolism of Macimorelin can be decreased when combined with Nilotinib.,decrease,no risk
Macimorelin,Nilvadipine,The risk or severity of QTc prolongation can be increased when Nilvadipine is combined with Macimorelin.,increase,risk
Macimorelin,Nimesulide,The therapeutic efficacy of Macimorelin can be decreased when used in combination with Nimesulide.,decrease,no risk
Macimorelin,Nimodipine,The risk or severity of QTc prolongation can be increased when Nimodipine is combined with Macimorelin.,increase,risk
Macimorelin,Nitrendipine,The risk or severity of QTc prolongation can be increased when Nitrendipine is combined with Macimorelin.,increase,risk
Macimorelin,Norfloxacin,The risk or severity of QTc prolongation can be increased when Norfloxacin is combined with Macimorelin.,increase,risk
Macimorelin,Nortriptyline,The therapeutic efficacy of Macimorelin can be decreased when used in combination with Nortriptyline.,decrease,no risk
Macimorelin,Octreotide,The therapeutic efficacy of Macimorelin can be decreased when used in combination with Octreotide.,decrease,no risk
Macimorelin,Ofloxacin,The risk or severity of QTc prolongation can be increased when Ofloxacin is combined with Macimorelin.,increase,risk
Macimorelin,Olanzapine,The therapeutic efficacy of Macimorelin can be decreased when used in combination with Olanzapine.,decrease,no risk
Macimorelin,Olodaterol,The risk or severity of QTc prolongation can be increased when Olodaterol is combined with Macimorelin.,increase,risk
Macimorelin,Omaveloxolone,The serum concentration of Macimorelin can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Macimorelin,Ondansetron,The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Macimorelin.,increase,risk
Macimorelin,Orphenadrine,The therapeutic efficacy of Macimorelin can be decreased when used in combination with Orphenadrine.,decrease,no risk
Macimorelin,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Macimorelin.,increase,risk
Macimorelin,Oxaprozin,The therapeutic efficacy of Macimorelin can be decreased when used in combination with Oxaprozin.,decrease,no risk
Macimorelin,Oxatomide,The risk or severity of QTc prolongation can be increased when Oxatomide is combined with Macimorelin.,increase,risk
Macimorelin,Oxybutynin,The therapeutic efficacy of Macimorelin can be decreased when used in combination with Oxybutynin.,decrease,no risk
Macimorelin,Oxyphenbutazone,The therapeutic efficacy of Macimorelin can be decreased when used in combination with Oxyphenbutazone.,decrease,no risk
Macimorelin,Oxyphencyclimine,The therapeutic efficacy of Macimorelin can be decreased when used in combination with Oxyphencyclimine.,decrease,no risk
Macimorelin,Oxyphenonium,The therapeutic efficacy of Macimorelin can be decreased when used in combination with Oxyphenonium.,decrease,no risk
Macimorelin,Oxytocin,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Macimorelin.,increase,risk
Macimorelin,Quetiapine,The therapeutic efficacy of Macimorelin can be decreased when used in combination with Quetiapine.,decrease,no risk
Macimorelin,Quinidine,The therapeutic efficacy of Macimorelin can be decreased when used in combination with Quinidine.,decrease,no risk
Macimorelin,Quinine,The risk or severity of QTc prolongation can be increased when Quinine is combined with Macimorelin.,increase,risk
Macimorelin,Quizartinib,The risk or severity of QTc prolongation can be increased when Macimorelin is combined with Quizartinib.,increase,risk
Macimorelin,Umeclidinium,The therapeutic efficacy of Macimorelin can be decreased when used in combination with Umeclidinium.,decrease,no risk
Macimorelin,Vadadustat,The serum concentration of Macimorelin can be increased when it is combined with Vadadustat.,increase,no risk
Macimorelin,Valdecoxib,The therapeutic efficacy of Macimorelin can be decreased when used in combination with Valdecoxib.,decrease,no risk
Macimorelin,Valproic acid,The risk or severity of QTc prolongation can be increased when Valproic acid is combined with Macimorelin.,increase,risk
Macimorelin,Vandetanib,The risk or severity of QTc prolongation can be increased when Vandetanib is combined with Macimorelin.,increase,risk
Macimorelin,Vardenafil,The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Macimorelin.,increase,risk
Macimorelin,Vemurafenib,The risk or severity of QTc prolongation can be increased when Vemurafenib is combined with Macimorelin.,increase,risk
Macimorelin,Venetoclax,The metabolism of Macimorelin can be decreased when combined with Venetoclax.,decrease,no risk
Macimorelin,Verapamil,The metabolism of Macimorelin can be decreased when combined with Verapamil.,decrease,no risk
Macimorelin,Vernakalant,The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Macimorelin.,increase,risk
Macimorelin,Vilanterol,The risk or severity of QTc prolongation and ventricular arrhythmias can be increased when Vilanterol is combined with Macimorelin.,increase,risk
Macimorelin,Viloxazine,The metabolism of Macimorelin can be decreased when combined with Viloxazine.,decrease,no risk
Macimorelin,Voriconazole,The metabolism of Macimorelin can be decreased when combined with Voriconazole.,decrease,no risk
Macimorelin,Vorinostat,The risk or severity of QTc prolongation can be increased when Vorinostat is combined with Macimorelin.,increase,risk
Macimorelin,Zimelidine,The metabolism of Macimorelin can be decreased when combined with Zimelidine.,decrease,no risk
Macimorelin,Ziprasidone,The therapeutic efficacy of Macimorelin can be decreased when used in combination with Ziprasidone.,decrease,no risk
Macimorelin,Zonisamide,The risk or severity of QTc prolongation can be increased when Zonisamide is combined with Macimorelin.,increase,risk
Macimorelin,Zuclopenthixol,The risk or severity of QTc prolongation can be increased when Zuclopenthixol is combined with Macimorelin.,increase,risk
Abexinostat,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Gadobenic acid is combined with Abexinostat.,increase,risk
Abexinostat,Galantamine,The risk or severity of QTc prolongation can be increased when Galantamine is combined with Abexinostat.,increase,risk
Abexinostat,Gatifloxacin,The risk or severity of QTc prolongation can be increased when Gatifloxacin is combined with Abexinostat.,increase,risk
Abexinostat,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Gemifloxacin is combined with Abexinostat.,increase,risk
Abexinostat,Gepirone,The risk or severity of QTc prolongation can be increased when Gepirone is combined with Abexinostat.,increase,risk
Abexinostat,Gilteritinib,The risk or severity of QTc prolongation can be increased when Gilteritinib is combined with Abexinostat.,increase,risk
Abexinostat,Glasdegib,The risk or severity of QTc prolongation can be increased when Abexinostat is combined with Glasdegib.,increase,risk
Abexinostat,Goserelin,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Abexinostat.,increase,risk
Abexinostat,Granisetron,The risk or severity of QTc prolongation can be increased when Granisetron is combined with Abexinostat.,increase,risk
Abexinostat,Grepafloxacin,The risk or severity of QTc prolongation can be increased when Abexinostat is combined with Grepafloxacin.,increase,risk
Abexinostat,Halofantrine,The risk or severity of QTc prolongation can be increased when Abexinostat is combined with Halofantrine.,increase,risk
Abexinostat,Haloperidol,The risk or severity of QTc prolongation can be increased when Abexinostat is combined with Haloperidol.,increase,risk
Abexinostat,Histrelin,The risk or severity of QTc prolongation can be increased when Histrelin is combined with Abexinostat.,increase,risk
Abexinostat,Hydrochlorothiazide,The risk or severity of QTc prolongation can be increased when Hydrochlorothiazide is combined with Abexinostat.,increase,risk
Abexinostat,Hydroxychloroquine,The risk or severity of QTc prolongation can be increased when Hydroxychloroquine is combined with Abexinostat.,increase,risk
Abexinostat,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Abexinostat is combined with Hydroxyzine.,increase,risk
Abexinostat,Hyoscyamine,The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Abexinostat.,increase,risk
Abexinostat,Ketoconazole,The risk or severity of QTc prolongation can be increased when Ketoconazole is combined with Abexinostat.,increase,risk
Abexinostat,Nalidixic acid,The risk or severity of QTc prolongation can be increased when Nalidixic acid is combined with Abexinostat.,increase,risk
Abexinostat,Nelarabine,The risk or severity of adverse effects can be increased when Nelarabine is combined with Abexinostat.,increase,risk
Abexinostat,Nelfinavir,The risk or severity of QTc prolongation can be increased when Nelfinavir is combined with Abexinostat.,increase,risk
Abexinostat,Nicardipine,The risk or severity of QTc prolongation can be increased when Nicardipine is combined with Abexinostat.,increase,risk
Abexinostat,Nifedipine,The risk or severity of QTc prolongation can be increased when Nifedipine is combined with Abexinostat.,increase,risk
Abexinostat,Nilotinib,The risk or severity of QTc prolongation can be increased when Abexinostat is combined with Nilotinib.,increase,risk
Abexinostat,Nilvadipine,The risk or severity of QTc prolongation can be increased when Nilvadipine is combined with Abexinostat.,increase,risk
Abexinostat,Nimodipine,The risk or severity of QTc prolongation can be increased when Nimodipine is combined with Abexinostat.,increase,risk
Abexinostat,Nitrendipine,The risk or severity of QTc prolongation can be increased when Nitrendipine is combined with Abexinostat.,increase,risk
Abexinostat,Norfloxacin,The risk or severity of QTc prolongation can be increased when Norfloxacin is combined with Abexinostat.,increase,risk
Abexinostat,Nortriptyline,The risk or severity of QTc prolongation can be increased when Nortriptyline is combined with Abexinostat.,increase,risk
Abexinostat,Octreotide,The risk or severity of QTc prolongation can be increased when Octreotide is combined with Abexinostat.,increase,risk
Abexinostat,Ofloxacin,The risk or severity of QTc prolongation can be increased when Ofloxacin is combined with Abexinostat.,increase,risk
Abexinostat,Olanzapine,The risk or severity of QTc prolongation can be increased when Olanzapine is combined with Abexinostat.,increase,risk
Abexinostat,Olodaterol,The risk or severity of QTc prolongation can be increased when Olodaterol is combined with Abexinostat.,increase,risk
Abexinostat,Ondansetron,The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Abexinostat.,increase,risk
Abexinostat,Orphenadrine,The risk or severity of QTc prolongation can be increased when Orphenadrine is combined with Abexinostat.,increase,risk
Abexinostat,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Abexinostat.,increase,risk
Abexinostat,Oxatomide,The risk or severity of QTc prolongation can be increased when Abexinostat is combined with Oxatomide.,increase,risk
Abexinostat,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Abexinostat is combined with Oxetacaine.,increase,risk
Abexinostat,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Abexinostat is combined with Oxybuprocaine.,increase,risk
Abexinostat,Oxytocin,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Abexinostat.,increase,risk
Abexinostat,Quetiapine,The risk or severity of QTc prolongation can be increased when Quetiapine is combined with Abexinostat.,increase,risk
Abexinostat,Quinidine,The risk or severity of QTc prolongation can be increased when Abexinostat is combined with Quinidine.,increase,risk
Abexinostat,Quinine,The risk or severity of QTc prolongation can be increased when Abexinostat is combined with Quinine.,increase,risk
Abexinostat,Quizartinib,The risk or severity of QTc prolongation can be increased when Abexinostat is combined with Quizartinib.,increase,risk
Abexinostat,Valproic acid,The risk or severity of QTc prolongation can be increased when Abexinostat is combined with Valproic acid.,increase,risk
Abexinostat,Vandetanib,The risk or severity of QTc prolongation can be increased when Abexinostat is combined with Vandetanib.,increase,risk
Abexinostat,Vardenafil,The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Abexinostat.,increase,risk
Abexinostat,Vemurafenib,The risk or severity of QTc prolongation can be increased when Abexinostat is combined with Vemurafenib.,increase,risk
Abexinostat,Vernakalant,The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Abexinostat.,increase,risk
Abexinostat,Vilanterol,The risk or severity of QTc prolongation and ventricular arrhythmias can be increased when Vilanterol is combined with Abexinostat.,increase,risk
Abexinostat,Voriconazole,The risk or severity of QTc prolongation can be increased when Voriconazole is combined with Abexinostat.,increase,risk
Abexinostat,Vorinostat,The risk or severity of gastrointestinal bleeding and thrombocytopenia can be increased when Abexinostat is combined with Vorinostat.,increase,risk
Abexinostat,Ziprasidone,The risk or severity of QTc prolongation can be increased when Abexinostat is combined with Ziprasidone.,increase,risk
Abexinostat,Zonisamide,The risk or severity of QTc prolongation can be increased when Zonisamide is combined with Abexinostat.,increase,risk
Abexinostat,Zuclopenthixol,The risk or severity of QTc prolongation can be increased when Abexinostat is combined with Zuclopenthixol.,increase,risk
Dovitinib,Gadoxetic acid,The excretion of Gadoxetic acid can be decreased when combined with Dovitinib.,decrease,no risk
Dovitinib,Gefitinib,Dovitinib may decrease the excretion rate of Gefitinib which could result in a higher serum level.,decrease,no risk
Dovitinib,Gemfibrozil,The metabolism of Gemfibrozil can be decreased when combined with Dovitinib.,decrease,no risk
Dovitinib,Gepirone,The serum concentration of Gepirone can be increased when it is combined with Dovitinib.,increase,no risk
Dovitinib,Gilteritinib,The metabolism of Gilteritinib can be decreased when combined with Dovitinib.,decrease,no risk
Dovitinib,Glasdegib,Dovitinib may decrease the excretion rate of Glasdegib which could result in a higher serum level.,decrease,no risk
Dovitinib,Glecaprevir,Dovitinib may decrease the excretion rate of Glecaprevir which could result in a higher serum level.,decrease,no risk
Dovitinib,Gliclazide,The metabolism of Gliclazide can be decreased when combined with Dovitinib.,decrease,no risk
Dovitinib,Glyburide,Dovitinib may decrease the excretion rate of Glyburide which could result in a higher serum level.,decrease,no risk
Dovitinib,Grazoprevir,The excretion of Grazoprevir can be decreased when combined with Dovitinib.,decrease,no risk
Dovitinib,Grepafloxacin,The metabolism of Grepafloxacin can be increased when combined with Dovitinib.,increase,no risk
Dovitinib,Guanabenz,The metabolism of Guanabenz can be increased when combined with Dovitinib.,increase,no risk
Dovitinib,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Dovitinib.,increase,no risk
Dovitinib,Hydromorphone,The metabolism of Hydromorphone can be decreased when combined with Dovitinib.,decrease,no risk
Dovitinib,Nabumetone,The metabolism of Nabumetone can be increased when combined with Dovitinib.,increase,no risk
Dovitinib,Naldemedine,The metabolism of Naldemedine can be decreased when combined with Dovitinib.,decrease,no risk
Dovitinib,Nalmefene,The metabolism of Nalmefene can be decreased when combined with Dovitinib.,decrease,no risk
Dovitinib,Naproxen,The metabolism of Naproxen can be increased when combined with Dovitinib.,increase,no risk
Dovitinib,Nebivolol,The metabolism of Nebivolol can be decreased when combined with Dovitinib.,decrease,no risk
Dovitinib,Neratinib,The metabolism of Neratinib can be decreased when combined with Dovitinib.,decrease,no risk
Dovitinib,Netupitant,The metabolism of Netupitant can be decreased when combined with Dovitinib.,decrease,no risk
Dovitinib,Nifedipine,The metabolism of Nifedipine can be increased when combined with Dovitinib.,increase,no risk
Dovitinib,Nilotinib,The metabolism of Nilotinib can be decreased when combined with Dovitinib.,decrease,no risk
Dovitinib,Nilutamide,The metabolism of Nilutamide can be decreased when combined with Dovitinib.,decrease,no risk
Dovitinib,Nintedanib,The metabolism of Nintedanib can be decreased when combined with Dovitinib.,decrease,no risk
Dovitinib,Nirogacestat,The metabolism of Nirogacestat can be decreased when combined with Dovitinib.,decrease,no risk
Dovitinib,Nitrofurantoin,Dovitinib may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.,decrease,no risk
Dovitinib,Norethisterone,The metabolism of Norethisterone can be decreased when combined with Dovitinib.,decrease,no risk
Dovitinib,Nortriptyline,The metabolism of Nortriptyline can be decreased when combined with Dovitinib.,decrease,no risk
Dovitinib,Olanzapine,The metabolism of Olanzapine can be increased when combined with Dovitinib.,increase,no risk
Dovitinib,Olaparib,The metabolism of Olaparib can be decreased when combined with Dovitinib.,decrease,no risk
Dovitinib,Ombitasvir,Dovitinib may decrease the excretion rate of Ombitasvir which could result in a higher serum level.,decrease,no risk
Dovitinib,Omeprazole,The metabolism of Omeprazole can be decreased when combined with Dovitinib.,decrease,no risk
Dovitinib,Ondansetron,The metabolism of Ondansetron can be increased when combined with Dovitinib.,increase,no risk
Dovitinib,Osimertinib,The metabolism of Osimertinib can be decreased when combined with Dovitinib.,decrease,no risk
Dovitinib,Ouabain,The excretion of Ouabain can be decreased when combined with Dovitinib.,decrease,no risk
Dovitinib,Oxaliplatin,Dovitinib may decrease the excretion rate of Oxaliplatin which could result in a higher serum level.,decrease,no risk
Dovitinib,Oxazepam,The metabolism of Oxazepam can be decreased when combined with Dovitinib.,decrease,no risk
Dovitinib,Oxtriphylline,The metabolism of Oxtriphylline can be increased when combined with Dovitinib.,increase,no risk
Dovitinib,Ozanimod,Dovitinib may decrease the excretion rate of Ozanimod which could result in a higher serum level.,decrease,no risk
Dovitinib,Quinidine,The metabolism of Quinidine can be decreased when combined with Dovitinib.,decrease,no risk
Dovitinib,Quinine,The metabolism of Quinine can be decreased when combined with Dovitinib.,decrease,no risk
Dovitinib,Ubrogepant,The serum concentration of Ubrogepant can be increased when it is combined with Dovitinib.,increase,no risk
Dovitinib,Vadadustat,The metabolism of Vadadustat can be decreased when combined with Dovitinib.,decrease,no risk
Dovitinib,Valproic acid,The metabolism of Valproic acid can be decreased when combined with Dovitinib.,decrease,no risk
Dovitinib,Valsartan,The excretion of Valsartan can be decreased when combined with Dovitinib.,decrease,no risk
Dovitinib,Vandetanib,The metabolism of Vandetanib can be decreased when combined with Dovitinib.,decrease,no risk
Dovitinib,Vardenafil,The metabolism of Vardenafil can be decreased when combined with Dovitinib.,decrease,no risk
Dovitinib,Velpatasvir,Dovitinib may decrease the excretion rate of Velpatasvir which could result in a higher serum level.,decrease,no risk
Dovitinib,Vemurafenib,The metabolism of Vemurafenib can be decreased when combined with Dovitinib.,decrease,no risk
Dovitinib,Venetoclax,The metabolism of Venetoclax can be decreased when combined with Dovitinib.,decrease,no risk
Dovitinib,Verapamil,The metabolism of Verapamil can be increased when combined with Dovitinib.,increase,no risk
Dovitinib,Vilazodone,The metabolism of Vilazodone can be decreased when combined with Dovitinib.,decrease,no risk
Dovitinib,Vinblastine,The metabolism of Vinblastine can be decreased when combined with Dovitinib.,decrease,no risk
Dovitinib,Vincristine,The metabolism of Vincristine can be decreased when combined with Dovitinib.,decrease,no risk
Dovitinib,Vindesine,The metabolism of Vindesine can be decreased when combined with Dovitinib.,decrease,no risk
Dovitinib,Vinflunine,The metabolism of Vinflunine can be decreased when combined with Dovitinib.,decrease,no risk
Dovitinib,Vinorelbine,The metabolism of Vinorelbine can be decreased when combined with Dovitinib.,decrease,no risk
Dovitinib,Vorapaxar,The metabolism of Vorapaxar can be decreased when combined with Dovitinib.,decrease,no risk
Dovitinib,Voriconazole,The serum concentration of Dovitinib can be increased when it is combined with Voriconazole.,increase,no risk
Dovitinib,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Dovitinib.,decrease,no risk
Dovitinib,Voxelotor,The serum concentration of Voxelotor can be increased when it is combined with Dovitinib.,increase,no risk
Dovitinib,Voxilaprevir,Dovitinib may decrease the excretion rate of Voxilaprevir which could result in a higher serum level.,decrease,no risk
Dovitinib,Warfarin,The serum concentration of Warfarin can be increased when it is combined with Dovitinib.,increase,no risk
Dovitinib,Zanubrutinib,The metabolism of Zanubrutinib can be decreased when combined with Dovitinib.,decrease,no risk
Dovitinib,Zavegepant,The serum concentration of Zavegepant can be increased when it is combined with Dovitinib.,increase,no risk
Dovitinib,Zidovudine,Dovitinib may decrease the excretion rate of Zidovudine which could result in a higher serum level.,decrease,no risk
Dovitinib,Zileuton,The metabolism of Zileuton can be increased when combined with Dovitinib.,increase,no risk
Dovitinib,Ziprasidone,The metabolism of Ziprasidone can be decreased when combined with Dovitinib.,decrease,no risk
Dovitinib,Zolmitriptan,The metabolism of Zolmitriptan can be increased when combined with Dovitinib.,increase,no risk
Dovitinib,Zolpidem,The metabolism of Zolpidem can be decreased when combined with Dovitinib.,decrease,no risk
Dovitinib,Zonisamide,The metabolism of Zonisamide can be decreased when combined with Dovitinib.,decrease,no risk
Dovitinib,Zopiclone,The metabolism of Zopiclone can be decreased when combined with Dovitinib.,decrease,no risk
Dovitinib,Zotepine,The metabolism of Zotepine can be increased when combined with Dovitinib.,increase,no risk
Dovitinib,Zuclopenthixol,The metabolism of Zuclopenthixol can be decreased when combined with Dovitinib.,decrease,no risk
Olaparib,Boceprevir,The metabolism of Olaparib can be decreased when combined with Boceprevir.,decrease,no risk
Olaparib,"Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated)","The therapeutic efficacy of Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated) can be decreased when used in combination with Olaparib.",decrease,no risk
Olaparib,Bortezomib,The metabolism of Bortezomib can be decreased when combined with Olaparib.,decrease,no risk
Olaparib,Bosentan,The metabolism of Olaparib can be increased when combined with Bosentan.,increase,no risk
Olaparib,Bosutinib,The metabolism of Bosutinib can be decreased when combined with Olaparib.,decrease,no risk
Olaparib,Brentuximab vedotin,The metabolism of Brentuximab vedotin can be decreased when combined with Olaparib.,decrease,no risk
Olaparib,Brigatinib,The metabolism of Brigatinib can be decreased when combined with Olaparib.,decrease,no risk
Olaparib,Brodalumab,The risk or severity of adverse effects can be increased when Olaparib is combined with Brodalumab.,increase,risk
Olaparib,Budesonide,The metabolism of Olaparib can be increased when combined with Budesonide.,increase,no risk
Olaparib,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Olaparib is combined with Bupivacaine.,increase,risk
Olaparib,Buprenorphine,The metabolism of Olaparib can be decreased when combined with Buprenorphine.,decrease,no risk
Olaparib,Buspirone,The metabolism of Olaparib can be decreased when combined with Buspirone.,decrease,no risk
Olaparib,Busulfan,The metabolism of Busulfan can be decreased when combined with Olaparib.,decrease,no risk
Olaparib,Butacaine,The risk or severity of methemoglobinemia can be increased when Olaparib is combined with Butacaine.,increase,risk
Olaparib,Butalbital,The metabolism of Olaparib can be increased when combined with Butalbital.,increase,no risk
Olaparib,Butamben,The risk or severity of methemoglobinemia can be increased when Olaparib is combined with Butamben.,increase,risk
Olaparib,Gefitinib,The metabolism of Olaparib can be decreased when combined with Gefitinib.,decrease,no risk
Olaparib,Gemcitabine,The risk or severity of adverse effects can be increased when Gemcitabine is combined with Olaparib.,increase,risk
Olaparib,Gemtuzumab ozogamicin,The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Olaparib.,increase,risk
Olaparib,Gepirone,The serum concentration of Gepirone can be increased when it is combined with Olaparib.,increase,no risk
Olaparib,Gilteritinib,The metabolism of Olaparib can be decreased when combined with Gilteritinib.,decrease,no risk
Olaparib,Ginkgo biloba,The metabolism of Olaparib can be decreased when combined with Ginkgo biloba.,decrease,no risk
Olaparib,Glatiramer,The risk or severity of adverse effects can be increased when Glatiramer is combined with Olaparib.,increase,risk
Olaparib,Glecaprevir,The metabolism of Olaparib can be decreased when combined with Glecaprevir.,decrease,no risk
Olaparib,Glofitamab,The serum concentration of Olaparib can be increased when it is combined with Glofitamab.,increase,no risk
Olaparib,Glyburide,The metabolism of Olaparib can be decreased when combined with Glyburide.,decrease,no risk
Olaparib,Glycerol phenylbutyrate,The metabolism of Olaparib can be increased when combined with Glycerol phenylbutyrate.,increase,no risk
Olaparib,Golimumab,The metabolism of Olaparib can be increased when combined with Golimumab.,increase,no risk
Olaparib,Grapefruit,The serum concentration of Olaparib can be increased when it is combined with Grapefruit.,increase,no risk
Olaparib,Griseofulvin,The metabolism of Olaparib can be increased when combined with Griseofulvin.,increase,no risk
Olaparib,Guselkumab,The risk or severity of adverse effects can be increased when Olaparib is combined with Guselkumab.,increase,risk
Olaparib,Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Olaparib.,decrease,no risk
Olaparib,Halofantrine,The metabolism of Olaparib can be decreased when combined with Halofantrine.,decrease,no risk
Olaparib,Haloperidol,The metabolism of Olaparib can be decreased when combined with Haloperidol.,decrease,no risk
Olaparib,Heparin,The risk or severity of bleeding can be increased when Heparin is combined with Olaparib.,increase,risk
Olaparib,Hepatitis A Vaccine,The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Olaparib.,decrease,no risk
Olaparib,Hepatitis B Vaccine (Recombinant),The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Olaparib.,decrease,no risk
Olaparib,Human adenovirus e serotype 4 strain cl-68578 antigen,The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Olaparib.,increase,risk
Olaparib,Hydralazine,The serum concentration of Olaparib can be increased when it is combined with Hydralazine.,increase,no risk
Olaparib,Hydrochlorothiazide,The risk or severity of neutropenia and thrombocytopenia can be increased when Hydrochlorothiazide is combined with Olaparib.,increase,risk
Olaparib,Hydrocortamate,The metabolism of Olaparib can be increased when combined with Hydrocortamate.,increase,no risk
Olaparib,Hydrocortisone,The metabolism of Olaparib can be increased when combined with Hydrocortisone.,increase,no risk
Olaparib,Hydrocortisone acetate,The metabolism of Olaparib can be increased when combined with Hydrocortisone acetate.,increase,no risk
Olaparib,Hydrocortisone butyrate,The metabolism of Olaparib can be increased when combined with Hydrocortisone butyrate.,increase,no risk
Olaparib,Hydrocortisone cypionate,The metabolism of Olaparib can be decreased when combined with Hydrocortisone cypionate.,decrease,no risk
Olaparib,Hydrocortisone phosphate,The metabolism of Olaparib can be decreased when combined with Hydrocortisone phosphate.,decrease,no risk
Olaparib,Hydrocortisone succinate,The metabolism of Olaparib can be increased when combined with Hydrocortisone succinate.,increase,no risk
Olaparib,Hydroflumethiazide,The risk or severity of neutropenia and thrombocytopenia can be increased when Hydroflumethiazide is combined with Olaparib.,increase,risk
Olaparib,Hydroxychloroquine,The risk or severity of adverse effects can be increased when Hydroxychloroquine is combined with Olaparib.,increase,risk
Olaparib,Hydroxyprogesterone caproate,The metabolism of Olaparib can be decreased when combined with Hydroxyprogesterone caproate.,decrease,no risk
Olaparib,Hydroxyurea,The risk or severity of adverse effects can be increased when Hydroxyurea is combined with Olaparib.,increase,risk
Olaparib,Hydroxyzine,The metabolism of Olaparib can be decreased when combined with Hydroxyzine.,decrease,no risk
Olaparib,Janssen COVID-19 Vaccine,The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Olaparib.,decrease,no risk
Olaparib,Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated),The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Olaparib.,decrease,no risk
Olaparib,Ketazolam,The serum concentration of Olaparib can be increased when it is combined with Ketazolam.,increase,no risk
Olaparib,Ketoconazole,The metabolism of Olaparib can be decreased when combined with Ketoconazole.,decrease,no risk
Olaparib,Nadroparin,The risk or severity of bleeding can be increased when Nadroparin is combined with Olaparib.,increase,risk
Olaparib,Nafcillin,The metabolism of Olaparib can be increased when combined with Nafcillin.,increase,no risk
Olaparib,Natalizumab,The risk or severity of immunosuppression can be increased when Olaparib is combined with Natalizumab.,increase,risk
Olaparib,Nateglinide,The metabolism of Olaparib can be decreased when combined with Nateglinide.,decrease,no risk
Olaparib,Nefazodone,The metabolism of Olaparib can be decreased when combined with Nefazodone.,decrease,no risk
Olaparib,Nelarabine,The risk or severity of adverse effects can be increased when Nelarabine is combined with Olaparib.,increase,risk
Olaparib,Nelfinavir,The metabolism of Olaparib can be decreased when combined with Nelfinavir.,decrease,no risk
Olaparib,Neratinib,The metabolism of Neratinib can be decreased when combined with Olaparib.,decrease,no risk
Olaparib,Netupitant,The metabolism of Olaparib can be decreased when combined with Netupitant.,decrease,no risk
Olaparib,Nevirapine,The metabolism of Olaparib can be decreased when combined with Nevirapine.,decrease,no risk
Olaparib,Niacin,The serum concentration of Olaparib can be increased when it is combined with Niacin.,increase,no risk
Olaparib,Nicardipine,The metabolism of Olaparib can be decreased when combined with Nicardipine.,decrease,no risk
Olaparib,Nifedipine,The metabolism of Olaparib can be decreased when combined with Nifedipine.,decrease,no risk
Olaparib,Nilotinib,The metabolism of Olaparib can be decreased when combined with Nilotinib.,decrease,no risk
Olaparib,Nilvadipine,The metabolism of Olaparib can be decreased when combined with Nilvadipine.,decrease,no risk
Olaparib,Nimesulide,The risk or severity of bleeding can be increased when Nimesulide is combined with Olaparib.,increase,risk
Olaparib,Nintedanib,The metabolism of Olaparib can be decreased when combined with Nintedanib.,decrease,no risk
Olaparib,Nisoldipine,The metabolism of Olaparib can be decreased when combined with Nisoldipine.,decrease,no risk
Olaparib,Nitrendipine,The metabolism of Olaparib can be decreased when combined with Nitrendipine.,decrease,no risk
Olaparib,Norethisterone,The metabolism of Olaparib can be decreased when combined with Norethisterone.,decrease,no risk
Olaparib,Norgestimate,The metabolism of Olaparib can be increased when combined with Norgestimate.,increase,no risk
Olaparib,Nortriptyline,The metabolism of Nortriptyline can be decreased when combined with Olaparib.,decrease,no risk
Olaparib,Noscapine,The serum concentration of Olaparib can be increased when it is combined with Noscapine.,increase,no risk
Olaparib,Nuvaxovid,The therapeutic efficacy of Nuvaxovid can be decreased when used in combination with Olaparib.,decrease,no risk
Olaparib,Obinutuzumab,The risk or severity of adverse effects can be increased when Obinutuzumab is combined with Olaparib.,increase,risk
Olaparib,Ocrelizumab,The risk or severity of adverse effects can be increased when Olaparib is combined with Ocrelizumab.,increase,risk
Olaparib,Octreotide,The serum concentration of Olaparib can be increased when it is combined with Octreotide.,increase,no risk
Olaparib,Ofatumumab,The risk or severity of adverse effects can be increased when Ofatumumab is combined with Olaparib.,increase,risk
Olaparib,Olutasidenib,The metabolism of Olaparib can be increased when combined with Olutasidenib.,increase,no risk
Olaparib,Omaveloxolone,The serum concentration of Olaparib can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Olaparib,Ondansetron,The metabolism of Olaparib can be decreased when combined with Ondansetron.,decrease,no risk
Olaparib,Oritavancin,The metabolism of Olaparib can be increased when combined with Oritavancin.,increase,no risk
Olaparib,Orphenadrine,The metabolism of Olaparib can be decreased when combined with Orphenadrine.,decrease,no risk
Olaparib,Osilodrostat,The metabolism of Olaparib can be decreased when combined with Osilodrostat.,decrease,no risk
Olaparib,Osimertinib,The metabolism of Osimertinib can be decreased when combined with Olaparib.,decrease,no risk
Olaparib,Oxaliplatin,The risk or severity of adverse effects can be increased when Oxaliplatin is combined with Olaparib.,increase,risk
Olaparib,Oxcarbazepine,The metabolism of Olaparib can be increased when combined with Oxcarbazepine.,increase,no risk
Olaparib,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Olaparib is combined with Oxetacaine.,increase,risk
Olaparib,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Olaparib is combined with Oxybuprocaine.,increase,risk
Olaparib,Oxybutynin,The serum concentration of Olaparib can be increased when it is combined with Oxybutynin.,increase,no risk
Olaparib,Oxycodone,The metabolism of Olaparib can be decreased when combined with Oxycodone.,decrease,no risk
Olaparib,Ozanimod,The risk or severity of adverse effects can be increased when Olaparib is combined with Ozanimod.,increase,risk
Olaparib,Quetiapine,The metabolism of Olaparib can be decreased when combined with Quetiapine.,decrease,no risk
Olaparib,Quinidine,The metabolism of Olaparib can be decreased when combined with Quinidine.,decrease,no risk
Olaparib,Quinine,The metabolism of Olaparib can be increased when combined with Quinine.,increase,no risk
Olaparib,Quinupristin,The metabolism of Olaparib can be decreased when combined with Quinupristin.,decrease,no risk
Olaparib,Quizartinib,The metabolism of Olaparib can be decreased when combined with Quizartinib.,decrease,no risk
Olaparib,Ublituximab,The risk or severity of infection can be increased when Ublituximab is combined with Olaparib.,increase,risk
Olaparib,Ubrogepant,The serum concentration of Ubrogepant can be increased when it is combined with Olaparib.,increase,no risk
Olaparib,Udenafil,The metabolism of Olaparib can be decreased when combined with Udenafil.,decrease,no risk
Olaparib,Upadacitinib,The risk or severity of adverse effects can be increased when Olaparib is combined with Upadacitinib.,increase,risk
Olaparib,Urokinase,The risk or severity of bleeding can be increased when Urokinase is combined with Olaparib.,increase,risk
Olaparib,Vadadustat,The serum concentration of Olaparib can be increased when it is combined with Vadadustat.,increase,no risk
Olaparib,Valbenazine,The metabolism of Olaparib can be decreased when combined with Valbenazine.,decrease,no risk
Olaparib,Valproic acid,The serum concentration of Olaparib can be increased when it is combined with Valproic acid.,increase,no risk
Olaparib,Vandetanib,The metabolism of Vandetanib can be decreased when combined with Olaparib.,decrease,no risk
Olaparib,Vardenafil,The metabolism of Vardenafil can be decreased when combined with Olaparib.,decrease,no risk
Olaparib,Varicella zoster vaccine (live/attenuated),The risk or severity of infection can be increased when Varicella zoster vaccine (live/attenuated) is combined with Olaparib.,increase,risk
Olaparib,Varicella zoster vaccine (recombinant),The therapeutic efficacy of Varicella zoster vaccine (recombinant) can be decreased when used in combination with Olaparib.,decrease,no risk
Olaparib,Vedolizumab,The risk or severity of adverse effects can be increased when Vedolizumab is combined with Olaparib.,increase,risk
Olaparib,Vemurafenib,The metabolism of Olaparib can be increased when combined with Vemurafenib.,increase,no risk
Olaparib,Venetoclax,The metabolism of Olaparib can be decreased when combined with Venetoclax.,decrease,no risk
Olaparib,Verapamil,The metabolism of Olaparib can be decreased when combined with Verapamil.,decrease,no risk
Olaparib,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Olaparib.,decrease,no risk
Olaparib,Vilanterol,The risk or severity of adverse effects can be increased when Olaparib is combined with Vilanterol.,increase,risk
Olaparib,Viloxazine,The metabolism of Olaparib can be decreased when combined with Viloxazine.,decrease,no risk
Olaparib,Vinblastine,The metabolism of Olaparib can be increased when combined with Vinblastine.,increase,no risk
Olaparib,Vincristine,The metabolism of Vincristine can be decreased when combined with Olaparib.,decrease,no risk
Olaparib,Vindesine,The metabolism of Vindesine can be decreased when combined with Olaparib.,decrease,no risk
Olaparib,Vinflunine,The metabolism of Vinflunine can be decreased when combined with Olaparib.,decrease,no risk
Olaparib,Vinorelbine,The metabolism of Vinorelbine can be decreased when combined with Olaparib.,decrease,no risk
Olaparib,Vitamin E,The metabolism of Olaparib can be increased when combined with Vitamin E.,increase,no risk
Olaparib,Voclosporin,The risk or severity of adverse effects can be increased when Olaparib is combined with Voclosporin.,increase,risk
Olaparib,Vonoprazan,The metabolism of Olaparib can be decreased when combined with Vonoprazan.,decrease,no risk
Olaparib,Vorapaxar,The metabolism of Olaparib can be decreased when combined with Vorapaxar.,decrease,no risk
Olaparib,Voriconazole,The metabolism of Olaparib can be decreased when combined with Voriconazole.,decrease,no risk
Olaparib,Vorinostat,The risk or severity of adverse effects can be increased when Vorinostat is combined with Olaparib.,increase,risk
Olaparib,Vortioxetine,The metabolism of Olaparib can be decreased when combined with Vortioxetine.,decrease,no risk
Olaparib,Voxelotor,The serum concentration of Olaparib can be increased when it is combined with Voxelotor.,increase,no risk
Olaparib,Warfarin,The serum concentration of Warfarin can be increased when it is combined with Olaparib.,increase,no risk
Olaparib,Ximelagatran,The risk or severity of bleeding can be increased when Ximelagatran is combined with Olaparib.,increase,risk
Olaparib,Yellow fever vaccine,The risk or severity of infection can be increased when Yellow fever vaccine is combined with Olaparib.,increase,risk
Olaparib,Zafirlukast,The serum concentration of Olaparib can be increased when it is combined with Zafirlukast.,increase,no risk
Olaparib,Zaleplon,The metabolism of Olaparib can be decreased when combined with Zaleplon.,decrease,no risk
Olaparib,Zanubrutinib,The metabolism of Zanubrutinib can be decreased when combined with Olaparib.,decrease,no risk
Olaparib,Zidovudine,The risk or severity of adverse effects can be increased when Zidovudine is combined with Olaparib.,increase,risk
Olaparib,Zimelidine,The metabolism of Olaparib can be decreased when combined with Zimelidine.,decrease,no risk
Olaparib,Ziprasidone,The metabolism of Olaparib can be decreased when combined with Ziprasidone.,decrease,no risk
Olaparib,Zonisamide,The metabolism of Olaparib can be decreased when combined with Zonisamide.,decrease,no risk
Olaparib,Zopiclone,The metabolism of Zopiclone can be decreased when combined with Olaparib.,decrease,no risk
Olaparib,Zuclopenthixol,The metabolism of Olaparib can be decreased when combined with Zuclopenthixol.,decrease,no risk
Leronlimab,Natalizumab,The risk or severity of adverse effects can be increased when Natalizumab is combined with Leronlimab.,increase,risk
Leronlimab,Necitumumab,The risk or severity of adverse effects can be increased when Leronlimab is combined with Necitumumab.,increase,risk
Leronlimab,Nivolumab,The risk or severity of adverse effects can be increased when Leronlimab is combined with Nivolumab.,increase,risk
Leronlimab,Obiltoxaximab,The risk or severity of adverse effects can be increased when Obiltoxaximab is combined with Leronlimab.,increase,risk
Leronlimab,Obinutuzumab,The risk or severity of adverse effects can be increased when Leronlimab is combined with Obinutuzumab.,increase,risk
Leronlimab,Ocrelizumab,The risk or severity of adverse effects can be increased when Leronlimab is combined with Ocrelizumab.,increase,risk
Leronlimab,Odesivimab,The risk or severity of adverse effects can be increased when Leronlimab is combined with Odesivimab.,increase,risk
Leronlimab,Ofatumumab,The risk or severity of adverse effects can be increased when Leronlimab is combined with Ofatumumab.,increase,risk
Leronlimab,Olaratumab,The risk or severity of adverse effects can be increased when Leronlimab is combined with Olaratumab.,increase,risk
Leronlimab,Omalizumab,The risk or severity of adverse effects can be increased when Omalizumab is combined with Leronlimab.,increase,risk
Leronlimab,Quinestrol,Quinestrol may increase the thrombogenic activities of Leronlimab.,increase,no risk
Leronlimab,Ublituximab,The risk or severity of adverse effects can be increased when Leronlimab is combined with Ublituximab.,increase,risk
Leronlimab,Ustekinumab,The risk or severity of adverse effects can be increased when Ustekinumab is combined with Leronlimab.,increase,risk
Leronlimab,Varicella zoster vaccine (live/attenuated),The therapeutic efficacy of Varicella zoster vaccine (live/attenuated) can be decreased when used in combination with Leronlimab.,decrease,no risk
Leronlimab,Vedolizumab,The risk or severity of adverse effects can be increased when Leronlimab is combined with Vedolizumab.,increase,risk
Leronlimab,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Leronlimab.,decrease,no risk
Leronlimab,Yellow fever vaccine,The therapeutic efficacy of Yellow fever vaccine can be decreased when used in combination with Leronlimab.,decrease,no risk
GI-5005,Gemtuzumab ozogamicin,The therapeutic efficacy of GI-5005 can be decreased when used in combination with Gemtuzumab ozogamicin.,decrease,no risk
GI-5005,Glatiramer,The therapeutic efficacy of GI-5005 can be decreased when used in combination with Glatiramer.,decrease,no risk
GI-5005,Golimumab,The therapeutic efficacy of GI-5005 can be decreased when used in combination with Golimumab.,decrease,no risk
GI-5005,Guselkumab,The therapeutic efficacy of GI-5005 can be decreased when used in combination with Guselkumab.,decrease,no risk
GI-5005,Hydrocortisone,The therapeutic efficacy of GI-5005 can be decreased when used in combination with Hydrocortisone.,decrease,no risk
GI-5005,Hydrocortisone acetate,The therapeutic efficacy of GI-5005 can be decreased when used in combination with Hydrocortisone acetate.,decrease,no risk
GI-5005,Hydrocortisone butyrate,The therapeutic efficacy of GI-5005 can be decreased when used in combination with Hydrocortisone butyrate.,decrease,no risk
GI-5005,Hydrocortisone succinate,The therapeutic efficacy of GI-5005 can be decreased when used in combination with Hydrocortisone succinate.,decrease,no risk
GI-5005,Hydroxychloroquine,The therapeutic efficacy of GI-5005 can be decreased when used in combination with Hydroxychloroquine.,decrease,no risk
GI-5005,Hydroxyurea,The therapeutic efficacy of GI-5005 can be decreased when used in combination with Hydroxyurea.,decrease,no risk
GI-5005,Natalizumab,The therapeutic efficacy of GI-5005 can be decreased when used in combination with Natalizumab.,decrease,no risk
GI-5005,Nelarabine,The therapeutic efficacy of GI-5005 can be decreased when used in combination with Nelarabine.,decrease,no risk
GI-5005,Nilotinib,The therapeutic efficacy of GI-5005 can be decreased when used in combination with Nilotinib.,decrease,no risk
GI-5005,Obinutuzumab,The therapeutic efficacy of GI-5005 can be decreased when used in combination with Obinutuzumab.,decrease,no risk
GI-5005,Ocrelizumab,The therapeutic efficacy of GI-5005 can be decreased when used in combination with Ocrelizumab.,decrease,no risk
GI-5005,Ofatumumab,The therapeutic efficacy of GI-5005 can be decreased when used in combination with Ofatumumab.,decrease,no risk
GI-5005,Olaparib,The therapeutic efficacy of GI-5005 can be decreased when used in combination with Olaparib.,decrease,no risk
GI-5005,Oxaliplatin,The therapeutic efficacy of GI-5005 can be decreased when used in combination with Oxaliplatin.,decrease,no risk
GI-5005,Ozanimod,The therapeutic efficacy of GI-5005 can be decreased when used in combination with Ozanimod.,decrease,no risk
GI-5005,Ublituximab,The therapeutic efficacy of GI-5005 can be decreased when used in combination with Ublituximab.,decrease,no risk
GI-5005,Upadacitinib,The therapeutic efficacy of GI-5005 can be decreased when used in combination with Upadacitinib.,decrease,no risk
GI-5005,Vedolizumab,The therapeutic efficacy of GI-5005 can be decreased when used in combination with Vedolizumab.,decrease,no risk
GI-5005,Vilanterol,The therapeutic efficacy of GI-5005 can be decreased when used in combination with Vilanterol.,decrease,no risk
GI-5005,Vinblastine,The therapeutic efficacy of GI-5005 can be decreased when used in combination with Vinblastine.,decrease,no risk
GI-5005,Vincristine,The therapeutic efficacy of GI-5005 can be decreased when used in combination with Vincristine.,decrease,no risk
GI-5005,Vindesine,The therapeutic efficacy of GI-5005 can be decreased when used in combination with Vindesine.,decrease,no risk
GI-5005,Vinorelbine,The therapeutic efficacy of GI-5005 can be decreased when used in combination with Vinorelbine.,decrease,no risk
GI-5005,Voclosporin,The therapeutic efficacy of GI-5005 can be decreased when used in combination with Voclosporin.,decrease,no risk
GI-5005,Vorinostat,The therapeutic efficacy of GI-5005 can be decreased when used in combination with Vorinostat.,decrease,no risk
GI-5005,Zidovudine,The therapeutic efficacy of GI-5005 can be decreased when used in combination with Zidovudine.,decrease,no risk
Sifalimumab,Natalizumab,The risk or severity of adverse effects can be increased when Natalizumab is combined with Sifalimumab.,increase,risk
Sifalimumab,Necitumumab,The risk or severity of adverse effects can be increased when Necitumumab is combined with Sifalimumab.,increase,risk
Sifalimumab,Nivolumab,The risk or severity of adverse effects can be increased when Nivolumab is combined with Sifalimumab.,increase,risk
Sifalimumab,Obiltoxaximab,The risk or severity of adverse effects can be increased when Obiltoxaximab is combined with Sifalimumab.,increase,risk
Sifalimumab,Obinutuzumab,The risk or severity of adverse effects can be increased when Obinutuzumab is combined with Sifalimumab.,increase,risk
Sifalimumab,Ocrelizumab,The risk or severity of adverse effects can be increased when Ocrelizumab is combined with Sifalimumab.,increase,risk
Sifalimumab,Odesivimab,The risk or severity of adverse effects can be increased when Sifalimumab is combined with Odesivimab.,increase,risk
Sifalimumab,Ofatumumab,The risk or severity of adverse effects can be increased when Ofatumumab is combined with Sifalimumab.,increase,risk
Sifalimumab,Olaratumab,The risk or severity of adverse effects can be increased when Olaratumab is combined with Sifalimumab.,increase,risk
Sifalimumab,Omalizumab,The risk or severity of adverse effects can be increased when Omalizumab is combined with Sifalimumab.,increase,risk
Sifalimumab,Quinestrol,Quinestrol may increase the thrombogenic activities of Sifalimumab.,increase,no risk
Sifalimumab,Ublituximab,The risk or severity of adverse effects can be increased when Ublituximab is combined with Sifalimumab.,increase,risk
Sifalimumab,Ustekinumab,The risk or severity of adverse effects can be increased when Ustekinumab is combined with Sifalimumab.,increase,risk
Sifalimumab,Vedolizumab,The risk or severity of adverse effects can be increased when Vedolizumab is combined with Sifalimumab.,increase,risk
Urelumab,Natalizumab,The risk or severity of adverse effects can be increased when Natalizumab is combined with Urelumab.,increase,risk
Urelumab,Necitumumab,The risk or severity of adverse effects can be increased when Necitumumab is combined with Urelumab.,increase,risk
Urelumab,Nivolumab,The risk or severity of adverse effects can be increased when Nivolumab is combined with Urelumab.,increase,risk
Urelumab,Obiltoxaximab,The risk or severity of adverse effects can be increased when Obiltoxaximab is combined with Urelumab.,increase,risk
Urelumab,Obinutuzumab,The risk or severity of adverse effects can be increased when Obinutuzumab is combined with Urelumab.,increase,risk
Urelumab,Ocrelizumab,The risk or severity of adverse effects can be increased when Ocrelizumab is combined with Urelumab.,increase,risk
Urelumab,Odesivimab,The risk or severity of adverse effects can be increased when Urelumab is combined with Odesivimab.,increase,risk
Urelumab,Ofatumumab,The risk or severity of adverse effects can be increased when Ofatumumab is combined with Urelumab.,increase,risk
Urelumab,Olaratumab,The risk or severity of adverse effects can be increased when Olaratumab is combined with Urelumab.,increase,risk
Urelumab,Omalizumab,The risk or severity of adverse effects can be increased when Omalizumab is combined with Urelumab.,increase,risk
Urelumab,Quinestrol,Quinestrol may increase the thrombogenic activities of Urelumab.,increase,no risk
Urelumab,Ublituximab,The risk or severity of adverse effects can be increased when Ublituximab is combined with Urelumab.,increase,risk
Urelumab,Ustekinumab,The risk or severity of adverse effects can be increased when Ustekinumab is combined with Urelumab.,increase,risk
Urelumab,Vedolizumab,The risk or severity of adverse effects can be increased when Vedolizumab is combined with Urelumab.,increase,risk
Lebrikizumab,Natalizumab,The risk or severity of adverse effects can be increased when Natalizumab is combined with Lebrikizumab.,increase,risk
Lebrikizumab,Necitumumab,The risk or severity of adverse effects can be increased when Necitumumab is combined with Lebrikizumab.,increase,risk
Lebrikizumab,Nivolumab,The risk or severity of adverse effects can be increased when Nivolumab is combined with Lebrikizumab.,increase,risk
Lebrikizumab,Obiltoxaximab,The risk or severity of adverse effects can be increased when Obiltoxaximab is combined with Lebrikizumab.,increase,risk
Lebrikizumab,Obinutuzumab,The risk or severity of adverse effects can be increased when Obinutuzumab is combined with Lebrikizumab.,increase,risk
Lebrikizumab,Ocrelizumab,The risk or severity of adverse effects can be increased when Lebrikizumab is combined with Ocrelizumab.,increase,risk
Lebrikizumab,Odesivimab,The risk or severity of adverse effects can be increased when Lebrikizumab is combined with Odesivimab.,increase,risk
Lebrikizumab,Ofatumumab,The risk or severity of adverse effects can be increased when Ofatumumab is combined with Lebrikizumab.,increase,risk
Lebrikizumab,Olaratumab,The risk or severity of adverse effects can be increased when Olaratumab is combined with Lebrikizumab.,increase,risk
Lebrikizumab,Omalizumab,The risk or severity of adverse effects can be increased when Omalizumab is combined with Lebrikizumab.,increase,risk
Lebrikizumab,Quinestrol,Quinestrol may increase the thrombogenic activities of Lebrikizumab.,increase,no risk
Lebrikizumab,Ublituximab,The risk or severity of adverse effects can be increased when Ublituximab is combined with Lebrikizumab.,increase,risk
Lebrikizumab,Ustekinumab,The risk or severity of adverse effects can be increased when Ustekinumab is combined with Lebrikizumab.,increase,risk
Lebrikizumab,Vedolizumab,The risk or severity of adverse effects can be increased when Vedolizumab is combined with Lebrikizumab.,increase,risk
Radezolid,BCG vaccine,The therapeutic efficacy of BCG vaccine can be decreased when used in combination with Radezolid.,decrease,no risk
Radezolid,Benzocaine,The risk or severity of methemoglobinemia can be increased when Radezolid is combined with Benzocaine.,increase,risk
Radezolid,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Radezolid is combined with Benzyl alcohol.,increase,risk
Radezolid,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Radezolid is combined with Bupivacaine.,increase,risk
Radezolid,Butacaine,The risk or severity of methemoglobinemia can be increased when Radezolid is combined with Butacaine.,increase,risk
Radezolid,Butamben,The risk or severity of methemoglobinemia can be increased when Radezolid is combined with Butamben.,increase,risk
Radezolid,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Radezolid is combined with Oxetacaine.,increase,risk
Radezolid,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Radezolid is combined with Oxybuprocaine.,increase,risk
Radezolid,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Radezolid.,decrease,no risk
Radezolid,Warfarin,The risk or severity of bleeding can be increased when Radezolid is combined with Warfarin.,increase,risk
Transcrocetinate,Benzocaine,The risk or severity of methemoglobinemia can be increased when Transcrocetinate is combined with Benzocaine.,increase,risk
Transcrocetinate,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Transcrocetinate is combined with Benzyl alcohol.,increase,risk
Transcrocetinate,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Transcrocetinate is combined with Bupivacaine.,increase,risk
Transcrocetinate,Butacaine,The risk or severity of methemoglobinemia can be increased when Transcrocetinate is combined with Butacaine.,increase,risk
Transcrocetinate,Butamben,The risk or severity of methemoglobinemia can be increased when Transcrocetinate is combined with Butamben.,increase,risk
Transcrocetinate,Nelarabine,The risk or severity of adverse effects can be increased when Nelarabine is combined with Transcrocetinate.,increase,risk
Transcrocetinate,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Transcrocetinate is combined with Oxetacaine.,increase,risk
Transcrocetinate,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Transcrocetinate is combined with Oxybuprocaine.,increase,risk
Iniparib,Benzocaine,The risk or severity of methemoglobinemia can be increased when Iniparib is combined with Benzocaine.,increase,risk
Iniparib,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Iniparib is combined with Benzyl alcohol.,increase,risk
Iniparib,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Iniparib is combined with Bupivacaine.,increase,risk
Iniparib,Butacaine,The risk or severity of methemoglobinemia can be increased when Iniparib is combined with Butacaine.,increase,risk
Iniparib,Butamben,The risk or severity of methemoglobinemia can be increased when Iniparib is combined with Butamben.,increase,risk
Iniparib,Nelarabine,The risk or severity of adverse effects can be increased when Nelarabine is combined with Iniparib.,increase,risk
Iniparib,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Iniparib is combined with Oxetacaine.,increase,risk
Iniparib,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Iniparib is combined with Oxybuprocaine.,increase,risk
Binimetinib,Gatifloxacin,The metabolism of Binimetinib can be decreased when combined with Gatifloxacin.,decrease,no risk
Binimetinib,Gefitinib,Gefitinib may decrease the excretion rate of Binimetinib which could result in a higher serum level.,decrease,no risk
Binimetinib,Gemcitabine,The serum concentration of Binimetinib can be increased when it is combined with Gemcitabine.,increase,no risk
Binimetinib,Gemfibrozil,The metabolism of Binimetinib can be decreased when combined with Gemfibrozil.,decrease,no risk
Binimetinib,Gemifloxacin,The metabolism of Binimetinib can be decreased when combined with Gemifloxacin.,decrease,no risk
Binimetinib,Gilteritinib,Gilteritinib may decrease the excretion rate of Binimetinib which could result in a higher serum level.,decrease,no risk
Binimetinib,Givosiran,The serum concentration of Binimetinib can be increased when it is combined with Givosiran.,increase,no risk
Binimetinib,Glasdegib,The serum concentration of Binimetinib can be increased when it is combined with Glasdegib.,increase,no risk
Binimetinib,Glecaprevir,The serum concentration of Binimetinib can be increased when it is combined with Glecaprevir.,increase,no risk
Binimetinib,Glofitamab,The serum concentration of Binimetinib can be increased when it is combined with Glofitamab.,increase,no risk
Binimetinib,Golimumab,The metabolism of Binimetinib can be increased when combined with Golimumab.,increase,no risk
Binimetinib,Grazoprevir,Grazoprevir may decrease the excretion rate of Binimetinib which could result in a higher serum level.,decrease,no risk
Binimetinib,Grepafloxacin,The metabolism of Binimetinib can be decreased when combined with Grepafloxacin.,decrease,no risk
Binimetinib,Guanabenz,The metabolism of Binimetinib can be decreased when combined with Guanabenz.,decrease,no risk
Binimetinib,Haloperidol,The metabolism of Binimetinib can be decreased when combined with Haloperidol.,decrease,no risk
Binimetinib,Hydrocortisone,The metabolism of Binimetinib can be increased when combined with Hydrocortisone.,increase,no risk
Binimetinib,Hydroxyprogesterone caproate,The metabolism of Binimetinib can be increased when combined with Hydroxyprogesterone caproate.,increase,no risk
Binimetinib,Ketoconazole,The serum concentration of Binimetinib can be increased when it is combined with Ketoconazole.,increase,no risk
Binimetinib,Nabumetone,The metabolism of Binimetinib can be decreased when combined with Nabumetone.,decrease,no risk
Binimetinib,Nafcillin,The metabolism of Binimetinib can be increased when combined with Nafcillin.,increase,no risk
Binimetinib,Nalidixic acid,The metabolism of Binimetinib can be decreased when combined with Nalidixic acid.,decrease,no risk
Binimetinib,Naproxen,The metabolism of Binimetinib can be decreased when combined with Naproxen.,decrease,no risk
Binimetinib,Nelfinavir,The metabolism of Binimetinib can be increased when combined with Nelfinavir.,increase,no risk
Binimetinib,Neratinib,The serum concentration of Binimetinib can be increased when it is combined with Neratinib.,increase,no risk
Binimetinib,Netupitant,The serum concentration of Binimetinib can be increased when it is combined with Netupitant.,increase,no risk
Binimetinib,Nevirapine,The metabolism of Binimetinib can be decreased when combined with Nevirapine.,decrease,no risk
Binimetinib,Nicardipine,The metabolism of Binimetinib can be decreased when combined with Nicardipine.,decrease,no risk
Binimetinib,Niclosamide,The metabolism of Binimetinib can be decreased when combined with Niclosamide.,decrease,no risk
Binimetinib,Nifedipine,The metabolism of Binimetinib can be decreased when combined with Nifedipine.,decrease,no risk
Binimetinib,Nilotinib,The serum concentration of Binimetinib can be increased when it is combined with Nilotinib.,increase,no risk
Binimetinib,Nilutamide,The metabolism of Binimetinib can be decreased when combined with Nilutamide.,decrease,no risk
Binimetinib,Nilvadipine,The metabolism of Binimetinib can be decreased when combined with Nilvadipine.,decrease,no risk
Binimetinib,Nintedanib,The serum concentration of Binimetinib can be increased when it is combined with Nintedanib.,increase,no risk
Binimetinib,Nirogacestat,The serum concentration of Binimetinib can be increased when it is combined with Nirogacestat.,increase,no risk
Binimetinib,Norethisterone,The metabolism of Binimetinib can be increased when combined with Norethisterone.,increase,no risk
Binimetinib,Norfloxacin,The metabolism of Binimetinib can be decreased when combined with Norfloxacin.,decrease,no risk
Binimetinib,Norgestimate,The serum concentration of Binimetinib can be increased when it is combined with Norgestimate.,increase,no risk
Binimetinib,Nortriptyline,The serum concentration of Nortriptyline can be increased when it is combined with Binimetinib.,increase,no risk
Binimetinib,Novobiocin,Novobiocin may decrease the excretion rate of Binimetinib which could result in a higher serum level.,decrease,no risk
Binimetinib,Obeticholic acid,The risk or severity of adverse effects can be increased when Obeticholic acid is combined with Binimetinib.,increase,risk
Binimetinib,Olanzapine,The metabolism of Binimetinib can be decreased when combined with Olanzapine.,decrease,no risk
Binimetinib,Omadacycline,The serum concentration of Binimetinib can be increased when it is combined with Omadacycline.,increase,no risk
Binimetinib,Ombitasvir,The metabolism of Binimetinib can be decreased when combined with Ombitasvir.,decrease,no risk
Binimetinib,Omeprazole,The metabolism of Binimetinib can be decreased when combined with Omeprazole.,decrease,no risk
Binimetinib,Ondansetron,The metabolism of Binimetinib can be decreased when combined with Ondansetron.,decrease,no risk
Binimetinib,Oritavancin,The metabolism of Binimetinib can be decreased when combined with Oritavancin.,decrease,no risk
Binimetinib,Orphenadrine,The metabolism of Binimetinib can be decreased when combined with Orphenadrine.,decrease,no risk
Binimetinib,Osilodrostat,The serum concentration of Binimetinib can be increased when it is combined with Osilodrostat.,increase,no risk
Binimetinib,Osimertinib,The serum concentration of Binimetinib can be decreased when it is combined with Osimertinib.,decrease,no risk
Binimetinib,Oteseconazole,The serum concentration of Binimetinib can be increased when it is combined with Oteseconazole.,increase,no risk
Binimetinib,Oxcarbazepine,The metabolism of Binimetinib can be decreased when combined with Oxcarbazepine.,decrease,no risk
Binimetinib,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Binimetinib is combined with Oxetacaine.,increase,risk
Binimetinib,Oxtriphylline,The metabolism of Binimetinib can be decreased when combined with Oxtriphylline.,decrease,no risk
Binimetinib,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Binimetinib is combined with Oxybuprocaine.,increase,risk
Binimetinib,Quinidine,The serum concentration of Binimetinib can be increased when it is combined with Quinidine.,increase,no risk
Binimetinib,Quinine,The serum concentration of Binimetinib can be increased when it is combined with Quinine.,increase,no risk
Binimetinib,Quizartinib,The serum concentration of Binimetinib can be increased when it is combined with Quizartinib.,increase,no risk
Binimetinib,Ubrogepant,The serum concentration of Binimetinib can be increased when it is combined with Ubrogepant.,increase,no risk
Binimetinib,Umbralisib,The serum concentration of Binimetinib can be increased when it is combined with Umbralisib.,increase,no risk
Binimetinib,Umeclidinium,The serum concentration of Binimetinib can be increased when it is combined with Umeclidinium.,increase,no risk
Binimetinib,Vadadustat,Vadadustat may decrease the excretion rate of Binimetinib which could result in a higher serum level.,decrease,no risk
Binimetinib,Valproic acid,The metabolism of Binimetinib can be decreased when combined with Valproic acid.,decrease,no risk
Binimetinib,Vandetanib,The serum concentration of Binimetinib can be increased when it is combined with Vandetanib.,increase,no risk
Binimetinib,Vardenafil,The serum concentration of Binimetinib can be increased when it is combined with Vardenafil.,increase,no risk
Binimetinib,Velpatasvir,The serum concentration of Binimetinib can be increased when it is combined with Velpatasvir.,increase,no risk
Binimetinib,Vemurafenib,The serum concentration of Binimetinib can be increased when it is combined with Vemurafenib.,increase,no risk
Binimetinib,Venetoclax,The serum concentration of Binimetinib can be increased when it is combined with Venetoclax.,increase,no risk
Binimetinib,Venlafaxine,Venlafaxine may increase the excretion rate of Binimetinib which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Binimetinib,Verapamil,The serum concentration of Binimetinib can be increased when it is combined with Verapamil.,increase,no risk
Binimetinib,Viloxazine,The metabolism of Binimetinib can be decreased when combined with Viloxazine.,decrease,no risk
Binimetinib,Vinblastine,The serum concentration of Binimetinib can be increased when it is combined with Vinblastine.,increase,no risk
Binimetinib,Vincristine,The serum concentration of Binimetinib can be increased when it is combined with Vincristine.,increase,no risk
Binimetinib,Vinflunine,The serum concentration of Binimetinib can be increased when it is combined with Vinflunine.,increase,no risk
Binimetinib,Vismodegib,Vismodegib may decrease the excretion rate of Binimetinib which could result in a higher serum level.,decrease,no risk
Binimetinib,Voclosporin,The serum concentration of Binimetinib can be increased when it is combined with Voclosporin.,increase,no risk
Binimetinib,Vonoprazan,The metabolism of Binimetinib can be decreased when combined with Vonoprazan.,decrease,no risk
Binimetinib,Vorapaxar,The serum concentration of Binimetinib can be increased when it is combined with Vorapaxar.,increase,no risk
Binimetinib,Voriconazole,The metabolism of Binimetinib can be decreased when combined with Voriconazole.,decrease,no risk
Binimetinib,Voxilaprevir,The serum concentration of Binimetinib can be increased when it is combined with Voxilaprevir.,increase,no risk
Binimetinib,Warfarin,The metabolism of Binimetinib can be decreased when combined with Warfarin.,decrease,no risk
Binimetinib,Zafirlukast,The metabolism of Binimetinib can be decreased when combined with Zafirlukast.,decrease,no risk
Binimetinib,Zidovudine,The metabolism of Binimetinib can be increased when combined with Zidovudine.,increase,no risk
Binimetinib,Zileuton,The metabolism of Binimetinib can be decreased when combined with Zileuton.,decrease,no risk
Binimetinib,Zolmitriptan,The metabolism of Binimetinib can be decreased when combined with Zolmitriptan.,decrease,no risk
Binimetinib,Zolpidem,The metabolism of Binimetinib can be decreased when combined with Zolpidem.,decrease,no risk
Binimetinib,Zonisamide,The serum concentration of Binimetinib can be increased when it is combined with Zonisamide.,increase,no risk
Binimetinib,Zotepine,The metabolism of Binimetinib can be decreased when combined with Zotepine.,decrease,no risk
Ivacaftor,Galantamine,The serum concentration of Galantamine can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Gefitinib,The serum concentration of Gefitinib can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Gemcitabine,The serum concentration of Gemcitabine can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Gemfibrozil,The serum concentration of Gemfibrozil can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Gepirone,The serum concentration of Gepirone can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Gestrinone,The serum concentration of Gestrinone can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Gilteritinib,The serum concentration of Gilteritinib can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Glasdegib,The serum concentration of Glasdegib can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Glecaprevir,The serum concentration of Glecaprevir can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Gliclazide,The serum concentration of Gliclazide can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Glimepiride,The serum concentration of Glimepiride can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Glipizide,The serum concentration of Glipizide can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Gliquidone,The serum concentration of Gliquidone can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Glofitamab,The serum concentration of Ivacaftor can be increased when it is combined with Glofitamab.,increase,no risk
Ivacaftor,Glyburide,The serum concentration of Glyburide can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Golimumab,The metabolism of Ivacaftor can be increased when combined with Golimumab.,increase,no risk
Ivacaftor,Granisetron,The serum concentration of Granisetron can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Grazoprevir,The serum concentration of Grazoprevir can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Grepafloxacin,The serum concentration of Grepafloxacin can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Guanfacine,The serum concentration of Guanfacine can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Halcinonide,The serum concentration of Halcinonide can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Halofantrine,The serum concentration of Halofantrine can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Haloperidol,The metabolism of Ivacaftor can be decreased when combined with Haloperidol.,decrease,no risk
Ivacaftor,Halothane,The serum concentration of Halothane can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Hydrocodone,The serum concentration of Hydrocodone can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Hydrocortisone,The serum concentration of Hydrocortisone can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Hydrocortisone acetate,The serum concentration of Hydrocortisone acetate can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Hydrocortisone butyrate,The serum concentration of Hydrocortisone butyrate can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Hydrocortisone cypionate,The serum concentration of Hydrocortisone cypionate can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Hydrocortisone phosphate,The serum concentration of Hydrocortisone phosphate can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Hydrocortisone probutate,The serum concentration of Hydrocortisone probutate can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Hydrocortisone succinate,The serum concentration of Hydrocortisone succinate can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Hydrocortisone valerate,The serum concentration of Hydrocortisone valerate can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Hydromorphone,The serum concentration of Hydromorphone can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Hydroxychloroquine,The serum concentration of Hydroxychloroquine can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Hydroxyprogesterone caproate,The serum concentration of Hydroxyprogesterone caproate can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Hydroxyzine,The serum concentration of Hydroxyzine can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Ketamine,The serum concentration of Ketamine can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Ketazolam,The serum concentration of Ketazolam can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Ketoconazole,The metabolism of Ivacaftor can be decreased when combined with Ketoconazole.,decrease,no risk
Ivacaftor,Ketorolac,The serum concentration of Ketorolac can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Nabilone,The serum concentration of Nabilone can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Nabumetone,The serum concentration of Nabumetone can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Naloxegol,The serum concentration of Naloxegol can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Naproxen,The serum concentration of Naproxen can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Nateglinide,The serum concentration of Nateglinide can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Nebivolol,The serum concentration of Nebivolol can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Nefazodone,The metabolism of Ivacaftor can be decreased when combined with Nefazodone.,decrease,no risk
Ivacaftor,Nelfinavir,The metabolism of Ivacaftor can be decreased when combined with Nelfinavir.,decrease,no risk
Ivacaftor,Neratinib,The serum concentration of Neratinib can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Netupitant,The metabolism of Ivacaftor can be decreased when combined with Netupitant.,decrease,no risk
Ivacaftor,Nevirapine,The serum concentration of Nevirapine can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Nicardipine,The metabolism of Ivacaftor can be decreased when combined with Nicardipine.,decrease,no risk
Ivacaftor,Niclosamide,The serum concentration of Niclosamide can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Nifedipine,The serum concentration of Nifedipine can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Nilotinib,The metabolism of Ivacaftor can be decreased when combined with Nilotinib.,decrease,no risk
Ivacaftor,Nilvadipine,The metabolism of Ivacaftor can be decreased when combined with Nilvadipine.,decrease,no risk
Ivacaftor,Nimesulide,The serum concentration of Nimesulide can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Nimodipine,The serum concentration of Nimodipine can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Nintedanib,The serum concentration of Nintedanib can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Nirmatrelvir,The serum concentration of Nirmatrelvir can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Nirogacestat,The serum concentration of Nirogacestat can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Nisoldipine,The serum concentration of Nisoldipine can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Nitrazepam,The serum concentration of Nitrazepam can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Nitrendipine,The serum concentration of Nitrendipine can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Nomegestrol,The serum concentration of Nomegestrol can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Nomegestrol acetate,The serum concentration of Nomegestrol acetate can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Norelgestromin,The serum concentration of Norelgestromin can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Norethisterone,The serum concentration of Norethisterone can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Norethynodrel,The serum concentration of Norethynodrel can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Norgestimate,The serum concentration of Norgestimate can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Norgestrel,The serum concentration of Norgestrel can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Nortriptyline,The serum concentration of Nortriptyline can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Nylidrin,The serum concentration of Nylidrin can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Olaparib,The serum concentration of Olaparib can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Oliceridine,The serum concentration of Oliceridine can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Olodaterol,The serum concentration of Olodaterol can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Olutasidenib,The serum concentration of Olutasidenib can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Omadacycline,The serum concentration of Omadacycline can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Omaveloxolone,The serum concentration of Omaveloxolone can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Ombitasvir,The serum concentration of Ombitasvir can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Ondansetron,The serum concentration of Ondansetron can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Opium,The serum concentration of Opium can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Orphenadrine,The serum concentration of Orphenadrine can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Osilodrostat,The serum concentration of Osilodrostat can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Osimertinib,The serum concentration of Osimertinib can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Ospemifene,The serum concentration of Ospemifene can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Oxcarbazepine,The metabolism of Ivacaftor can be increased when combined with Oxcarbazepine.,increase,no risk
Ivacaftor,Oxybutynin,The serum concentration of Oxybutynin can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Oxycodone,The serum concentration of Oxycodone can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Oxymorphone,The serum concentration of Oxymorphone can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Quazepam,The serum concentration of Quazepam can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Quetiapine,The serum concentration of Quetiapine can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Quinidine,The serum concentration of Quinidine can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Quinine,The serum concentration of Quinine can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Quizartinib,The serum concentration of Quizartinib can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Ubrogepant,The serum concentration of Ubrogepant can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Udenafil,The serum concentration of Udenafil can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Ulipristal,The serum concentration of Ulipristal can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Umeclidinium,The serum concentration of Umeclidinium can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Upadacitinib,The serum concentration of Upadacitinib can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Vadadustat,The serum concentration of Ivacaftor can be increased when it is combined with Vadadustat.,increase,no risk
Ivacaftor,Valbenazine,The serum concentration of Valbenazine can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Valdecoxib,The serum concentration of Valdecoxib can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Valproic acid,The serum concentration of Valproic acid can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Valsartan,The serum concentration of Valsartan can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Vamorolone,The serum concentration of Vamorolone can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Vandetanib,The serum concentration of Vandetanib can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Vardenafil,The metabolism of Vardenafil can be decreased when combined with Ivacaftor.,decrease,no risk
Ivacaftor,Velpatasvir,The serum concentration of Velpatasvir can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Vemurafenib,The serum concentration of Vemurafenib can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Venetoclax,The metabolism of Ivacaftor can be decreased when combined with Venetoclax.,decrease,no risk
Ivacaftor,Venlafaxine,The serum concentration of Venlafaxine can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Verapamil,The metabolism of Ivacaftor can be decreased when combined with Verapamil.,decrease,no risk
Ivacaftor,Vilanterol,The serum concentration of Vilanterol can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Vilazodone,The serum concentration of Vilazodone can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Viloxazine,The metabolism of Ivacaftor can be decreased when combined with Viloxazine.,decrease,no risk
Ivacaftor,Vinblastine,The serum concentration of Vinblastine can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Vincristine,The serum concentration of Vincristine can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Vindesine,The serum concentration of Vindesine can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Vinflunine,The serum concentration of Vinflunine can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Vinorelbine,The serum concentration of Vinorelbine can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Vitamin D,The serum concentration of Vitamin D can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Vitamin E,The serum concentration of Vitamin E can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Voclosporin,The serum concentration of Voclosporin can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Vonoprazan,The serum concentration of Vonoprazan can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Vorapaxar,The serum concentration of Vorapaxar can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Voriconazole,The serum concentration of Ivacaftor can be increased when it is combined with Voriconazole.,increase,no risk
Ivacaftor,Vortioxetine,The serum concentration of Vortioxetine can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Voxelotor,The serum concentration of Voxelotor can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Voxilaprevir,The serum concentration of Voxilaprevir can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Warfarin,The serum concentration of Warfarin can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Ximelagatran,The serum concentration of Ximelagatran can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Yohimbine,The serum concentration of Yohimbine can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Zafirlukast,The serum concentration of Zafirlukast can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Zaleplon,The serum concentration of Zaleplon can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Zanubrutinib,The serum concentration of Zanubrutinib can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Zidovudine,The serum concentration of Zidovudine can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Zileuton,The serum concentration of Zileuton can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Zimelidine,The metabolism of Ivacaftor can be decreased when combined with Zimelidine.,decrease,no risk
Ivacaftor,Ziprasidone,The metabolism of Ivacaftor can be decreased when combined with Ziprasidone.,decrease,no risk
Ivacaftor,Zolpidem,The serum concentration of Zolpidem can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Zonisamide,The serum concentration of Zonisamide can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Zopiclone,The serum concentration of Zopiclone can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Zotepine,The serum concentration of Zotepine can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Zuclopenthixol,The serum concentration of Zuclopenthixol can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Zuranolone,The serum concentration of Zuranolone can be increased when it is combined with Ivacaftor.,increase,no risk
Obeticholic acid,Gemfibrozil,The therapeutic efficacy of Obeticholic acid can be decreased when used in combination with Gemfibrozil.,decrease,no risk
Obeticholic acid,Gestrinone,The therapeutic efficacy of Obeticholic acid can be decreased when used in combination with Gestrinone.,decrease,no risk
Obeticholic acid,Glyburide,The risk or severity of adverse effects can be increased when Glyburide is combined with Obeticholic acid.,increase,risk
Obeticholic acid,Grepafloxacin,The metabolism of Grepafloxacin can be decreased when combined with Obeticholic acid.,decrease,no risk
Obeticholic acid,Guanabenz,The metabolism of Guanabenz can be decreased when combined with Obeticholic acid.,decrease,no risk
Obeticholic acid,Haloperidol,The metabolism of Haloperidol can be decreased when combined with Obeticholic acid.,decrease,no risk
Obeticholic acid,Heparin,The risk or severity of bleeding and bruising can be increased when Heparin is combined with Obeticholic acid.,increase,risk
Obeticholic acid,Hydrotalcite,Hydrotalcite can cause a decrease in the absorption of Obeticholic acid resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Obeticholic acid,Kaolin,Kaolin can cause a decrease in the absorption of Obeticholic acid resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Obeticholic acid,Ketoconazole,The risk or severity of adverse effects can be increased when Ketoconazole is combined with Obeticholic acid.,increase,risk
Obeticholic acid,Nabumetone,The metabolism of Nabumetone can be decreased when combined with Obeticholic acid.,decrease,no risk
Obeticholic acid,Nadroparin,The risk or severity of bleeding and bruising can be increased when Nadroparin is combined with Obeticholic acid.,increase,risk
Obeticholic acid,Naproxen,The metabolism of Naproxen can be decreased when combined with Obeticholic acid.,decrease,no risk
Obeticholic acid,Nifedipine,The metabolism of Nifedipine can be decreased when combined with Obeticholic acid.,decrease,no risk
Obeticholic acid,Nimesulide,The risk or severity of adverse effects can be increased when Nimesulide is combined with Obeticholic acid.,increase,risk
Obeticholic acid,Nomegestrol acetate,The therapeutic efficacy of Obeticholic acid can be decreased when used in combination with Nomegestrol acetate.,decrease,no risk
Obeticholic acid,Norethisterone,The therapeutic efficacy of Obeticholic acid can be decreased when used in combination with Norethisterone.,decrease,no risk
Obeticholic acid,Norethynodrel,The therapeutic efficacy of Obeticholic acid can be decreased when used in combination with Norethynodrel.,decrease,no risk
Obeticholic acid,Norgestimate,The therapeutic efficacy of Obeticholic acid can be decreased when used in combination with Norgestimate.,decrease,no risk
Obeticholic acid,Norgestrel,The therapeutic efficacy of Obeticholic acid can be decreased when used in combination with Norgestrel.,decrease,no risk
Obeticholic acid,Olanzapine,The metabolism of Olanzapine can be decreased when combined with Obeticholic acid.,decrease,no risk
Obeticholic acid,Olmesartan,The risk or severity of adverse effects can be increased when Olmesartan is combined with Obeticholic acid.,increase,risk
Obeticholic acid,Ondansetron,The metabolism of Ondansetron can be decreased when combined with Obeticholic acid.,decrease,no risk
Obeticholic acid,Oxtriphylline,The metabolism of Oxtriphylline can be decreased when combined with Obeticholic acid.,decrease,no risk
Obeticholic acid,Quinidine,The risk or severity of adverse effects can be increased when Quinidine is combined with Obeticholic acid.,increase,risk
Obeticholic acid,Quinine,The metabolism of Quinine can be decreased when combined with Obeticholic acid.,decrease,no risk
Obeticholic acid,Urokinase,The risk or severity of bleeding and bruising can be increased when Urokinase is combined with Obeticholic acid.,increase,risk
Obeticholic acid,Ursodeoxycholic acid,The risk or severity of adverse effects can be increased when Ursodeoxycholic acid is combined with Obeticholic acid.,increase,risk
Obeticholic acid,Verapamil,The metabolism of Verapamil can be decreased when combined with Obeticholic acid.,decrease,no risk
Obeticholic acid,Vinblastine,The risk or severity of adverse effects can be increased when Vinblastine is combined with Obeticholic acid.,increase,risk
Obeticholic acid,Vorapaxar,The risk or severity of adverse effects can be increased when Vorapaxar is combined with Obeticholic acid.,increase,risk
Obeticholic acid,Voxilaprevir,The metabolism of Voxilaprevir can be decreased when combined with Obeticholic acid.,decrease,no risk
Obeticholic acid,Warfarin,The therapeutic efficacy of Warfarin can be decreased when used in combination with Obeticholic acid.,decrease,no risk
Obeticholic acid,Ximelagatran,The risk or severity of bleeding and bruising can be increased when Ximelagatran is combined with Obeticholic acid.,increase,risk
Obeticholic acid,Zileuton,The metabolism of Zileuton can be decreased when combined with Obeticholic acid.,decrease,no risk
Obeticholic acid,Zolmitriptan,The metabolism of Zolmitriptan can be decreased when combined with Obeticholic acid.,decrease,no risk
Obeticholic acid,Zolpidem,The metabolism of Zolpidem can be decreased when combined with Obeticholic acid.,decrease,no risk
Obeticholic acid,Zotepine,The metabolism of Zotepine can be decreased when combined with Obeticholic acid.,decrease,no risk
Ebselen,Gatifloxacin,The therapeutic efficacy of Furosemide can be decreased when used in combination with Ebselen.,decrease,no risk
Ebselen,Gemifloxacin,Ebselen may increase the neuroexcitatory activities of Gatifloxacin.,increase,no risk
Ebselen,Gentamicin,Ebselen may increase the neuroexcitatory activities of Gemifloxacin.,increase,no risk
Ebselen,Gliclazide,The risk or severity of nephrotoxicity can be increased when Ebselen is combined with Gentamicin.,increase,risk
Ebselen,Glimepiride,The protein binding of Gliclazide can be decreased when combined with Ebselen.,decrease,no risk
Ebselen,Glipizide,The protein binding of Glimepiride can be decreased when combined with Ebselen.,decrease,no risk
Ebselen,Gliquidone,The protein binding of Glipizide can be decreased when combined with Ebselen.,decrease,no risk
Ebselen,Glyburide,The protein binding of Gliquidone can be decreased when combined with Ebselen.,decrease,no risk
Ebselen,Glycol salicylate,The protein binding of Glyburide can be decreased when combined with Ebselen.,decrease,no risk
Ebselen,Grepafloxacin,The risk or severity of adverse effects can be increased when Glycol salicylate is combined with Ebselen.,increase,risk
Ebselen,Guanabenz,Ebselen may increase the neuroexcitatory activities of Grepafloxacin.,increase,no risk
Ebselen,Guanadrel,The therapeutic efficacy of Guanabenz can be decreased when used in combination with Ebselen.,decrease,no risk
Ebselen,Guanethidine,The therapeutic efficacy of Guanadrel can be decreased when used in combination with Ebselen.,decrease,no risk
Ebselen,Guanfacine,The therapeutic efficacy of Guanethidine can be decreased when used in combination with Ebselen.,decrease,no risk
Ebselen,Guanoxan,The therapeutic efficacy of Guanfacine can be decreased when used in combination with Ebselen.,decrease,no risk
Ebselen,Haloperidol,The therapeutic efficacy of Guanoxan can be decreased when used in combination with Ebselen.,decrease,no risk
Ebselen,Halothane,The therapeutic efficacy of Haloperidol can be increased when used in combination with Ebselen.,increase,no risk
Ebselen,Heparin,The risk or severity of hypertension can be increased when Halothane is combined with Ebselen.,increase,risk
Ebselen,Hydralazine,The risk or severity of bleeding and hemorrhage can be increased when Ebselen is combined with Heparin.,increase,risk
Ebselen,Hydrochlorothiazide,Ebselen may decrease the antihypertensive activities of Hydralazine.,decrease,no risk
Ebselen,Hydrocortisone,The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with Ebselen.,decrease,no risk
Ebselen,Hydrocortisone acetate,The risk or severity of gastrointestinal irritation can be increased when Hydrocortisone is combined with Ebselen.,increase,risk
Ebselen,Hydrocortisone butyrate,The risk or severity of gastrointestinal irritation can be increased when Hydrocortisone acetate is combined with Ebselen.,increase,risk
Ebselen,Hydrocortisone cypionate,The risk or severity of gastrointestinal irritation can be increased when Hydrocortisone butyrate is combined with Ebselen.,increase,risk
Ebselen,Hydrocortisone succinate,The risk or severity of gastrointestinal irritation can be increased when Hydrocortisone cypionate is combined with Ebselen.,increase,risk
Ebselen,Hydroflumethiazide,The risk or severity of gastrointestinal irritation can be increased when Hydrocortisone succinate is combined with Ebselen.,increase,risk
Ebselen,Kanamycin,The therapeutic efficacy of Isradipine can be decreased when used in combination with Ebselen.,decrease,no risk
Ebselen,Ketoprofen,The risk or severity of nephrotoxicity can be increased when Ebselen is combined with Kanamycin.,increase,risk
Ebselen,Ketorolac,The risk or severity of adverse effects can be increased when Ketoprofen is combined with Ebselen.,increase,risk
Sotatercept,Natalizumab,The risk or severity of adverse effects can be increased when Natalizumab is combined with Sotatercept.,increase,risk
Sotatercept,Necitumumab,The risk or severity of adverse effects can be increased when Necitumumab is combined with Sotatercept.,increase,risk
Sotatercept,Nivolumab,The risk or severity of adverse effects can be increased when Nivolumab is combined with Sotatercept.,increase,risk
Sotatercept,Obiltoxaximab,The risk or severity of adverse effects can be increased when Obiltoxaximab is combined with Sotatercept.,increase,risk
Sotatercept,Obinutuzumab,The risk or severity of adverse effects can be increased when Obinutuzumab is combined with Sotatercept.,increase,risk
Sotatercept,Ocrelizumab,The risk or severity of adverse effects can be increased when Ocrelizumab is combined with Sotatercept.,increase,risk
Sotatercept,Odesivimab,The risk or severity of adverse effects can be increased when Sotatercept is combined with Odesivimab.,increase,risk
Sotatercept,Ofatumumab,The risk or severity of adverse effects can be increased when Ofatumumab is combined with Sotatercept.,increase,risk
Sotatercept,Olaratumab,The risk or severity of adverse effects can be increased when Olaratumab is combined with Sotatercept.,increase,risk
Sotatercept,Omalizumab,The risk or severity of adverse effects can be increased when Omalizumab is combined with Sotatercept.,increase,risk
Sotatercept,Quinestrol,Quinestrol may increase the thrombogenic activities of Sotatercept.,increase,no risk
Sotatercept,Ublituximab,The risk or severity of adverse effects can be increased when Ublituximab is combined with Sotatercept.,increase,risk
Sotatercept,Ustekinumab,The risk or severity of adverse effects can be increased when Ustekinumab is combined with Sotatercept.,increase,risk
Sotatercept,Vedolizumab,The risk or severity of adverse effects can be increased when Vedolizumab is combined with Sotatercept.,increase,risk
Glembatumumab vedotin,Human varicella-zoster immune globulin,The risk or severity of adverse effects can be increased when Glembatumumab vedotin is combined with Human varicella-zoster immune globulin.,increase,risk
Glembatumumab vedotin,Natalizumab,The risk or severity of adverse effects can be increased when Natalizumab is combined with Glembatumumab vedotin.,increase,risk
Glembatumumab vedotin,Necitumumab,The risk or severity of adverse effects can be increased when Glembatumumab vedotin is combined with Necitumumab.,increase,risk
Glembatumumab vedotin,Nelarabine,The risk or severity of adverse effects can be increased when Nelarabine is combined with Glembatumumab vedotin.,increase,risk
Glembatumumab vedotin,Nivolumab,The risk or severity of adverse effects can be increased when Glembatumumab vedotin is combined with Nivolumab.,increase,risk
Glembatumumab vedotin,Obiltoxaximab,The risk or severity of adverse effects can be increased when Obiltoxaximab is combined with Glembatumumab vedotin.,increase,risk
Glembatumumab vedotin,Obinutuzumab,The risk or severity of adverse effects can be increased when Glembatumumab vedotin is combined with Obinutuzumab.,increase,risk
Glembatumumab vedotin,Ocrelizumab,The risk or severity of adverse effects can be increased when Glembatumumab vedotin is combined with Ocrelizumab.,increase,risk
Glembatumumab vedotin,Odesivimab,The risk or severity of adverse effects can be increased when Glembatumumab vedotin is combined with Odesivimab.,increase,risk
Glembatumumab vedotin,Ofatumumab,The risk or severity of adverse effects can be increased when Glembatumumab vedotin is combined with Ofatumumab.,increase,risk
Glembatumumab vedotin,Olaratumab,The risk or severity of adverse effects can be increased when Glembatumumab vedotin is combined with Olaratumab.,increase,risk
Glembatumumab vedotin,Omalizumab,The risk or severity of adverse effects can be increased when Omalizumab is combined with Glembatumumab vedotin.,increase,risk
Glembatumumab vedotin,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Glembatumumab vedotin is combined with Oxetacaine.,increase,risk
Glembatumumab vedotin,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Glembatumumab vedotin is combined with Oxybuprocaine.,increase,risk
Glembatumumab vedotin,Quinestrol,Quinestrol may increase the thrombogenic activities of Glembatumumab vedotin.,increase,no risk
Glembatumumab vedotin,Ublituximab,The risk or severity of adverse effects can be increased when Glembatumumab vedotin is combined with Ublituximab.,increase,risk
Glembatumumab vedotin,Ustekinumab,The risk or severity of adverse effects can be increased when Ustekinumab is combined with Glembatumumab vedotin.,increase,risk
Glembatumumab vedotin,Vedolizumab,The risk or severity of adverse effects can be increased when Glembatumumab vedotin is combined with Vedolizumab.,increase,risk
Tecovirimat,Gemfibrozil,The metabolism of Tecovirimat can be decreased when combined with Gemfibrozil.,decrease,no risk
Tecovirimat,Gestrinone,The metabolism of Gestrinone can be increased when combined with Tecovirimat.,increase,no risk
Tecovirimat,Gilteritinib,The metabolism of Gilteritinib can be increased when combined with Tecovirimat.,increase,no risk
Tecovirimat,Glasdegib,The metabolism of Glasdegib can be increased when combined with Tecovirimat.,increase,no risk
Tecovirimat,Gliclazide,The metabolism of Gliclazide can be decreased when combined with Tecovirimat.,decrease,no risk
Tecovirimat,Glyburide,The metabolism of Glyburide can be decreased when combined with Tecovirimat.,decrease,no risk
Tecovirimat,Halofantrine,The metabolism of Halofantrine can be increased when combined with Tecovirimat.,increase,no risk
Tecovirimat,Human adenovirus e serotype 4 strain cl-68578 antigen,The therapeutic efficacy of Human adenovirus e serotype 4 strain cl-68578 antigen can be decreased when used in combination with Tecovirimat.,decrease,no risk
Tecovirimat,Hydroxychloroquine,The metabolism of Hydroxychloroquine can be increased when combined with Tecovirimat.,increase,no risk
Tecovirimat,Hydroxyprogesterone caproate,The metabolism of Hydroxyprogesterone caproate can be increased when combined with Tecovirimat.,increase,no risk
Tecovirimat,Ketamine,The metabolism of Ketamine can be increased when combined with Tecovirimat.,increase,no risk
Tecovirimat,Ketorolac,The metabolism of Ketorolac can be increased when combined with Tecovirimat.,increase,no risk
Tecovirimat,Naproxen,The metabolism of Naproxen can be increased when combined with Tecovirimat.,increase,no risk
Tecovirimat,Nebivolol,The metabolism of Nebivolol can be decreased when combined with Tecovirimat.,decrease,no risk
Tecovirimat,Neratinib,The metabolism of Neratinib can be increased when combined with Tecovirimat.,increase,no risk
Tecovirimat,Netupitant,The metabolism of Netupitant can be increased when combined with Tecovirimat.,increase,no risk
Tecovirimat,Nicardipine,The metabolism of Nicardipine can be increased when combined with Tecovirimat.,increase,no risk
Tecovirimat,Nilotinib,The metabolism of Nilotinib can be increased when combined with Tecovirimat.,increase,no risk
Tecovirimat,Nilutamide,The metabolism of Nilutamide can be decreased when combined with Tecovirimat.,decrease,no risk
Tecovirimat,Nintedanib,The metabolism of Nintedanib can be increased when combined with Tecovirimat.,increase,no risk
Tecovirimat,Nirogacestat,The metabolism of Nirogacestat can be decreased when combined with Tecovirimat.,decrease,no risk
Tecovirimat,Nomegestrol,The metabolism of Nomegestrol can be increased when combined with Tecovirimat.,increase,no risk
Tecovirimat,Nomegestrol acetate,The metabolism of Nomegestrol acetate can be increased when combined with Tecovirimat.,increase,no risk
Tecovirimat,Norelgestromin,The metabolism of Norelgestromin can be increased when combined with Tecovirimat.,increase,no risk
Tecovirimat,Norethisterone,The metabolism of Norethisterone can be increased when combined with Tecovirimat.,increase,no risk
Tecovirimat,Norethynodrel,The metabolism of Norethynodrel can be increased when combined with Tecovirimat.,increase,no risk
Tecovirimat,Norgestimate,The metabolism of Norgestimate can be increased when combined with Tecovirimat.,increase,no risk
Tecovirimat,Norgestrel,The metabolism of Norgestrel can be increased when combined with Tecovirimat.,increase,no risk
Tecovirimat,Nortriptyline,The metabolism of Nortriptyline can be increased when combined with Tecovirimat.,increase,no risk
Tecovirimat,Olaparib,The metabolism of Olaparib can be increased when combined with Tecovirimat.,increase,no risk
Tecovirimat,Oliceridine,The serum concentration of Oliceridine can be decreased when it is combined with Tecovirimat.,decrease,no risk
Tecovirimat,Olodaterol,The metabolism of Olodaterol can be increased when combined with Tecovirimat.,increase,no risk
Tecovirimat,Ombitasvir,The metabolism of Ombitasvir can be increased when combined with Tecovirimat.,increase,no risk
Tecovirimat,Omeprazole,The metabolism of Omeprazole can be decreased when combined with Tecovirimat.,decrease,no risk
Tecovirimat,Osimertinib,The metabolism of Osimertinib can be increased when combined with Tecovirimat.,increase,no risk
Tecovirimat,Ozanimod,The metabolism of Ozanimod can be increased when combined with Tecovirimat.,increase,no risk
Tecovirimat,Quinidine,The metabolism of Quinidine can be increased when combined with Tecovirimat.,increase,no risk
Tecovirimat,Quinine,The metabolism of Quinine can be decreased when combined with Tecovirimat.,decrease,no risk
Tecovirimat,Ubrogepant,The serum concentration of Ubrogepant can be decreased when it is combined with Tecovirimat.,decrease,no risk
Tecovirimat,Ulipristal,The metabolism of Ulipristal can be increased when combined with Tecovirimat.,increase,no risk
Tecovirimat,Valproic acid,The metabolism of Valproic acid can be decreased when combined with Tecovirimat.,decrease,no risk
Tecovirimat,Vandetanib,The metabolism of Vandetanib can be increased when combined with Tecovirimat.,increase,no risk
Tecovirimat,Varicella zoster vaccine (live/attenuated),The therapeutic efficacy of Varicella zoster vaccine (live/attenuated) can be decreased when used in combination with Tecovirimat.,decrease,no risk
Tecovirimat,Velpatasvir,The metabolism of Velpatasvir can be increased when combined with Tecovirimat.,increase,no risk
Tecovirimat,Vemurafenib,The metabolism of Vemurafenib can be increased when combined with Tecovirimat.,increase,no risk
Tecovirimat,Venetoclax,The metabolism of Venetoclax can be increased when combined with Tecovirimat.,increase,no risk
Tecovirimat,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Tecovirimat.,decrease,no risk
Tecovirimat,Vilazodone,The metabolism of Vilazodone can be decreased when combined with Tecovirimat.,decrease,no risk
Tecovirimat,Vinblastine,The metabolism of Vinblastine can be increased when combined with Tecovirimat.,increase,no risk
Tecovirimat,Vincristine,The metabolism of Vincristine can be increased when combined with Tecovirimat.,increase,no risk
Tecovirimat,Vindesine,The metabolism of Vindesine can be increased when combined with Tecovirimat.,increase,no risk
Tecovirimat,Vinflunine,The metabolism of Vinflunine can be increased when combined with Tecovirimat.,increase,no risk
Tecovirimat,Vinorelbine,The metabolism of Vinorelbine can be increased when combined with Tecovirimat.,increase,no risk
Tecovirimat,Vorapaxar,The metabolism of Vorapaxar can be increased when combined with Tecovirimat.,increase,no risk
Tecovirimat,Voriconazole,The metabolism of Voriconazole can be decreased when combined with Tecovirimat.,decrease,no risk
Tecovirimat,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Tecovirimat.,decrease,no risk
Tecovirimat,Voxelotor,The metabolism of Voxelotor can be decreased when combined with Tecovirimat.,decrease,no risk
Tecovirimat,Voxilaprevir,The metabolism of Voxilaprevir can be increased when combined with Tecovirimat.,increase,no risk
Tecovirimat,Warfarin,The metabolism of Warfarin can be increased when combined with Tecovirimat.,increase,no risk
Tecovirimat,Yellow fever vaccine,The therapeutic efficacy of Yellow fever vaccine can be decreased when used in combination with Tecovirimat.,decrease,no risk
Tecovirimat,Zanubrutinib,The metabolism of Zanubrutinib can be increased when combined with Tecovirimat.,increase,no risk
Tecovirimat,Zidovudine,The metabolism of Zidovudine can be increased when combined with Tecovirimat.,increase,no risk
Tecovirimat,Ziprasidone,The metabolism of Ziprasidone can be increased when combined with Tecovirimat.,increase,no risk
Tecovirimat,Zolpidem,The metabolism of Zolpidem can be decreased when combined with Tecovirimat.,decrease,no risk
Tecovirimat,Zonisamide,The metabolism of Zonisamide can be decreased when combined with Tecovirimat.,decrease,no risk
Tecovirimat,Zopiclone,The metabolism of Zopiclone can be increased when combined with Tecovirimat.,increase,no risk
Tecovirimat,Zuclopenthixol,The metabolism of Zuclopenthixol can be increased when combined with Tecovirimat.,increase,no risk
Tecovirimat,Zuranolone,The serum concentration of Zuranolone can be decreased when it is combined with Tecovirimat.,decrease,no risk
AMG-222,Gatifloxacin,The therapeutic efficacy of AMG-222 can be increased when used in combination with Gatifloxacin.,increase,no risk
AMG-222,Gefapixant,The therapeutic efficacy of AMG-222 can be increased when used in combination with Gefapixant.,increase,no risk
AMG-222,Gemifloxacin,The therapeutic efficacy of AMG-222 can be increased when used in combination with Gemifloxacin.,increase,no risk
AMG-222,Gliclazide,AMG-222 may increase the hypoglycemic activities of Gliclazide.,increase,no risk
AMG-222,Glimepiride,AMG-222 may increase the hypoglycemic activities of Glimepiride.,increase,no risk
AMG-222,Glipizide,AMG-222 may increase the hypoglycemic activities of Glipizide.,increase,no risk
AMG-222,Gliquidone,AMG-222 may increase the hypoglycemic activities of Gliquidone.,increase,no risk
AMG-222,Glyburide,AMG-222 may increase the hypoglycemic activities of Glyburide.,increase,no risk
AMG-222,Glymidine,The therapeutic efficacy of AMG-222 can be increased when used in combination with Glymidine.,increase,no risk
AMG-222,Goserelin,The therapeutic efficacy of AMG-222 can be decreased when used in combination with Goserelin.,decrease,no risk
AMG-222,Grepafloxacin,The therapeutic efficacy of AMG-222 can be increased when used in combination with Grepafloxacin.,increase,no risk
AMG-222,Halcinonide,The risk or severity of hyperglycemia can be increased when Halcinonide is combined with AMG-222.,increase,risk
AMG-222,Haloperidol,The therapeutic efficacy of AMG-222 can be decreased when used in combination with Haloperidol.,decrease,no risk
AMG-222,Histrelin,The therapeutic efficacy of AMG-222 can be decreased when used in combination with Histrelin.,decrease,no risk
AMG-222,Hydrochlorothiazide,The therapeutic efficacy of AMG-222 can be decreased when used in combination with Hydrochlorothiazide.,decrease,no risk
AMG-222,Hydrocortisone,The risk or severity of hyperglycemia can be increased when Hydrocortisone is combined with AMG-222.,increase,risk
AMG-222,Hydrocortisone acetate,The risk or severity of hyperglycemia can be increased when Hydrocortisone acetate is combined with AMG-222.,increase,risk
AMG-222,Hydrocortisone butyrate,The risk or severity of hyperglycemia can be increased when Hydrocortisone butyrate is combined with AMG-222.,increase,risk
AMG-222,Hydrocortisone cypionate,The risk or severity of hyperglycemia can be increased when Hydrocortisone cypionate is combined with AMG-222.,increase,risk
AMG-222,Hydrocortisone probutate,The risk or severity of hyperglycemia can be increased when Hydrocortisone probutate is combined with AMG-222.,increase,risk
AMG-222,Hydrocortisone succinate,The risk or severity of hyperglycemia can be increased when Hydrocortisone succinate is combined with AMG-222.,increase,risk
AMG-222,Hydrocortisone valerate,The risk or severity of hyperglycemia can be increased when Hydrocortisone valerate is combined with AMG-222.,increase,risk
AMG-222,Hydroflumethiazide,The therapeutic efficacy of AMG-222 can be decreased when used in combination with Hydroflumethiazide.,decrease,no risk
AMG-222,Hydroxychloroquine,The therapeutic efficacy of AMG-222 can be increased when used in combination with Hydroxychloroquine.,increase,no risk
AMG-222,Hydroxyprogesterone caproate,The therapeutic efficacy of AMG-222 can be decreased when used in combination with Hydroxyprogesterone caproate.,decrease,no risk
AMG-222,Nadolol,The therapeutic efficacy of AMG-222 can be increased when used in combination with Nadolol.,increase,no risk
AMG-222,Nalidixic acid,The therapeutic efficacy of AMG-222 can be increased when used in combination with Nalidixic acid.,increase,no risk
AMG-222,Nandrolone decanoate,Nandrolone decanoate may increase the hypoglycemic activities of AMG-222.,increase,no risk
AMG-222,Nandrolone phenpropionate,Nandrolone phenpropionate may increase the hypoglycemic activities of AMG-222.,increase,no risk
AMG-222,Nateglinide,The risk or severity of hypoglycemia can be increased when Nateglinide is combined with AMG-222.,increase,risk
AMG-222,Nebivolol,The therapeutic efficacy of AMG-222 can be increased when used in combination with Nebivolol.,increase,no risk
AMG-222,Nefazodone,The risk or severity of hypoglycemia can be increased when Nefazodone is combined with AMG-222.,increase,risk
AMG-222,Nelfinavir,The therapeutic efficacy of AMG-222 can be decreased when used in combination with Nelfinavir.,decrease,no risk
AMG-222,Niacin,The therapeutic efficacy of AMG-222 can be decreased when used in combination with Niacin.,decrease,no risk
AMG-222,Nialamide,Nialamide may increase the hypoglycemic activities of AMG-222.,increase,no risk
AMG-222,Nicardipine,The risk or severity of hypoglycemia can be increased when Nicardipine is combined with AMG-222.,increase,risk
AMG-222,Nifedipine,The risk or severity of hypoglycemia can be increased when Nifedipine is combined with AMG-222.,increase,risk
AMG-222,Nilotinib,The therapeutic efficacy of AMG-222 can be decreased when used in combination with Nilotinib.,decrease,no risk
AMG-222,Nilvadipine,The risk or severity of hypoglycemia can be increased when Nilvadipine is combined with AMG-222.,increase,risk
AMG-222,Nimesulide,The risk or severity of hypoglycemia can be increased when Nimesulide is combined with AMG-222.,increase,risk
AMG-222,Nimodipine,The risk or severity of hypoglycemia can be increased when Nimodipine is combined with AMG-222.,increase,risk
AMG-222,Nisoldipine,The risk or severity of hypoglycemia can be increased when Nisoldipine is combined with AMG-222.,increase,risk
AMG-222,Nitrendipine,The risk or severity of hypoglycemia can be increased when Nitrendipine is combined with AMG-222.,increase,risk
AMG-222,Norethisterone,The therapeutic efficacy of AMG-222 can be decreased when used in combination with Norethisterone.,decrease,no risk
AMG-222,Norfloxacin,The therapeutic efficacy of AMG-222 can be increased when used in combination with Norfloxacin.,increase,no risk
AMG-222,Norgestimate,The therapeutic efficacy of AMG-222 can be decreased when used in combination with Norgestimate.,decrease,no risk
AMG-222,Nortriptyline,Nortriptyline may decrease the hypoglycemic activities of AMG-222.,decrease,no risk
AMG-222,Nylidrin,The risk or severity of hypoglycemia can be increased when Nylidrin is combined with AMG-222.,increase,risk
AMG-222,Octreotide,The therapeutic efficacy of AMG-222 can be decreased when used in combination with Octreotide.,decrease,no risk
AMG-222,Ofloxacin,The therapeutic efficacy of AMG-222 can be increased when used in combination with Ofloxacin.,increase,no risk
AMG-222,Olanzapine,The therapeutic efficacy of AMG-222 can be decreased when used in combination with Olanzapine.,decrease,no risk
AMG-222,Olsalazine,Olsalazine may increase the hypoglycemic activities of AMG-222.,increase,no risk
AMG-222,Oxandrolone,Oxandrolone may increase the hypoglycemic activities of AMG-222.,increase,no risk
AMG-222,Oxprenolol,The therapeutic efficacy of AMG-222 can be increased when used in combination with Oxprenolol.,increase,no risk
AMG-222,Oxymetholone,Oxymetholone may increase the hypoglycemic activities of AMG-222.,increase,no risk
AMG-222,Quetiapine,The therapeutic efficacy of AMG-222 can be decreased when used in combination with Quetiapine.,decrease,no risk
AMG-222,Quinapril,The risk or severity of angioedema can be increased when AMG-222 is combined with Quinapril.,increase,risk
AMG-222,Quinethazone,The therapeutic efficacy of AMG-222 can be decreased when used in combination with Quinethazone.,decrease,no risk
AMG-222,Quinine,The risk or severity of hypoglycemia can be increased when Quinine is combined with AMG-222.,increase,risk
AMG-222,Quinupramine,Quinupramine may decrease the hypoglycemic activities of AMG-222.,decrease,no risk
AMG-222,Ubidecarenone,The risk or severity of hypoglycemia can be increased when Ubidecarenone is combined with AMG-222.,increase,risk
AMG-222,Udenafil,The therapeutic efficacy of AMG-222 can be increased when used in combination with Udenafil.,increase,no risk
AMG-222,Ulobetasol,The risk or severity of hyperglycemia can be increased when Ulobetasol is combined with AMG-222.,increase,risk
AMG-222,Urokinase,The risk or severity of angioedema can be increased when Urokinase is combined with AMG-222.,increase,risk
AMG-222,Valdecoxib,The therapeutic efficacy of AMG-222 can be increased when used in combination with Valdecoxib.,increase,no risk
AMG-222,Valsartan,The risk or severity of angioedema can be increased when Valsartan is combined with AMG-222.,increase,risk
AMG-222,Vamorolone,The risk or severity of hyperglycemia can be increased when Vamorolone is combined with AMG-222.,increase,risk
AMG-222,Vemurafenib,The therapeutic efficacy of AMG-222 can be increased when used in combination with Vemurafenib.,increase,no risk
AMG-222,Venlafaxine,The risk or severity of hypoglycemia can be increased when Venlafaxine is combined with AMG-222.,increase,risk
AMG-222,Verapamil,The risk or severity of hypoglycemia can be increased when Verapamil is combined with AMG-222.,increase,risk
AMG-222,Vildagliptin,The risk or severity of angioedema can be increased when Vildagliptin is combined with AMG-222.,increase,risk
AMG-222,Vorinostat,The therapeutic efficacy of AMG-222 can be decreased when used in combination with Vorinostat.,decrease,no risk
AMG-222,Xylometazoline,The risk or severity of hypoglycemia can be increased when Xylometazoline is combined with AMG-222.,increase,risk
AMG-222,Ziconotide,The risk or severity of hypoglycemia can be increased when Ziconotide is combined with AMG-222.,increase,risk
AMG-222,Zimelidine,The risk or severity of hypoglycemia can be increased when Zimelidine is combined with AMG-222.,increase,risk
AMG-222,Ziprasidone,The therapeutic efficacy of AMG-222 can be decreased when used in combination with Ziprasidone.,decrease,no risk
AMG-222,Zofenopril,The risk or severity of angioedema can be increased when AMG-222 is combined with Zofenopril.,increase,risk
AMG-222,Zonisamide,The therapeutic efficacy of AMG-222 can be increased when used in combination with Zonisamide.,increase,no risk
Aldoxorubicin,Benzocaine,The risk or severity of methemoglobinemia can be increased when Aldoxorubicin is combined with Benzocaine.,increase,risk
Aldoxorubicin,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Aldoxorubicin is combined with Benzyl alcohol.,increase,risk
Aldoxorubicin,Bevacizumab,The risk or severity of cardiotoxicity can be increased when Bevacizumab is combined with Aldoxorubicin.,increase,risk
Aldoxorubicin,Bleomycin,The risk or severity of cardiotoxicity can be increased when Bleomycin is combined with Aldoxorubicin.,increase,risk
Aldoxorubicin,Bortezomib,The risk or severity of cardiotoxicity can be increased when Bortezomib is combined with Aldoxorubicin.,increase,risk
Aldoxorubicin,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Aldoxorubicin is combined with Bupivacaine.,increase,risk
Aldoxorubicin,Busulfan,The risk or severity of cardiotoxicity can be increased when Busulfan is combined with Aldoxorubicin.,increase,risk
Aldoxorubicin,Butacaine,The risk or severity of methemoglobinemia can be increased when Aldoxorubicin is combined with Butacaine.,increase,risk
Aldoxorubicin,Butamben,The risk or severity of methemoglobinemia can be increased when Aldoxorubicin is combined with Butamben.,increase,risk
Aldoxorubicin,Nelarabine,The risk or severity of adverse effects can be increased when Nelarabine is combined with Aldoxorubicin.,increase,risk
Aldoxorubicin,Ouabain,Ouabain may decrease the cardiotoxic activities of Aldoxorubicin.,decrease,no risk
Aldoxorubicin,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Aldoxorubicin is combined with Oxetacaine.,increase,risk
Aldoxorubicin,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Aldoxorubicin is combined with Oxybuprocaine.,increase,risk
Aldoxorubicin,Vinblastine,The risk or severity of cardiotoxicity can be increased when Vinblastine is combined with Aldoxorubicin.,increase,risk
Aldoxorubicin,Vincristine,The risk or severity of cardiotoxicity can be increased when Vincristine is combined with Aldoxorubicin.,increase,risk
Aldoxorubicin,Vindesine,The risk or severity of cardiotoxicity can be increased when Vindesine is combined with Aldoxorubicin.,increase,risk
Aldoxorubicin,Vinorelbine,The risk or severity of cardiotoxicity can be increased when Vinorelbine is combined with Aldoxorubicin.,increase,risk
Cariprazine,Gabapentin,The risk or severity of CNS depression can be increased when Gabapentin is combined with Cariprazine.,increase,risk
Cariprazine,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Cariprazine is combined with Gabapentin enacarbil.,increase,risk
Cariprazine,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with Cariprazine.,increase,risk
Cariprazine,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Cariprazine is combined with Ganaxolone.",increase,risk
Cariprazine,Gepirone,The risk or severity of serotonin syndrome can be increased when Gepirone is combined with Cariprazine.,increase,risk
Cariprazine,Gilteritinib,The therapeutic efficacy of Cariprazine can be decreased when used in combination with Gilteritinib.,decrease,no risk
Cariprazine,Glofitamab,The serum concentration of Cariprazine can be increased when it is combined with Glofitamab.,increase,no risk
Cariprazine,Glutethimide,The risk or severity of CNS depression can be increased when Glutethimide is combined with Cariprazine.,increase,risk
Cariprazine,Granisetron,The risk or severity of CNS depression can be increased when Granisetron is combined with Cariprazine.,increase,risk
Cariprazine,Guanabenz,Cariprazine may decrease the antihypertensive activities of Guanabenz.,decrease,no risk
Cariprazine,Guanadrel,Cariprazine may decrease the antihypertensive activities of Guanadrel.,decrease,no risk
Cariprazine,Guanethidine,Cariprazine may decrease the antihypertensive activities of Guanethidine.,decrease,no risk
Cariprazine,Guanfacine,The risk or severity of CNS depression can be increased when Guanfacine is combined with Cariprazine.,increase,risk
Cariprazine,Guanoxan,Cariprazine may decrease the antihypertensive activities of Guanoxan.,decrease,no risk
Cariprazine,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with Cariprazine.,increase,risk
Cariprazine,Haloperidol,The metabolism of Cariprazine can be decreased when combined with Haloperidol.,decrease,no risk
Cariprazine,Halothane,The risk or severity of CNS depression can be increased when Halothane is combined with Cariprazine.,increase,risk
Cariprazine,Hexafluronium,The risk or severity of CNS depression can be increased when Hexafluronium is combined with Cariprazine.,increase,risk
Cariprazine,Hydralazine,Cariprazine may decrease the antihypertensive activities of Hydralazine.,decrease,no risk
Cariprazine,Hydrochlorothiazide,Cariprazine may decrease the antihypertensive activities of Hydrochlorothiazide.,decrease,no risk
Cariprazine,Hydrocodone,Cariprazine may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Cariprazine,Hydroflumethiazide,Cariprazine may decrease the antihypertensive activities of Hydroflumethiazide.,decrease,no risk
Cariprazine,Hydromorphone,The risk or severity of CNS depression can be increased when Hydromorphone is combined with Cariprazine.,increase,risk
Cariprazine,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Cariprazine.,increase,no risk
Cariprazine,Ketamine,The risk or severity of CNS depression can be increased when Ketamine is combined with Cariprazine.,increase,risk
Cariprazine,Ketazolam,The risk or severity of CNS depression can be increased when Ketazolam is combined with Cariprazine.,increase,risk
Cariprazine,Ketoconazole,The metabolism of Cariprazine can be decreased when combined with Ketoconazole.,decrease,no risk
Cariprazine,Ketoprofen,The risk or severity of hypertension can be increased when Ketoprofen is combined with Cariprazine.,increase,risk
Cariprazine,Ketorolac,The risk or severity of hypertension can be increased when Ketorolac is combined with Cariprazine.,increase,risk
AV-412,Benzocaine,The risk or severity of methemoglobinemia can be increased when AV-412 is combined with Benzocaine.,increase,risk
AV-412,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when AV-412 is combined with Benzyl alcohol.,increase,risk
AV-412,Bupivacaine,The risk or severity of methemoglobinemia can be increased when AV-412 is combined with Bupivacaine.,increase,risk
AV-412,Butacaine,The risk or severity of methemoglobinemia can be increased when AV-412 is combined with Butacaine.,increase,risk
AV-412,Butamben,The risk or severity of methemoglobinemia can be increased when AV-412 is combined with Butamben.,increase,risk
AV-412,Nelarabine,The risk or severity of adverse effects can be increased when Nelarabine is combined with AV-412.,increase,risk
AV-412,Oxetacaine,The risk or severity of methemoglobinemia can be increased when AV-412 is combined with Oxetacaine.,increase,risk
AV-412,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when AV-412 is combined with Oxybuprocaine.,increase,risk
GlycoPEG-GCSF,Nonacog beta pegol,The therapeutic efficacy of Nonacog beta pegol can be decreased when used in combination with GlycoPEG-GCSF.,decrease,no risk
Benralizumab,Natalizumab,The risk or severity of adverse effects can be increased when Natalizumab is combined with Benralizumab.,increase,risk
Benralizumab,Necitumumab,The risk or severity of adverse effects can be increased when Necitumumab is combined with Benralizumab.,increase,risk
Benralizumab,Nivolumab,The risk or severity of adverse effects can be increased when Nivolumab is combined with Benralizumab.,increase,risk
Benralizumab,Obiltoxaximab,The risk or severity of adverse effects can be increased when Obiltoxaximab is combined with Benralizumab.,increase,risk
Benralizumab,Obinutuzumab,The risk or severity of adverse effects can be increased when Obinutuzumab is combined with Benralizumab.,increase,risk
Benralizumab,Ocrelizumab,The risk or severity of adverse effects can be increased when Ocrelizumab is combined with Benralizumab.,increase,risk
Benralizumab,Odesivimab,The risk or severity of adverse effects can be increased when Benralizumab is combined with Odesivimab.,increase,risk
Benralizumab,Ofatumumab,The risk or severity of adverse effects can be increased when Ofatumumab is combined with Benralizumab.,increase,risk
Benralizumab,Olaratumab,The risk or severity of adverse effects can be increased when Olaratumab is combined with Benralizumab.,increase,risk
Benralizumab,Omalizumab,The risk or severity of adverse effects can be increased when Omalizumab is combined with Benralizumab.,increase,risk
Benralizumab,Quinestrol,Quinestrol may increase the thrombogenic activities of Benralizumab.,increase,no risk
Benralizumab,Ublituximab,The risk or severity of adverse effects can be increased when Ublituximab is combined with Benralizumab.,increase,risk
Benralizumab,Ustekinumab,The risk or severity of adverse effects can be increased when Ustekinumab is combined with Benralizumab.,increase,risk
Benralizumab,Vedolizumab,The risk or severity of adverse effects can be increased when Vedolizumab is combined with Benralizumab.,increase,risk
Brentuximab vedotin,Boceprevir,The metabolism of Brentuximab vedotin can be decreased when combined with Boceprevir.,decrease,no risk
Brentuximab vedotin,"Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated)","The therapeutic efficacy of Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated) can be decreased when used in combination with Brentuximab vedotin.",decrease,no risk
Brentuximab vedotin,Bortezomib,The serum concentration of Bortezomib can be increased when it is combined with Brentuximab vedotin.,increase,no risk
Brentuximab vedotin,Bosentan,The metabolism of Brentuximab vedotin can be increased when combined with Bosentan.,increase,no risk
Brentuximab vedotin,Bosutinib,The metabolism of Brentuximab vedotin can be decreased when combined with Bosutinib.,decrease,no risk
Brentuximab vedotin,Brigatinib,The serum concentration of Brigatinib can be increased when it is combined with Brentuximab vedotin.,increase,no risk
Brentuximab vedotin,Brodalumab,The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Brodalumab.,increase,risk
Brentuximab vedotin,Brolucizumab,The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Brolucizumab.,increase,risk
Brentuximab vedotin,Budesonide,The metabolism of Brentuximab vedotin can be increased when combined with Budesonide.,increase,no risk
Brentuximab vedotin,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Brentuximab vedotin is combined with Bupivacaine.,increase,risk
Brentuximab vedotin,Buprenorphine,The metabolism of Brentuximab vedotin can be decreased when combined with Buprenorphine.,decrease,no risk
Brentuximab vedotin,Burosumab,The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Burosumab.,increase,risk
Brentuximab vedotin,Busulfan,The serum concentration of Busulfan can be increased when it is combined with Brentuximab vedotin.,increase,no risk
Brentuximab vedotin,Butacaine,The risk or severity of methemoglobinemia can be increased when Brentuximab vedotin is combined with Butacaine.,increase,risk
Brentuximab vedotin,Butalbital,The metabolism of Brentuximab vedotin can be increased when combined with Butalbital.,increase,no risk
Brentuximab vedotin,Butamben,The risk or severity of methemoglobinemia can be increased when Brentuximab vedotin is combined with Butamben.,increase,risk
Brentuximab vedotin,Galcanezumab,The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Galcanezumab.,increase,risk
Brentuximab vedotin,Gemcitabine,The risk or severity of adverse effects can be increased when Gemcitabine is combined with Brentuximab vedotin.,increase,risk
Brentuximab vedotin,Gemtuzumab ozogamicin,The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Brentuximab vedotin.,increase,risk
Brentuximab vedotin,Gepirone,The serum concentration of Gepirone can be increased when it is combined with Brentuximab vedotin.,increase,no risk
Brentuximab vedotin,Gilteritinib,The metabolism of Brentuximab vedotin can be decreased when combined with Gilteritinib.,decrease,no risk
Brentuximab vedotin,Ginkgo biloba,The metabolism of Brentuximab vedotin can be decreased when combined with Ginkgo biloba.,decrease,no risk
Brentuximab vedotin,Glasdegib,The serum concentration of Brentuximab vedotin can be increased when it is combined with Glasdegib.,increase,no risk
Brentuximab vedotin,Glatiramer,The risk or severity of adverse effects can be increased when Glatiramer is combined with Brentuximab vedotin.,increase,risk
Brentuximab vedotin,Glecaprevir,The serum concentration of Brentuximab vedotin can be increased when it is combined with Glecaprevir.,increase,no risk
Brentuximab vedotin,Glofitamab,The serum concentration of Brentuximab vedotin can be increased when it is combined with Glofitamab.,increase,no risk
Brentuximab vedotin,Glyburide,The metabolism of Brentuximab vedotin can be decreased when combined with Glyburide.,decrease,no risk
Brentuximab vedotin,Glycerol phenylbutyrate,The metabolism of Brentuximab vedotin can be increased when combined with Glycerol phenylbutyrate.,increase,no risk
Brentuximab vedotin,Golimumab,The metabolism of Brentuximab vedotin can be increased when combined with Golimumab.,increase,no risk
Brentuximab vedotin,Grapefruit,The serum concentration of Brentuximab vedotin can be increased when it is combined with Grapefruit.,increase,no risk
Brentuximab vedotin,Grazoprevir,The serum concentration of Brentuximab vedotin can be increased when it is combined with Grazoprevir.,increase,no risk
Brentuximab vedotin,Griseofulvin,The metabolism of Brentuximab vedotin can be increased when combined with Griseofulvin.,increase,no risk
Brentuximab vedotin,Guselkumab,The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Guselkumab.,increase,risk
Brentuximab vedotin,Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Brentuximab vedotin.,decrease,no risk
Brentuximab vedotin,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Brentuximab vedotin.,increase,no risk
Brentuximab vedotin,Hepatitis A Vaccine,The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Brentuximab vedotin.,decrease,no risk
Brentuximab vedotin,Hepatitis B immune globulin,The risk or severity of adverse effects can be increased when Hepatitis B immune globulin is combined with Brentuximab vedotin.,increase,risk
Brentuximab vedotin,Hepatitis B Vaccine (Recombinant),The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Brentuximab vedotin.,decrease,no risk
Brentuximab vedotin,Human adenovirus e serotype 4 strain cl-68578 antigen,The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Brentuximab vedotin.,increase,risk
Brentuximab vedotin,Human cytomegalovirus immune globulin,The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Human cytomegalovirus immune globulin.,increase,risk
Brentuximab vedotin,Human immunoglobulin G,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Brentuximab vedotin.,increase,risk
Brentuximab vedotin,Human Rho(D) immune globulin,The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Human Rho(D) immune globulin.,increase,risk
Brentuximab vedotin,Human varicella-zoster immune globulin,The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Human varicella-zoster immune globulin.,increase,risk
Brentuximab vedotin,Hydralazine,The serum concentration of Brentuximab vedotin can be increased when it is combined with Hydralazine.,increase,no risk
Brentuximab vedotin,Hydrocortamate,The metabolism of Brentuximab vedotin can be increased when combined with Hydrocortamate.,increase,no risk
Brentuximab vedotin,Hydrocortisone,The metabolism of Brentuximab vedotin can be increased when combined with Hydrocortisone.,increase,no risk
Brentuximab vedotin,Hydrocortisone acetate,The metabolism of Brentuximab vedotin can be increased when combined with Hydrocortisone acetate.,increase,no risk
Brentuximab vedotin,Hydrocortisone butyrate,The metabolism of Brentuximab vedotin can be increased when combined with Hydrocortisone butyrate.,increase,no risk
Brentuximab vedotin,Hydrocortisone succinate,The metabolism of Brentuximab vedotin can be increased when combined with Hydrocortisone succinate.,increase,no risk
Brentuximab vedotin,Hydroxychloroquine,The risk or severity of adverse effects can be increased when Hydroxychloroquine is combined with Brentuximab vedotin.,increase,risk
Brentuximab vedotin,Hydroxyurea,The risk or severity of adverse effects can be increased when Hydroxyurea is combined with Brentuximab vedotin.,increase,risk
Brentuximab vedotin,Janssen COVID-19 Vaccine,The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Brentuximab vedotin.,decrease,no risk
Brentuximab vedotin,Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated),The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Brentuximab vedotin.,decrease,no risk
Brentuximab vedotin,Ketazolam,The serum concentration of Brentuximab vedotin can be increased when it is combined with Ketazolam.,increase,no risk
Brentuximab vedotin,Ketoconazole,The serum concentration of Brentuximab vedotin can be increased when it is combined with Ketoconazole.,increase,no risk
Brentuximab vedotin,Nafcillin,The metabolism of Brentuximab vedotin can be increased when combined with Nafcillin.,increase,no risk
Brentuximab vedotin,Natalizumab,The risk or severity of immunosuppression can be increased when Brentuximab vedotin is combined with Natalizumab.,increase,risk
Brentuximab vedotin,Necitumumab,The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Necitumumab.,increase,risk
Brentuximab vedotin,Nefazodone,The metabolism of Brentuximab vedotin can be decreased when combined with Nefazodone.,decrease,no risk
Brentuximab vedotin,Nelarabine,The risk or severity of adverse effects can be increased when Nelarabine is combined with Brentuximab vedotin.,increase,risk
Brentuximab vedotin,Nelfinavir,The metabolism of Brentuximab vedotin can be decreased when combined with Nelfinavir.,decrease,no risk
Brentuximab vedotin,Neratinib,The serum concentration of Brentuximab vedotin can be increased when it is combined with Neratinib.,increase,no risk
Brentuximab vedotin,Netupitant,The serum concentration of Brentuximab vedotin can be increased when it is combined with Netupitant.,increase,no risk
Brentuximab vedotin,Niacin,The serum concentration of Brentuximab vedotin can be increased when it is combined with Niacin.,increase,no risk
Brentuximab vedotin,Nicardipine,The metabolism of Brentuximab vedotin can be decreased when combined with Nicardipine.,decrease,no risk
Brentuximab vedotin,Nilotinib,The serum concentration of Brentuximab vedotin can be increased when it is combined with Nilotinib.,increase,no risk
Brentuximab vedotin,Nilvadipine,The metabolism of Brentuximab vedotin can be decreased when combined with Nilvadipine.,decrease,no risk
Brentuximab vedotin,Nintedanib,The metabolism of Brentuximab vedotin can be decreased when combined with Nintedanib.,decrease,no risk
Brentuximab vedotin,Nirogacestat,The serum concentration of Brentuximab vedotin can be increased when it is combined with Nirogacestat.,increase,no risk
Brentuximab vedotin,Nivolumab,The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Nivolumab.,increase,risk
Brentuximab vedotin,Norethisterone,The metabolism of Brentuximab vedotin can be decreased when combined with Norethisterone.,decrease,no risk
Brentuximab vedotin,Norgestimate,The serum concentration of Brentuximab vedotin can be increased when it is combined with Norgestimate.,increase,no risk
Brentuximab vedotin,Nortriptyline,The serum concentration of Nortriptyline can be increased when it is combined with Brentuximab vedotin.,increase,no risk
Brentuximab vedotin,Noscapine,The serum concentration of Brentuximab vedotin can be increased when it is combined with Noscapine.,increase,no risk
Brentuximab vedotin,Nuvaxovid,The therapeutic efficacy of Nuvaxovid can be decreased when used in combination with Brentuximab vedotin.,decrease,no risk
Brentuximab vedotin,Obiltoxaximab,The risk or severity of adverse effects can be increased when Obiltoxaximab is combined with Brentuximab vedotin.,increase,risk
Brentuximab vedotin,Obinutuzumab,The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Obinutuzumab.,increase,risk
Brentuximab vedotin,Ocrelizumab,Ocrelizumab may increase the immunosuppressive activities of Brentuximab vedotin.,increase,no risk
Brentuximab vedotin,Octreotide,The serum concentration of Brentuximab vedotin can be increased when it is combined with Octreotide.,increase,no risk
Brentuximab vedotin,Odesivimab,The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Odesivimab.,increase,risk
Brentuximab vedotin,Ofatumumab,The risk or severity of adverse effects can be increased when Ofatumumab is combined with Brentuximab vedotin.,increase,risk
Brentuximab vedotin,Olaparib,The metabolism of Brentuximab vedotin can be decreased when combined with Olaparib.,decrease,no risk
Brentuximab vedotin,Olaratumab,The risk or severity of adverse effects can be increased when Olaratumab is combined with Brentuximab vedotin.,increase,risk
Brentuximab vedotin,Olutasidenib,The metabolism of Brentuximab vedotin can be increased when combined with Olutasidenib.,increase,no risk
Brentuximab vedotin,Omadacycline,The serum concentration of Brentuximab vedotin can be increased when it is combined with Omadacycline.,increase,no risk
Brentuximab vedotin,Omalizumab,The risk or severity of adverse effects can be increased when Omalizumab is combined with Brentuximab vedotin.,increase,risk
Brentuximab vedotin,Omaveloxolone,The serum concentration of Brentuximab vedotin can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Brentuximab vedotin,Ombitasvir,The serum concentration of Brentuximab vedotin can be increased when it is combined with Ombitasvir.,increase,no risk
Brentuximab vedotin,Oritavancin,The metabolism of Brentuximab vedotin can be increased when combined with Oritavancin.,increase,no risk
Brentuximab vedotin,Orphenadrine,The metabolism of Brentuximab vedotin can be decreased when combined with Orphenadrine.,decrease,no risk
Brentuximab vedotin,Osilodrostat,The metabolism of Brentuximab vedotin can be decreased when combined with Osilodrostat.,decrease,no risk
Brentuximab vedotin,Osimertinib,The serum concentration of Osimertinib can be increased when it is combined with Brentuximab vedotin.,increase,no risk
Brentuximab vedotin,Oxaliplatin,The risk or severity of adverse effects can be increased when Oxaliplatin is combined with Brentuximab vedotin.,increase,risk
Brentuximab vedotin,Oxcarbazepine,The metabolism of Brentuximab vedotin can be increased when combined with Oxcarbazepine.,increase,no risk
Brentuximab vedotin,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Brentuximab vedotin is combined with Oxetacaine.,increase,risk
Brentuximab vedotin,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Brentuximab vedotin is combined with Oxybuprocaine.,increase,risk
Brentuximab vedotin,Oxybutynin,The serum concentration of Brentuximab vedotin can be increased when it is combined with Oxybutynin.,increase,no risk
Brentuximab vedotin,Ozanimod,The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Ozanimod.,increase,risk
Brentuximab vedotin,Quinestrol,Quinestrol may increase the thrombogenic activities of Brentuximab vedotin.,increase,no risk
Brentuximab vedotin,Quinidine,The serum concentration of Brentuximab vedotin can be increased when it is combined with Quinidine.,increase,no risk
Brentuximab vedotin,Quinine,The serum concentration of Brentuximab vedotin can be increased when it is combined with Quinine.,increase,no risk
Brentuximab vedotin,Quinupristin,The metabolism of Brentuximab vedotin can be decreased when combined with Quinupristin.,decrease,no risk
Brentuximab vedotin,Quizartinib,The serum concentration of Brentuximab vedotin can be increased when it is combined with Quizartinib.,increase,no risk
Danoprevir,Galantamine,The metabolism of Galantamine can be decreased when combined with Danoprevir.,decrease,no risk
Danoprevir,Gefitinib,The metabolism of Gefitinib can be decreased when combined with Danoprevir.,decrease,no risk
Danoprevir,Gemfibrozil,The metabolism of Gemfibrozil can be decreased when combined with Danoprevir.,decrease,no risk
Danoprevir,Gepirone,The serum concentration of Gepirone can be increased when it is combined with Danoprevir.,increase,no risk
Danoprevir,Gestrinone,The metabolism of Gestrinone can be decreased when combined with Danoprevir.,decrease,no risk
Danoprevir,Gilteritinib,The metabolism of Gilteritinib can be decreased when combined with Danoprevir.,decrease,no risk
Danoprevir,Glasdegib,The serum concentration of Glasdegib can be increased when it is combined with Danoprevir.,increase,no risk
Danoprevir,Glyburide,The metabolism of Glyburide can be decreased when combined with Danoprevir.,decrease,no risk
Danoprevir,Granisetron,The metabolism of Granisetron can be decreased when combined with Danoprevir.,decrease,no risk
Danoprevir,Grazoprevir,The metabolism of Grazoprevir can be decreased when combined with Danoprevir.,decrease,no risk
Danoprevir,Grepafloxacin,The metabolism of Grepafloxacin can be decreased when combined with Danoprevir.,decrease,no risk
Danoprevir,Guanfacine,The metabolism of Guanfacine can be decreased when combined with Danoprevir.,decrease,no risk
Danoprevir,Halofantrine,The metabolism of Halofantrine can be decreased when combined with Danoprevir.,decrease,no risk
Danoprevir,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Danoprevir.,increase,no risk
Danoprevir,Hydrocodone,The metabolism of Hydrocodone can be decreased when combined with Danoprevir.,decrease,no risk
Danoprevir,Hydrocortisone,The metabolism of Hydrocortisone can be decreased when combined with Danoprevir.,decrease,no risk
Danoprevir,Hydrocortisone acetate,The metabolism of Hydrocortisone acetate can be decreased when combined with Danoprevir.,decrease,no risk
Danoprevir,Hydrocortisone butyrate,The metabolism of Hydrocortisone butyrate can be decreased when combined with Danoprevir.,decrease,no risk
Danoprevir,Hydrocortisone cypionate,The metabolism of Hydrocortisone cypionate can be decreased when combined with Danoprevir.,decrease,no risk
Danoprevir,Hydrocortisone phosphate,The metabolism of Hydrocortisone phosphate can be decreased when combined with Danoprevir.,decrease,no risk
Danoprevir,Hydrocortisone succinate,The metabolism of Hydrocortisone succinate can be decreased when combined with Danoprevir.,decrease,no risk
Danoprevir,Hydroxychloroquine,The metabolism of Hydroxychloroquine can be decreased when combined with Danoprevir.,decrease,no risk
Danoprevir,Hydroxyprogesterone caproate,The metabolism of Hydroxyprogesterone caproate can be decreased when combined with Danoprevir.,decrease,no risk
Danoprevir,Hydroxyzine,The metabolism of Hydroxyzine can be decreased when combined with Danoprevir.,decrease,no risk
Danoprevir,Ketamine,The metabolism of Ketamine can be decreased when combined with Danoprevir.,decrease,no risk
Danoprevir,Ketazolam,The metabolism of Ketazolam can be decreased when combined with Danoprevir.,decrease,no risk
Danoprevir,Ketoconazole,The metabolism of Ketoconazole can be decreased when combined with Danoprevir.,decrease,no risk
Danoprevir,Nabilone,The metabolism of Nabilone can be decreased when combined with Danoprevir.,decrease,no risk
Danoprevir,Naloxegol,The metabolism of Naloxegol can be decreased when combined with Danoprevir.,decrease,no risk
Danoprevir,Nateglinide,The metabolism of Nateglinide can be decreased when combined with Danoprevir.,decrease,no risk
Danoprevir,Nebivolol,The metabolism of Nebivolol can be decreased when combined with Danoprevir.,decrease,no risk
Danoprevir,Nefazodone,The metabolism of Nefazodone can be decreased when combined with Danoprevir.,decrease,no risk
Danoprevir,Nelfinavir,The metabolism of Nelfinavir can be decreased when combined with Danoprevir.,decrease,no risk
Danoprevir,Neratinib,The serum concentration of Neratinib can be increased when it is combined with Danoprevir.,increase,no risk
Danoprevir,Netupitant,The metabolism of Netupitant can be decreased when combined with Danoprevir.,decrease,no risk
Danoprevir,Nevirapine,The metabolism of Nevirapine can be decreased when combined with Danoprevir.,decrease,no risk
Danoprevir,Nicardipine,The metabolism of Nicardipine can be decreased when combined with Danoprevir.,decrease,no risk
Danoprevir,Nicergoline,The serum concentration of Nicergoline can be increased when it is combined with Danoprevir.,increase,no risk
Danoprevir,Nifedipine,The metabolism of Nifedipine can be decreased when combined with Danoprevir.,decrease,no risk
Danoprevir,Nilotinib,The metabolism of Nilotinib can be decreased when combined with Danoprevir.,decrease,no risk
Danoprevir,Nilvadipine,The metabolism of Nilvadipine can be decreased when combined with Danoprevir.,decrease,no risk
Danoprevir,Nimesulide,The metabolism of Nimesulide can be decreased when combined with Danoprevir.,decrease,no risk
Danoprevir,Nimodipine,The metabolism of Nimodipine can be decreased when combined with Danoprevir.,decrease,no risk
Danoprevir,Nintedanib,The metabolism of Nintedanib can be decreased when combined with Danoprevir.,decrease,no risk
Danoprevir,Nirmatrelvir,The metabolism of Nirmatrelvir can be decreased when combined with Danoprevir.,decrease,no risk
Danoprevir,Nirogacestat,The serum concentration of Nirogacestat can be increased when it is combined with Danoprevir.,increase,no risk
Danoprevir,Nisoldipine,The metabolism of Nisoldipine can be decreased when combined with Danoprevir.,decrease,no risk
Danoprevir,Nitrazepam,The metabolism of Nitrazepam can be decreased when combined with Danoprevir.,decrease,no risk
Danoprevir,Nitrendipine,The metabolism of Nitrendipine can be decreased when combined with Danoprevir.,decrease,no risk
Danoprevir,Nomegestrol,The metabolism of Nomegestrol can be decreased when combined with Danoprevir.,decrease,no risk
Danoprevir,Nomegestrol acetate,The metabolism of Nomegestrol acetate can be decreased when combined with Danoprevir.,decrease,no risk
Danoprevir,Norelgestromin,The metabolism of Norelgestromin can be decreased when combined with Danoprevir.,decrease,no risk
Danoprevir,Norethisterone,The metabolism of Norethisterone can be decreased when combined with Danoprevir.,decrease,no risk
Danoprevir,Norethynodrel,The metabolism of Norethynodrel can be decreased when combined with Danoprevir.,decrease,no risk
Danoprevir,Norgestimate,The metabolism of Norgestimate can be decreased when combined with Danoprevir.,decrease,no risk
Danoprevir,Norgestrel,The metabolism of Norgestrel can be decreased when combined with Danoprevir.,decrease,no risk
Danoprevir,Nortriptyline,The metabolism of Nortriptyline can be decreased when combined with Danoprevir.,decrease,no risk
Danoprevir,Nylidrin,The metabolism of Nylidrin can be decreased when combined with Danoprevir.,decrease,no risk
Danoprevir,Olaparib,The metabolism of Olaparib can be decreased when combined with Danoprevir.,decrease,no risk
Danoprevir,Oliceridine,The serum concentration of Oliceridine can be increased when it is combined with Danoprevir.,increase,no risk
Danoprevir,Olutasidenib,The metabolism of Olutasidenib can be decreased when combined with Danoprevir.,decrease,no risk
Danoprevir,Omaveloxolone,The serum concentration of Omaveloxolone can be increased when it is combined with Danoprevir.,increase,no risk
Danoprevir,Ondansetron,The metabolism of Ondansetron can be decreased when combined with Danoprevir.,decrease,no risk
Danoprevir,Opium,The metabolism of Opium can be decreased when combined with Danoprevir.,decrease,no risk
Danoprevir,Orphenadrine,The metabolism of Orphenadrine can be decreased when combined with Danoprevir.,decrease,no risk
Danoprevir,Osilodrostat,The serum concentration of Osilodrostat can be increased when it is combined with Danoprevir.,increase,no risk
Danoprevir,Osimertinib,The metabolism of Osimertinib can be decreased when combined with Danoprevir.,decrease,no risk
Danoprevir,Ospemifene,The metabolism of Ospemifene can be decreased when combined with Danoprevir.,decrease,no risk
Danoprevir,Oxybutynin,The metabolism of Oxybutynin can be decreased when combined with Danoprevir.,decrease,no risk
Danoprevir,Oxycodone,The metabolism of Oxycodone can be decreased when combined with Danoprevir.,decrease,no risk
Danoprevir,Oxymorphone,The metabolism of Oxymorphone can be decreased when combined with Danoprevir.,decrease,no risk
Danoprevir,Quazepam,The metabolism of Quazepam can be decreased when combined with Danoprevir.,decrease,no risk
Danoprevir,Quetiapine,The serum concentration of Quetiapine can be increased when it is combined with Danoprevir.,increase,no risk
Danoprevir,Quinidine,The metabolism of Quinidine can be decreased when combined with Danoprevir.,decrease,no risk
Danoprevir,Quinine,The metabolism of Quinine can be decreased when combined with Danoprevir.,decrease,no risk
Danoprevir,Quizartinib,The serum concentration of Quizartinib can be increased when it is combined with Danoprevir.,increase,no risk
Danoprevir,Ubrogepant,The serum concentration of Ubrogepant can be increased when it is combined with Danoprevir.,increase,no risk
Danoprevir,Udenafil,The metabolism of Udenafil can be decreased when combined with Danoprevir.,decrease,no risk
Danoprevir,Ulipristal,The metabolism of Ulipristal can be decreased when combined with Danoprevir.,decrease,no risk
Danoprevir,Upadacitinib,The metabolism of Upadacitinib can be decreased when combined with Danoprevir.,decrease,no risk
Danoprevir,Valbenazine,The serum concentration of Valbenazine can be increased when it is combined with Danoprevir.,increase,no risk
Danoprevir,Valdecoxib,The metabolism of Valdecoxib can be decreased when combined with Danoprevir.,decrease,no risk
Danoprevir,Vamorolone,The serum concentration of Vamorolone can be increased when it is combined with Danoprevir.,increase,no risk
Danoprevir,Vandetanib,The metabolism of Vandetanib can be decreased when combined with Danoprevir.,decrease,no risk
Danoprevir,Vardenafil,The metabolism of Vardenafil can be decreased when combined with Danoprevir.,decrease,no risk
Danoprevir,Velpatasvir,The metabolism of Velpatasvir can be decreased when combined with Danoprevir.,decrease,no risk
Danoprevir,Vemurafenib,The metabolism of Vemurafenib can be decreased when combined with Danoprevir.,decrease,no risk
Danoprevir,Venetoclax,The metabolism of Venetoclax can be decreased when combined with Danoprevir.,decrease,no risk
Danoprevir,Venlafaxine,The metabolism of Venlafaxine can be decreased when combined with Danoprevir.,decrease,no risk
Danoprevir,Verapamil,The metabolism of Verapamil can be decreased when combined with Danoprevir.,decrease,no risk
Danoprevir,Vilanterol,The serum concentration of Vilanterol can be increased when it is combined with Danoprevir.,increase,no risk
Danoprevir,Vilazodone,The metabolism of Vilazodone can be decreased when combined with Danoprevir.,decrease,no risk
Danoprevir,Vinblastine,The metabolism of Vinblastine can be decreased when combined with Danoprevir.,decrease,no risk
Danoprevir,Vincristine,The metabolism of Vincristine can be decreased when combined with Danoprevir.,decrease,no risk
Danoprevir,Vindesine,The metabolism of Vindesine can be decreased when combined with Danoprevir.,decrease,no risk
Danoprevir,Vinflunine,The metabolism of Vinflunine can be decreased when combined with Danoprevir.,decrease,no risk
Danoprevir,Vinorelbine,The metabolism of Vinorelbine can be decreased when combined with Danoprevir.,decrease,no risk
Danoprevir,Vitamin D,The metabolism of Vitamin D can be decreased when combined with Danoprevir.,decrease,no risk
Danoprevir,Vitamin E,The metabolism of Vitamin E can be decreased when combined with Danoprevir.,decrease,no risk
Danoprevir,Voclosporin,The metabolism of Voclosporin can be decreased when combined with Danoprevir.,decrease,no risk
Danoprevir,Vonoprazan,The metabolism of Vonoprazan can be decreased when combined with Danoprevir.,decrease,no risk
Danoprevir,Vorapaxar,The metabolism of Vorapaxar can be decreased when combined with Danoprevir.,decrease,no risk
Danoprevir,Voriconazole,The metabolism of Voriconazole can be decreased when combined with Danoprevir.,decrease,no risk
Danoprevir,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Danoprevir.,decrease,no risk
Danoprevir,Voxelotor,The serum concentration of Voxelotor can be increased when it is combined with Danoprevir.,increase,no risk
Danoprevir,Voxilaprevir,The metabolism of Voxilaprevir can be decreased when combined with Danoprevir.,decrease,no risk
Danoprevir,Warfarin,The metabolism of Warfarin can be decreased when combined with Danoprevir.,decrease,no risk
Danoprevir,Yohimbine,The metabolism of Yohimbine can be decreased when combined with Danoprevir.,decrease,no risk
Danoprevir,Zaleplon,The metabolism of Zaleplon can be decreased when combined with Danoprevir.,decrease,no risk
Danoprevir,Zanubrutinib,The metabolism of Zanubrutinib can be decreased when combined with Danoprevir.,decrease,no risk
Danoprevir,Zidovudine,The metabolism of Zidovudine can be decreased when combined with Danoprevir.,decrease,no risk
Danoprevir,Zileuton,The metabolism of Zileuton can be decreased when combined with Danoprevir.,decrease,no risk
Danoprevir,Ziprasidone,The metabolism of Ziprasidone can be decreased when combined with Danoprevir.,decrease,no risk
Danoprevir,Zolpidem,The metabolism of Zolpidem can be decreased when combined with Danoprevir.,decrease,no risk
Danoprevir,Zonisamide,The metabolism of Zonisamide can be decreased when combined with Danoprevir.,decrease,no risk
Danoprevir,Zopiclone,The metabolism of Zopiclone can be decreased when combined with Danoprevir.,decrease,no risk
Danoprevir,Zotepine,The metabolism of Zotepine can be decreased when combined with Danoprevir.,decrease,no risk
Danoprevir,Zuclopenthixol,The metabolism of Zuclopenthixol can be decreased when combined with Danoprevir.,decrease,no risk
Danoprevir,Zuranolone,The serum concentration of Zuranolone can be increased when it is combined with Danoprevir.,increase,no risk
Filanesib,Benzocaine,The risk or severity of methemoglobinemia can be increased when Filanesib is combined with Benzocaine.,increase,risk
Filanesib,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Filanesib is combined with Benzyl alcohol.,increase,risk
Filanesib,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Filanesib is combined with Bupivacaine.,increase,risk
Filanesib,Butacaine,The risk or severity of methemoglobinemia can be increased when Filanesib is combined with Butacaine.,increase,risk
Filanesib,Butamben,The risk or severity of methemoglobinemia can be increased when Filanesib is combined with Butamben.,increase,risk
Filanesib,Nelarabine,The risk or severity of adverse effects can be increased when Nelarabine is combined with Filanesib.,increase,risk
Filanesib,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Filanesib is combined with Oxetacaine.,increase,risk
Filanesib,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Filanesib is combined with Oxybuprocaine.,increase,risk
Olaratumab,Human varicella-zoster immune globulin,The risk or severity of adverse effects can be increased when Olaratumab is combined with Human varicella-zoster immune globulin.,increase,risk
Olaratumab,Natalizumab,The risk or severity of adverse effects can be increased when Natalizumab is combined with Olaratumab.,increase,risk
Olaratumab,Necitumumab,The risk or severity of adverse effects can be increased when Olaratumab is combined with Necitumumab.,increase,risk
Olaratumab,Nivolumab,The risk or severity of adverse effects can be increased when Olaratumab is combined with Nivolumab.,increase,risk
Olaratumab,Obiltoxaximab,The risk or severity of adverse effects can be increased when Obiltoxaximab is combined with Olaratumab.,increase,risk
Olaratumab,Obinutuzumab,The risk or severity of adverse effects can be increased when Olaratumab is combined with Obinutuzumab.,increase,risk
Olaratumab,Ocrelizumab,The risk or severity of adverse effects can be increased when Olaratumab is combined with Ocrelizumab.,increase,risk
Olaratumab,Odesivimab,The risk or severity of adverse effects can be increased when Olaratumab is combined with Odesivimab.,increase,risk
Olaratumab,Ofatumumab,The risk or severity of adverse effects can be increased when Olaratumab is combined with Ofatumumab.,increase,risk
Olaratumab,Omalizumab,The risk or severity of adverse effects can be increased when Omalizumab is combined with Olaratumab.,increase,risk
Olaratumab,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Olaratumab is combined with Oxetacaine.,increase,risk
Olaratumab,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Olaratumab is combined with Oxybuprocaine.,increase,risk
Olaratumab,Quinestrol,Quinestrol may increase the thrombogenic activities of Olaratumab.,increase,no risk
Olaratumab,Ublituximab,The risk or severity of adverse effects can be increased when Olaratumab is combined with Ublituximab.,increase,risk
Olaratumab,Ustekinumab,The risk or severity of adverse effects can be increased when Ustekinumab is combined with Olaratumab.,increase,risk
Olaratumab,Vedolizumab,The risk or severity of adverse effects can be increased when Olaratumab is combined with Vedolizumab.,increase,risk
Trofinetide,Gilteritinib,The metabolism of Gilteritinib can be decreased when combined with Trofinetide.,decrease,no risk
Trofinetide,Glecaprevir,The serum concentration of Glecaprevir can be increased when it is combined with Trofinetide.,increase,no risk
Trofinetide,Grazoprevir,The serum concentration of Grazoprevir can be increased when it is combined with Trofinetide.,increase,no risk
Trofinetide,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Trofinetide.,increase,no risk
Trofinetide,Hydroxyzine,The metabolism of Hydroxyzine can be decreased when combined with Trofinetide.,decrease,no risk
Trofinetide,Neratinib,The metabolism of Neratinib can be decreased when combined with Trofinetide.,decrease,no risk
Trofinetide,Netupitant,The metabolism of Netupitant can be decreased when combined with Trofinetide.,decrease,no risk
Trofinetide,Nilotinib,The metabolism of Nilotinib can be decreased when combined with Trofinetide.,decrease,no risk
Trofinetide,Nintedanib,The metabolism of Nintedanib can be decreased when combined with Trofinetide.,decrease,no risk
Trofinetide,Norethisterone,The metabolism of Norethisterone can be decreased when combined with Trofinetide.,decrease,no risk
Trofinetide,Nortriptyline,The metabolism of Nortriptyline can be decreased when combined with Trofinetide.,decrease,no risk
Trofinetide,Olaparib,The metabolism of Olaparib can be decreased when combined with Trofinetide.,decrease,no risk
Trofinetide,Osimertinib,The metabolism of Osimertinib can be decreased when combined with Trofinetide.,decrease,no risk
Trofinetide,Ouabain,The serum concentration of Ouabain can be increased when it is combined with Trofinetide.,increase,no risk
Trofinetide,Quinidine,The metabolism of Quinidine can be decreased when combined with Trofinetide.,decrease,no risk
Trofinetide,Ubrogepant,The serum concentration of Ubrogepant can be increased when it is combined with Trofinetide.,increase,no risk
Trofinetide,Valsartan,The serum concentration of Valsartan can be increased when it is combined with Trofinetide.,increase,no risk
Trofinetide,Vandetanib,The metabolism of Vandetanib can be decreased when combined with Trofinetide.,decrease,no risk
Trofinetide,Vardenafil,The metabolism of Vardenafil can be decreased when combined with Trofinetide.,decrease,no risk
Trofinetide,Vemurafenib,The metabolism of Vemurafenib can be decreased when combined with Trofinetide.,decrease,no risk
Trofinetide,Venetoclax,The metabolism of Venetoclax can be decreased when combined with Trofinetide.,decrease,no risk
Trofinetide,Vinblastine,The metabolism of Vinblastine can be decreased when combined with Trofinetide.,decrease,no risk
Trofinetide,Vincristine,The metabolism of Vincristine can be decreased when combined with Trofinetide.,decrease,no risk
Trofinetide,Vindesine,The metabolism of Vindesine can be decreased when combined with Trofinetide.,decrease,no risk
Trofinetide,Vinflunine,The metabolism of Vinflunine can be decreased when combined with Trofinetide.,decrease,no risk
Trofinetide,Vinorelbine,The metabolism of Vinorelbine can be decreased when combined with Trofinetide.,decrease,no risk
Trofinetide,Vorapaxar,The metabolism of Vorapaxar can be decreased when combined with Trofinetide.,decrease,no risk
Trofinetide,Voxelotor,The serum concentration of Voxelotor can be increased when it is combined with Trofinetide.,increase,no risk
Trofinetide,Voxilaprevir,The serum concentration of Voxilaprevir can be increased when it is combined with Trofinetide.,increase,no risk
Trofinetide,Warfarin,The metabolism of Warfarin can be decreased when combined with Trofinetide.,decrease,no risk
Trofinetide,Zanubrutinib,The metabolism of Zanubrutinib can be decreased when combined with Trofinetide.,decrease,no risk
Trofinetide,Zavegepant,The serum concentration of Zavegepant can be increased when it is combined with Trofinetide.,increase,no risk
Trofinetide,Ziprasidone,The metabolism of Ziprasidone can be decreased when combined with Trofinetide.,decrease,no risk
Trofinetide,Zopiclone,The metabolism of Zopiclone can be decreased when combined with Trofinetide.,decrease,no risk
Trofinetide,Zuclopenthixol,The metabolism of Zuclopenthixol can be decreased when combined with Trofinetide.,decrease,no risk
Favipiravir,Gemcitabine,The serum concentration of Gemcitabine can be increased when it is combined with Favipiravir.,increase,no risk
Favipiravir,Gilteritinib,The serum concentration of Gilteritinib can be increased when it is combined with Favipiravir.,increase,no risk
Favipiravir,Glasdegib,The serum concentration of Glasdegib can be increased when it is combined with Favipiravir.,increase,no risk
Favipiravir,Glecaprevir,The serum concentration of Glecaprevir can be increased when it is combined with Favipiravir.,increase,no risk
Favipiravir,Grazoprevir,The serum concentration of Grazoprevir can be increased when it is combined with Favipiravir.,increase,no risk
Favipiravir,Grepafloxacin,The excretion of Grepafloxacin can be decreased when combined with Favipiravir.,decrease,no risk
Favipiravir,Halofantrine,The metabolism of Halofantrine can be decreased when combined with Favipiravir.,decrease,no risk
Favipiravir,Halothane,The metabolism of Halothane can be decreased when combined with Favipiravir.,decrease,no risk
Favipiravir,Human adenovirus e serotype 4 strain cl-68578 antigen,The therapeutic efficacy of Human adenovirus e serotype 4 strain cl-68578 antigen can be decreased when used in combination with Favipiravir.,decrease,no risk
Favipiravir,Hydrochlorothiazide,The excretion of Hydrochlorothiazide can be decreased when combined with Favipiravir.,decrease,no risk
Favipiravir,Hydrocortisone,The excretion of Hydrocortisone can be decreased when combined with Favipiravir.,decrease,no risk
Favipiravir,Hydroxychloroquine,The metabolism of Hydroxychloroquine can be decreased when combined with Favipiravir.,decrease,no risk
Favipiravir,Ketamine,The metabolism of Ketamine can be decreased when combined with Favipiravir.,decrease,no risk
Favipiravir,Ketorolac,The metabolism of Ketorolac can be decreased when combined with Favipiravir.,decrease,no risk
Favipiravir,Naloxegol,The serum concentration of Naloxegol can be increased when it is combined with Favipiravir.,increase,no risk
Favipiravir,Naproxen,The metabolism of Naproxen can be decreased when combined with Favipiravir.,decrease,no risk
Favipiravir,Nicardipine,The metabolism of Nicardipine can be decreased when combined with Favipiravir.,decrease,no risk
Favipiravir,Nilvadipine,The metabolism of Nilvadipine can be decreased when combined with Favipiravir.,decrease,no risk
Favipiravir,Nintedanib,The serum concentration of Nintedanib can be increased when it is combined with Favipiravir.,increase,no risk
Favipiravir,Nirogacestat,The serum concentration of Nirogacestat can be increased when it is combined with Favipiravir.,increase,no risk
Favipiravir,Nortriptyline,The serum concentration of Nortriptyline can be increased when it is combined with Favipiravir.,increase,no risk
Favipiravir,Olodaterol,The metabolism of Olodaterol can be decreased when combined with Favipiravir.,decrease,no risk
Favipiravir,Omadacycline,The serum concentration of Omadacycline can be increased when it is combined with Favipiravir.,increase,no risk
Favipiravir,Ombitasvir,The serum concentration of Ombitasvir can be increased when it is combined with Favipiravir.,increase,no risk
Favipiravir,Oseltamivir,The excretion of Oseltamivir can be decreased when combined with Favipiravir.,decrease,no risk
Favipiravir,Osimertinib,The serum concentration of Osimertinib can be increased when it is combined with Favipiravir.,increase,no risk
Favipiravir,Oxytetracycline,The excretion of Oxytetracycline can be decreased when combined with Favipiravir.,decrease,no risk
Favipiravir,Ozanimod,The metabolism of Ozanimod can be decreased when combined with Favipiravir.,decrease,no risk
Favipiravir,Quinapril,The excretion of Quinapril can be decreased when combined with Favipiravir.,decrease,no risk
Favipiravir,Quinidine,The serum concentration of Quinidine can be increased when it is combined with Favipiravir.,increase,no risk
Favipiravir,Quinine,The serum concentration of Quinine can be increased when it is combined with Favipiravir.,increase,no risk
Favipiravir,Quizartinib,The serum concentration of Quizartinib can be increased when it is combined with Favipiravir.,increase,no risk
Favipiravir,Ubrogepant,The serum concentration of Ubrogepant can be increased when it is combined with Favipiravir.,increase,no risk
Favipiravir,Umeclidinium,The serum concentration of Umeclidinium can be increased when it is combined with Favipiravir.,increase,no risk
Favipiravir,Vadadustat,The serum concentration of Vadadustat can be increased when it is combined with Favipiravir.,increase,no risk
Favipiravir,Valaciclovir,The excretion of Valaciclovir can be decreased when combined with Favipiravir.,decrease,no risk
Favipiravir,Valproic acid,The excretion of Valproic acid can be decreased when combined with Favipiravir.,decrease,no risk
Favipiravir,Vardenafil,The serum concentration of Vardenafil can be increased when it is combined with Favipiravir.,increase,no risk
Favipiravir,Varicella zoster vaccine (live/attenuated),The therapeutic efficacy of Varicella zoster vaccine (live/attenuated) can be decreased when used in combination with Favipiravir.,decrease,no risk
Favipiravir,Velpatasvir,The serum concentration of Velpatasvir can be increased when it is combined with Favipiravir.,increase,no risk
Favipiravir,Vemurafenib,The serum concentration of Vemurafenib can be increased when it is combined with Favipiravir.,increase,no risk
Favipiravir,Venetoclax,The serum concentration of Venetoclax can be increased when it is combined with Favipiravir.,increase,no risk
Favipiravir,Verapamil,The serum concentration of Verapamil can be increased when it is combined with Favipiravir.,increase,no risk
Favipiravir,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Favipiravir.,decrease,no risk
Favipiravir,Vinblastine,The serum concentration of Vinblastine can be increased when it is combined with Favipiravir.,increase,no risk
Favipiravir,Vincristine,The excretion of Vincristine can be decreased when combined with Favipiravir.,decrease,no risk
Favipiravir,Vinflunine,The serum concentration of Vinflunine can be increased when it is combined with Favipiravir.,increase,no risk
Favipiravir,Voclosporin,The serum concentration of Voclosporin can be increased when it is combined with Favipiravir.,increase,no risk
Favipiravir,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Favipiravir.,decrease,no risk
Favipiravir,Voxilaprevir,The serum concentration of Voxilaprevir can be increased when it is combined with Favipiravir.,increase,no risk
Favipiravir,Yellow fever vaccine,The therapeutic efficacy of Yellow fever vaccine can be decreased when used in combination with Favipiravir.,decrease,no risk
Favipiravir,Zalcitabine,The excretion of Zalcitabine can be decreased when combined with Favipiravir.,decrease,no risk
Favipiravir,Zidovudine,The excretion of Zidovudine can be decreased when combined with Favipiravir.,decrease,no risk
Favipiravir,Zopiclone,The metabolism of Zopiclone can be decreased when combined with Favipiravir.,decrease,no risk
IPH 2101,Natalizumab,The risk or severity of adverse effects can be increased when Natalizumab is combined with IPH 2101.,increase,risk
IPH 2101,Necitumumab,The risk or severity of adverse effects can be increased when IPH 2101 is combined with Necitumumab.,increase,risk
IPH 2101,Nivolumab,The risk or severity of adverse effects can be increased when IPH 2101 is combined with Nivolumab.,increase,risk
IPH 2101,Obiltoxaximab,The risk or severity of adverse effects can be increased when Obiltoxaximab is combined with IPH 2101.,increase,risk
IPH 2101,Obinutuzumab,The risk or severity of adverse effects can be increased when IPH 2101 is combined with Obinutuzumab.,increase,risk
IPH 2101,Ocrelizumab,The risk or severity of adverse effects can be increased when IPH 2101 is combined with Ocrelizumab.,increase,risk
IPH 2101,Odesivimab,The risk or severity of adverse effects can be increased when IPH 2101 is combined with Odesivimab.,increase,risk
IPH 2101,Ofatumumab,The risk or severity of adverse effects can be increased when IPH 2101 is combined with Ofatumumab.,increase,risk
IPH 2101,Olaratumab,The risk or severity of adverse effects can be increased when Olaratumab is combined with IPH 2101.,increase,risk
IPH 2101,Omalizumab,The risk or severity of adverse effects can be increased when Omalizumab is combined with IPH 2101.,increase,risk
IPH 2101,Quinestrol,Quinestrol may increase the thrombogenic activities of IPH 2101.,increase,no risk
IPH 2101,Ublituximab,The risk or severity of adverse effects can be increased when IPH 2101 is combined with Ublituximab.,increase,risk
IPH 2101,Ustekinumab,The risk or severity of adverse effects can be increased when Ustekinumab is combined with IPH 2101.,increase,risk
IPH 2101,Vedolizumab,The risk or severity of adverse effects can be increased when IPH 2101 is combined with Vedolizumab.,increase,risk
TB-402,Natalizumab,The risk or severity of adverse effects can be increased when Natalizumab is combined with TB-402.,increase,risk
TB-402,Necitumumab,The risk or severity of adverse effects can be increased when TB-402 is combined with Necitumumab.,increase,risk
TB-402,Nivolumab,The risk or severity of adverse effects can be increased when TB-402 is combined with Nivolumab.,increase,risk
TB-402,Obiltoxaximab,The risk or severity of adverse effects can be increased when Obiltoxaximab is combined with TB-402.,increase,risk
TB-402,Obinutuzumab,The risk or severity of adverse effects can be increased when TB-402 is combined with Obinutuzumab.,increase,risk
TB-402,Ocrelizumab,The risk or severity of adverse effects can be increased when TB-402 is combined with Ocrelizumab.,increase,risk
TB-402,Odesivimab,The risk or severity of adverse effects can be increased when TB-402 is combined with Odesivimab.,increase,risk
TB-402,Ofatumumab,The risk or severity of adverse effects can be increased when TB-402 is combined with Ofatumumab.,increase,risk
TB-402,Olaratumab,The risk or severity of adverse effects can be increased when Olaratumab is combined with TB-402.,increase,risk
TB-402,Omalizumab,The risk or severity of adverse effects can be increased when Omalizumab is combined with TB-402.,increase,risk
TB-402,Quinestrol,Quinestrol may increase the thrombogenic activities of TB-402.,increase,no risk
TB-402,Ublituximab,The risk or severity of adverse effects can be increased when TB-402 is combined with Ublituximab.,increase,risk
TB-402,Ustekinumab,The risk or severity of adverse effects can be increased when Ustekinumab is combined with TB-402.,increase,risk
TB-402,Vedolizumab,The risk or severity of adverse effects can be increased when TB-402 is combined with Vedolizumab.,increase,risk
Gevokizumab,Natalizumab,The risk or severity of adverse effects can be increased when Natalizumab is combined with Gevokizumab.,increase,risk
Gevokizumab,Necitumumab,The risk or severity of adverse effects can be increased when Necitumumab is combined with Gevokizumab.,increase,risk
Gevokizumab,Nivolumab,The risk or severity of adverse effects can be increased when Nivolumab is combined with Gevokizumab.,increase,risk
Gevokizumab,Obiltoxaximab,The risk or severity of adverse effects can be increased when Obiltoxaximab is combined with Gevokizumab.,increase,risk
Gevokizumab,Obinutuzumab,The risk or severity of adverse effects can be increased when Obinutuzumab is combined with Gevokizumab.,increase,risk
Gevokizumab,Ocrelizumab,The risk or severity of adverse effects can be increased when Ocrelizumab is combined with Gevokizumab.,increase,risk
Gevokizumab,Odesivimab,The risk or severity of adverse effects can be increased when Gevokizumab is combined with Odesivimab.,increase,risk
Gevokizumab,Ofatumumab,The risk or severity of adverse effects can be increased when Ofatumumab is combined with Gevokizumab.,increase,risk
Gevokizumab,Olaratumab,The risk or severity of adverse effects can be increased when Olaratumab is combined with Gevokizumab.,increase,risk
Gevokizumab,Omalizumab,The risk or severity of adverse effects can be increased when Omalizumab is combined with Gevokizumab.,increase,risk
Gevokizumab,Quinestrol,Quinestrol may increase the thrombogenic activities of Gevokizumab.,increase,no risk
Gevokizumab,Ublituximab,The risk or severity of adverse effects can be increased when Ublituximab is combined with Gevokizumab.,increase,risk
Gevokizumab,Ustekinumab,The risk or severity of adverse effects can be increased when Ustekinumab is combined with Gevokizumab.,increase,risk
Gevokizumab,Vedolizumab,The risk or severity of adverse effects can be increased when Vedolizumab is combined with Gevokizumab.,increase,risk
Lumateperone,Gabapentin,The risk or severity of CNS depression can be increased when Gabapentin is combined with Lumateperone.,increase,risk
Lumateperone,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Lumateperone is combined with Gabapentin enacarbil.,increase,risk
Lumateperone,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with Lumateperone.,increase,risk
Lumateperone,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Lumateperone is combined with Ganaxolone.",increase,risk
Lumateperone,Gemfibrozil,The serum concentration of Lumateperone can be increased when it is combined with Gemfibrozil.,increase,no risk
Lumateperone,Gepirone,The risk or severity of CNS depression can be increased when Lumateperone is combined with Gepirone.,increase,risk
Lumateperone,Glecaprevir,The serum concentration of Lumateperone can be increased when it is combined with Glecaprevir.,increase,no risk
Lumateperone,Glofitamab,The serum concentration of Lumateperone can be increased when it is combined with Glofitamab.,increase,no risk
Lumateperone,Glutethimide,The risk or severity of CNS depression can be increased when Glutethimide is combined with Lumateperone.,increase,risk
Lumateperone,Glycerol phenylbutyrate,The serum concentration of Lumateperone can be decreased when it is combined with Glycerol phenylbutyrate.,decrease,no risk
Lumateperone,Granisetron,The risk or severity of CNS depression can be increased when Granisetron is combined with Lumateperone.,increase,risk
Lumateperone,Griseofulvin,The serum concentration of Lumateperone can be decreased when it is combined with Griseofulvin.,decrease,no risk
Lumateperone,Guanfacine,The risk or severity of CNS depression can be increased when Guanfacine is combined with Lumateperone.,increase,risk
Lumateperone,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with Lumateperone.,increase,risk
Lumateperone,Haloperidol,The serum concentration of Lumateperone can be increased when it is combined with Haloperidol.,increase,no risk
Lumateperone,Halothane,The risk or severity of CNS depression can be increased when Halothane is combined with Lumateperone.,increase,risk
Lumateperone,Hexafluronium,The risk or severity of CNS depression can be increased when Hexafluronium is combined with Lumateperone.,increase,risk
Lumateperone,Hydrocodone,Lumateperone may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Lumateperone,Hydrocortamate,The serum concentration of Lumateperone can be decreased when it is combined with Hydrocortamate.,decrease,no risk
Lumateperone,Hydrocortisone,The serum concentration of Lumateperone can be decreased when it is combined with Hydrocortisone.,decrease,no risk
Lumateperone,Hydrocortisone acetate,The serum concentration of Lumateperone can be decreased when it is combined with Hydrocortisone acetate.,decrease,no risk
Lumateperone,Hydrocortisone butyrate,The serum concentration of Lumateperone can be decreased when it is combined with Hydrocortisone butyrate.,decrease,no risk
Lumateperone,Hydrocortisone probutate,The serum concentration of Lumateperone can be decreased when it is combined with Hydrocortisone probutate.,decrease,no risk
Lumateperone,Hydrocortisone succinate,The serum concentration of Lumateperone can be decreased when it is combined with Hydrocortisone succinate.,decrease,no risk
Lumateperone,Hydrocortisone valerate,The serum concentration of Lumateperone can be decreased when it is combined with Hydrocortisone valerate.,decrease,no risk
Lumateperone,Hydromorphone,The risk or severity of CNS depression can be increased when Hydromorphone is combined with Lumateperone.,increase,risk
Lumateperone,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Lumateperone.,increase,no risk
Lumateperone,Ketamine,The serum concentration of Lumateperone can be decreased when it is combined with Ketamine.,decrease,no risk
Lumateperone,Ketazolam,The risk or severity of CNS depression can be increased when Ketazolam is combined with Lumateperone.,increase,risk
Lumateperone,Ketoconazole,The serum concentration of Lumateperone can be increased when it is combined with Ketoconazole.,increase,no risk
Lumateperone,Nabilone,Nabilone may increase the central nervous system depressant (CNS depressant) activities of Lumateperone.,increase,no risk
Lumateperone,Nafcillin,The serum concentration of Lumateperone can be decreased when it is combined with Nafcillin.,decrease,no risk
Lumateperone,Nalbuphine,The risk or severity of CNS depression can be increased when Nalbuphine is combined with Lumateperone.,increase,risk
Lumateperone,Naratriptan,The risk or severity of adverse effects can be increased when Naratriptan is combined with Lumateperone.,increase,risk
Lumateperone,Nefazodone,The serum concentration of Lumateperone can be increased when it is combined with Nefazodone.,increase,no risk
Lumateperone,Nelfinavir,The serum concentration of Lumateperone can be increased when it is combined with Nelfinavir.,increase,no risk
Lumateperone,Netupitant,The serum concentration of Lumateperone can be increased when it is combined with Netupitant.,increase,no risk
Lumateperone,Nialamide,The risk or severity of CNS depression can be increased when Nialamide is combined with Lumateperone.,increase,risk
Lumateperone,Nicardipine,The serum concentration of Lumateperone can be increased when it is combined with Nicardipine.,increase,no risk
Lumateperone,Nifedipine,The serum concentration of Lumateperone can be decreased when it is combined with Nifedipine.,decrease,no risk
Lumateperone,Nilotinib,The serum concentration of Lumateperone can be increased when it is combined with Nilotinib.,increase,no risk
Lumateperone,Nilvadipine,The serum concentration of Lumateperone can be increased when it is combined with Nilvadipine.,increase,no risk
Lumateperone,Nitrazepam,The risk or severity of CNS depression can be increased when Nitrazepam is combined with Lumateperone.,increase,risk
Lumateperone,Nitrous oxide,The risk or severity of CNS depression can be increased when Lumateperone is combined with Nitrous oxide.,increase,risk
Lumateperone,Nomifensine,The risk or severity of CNS depression can be increased when Nomifensine is combined with Lumateperone.,increase,risk
Lumateperone,Norgestimate,The serum concentration of Lumateperone can be decreased when it is combined with Norgestimate.,decrease,no risk
Lumateperone,Normethadone,The risk or severity of CNS depression can be increased when Lumateperone is combined with Normethadone.,increase,risk
Lumateperone,Nortriptyline,The risk or severity of adverse effects can be increased when Nortriptyline is combined with Lumateperone.,increase,risk
Lumateperone,Olanzapine,The risk or severity of adverse effects can be increased when Lumateperone is combined with Olanzapine.,increase,risk
Lumateperone,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Lumateperone is combined with Oliceridine.",increase,risk
Lumateperone,Olutasidenib,The serum concentration of Lumateperone can be decreased when it is combined with Olutasidenib.,decrease,no risk
Lumateperone,Omaveloxolone,The serum concentration of Lumateperone can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Lumateperone,Ombitasvir,The serum concentration of Lumateperone can be increased when it is combined with Ombitasvir.,increase,no risk
Lumateperone,Ondansetron,The risk or severity of CNS depression can be increased when Ondansetron is combined with Lumateperone.,increase,risk
Lumateperone,Opicapone,The therapeutic efficacy of Opicapone can be decreased when used in combination with Lumateperone.,decrease,no risk
Lumateperone,Opium,The risk or severity of CNS depression can be increased when Lumateperone is combined with Opium.,increase,risk
Lumateperone,Oritavancin,The serum concentration of Lumateperone can be decreased when it is combined with Oritavancin.,decrease,no risk
Lumateperone,Orphenadrine,Lumateperone may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Lumateperone,Oxazepam,The risk or severity of CNS depression can be increased when Oxazepam is combined with Lumateperone.,increase,risk
Lumateperone,Oxcarbazepine,The serum concentration of Lumateperone can be decreased when it is combined with Oxcarbazepine.,decrease,no risk
Lumateperone,Oxiconazole,The serum concentration of Lumateperone can be decreased when it is combined with Oxiconazole.,decrease,no risk
Lumateperone,Oxitriptan,The risk or severity of CNS depression can be increased when Oxitriptan is combined with Lumateperone.,increase,risk
Lumateperone,Oxprenolol,The risk or severity of CNS depression can be increased when Oxprenolol is combined with Lumateperone.,increase,risk
Lumateperone,Oxybuprocaine,The risk or severity of CNS depression can be increased when Oxybuprocaine is combined with Lumateperone.,increase,risk
Lumateperone,Oxycodone,The risk or severity of CNS depression can be increased when Oxycodone is combined with Lumateperone.,increase,risk
Lumateperone,Oxymorphone,The risk or severity of CNS depression can be increased when Oxymorphone is combined with Lumateperone.,increase,risk
Lumateperone,Quazepam,The risk or severity of CNS depression can be increased when Quazepam is combined with Lumateperone.,increase,risk
Lumateperone,Quetiapine,The risk or severity of adverse effects can be increased when Lumateperone is combined with Quetiapine.,increase,risk
Lumateperone,Quinagolide,The therapeutic efficacy of Quinagolide can be decreased when used in combination with Lumateperone.,decrease,no risk
Lumateperone,Quinine,The serum concentration of Lumateperone can be decreased when it is combined with Quinine.,decrease,no risk
Lumateperone,Quinupramine,The risk or severity of CNS depression can be increased when Lumateperone is combined with Quinupramine.,increase,risk
Lumateperone,Quizartinib,The serum concentration of Lumateperone can be increased when it is combined with Quizartinib.,increase,no risk
Lumateperone,Urethane,The risk or severity of CNS depression can be increased when Urethane is combined with Lumateperone.,increase,risk
Lumateperone,Vadadustat,The serum concentration of Lumateperone can be increased when it is combined with Vadadustat.,increase,no risk
Lumateperone,Valproic acid,The serum concentration of Lumateperone can be increased when it is combined with Valproic acid.,increase,no risk
Lumateperone,Vecuronium,The risk or severity of CNS depression can be increased when Vecuronium is combined with Lumateperone.,increase,risk
Lumateperone,Vemurafenib,The serum concentration of Lumateperone can be decreased when it is combined with Vemurafenib.,decrease,no risk
Lumateperone,Venetoclax,The serum concentration of Lumateperone can be increased when it is combined with Venetoclax.,increase,no risk
Lumateperone,Venlafaxine,The risk or severity of adverse effects can be increased when Venlafaxine is combined with Lumateperone.,increase,risk
Lumateperone,Verapamil,The serum concentration of Lumateperone can be increased when it is combined with Verapamil.,increase,no risk
Lumateperone,Vigabatrin,The risk or severity of CNS depression can be increased when Vigabatrin is combined with Lumateperone.,increase,risk
Lumateperone,Vilazodone,The risk or severity of adverse effects can be increased when Vilazodone is combined with Lumateperone.,increase,risk
Lumateperone,Viloxazine,The metabolism of Lumateperone can be decreased when combined with Viloxazine.,decrease,no risk
Lumateperone,Vinblastine,The serum concentration of Lumateperone can be decreased when it is combined with Vinblastine.,decrease,no risk
Lumateperone,Vitamin E,The serum concentration of Lumateperone can be decreased when it is combined with Vitamin E.,decrease,no risk
Lumateperone,Voriconazole,The serum concentration of Lumateperone can be increased when it is combined with Voriconazole.,increase,no risk
Lumateperone,Vortioxetine,The risk or severity of adverse effects can be increased when Vortioxetine is combined with Lumateperone.,increase,risk
Lumateperone,Warfarin,The serum concentration of Lumateperone can be decreased when it is combined with Warfarin.,decrease,no risk
Lumateperone,Yohimbine,The risk or severity of CNS depression can be increased when Yohimbine is combined with Lumateperone.,increase,risk
Lumateperone,Zaleplon,The risk or severity of CNS depression can be increased when Zaleplon is combined with Lumateperone.,increase,risk
Lumateperone,Ziconotide,The risk or severity of CNS depression can be increased when Lumateperone is combined with Ziconotide.,increase,risk
Lumateperone,Zidovudine,The metabolism of Lumateperone can be increased when combined with Zidovudine.,increase,no risk
Lumateperone,Zimelidine,The serum concentration of Lumateperone can be increased when it is combined with Zimelidine.,increase,no risk
Lumateperone,Ziprasidone,The serum concentration of Lumateperone can be increased when it is combined with Ziprasidone.,increase,no risk
Lumateperone,Zolmitriptan,The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Lumateperone.,increase,risk
Lumateperone,Zolpidem,Lumateperone may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Lumateperone,Zonisamide,The risk or severity of CNS depression can be increased when Zonisamide is combined with Lumateperone.,increase,risk
Lumateperone,Zopiclone,The risk or severity of adverse effects can be increased when Lumateperone is combined with Zopiclone.,increase,risk
Lumateperone,Zotepine,The risk or severity of adverse effects can be increased when Lumateperone is combined with Zotepine.,increase,risk
Lumateperone,Zuclopenthixol,The risk or severity of adverse effects can be increased when Lumateperone is combined with Zuclopenthixol.,increase,risk
Lumateperone,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Lumateperone.,increase,risk
Caplacizumab,Galcanezumab,The risk or severity of adverse effects can be increased when Caplacizumab is combined with Galcanezumab.,increase,risk
Caplacizumab,Gemcitabine,The risk or severity of bleeding can be increased when Caplacizumab is combined with Gemcitabine.,increase,risk
Caplacizumab,Gemtuzumab ozogamicin,The risk or severity of bleeding can be increased when Caplacizumab is combined with Gemtuzumab ozogamicin.,increase,risk
Caplacizumab,Ginkgo biloba,Ginkgo biloba may increase the antiplatelet activities of Caplacizumab.,increase,no risk
Caplacizumab,Glofitamab,The risk or severity of adverse effects can be increased when Caplacizumab is combined with Glofitamab.,increase,risk
Caplacizumab,Glucosamine,Glucosamine may increase the antiplatelet activities of Caplacizumab.,increase,no risk
Caplacizumab,Glycol salicylate,The risk or severity of bleeding can be increased when Glycol salicylate is combined with Caplacizumab.,increase,risk
Caplacizumab,Golimumab,The risk or severity of adverse effects can be increased when Caplacizumab is combined with Golimumab.,increase,risk
Caplacizumab,Guselkumab,The risk or severity of adverse effects can be increased when Caplacizumab is combined with Guselkumab.,increase,risk
Caplacizumab,Heparin,The risk or severity of bleeding can be increased when Caplacizumab is combined with Heparin.,increase,risk
Caplacizumab,Hepatitis B immune globulin,The risk or severity of adverse effects can be increased when Hepatitis B immune globulin is combined with Caplacizumab.,increase,risk
Caplacizumab,Human cytomegalovirus immune globulin,The risk or severity of adverse effects can be increased when Caplacizumab is combined with Human cytomegalovirus immune globulin.,increase,risk
Caplacizumab,Human immunoglobulin G,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Caplacizumab.,increase,risk
Caplacizumab,Human Rho(D) immune globulin,The risk or severity of adverse effects can be increased when Caplacizumab is combined with Human Rho(D) immune globulin.,increase,risk
Caplacizumab,Human varicella-zoster immune globulin,The risk or severity of adverse effects can be increased when Caplacizumab is combined with Human varicella-zoster immune globulin.,increase,risk
Caplacizumab,Hydroxyurea,The risk or severity of bleeding can be increased when Caplacizumab is combined with Hydroxyurea.,increase,risk
Caplacizumab,Ketoprofen,The risk or severity of bleeding can be increased when Ketoprofen is combined with Caplacizumab.,increase,risk
Caplacizumab,Ketorolac,The risk or severity of bleeding can be increased when Ketorolac is combined with Caplacizumab.,increase,risk
Caplacizumab,Nabumetone,The risk or severity of bleeding can be increased when Nabumetone is combined with Caplacizumab.,increase,risk
Caplacizumab,Nadroparin,The risk or severity of bleeding can be increased when Caplacizumab is combined with Nadroparin.,increase,risk
Caplacizumab,Naproxen,The risk or severity of bleeding can be increased when Naproxen is combined with Caplacizumab.,increase,risk
Caplacizumab,Natalizumab,The risk or severity of adverse effects can be increased when Natalizumab is combined with Caplacizumab.,increase,risk
Caplacizumab,Necitumumab,The risk or severity of adverse effects can be increased when Caplacizumab is combined with Necitumumab.,increase,risk
Caplacizumab,Nefazodone,The risk or severity of hemorrhage can be increased when Nefazodone is combined with Caplacizumab.,increase,risk
Caplacizumab,Nelarabine,The risk or severity of bleeding can be increased when Caplacizumab is combined with Nelarabine.,increase,risk
Caplacizumab,Nialamide,The risk or severity of bleeding and hemorrhage can be increased when Nialamide is combined with Caplacizumab.,increase,risk
Caplacizumab,Nilotinib,The risk or severity of bleeding can be increased when Caplacizumab is combined with Nilotinib.,increase,risk
Caplacizumab,Nimesulide,The risk or severity of bleeding can be increased when Nimesulide is combined with Caplacizumab.,increase,risk
Caplacizumab,Nivolumab,The risk or severity of adverse effects can be increased when Caplacizumab is combined with Nivolumab.,increase,risk
Caplacizumab,Obeticholic acid,The risk or severity of adverse effects can be increased when Caplacizumab is combined with Obeticholic acid.,increase,risk
Caplacizumab,Obiltoxaximab,The risk or severity of adverse effects can be increased when Obiltoxaximab is combined with Caplacizumab.,increase,risk
Caplacizumab,Obinutuzumab,The risk or severity of adverse effects can be increased when Caplacizumab is combined with Obinutuzumab.,increase,risk
Caplacizumab,Ocrelizumab,The risk or severity of adverse effects can be increased when Caplacizumab is combined with Ocrelizumab.,increase,risk
Caplacizumab,Odesivimab,The risk or severity of adverse effects can be increased when Caplacizumab is combined with Odesivimab.,increase,risk
Caplacizumab,Ofatumumab,The risk or severity of adverse effects can be increased when Caplacizumab is combined with Ofatumumab.,increase,risk
Caplacizumab,Olaparib,The risk or severity of bleeding can be increased when Caplacizumab is combined with Olaparib.,increase,risk
Caplacizumab,Olaratumab,The risk or severity of adverse effects can be increased when Olaratumab is combined with Caplacizumab.,increase,risk
Caplacizumab,Olsalazine,The risk or severity of bleeding can be increased when Caplacizumab is combined with Olsalazine.,increase,risk
Caplacizumab,Omalizumab,The risk or severity of adverse effects can be increased when Omalizumab is combined with Caplacizumab.,increase,risk
Caplacizumab,Omega-3 fatty acids,Omega-3 fatty acids may increase the antiplatelet activities of Caplacizumab.,increase,no risk
Caplacizumab,Omega-3-acid ethyl esters,The risk or severity of bleeding can be increased when Omega-3-acid ethyl esters is combined with Caplacizumab.,increase,risk
Caplacizumab,Oxaliplatin,The risk or severity of bleeding can be increased when Caplacizumab is combined with Oxaliplatin.,increase,risk
Caplacizumab,Oxaprozin,The risk or severity of bleeding can be increased when Oxaprozin is combined with Caplacizumab.,increase,risk
Caplacizumab,Oxyphenbutazone,The risk or severity of bleeding can be increased when Oxyphenbutazone is combined with Caplacizumab.,increase,risk
Caplacizumab,Quinestrol,Quinestrol may increase the thrombogenic activities of Caplacizumab.,increase,no risk
Caplacizumab,Ublituximab,The risk or severity of adverse effects can be increased when Caplacizumab is combined with Ublituximab.,increase,risk
Caplacizumab,Urokinase,Caplacizumab may increase the anticoagulant activities of Urokinase.,increase,no risk
Caplacizumab,Ursodeoxycholic acid,The risk or severity of adverse effects can be increased when Caplacizumab is combined with Ursodeoxycholic acid.,increase,risk
Caplacizumab,Ustekinumab,The risk or severity of adverse effects can be increased when Ustekinumab is combined with Caplacizumab.,increase,risk
Caplacizumab,Valdecoxib,The risk or severity of bleeding can be increased when Valdecoxib is combined with Caplacizumab.,increase,risk
Caplacizumab,Vedolizumab,The risk or severity of adverse effects can be increased when Caplacizumab is combined with Vedolizumab.,increase,risk
Caplacizumab,Venlafaxine,The risk or severity of bleeding can be increased when Caplacizumab is combined with Venlafaxine.,increase,risk
Caplacizumab,Vinblastine,The risk or severity of bleeding can be increased when Caplacizumab is combined with Vinblastine.,increase,risk
Caplacizumab,Vindesine,The risk or severity of bleeding can be increased when Caplacizumab is combined with Vindesine.,increase,risk
Caplacizumab,Vinorelbine,The risk or severity of bleeding can be increased when Caplacizumab is combined with Vinorelbine.,increase,risk
Caplacizumab,Vitamin E,Vitamin E may increase the antiplatelet activities of Caplacizumab.,increase,no risk
Caplacizumab,Vorapaxar,The risk or severity of bleeding can be increased when Caplacizumab is combined with Vorapaxar.,increase,risk
Caplacizumab,Vorinostat,The risk or severity of bleeding can be increased when Caplacizumab is combined with Vorinostat.,increase,risk
Caplacizumab,Vortioxetine,The risk or severity of bleeding can be increased when Vortioxetine is combined with Caplacizumab.,increase,risk
Caplacizumab,Warfarin,The risk or severity of bleeding can be increased when Caplacizumab is combined with Warfarin.,increase,risk
Caplacizumab,Ximelagatran,The risk or severity of bleeding can be increased when Caplacizumab is combined with Ximelagatran.,increase,risk
Caplacizumab,Zidovudine,The risk or severity of bleeding can be increased when Caplacizumab is combined with Zidovudine.,increase,risk
Caplacizumab,Zimelidine,The risk or severity of hemorrhage can be increased when Zimelidine is combined with Caplacizumab.,increase,risk
IMC-1C11,Natalizumab,The risk or severity of adverse effects can be increased when Natalizumab is combined with IMC-1C11.,increase,risk
IMC-1C11,Necitumumab,The risk or severity of adverse effects can be increased when IMC-1C11 is combined with Necitumumab.,increase,risk
IMC-1C11,Nivolumab,The risk or severity of adverse effects can be increased when IMC-1C11 is combined with Nivolumab.,increase,risk
IMC-1C11,Obiltoxaximab,The risk or severity of adverse effects can be increased when Obiltoxaximab is combined with IMC-1C11.,increase,risk
IMC-1C11,Obinutuzumab,The risk or severity of adverse effects can be increased when IMC-1C11 is combined with Obinutuzumab.,increase,risk
IMC-1C11,Ocrelizumab,The risk or severity of adverse effects can be increased when IMC-1C11 is combined with Ocrelizumab.,increase,risk
IMC-1C11,Odesivimab,The risk or severity of adverse effects can be increased when IMC-1C11 is combined with Odesivimab.,increase,risk
IMC-1C11,Ofatumumab,The risk or severity of adverse effects can be increased when IMC-1C11 is combined with Ofatumumab.,increase,risk
IMC-1C11,Olaratumab,The risk or severity of adverse effects can be increased when Olaratumab is combined with IMC-1C11.,increase,risk
IMC-1C11,Omalizumab,The risk or severity of adverse effects can be increased when Omalizumab is combined with IMC-1C11.,increase,risk
IMC-1C11,Quinestrol,Quinestrol may increase the thrombogenic activities of IMC-1C11.,increase,no risk
IMC-1C11,Ublituximab,The risk or severity of adverse effects can be increased when IMC-1C11 is combined with Ublituximab.,increase,risk
IMC-1C11,Ustekinumab,The risk or severity of adverse effects can be increased when Ustekinumab is combined with IMC-1C11.,increase,risk
IMC-1C11,Vedolizumab,The risk or severity of adverse effects can be increased when IMC-1C11 is combined with Vedolizumab.,increase,risk
YKP-1358,Gabapentin,The risk or severity of CNS depression can be increased when Gabapentin is combined with YKP-1358.,increase,risk
YKP-1358,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when YKP-1358 is combined with Gabapentin enacarbil.,increase,risk
YKP-1358,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with YKP-1358.,increase,risk
YKP-1358,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when YKP-1358 is combined with Ganaxolone.",increase,risk
YKP-1358,Gepirone,The risk or severity of serotonin syndrome can be increased when Gepirone is combined with YKP-1358.,increase,risk
YKP-1358,Gilteritinib,The therapeutic efficacy of YKP-1358 can be decreased when used in combination with Gilteritinib.,decrease,no risk
YKP-1358,Glutethimide,The risk or severity of CNS depression can be increased when Glutethimide is combined with YKP-1358.,increase,risk
YKP-1358,Granisetron,The risk or severity of CNS depression can be increased when Granisetron is combined with YKP-1358.,increase,risk
YKP-1358,Guanfacine,The risk or severity of CNS depression can be increased when Guanfacine is combined with YKP-1358.,increase,risk
YKP-1358,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with YKP-1358.,increase,risk
YKP-1358,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with YKP-1358.,increase,risk
YKP-1358,Halothane,The risk or severity of CNS depression can be increased when Halothane is combined with YKP-1358.,increase,risk
YKP-1358,Hexafluronium,The risk or severity of CNS depression can be increased when Hexafluronium is combined with YKP-1358.,increase,risk
YKP-1358,Hydrocodone,YKP-1358 may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
YKP-1358,Hydromorphone,The risk or severity of CNS depression can be increased when Hydromorphone is combined with YKP-1358.,increase,risk
YKP-1358,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of YKP-1358.,increase,no risk
YKP-1358,Ketamine,The risk or severity of CNS depression can be increased when Ketamine is combined with YKP-1358.,increase,risk
YKP-1358,Ketazolam,The risk or severity of CNS depression can be increased when Ketazolam is combined with YKP-1358.,increase,risk
YKP-1358,Nabilone,Nabilone may increase the central nervous system depressant (CNS depressant) activities of YKP-1358.,increase,no risk
YKP-1358,Nalbuphine,The risk or severity of CNS depression can be increased when Nalbuphine is combined with YKP-1358.,increase,risk
YKP-1358,Naltrexone,The risk or severity of serotonin syndrome can be increased when Naltrexone is combined with YKP-1358.,increase,risk
YKP-1358,Naratriptan,The risk or severity of CNS depression can be increased when Naratriptan is combined with YKP-1358.,increase,risk
YKP-1358,Nefazodone,The risk or severity of adverse effects can be increased when YKP-1358 is combined with Nefazodone.,increase,risk
YKP-1358,Nialamide,The risk or severity of CNS depression can be increased when Nialamide is combined with YKP-1358.,increase,risk
YKP-1358,Nitrazepam,The risk or severity of CNS depression can be increased when Nitrazepam is combined with YKP-1358.,increase,risk
YKP-1358,Nitrous oxide,The risk or severity of CNS depression can be increased when YKP-1358 is combined with Nitrous oxide.,increase,risk
YKP-1358,Nomifensine,The risk or severity of CNS depression can be increased when Nomifensine is combined with YKP-1358.,increase,risk
YKP-1358,Normethadone,The risk or severity of CNS depression can be increased when YKP-1358 is combined with Normethadone.,increase,risk
YKP-1358,Nortriptyline,The risk or severity of CNS depression can be increased when Nortriptyline is combined with YKP-1358.,increase,risk
YKP-1358,Olanzapine,The risk or severity of CNS depression can be increased when Olanzapine is combined with YKP-1358.,increase,risk
YKP-1358,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when YKP-1358 is combined with Oliceridine.",increase,risk
YKP-1358,Ondansetron,The risk or severity of CNS depression can be increased when Ondansetron is combined with YKP-1358.,increase,risk
YKP-1358,Opium,The risk or severity of CNS depression can be increased when YKP-1358 is combined with Opium.,increase,risk
YKP-1358,Orphenadrine,YKP-1358 may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
YKP-1358,Oxazepam,The risk or severity of CNS depression can be increased when Oxazepam is combined with YKP-1358.,increase,risk
YKP-1358,Oxcarbazepine,The risk or severity of CNS depression can be increased when Oxcarbazepine is combined with YKP-1358.,increase,risk
YKP-1358,Oxitriptan,The risk or severity of CNS depression can be increased when Oxitriptan is combined with YKP-1358.,increase,risk
YKP-1358,Oxprenolol,The risk or severity of CNS depression can be increased when Oxprenolol is combined with YKP-1358.,increase,risk
YKP-1358,Oxybuprocaine,The risk or severity of CNS depression can be increased when Oxybuprocaine is combined with YKP-1358.,increase,risk
YKP-1358,Oxycodone,The risk or severity of CNS depression can be increased when Oxycodone is combined with YKP-1358.,increase,risk
YKP-1358,Oxymorphone,The risk or severity of CNS depression can be increased when Oxymorphone is combined with YKP-1358.,increase,risk
YKP-1358,Quazepam,The risk or severity of CNS depression can be increased when Quazepam is combined with YKP-1358.,increase,risk
YKP-1358,Quetiapine,The risk or severity of CNS depression can be increased when Quetiapine is combined with YKP-1358.,increase,risk
YKP-1358,Quinagolide,The therapeutic efficacy of Quinagolide can be decreased when used in combination with YKP-1358.,decrease,no risk
YKP-1358,Quinine,The risk or severity of CNS depression can be increased when Quinine is combined with YKP-1358.,increase,risk
YKP-1358,Quinupramine,The risk or severity of CNS depression can be increased when YKP-1358 is combined with Quinupramine.,increase,risk
YKP-1358,Urethane,The risk or severity of CNS depression can be increased when Urethane is combined with YKP-1358.,increase,risk
YKP-1358,Valproate bismuth,The risk or severity of serotonin syndrome can be increased when YKP-1358 is combined with Valproate bismuth.,increase,risk
YKP-1358,Valproic acid,The risk or severity of CNS depression can be increased when Valproic acid is combined with YKP-1358.,increase,risk
YKP-1358,Vecuronium,The risk or severity of CNS depression can be increased when Vecuronium is combined with YKP-1358.,increase,risk
YKP-1358,Venlafaxine,The risk or severity of serotonin syndrome can be increased when YKP-1358 is combined with Venlafaxine.,increase,risk
YKP-1358,Vigabatrin,The risk or severity of CNS depression can be increased when Vigabatrin is combined with YKP-1358.,increase,risk
YKP-1358,Vilazodone,The risk or severity of CNS depression can be increased when YKP-1358 is combined with Vilazodone.,increase,risk
YKP-1358,Viloxazine,The risk or severity of CNS depression can be increased when YKP-1358 is combined with Viloxazine.,increase,risk
YKP-1358,Vortioxetine,The risk or severity of CNS depression can be increased when YKP-1358 is combined with Vortioxetine.,increase,risk
YKP-1358,Warfarin,The risk or severity of adverse effects can be increased when YKP-1358 is combined with Warfarin.,increase,risk
YKP-1358,Yohimbine,The risk or severity of CNS depression can be increased when Yohimbine is combined with YKP-1358.,increase,risk
YKP-1358,Zaleplon,The risk or severity of CNS depression can be increased when Zaleplon is combined with YKP-1358.,increase,risk
YKP-1358,Ziconotide,The risk or severity of CNS depression can be increased when YKP-1358 is combined with Ziconotide.,increase,risk
YKP-1358,Zimelidine,The risk or severity of adverse effects can be increased when YKP-1358 is combined with Zimelidine.,increase,risk
YKP-1358,Ziprasidone,The risk or severity of adverse effects can be increased when YKP-1358 is combined with Ziprasidone.,increase,risk
YKP-1358,Zolmitriptan,The risk or severity of CNS depression can be increased when Zolmitriptan is combined with YKP-1358.,increase,risk
YKP-1358,Zolpidem,YKP-1358 may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
YKP-1358,Zonisamide,The risk or severity of CNS depression can be increased when Zonisamide is combined with YKP-1358.,increase,risk
YKP-1358,Zopiclone,The risk or severity of adverse effects can be increased when YKP-1358 is combined with Zopiclone.,increase,risk
YKP-1358,Zotepine,The risk or severity of CNS depression can be increased when YKP-1358 is combined with Zotepine.,increase,risk
YKP-1358,Zuclopenthixol,The risk or severity of CNS depression can be increased when Zuclopenthixol is combined with YKP-1358.,increase,risk
YKP-1358,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with YKP-1358.,increase,risk
Eldelumab,Natalizumab,The risk or severity of adverse effects can be increased when Natalizumab is combined with Eldelumab.,increase,risk
Eldelumab,Necitumumab,The risk or severity of adverse effects can be increased when Eldelumab is combined with Necitumumab.,increase,risk
Eldelumab,Nivolumab,The risk or severity of adverse effects can be increased when Eldelumab is combined with Nivolumab.,increase,risk
Eldelumab,Obiltoxaximab,The risk or severity of adverse effects can be increased when Obiltoxaximab is combined with Eldelumab.,increase,risk
Eldelumab,Obinutuzumab,The risk or severity of adverse effects can be increased when Eldelumab is combined with Obinutuzumab.,increase,risk
Eldelumab,Ocrelizumab,The risk or severity of adverse effects can be increased when Eldelumab is combined with Ocrelizumab.,increase,risk
Eldelumab,Odesivimab,The risk or severity of adverse effects can be increased when Eldelumab is combined with Odesivimab.,increase,risk
Eldelumab,Ofatumumab,The risk or severity of adverse effects can be increased when Eldelumab is combined with Ofatumumab.,increase,risk
Eldelumab,Olaratumab,The risk or severity of adverse effects can be increased when Olaratumab is combined with Eldelumab.,increase,risk
Eldelumab,Omalizumab,The risk or severity of adverse effects can be increased when Omalizumab is combined with Eldelumab.,increase,risk
Eldelumab,Quinestrol,Quinestrol may increase the thrombogenic activities of Eldelumab.,increase,no risk
Eldelumab,Ublituximab,The risk or severity of adverse effects can be increased when Eldelumab is combined with Ublituximab.,increase,risk
Eldelumab,Ustekinumab,The risk or severity of adverse effects can be increased when Ustekinumab is combined with Eldelumab.,increase,risk
Eldelumab,Vedolizumab,The risk or severity of adverse effects can be increased when Eldelumab is combined with Vedolizumab.,increase,risk
"1alpha,24S-Dihydroxyvitamin D2",Vamorolone,"The therapeutic efficacy of 1alpha,24S-Dihydroxyvitamin D2 can be decreased when used in combination with Vamorolone.",decrease,no risk
"1alpha,24S-Dihydroxyvitamin D2",Vitamin D,"The risk or severity of adverse effects can be increased when 1alpha,24S-Dihydroxyvitamin D2 is combined with Vitamin D.",increase,risk
Cenobamate,Brivaracetam,The serum concentration of Brivaracetam can be decreased when it is combined with Cenobamate.,decrease,no risk
Cenobamate,Bromazepam,The metabolism of Cenobamate can be decreased when combined with Bromazepam.,decrease,no risk
Cenobamate,Bromocriptine,The serum concentration of Bromocriptine can be decreased when it is combined with Cenobamate.,decrease,no risk
Cenobamate,Bromotheophylline,Cenobamate may increase the excretion rate of Bromotheophylline which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Cenobamate,Brompheniramine,The serum concentration of Brompheniramine can be decreased when it is combined with Cenobamate.,decrease,no risk
Cenobamate,Budesonide,The serum concentration of Budesonide can be decreased when it is combined with Cenobamate.,decrease,no risk
Cenobamate,Bupivacaine,The serum concentration of Bupivacaine can be decreased when it is combined with Cenobamate.,decrease,no risk
Cenobamate,Buprenorphine,The serum concentration of Buprenorphine can be decreased when it is combined with Cenobamate.,decrease,no risk
Cenobamate,Bupropion,The serum concentration of Bupropion can be decreased when it is combined with Cenobamate.,decrease,no risk
Cenobamate,Buspirone,The serum concentration of Buspirone can be decreased when it is combined with Cenobamate.,decrease,no risk
Cenobamate,Busulfan,The serum concentration of Busulfan can be decreased when it is combined with Cenobamate.,decrease,no risk
Cenobamate,Butacaine,The risk or severity of methemoglobinemia can be increased when Cenobamate is combined with Butacaine.,increase,risk
Cenobamate,Butamben,The risk or severity of methemoglobinemia can be increased when Cenobamate is combined with Butamben.,increase,risk
Cenobamate,Butriptyline,The therapeutic efficacy of Cenobamate can be decreased when used in combination with Butriptyline.,decrease,no risk
Cenobamate,Galantamine,The serum concentration of Galantamine can be decreased when it is combined with Cenobamate.,decrease,no risk
Cenobamate,Gamolenic acid,The therapeutic efficacy of Cenobamate can be decreased when used in combination with Gamolenic acid.,decrease,no risk
Cenobamate,Ganciclovir,The therapeutic efficacy of Cenobamate can be decreased when used in combination with Ganciclovir.,decrease,no risk
Cenobamate,Gefitinib,The serum concentration of Gefitinib can be decreased when it is combined with Cenobamate.,decrease,no risk
Cenobamate,Gemfibrozil,The serum concentration of Gemfibrozil can be decreased when it is combined with Cenobamate.,decrease,no risk
Cenobamate,Gepirone,The serum concentration of Gepirone can be decreased when it is combined with Cenobamate.,decrease,no risk
Cenobamate,Gestrinone,The serum concentration of Gestrinone can be decreased when it is combined with Cenobamate.,decrease,no risk
Cenobamate,Gilteritinib,The serum concentration of Gilteritinib can be decreased when it is combined with Cenobamate.,decrease,no risk
Cenobamate,Glasdegib,The serum concentration of Glasdegib can be decreased when it is combined with Cenobamate.,decrease,no risk
Cenobamate,Gliclazide,The serum concentration of Gliclazide can be increased when it is combined with Cenobamate.,increase,no risk
Cenobamate,Glofitamab,The serum concentration of Cenobamate can be increased when it is combined with Glofitamab.,increase,no risk
Cenobamate,Glyburide,The serum concentration of Glyburide can be decreased when it is combined with Cenobamate.,decrease,no risk
Cenobamate,Glycerin,The metabolism of Cenobamate can be increased when combined with Glycerin.,increase,no risk
Cenobamate,Golimumab,The metabolism of Cenobamate can be increased when combined with Golimumab.,increase,no risk
Cenobamate,Granisetron,The serum concentration of Granisetron can be decreased when it is combined with Cenobamate.,decrease,no risk
Cenobamate,Grazoprevir,The serum concentration of Grazoprevir can be decreased when it is combined with Cenobamate.,decrease,no risk
Cenobamate,Grepafloxacin,The serum concentration of Grepafloxacin can be decreased when it is combined with Cenobamate.,decrease,no risk
Cenobamate,Guanfacine,The serum concentration of Guanfacine can be decreased when it is combined with Cenobamate.,decrease,no risk
Cenobamate,Halcinonide,The serum concentration of Halcinonide can be decreased when it is combined with Cenobamate.,decrease,no risk
Cenobamate,Halofantrine,The serum concentration of Halofantrine can be decreased when it is combined with Cenobamate.,decrease,no risk
Cenobamate,Haloperidol,The serum concentration of Haloperidol can be decreased when it is combined with Cenobamate.,decrease,no risk
Cenobamate,Halothane,The serum concentration of Halothane can be decreased when it is combined with Cenobamate.,decrease,no risk
Cenobamate,Hydrocodone,The serum concentration of Hydrocodone can be decreased when it is combined with Cenobamate.,decrease,no risk
Cenobamate,Hydrocortisone,The serum concentration of Hydrocortisone can be decreased when it is combined with Cenobamate.,decrease,no risk
Cenobamate,Hydrocortisone acetate,The serum concentration of Hydrocortisone acetate can be decreased when it is combined with Cenobamate.,decrease,no risk
Cenobamate,Hydrocortisone butyrate,The serum concentration of Hydrocortisone butyrate can be decreased when it is combined with Cenobamate.,decrease,no risk
Cenobamate,Hydrocortisone cypionate,The serum concentration of Hydrocortisone cypionate can be decreased when it is combined with Cenobamate.,decrease,no risk
Cenobamate,Hydrocortisone phosphate,The serum concentration of Hydrocortisone phosphate can be decreased when it is combined with Cenobamate.,decrease,no risk
Cenobamate,Hydrocortisone probutate,The serum concentration of Hydrocortisone probutate can be decreased when it is combined with Cenobamate.,decrease,no risk
Cenobamate,Hydrocortisone succinate,The serum concentration of Hydrocortisone succinate can be decreased when it is combined with Cenobamate.,decrease,no risk
Cenobamate,Hydrocortisone valerate,The serum concentration of Hydrocortisone valerate can be decreased when it is combined with Cenobamate.,decrease,no risk
Cenobamate,Hydroxychloroquine,The therapeutic efficacy of Cenobamate can be decreased when used in combination with Hydroxychloroquine.,decrease,no risk
Cenobamate,Hydroxyprogesterone caproate,The serum concentration of Hydroxyprogesterone caproate can be decreased when it is combined with Cenobamate.,decrease,no risk
Cenobamate,Hydroxyzine,The serum concentration of Hydroxyzine can be decreased when it is combined with Cenobamate.,decrease,no risk
Cenobamate,Ketamine,The serum concentration of Ketamine can be decreased when it is combined with Cenobamate.,decrease,no risk
Cenobamate,Ketazolam,The serum concentration of Ketazolam can be decreased when it is combined with Cenobamate.,decrease,no risk
Cenobamate,Ketoconazole,The serum concentration of Ketoconazole can be decreased when it is combined with Cenobamate.,decrease,no risk
Cenobamate,Ketorolac,The metabolism of Ketorolac can be increased when combined with Cenobamate.,increase,no risk
Cenobamate,Nabilone,The serum concentration of Nabilone can be decreased when it is combined with Cenobamate.,decrease,no risk
Cenobamate,Nalidixic acid,The therapeutic efficacy of Cenobamate can be decreased when used in combination with Nalidixic acid.,decrease,no risk
Cenobamate,Naloxegol,The serum concentration of Naloxegol can be decreased when it is combined with Cenobamate.,decrease,no risk
Cenobamate,Naproxen,The metabolism of Naproxen can be increased when combined with Cenobamate.,increase,no risk
Cenobamate,Nateglinide,The serum concentration of Nateglinide can be decreased when it is combined with Cenobamate.,decrease,no risk
Cenobamate,Nebivolol,The serum concentration of Nebivolol can be decreased when it is combined with Cenobamate.,decrease,no risk
Cenobamate,Nefazodone,The serum concentration of Nefazodone can be decreased when it is combined with Cenobamate.,decrease,no risk
Cenobamate,Nelfinavir,The serum concentration of Nelfinavir can be decreased when it is combined with Cenobamate.,decrease,no risk
Cenobamate,Neratinib,The serum concentration of Neratinib can be decreased when it is combined with Cenobamate.,decrease,no risk
Cenobamate,Netupitant,The serum concentration of Netupitant can be decreased when it is combined with Cenobamate.,decrease,no risk
Cenobamate,Nevirapine,The serum concentration of Nevirapine can be decreased when it is combined with Cenobamate.,decrease,no risk
Cenobamate,Niacin,The metabolism of Cenobamate can be decreased when combined with Niacin.,decrease,no risk
Cenobamate,Nialamide,The therapeutic efficacy of Cenobamate can be decreased when used in combination with Nialamide.,decrease,no risk
Cenobamate,Nicardipine,The serum concentration of Nicardipine can be decreased when it is combined with Cenobamate.,decrease,no risk
Cenobamate,Nicotine,The serum concentration of Nicotine can be decreased when it is combined with Cenobamate.,decrease,no risk
Cenobamate,Nifedipine,The serum concentration of Nifedipine can be decreased when it is combined with Cenobamate.,decrease,no risk
Cenobamate,Nilotinib,The serum concentration of Nilotinib can be decreased when it is combined with Cenobamate.,decrease,no risk
Cenobamate,Nilutamide,The serum concentration of Nilutamide can be increased when it is combined with Cenobamate.,increase,no risk
Cenobamate,Nilvadipine,The serum concentration of Nilvadipine can be decreased when it is combined with Cenobamate.,decrease,no risk
Cenobamate,Nimesulide,The serum concentration of Nimesulide can be decreased when it is combined with Cenobamate.,decrease,no risk
Cenobamate,Nimodipine,The serum concentration of Nimodipine can be decreased when it is combined with Cenobamate.,decrease,no risk
Cenobamate,Nintedanib,The serum concentration of Nintedanib can be decreased when it is combined with Cenobamate.,decrease,no risk
Cenobamate,Nirmatrelvir,The serum concentration of Nirmatrelvir can be decreased when it is combined with Cenobamate.,decrease,no risk
Cenobamate,Nirogacestat,The serum concentration of Nirogacestat can be decreased when it is combined with Cenobamate.,decrease,no risk
Cenobamate,Nisoldipine,The serum concentration of Nisoldipine can be decreased when it is combined with Cenobamate.,decrease,no risk
Cenobamate,Nitrazepam,The serum concentration of Nitrazepam can be decreased when it is combined with Cenobamate.,decrease,no risk
Cenobamate,Nitrendipine,The serum concentration of Nitrendipine can be decreased when it is combined with Cenobamate.,decrease,no risk
Cenobamate,Nomegestrol,The serum concentration of Nomegestrol can be decreased when it is combined with Cenobamate.,decrease,no risk
Cenobamate,Nomegestrol acetate,The serum concentration of Nomegestrol acetate can be decreased when it is combined with Cenobamate.,decrease,no risk
Cenobamate,Nonoxynol-9,The metabolism of Nonoxynol-9 can be increased when combined with Cenobamate.,increase,no risk
Cenobamate,Norelgestromin,The serum concentration of Norelgestromin can be decreased when it is combined with Cenobamate.,decrease,no risk
Cenobamate,Norethisterone,The serum concentration of Norethisterone can be decreased when it is combined with Cenobamate.,decrease,no risk
Cenobamate,Norethynodrel,The serum concentration of Norethynodrel can be decreased when it is combined with Cenobamate.,decrease,no risk
Cenobamate,Norgestimate,The serum concentration of Norgestimate can be decreased when it is combined with Cenobamate.,decrease,no risk
Cenobamate,Norgestrel,The serum concentration of Norgestrel can be decreased when it is combined with Cenobamate.,decrease,no risk
Cenobamate,Nortriptyline,The serum concentration of Nortriptyline can be decreased when it is combined with Cenobamate.,decrease,no risk
Cenobamate,Nylidrin,The serum concentration of Nylidrin can be decreased when it is combined with Cenobamate.,decrease,no risk
Cenobamate,Olanzapine,The metabolism of Cenobamate can be decreased when combined with Olanzapine.,decrease,no risk
Cenobamate,Olaparib,The serum concentration of Olaparib can be decreased when it is combined with Cenobamate.,decrease,no risk
Cenobamate,Oliceridine,The serum concentration of Oliceridine can be decreased when it is combined with Cenobamate.,decrease,no risk
Cenobamate,Olodaterol,The metabolism of Olodaterol can be increased when combined with Cenobamate.,increase,no risk
Cenobamate,Olutasidenib,The serum concentration of Olutasidenib can be decreased when it is combined with Cenobamate.,decrease,no risk
Cenobamate,Omaveloxolone,The serum concentration of Omaveloxolone can be decreased when it is combined with Cenobamate.,decrease,no risk
Cenobamate,Ombitasvir,The metabolism of Ombitasvir can be increased when combined with Cenobamate.,increase,no risk
Cenobamate,Omeprazole,The serum concentration of Omeprazole can be increased when it is combined with Cenobamate.,increase,no risk
Cenobamate,Ondansetron,The serum concentration of Ondansetron can be decreased when it is combined with Cenobamate.,decrease,no risk
Cenobamate,Opium,The serum concentration of Opium can be decreased when it is combined with Cenobamate.,decrease,no risk
Cenobamate,Oritavancin,The metabolism of Cenobamate can be decreased when combined with Oritavancin.,decrease,no risk
Cenobamate,Orlistat,Orlistat can cause a decrease in the absorption of Cenobamate resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Cenobamate,Orphenadrine,The serum concentration of Orphenadrine can be decreased when it is combined with Cenobamate.,decrease,no risk
Cenobamate,Osilodrostat,The serum concentration of Osilodrostat can be decreased when it is combined with Cenobamate.,decrease,no risk
Cenobamate,Osimertinib,The serum concentration of Osimertinib can be decreased when it is combined with Cenobamate.,decrease,no risk
Cenobamate,Ospemifene,The serum concentration of Ospemifene can be decreased when it is combined with Cenobamate.,decrease,no risk
Cenobamate,Oxcarbazepine,The metabolism of Cenobamate can be increased when combined with Oxcarbazepine.,increase,no risk
Cenobamate,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Cenobamate is combined with Oxetacaine.,increase,risk
Cenobamate,Oxtriphylline,Cenobamate may increase the excretion rate of Oxtriphylline which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Cenobamate,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Cenobamate is combined with Oxybuprocaine.,increase,risk
Cenobamate,Oxybutynin,The serum concentration of Oxybutynin can be decreased when it is combined with Cenobamate.,decrease,no risk
Cenobamate,Oxycodone,The serum concentration of Oxycodone can be decreased when it is combined with Cenobamate.,decrease,no risk
Cenobamate,Oxymorphone,The serum concentration of Oxymorphone can be decreased when it is combined with Cenobamate.,decrease,no risk
Cenobamate,Ozanimod,The metabolism of Ozanimod can be increased when combined with Cenobamate.,increase,no risk
Cenobamate,Quazepam,The serum concentration of Quazepam can be decreased when it is combined with Cenobamate.,decrease,no risk
Cenobamate,Quetiapine,The serum concentration of Quetiapine can be decreased when it is combined with Cenobamate.,decrease,no risk
Cenobamate,Quinidine,The serum concentration of Quinidine can be decreased when it is combined with Cenobamate.,decrease,no risk
Cenobamate,Quinine,The serum concentration of Quinine can be decreased when it is combined with Cenobamate.,decrease,no risk
Cenobamate,Quinupramine,The therapeutic efficacy of Cenobamate can be decreased when used in combination with Quinupramine.,decrease,no risk
Cenobamate,Quizartinib,The serum concentration of Quizartinib can be decreased when it is combined with Cenobamate.,decrease,no risk
Amatuximab,Natalizumab,The risk or severity of adverse effects can be increased when Natalizumab is combined with Amatuximab.,increase,risk
Amatuximab,Necitumumab,The risk or severity of adverse effects can be increased when Necitumumab is combined with Amatuximab.,increase,risk
Amatuximab,Nivolumab,The risk or severity of adverse effects can be increased when Nivolumab is combined with Amatuximab.,increase,risk
Amatuximab,Obiltoxaximab,The risk or severity of adverse effects can be increased when Obiltoxaximab is combined with Amatuximab.,increase,risk
Amatuximab,Obinutuzumab,The risk or severity of adverse effects can be increased when Obinutuzumab is combined with Amatuximab.,increase,risk
Amatuximab,Ocrelizumab,The risk or severity of adverse effects can be increased when Ocrelizumab is combined with Amatuximab.,increase,risk
Amatuximab,Odesivimab,The risk or severity of adverse effects can be increased when Amatuximab is combined with Odesivimab.,increase,risk
Amatuximab,Ofatumumab,The risk or severity of adverse effects can be increased when Ofatumumab is combined with Amatuximab.,increase,risk
Amatuximab,Olaratumab,The risk or severity of adverse effects can be increased when Olaratumab is combined with Amatuximab.,increase,risk
Amatuximab,Omalizumab,The risk or severity of adverse effects can be increased when Omalizumab is combined with Amatuximab.,increase,risk
Amatuximab,Quinestrol,Quinestrol may increase the thrombogenic activities of Amatuximab.,increase,no risk
Amatuximab,Ublituximab,The risk or severity of adverse effects can be increased when Ublituximab is combined with Amatuximab.,increase,risk
Amatuximab,Ustekinumab,The risk or severity of adverse effects can be increased when Ustekinumab is combined with Amatuximab.,increase,risk
Amatuximab,Vedolizumab,The risk or severity of adverse effects can be increased when Vedolizumab is combined with Amatuximab.,increase,risk
Bisegliptin,Gatifloxacin,The therapeutic efficacy of Bisegliptin can be increased when used in combination with Gatifloxacin.,increase,no risk
Bisegliptin,Gefapixant,The therapeutic efficacy of Bisegliptin can be increased when used in combination with Gefapixant.,increase,no risk
Bisegliptin,Gemifloxacin,The therapeutic efficacy of Bisegliptin can be increased when used in combination with Gemifloxacin.,increase,no risk
Bisegliptin,Gliclazide,Bisegliptin may increase the hypoglycemic activities of Gliclazide.,increase,no risk
Bisegliptin,Glimepiride,Bisegliptin may increase the hypoglycemic activities of Glimepiride.,increase,no risk
Bisegliptin,Glipizide,Bisegliptin may increase the hypoglycemic activities of Glipizide.,increase,no risk
Bisegliptin,Gliquidone,Bisegliptin may increase the hypoglycemic activities of Gliquidone.,increase,no risk
Bisegliptin,Glyburide,Bisegliptin may increase the hypoglycemic activities of Glyburide.,increase,no risk
Bisegliptin,Glymidine,The therapeutic efficacy of Bisegliptin can be increased when used in combination with Glymidine.,increase,no risk
Bisegliptin,Goserelin,The therapeutic efficacy of Bisegliptin can be decreased when used in combination with Goserelin.,decrease,no risk
Bisegliptin,Grepafloxacin,The therapeutic efficacy of Bisegliptin can be increased when used in combination with Grepafloxacin.,increase,no risk
Bisegliptin,Halcinonide,The risk or severity of hyperglycemia can be increased when Halcinonide is combined with Bisegliptin.,increase,risk
Bisegliptin,Haloperidol,The therapeutic efficacy of Bisegliptin can be decreased when used in combination with Haloperidol.,decrease,no risk
Bisegliptin,Histrelin,The therapeutic efficacy of Bisegliptin can be decreased when used in combination with Histrelin.,decrease,no risk
Bisegliptin,Hydrochlorothiazide,The therapeutic efficacy of Bisegliptin can be decreased when used in combination with Hydrochlorothiazide.,decrease,no risk
Bisegliptin,Hydrocortisone,The risk or severity of hyperglycemia can be increased when Hydrocortisone is combined with Bisegliptin.,increase,risk
Bisegliptin,Hydrocortisone acetate,The risk or severity of hyperglycemia can be increased when Hydrocortisone acetate is combined with Bisegliptin.,increase,risk
Bisegliptin,Hydrocortisone butyrate,The risk or severity of hyperglycemia can be increased when Hydrocortisone butyrate is combined with Bisegliptin.,increase,risk
Bisegliptin,Hydrocortisone cypionate,The risk or severity of hyperglycemia can be increased when Hydrocortisone cypionate is combined with Bisegliptin.,increase,risk
Bisegliptin,Hydrocortisone probutate,The risk or severity of hyperglycemia can be increased when Hydrocortisone probutate is combined with Bisegliptin.,increase,risk
Bisegliptin,Hydrocortisone succinate,The risk or severity of hyperglycemia can be increased when Hydrocortisone succinate is combined with Bisegliptin.,increase,risk
Bisegliptin,Hydrocortisone valerate,The risk or severity of hyperglycemia can be increased when Hydrocortisone valerate is combined with Bisegliptin.,increase,risk
Bisegliptin,Hydroflumethiazide,The therapeutic efficacy of Bisegliptin can be decreased when used in combination with Hydroflumethiazide.,decrease,no risk
Bisegliptin,Hydroxychloroquine,The therapeutic efficacy of Bisegliptin can be increased when used in combination with Hydroxychloroquine.,increase,no risk
Bisegliptin,Hydroxyprogesterone caproate,The therapeutic efficacy of Bisegliptin can be decreased when used in combination with Hydroxyprogesterone caproate.,decrease,no risk
Bisegliptin,Nadolol,The therapeutic efficacy of Bisegliptin can be increased when used in combination with Nadolol.,increase,no risk
Bisegliptin,Nalidixic acid,The therapeutic efficacy of Bisegliptin can be increased when used in combination with Nalidixic acid.,increase,no risk
Bisegliptin,Nandrolone decanoate,Nandrolone decanoate may increase the hypoglycemic activities of Bisegliptin.,increase,no risk
Bisegliptin,Nandrolone phenpropionate,Nandrolone phenpropionate may increase the hypoglycemic activities of Bisegliptin.,increase,no risk
Bisegliptin,Nateglinide,The risk or severity of hypoglycemia can be increased when Nateglinide is combined with Bisegliptin.,increase,risk
Bisegliptin,Nebivolol,The therapeutic efficacy of Bisegliptin can be increased when used in combination with Nebivolol.,increase,no risk
Bisegliptin,Nefazodone,The risk or severity of hypoglycemia can be increased when Nefazodone is combined with Bisegliptin.,increase,risk
Bisegliptin,Nelfinavir,The therapeutic efficacy of Bisegliptin can be decreased when used in combination with Nelfinavir.,decrease,no risk
Bisegliptin,Niacin,The therapeutic efficacy of Bisegliptin can be decreased when used in combination with Niacin.,decrease,no risk
Bisegliptin,Nialamide,Nialamide may increase the hypoglycemic activities of Bisegliptin.,increase,no risk
Bisegliptin,Nicardipine,The risk or severity of hypoglycemia can be increased when Nicardipine is combined with Bisegliptin.,increase,risk
Bisegliptin,Nifedipine,The risk or severity of hypoglycemia can be increased when Nifedipine is combined with Bisegliptin.,increase,risk
Bisegliptin,Nilotinib,The therapeutic efficacy of Bisegliptin can be decreased when used in combination with Nilotinib.,decrease,no risk
Bisegliptin,Nilvadipine,The risk or severity of hypoglycemia can be increased when Nilvadipine is combined with Bisegliptin.,increase,risk
Bisegliptin,Nimesulide,The risk or severity of hypoglycemia can be increased when Nimesulide is combined with Bisegliptin.,increase,risk
Bisegliptin,Nimodipine,The risk or severity of hypoglycemia can be increased when Nimodipine is combined with Bisegliptin.,increase,risk
Bisegliptin,Nisoldipine,The risk or severity of hypoglycemia can be increased when Nisoldipine is combined with Bisegliptin.,increase,risk
Bisegliptin,Nitrendipine,The risk or severity of hypoglycemia can be increased when Nitrendipine is combined with Bisegliptin.,increase,risk
Bisegliptin,Norethisterone,The therapeutic efficacy of Bisegliptin can be decreased when used in combination with Norethisterone.,decrease,no risk
Bisegliptin,Norfloxacin,The therapeutic efficacy of Bisegliptin can be increased when used in combination with Norfloxacin.,increase,no risk
Bisegliptin,Norgestimate,The therapeutic efficacy of Bisegliptin can be decreased when used in combination with Norgestimate.,decrease,no risk
Bisegliptin,Nortriptyline,Nortriptyline may decrease the hypoglycemic activities of Bisegliptin.,decrease,no risk
Bisegliptin,Nylidrin,The risk or severity of hypoglycemia can be increased when Nylidrin is combined with Bisegliptin.,increase,risk
Bisegliptin,Octreotide,The therapeutic efficacy of Bisegliptin can be decreased when used in combination with Octreotide.,decrease,no risk
Bisegliptin,Ofloxacin,The therapeutic efficacy of Bisegliptin can be increased when used in combination with Ofloxacin.,increase,no risk
Bisegliptin,Olanzapine,The therapeutic efficacy of Bisegliptin can be decreased when used in combination with Olanzapine.,decrease,no risk
Bisegliptin,Olsalazine,Olsalazine may increase the hypoglycemic activities of Bisegliptin.,increase,no risk
Bisegliptin,Oxandrolone,Oxandrolone may increase the hypoglycemic activities of Bisegliptin.,increase,no risk
Bisegliptin,Oxprenolol,The therapeutic efficacy of Bisegliptin can be increased when used in combination with Oxprenolol.,increase,no risk
Bisegliptin,Oxymetholone,Oxymetholone may increase the hypoglycemic activities of Bisegliptin.,increase,no risk
Bisegliptin,Quetiapine,The therapeutic efficacy of Bisegliptin can be decreased when used in combination with Quetiapine.,decrease,no risk
Bisegliptin,Quinapril,The risk or severity of angioedema can be increased when Bisegliptin is combined with Quinapril.,increase,risk
Bisegliptin,Quinethazone,The therapeutic efficacy of Bisegliptin can be decreased when used in combination with Quinethazone.,decrease,no risk
Bisegliptin,Quinine,The risk or severity of hypoglycemia can be increased when Quinine is combined with Bisegliptin.,increase,risk
Bisegliptin,Quinupramine,Quinupramine may decrease the hypoglycemic activities of Bisegliptin.,decrease,no risk
Bisegliptin,Ubidecarenone,The risk or severity of hypoglycemia can be increased when Ubidecarenone is combined with Bisegliptin.,increase,risk
Bisegliptin,Udenafil,The therapeutic efficacy of Bisegliptin can be increased when used in combination with Udenafil.,increase,no risk
Bisegliptin,Ulobetasol,The risk or severity of hyperglycemia can be increased when Ulobetasol is combined with Bisegliptin.,increase,risk
Bisegliptin,Urokinase,The risk or severity of angioedema can be increased when Urokinase is combined with Bisegliptin.,increase,risk
Bisegliptin,Valdecoxib,The therapeutic efficacy of Bisegliptin can be increased when used in combination with Valdecoxib.,increase,no risk
Bisegliptin,Valsartan,The risk or severity of angioedema can be increased when Valsartan is combined with Bisegliptin.,increase,risk
Bisegliptin,Vamorolone,The risk or severity of hyperglycemia can be increased when Vamorolone is combined with Bisegliptin.,increase,risk
Bisegliptin,Vemurafenib,The therapeutic efficacy of Bisegliptin can be increased when used in combination with Vemurafenib.,increase,no risk
Bisegliptin,Venlafaxine,The risk or severity of hypoglycemia can be increased when Venlafaxine is combined with Bisegliptin.,increase,risk
Bisegliptin,Verapamil,The risk or severity of hypoglycemia can be increased when Verapamil is combined with Bisegliptin.,increase,risk
Bisegliptin,Vildagliptin,The risk or severity of angioedema can be increased when Vildagliptin is combined with Bisegliptin.,increase,risk
Bisegliptin,Vorinostat,The therapeutic efficacy of Bisegliptin can be decreased when used in combination with Vorinostat.,decrease,no risk
Bisegliptin,Xylometazoline,The risk or severity of hypoglycemia can be increased when Xylometazoline is combined with Bisegliptin.,increase,risk
Bisegliptin,Ziconotide,The risk or severity of hypoglycemia can be increased when Ziconotide is combined with Bisegliptin.,increase,risk
Bisegliptin,Zimelidine,The risk or severity of hypoglycemia can be increased when Zimelidine is combined with Bisegliptin.,increase,risk
Bisegliptin,Ziprasidone,The therapeutic efficacy of Bisegliptin can be decreased when used in combination with Ziprasidone.,decrease,no risk
Bisegliptin,Zofenopril,The risk or severity of angioedema can be increased when Bisegliptin is combined with Zofenopril.,increase,risk
Bisegliptin,Zonisamide,The therapeutic efficacy of Bisegliptin can be increased when used in combination with Zonisamide.,increase,no risk
Nivolumab,Human varicella-zoster immune globulin,The risk or severity of adverse effects can be increased when Nivolumab is combined with Human varicella-zoster immune globulin.,increase,risk
Nivolumab,Natalizumab,The risk or severity of adverse effects can be increased when Natalizumab is combined with Nivolumab.,increase,risk
Nivolumab,Necitumumab,The risk or severity of adverse effects can be increased when Nivolumab is combined with Necitumumab.,increase,risk
Nivolumab,Obiltoxaximab,The risk or severity of adverse effects can be increased when Obiltoxaximab is combined with Nivolumab.,increase,risk
Nivolumab,Obinutuzumab,The risk or severity of adverse effects can be increased when Obinutuzumab is combined with Nivolumab.,increase,risk
Nivolumab,Ocrelizumab,The risk or severity of adverse effects can be increased when Nivolumab is combined with Ocrelizumab.,increase,risk
Nivolumab,Odesivimab,The risk or severity of adverse effects can be increased when Nivolumab is combined with Odesivimab.,increase,risk
Nivolumab,Ofatumumab,The risk or severity of adverse effects can be increased when Ofatumumab is combined with Nivolumab.,increase,risk
Nivolumab,Olaratumab,The risk or severity of adverse effects can be increased when Olaratumab is combined with Nivolumab.,increase,risk
Nivolumab,Omalizumab,The risk or severity of adverse effects can be increased when Omalizumab is combined with Nivolumab.,increase,risk
Nivolumab,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Nivolumab is combined with Oxetacaine.,increase,risk
Nivolumab,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Nivolumab is combined with Oxybuprocaine.,increase,risk
Nivolumab,Quinestrol,Quinestrol may increase the thrombogenic activities of Nivolumab.,increase,no risk
Nivolumab,Ublituximab,The risk or severity of adverse effects can be increased when Nivolumab is combined with Ublituximab.,increase,risk
Nivolumab,Ustekinumab,The risk or severity of adverse effects can be increased when Ustekinumab is combined with Nivolumab.,increase,risk
Nivolumab,Vedolizumab,The risk or severity of adverse effects can be increased when Vedolizumab is combined with Nivolumab.,increase,risk
Tirbanibulin,Voriconazole,The serum concentration of Tirbanibulin can be increased when it is combined with Voriconazole.,increase,no risk
Tucatinib,Butacaine,The risk or severity of methemoglobinemia can be increased when Tucatinib is combined with Butacaine.,increase,risk
Tucatinib,Butamben,The risk or severity of methemoglobinemia can be increased when Tucatinib is combined with Butamben.,increase,risk
Tucatinib,Galantamine,The metabolism of Tucatinib can be decreased when combined with Galantamine.,decrease,no risk
Tucatinib,Ganciclovir,The excretion of Ganciclovir can be decreased when combined with Tucatinib.,decrease,no risk
Tucatinib,Gefitinib,The metabolism of Tucatinib can be decreased when combined with Gefitinib.,decrease,no risk
Tucatinib,Gemcitabine,Tucatinib may decrease the excretion rate of Gemcitabine which could result in a higher serum level.,decrease,no risk
Tucatinib,Gemfibrozil,The metabolism of Tucatinib can be decreased when combined with Gemfibrozil.,decrease,no risk
Tucatinib,Gentamicin,The serum concentration of Gentamicin can be increased when it is combined with Tucatinib.,increase,no risk
Tucatinib,Gepirone,The metabolism of Tucatinib can be decreased when combined with Gepirone.,decrease,no risk
Tucatinib,Gestrinone,The metabolism of Tucatinib can be decreased when combined with Gestrinone.,decrease,no risk
Tucatinib,Gilteritinib,Tucatinib may decrease the excretion rate of Gilteritinib which could result in a higher serum level.,decrease,no risk
Tucatinib,Glasdegib,Tucatinib may decrease the excretion rate of Glasdegib which could result in a higher serum level.,decrease,no risk
Tucatinib,Glecaprevir,Tucatinib may decrease the excretion rate of Glecaprevir which could result in a higher serum level.,decrease,no risk
Tucatinib,Glyburide,The metabolism of Tucatinib can be decreased when combined with Glyburide.,decrease,no risk
Tucatinib,Golimumab,The metabolism of Tucatinib can be increased when combined with Golimumab.,increase,no risk
Tucatinib,Granisetron,The metabolism of Tucatinib can be decreased when combined with Granisetron.,decrease,no risk
Tucatinib,Grazoprevir,Tucatinib may decrease the excretion rate of Grazoprevir which could result in a higher serum level.,decrease,no risk
Tucatinib,Grepafloxacin,The metabolism of Tucatinib can be decreased when combined with Grepafloxacin.,decrease,no risk
Tucatinib,Guanfacine,The metabolism of Tucatinib can be decreased when combined with Guanfacine.,decrease,no risk
Tucatinib,Guanidine,The excretion of Guanidine can be decreased when combined with Tucatinib.,decrease,no risk
Tucatinib,Halcinonide,The metabolism of Tucatinib can be decreased when combined with Halcinonide.,decrease,no risk
Tucatinib,Halofantrine,The metabolism of Tucatinib can be decreased when combined with Halofantrine.,decrease,no risk
Tucatinib,Haloperidol,The metabolism of Tucatinib can be decreased when combined with Haloperidol.,decrease,no risk
Tucatinib,Halothane,The metabolism of Tucatinib can be decreased when combined with Halothane.,decrease,no risk
Tucatinib,Histamine,The serum concentration of Histamine can be increased when it is combined with Tucatinib.,increase,no risk
Tucatinib,Hydrocodone,The metabolism of Tucatinib can be decreased when combined with Hydrocodone.,decrease,no risk
Tucatinib,Hydrocortisone,The metabolism of Tucatinib can be decreased when combined with Hydrocortisone.,decrease,no risk
Tucatinib,Hydrocortisone acetate,The metabolism of Tucatinib can be decreased when combined with Hydrocortisone acetate.,decrease,no risk
Tucatinib,Hydrocortisone butyrate,The metabolism of Tucatinib can be decreased when combined with Hydrocortisone butyrate.,decrease,no risk
Tucatinib,Hydrocortisone cypionate,The metabolism of Tucatinib can be decreased when combined with Hydrocortisone cypionate.,decrease,no risk
Tucatinib,Hydrocortisone phosphate,The metabolism of Tucatinib can be decreased when combined with Hydrocortisone phosphate.,decrease,no risk
Tucatinib,Hydrocortisone probutate,The metabolism of Tucatinib can be decreased when combined with Hydrocortisone probutate.,decrease,no risk
Tucatinib,Hydrocortisone succinate,The metabolism of Tucatinib can be decreased when combined with Hydrocortisone succinate.,decrease,no risk
Tucatinib,Hydrocortisone valerate,The metabolism of Tucatinib can be decreased when combined with Hydrocortisone valerate.,decrease,no risk
Tucatinib,Hydroxychloroquine,The metabolism of Tucatinib can be decreased when combined with Hydroxychloroquine.,decrease,no risk
Tucatinib,Hydroxyprogesterone caproate,The metabolism of Tucatinib can be decreased when combined with Hydroxyprogesterone caproate.,decrease,no risk
Tucatinib,Hydroxyzine,The metabolism of Hydroxyzine can be decreased when combined with Tucatinib.,decrease,no risk
Tucatinib,Ketamine,The metabolism of Tucatinib can be decreased when combined with Ketamine.,decrease,no risk
Tucatinib,Ketazolam,The metabolism of Tucatinib can be decreased when combined with Ketazolam.,decrease,no risk
Tucatinib,Ketoconazole,The metabolism of Tucatinib can be decreased when combined with Ketoconazole.,decrease,no risk
Tucatinib,Ketoprofen,The metabolism of Tucatinib can be decreased when combined with Ketoprofen.,decrease,no risk
Tucatinib,Ketorolac,The metabolism of Tucatinib can be decreased when combined with Ketorolac.,decrease,no risk
Tucatinib,Nabilone,The metabolism of Tucatinib can be decreased when combined with Nabilone.,decrease,no risk
Tucatinib,Nadolol,The excretion of Nadolol can be decreased when combined with Tucatinib.,decrease,no risk
Tucatinib,Naloxegol,The serum concentration of Naloxegol can be increased when it is combined with Tucatinib.,increase,no risk
Tucatinib,Naproxen,The metabolism of Tucatinib can be decreased when combined with Naproxen.,decrease,no risk
Tucatinib,Nateglinide,The metabolism of Tucatinib can be decreased when combined with Nateglinide.,decrease,no risk
Tucatinib,Nebivolol,The metabolism of Tucatinib can be decreased when combined with Nebivolol.,decrease,no risk
Tucatinib,Nefazodone,The metabolism of Tucatinib can be decreased when combined with Nefazodone.,decrease,no risk
Tucatinib,Nelfinavir,The metabolism of Tucatinib can be decreased when combined with Nelfinavir.,decrease,no risk
Tucatinib,Neratinib,The metabolism of Tucatinib can be decreased when combined with Neratinib.,decrease,no risk
Tucatinib,Netupitant,The metabolism of Tucatinib can be decreased when combined with Netupitant.,decrease,no risk
Tucatinib,Nevirapine,The metabolism of Tucatinib can be decreased when combined with Nevirapine.,decrease,no risk
Tucatinib,Nicardipine,The metabolism of Tucatinib can be decreased when combined with Nicardipine.,decrease,no risk
Tucatinib,Nifedipine,The metabolism of Tucatinib can be decreased when combined with Nifedipine.,decrease,no risk
Tucatinib,Nilotinib,The metabolism of Tucatinib can be decreased when combined with Nilotinib.,decrease,no risk
Tucatinib,Nilutamide,The metabolism of Tucatinib can be decreased when combined with Nilutamide.,decrease,no risk
Tucatinib,Nilvadipine,The metabolism of Tucatinib can be decreased when combined with Nilvadipine.,decrease,no risk
Tucatinib,Nimesulide,The metabolism of Tucatinib can be decreased when combined with Nimesulide.,decrease,no risk
Tucatinib,Nimodipine,The metabolism of Tucatinib can be decreased when combined with Nimodipine.,decrease,no risk
Tucatinib,Nintedanib,Tucatinib may decrease the excretion rate of Nintedanib which could result in a higher serum level.,decrease,no risk
Tucatinib,Nirmatrelvir,The metabolism of Tucatinib can be decreased when combined with Nirmatrelvir.,decrease,no risk
Tucatinib,Nirogacestat,Tucatinib may decrease the excretion rate of Nirogacestat which could result in a higher serum level.,decrease,no risk
Tucatinib,Nisoldipine,The metabolism of Tucatinib can be decreased when combined with Nisoldipine.,decrease,no risk
Tucatinib,Nitrazepam,The metabolism of Tucatinib can be decreased when combined with Nitrazepam.,decrease,no risk
Tucatinib,Nitrendipine,The metabolism of Tucatinib can be decreased when combined with Nitrendipine.,decrease,no risk
Tucatinib,Nomegestrol,The metabolism of Tucatinib can be decreased when combined with Nomegestrol.,decrease,no risk
Tucatinib,Nomegestrol acetate,The metabolism of Tucatinib can be decreased when combined with Nomegestrol acetate.,decrease,no risk
Tucatinib,Norelgestromin,The metabolism of Tucatinib can be decreased when combined with Norelgestromin.,decrease,no risk
Tucatinib,Norepinephrine,The serum concentration of Norepinephrine can be increased when it is combined with Tucatinib.,increase,no risk
Tucatinib,Norethisterone,The metabolism of Tucatinib can be decreased when combined with Norethisterone.,decrease,no risk
Tucatinib,Norethynodrel,The metabolism of Tucatinib can be decreased when combined with Norethynodrel.,decrease,no risk
Tucatinib,Norgestimate,The metabolism of Tucatinib can be decreased when combined with Norgestimate.,decrease,no risk
Tucatinib,Norgestrel,The metabolism of Tucatinib can be decreased when combined with Norgestrel.,decrease,no risk
Tucatinib,Nortriptyline,The metabolism of Tucatinib can be decreased when combined with Nortriptyline.,decrease,no risk
Tucatinib,Novobiocin,Novobiocin may decrease the excretion rate of Tucatinib which could result in a higher serum level.,decrease,no risk
Tucatinib,Nylidrin,The metabolism of Tucatinib can be decreased when combined with Nylidrin.,decrease,no risk
Tucatinib,Olaparib,The metabolism of Tucatinib can be decreased when combined with Olaparib.,decrease,no risk
Tucatinib,Oliceridine,The metabolism of Tucatinib can be decreased when combined with Oliceridine.,decrease,no risk
Tucatinib,Olodaterol,The metabolism of Tucatinib can be decreased when combined with Olodaterol.,decrease,no risk
Tucatinib,Olutasidenib,The metabolism of Tucatinib can be decreased when combined with Olutasidenib.,decrease,no risk
Tucatinib,Omadacycline,Tucatinib may decrease the excretion rate of Omadacycline which could result in a higher serum level.,decrease,no risk
Tucatinib,Omaveloxolone,The metabolism of Tucatinib can be decreased when combined with Omaveloxolone.,decrease,no risk
Tucatinib,Ombitasvir,Tucatinib may decrease the excretion rate of Ombitasvir which could result in a higher serum level.,decrease,no risk
Tucatinib,Ondansetron,The metabolism of Tucatinib can be decreased when combined with Ondansetron.,decrease,no risk
Tucatinib,Opium,The metabolism of Tucatinib can be decreased when combined with Opium.,decrease,no risk
Tucatinib,Orphenadrine,The metabolism of Tucatinib can be decreased when combined with Orphenadrine.,decrease,no risk
Tucatinib,Osilodrostat,The metabolism of Tucatinib can be decreased when combined with Osilodrostat.,decrease,no risk
Tucatinib,Osimertinib,Tucatinib may decrease the excretion rate of Osimertinib which could result in a higher serum level.,decrease,no risk
Tucatinib,Ospemifene,The metabolism of Tucatinib can be decreased when combined with Ospemifene.,decrease,no risk
Tucatinib,Oteseconazole,The serum concentration of Tucatinib can be increased when it is combined with Oteseconazole.,increase,no risk
Tucatinib,Oxaliplatin,The serum concentration of Oxaliplatin can be increased when it is combined with Tucatinib.,increase,no risk
Tucatinib,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Tucatinib is combined with Oxetacaine.,increase,risk
Tucatinib,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Tucatinib is combined with Oxybuprocaine.,increase,risk
Tucatinib,Oxybutynin,The metabolism of Tucatinib can be decreased when combined with Oxybutynin.,decrease,no risk
Tucatinib,Oxycodone,The metabolism of Tucatinib can be decreased when combined with Oxycodone.,decrease,no risk
Tucatinib,Oxymorphone,The metabolism of Tucatinib can be decreased when combined with Oxymorphone.,decrease,no risk
Tucatinib,Ozanimod,The metabolism of Ozanimod can be decreased when combined with Tucatinib.,decrease,no risk
Tucatinib,Quazepam,The metabolism of Tucatinib can be decreased when combined with Quazepam.,decrease,no risk
Tucatinib,Quetiapine,The metabolism of Tucatinib can be decreased when combined with Quetiapine.,decrease,no risk
Tucatinib,Quinidine,Tucatinib may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Tucatinib,Quinine,Tucatinib may decrease the excretion rate of Quinine which could result in a higher serum level.,decrease,no risk
Tucatinib,Quizartinib,Tucatinib may decrease the excretion rate of Quizartinib which could result in a higher serum level.,decrease,no risk
Tucatinib,Ubrogepant,The serum concentration of Ubrogepant can be increased when it is combined with Tucatinib.,increase,no risk
Tucatinib,Udenafil,The metabolism of Tucatinib can be decreased when combined with Udenafil.,decrease,no risk
Tucatinib,Ulipristal,The metabolism of Tucatinib can be decreased when combined with Ulipristal.,decrease,no risk
Tucatinib,Umbralisib,The serum concentration of Tucatinib can be increased when it is combined with Umbralisib.,increase,no risk
Tucatinib,Umeclidinium,Tucatinib may decrease the excretion rate of Umeclidinium which could result in a higher serum level.,decrease,no risk
Tucatinib,Upadacitinib,The metabolism of Tucatinib can be decreased when combined with Upadacitinib.,decrease,no risk
Tucatinib,Vadadustat,The serum concentration of Tucatinib can be increased when it is combined with Vadadustat.,increase,no risk
Tucatinib,Valbenazine,The metabolism of Tucatinib can be decreased when combined with Valbenazine.,decrease,no risk
Tucatinib,Valdecoxib,The metabolism of Tucatinib can be decreased when combined with Valdecoxib.,decrease,no risk
Tucatinib,Vamorolone,The metabolism of Tucatinib can be decreased when combined with Vamorolone.,decrease,no risk
Tucatinib,Vandetanib,The metabolism of Tucatinib can be decreased when combined with Vandetanib.,decrease,no risk
Tucatinib,Vardenafil,Tucatinib may decrease the excretion rate of Vardenafil which could result in a higher serum level.,decrease,no risk
Tucatinib,Varenicline,The excretion of Varenicline can be decreased when combined with Tucatinib.,decrease,no risk
Tucatinib,Velpatasvir,Tucatinib may decrease the excretion rate of Velpatasvir which could result in a higher serum level.,decrease,no risk
Tucatinib,Vemurafenib,The serum concentration of Tucatinib can be increased when it is combined with Vemurafenib.,increase,no risk
Tucatinib,Venetoclax,Tucatinib may decrease the excretion rate of Venetoclax which could result in a higher serum level.,decrease,no risk
Tucatinib,Venlafaxine,The metabolism of Tucatinib can be decreased when combined with Venlafaxine.,decrease,no risk
Tucatinib,Verapamil,Tucatinib may decrease the excretion rate of Verapamil which could result in a higher serum level.,decrease,no risk
Tucatinib,Vilanterol,The metabolism of Tucatinib can be decreased when combined with Vilanterol.,decrease,no risk
Tucatinib,Vilazodone,The metabolism of Tucatinib can be decreased when combined with Vilazodone.,decrease,no risk
Tucatinib,Vinblastine,Tucatinib may decrease the excretion rate of Vinblastine which could result in a higher serum level.,decrease,no risk
Tucatinib,Vincristine,Tucatinib may decrease the excretion rate of Vincristine which could result in a higher serum level.,decrease,no risk
Tucatinib,Vindesine,The metabolism of Tucatinib can be decreased when combined with Vindesine.,decrease,no risk
Tucatinib,Vinflunine,Tucatinib may decrease the excretion rate of Vinflunine which could result in a higher serum level.,decrease,no risk
Tucatinib,Vinorelbine,The metabolism of Tucatinib can be decreased when combined with Vinorelbine.,decrease,no risk
Tucatinib,Vismodegib,Vismodegib may decrease the excretion rate of Tucatinib which could result in a higher serum level.,decrease,no risk
Tucatinib,Vitamin D,The metabolism of Tucatinib can be decreased when combined with Vitamin D.,decrease,no risk
Tucatinib,Vitamin E,The metabolism of Tucatinib can be decreased when combined with Vitamin E.,decrease,no risk
Tucatinib,Voclosporin,Tucatinib may decrease the excretion rate of Voclosporin which could result in a higher serum level.,decrease,no risk
Tucatinib,Vonoprazan,The metabolism of Tucatinib can be decreased when combined with Vonoprazan.,decrease,no risk
Tucatinib,Vorapaxar,The metabolism of Tucatinib can be decreased when combined with Vorapaxar.,decrease,no risk
Tucatinib,Voriconazole,The metabolism of Tucatinib can be decreased when combined with Voriconazole.,decrease,no risk
Tucatinib,Vortioxetine,The metabolism of Tucatinib can be decreased when combined with Vortioxetine.,decrease,no risk
Tucatinib,Voxelotor,The metabolism of Tucatinib can be decreased when combined with Voxelotor.,decrease,no risk
Tucatinib,Voxilaprevir,Tucatinib may decrease the excretion rate of Voxilaprevir which could result in a higher serum level.,decrease,no risk
Tucatinib,Warfarin,The metabolism of Tucatinib can be decreased when combined with Warfarin.,decrease,no risk
Tucatinib,Yohimbine,The metabolism of Tucatinib can be decreased when combined with Yohimbine.,decrease,no risk
Tucatinib,Zaleplon,The metabolism of Tucatinib can be decreased when combined with Zaleplon.,decrease,no risk
Tucatinib,Zanubrutinib,The metabolism of Tucatinib can be decreased when combined with Zanubrutinib.,decrease,no risk
Tucatinib,Zidovudine,The metabolism of Tucatinib can be decreased when combined with Zidovudine.,decrease,no risk
Tucatinib,Zileuton,The metabolism of Tucatinib can be decreased when combined with Zileuton.,decrease,no risk
Tucatinib,Ziprasidone,The metabolism of Tucatinib can be decreased when combined with Ziprasidone.,decrease,no risk
Tucatinib,Zolpidem,The metabolism of Tucatinib can be decreased when combined with Zolpidem.,decrease,no risk
Tucatinib,Zonisamide,The metabolism of Tucatinib can be decreased when combined with Zonisamide.,decrease,no risk
Tucatinib,Zopiclone,The metabolism of Tucatinib can be decreased when combined with Zopiclone.,decrease,no risk
Tucatinib,Zotepine,The metabolism of Tucatinib can be decreased when combined with Zotepine.,decrease,no risk
Tucatinib,Zuclopenthixol,The metabolism of Tucatinib can be decreased when combined with Zuclopenthixol.,decrease,no risk
Tucatinib,Zuranolone,The metabolism of Tucatinib can be decreased when combined with Zuranolone.,decrease,no risk
Sertindole,Gabapentin,The risk or severity of CNS depression can be increased when Gabapentin is combined with Sertindole.,increase,risk
Sertindole,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Sertindole is combined with Gabapentin enacarbil.,increase,risk
Sertindole,Galantamine,The metabolism of Sertindole can be decreased when combined with Galantamine.,decrease,no risk
Sertindole,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with Sertindole.,increase,risk
Sertindole,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Sertindole is combined with Ganaxolone.",increase,risk
Sertindole,Gefitinib,The metabolism of Sertindole can be decreased when combined with Gefitinib.,decrease,no risk
Sertindole,Gepirone,The risk or severity of QTc prolongation can be increased when Gepirone is combined with Sertindole.,increase,risk
Sertindole,Gilteritinib,The therapeutic efficacy of Sertindole can be decreased when used in combination with Gilteritinib.,decrease,no risk
Sertindole,Givosiran,The serum concentration of Sertindole can be increased when it is combined with Givosiran.,increase,no risk
Sertindole,Glasdegib,The risk or severity of QTc prolongation can be increased when Sertindole is combined with Glasdegib.,increase,risk
Sertindole,Glofitamab,The serum concentration of Sertindole can be increased when it is combined with Glofitamab.,increase,no risk
Sertindole,Glutethimide,The risk or severity of CNS depression can be increased when Glutethimide is combined with Sertindole.,increase,risk
Sertindole,Glycerol phenylbutyrate,The metabolism of Sertindole can be decreased when combined with Glycerol phenylbutyrate.,decrease,no risk
Sertindole,Golimumab,The metabolism of Sertindole can be increased when combined with Golimumab.,increase,no risk
Sertindole,Granisetron,The risk or severity of CNS depression can be increased when Granisetron is combined with Sertindole.,increase,risk
Sertindole,Guanfacine,The risk or severity of CNS depression can be increased when Guanfacine is combined with Sertindole.,increase,risk
Sertindole,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with Sertindole.,increase,risk
Sertindole,Halofantrine,The metabolism of Sertindole can be decreased when combined with Halofantrine.,decrease,no risk
Sertindole,Haloperidol,The risk or severity of QTc prolongation can be increased when Sertindole is combined with Haloperidol.,increase,risk
Sertindole,Halothane,The risk or severity of CNS depression can be increased when Halothane is combined with Sertindole.,increase,risk
Sertindole,Hexafluronium,The risk or severity of CNS depression can be increased when Hexafluronium is combined with Sertindole.,increase,risk
Sertindole,Hydrocodone,Sertindole may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Sertindole,Hydromorphone,The risk or severity of CNS depression can be increased when Hydromorphone is combined with Sertindole.,increase,risk
Sertindole,Hydroxychloroquine,The metabolism of Sertindole can be decreased when combined with Hydroxychloroquine.,decrease,no risk
Sertindole,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Sertindole is combined with Hydroxyzine.,increase,risk
Sertindole,Ketamine,The risk or severity of CNS depression can be increased when Ketamine is combined with Sertindole.,increase,risk
Sertindole,Ketazolam,The risk or severity of CNS depression can be increased when Ketazolam is combined with Sertindole.,increase,risk
Sertindole,Ketoconazole,The metabolism of Sertindole can be decreased when combined with Ketoconazole.,decrease,no risk
Sertindole,Nabilone,Nabilone may increase the central nervous system depressant (CNS depressant) activities of Sertindole.,increase,no risk
Sertindole,Nadolol,The metabolism of Sertindole can be decreased when combined with Nadolol.,decrease,no risk
Sertindole,Nalbuphine,The risk or severity of CNS depression can be increased when Nalbuphine is combined with Sertindole.,increase,risk
Sertindole,Naltrexone,The risk or severity of serotonin syndrome can be increased when Naltrexone is combined with Sertindole.,increase,risk
Sertindole,Naratriptan,The risk or severity of adverse effects can be increased when Naratriptan is combined with Sertindole.,increase,risk
Sertindole,Nateglinide,The metabolism of Sertindole can be decreased when combined with Nateglinide.,decrease,no risk
Sertindole,Naxitamab,Sertindole may increase the neurotoxic activities of Naxitamab.,increase,no risk
Sertindole,Nebivolol,The metabolism of Sertindole can be decreased when combined with Nebivolol.,decrease,no risk
Sertindole,Nefazodone,The metabolism of Sertindole can be decreased when combined with Nefazodone.,decrease,no risk
Sertindole,Nelfinavir,The metabolism of Sertindole can be decreased when combined with Nelfinavir.,decrease,no risk
Sertindole,Neomycin,Neomycin may increase the neurotoxic activities of Sertindole.,increase,no risk
Sertindole,Netupitant,The metabolism of Sertindole can be decreased when combined with Netupitant.,decrease,no risk
Sertindole,Nevirapine,The metabolism of Sertindole can be decreased when combined with Nevirapine.,decrease,no risk
Sertindole,Niacin,The metabolism of Sertindole can be decreased when combined with Niacin.,decrease,no risk
Sertindole,Nialamide,The risk or severity of CNS depression can be increased when Nialamide is combined with Sertindole.,increase,risk
Sertindole,Nicardipine,The metabolism of Sertindole can be decreased when combined with Nicardipine.,decrease,no risk
Sertindole,Nicergoline,The metabolism of Sertindole can be decreased when combined with Nicergoline.,decrease,no risk
Sertindole,Nifedipine,The metabolism of Sertindole can be decreased when combined with Nifedipine.,decrease,no risk
Sertindole,Nilotinib,The metabolism of Sertindole can be decreased when combined with Nilotinib.,decrease,no risk
Sertindole,Nilvadipine,The metabolism of Sertindole can be decreased when combined with Nilvadipine.,decrease,no risk
Sertindole,Nirogacestat,The metabolism of Nirogacestat can be decreased when combined with Sertindole.,decrease,no risk
Sertindole,Nitrazepam,The risk or severity of CNS depression can be increased when Nitrazepam is combined with Sertindole.,increase,risk
Sertindole,Nitrous oxide,The risk or severity of CNS depression can be increased when Sertindole is combined with Nitrous oxide.,increase,risk
Sertindole,Nomifensine,The risk or severity of CNS depression can be increased when Nomifensine is combined with Sertindole.,increase,risk
Sertindole,Normethadone,The risk or severity of CNS depression can be increased when Sertindole is combined with Normethadone.,increase,risk
Sertindole,Nortriptyline,The metabolism of Nortriptyline can be decreased when combined with Sertindole.,decrease,no risk
Sertindole,Olanzapine,The risk or severity of CNS depression can be increased when Olanzapine is combined with Sertindole.,increase,risk
Sertindole,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Sertindole is combined with Oliceridine.",increase,risk
Sertindole,Omaveloxolone,The serum concentration of Sertindole can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Sertindole,Ondansetron,The risk or severity of CNS depression can be increased when Ondansetron is combined with Sertindole.,increase,risk
Sertindole,Opicapone,The therapeutic efficacy of Opicapone can be decreased when used in combination with Sertindole.,decrease,no risk
Sertindole,Opium,The risk or severity of CNS depression can be increased when Sertindole is combined with Opium.,increase,risk
Sertindole,Oritavancin,The metabolism of Sertindole can be decreased when combined with Oritavancin.,decrease,no risk
Sertindole,Orphenadrine,Sertindole may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Sertindole,Osilodrostat,The metabolism of Sertindole can be decreased when combined with Osilodrostat.,decrease,no risk
Sertindole,Ospemifene,The metabolism of Sertindole can be decreased when combined with Ospemifene.,decrease,no risk
Sertindole,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Sertindole.,increase,risk
Sertindole,Oxamniquine,The metabolism of Sertindole can be decreased when combined with Oxamniquine.,decrease,no risk
Sertindole,Oxazepam,The risk or severity of CNS depression can be increased when Oxazepam is combined with Sertindole.,increase,risk
Sertindole,Oxcarbazepine,The risk or severity of CNS depression can be increased when Oxcarbazepine is combined with Sertindole.,increase,risk
Sertindole,Oxitriptan,The risk or severity of CNS depression can be increased when Oxitriptan is combined with Sertindole.,increase,risk
Sertindole,Oxprenolol,The risk or severity of CNS depression can be increased when Oxprenolol is combined with Sertindole.,increase,risk
Sertindole,Oxybuprocaine,The risk or severity of CNS depression can be increased when Oxybuprocaine is combined with Sertindole.,increase,risk
Sertindole,Oxybutynin,The metabolism of Sertindole can be decreased when combined with Oxybutynin.,decrease,no risk
Sertindole,Oxycodone,The risk or severity of CNS depression can be increased when Oxycodone is combined with Sertindole.,increase,risk
Sertindole,Oxymorphone,The risk or severity of CNS depression can be increased when Oxymorphone is combined with Sertindole.,increase,risk
Sertindole,Quazepam,The risk or severity of CNS depression can be increased when Quazepam is combined with Sertindole.,increase,risk
Sertindole,Quetiapine,The risk or severity of CNS depression can be increased when Quetiapine is combined with Sertindole.,increase,risk
Sertindole,Quinagolide,The therapeutic efficacy of Quinagolide can be decreased when used in combination with Sertindole.,decrease,no risk
Sertindole,Quinidine,The metabolism of Sertindole can be decreased when combined with Quinidine.,decrease,no risk
Sertindole,Quinine,The metabolism of Sertindole can be decreased when combined with Quinine.,decrease,no risk
Sertindole,Quinupramine,The risk or severity of CNS depression can be increased when Sertindole is combined with Quinupramine.,increase,risk
Sertindole,Quizartinib,The risk or severity of QTc prolongation can be increased when Sertindole is combined with Quizartinib.,increase,risk
Sertindole,Umeclidinium,The metabolism of Umeclidinium can be decreased when combined with Sertindole.,decrease,no risk
Sertindole,Urethane,The risk or severity of CNS depression can be increased when Urethane is combined with Sertindole.,increase,risk
Sertindole,Vadadustat,The serum concentration of Sertindole can be increased when it is combined with Vadadustat.,increase,no risk
Sertindole,Valbenazine,The metabolism of Valbenazine can be decreased when combined with Sertindole.,decrease,no risk
Sertindole,Valproate bismuth,The risk or severity of serotonin syndrome can be increased when Sertindole is combined with Valproate bismuth.,increase,risk
Sertindole,Valproic acid,The risk or severity of CNS depression can be increased when Valproic acid is combined with Sertindole.,increase,risk
Sertindole,Vecuronium,The risk or severity of CNS depression can be increased when Vecuronium is combined with Sertindole.,increase,risk
Sertindole,Vemurafenib,The metabolism of Sertindole can be decreased when combined with Vemurafenib.,decrease,no risk
Sertindole,Venetoclax,The metabolism of Sertindole can be decreased when combined with Venetoclax.,decrease,no risk
Sertindole,Venlafaxine,The risk or severity of serotonin syndrome can be increased when Sertindole is combined with Venlafaxine.,increase,risk
Sertindole,Verapamil,The metabolism of Sertindole can be decreased when combined with Verapamil.,decrease,no risk
Sertindole,Vernakalant,The metabolism of Vernakalant can be decreased when combined with Sertindole.,decrease,no risk
Sertindole,Vigabatrin,The risk or severity of CNS depression can be increased when Vigabatrin is combined with Sertindole.,increase,risk
Sertindole,Vilanterol,The risk or severity of QTc prolongation and ventricular arrhythmias can be increased when Vilanterol is combined with Sertindole.,increase,risk
Sertindole,Vilazodone,The metabolism of Sertindole can be decreased when combined with Vilazodone.,decrease,no risk
Sertindole,Viloxazine,The metabolism of Sertindole can be decreased when combined with Viloxazine.,decrease,no risk
Sertindole,Vinblastine,The metabolism of Sertindole can be decreased when combined with Vinblastine.,decrease,no risk
Sertindole,Vincristine,Vincristine may increase the neurotoxic activities of Sertindole.,increase,no risk
Sertindole,Vinorelbine,The metabolism of Sertindole can be decreased when combined with Vinorelbine.,decrease,no risk
Sertindole,Viomycin,Sertindole may increase the neurotoxic activities of Viomycin.,increase,no risk
Sertindole,Voriconazole,The metabolism of Sertindole can be decreased when combined with Voriconazole.,decrease,no risk
Sertindole,Vortioxetine,The risk or severity of adverse effects can be increased when Vortioxetine is combined with Sertindole.,increase,risk
Sertindole,Warfarin,The risk or severity of adverse effects can be increased when Sertindole is combined with Warfarin.,increase,risk
Sertindole,Yohimbine,The risk or severity of CNS depression can be increased when Yohimbine is combined with Sertindole.,increase,risk
Sertindole,Zaleplon,The risk or severity of CNS depression can be increased when Zaleplon is combined with Sertindole.,increase,risk
Sertindole,Ziconotide,The risk or severity of CNS depression can be increased when Sertindole is combined with Ziconotide.,increase,risk
Sertindole,Zimelidine,The risk or severity of adverse effects can be increased when Sertindole is combined with Zimelidine.,increase,risk
Sertindole,Ziprasidone,The risk or severity of QTc prolongation can be increased when Sertindole is combined with Ziprasidone.,increase,risk
Sertindole,Zolmitriptan,The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Sertindole.,increase,risk
Sertindole,Zolpidem,Sertindole may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Sertindole,Zonisamide,The risk or severity of CNS depression can be increased when Zonisamide is combined with Sertindole.,increase,risk
Sertindole,Zopiclone,The risk or severity of adverse effects can be increased when Sertindole is combined with Zopiclone.,increase,risk
Sertindole,Zotepine,The risk or severity of CNS depression can be increased when Sertindole is combined with Zotepine.,increase,risk
Sertindole,Zuclopenthixol,The risk or severity of CNS depression can be increased when Zuclopenthixol is combined with Sertindole.,increase,risk
Sertindole,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Sertindole.,increase,risk
Spiramycin,BCG vaccine,The therapeutic efficacy of BCG vaccine can be decreased when used in combination with Spiramycin.,decrease,no risk
Spiramycin,Benzocaine,The risk or severity of methemoglobinemia can be increased when Spiramycin is combined with Benzocaine.,increase,risk
Spiramycin,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Spiramycin is combined with Benzyl alcohol.,increase,risk
Spiramycin,Betamethasone,The serum concentration of Betamethasone can be increased when it is combined with Spiramycin.,increase,no risk
Spiramycin,Budesonide,The serum concentration of Budesonide can be increased when it is combined with Spiramycin.,increase,no risk
Spiramycin,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Spiramycin is combined with Bupivacaine.,increase,risk
Spiramycin,Butacaine,The risk or severity of methemoglobinemia can be increased when Spiramycin is combined with Butacaine.,increase,risk
Spiramycin,Butamben,The risk or severity of methemoglobinemia can be increased when Spiramycin is combined with Butamben.,increase,risk
Spiramycin,Hydrocortisone,The serum concentration of Hydrocortisone can be increased when it is combined with Spiramycin.,increase,no risk
Spiramycin,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Spiramycin is combined with Oxetacaine.,increase,risk
Spiramycin,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Spiramycin is combined with Oxybuprocaine.,increase,risk
Spiramycin,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Spiramycin.,decrease,no risk
Spiramycin,Warfarin,The risk or severity of bleeding can be increased when Spiramycin is combined with Warfarin.,increase,risk
Methenamine,Vonoprazan,The therapeutic efficacy of Methenamine can be decreased when used in combination with Vonoprazan.,decrease,no risk
Methenamine,Warfarin,The risk or severity of bleeding can be increased when Methenamine is combined with Warfarin.,increase,risk
Methenamine,Zonisamide,The serum concentration of the active metabolites of Methenamine can be reduced when Methenamine is used in combination with Zonisamide resulting in a loss in efficacy., ,no risk
Sulfathiazole,Benzylpenicillin,Sulfathiazole may decrease the excretion rate of Benzylpenicillin which could result in a higher serum level.,decrease,no risk
Mianserin,Boceprevir,The metabolism of Mianserin can be decreased when combined with Boceprevir.,decrease,no risk
Mianserin,Bortezomib,The metabolism of Mianserin can be decreased when combined with Bortezomib.,decrease,no risk
Mianserin,Bosentan,Mianserin may decrease the antihypertensive activities of Bosentan.,decrease,no risk
Mianserin,Botulinum toxin type A,The risk or severity of CNS depression can be increased when Botulinum toxin type A is combined with Mianserin.,increase,risk
Mianserin,Botulinum toxin type B,The risk or severity of CNS depression can be increased when Botulinum toxin type B is combined with Mianserin.,increase,risk
Mianserin,Bretylium,Mianserin may decrease the antihypertensive activities of Bretylium.,decrease,no risk
Mianserin,Brexanolone,The therapeutic efficacy of Brexanolone can be decreased when used in combination with Mianserin.,decrease,no risk
Mianserin,Brexpiprazole,The risk or severity of adverse effects can be increased when Mianserin is combined with Brexpiprazole.,increase,risk
Mianserin,Brimonidine,The therapeutic efficacy of Brimonidine can be decreased when used in combination with Mianserin.,decrease,no risk
Mianserin,Brivaracetam,The therapeutic efficacy of Brivaracetam can be decreased when used in combination with Mianserin.,decrease,no risk
Mianserin,Bromazepam,The risk or severity of CNS depression can be increased when Bromazepam is combined with Mianserin.,increase,risk
Mianserin,Bromocriptine,The therapeutic efficacy of Bromocriptine can be decreased when used in combination with Mianserin.,decrease,no risk
Mianserin,Bromotheophylline,The metabolism of Bromotheophylline can be decreased when combined with Mianserin.,decrease,no risk
Mianserin,Bromperidol,The risk or severity of adverse effects can be increased when Mianserin is combined with Bromperidol.,increase,risk
Mianserin,Brompheniramine,Mianserin may increase the anticholinergic activities of Brompheniramine.,increase,no risk
Mianserin,Buclizine,Mianserin may increase the anticholinergic activities of Buclizine.,increase,no risk
Mianserin,Bumadizone,The risk or severity of hypertension can be increased when Mianserin is combined with Bumadizone.,increase,risk
Mianserin,Bupivacaine,The risk or severity of CNS depression can be increased when Bupivacaine is combined with Mianserin.,increase,risk
Mianserin,Buprenorphine,Mianserin may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Mianserin,Bupropion,The metabolism of Mianserin can be decreased when combined with Bupropion.,decrease,no risk
Mianserin,Buspirone,The risk or severity of CNS depression can be increased when Buspirone is combined with Mianserin.,increase,risk
Mianserin,Butabarbital,Mianserin may increase the central nervous system depressant (CNS depressant) activities of Butabarbital.,increase,no risk
Mianserin,Butalbital,The therapeutic efficacy of Butalbital can be decreased when used in combination with Mianserin.,decrease,no risk
Mianserin,Butaperazine,The risk or severity of adverse effects can be increased when Mianserin is combined with Butaperazine.,increase,risk
Mianserin,Butobarbital,The risk or severity of CNS depression can be increased when Butobarbital is combined with Mianserin.,increase,risk
Mianserin,Butorphanol,The risk or severity of CNS depression can be increased when Butorphanol is combined with Mianserin.,increase,risk
Mianserin,Butriptyline,The risk or severity of CNS depression can be increased when Mianserin is combined with Butriptyline.,increase,risk
Mianserin,Butylscopolamine,Mianserin may increase the anticholinergic activities of Butylscopolamine.,increase,no risk
Mianserin,Gabapentin,The therapeutic efficacy of Gabapentin can be decreased when used in combination with Mianserin.,decrease,no risk
Mianserin,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Mianserin is combined with Gabapentin enacarbil.,increase,risk
Mianserin,Galantamine,The metabolism of Mianserin can be decreased when combined with Galantamine.,decrease,no risk
Mianserin,Gallamine triethiodide,Mianserin may increase the anticholinergic activities of Gallamine triethiodide.,increase,no risk
Mianserin,Ganaxolone,The therapeutic efficacy of Ganaxolone can be decreased when used in combination with Mianserin.,decrease,no risk
Mianserin,Gatifloxacin,The metabolism of Mianserin can be decreased when combined with Gatifloxacin.,decrease,no risk
Mianserin,Gefitinib,The metabolism of Mianserin can be decreased when combined with Gefitinib.,decrease,no risk
Mianserin,Gemfibrozil,The metabolism of Mianserin can be decreased when combined with Gemfibrozil.,decrease,no risk
Mianserin,Gemifloxacin,The metabolism of Mianserin can be decreased when combined with Gemifloxacin.,decrease,no risk
Mianserin,Gepirone,The risk or severity of serotonin syndrome can be increased when Gepirone is combined with Mianserin.,increase,risk
Mianserin,Gilteritinib,The therapeutic efficacy of Mianserin can be decreased when used in combination with Gilteritinib.,decrease,no risk
Mianserin,Givosiran,The serum concentration of Mianserin can be increased when it is combined with Givosiran.,increase,no risk
Mianserin,Glofitamab,The serum concentration of Mianserin can be increased when it is combined with Glofitamab.,increase,no risk
Mianserin,Glutethimide,The risk or severity of CNS depression can be increased when Glutethimide is combined with Mianserin.,increase,risk
Mianserin,Glycerol phenylbutyrate,The metabolism of Mianserin can be decreased when combined with Glycerol phenylbutyrate.,decrease,no risk
Mianserin,Glycopyrronium,Mianserin may increase the anticholinergic activities of Glycopyrronium.,increase,no risk
Mianserin,Golimumab,The metabolism of Mianserin can be increased when combined with Golimumab.,increase,no risk
Mianserin,Granisetron,The risk or severity of CNS depression can be increased when Granisetron is combined with Mianserin.,increase,risk
Mianserin,Grepafloxacin,The metabolism of Mianserin can be decreased when combined with Grepafloxacin.,decrease,no risk
Mianserin,Guanabenz,The therapeutic efficacy of Guanabenz can be decreased when used in combination with Mianserin.,decrease,no risk
Mianserin,Guanadrel,Mianserin may decrease the antihypertensive activities of Guanadrel.,decrease,no risk
Mianserin,Guanethidine,Mianserin may decrease the antihypertensive activities of Guanethidine.,decrease,no risk
Mianserin,Guanfacine,The therapeutic efficacy of Guanfacine can be decreased when used in combination with Mianserin.,decrease,no risk
Mianserin,Guanoxan,Mianserin may decrease the antihypertensive activities of Guanoxan.,decrease,no risk
Mianserin,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with Mianserin.,increase,risk
Mianserin,Halofantrine,The metabolism of Mianserin can be decreased when combined with Halofantrine.,decrease,no risk
Mianserin,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Mianserin.,increase,risk
Mianserin,Halothane,The risk or severity of CNS depression can be increased when Halothane is combined with Mianserin.,increase,risk
Mianserin,Hexafluronium,The risk or severity of CNS depression can be increased when Hexafluronium is combined with Mianserin.,increase,risk
Mianserin,Hexocyclium,Mianserin may increase the anticholinergic activities of Hexocyclium.,increase,no risk
Mianserin,Homatropine methylbromide,Mianserin may increase the anticholinergic activities of Homatropine methylbromide.,increase,no risk
Mianserin,Hydralazine,Mianserin may decrease the antihypertensive activities of Hydralazine.,decrease,no risk
Mianserin,Hydrochlorothiazide,Mianserin may decrease the antihypertensive activities of Hydrochlorothiazide.,decrease,no risk
Mianserin,Hydrocodone,Mianserin may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Mianserin,Hydrocortisone,The metabolism of Mianserin can be increased when combined with Hydrocortisone.,increase,no risk
Mianserin,Hydroflumethiazide,Mianserin may decrease the antihypertensive activities of Hydroflumethiazide.,decrease,no risk
Mianserin,Hydromorphone,The risk or severity of CNS depression can be increased when Hydromorphone is combined with Mianserin.,increase,risk
Mianserin,Hydroxychloroquine,The metabolism of Mianserin can be decreased when combined with Hydroxychloroquine.,decrease,no risk
Mianserin,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Mianserin.,increase,no risk
Mianserin,Hyoscyamine,Mianserin may increase the anticholinergic activities of Hyoscyamine.,increase,no risk
Mianserin,Ketamine,The risk or severity of CNS depression can be increased when Ketamine is combined with Mianserin.,increase,risk
Mianserin,Ketazolam,The risk or severity of CNS depression can be increased when Ketazolam is combined with Mianserin.,increase,risk
Mianserin,Ketoconazole,The metabolism of Mianserin can be decreased when combined with Ketoconazole.,decrease,no risk
Mianserin,Ketoprofen,The risk or severity of hypertension can be increased when Ketoprofen is combined with Mianserin.,increase,risk
Mianserin,Ketorolac,The risk or severity of hypertension can be increased when Ketorolac is combined with Mianserin.,increase,risk
Mianserin,Nabilone,Nabilone may increase the central nervous system depressant (CNS depressant) activities of Mianserin.,increase,no risk
Mianserin,Nabumetone,The metabolism of Mianserin can be decreased when combined with Nabumetone.,decrease,no risk
Mianserin,Nadolol,Mianserin may decrease the antihypertensive activities of Nadolol.,decrease,no risk
Mianserin,Nafcillin,The metabolism of Mianserin can be increased when combined with Nafcillin.,increase,no risk
Mianserin,Nalbuphine,The risk or severity of CNS depression can be increased when Nalbuphine is combined with Mianserin.,increase,risk
Mianserin,Nalidixic acid,The metabolism of Mianserin can be decreased when combined with Nalidixic acid.,decrease,no risk
Mianserin,Naltrexone,The risk or severity of serotonin syndrome can be increased when Naltrexone is combined with Mianserin.,increase,risk
Mianserin,Naphazoline,The therapeutic efficacy of Naphazoline can be decreased when used in combination with Mianserin.,decrease,no risk
Mianserin,Naproxen,The metabolism of Mianserin can be decreased when combined with Naproxen.,decrease,no risk
Mianserin,Naratriptan,The risk or severity of adverse effects can be increased when Naratriptan is combined with Mianserin.,increase,risk
Mianserin,Nateglinide,The metabolism of Mianserin can be decreased when combined with Nateglinide.,decrease,no risk
Mianserin,Naxitamab,The risk or severity of hypertension can be increased when Mianserin is combined with Naxitamab.,increase,risk
Mianserin,Nebivolol,Mianserin may decrease the antihypertensive activities of Nebivolol.,decrease,no risk
Mianserin,Nefazodone,The metabolism of Mianserin can be decreased when combined with Nefazodone.,decrease,no risk
Mianserin,Nelfinavir,The metabolism of Mianserin can be decreased when combined with Nelfinavir.,decrease,no risk
Mianserin,Netupitant,The metabolism of Mianserin can be decreased when combined with Netupitant.,decrease,no risk
Mianserin,Nevirapine,The metabolism of Mianserin can be increased when combined with Nevirapine.,increase,no risk
Mianserin,Niacin,The metabolism of Mianserin can be decreased when combined with Niacin.,decrease,no risk
Mianserin,Nialamide,The risk or severity of adverse effects can be increased when Nialamide is combined with Mianserin.,increase,risk
Mianserin,Nicardipine,Mianserin may increase the anticholinergic activities of Nicardipine.,increase,no risk
Mianserin,Nicergoline,The risk or severity of hypertension can be increased when Nicergoline is combined with Mianserin.,increase,risk
Mianserin,Niclosamide,The metabolism of Mianserin can be decreased when combined with Niclosamide.,decrease,no risk
Mianserin,Nicorandil,Mianserin may decrease the antihypertensive activities of Nicorandil.,decrease,no risk
Mianserin,Nicotine,The metabolism of Mianserin can be decreased when combined with Nicotine.,decrease,no risk
Mianserin,Nifedipine,The metabolism of Mianserin can be decreased when combined with Nifedipine.,decrease,no risk
Mianserin,Nilotinib,The metabolism of Mianserin can be decreased when combined with Nilotinib.,decrease,no risk
Mianserin,Nilvadipine,The metabolism of Mianserin can be decreased when combined with Nilvadipine.,decrease,no risk
Mianserin,Nimesulide,The risk or severity of hypertension can be increased when Nimesulide is combined with Mianserin.,increase,risk
Mianserin,Nimodipine,Mianserin may decrease the antihypertensive activities of Nimodipine.,decrease,no risk
Mianserin,Nirogacestat,The metabolism of Mianserin can be increased when combined with Nirogacestat.,increase,no risk
Mianserin,Nisoldipine,Mianserin may decrease the antihypertensive activities of Nisoldipine.,decrease,no risk
Mianserin,Nitrazepam,The therapeutic efficacy of Nitrazepam can be decreased when used in combination with Mianserin.,decrease,no risk
Mianserin,Nitrendipine,Mianserin may decrease the antihypertensive activities of Nitrendipine.,decrease,no risk
Mianserin,Nitroglycerin,Mianserin may decrease the antihypertensive activities of Nitroglycerin.,decrease,no risk
Mianserin,Nitroprusside,Mianserin may decrease the antihypertensive activities of Nitroprusside.,decrease,no risk
Mianserin,Nitrous oxide,The risk or severity of CNS depression can be increased when Mianserin is combined with Nitrous oxide.,increase,risk
Mianserin,Nomifensine,The risk or severity of CNS depression can be increased when Nomifensine is combined with Mianserin.,increase,risk
Mianserin,Norepinephrine,The therapeutic efficacy of Norepinephrine can be decreased when used in combination with Mianserin.,decrease,no risk
Mianserin,Norfloxacin,The metabolism of Mianserin can be decreased when combined with Norfloxacin.,decrease,no risk
Mianserin,Norgestimate,The metabolism of Mianserin can be decreased when combined with Norgestimate.,decrease,no risk
Mianserin,Normethadone,The risk or severity of CNS depression can be increased when Mianserin is combined with Normethadone.,increase,risk
Mianserin,Nortriptyline,Mianserin may increase the anticholinergic activities of Nortriptyline.,increase,no risk
Mianserin,Nylidrin,The risk or severity of hypertension can be increased when Mianserin is combined with Nylidrin.,increase,risk
Mianserin,Obeticholic acid,The metabolism of Mianserin can be decreased when combined with Obeticholic acid.,decrease,no risk
Mianserin,Olanzapine,Mianserin may increase the anticholinergic activities of Olanzapine.,increase,no risk
Mianserin,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Mianserin is combined with Oliceridine.",increase,risk
Mianserin,Olmesartan,Mianserin may decrease the antihypertensive activities of Olmesartan.,decrease,no risk
Mianserin,Olodaterol,The risk or severity of hypertension can be increased when Mianserin is combined with Olodaterol.,increase,risk
Mianserin,Omaveloxolone,The serum concentration of Mianserin can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Mianserin,Ondansetron,The risk or severity of CNS depression can be increased when Ondansetron is combined with Mianserin.,increase,risk
Mianserin,Opium,The risk or severity of CNS depression can be increased when Mianserin is combined with Opium.,increase,risk
Mianserin,Orciprenaline,The risk or severity of hypertension can be increased when Orciprenaline is combined with Mianserin.,increase,risk
Mianserin,Oritavancin,The metabolism of Mianserin can be decreased when combined with Oritavancin.,decrease,no risk
Mianserin,Orphenadrine,Mianserin may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Mianserin,Osilodrostat,The metabolism of Mianserin can be decreased when combined with Osilodrostat.,decrease,no risk
Mianserin,Osimertinib,The serum concentration of Mianserin can be decreased when it is combined with Osimertinib.,decrease,no risk
Mianserin,Ospemifene,The metabolism of Mianserin can be decreased when combined with Ospemifene.,decrease,no risk
Mianserin,Oxamniquine,The metabolism of Mianserin can be decreased when combined with Oxamniquine.,decrease,no risk
Mianserin,Oxaprozin,The risk or severity of hypertension can be increased when Oxaprozin is combined with Mianserin.,increase,risk
Mianserin,Oxazepam,The risk or severity of CNS depression can be increased when Oxazepam is combined with Mianserin.,increase,risk
Mianserin,Oxcarbazepine,The therapeutic efficacy of Oxcarbazepine can be decreased when used in combination with Mianserin.,decrease,no risk
Mianserin,Oxitriptan,The risk or severity of CNS depression can be increased when Oxitriptan is combined with Mianserin.,increase,risk
Mianserin,Oxprenolol,The risk or severity of CNS depression can be increased when Oxprenolol is combined with Mianserin.,increase,risk
Mianserin,Oxtriphylline,The metabolism of Mianserin can be decreased when combined with Oxtriphylline.,decrease,no risk
Mianserin,Oxybuprocaine,The risk or severity of CNS depression can be increased when Oxybuprocaine is combined with Mianserin.,increase,risk
Mianserin,Oxybutynin,Mianserin may increase the anticholinergic activities of Oxybutynin.,increase,no risk
Mianserin,Oxycodone,The risk or severity of CNS depression can be increased when Oxycodone is combined with Mianserin.,increase,risk
Mianserin,Oxymetazoline,The therapeutic efficacy of Oxymetazoline can be decreased when used in combination with Mianserin.,decrease,no risk
Mianserin,Oxymorphone,The risk or severity of CNS depression can be increased when Oxymorphone is combined with Mianserin.,increase,risk
Mianserin,Oxyphenbutazone,The risk or severity of hypertension can be increased when Oxyphenbutazone is combined with Mianserin.,increase,risk
Mianserin,Oxyphencyclimine,Mianserin may increase the anticholinergic activities of Oxyphencyclimine.,increase,no risk
Mianserin,Oxyphenonium,Mianserin may increase the anticholinergic activities of Oxyphenonium.,increase,no risk
Mianserin,Quazepam,The risk or severity of CNS depression can be increased when Quazepam is combined with Mianserin.,increase,risk
Mianserin,Quetiapine,Mianserin may increase the anticholinergic activities of Quetiapine.,increase,no risk
Mianserin,Quinapril,Mianserin may decrease the antihypertensive activities of Quinapril.,decrease,no risk
Mianserin,Quinidine,Mianserin may increase the anticholinergic activities of Quinidine.,increase,no risk
Mianserin,Quinine,The metabolism of Mianserin can be decreased when combined with Quinine.,decrease,no risk
Mianserin,Quinupramine,The risk or severity of CNS depression can be increased when Mianserin is combined with Quinupramine.,increase,risk
Mianserin,Umeclidinium,Mianserin may increase the anticholinergic activities of Umeclidinium.,increase,no risk
Mianserin,Urethane,The risk or severity of CNS depression can be increased when Urethane is combined with Mianserin.,increase,risk
Mianserin,Vadadustat,The serum concentration of Mianserin can be decreased when it is combined with Vadadustat.,decrease,no risk
Mianserin,Valbenazine,The metabolism of Valbenazine can be decreased when combined with Mianserin.,decrease,no risk
Mianserin,Valdecoxib,The risk or severity of hypertension can be increased when Valdecoxib is combined with Mianserin.,increase,risk
Mianserin,Valproate bismuth,The risk or severity of serotonin syndrome can be increased when Mianserin is combined with Valproate bismuth.,increase,risk
Mianserin,Valproic acid,The therapeutic efficacy of Valproic acid can be decreased when used in combination with Mianserin.,decrease,no risk
Mianserin,Valsartan,Mianserin may decrease the antihypertensive activities of Valsartan.,decrease,no risk
Mianserin,Vecuronium,The risk or severity of CNS depression can be increased when Vecuronium is combined with Mianserin.,increase,risk
Mianserin,Velpatasvir,The metabolism of Velpatasvir can be decreased when combined with Mianserin.,decrease,no risk
Mianserin,Vemurafenib,The serum concentration of Mianserin can be increased when it is combined with Vemurafenib.,increase,no risk
Mianserin,Venetoclax,The metabolism of Mianserin can be decreased when combined with Venetoclax.,decrease,no risk
Mianserin,Venlafaxine,The risk or severity of serotonin syndrome can be increased when Mianserin is combined with Venlafaxine.,increase,risk
Mianserin,Verapamil,The metabolism of Mianserin can be decreased when combined with Verapamil.,decrease,no risk
Mianserin,Vernakalant,The metabolism of Vernakalant can be decreased when combined with Mianserin.,decrease,no risk
Mianserin,Vigabatrin,The therapeutic efficacy of Vigabatrin can be decreased when used in combination with Mianserin.,decrease,no risk
Mianserin,Vilanterol,The risk or severity of hypertension can be increased when Mianserin is combined with Vilanterol.,increase,risk
Mianserin,Vilazodone,The metabolism of Mianserin can be decreased when combined with Vilazodone.,decrease,no risk
Mianserin,Viloxazine,The metabolism of Mianserin can be decreased when combined with Viloxazine.,decrease,no risk
Mianserin,Vinblastine,The metabolism of Mianserin can be decreased when combined with Vinblastine.,decrease,no risk
Mianserin,Vinorelbine,The metabolism of Mianserin can be decreased when combined with Vinorelbine.,decrease,no risk
Mianserin,Voriconazole,The metabolism of Mianserin can be decreased when combined with Voriconazole.,decrease,no risk
Mianserin,Vortioxetine,The risk or severity of adverse effects can be increased when Mianserin is combined with Vortioxetine.,increase,risk
Mianserin,Voxelotor,The metabolism of Voxelotor can be decreased when combined with Mianserin.,decrease,no risk
Mianserin,Voxilaprevir,The metabolism of Voxilaprevir can be decreased when combined with Mianserin.,decrease,no risk
Mianserin,Warfarin,The metabolism of Mianserin can be decreased when combined with Warfarin.,decrease,no risk
Teicoplanin,BCG vaccine,The therapeutic efficacy of BCG vaccine can be decreased when used in combination with Teicoplanin.,decrease,no risk
Teicoplanin,Benzocaine,The risk or severity of methemoglobinemia can be increased when Teicoplanin is combined with Benzocaine.,increase,risk
Teicoplanin,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Teicoplanin is combined with Benzyl alcohol.,increase,risk
Teicoplanin,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Teicoplanin is combined with Bupivacaine.,increase,risk
Teicoplanin,Butacaine,The risk or severity of methemoglobinemia can be increased when Teicoplanin is combined with Butacaine.,increase,risk
Teicoplanin,Butamben,The risk or severity of methemoglobinemia can be increased when Teicoplanin is combined with Butamben.,increase,risk
Teicoplanin,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Teicoplanin is combined with Oxetacaine.,increase,risk
Teicoplanin,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Teicoplanin is combined with Oxybuprocaine.,increase,risk
Teicoplanin,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Teicoplanin.,decrease,no risk
Teicoplanin,Warfarin,The risk or severity of bleeding can be increased when Teicoplanin is combined with Warfarin.,increase,risk
Sulfadimethoxine,Benzylpenicillin,Sulfadimethoxine may decrease the excretion rate of Benzylpenicillin which could result in a higher serum level.,decrease,no risk
Sulfadimethoxine,Bexagliflozin,The therapeutic efficacy of Bexagliflozin can be increased when used in combination with Sulfadimethoxine.,increase,no risk
Sulfadimethoxine,Bromocriptine,The therapeutic efficacy of Bromocriptine can be increased when used in combination with Sulfadimethoxine.,increase,no risk
Sulfadimethoxine,Gliclazide,The therapeutic efficacy of Gliclazide can be increased when used in combination with Sulfadimethoxine.,increase,no risk
Sulfadimethoxine,Glimepiride,The therapeutic efficacy of Glimepiride can be increased when used in combination with Sulfadimethoxine.,increase,no risk
Sulfadimethoxine,Glipizide,The therapeutic efficacy of Glipizide can be increased when used in combination with Sulfadimethoxine.,increase,no risk
Sulfadimethoxine,Gliquidone,The therapeutic efficacy of Gliquidone can be increased when used in combination with Sulfadimethoxine.,increase,no risk
Sulfadimethoxine,Glyburide,The therapeutic efficacy of Glyburide can be increased when used in combination with Sulfadimethoxine.,increase,no risk
Sulfadimethoxine,Glymidine,The therapeutic efficacy of Glymidine can be increased when used in combination with Sulfadimethoxine.,increase,no risk
Sulfadimethoxine,Ketoprofen,The risk or severity of adverse effects can be increased when Ketoprofen is combined with Sulfadimethoxine.,increase,risk
Sulfadimethoxine,Nateglinide,The therapeutic efficacy of Nateglinide can be increased when used in combination with Sulfadimethoxine.,increase,no risk
Sulfadimethoxine,Nicotine,The risk or severity of adverse effects can be increased when Sulfadimethoxine is combined with Nicotine.,increase,risk
Sulfadimethoxine,Quinine,The therapeutic efficacy of Quinine can be increased when used in combination with Sulfadimethoxine.,increase,no risk
Sulfadimethoxine,Vildagliptin,The therapeutic efficacy of Vildagliptin can be increased when used in combination with Sulfadimethoxine.,increase,no risk
Nylidrin,Galantamine,Galantamine may increase the bradycardic activities of Nylidrin.,increase,no risk
Nylidrin,Gallamine triethiodide,Nylidrin may increase the neuromuscular blocking activities of Gallamine triethiodide.,increase,no risk
Nylidrin,Gliclazide,The risk or severity of hypoglycemia can be increased when Nylidrin is combined with Gliclazide.,increase,risk
Nylidrin,Glimepiride,The risk or severity of hypoglycemia can be increased when Nylidrin is combined with Glimepiride.,increase,risk
Nylidrin,Glipizide,The risk or severity of hypoglycemia can be increased when Nylidrin is combined with Glipizide.,increase,risk
Nylidrin,Gliquidone,The risk or severity of hypoglycemia can be increased when Nylidrin is combined with Gliquidone.,increase,risk
Nylidrin,Glofitamab,The serum concentration of Nylidrin can be increased when it is combined with Glofitamab.,increase,no risk
Nylidrin,Gluconic Acid,The therapeutic efficacy of Gluconic Acid can be decreased when used in combination with Nylidrin.,decrease,no risk
Nylidrin,Glyburide,The therapeutic efficacy of Glyburide can be decreased when used in combination with Nylidrin.,decrease,no risk
Nylidrin,Glycerin,The therapeutic efficacy of Glycerin can be decreased when used in combination with Nylidrin.,decrease,no risk
Nylidrin,Glycopyrronium,The risk or severity of Tachycardia can be increased when Glycopyrronium is combined with Nylidrin.,increase,risk
Nylidrin,Glymidine,The risk or severity of hypoglycemia can be increased when Nylidrin is combined with Glymidine.,increase,risk
Nylidrin,Guanabenz,Nylidrin may decrease the antihypertensive activities of Guanabenz.,decrease,no risk
Nylidrin,Guanadrel,Nylidrin may decrease the antihypertensive activities of Guanadrel.,decrease,no risk
Nylidrin,Guanethidine,Nylidrin may decrease the antihypertensive activities of Guanethidine.,decrease,no risk
Nylidrin,Guanfacine,Nylidrin may decrease the antihypertensive activities of Guanfacine.,decrease,no risk
Nylidrin,Guanoxan,Nylidrin may decrease the antihypertensive activities of Guanoxan.,decrease,no risk
Nylidrin,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Nylidrin.,increase,no risk
Nylidrin,Halothane,The risk or severity of hypertension can be increased when Halothane is combined with Nylidrin.,increase,risk
Nylidrin,Heparin,The risk or severity of hyperkalemia can be increased when Heparin is combined with Nylidrin.,increase,risk
Nylidrin,Hexocyclium,The risk or severity of Tachycardia can be increased when Nylidrin is combined with Hexocyclium.,increase,risk
Nylidrin,Homatropine methylbromide,The risk or severity of Tachycardia can be increased when Homatropine methylbromide is combined with Nylidrin.,increase,risk
Nylidrin,Hydralazine,Nylidrin may decrease the antihypertensive activities of Hydralazine.,decrease,no risk
Nylidrin,Hydrochlorothiazide,Nylidrin may decrease the antihypertensive activities of Hydrochlorothiazide.,decrease,no risk
Nylidrin,Hydroflumethiazide,Nylidrin may decrease the antihypertensive activities of Hydroflumethiazide.,decrease,no risk
Nylidrin,Hydrotalcite,The risk or severity of hypotension can be increased when Hydrotalcite is combined with Nylidrin.,increase,risk
Nylidrin,Hyoscyamine,Hyoscyamine may increase the arrhythmogenic activities of Nylidrin.,increase,no risk
Nylidrin,Ketamine,The risk or severity of Tachycardia can be increased when Ketamine is combined with Nylidrin.,increase,risk
Nylidrin,Ketoconazole,The metabolism of Nylidrin can be decreased when combined with Ketoconazole.,decrease,no risk
Nylidrin,Ketoprofen,The risk or severity of hypertension can be increased when Ketoprofen is combined with Nylidrin.,increase,risk
Nylidrin,Ketorolac,The risk or severity of hypertension can be increased when Ketorolac is combined with Nylidrin.,increase,risk
Nylidrin,Nabilone,The risk or severity of Tachycardia can be increased when Nabilone is combined with Nylidrin.,increase,risk
Nylidrin,Nabumetone,The risk or severity of hypertension can be increased when Nabumetone is combined with Nylidrin.,increase,risk
Nylidrin,Nadolol,Nadolol may increase the arrhythmogenic activities of Nylidrin.,increase,no risk
Nylidrin,Nadroparin,The risk or severity of hyperkalemia can be increased when Nylidrin is combined with Nadroparin.,increase,risk
Nylidrin,Nafcillin,The therapeutic efficacy of Nylidrin can be decreased when used in combination with Nafcillin.,decrease,no risk
Nylidrin,Naphazoline,The risk or severity of hypertension can be increased when Nylidrin is combined with Naphazoline.,increase,risk
Nylidrin,Naproxen,The risk or severity of hypertension can be increased when Naproxen is combined with Nylidrin.,increase,risk
Nylidrin,Naratriptan,The risk or severity of hypertension can be increased when Naratriptan is combined with Nylidrin.,increase,risk
Nylidrin,Nateglinide,The risk or severity of hypoglycemia can be increased when Nylidrin is combined with Nateglinide.,increase,risk
Nylidrin,Naxitamab,The risk or severity of hypertension can be increased when Nylidrin is combined with Naxitamab.,increase,risk
Nylidrin,Nebivolol,Nebivolol may increase the arrhythmogenic activities of Nylidrin.,increase,no risk
Nylidrin,Nefazodone,The metabolism of Nylidrin can be decreased when combined with Nefazodone.,decrease,no risk
Nylidrin,Nelfinavir,The metabolism of Nylidrin can be decreased when combined with Nelfinavir.,decrease,no risk
Nylidrin,Netupitant,The metabolism of Nylidrin can be decreased when combined with Netupitant.,decrease,no risk
Nylidrin,Nialamide,The risk or severity of hypertension can be increased when Nialamide is combined with Nylidrin.,increase,risk
Nylidrin,Nicardipine,Nicardipine may increase the arrhythmogenic activities of Nylidrin.,increase,no risk
Nylidrin,Nicergoline,Nicergoline may increase the hypertensive and vasoconstricting activities of Nylidrin.,increase,no risk
Nylidrin,Nicorandil,Nylidrin may increase the arrhythmogenic activities of Nicorandil.,increase,no risk
Nylidrin,Nicotine,The risk or severity of Tachycardia can be increased when Nicotine is combined with Nylidrin.,increase,risk
Nylidrin,Nifedipine,Nifedipine may increase the arrhythmogenic activities of Nylidrin.,increase,no risk
Nylidrin,Nilotinib,The metabolism of Nylidrin can be decreased when combined with Nilotinib.,decrease,no risk
Nylidrin,Nilvadipine,Nylidrin may increase the arrhythmogenic activities of Nilvadipine.,increase,no risk
Nylidrin,Nimesulide,Nimesulide may increase the arrhythmogenic activities of Nylidrin.,increase,no risk
Nylidrin,Nimodipine,Nimodipine may increase the arrhythmogenic activities of Nylidrin.,increase,no risk
Nylidrin,Nisoldipine,Nisoldipine may increase the arrhythmogenic activities of Nylidrin.,increase,no risk
Nylidrin,Nitrendipine,Nitrendipine may increase the arrhythmogenic activities of Nylidrin.,increase,no risk
Nylidrin,Nitrofurantoin,The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Nylidrin.,increase,risk
Nylidrin,Nitroglycerin,Nylidrin may increase the vasodilatory activities of Nitroglycerin.,increase,no risk
Nylidrin,Nitroprusside,Nylidrin may increase the hypotensive activities of Nitroprusside.,increase,no risk
Nylidrin,Nitrous oxide,The risk or severity of hypertension can be increased when Nylidrin is combined with Nitrous oxide.,increase,risk
Nylidrin,Norepinephrine,The therapeutic efficacy of Nylidrin can be increased when used in combination with Norepinephrine.,increase,no risk
Nylidrin,Nortriptyline,The therapeutic efficacy of Nylidrin can be decreased when used in combination with Nortriptyline.,decrease,no risk
Nylidrin,Octreotide,The serum concentration of the active metabolites of Octreotide can be increased when Octreotide is used in combination with Nylidrin.,increase,no risk
Nylidrin,Olanzapine,The therapeutic efficacy of Nylidrin can be decreased when used in combination with Olanzapine.,decrease,no risk
Nylidrin,Olmesartan,Nylidrin may decrease the antihypertensive activities of Olmesartan.,decrease,no risk
Nylidrin,Olodaterol,The risk or severity of hypertension can be increased when Nylidrin is combined with Olodaterol.,increase,risk
Nylidrin,Omaveloxolone,The serum concentration of Nylidrin can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Nylidrin,Orciprenaline,The risk or severity of hypertension can be increased when Orciprenaline is combined with Nylidrin.,increase,risk
Nylidrin,Orphenadrine,The risk or severity of Tachycardia can be increased when Orphenadrine is combined with Nylidrin.,increase,risk
Nylidrin,Oteseconazole,The therapeutic efficacy of Oteseconazole can be increased when used in combination with Nylidrin.,increase,no risk
Nylidrin,Ouabain,The serum concentration of Ouabain can be increased when it is combined with Nylidrin.,increase,no risk
Nylidrin,Oxaprozin,The risk or severity of hypertension can be increased when Oxaprozin is combined with Nylidrin.,increase,risk
Nylidrin,Oxprenolol,Oxprenolol may increase the arrhythmogenic activities of Nylidrin.,increase,no risk
Nylidrin,Oxtriphylline,The risk or severity of adverse effects can be increased when Nylidrin is combined with Oxtriphylline.,increase,risk
Nylidrin,Oxybutynin,The risk or severity of Tachycardia can be increased when Oxybutynin is combined with Nylidrin.,increase,risk
Nylidrin,Oxymetazoline,The risk or severity of hypertension can be increased when Oxymetazoline is combined with Nylidrin.,increase,risk
Nylidrin,Oxyphenbutazone,The risk or severity of hypertension can be increased when Oxyphenbutazone is combined with Nylidrin.,increase,risk
Nylidrin,Oxyphencyclimine,The risk or severity of Tachycardia can be increased when Oxyphencyclimine is combined with Nylidrin.,increase,risk
Nylidrin,Oxyphenisatin acetate,The therapeutic efficacy of Oxyphenisatin acetate can be decreased when used in combination with Nylidrin.,decrease,no risk
Nylidrin,Oxyphenonium,The risk or severity of Tachycardia can be increased when Oxyphenonium is combined with Nylidrin.,increase,risk
Nylidrin,Quetiapine,The therapeutic efficacy of Nylidrin can be decreased when used in combination with Quetiapine.,decrease,no risk
Nylidrin,Quinapril,Nylidrin may decrease the antihypertensive activities of Quinapril.,decrease,no risk
Nylidrin,Quinidine,Quinidine may increase the arrhythmogenic activities of Nylidrin.,increase,no risk
Nylidrin,Quinine,The risk or severity of hypoglycemia can be increased when Nylidrin is combined with Quinine.,increase,risk
Nylidrin,Quinupramine,The risk or severity of hypertension can be increased when Quinupramine is combined with Nylidrin.,increase,risk
Nylidrin,Umeclidinium,The risk or severity of Tachycardia can be increased when Nylidrin is combined with Umeclidinium.,increase,risk
Nylidrin,Vadadustat,The serum concentration of Nylidrin can be increased when it is combined with Vadadustat.,increase,no risk
Nylidrin,Valdecoxib,The risk or severity of hypertension can be increased when Valdecoxib is combined with Nylidrin.,increase,risk
Nylidrin,Valsartan,Nylidrin may decrease the antihypertensive activities of Valsartan.,decrease,no risk
Nylidrin,Vecuronium,Nylidrin may increase the neuromuscular blocking activities of Vecuronium.,increase,no risk
Nylidrin,Venetoclax,The metabolism of Nylidrin can be decreased when combined with Venetoclax.,decrease,no risk
Nylidrin,Venlafaxine,Venlafaxine may increase the tachycardic activities of Nylidrin.,increase,no risk
Nylidrin,Verapamil,Verapamil may increase the arrhythmogenic activities of Nylidrin.,increase,no risk
Nylidrin,Vernakalant,Nylidrin may increase the arrhythmogenic activities of Vernakalant.,increase,no risk
Nylidrin,Vilanterol,The risk or severity of hypertension can be increased when Nylidrin is combined with Vilanterol.,increase,risk
Nylidrin,Vilazodone,The risk or severity of hypertension can be increased when Nylidrin is combined with Vilazodone.,increase,risk
Nylidrin,Vildagliptin,The risk or severity of hypoglycemia can be increased when Nylidrin is combined with Vildagliptin.,increase,risk
Nylidrin,Viloxazine,The metabolism of Nylidrin can be decreased when combined with Viloxazine.,decrease,no risk
Nylidrin,Voriconazole,The metabolism of Nylidrin can be decreased when combined with Voriconazole.,decrease,no risk
Nylidrin,Vortioxetine,The risk or severity of hypertension can be increased when Nylidrin is combined with Vortioxetine.,increase,risk
Nylidrin,Xamoterol,The risk or severity of hypertension can be increased when Nylidrin is combined with Xamoterol.,increase,risk
Nylidrin,Xylometazoline,Nylidrin may increase the arrhythmogenic activities of Xylometazoline.,increase,no risk
Nylidrin,Yohimbine,The risk or severity of hypertension can be increased when Yohimbine is combined with Nylidrin.,increase,risk
Nylidrin,Ziconotide,Nylidrin may increase the arrhythmogenic activities of Ziconotide.,increase,no risk
Nylidrin,Zimelidine,The metabolism of Nylidrin can be decreased when combined with Zimelidine.,decrease,no risk
Nylidrin,Ziprasidone,The therapeutic efficacy of Nylidrin can be decreased when used in combination with Ziprasidone.,decrease,no risk
Nylidrin,Zofenopril,Nylidrin may decrease the antihypertensive activities of Zofenopril.,decrease,no risk
Nylidrin,Zolmitriptan,The risk or severity of hypertension can be increased when Zolmitriptan is combined with Nylidrin.,increase,risk
Nylidrin,Zonisamide,Zonisamide may increase the arrhythmogenic activities of Nylidrin.,increase,no risk
Nylidrin,Zuclopenthixol,The therapeutic efficacy of Nylidrin can be decreased when used in combination with Zuclopenthixol.,decrease,no risk
Pizotifen,Butaperazine,The risk or severity of CNS depression can be increased when Pizotifen is combined with Butaperazine.,increase,risk
Pizotifen,Butobarbital,The risk or severity of CNS depression can be increased when Butobarbital is combined with Pizotifen.,increase,risk
Pizotifen,Butorphanol,The risk or severity of adverse effects can be increased when Pizotifen is combined with Butorphanol.,increase,risk
Pizotifen,Butriptyline,The risk or severity of CNS depression can be increased when Pizotifen is combined with Butriptyline.,increase,risk
Pizotifen,Butylscopolamine,The risk or severity of adverse effects can be increased when Pizotifen is combined with Butylscopolamine.,increase,risk
Pizotifen,Gabapentin,The risk or severity of CNS depression can be increased when Gabapentin is combined with Pizotifen.,increase,risk
Pizotifen,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Pizotifen is combined with Gabapentin enacarbil.,increase,risk
Pizotifen,Galantamine,The therapeutic efficacy of Pizotifen can be decreased when used in combination with Galantamine.,decrease,no risk
Pizotifen,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with Pizotifen.,increase,risk
Pizotifen,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Pizotifen is combined with Ganaxolone.",increase,risk
Pizotifen,Gepirone,The risk or severity of serotonin syndrome can be increased when Gepirone is combined with Pizotifen.,increase,risk
Pizotifen,Gilteritinib,The therapeutic efficacy of Pizotifen can be decreased when used in combination with Gilteritinib.,decrease,no risk
Pizotifen,Ginkgo biloba,The therapeutic efficacy of Pizotifen can be decreased when used in combination with Ginkgo biloba.,decrease,no risk
Pizotifen,Glucagon,Pizotifen may increase the gastrointestinal motility reducing activities of Glucagon.,increase,no risk
Pizotifen,Glutethimide,The risk or severity of CNS depression can be increased when Glutethimide is combined with Pizotifen.,increase,risk
Pizotifen,Glycerin,The therapeutic efficacy of Glycerin can be decreased when used in combination with Pizotifen.,decrease,no risk
Pizotifen,Glycopyrronium,The risk or severity of adverse effects can be increased when Pizotifen is combined with Glycopyrronium.,increase,risk
Pizotifen,Granisetron,The risk or severity of CNS depression can be increased when Granisetron is combined with Pizotifen.,increase,risk
Pizotifen,Guanabenz,The therapeutic efficacy of Guanabenz can be decreased when used in combination with Pizotifen.,decrease,no risk
Pizotifen,Guanadrel,Pizotifen may decrease the antihypertensive activities of Guanadrel.,decrease,no risk
Pizotifen,Guanethidine,Pizotifen may decrease the antihypertensive activities of Guanethidine.,decrease,no risk
Pizotifen,Guanfacine,The therapeutic efficacy of Guanfacine can be decreased when used in combination with Pizotifen.,decrease,no risk
Pizotifen,Guanoxan,Pizotifen may decrease the antihypertensive activities of Guanoxan.,decrease,no risk
Pizotifen,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with Pizotifen.,increase,risk
Pizotifen,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Pizotifen.,increase,risk
Pizotifen,Halothane,The risk or severity of CNS depression can be increased when Halothane is combined with Pizotifen.,increase,risk
Pizotifen,Hexafluronium,The risk or severity of CNS depression can be increased when Hexafluronium is combined with Pizotifen.,increase,risk
Pizotifen,Hexocyclium,The risk or severity of adverse effects can be increased when Pizotifen is combined with Hexocyclium.,increase,risk
Pizotifen,Homatropine,The risk or severity of adverse effects can be increased when Pizotifen is combined with Homatropine.,increase,risk
Pizotifen,Homatropine methylbromide,The risk or severity of adverse effects can be increased when Homatropine methylbromide is combined with Pizotifen.,increase,risk
Pizotifen,Huperzine A,The therapeutic efficacy of Pizotifen can be decreased when used in combination with Huperzine A.,decrease,no risk
Pizotifen,Hydralazine,Pizotifen may decrease the antihypertensive activities of Hydralazine.,decrease,no risk
Pizotifen,Hydrochlorothiazide,Pizotifen may decrease the antihypertensive activities of Hydrochlorothiazide.,decrease,no risk
Pizotifen,Hydrocodone,Pizotifen may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Pizotifen,Hydroflumethiazide,Pizotifen may decrease the antihypertensive activities of Hydroflumethiazide.,decrease,no risk
Pizotifen,Hydromorphone,The risk or severity of adverse effects can be increased when Pizotifen is combined with Hydromorphone.,increase,risk
Pizotifen,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Pizotifen.,increase,no risk
Pizotifen,Hyoscyamine,Pizotifen may increase the anticholinergic activities of Hyoscyamine.,increase,no risk
Pizotifen,Ketamine,The risk or severity of CNS depression can be increased when Ketamine is combined with Pizotifen.,increase,risk
Pizotifen,Ketazolam,The risk or severity of CNS depression can be increased when Ketazolam is combined with Pizotifen.,increase,risk
Pizotifen,Ketoprofen,The risk or severity of hypertension can be increased when Ketoprofen is combined with Pizotifen.,increase,risk
Pizotifen,Ketorolac,The risk or severity of hypertension can be increased when Ketorolac is combined with Pizotifen.,increase,risk
Pizotifen,Nabilone,Nabilone may increase the central nervous system depressant (CNS depressant) activities of Pizotifen.,increase,no risk
Pizotifen,Nabumetone,The risk or severity of hypertension can be increased when Nabumetone is combined with Pizotifen.,increase,risk
Pizotifen,Nadolol,Nadolol may increase the orthostatic hypotensive activities of Pizotifen.,increase,no risk
Pizotifen,Nalbuphine,The risk or severity of adverse effects can be increased when Pizotifen is combined with Nalbuphine.,increase,risk
Pizotifen,Naloxegol,The risk or severity of adverse effects can be increased when Pizotifen is combined with Naloxegol.,increase,risk
Pizotifen,Naltrexone,The risk or severity of adverse effects can be increased when Pizotifen is combined with Naltrexone.,increase,risk
Pizotifen,Naphazoline,The therapeutic efficacy of Naphazoline can be decreased when used in combination with Pizotifen.,decrease,no risk
Pizotifen,Naproxen,The risk or severity of hypertension can be increased when Naproxen is combined with Pizotifen.,increase,risk
Pizotifen,Naratriptan,The risk or severity of CNS depression can be increased when Naratriptan is combined with Pizotifen.,increase,risk
Pizotifen,Naxitamab,The risk or severity of hypertension can be increased when Pizotifen is combined with Naxitamab.,increase,risk
Pizotifen,Nebivolol,The therapeutic efficacy of Nebivolol can be decreased when used in combination with Pizotifen.,decrease,no risk
Pizotifen,Nefazodone,"Nefazodone may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Pizotifen.",increase,no risk
Pizotifen,Neostigmine,The therapeutic efficacy of Pizotifen can be decreased when used in combination with Neostigmine.,decrease,no risk
Pizotifen,Nialamide,Nialamide may increase the anticholinergic activities of Pizotifen.,increase,no risk
Pizotifen,Nicardipine,"Nicardipine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Pizotifen.",increase,no risk
Pizotifen,Nicergoline,"Nicergoline may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Pizotifen.",increase,no risk
Pizotifen,Nicorandil,Pizotifen may decrease the antihypertensive activities of Nicorandil.,decrease,no risk
Pizotifen,Nicotine,The risk or severity of Tachycardia can be increased when Nicotine is combined with Pizotifen.,increase,risk
Pizotifen,Nifedipine,The risk or severity of hypotension can be increased when Pizotifen is combined with Nifedipine.,increase,risk
Pizotifen,Nilvadipine,Pizotifen may decrease the antihypertensive activities of Nilvadipine.,decrease,no risk
Pizotifen,Nimesulide,The risk or severity of hypertension can be increased when Nimesulide is combined with Pizotifen.,increase,risk
Pizotifen,Nimodipine,Pizotifen may decrease the antihypertensive activities of Nimodipine.,decrease,no risk
Pizotifen,Nisoldipine,Pizotifen may decrease the antihypertensive activities of Nisoldipine.,decrease,no risk
Pizotifen,Nitrazepam,The risk or severity of CNS depression can be increased when Nitrazepam is combined with Pizotifen.,increase,risk
Pizotifen,Nitrendipine,Pizotifen may decrease the antihypertensive activities of Nitrendipine.,decrease,no risk
Pizotifen,Nitroglycerin,Pizotifen may decrease the antihypertensive activities of Nitroglycerin.,decrease,no risk
Pizotifen,Nitroprusside,Pizotifen may decrease the antihypertensive activities of Nitroprusside.,decrease,no risk
Pizotifen,Nitrous oxide,The risk or severity of CNS depression can be increased when Pizotifen is combined with Nitrous oxide.,increase,risk
Pizotifen,Nizatidine,The therapeutic efficacy of Pizotifen can be decreased when used in combination with Nizatidine.,decrease,no risk
Pizotifen,Nomifensine,The risk or severity of CNS depression can be increased when Nomifensine is combined with Pizotifen.,increase,risk
Pizotifen,Norepinephrine,The therapeutic efficacy of Norepinephrine can be decreased when used in combination with Pizotifen.,decrease,no risk
Pizotifen,Normethadone,The risk or severity of adverse effects can be increased when Pizotifen is combined with Normethadone.,increase,risk
Pizotifen,Nortriptyline,"Nortriptyline may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Pizotifen.",increase,no risk
Pizotifen,Nylidrin,The therapeutic efficacy of Nylidrin can be decreased when used in combination with Pizotifen.,decrease,no risk
Pizotifen,Olanzapine,"Olanzapine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Pizotifen.",increase,no risk
Pizotifen,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Pizotifen is combined with Oliceridine.",increase,risk
Pizotifen,Olmesartan,Pizotifen may decrease the antihypertensive activities of Olmesartan.,decrease,no risk
Pizotifen,Olodaterol,The therapeutic efficacy of Olodaterol can be decreased when used in combination with Pizotifen.,decrease,no risk
Pizotifen,Ondansetron,The risk or severity of CNS depression can be increased when Ondansetron is combined with Pizotifen.,increase,risk
Pizotifen,Opium,The risk or severity of adverse effects can be increased when Pizotifen is combined with Opium.,increase,risk
Pizotifen,Orciprenaline,The therapeutic efficacy of Orciprenaline can be decreased when used in combination with Pizotifen.,decrease,no risk
Pizotifen,Orphenadrine,Pizotifen may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Pizotifen,Oxaprozin,The risk or severity of hypertension can be increased when Oxaprozin is combined with Pizotifen.,increase,risk
Pizotifen,Oxazepam,The risk or severity of CNS depression can be increased when Oxazepam is combined with Pizotifen.,increase,risk
Pizotifen,Oxcarbazepine,The risk or severity of CNS depression can be increased when Oxcarbazepine is combined with Pizotifen.,increase,risk
Pizotifen,Oxitriptan,The risk or severity of CNS depression can be increased when Oxitriptan is combined with Pizotifen.,increase,risk
Pizotifen,Oxprenolol,Oxprenolol may increase the orthostatic hypotensive activities of Pizotifen.,increase,no risk
Pizotifen,Oxybuprocaine,The risk or severity of CNS depression can be increased when Oxybuprocaine is combined with Pizotifen.,increase,risk
Pizotifen,Oxybutynin,The risk or severity of adverse effects can be increased when Oxybutynin is combined with Pizotifen.,increase,risk
Pizotifen,Oxycodone,The risk or severity of adverse effects can be increased when Pizotifen is combined with Oxycodone.,increase,risk
Pizotifen,Oxymetazoline,The therapeutic efficacy of Oxymetazoline can be decreased when used in combination with Pizotifen.,decrease,no risk
Pizotifen,Oxymorphone,The risk or severity of adverse effects can be increased when Pizotifen is combined with Oxymorphone.,increase,risk
Pizotifen,Oxyphenbutazone,The risk or severity of hypertension can be increased when Oxyphenbutazone is combined with Pizotifen.,increase,risk
Pizotifen,Oxyphencyclimine,The risk or severity of adverse effects can be increased when Oxyphencyclimine is combined with Pizotifen.,increase,risk
Pizotifen,Oxyphenisatin acetate,The therapeutic efficacy of Oxyphenisatin acetate can be decreased when used in combination with Pizotifen.,decrease,no risk
Pizotifen,Oxyphenonium,The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Pizotifen.,increase,risk
Pizotifen,Quazepam,The risk or severity of CNS depression can be increased when Quazepam is combined with Pizotifen.,increase,risk
Pizotifen,Quetiapine,"Quetiapine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Pizotifen.",increase,no risk
Pizotifen,Quinapril,Pizotifen may decrease the antihypertensive activities of Quinapril.,decrease,no risk
Pizotifen,Quinethazone,The serum concentration of Quinethazone can be increased when it is combined with Pizotifen.,increase,no risk
Pizotifen,Quinidine,"Quinidine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Pizotifen.",increase,no risk
Pizotifen,Quinine,The risk or severity of CNS depression can be increased when Quinine is combined with Pizotifen.,increase,risk
Pizotifen,Quinupramine,The risk or severity of CNS depression can be increased when Pizotifen is combined with Quinupramine.,increase,risk
Pizotifen,Udenafil,The risk or severity of hypotension and syncope can be increased when Udenafil is combined with Pizotifen.,increase,risk
Pizotifen,Umeclidinium,The risk or severity of adverse effects can be increased when Pizotifen is combined with Umeclidinium.,increase,risk
Pizotifen,Urethane,The risk or severity of CNS depression can be increased when Urethane is combined with Pizotifen.,increase,risk
Pizotifen,Valdecoxib,The risk or severity of hypertension can be increased when Valdecoxib is combined with Pizotifen.,increase,risk
Pizotifen,Valproate bismuth,The risk or severity of serotonin syndrome can be increased when Pizotifen is combined with Valproate bismuth.,increase,risk
Pizotifen,Valproic acid,The risk or severity of CNS depression can be increased when Valproic acid is combined with Pizotifen.,increase,risk
Pizotifen,Valsartan,Pizotifen may decrease the antihypertensive activities of Valsartan.,decrease,no risk
Pizotifen,Vardenafil,The risk or severity of hypotension and syncope can be increased when Vardenafil is combined with Pizotifen.,increase,risk
Pizotifen,Vecuronium,The risk or severity of CNS depression can be increased when Vecuronium is combined with Pizotifen.,increase,risk
Pizotifen,Venlafaxine,The risk or severity of serotonin syndrome can be increased when Pizotifen is combined with Venlafaxine.,increase,risk
Pizotifen,Verapamil,The risk or severity of hypotension can be increased when Pizotifen is combined with Verapamil.,increase,risk
Pizotifen,Vibegron,The therapeutic efficacy of Vibegron can be decreased when used in combination with Pizotifen.,decrease,no risk
Pizotifen,Vigabatrin,The risk or severity of CNS depression can be increased when Vigabatrin is combined with Pizotifen.,increase,risk
Pizotifen,Vilanterol,The therapeutic efficacy of Vilanterol can be decreased when used in combination with Pizotifen.,decrease,no risk
Pizotifen,Vilazodone,The risk or severity of CNS depression can be increased when Pizotifen is combined with Vilazodone.,increase,risk
Pizotifen,Viloxazine,The risk or severity of CNS depression can be increased when Pizotifen is combined with Viloxazine.,increase,risk
Pizotifen,Vortioxetine,The risk or severity of CNS depression can be increased when Pizotifen is combined with Vortioxetine.,increase,risk
Pizotifen,Warfarin,The risk or severity of adverse effects can be increased when Pizotifen is combined with Warfarin.,increase,risk
Pizotifen,Xamoterol,The therapeutic efficacy of Xamoterol can be decreased when used in combination with Pizotifen.,decrease,no risk
Pizotifen,Xylometazoline,The therapeutic efficacy of Xylometazoline can be decreased when used in combination with Pizotifen.,decrease,no risk
Pizotifen,Yohimbine,The risk or severity of CNS depression can be increased when Yohimbine is combined with Pizotifen.,increase,risk
Pizotifen,Zaleplon,The risk or severity of CNS depression can be increased when Zaleplon is combined with Pizotifen.,increase,risk
Pizotifen,Ziconotide,The risk or severity of CNS depression can be increased when Pizotifen is combined with Ziconotide.,increase,risk
Pizotifen,Zimelidine,The risk or severity of adverse effects can be increased when Pizotifen is combined with Zimelidine.,increase,risk
Pizotifen,Ziprasidone,The risk or severity of adverse effects can be increased when Pizotifen is combined with Ziprasidone.,increase,risk
Pizotifen,Zofenopril,Pizotifen may decrease the antihypertensive activities of Zofenopril.,decrease,no risk
Pizotifen,Zolmitriptan,The risk or severity of CNS depression can be increased when Zolmitriptan is combined with Pizotifen.,increase,risk
Pizotifen,Zolpidem,Pizotifen may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Pizotifen,Zonisamide,The risk or severity of CNS depression can be increased when Zonisamide is combined with Pizotifen.,increase,risk
Pizotifen,Zopiclone,The risk or severity of adverse effects can be increased when Pizotifen is combined with Zopiclone.,increase,risk
Pizotifen,Zotepine,The risk or severity of CNS depression can be increased when Pizotifen is combined with Zotepine.,increase,risk
Pizotifen,Zuclopenthixol,"Zuclopenthixol may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Pizotifen.",increase,no risk
Pizotifen,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Pizotifen.,increase,risk
Pentaerythritol tetranitrate,Gabapentin enacarbil,Pentaerythritol tetranitrate may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Pentaerythritol tetranitrate,Gadobenic acid,Gadobenic acid may decrease the excretion rate of Pentaerythritol tetranitrate which could result in a higher serum level.,decrease,no risk
Pentaerythritol tetranitrate,Gadodiamide,Gadodiamide may decrease the excretion rate of Pentaerythritol tetranitrate which could result in a higher serum level.,decrease,no risk
Pentaerythritol tetranitrate,Gadofosveset trisodium,Pentaerythritol tetranitrate may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Pentaerythritol tetranitrate,Gadopentetic acid,Gadopentetic acid may decrease the excretion rate of Pentaerythritol tetranitrate which could result in a higher serum level.,decrease,no risk
Pentaerythritol tetranitrate,Gadoteric acid,Pentaerythritol tetranitrate may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Pentaerythritol tetranitrate,Gadoteridol,Gadoteridol may decrease the excretion rate of Pentaerythritol tetranitrate which could result in a higher serum level.,decrease,no risk
Pentaerythritol tetranitrate,Ganciclovir,Ganciclovir may decrease the excretion rate of Pentaerythritol tetranitrate which could result in a higher serum level.,decrease,no risk
Pentaerythritol tetranitrate,Gemcitabine,Gemcitabine may decrease the excretion rate of Pentaerythritol tetranitrate which could result in a higher serum level.,decrease,no risk
Pentaerythritol tetranitrate,Gemfibrozil,Gemfibrozil may decrease the excretion rate of Pentaerythritol tetranitrate which could result in a higher serum level.,decrease,no risk
Pentaerythritol tetranitrate,Gentamicin,Pentaerythritol tetranitrate may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Pentaerythritol tetranitrate,Gimeracil,Pentaerythritol tetranitrate may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Pentaerythritol tetranitrate,Givosiran,Givosiran may decrease the excretion rate of Pentaerythritol tetranitrate which could result in a higher serum level.,decrease,no risk
Pentaerythritol tetranitrate,Glipizide,Glipizide may decrease the excretion rate of Pentaerythritol tetranitrate which could result in a higher serum level.,decrease,no risk
Pentaerythritol tetranitrate,Glycerol phenylbutyrate,Pentaerythritol tetranitrate may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Pentaerythritol tetranitrate,Golodirsen,Pentaerythritol tetranitrate may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Pentaerythritol tetranitrate,Goserelin,Goserelin may decrease the excretion rate of Pentaerythritol tetranitrate which could result in a higher serum level.,decrease,no risk
Pentaerythritol tetranitrate,Guanethidine,Guanethidine may decrease the excretion rate of Pentaerythritol tetranitrate which could result in a higher serum level.,decrease,no risk
Pentaerythritol tetranitrate,Guanfacine,Guanfacine may decrease the excretion rate of Pentaerythritol tetranitrate which could result in a higher serum level.,decrease,no risk
Pentaerythritol tetranitrate,Haloperidol,Haloperidol may decrease the excretion rate of Pentaerythritol tetranitrate which could result in a higher serum level.,decrease,no risk
Pentaerythritol tetranitrate,Hydralazine,Hydralazine may decrease the excretion rate of Pentaerythritol tetranitrate which could result in a higher serum level.,decrease,no risk
Pentaerythritol tetranitrate,Hydrochlorothiazide,Hydrochlorothiazide may increase the excretion rate of Pentaerythritol tetranitrate which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Pentaerythritol tetranitrate,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of Pentaerythritol tetranitrate which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Pentaerythritol tetranitrate,Hydromorphone,Hydromorphone may decrease the excretion rate of Pentaerythritol tetranitrate which could result in a higher serum level.,decrease,no risk
Pentaerythritol tetranitrate,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Pentaerythritol tetranitrate which could result in a higher serum level.,decrease,no risk
Pentaerythritol tetranitrate,Hydroxyethyl Starch,Pentaerythritol tetranitrate may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Pentaerythritol tetranitrate,Kanamycin,Pentaerythritol tetranitrate may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Pentaerythritol tetranitrate,Ketamine,Ketamine may decrease the excretion rate of Pentaerythritol tetranitrate which could result in a higher serum level.,decrease,no risk
Pentaerythritol tetranitrate,Ketazolam,Ketazolam may decrease the excretion rate of Pentaerythritol tetranitrate which could result in a higher serum level.,decrease,no risk
Pentaerythritol tetranitrate,Ketoprofen,Ketoprofen may decrease the excretion rate of Pentaerythritol tetranitrate which could result in a higher serum level.,decrease,no risk
Pentaerythritol tetranitrate,Ketorolac,Ketorolac may decrease the excretion rate of Pentaerythritol tetranitrate which could result in a higher serum level.,decrease,no risk
Pentaerythritol tetranitrate,N-acetyltyrosine,Pentaerythritol tetranitrate may decrease the excretion rate of N-acetyltyrosine which could result in a higher serum level.,decrease,no risk
Pentaerythritol tetranitrate,Nabumetone,Nabumetone may decrease the excretion rate of Pentaerythritol tetranitrate which could result in a higher serum level.,decrease,no risk
Pentaerythritol tetranitrate,Nadolol,Nadolol may decrease the excretion rate of Pentaerythritol tetranitrate which could result in a higher serum level.,decrease,no risk
Pentaerythritol tetranitrate,Naldemedine,Pentaerythritol tetranitrate may decrease the excretion rate of Naldemedine which could result in a higher serum level.,decrease,no risk
Pentaerythritol tetranitrate,Nalmefene,Pentaerythritol tetranitrate may decrease the excretion rate of Nalmefene which could result in a higher serum level.,decrease,no risk
Pentaerythritol tetranitrate,Naloxone,Naloxone may decrease the excretion rate of Pentaerythritol tetranitrate which could result in a higher serum level.,decrease,no risk
Pentaerythritol tetranitrate,Naproxen,Naproxen may decrease the excretion rate of Pentaerythritol tetranitrate which could result in a higher serum level.,decrease,no risk
Pentaerythritol tetranitrate,Nateglinide,Nateglinide may decrease the excretion rate of Pentaerythritol tetranitrate which could result in a higher serum level.,decrease,no risk
Pentaerythritol tetranitrate,Nedaplatin,Pentaerythritol tetranitrate may decrease the excretion rate of Nedaplatin which could result in a higher serum level.,decrease,no risk
Pentaerythritol tetranitrate,Nedocromil,Nedocromil may decrease the excretion rate of Pentaerythritol tetranitrate which could result in a higher serum level.,decrease,no risk
Pentaerythritol tetranitrate,Nefazodone,Nefazodone may decrease the excretion rate of Pentaerythritol tetranitrate which could result in a higher serum level.,decrease,no risk
Pentaerythritol tetranitrate,Neomycin,Pentaerythritol tetranitrate may decrease the excretion rate of Neomycin which could result in a higher serum level.,decrease,no risk
Pentaerythritol tetranitrate,Netilmicin,Pentaerythritol tetranitrate may decrease the excretion rate of Netilmicin which could result in a higher serum level.,decrease,no risk
Pentaerythritol tetranitrate,Nicardipine,Nicardipine may increase the vasodilatory activities of Pentaerythritol tetranitrate.,increase,no risk
Pentaerythritol tetranitrate,Nicorandil,Pentaerythritol tetranitrate may decrease the excretion rate of Nicorandil which could result in a higher serum level.,decrease,no risk
Pentaerythritol tetranitrate,Nifedipine,Nifedipine may increase the vasodilatory activities of Pentaerythritol tetranitrate.,increase,no risk
Pentaerythritol tetranitrate,Nilutamide,Nilutamide may decrease the excretion rate of Pentaerythritol tetranitrate which could result in a higher serum level.,decrease,no risk
Pentaerythritol tetranitrate,Nilvadipine,Nilvadipine may increase the vasodilatory activities of Pentaerythritol tetranitrate.,increase,no risk
Pentaerythritol tetranitrate,Nimesulide,Nimesulide may increase the vasodilatory activities of Pentaerythritol tetranitrate.,increase,no risk
Pentaerythritol tetranitrate,Nimodipine,Nimodipine may increase the vasodilatory activities of Pentaerythritol tetranitrate.,increase,no risk
Pentaerythritol tetranitrate,Nisoldipine,Nisoldipine may increase the vasodilatory activities of Pentaerythritol tetranitrate.,increase,no risk
Pentaerythritol tetranitrate,Nitrendipine,Nitrendipine may increase the vasodilatory activities of Pentaerythritol tetranitrate.,increase,no risk
Pentaerythritol tetranitrate,Nitric Oxide,Nitric Oxide may decrease the excretion rate of Pentaerythritol tetranitrate which could result in a higher serum level.,decrease,no risk
Pentaerythritol tetranitrate,Nitrofurantoin,Nitrofurantoin may decrease the excretion rate of Pentaerythritol tetranitrate which could result in a higher serum level.,decrease,no risk
Pentaerythritol tetranitrate,Nitroprusside,Nitroprusside may decrease the excretion rate of Pentaerythritol tetranitrate which could result in a higher serum level.,decrease,no risk
Pentaerythritol tetranitrate,Nylidrin,Nylidrin may increase the vasodilatory activities of Pentaerythritol tetranitrate.,increase,no risk
Pentaerythritol tetranitrate,Octinoxate,Pentaerythritol tetranitrate may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Pentaerythritol tetranitrate,Olsalazine,Olsalazine may decrease the excretion rate of Pentaerythritol tetranitrate which could result in a higher serum level.,decrease,no risk
Pentaerythritol tetranitrate,Opium,Pentaerythritol tetranitrate may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Pentaerythritol tetranitrate,Oseltamivir,Oseltamivir may decrease the excretion rate of Pentaerythritol tetranitrate which could result in a higher serum level.,decrease,no risk
Pentaerythritol tetranitrate,Oxacillin,Oxacillin may decrease the excretion rate of Pentaerythritol tetranitrate which could result in a higher serum level.,decrease,no risk
Pentaerythritol tetranitrate,Oxaprozin,Oxaprozin may decrease the excretion rate of Pentaerythritol tetranitrate which could result in a higher serum level.,decrease,no risk
Pentaerythritol tetranitrate,Oxazepam,Oxazepam may decrease the excretion rate of Pentaerythritol tetranitrate which could result in a higher serum level.,decrease,no risk
Pentaerythritol tetranitrate,Oxybenzone,Oxybenzone may decrease the excretion rate of Pentaerythritol tetranitrate which could result in a higher serum level.,decrease,no risk
Pentaerythritol tetranitrate,Oxyphenbutazone,Oxyphenbutazone may decrease the excretion rate of Pentaerythritol tetranitrate which could result in a higher serum level.,decrease,no risk
Pentaerythritol tetranitrate,Oxyquinoline,Pentaerythritol tetranitrate may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Pentaerythritol tetranitrate,Quetiapine,Quetiapine may decrease the excretion rate of Pentaerythritol tetranitrate which could result in a higher serum level.,decrease,no risk
Pentaerythritol tetranitrate,Quinethazone,Quinethazone may increase the excretion rate of Pentaerythritol tetranitrate which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Pentaerythritol tetranitrate,Quinidine,Pentaerythritol tetranitrate may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Pentaerythritol tetranitrate,Udenafil,The risk or severity of hypotension can be increased when Udenafil is combined with Pentaerythritol tetranitrate.,increase,risk
Pentaerythritol tetranitrate,Vaborbactam,Pentaerythritol tetranitrate may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Pentaerythritol tetranitrate,Valaciclovir,Valaciclovir may decrease the excretion rate of Pentaerythritol tetranitrate which could result in a higher serum level.,decrease,no risk
Pentaerythritol tetranitrate,Valbenazine,Pentaerythritol tetranitrate may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
Pentaerythritol tetranitrate,Valdecoxib,Valdecoxib may decrease the excretion rate of Pentaerythritol tetranitrate which could result in a higher serum level.,decrease,no risk
Pentaerythritol tetranitrate,Valganciclovir,Valganciclovir may decrease the excretion rate of Pentaerythritol tetranitrate which could result in a higher serum level.,decrease,no risk
Pentaerythritol tetranitrate,Vancomycin,Pentaerythritol tetranitrate may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Pentaerythritol tetranitrate,Vardenafil,The risk or severity of hypotension can be increased when Vardenafil is combined with Pentaerythritol tetranitrate.,increase,risk
Pentaerythritol tetranitrate,Varenicline,Varenicline may decrease the excretion rate of Pentaerythritol tetranitrate which could result in a higher serum level.,decrease,no risk
Pentaerythritol tetranitrate,Venlafaxine,Venlafaxine may decrease the excretion rate of Pentaerythritol tetranitrate which could result in a higher serum level.,decrease,no risk
Pentaerythritol tetranitrate,Verapamil,Verapamil may increase the vasodilatory activities of Pentaerythritol tetranitrate.,increase,no risk
Pentaerythritol tetranitrate,Vilanterol,Pentaerythritol tetranitrate may decrease the excretion rate of Vilanterol which could result in a higher serum level.,decrease,no risk
Pentaerythritol tetranitrate,Viloxazine,Pentaerythritol tetranitrate may decrease the excretion rate of Viloxazine which could result in a higher serum level.,decrease,no risk
Pentaerythritol tetranitrate,Vortioxetine,Pentaerythritol tetranitrate may decrease the excretion rate of Vortioxetine which could result in a higher serum level.,decrease,no risk
Pentaerythritol tetranitrate,Warfarin,Pentaerythritol tetranitrate may decrease the excretion rate of Warfarin which could result in a higher serum level.,decrease,no risk
Pentaerythritol tetranitrate,Zaleplon,Zaleplon may decrease the excretion rate of Pentaerythritol tetranitrate which could result in a higher serum level.,decrease,no risk
Pentaerythritol tetranitrate,Zanamivir,Zanamivir may decrease the excretion rate of Pentaerythritol tetranitrate which could result in a higher serum level.,decrease,no risk
Pentaerythritol tetranitrate,Zonisamide,Zonisamide may increase the vasodilatory activities of Pentaerythritol tetranitrate.,increase,no risk
Rimonabant,Gabapentin,The risk or severity of adverse effects can be increased when Rimonabant is combined with Gabapentin.,increase,risk
Rimonabant,Gabapentin enacarbil,The risk or severity of adverse effects can be increased when Rimonabant is combined with Gabapentin enacarbil.,increase,risk
Rimonabant,Gallamine triethiodide,The risk or severity of adverse effects can be increased when Rimonabant is combined with Gallamine triethiodide.,increase,risk
Rimonabant,Ganaxolone,The risk or severity of adverse effects can be increased when Rimonabant is combined with Ganaxolone.,increase,risk
Rimonabant,Gepirone,The risk or severity of adverse effects can be increased when Rimonabant is combined with Gepirone.,increase,risk
Rimonabant,Glofitamab,The serum concentration of Rimonabant can be increased when it is combined with Glofitamab.,increase,no risk
Rimonabant,Glutethimide,The risk or severity of adverse effects can be increased when Rimonabant is combined with Glutethimide.,increase,risk
Rimonabant,Glycopyrronium,The risk or severity of Tachycardia and drowsiness can be increased when Glycopyrronium is combined with Rimonabant.,increase,risk
Rimonabant,Granisetron,The risk or severity of adverse effects can be increased when Rimonabant is combined with Granisetron.,increase,risk
Rimonabant,Guanabenz,The risk or severity of Tachycardia can be increased when Guanabenz is combined with Rimonabant.,increase,risk
Rimonabant,Guanfacine,The risk or severity of adverse effects can be increased when Rimonabant is combined with Guanfacine.,increase,risk
Rimonabant,Halazepam,The risk or severity of adverse effects can be increased when Rimonabant is combined with Halazepam.,increase,risk
Rimonabant,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Rimonabant.,increase,no risk
Rimonabant,Halothane,The risk or severity of adverse effects can be increased when Rimonabant is combined with Halothane.,increase,risk
Rimonabant,Hexafluronium,The risk or severity of adverse effects can be increased when Rimonabant is combined with Hexafluronium.,increase,risk
Rimonabant,Hexocyclium,The risk or severity of Tachycardia and drowsiness can be increased when Hexocyclium is combined with Rimonabant.,increase,risk
Rimonabant,Homatropine methylbromide,The risk or severity of Tachycardia and drowsiness can be increased when Homatropine methylbromide is combined with Rimonabant.,increase,risk
Rimonabant,Hydrocodone,The risk or severity of adverse effects can be increased when Rimonabant is combined with Hydrocodone.,increase,risk
Rimonabant,Hydromorphone,The risk or severity of adverse effects can be increased when Rimonabant is combined with Hydromorphone.,increase,risk
Rimonabant,Hydroxyzine,The risk or severity of adverse effects can be increased when Rimonabant is combined with Hydroxyzine.,increase,risk
Rimonabant,Hyoscyamine,The risk or severity of Tachycardia and drowsiness can be increased when Hyoscyamine is combined with Rimonabant.,increase,risk
Rimonabant,Ketamine,The risk or severity of adverse effects can be increased when Rimonabant is combined with Ketamine.,increase,risk
Rimonabant,Ketazolam,The risk or severity of adverse effects can be increased when Rimonabant is combined with Ketazolam.,increase,risk
Rimonabant,Ketoconazole,The metabolism of Rimonabant can be decreased when combined with Ketoconazole.,decrease,no risk
Rimonabant,Nabilone,The risk or severity of adverse effects can be increased when Rimonabant is combined with Nabilone.,increase,risk
Rimonabant,Nalbuphine,The risk or severity of adverse effects can be increased when Rimonabant is combined with Nalbuphine.,increase,risk
Rimonabant,Naphazoline,The risk or severity of Tachycardia can be increased when Rimonabant is combined with Naphazoline.,increase,risk
Rimonabant,Naratriptan,The risk or severity of adverse effects can be increased when Rimonabant is combined with Naratriptan.,increase,risk
Rimonabant,Nefazodone,The metabolism of Rimonabant can be decreased when combined with Nefazodone.,decrease,no risk
Rimonabant,Nelfinavir,The metabolism of Rimonabant can be decreased when combined with Nelfinavir.,decrease,no risk
Rimonabant,Netupitant,The metabolism of Rimonabant can be decreased when combined with Netupitant.,decrease,no risk
Rimonabant,Nialamide,The risk or severity of adverse effects can be increased when Rimonabant is combined with Nialamide.,increase,risk
Rimonabant,Nicardipine,The risk or severity of Tachycardia and drowsiness can be increased when Nicardipine is combined with Rimonabant.,increase,risk
Rimonabant,Nicotine,The risk or severity of Tachycardia can be increased when Nicotine is combined with Rimonabant.,increase,risk
Rimonabant,Nilotinib,The metabolism of Rimonabant can be decreased when combined with Nilotinib.,decrease,no risk
Rimonabant,Nilvadipine,The metabolism of Rimonabant can be decreased when combined with Nilvadipine.,decrease,no risk
Rimonabant,Nitrazepam,The risk or severity of adverse effects can be increased when Rimonabant is combined with Nitrazepam.,increase,risk
Rimonabant,Nitrous oxide,The risk or severity of adverse effects can be increased when Rimonabant is combined with Nitrous oxide.,increase,risk
Rimonabant,Nomifensine,The risk or severity of adverse effects can be increased when Rimonabant is combined with Nomifensine.,increase,risk
Rimonabant,Norepinephrine,The risk or severity of Tachycardia can be increased when Rimonabant is combined with Norepinephrine.,increase,risk
Rimonabant,Normethadone,The risk or severity of adverse effects can be increased when Rimonabant is combined with Normethadone.,increase,risk
Rimonabant,Nortriptyline,The risk or severity of adverse effects can be increased when Rimonabant is combined with Nortriptyline.,increase,risk
Rimonabant,Nylidrin,The risk or severity of Tachycardia can be increased when Rimonabant is combined with Nylidrin.,increase,risk
Rimonabant,Olanzapine,The risk or severity of adverse effects can be increased when Rimonabant is combined with Olanzapine.,increase,risk
Rimonabant,Oliceridine,The risk or severity of adverse effects can be increased when Rimonabant is combined with Oliceridine.,increase,risk
Rimonabant,Olodaterol,The risk or severity of Tachycardia can be increased when Rimonabant is combined with Olodaterol.,increase,risk
Rimonabant,Omaveloxolone,The serum concentration of Rimonabant can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Rimonabant,Ondansetron,The risk or severity of adverse effects can be increased when Rimonabant is combined with Ondansetron.,increase,risk
Rimonabant,Opium,The risk or severity of adverse effects can be increased when Rimonabant is combined with Opium.,increase,risk
Rimonabant,Orciprenaline,The risk or severity of Tachycardia can be increased when Rimonabant is combined with Orciprenaline.,increase,risk
Rimonabant,Orphenadrine,The risk or severity of adverse effects can be increased when Rimonabant is combined with Orphenadrine.,increase,risk
Rimonabant,Oxazepam,The risk or severity of adverse effects can be increased when Rimonabant is combined with Oxazepam.,increase,risk
Rimonabant,Oxcarbazepine,The risk or severity of adverse effects can be increased when Rimonabant is combined with Oxcarbazepine.,increase,risk
Rimonabant,Oxitriptan,The risk or severity of adverse effects can be increased when Rimonabant is combined with Oxitriptan.,increase,risk
Rimonabant,Oxprenolol,The risk or severity of adverse effects can be increased when Rimonabant is combined with Oxprenolol.,increase,risk
Rimonabant,Oxybuprocaine,The risk or severity of adverse effects can be increased when Rimonabant is combined with Oxybuprocaine.,increase,risk
Rimonabant,Oxybutynin,The risk or severity of Tachycardia and drowsiness can be increased when Oxybutynin is combined with Rimonabant.,increase,risk
Rimonabant,Oxycodone,The risk or severity of adverse effects can be increased when Rimonabant is combined with Oxycodone.,increase,risk
Rimonabant,Oxymetazoline,The risk or severity of Tachycardia can be increased when Rimonabant is combined with Oxymetazoline.,increase,risk
Rimonabant,Oxymorphone,The risk or severity of adverse effects can be increased when Rimonabant is combined with Oxymorphone.,increase,risk
Rimonabant,Oxyphencyclimine,The risk or severity of Tachycardia and drowsiness can be increased when Oxyphencyclimine is combined with Rimonabant.,increase,risk
Rimonabant,Oxyphenonium,The risk or severity of Tachycardia and drowsiness can be increased when Oxyphenonium is combined with Rimonabant.,increase,risk
Rimonabant,Quazepam,The risk or severity of adverse effects can be increased when Rimonabant is combined with Quazepam.,increase,risk
Rimonabant,Quetiapine,The risk or severity of adverse effects can be increased when Rimonabant is combined with Quetiapine.,increase,risk
Rimonabant,Quinidine,The risk or severity of Tachycardia and drowsiness can be increased when Quinidine is combined with Rimonabant.,increase,risk
Rimonabant,Quinine,The risk or severity of adverse effects can be increased when Rimonabant is combined with Quinine.,increase,risk
Rimonabant,Quinupramine,The risk or severity of adverse effects can be increased when Rimonabant is combined with Quinupramine.,increase,risk
Rimonabant,Umeclidinium,The risk or severity of Tachycardia and drowsiness can be increased when Umeclidinium is combined with Rimonabant.,increase,risk
Rimonabant,Urethane,The risk or severity of adverse effects can be increased when Rimonabant is combined with Urethane.,increase,risk
Rimonabant,Vadadustat,The serum concentration of Rimonabant can be increased when it is combined with Vadadustat.,increase,no risk
Rimonabant,Valproic acid,The risk or severity of adverse effects can be increased when Rimonabant is combined with Valproic acid.,increase,risk
Rimonabant,Vecuronium,The risk or severity of adverse effects can be increased when Rimonabant is combined with Vecuronium.,increase,risk
Rimonabant,Venetoclax,The metabolism of Rimonabant can be decreased when combined with Venetoclax.,decrease,no risk
Rimonabant,Venlafaxine,The risk or severity of adverse effects can be increased when Rimonabant is combined with Venlafaxine.,increase,risk
Rimonabant,Verapamil,The metabolism of Rimonabant can be decreased when combined with Verapamil.,decrease,no risk
Rimonabant,Vigabatrin,The risk or severity of adverse effects can be increased when Rimonabant is combined with Vigabatrin.,increase,risk
Rimonabant,Vilanterol,The risk or severity of Tachycardia can be increased when Rimonabant is combined with Vilanterol.,increase,risk
Rimonabant,Vilazodone,The risk or severity of adverse effects can be increased when Rimonabant is combined with Vilazodone.,increase,risk
Rimonabant,Viloxazine,The metabolism of Rimonabant can be decreased when combined with Viloxazine.,decrease,no risk
Rimonabant,Voriconazole,The metabolism of Rimonabant can be decreased when combined with Voriconazole.,decrease,no risk
Rimonabant,Vortioxetine,The risk or severity of adverse effects can be increased when Rimonabant is combined with Vortioxetine.,increase,risk
Rimonabant,Xamoterol,The risk or severity of Tachycardia can be increased when Rimonabant is combined with Xamoterol.,increase,risk
Rimonabant,Xylometazoline,The risk or severity of Tachycardia can be increased when Rimonabant is combined with Xylometazoline.,increase,risk
Rimonabant,Yohimbine,The risk or severity of adverse effects can be increased when Rimonabant is combined with Yohimbine.,increase,risk
Rimonabant,Zaleplon,The risk or severity of adverse effects can be increased when Rimonabant is combined with Zaleplon.,increase,risk
Rimonabant,Ziconotide,The risk or severity of adverse effects can be increased when Rimonabant is combined with Ziconotide.,increase,risk
Rimonabant,Zimelidine,The risk or severity of adverse effects can be increased when Rimonabant is combined with Zimelidine.,increase,risk
Rimonabant,Ziprasidone,The risk or severity of adverse effects can be increased when Rimonabant is combined with Ziprasidone.,increase,risk
Rimonabant,Zolmitriptan,The risk or severity of adverse effects can be increased when Rimonabant is combined with Zolmitriptan.,increase,risk
Rimonabant,Zolpidem,The risk or severity of adverse effects can be increased when Rimonabant is combined with Zolpidem.,increase,risk
Rimonabant,Zonisamide,The risk or severity of adverse effects can be increased when Rimonabant is combined with Zonisamide.,increase,risk
Rimonabant,Zopiclone,The risk or severity of adverse effects can be increased when Rimonabant is combined with Zopiclone.,increase,risk
Rimonabant,Zotepine,The risk or severity of adverse effects can be increased when Rimonabant is combined with Zotepine.,increase,risk
Rimonabant,Zuclopenthixol,The risk or severity of adverse effects can be increased when Rimonabant is combined with Zuclopenthixol.,increase,risk
Rimonabant,Zuranolone,The risk or severity of adverse effects can be increased when Rimonabant is combined with Zuranolone.,increase,risk
Rubitecan,Benzocaine,The risk or severity of methemoglobinemia can be increased when Rubitecan is combined with Benzocaine.,increase,risk
Rubitecan,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Rubitecan is combined with Benzyl alcohol.,increase,risk
Rubitecan,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Rubitecan is combined with Bupivacaine.,increase,risk
Rubitecan,Butacaine,The risk or severity of methemoglobinemia can be increased when Rubitecan is combined with Butacaine.,increase,risk
Rubitecan,Butamben,The risk or severity of methemoglobinemia can be increased when Rubitecan is combined with Butamben.,increase,risk
Rubitecan,Nelarabine,The risk or severity of adverse effects can be increased when Nelarabine is combined with Rubitecan.,increase,risk
Rubitecan,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Rubitecan is combined with Oxetacaine.,increase,risk
Rubitecan,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Rubitecan is combined with Oxybuprocaine.,increase,risk
Garenoxacin,Gadobenic acid,The metabolism of Frovatriptan can be decreased when combined with Garenoxacin.,decrease,no risk
Garenoxacin,Galantamine,The risk or severity of QTc prolongation can be increased when Gadobenic acid is combined with Garenoxacin.,increase,risk
Garenoxacin,Gatifloxacin,The risk or severity of QTc prolongation can be increased when Galantamine is combined with Garenoxacin.,increase,risk
Garenoxacin,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Gatifloxacin is combined with Garenoxacin.,increase,risk
Garenoxacin,Gepirone,The risk or severity of QTc prolongation can be increased when Gemifloxacin is combined with Garenoxacin.,increase,risk
Garenoxacin,Gilteritinib,The risk or severity of QTc prolongation can be increased when Gepirone is combined with Garenoxacin.,increase,risk
Garenoxacin,Glasdegib,The risk or severity of QTc prolongation can be increased when Garenoxacin is combined with Gilteritinib.,increase,risk
Garenoxacin,Gliclazide,The risk or severity of QTc prolongation can be increased when Garenoxacin is combined with Glasdegib.,increase,risk
Garenoxacin,Glimepiride,The therapeutic efficacy of Gliclazide can be increased when used in combination with Garenoxacin.,increase,no risk
Garenoxacin,Glipizide,The therapeutic efficacy of Glimepiride can be increased when used in combination with Garenoxacin.,increase,no risk
Garenoxacin,Gliquidone,The therapeutic efficacy of Glipizide can be increased when used in combination with Garenoxacin.,increase,no risk
Garenoxacin,Glyburide,The therapeutic efficacy of Gliquidone can be increased when used in combination with Garenoxacin.,increase,no risk
Garenoxacin,Glycol salicylate,The therapeutic efficacy of Glyburide can be increased when used in combination with Garenoxacin.,increase,no risk
Lumiliximab,Natalizumab,The risk or severity of adverse effects can be increased when Natalizumab is combined with Lumiliximab.,increase,risk
Lumiliximab,Necitumumab,The risk or severity of adverse effects can be increased when Lumiliximab is combined with Necitumumab.,increase,risk
Lumiliximab,Nivolumab,The risk or severity of adverse effects can be increased when Lumiliximab is combined with Nivolumab.,increase,risk
Lumiliximab,Obiltoxaximab,The risk or severity of adverse effects can be increased when Obiltoxaximab is combined with Lumiliximab.,increase,risk
Lumiliximab,Obinutuzumab,The risk or severity of adverse effects can be increased when Lumiliximab is combined with Obinutuzumab.,increase,risk
Lumiliximab,Ocrelizumab,The risk or severity of adverse effects can be increased when Lumiliximab is combined with Ocrelizumab.,increase,risk
Lumiliximab,Odesivimab,The risk or severity of adverse effects can be increased when Lumiliximab is combined with Odesivimab.,increase,risk
Lumiliximab,Ofatumumab,The risk or severity of adverse effects can be increased when Lumiliximab is combined with Ofatumumab.,increase,risk
Lumiliximab,Olaratumab,The risk or severity of adverse effects can be increased when Olaratumab is combined with Lumiliximab.,increase,risk
Lumiliximab,Omalizumab,The risk or severity of adverse effects can be increased when Omalizumab is combined with Lumiliximab.,increase,risk
Lumiliximab,Quinestrol,Quinestrol may increase the thrombogenic activities of Lumiliximab.,increase,no risk
Lumiliximab,Ublituximab,The risk or severity of adverse effects can be increased when Lumiliximab is combined with Ublituximab.,increase,risk
Lumiliximab,Ustekinumab,The risk or severity of adverse effects can be increased when Ustekinumab is combined with Lumiliximab.,increase,risk
Lumiliximab,Vedolizumab,The risk or severity of adverse effects can be increased when Lumiliximab is combined with Vedolizumab.,increase,risk
Plevitrexed,Benzocaine,The risk or severity of methemoglobinemia can be increased when Plevitrexed is combined with Benzocaine.,increase,risk
Plevitrexed,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Plevitrexed is combined with Benzyl alcohol.,increase,risk
Plevitrexed,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Plevitrexed is combined with Bupivacaine.,increase,risk
Plevitrexed,Butacaine,The risk or severity of methemoglobinemia can be increased when Plevitrexed is combined with Butacaine.,increase,risk
Plevitrexed,Butamben,The risk or severity of methemoglobinemia can be increased when Plevitrexed is combined with Butamben.,increase,risk
Plevitrexed,Nelarabine,The risk or severity of adverse effects can be increased when Nelarabine is combined with Plevitrexed.,increase,risk
Plevitrexed,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Plevitrexed is combined with Oxetacaine.,increase,risk
Plevitrexed,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Plevitrexed is combined with Oxybuprocaine.,increase,risk
Ruxolitinib,Bacillus calmette-guerin substrain connaught live antigen,The risk or severity of infection can be increased when Bacillus calmette-guerin substrain connaught live antigen is combined with Ruxolitinib.,increase,risk
Ruxolitinib,Bacillus calmette-guerin substrain russian BCG-I live antigen,The therapeutic efficacy of Bacillus calmette-guerin substrain russian BCG-I live antigen can be decreased when used in combination with Ruxolitinib.,decrease,no risk
Ruxolitinib,Bacillus calmette-guerin substrain tice live antigen,The risk or severity of infection can be increased when Bacillus calmette-guerin substrain tice live antigen is combined with Ruxolitinib.,increase,risk
Ruxolitinib,Bacitracin,Bacitracin may decrease the excretion rate of Ruxolitinib which could result in a higher serum level.,decrease,no risk
Ruxolitinib,Baclofen,Baclofen may decrease the excretion rate of Ruxolitinib which could result in a higher serum level.,decrease,no risk
Ruxolitinib,Balsalazide,Balsalazide may decrease the excretion rate of Ruxolitinib which could result in a higher serum level.,decrease,no risk
Ruxolitinib,Baricitinib,The risk or severity of adverse effects can be increased when Ruxolitinib is combined with Baricitinib.,increase,risk
Ruxolitinib,Basiliximab,The risk or severity of adverse effects can be increased when Basiliximab is combined with Ruxolitinib.,increase,risk
Ruxolitinib,BCG vaccine,The risk or severity of infection can be increased when BCG vaccine is combined with Ruxolitinib.,increase,risk
Ruxolitinib,Beclomethasone dipropionate,The metabolism of Ruxolitinib can be increased when combined with Beclomethasone dipropionate.,increase,no risk
Ruxolitinib,Belatacept,The risk or severity of adverse effects can be increased when Belatacept is combined with Ruxolitinib.,increase,risk
Ruxolitinib,Belimumab,The risk or severity of adverse effects can be increased when Ruxolitinib is combined with Belimumab.,increase,risk
Ruxolitinib,Belinostat,The risk or severity of adverse effects can be increased when Belinostat is combined with Ruxolitinib.,increase,risk
Ruxolitinib,Belumosudil,The risk or severity of adverse effects can be increased when Ruxolitinib is combined with Belumosudil.,increase,risk
Ruxolitinib,Belzutifan,The serum concentration of Ruxolitinib can be decreased when it is combined with Belzutifan.,decrease,no risk
Ruxolitinib,Bemiparin,The risk or severity of bleeding can be increased when Bemiparin is combined with Ruxolitinib.,increase,risk
Ruxolitinib,Bendamustine,The risk or severity of adverse effects can be increased when Bendamustine is combined with Ruxolitinib.,increase,risk
Ruxolitinib,Bendroflumethiazide,Ruxolitinib may increase the bradycardic activities of Bendroflumethiazide.,increase,no risk
Ruxolitinib,Benorilate,Benorilate may decrease the excretion rate of Ruxolitinib which could result in a higher serum level.,decrease,no risk
Ruxolitinib,Benoxaprofen,Benoxaprofen may decrease the excretion rate of Ruxolitinib which could result in a higher serum level.,decrease,no risk
Ruxolitinib,Benserazide,Ruxolitinib may decrease the excretion rate of Benserazide which could result in a higher serum level.,decrease,no risk
Ruxolitinib,Benzatropine,Benzatropine may decrease the excretion rate of Ruxolitinib which could result in a higher serum level.,decrease,no risk
Ruxolitinib,Benznidazole,Ruxolitinib may decrease the excretion rate of Benznidazole which could result in a higher serum level.,decrease,no risk
Ruxolitinib,Benzocaine,The risk or severity of methemoglobinemia can be increased when Ruxolitinib is combined with Benzocaine.,increase,risk
Ruxolitinib,Benzthiazide,Benzthiazide may increase the excretion rate of Ruxolitinib which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ruxolitinib,Benzydamine,Benzydamine may decrease the excretion rate of Ruxolitinib which could result in a higher serum level.,decrease,no risk
Ruxolitinib,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Ruxolitinib is combined with Benzyl alcohol.,increase,risk
Ruxolitinib,Bepotastine,Bepotastine may decrease the excretion rate of Ruxolitinib which could result in a higher serum level.,decrease,no risk
Ruxolitinib,Bepridil,Ruxolitinib may increase the bradycardic activities of Bepridil.,increase,no risk
Ruxolitinib,Beractant,Ruxolitinib may increase the bradycardic activities of Beractant.,increase,no risk
Ruxolitinib,Berotralstat,The serum concentration of Ruxolitinib can be increased when it is combined with Berotralstat.,increase,no risk
Ruxolitinib,Betamethasone,The metabolism of Ruxolitinib can be increased when combined with Betamethasone.,increase,no risk
Ruxolitinib,Betamethasone phosphate,The metabolism of Ruxolitinib can be increased when combined with Betamethasone phosphate.,increase,no risk
Ruxolitinib,Betaxolol,Ruxolitinib may increase the bradycardic activities of Betaxolol.,increase,no risk
Ruxolitinib,Betrixaban,The risk or severity of bleeding can be increased when Betrixaban is combined with Ruxolitinib.,increase,risk
Ruxolitinib,Bexarotene,The metabolism of Ruxolitinib can be increased when combined with Bexarotene.,increase,no risk
Ruxolitinib,Bicalutamide,The metabolism of Ruxolitinib can be decreased when combined with Bicalutamide.,decrease,no risk
Ruxolitinib,Bicisate,Ruxolitinib may decrease the excretion rate of Bicisate which could result in a higher serum level.,decrease,no risk
Ruxolitinib,Bifonazole,The metabolism of Ruxolitinib can be decreased when combined with Bifonazole.,decrease,no risk
Ruxolitinib,Bimekizumab,The metabolism of Ruxolitinib can be increased when combined with Bimekizumab.,increase,no risk
Ruxolitinib,Bismuth subgallate,Ruxolitinib may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Ruxolitinib,Bisoprolol,Ruxolitinib may increase the bradycardic activities of Bisoprolol.,increase,no risk
Ruxolitinib,Bisoxatin,Ruxolitinib may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,decrease,no risk
Ruxolitinib,Bivalirudin,The risk or severity of bleeding can be increased when Bivalirudin is combined with Ruxolitinib.,increase,risk
Ruxolitinib,Bleomycin,The risk or severity of adverse effects can be increased when Bleomycin is combined with Ruxolitinib.,increase,risk
Ruxolitinib,Blinatumomab,The risk or severity of adverse effects can be increased when Ruxolitinib is combined with Blinatumomab.,increase,risk
Ruxolitinib,Boceprevir,The metabolism of Ruxolitinib can be decreased when combined with Boceprevir.,decrease,no risk
Ruxolitinib,"Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated)","The therapeutic efficacy of Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated) can be decreased when used in combination with Ruxolitinib.",decrease,no risk
Ruxolitinib,Bortezomib,The risk or severity of adverse effects can be increased when Bortezomib is combined with Ruxolitinib.,increase,risk
Ruxolitinib,Bosentan,The metabolism of Ruxolitinib can be increased when combined with Bosentan.,increase,no risk
Ruxolitinib,Bosutinib,The metabolism of Ruxolitinib can be decreased when combined with Bosutinib.,decrease,no risk
Ruxolitinib,Brentuximab vedotin,The serum concentration of Ruxolitinib can be increased when it is combined with Brentuximab vedotin.,increase,no risk
Ruxolitinib,Bretylium,Ruxolitinib may increase the bradycardic activities of Bretylium.,increase,no risk
Ruxolitinib,Brivaracetam,Brivaracetam may decrease the excretion rate of Ruxolitinib which could result in a higher serum level.,decrease,no risk
Ruxolitinib,Brodalumab,The risk or severity of adverse effects can be increased when Ruxolitinib is combined with Brodalumab.,increase,risk
Ruxolitinib,Bromazepam,Bromazepam may decrease the excretion rate of Ruxolitinib which could result in a higher serum level.,decrease,no risk
Ruxolitinib,Bromotheophylline,Bromotheophylline may increase the excretion rate of Ruxolitinib which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ruxolitinib,Budesonide,The metabolism of Ruxolitinib can be increased when combined with Budesonide.,increase,no risk
Ruxolitinib,Bumadizone,Bumadizone may decrease the excretion rate of Ruxolitinib which could result in a higher serum level.,decrease,no risk
Ruxolitinib,Bumetanide,Bumetanide may increase the excretion rate of Ruxolitinib which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ruxolitinib,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Ruxolitinib is combined with Bupivacaine.,increase,risk
Ruxolitinib,Buprenorphine,The metabolism of Ruxolitinib can be decreased when combined with Buprenorphine.,decrease,no risk
Ruxolitinib,Bupropion,Bupropion may decrease the excretion rate of Ruxolitinib which could result in a higher serum level.,decrease,no risk
Ruxolitinib,Buspirone,Buspirone may decrease the excretion rate of Ruxolitinib which could result in a higher serum level.,decrease,no risk
Ruxolitinib,Busulfan,The risk or severity of adverse effects can be increased when Busulfan is combined with Ruxolitinib.,increase,risk
Ruxolitinib,Butabarbital,Butabarbital may decrease the excretion rate of Ruxolitinib which could result in a higher serum level.,decrease,no risk
Ruxolitinib,Butacaine,The risk or severity of methemoglobinemia can be increased when Ruxolitinib is combined with Butacaine.,increase,risk
Ruxolitinib,Butalbital,The metabolism of Ruxolitinib can be increased when combined with Butalbital.,increase,no risk
Ruxolitinib,Butamben,The risk or severity of methemoglobinemia can be increased when Ruxolitinib is combined with Butamben.,increase,risk
Ruxolitinib,Gabapentin enacarbil,Gabapentin enacarbil may decrease the excretion rate of Ruxolitinib which could result in a higher serum level.,decrease,no risk
Ruxolitinib,Gadobenic acid,Gadobenic acid may decrease the excretion rate of Ruxolitinib which could result in a higher serum level.,decrease,no risk
Ruxolitinib,Gadodiamide,Gadodiamide may decrease the excretion rate of Ruxolitinib which could result in a higher serum level.,decrease,no risk
Ruxolitinib,Gadofosveset trisodium,Gadofosveset trisodium may decrease the excretion rate of Ruxolitinib which could result in a higher serum level.,decrease,no risk
Ruxolitinib,Gadopentetic acid,Gadopentetic acid may decrease the excretion rate of Ruxolitinib which could result in a higher serum level.,decrease,no risk
Ruxolitinib,Gadoteric acid,Ruxolitinib may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Ruxolitinib,Gadoteridol,Gadoteridol may decrease the excretion rate of Ruxolitinib which could result in a higher serum level.,decrease,no risk
Ruxolitinib,Galantamine,Ruxolitinib may increase the bradycardic activities of Galantamine.,increase,no risk
Ruxolitinib,Ganciclovir,Ganciclovir may decrease the excretion rate of Ruxolitinib which could result in a higher serum level.,decrease,no risk
Ruxolitinib,Gemcitabine,The risk or severity of adverse effects can be increased when Gemcitabine is combined with Ruxolitinib.,increase,risk
Ruxolitinib,Gemfibrozil,The metabolism of Ruxolitinib can be decreased when combined with Gemfibrozil.,decrease,no risk
Ruxolitinib,Gemtuzumab ozogamicin,The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Ruxolitinib.,increase,risk
Ruxolitinib,Gentamicin,Ruxolitinib may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Ruxolitinib,Gilteritinib,The metabolism of Ruxolitinib can be decreased when combined with Gilteritinib.,decrease,no risk
Ruxolitinib,Gimeracil,Ruxolitinib may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Ruxolitinib,Ginkgo biloba,The metabolism of Ruxolitinib can be decreased when combined with Ginkgo biloba.,decrease,no risk
Ruxolitinib,Givosiran,Givosiran may decrease the excretion rate of Ruxolitinib which could result in a higher serum level.,decrease,no risk
Ruxolitinib,Glatiramer,The risk or severity of adverse effects can be increased when Glatiramer is combined with Ruxolitinib.,increase,risk
Ruxolitinib,Glecaprevir,The metabolism of Ruxolitinib can be decreased when combined with Glecaprevir.,decrease,no risk
Ruxolitinib,Gliclazide,The metabolism of Ruxolitinib can be decreased when combined with Gliclazide.,decrease,no risk
Ruxolitinib,Glimepiride,The metabolism of Ruxolitinib can be decreased when combined with Glimepiride.,decrease,no risk
Ruxolitinib,Glipizide,Glipizide may decrease the excretion rate of Ruxolitinib which could result in a higher serum level.,decrease,no risk
Ruxolitinib,Gliquidone,The metabolism of Ruxolitinib can be decreased when combined with Gliquidone.,decrease,no risk
Ruxolitinib,Glofitamab,The serum concentration of Ruxolitinib can be increased when it is combined with Glofitamab.,increase,no risk
Ruxolitinib,Glyburide,The metabolism of Ruxolitinib can be decreased when combined with Glyburide.,decrease,no risk
Ruxolitinib,Glycerol phenylbutyrate,The metabolism of Ruxolitinib can be increased when combined with Glycerol phenylbutyrate.,increase,no risk
Ruxolitinib,Golimumab,The metabolism of Ruxolitinib can be increased when combined with Golimumab.,increase,no risk
Ruxolitinib,Golodirsen,Ruxolitinib may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Ruxolitinib,Goserelin,Goserelin may decrease the excretion rate of Ruxolitinib which could result in a higher serum level.,decrease,no risk
Ruxolitinib,Grapefruit,The serum concentration of Ruxolitinib can be increased when it is combined with Grapefruit.,increase,no risk
Ruxolitinib,Griseofulvin,The metabolism of Ruxolitinib can be increased when combined with Griseofulvin.,increase,no risk
Ruxolitinib,Guanethidine,Guanethidine may decrease the excretion rate of Ruxolitinib which could result in a higher serum level.,decrease,no risk
Ruxolitinib,Guanfacine,Ruxolitinib may increase the bradycardic activities of Guanfacine.,increase,no risk
Ruxolitinib,Guselkumab,The risk or severity of adverse effects can be increased when Ruxolitinib is combined with Guselkumab.,increase,risk
Ruxolitinib,Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Ruxolitinib.,decrease,no risk
Ruxolitinib,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Ruxolitinib.,increase,no risk
Ruxolitinib,Halothane,The metabolism of Ruxolitinib can be decreased when combined with Halothane.,decrease,no risk
Ruxolitinib,Heparin,The risk or severity of bleeding can be increased when Heparin is combined with Ruxolitinib.,increase,risk
Ruxolitinib,Hepatitis A Vaccine,The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Ruxolitinib.,decrease,no risk
Ruxolitinib,Hepatitis B Vaccine (Recombinant),The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Ruxolitinib.,decrease,no risk
Ruxolitinib,Human adenovirus e serotype 4 strain cl-68578 antigen,The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Ruxolitinib.,increase,risk
Ruxolitinib,Hydralazine,The serum concentration of Ruxolitinib can be increased when it is combined with Hydralazine.,increase,no risk
Ruxolitinib,Hydrochlorothiazide,Hydrochlorothiazide may increase the excretion rate of Ruxolitinib which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ruxolitinib,Hydrocortamate,The metabolism of Ruxolitinib can be increased when combined with Hydrocortamate.,increase,no risk
Ruxolitinib,Hydrocortisone,The metabolism of Ruxolitinib can be increased when combined with Hydrocortisone.,increase,no risk
Ruxolitinib,Hydrocortisone acetate,The metabolism of Ruxolitinib can be increased when combined with Hydrocortisone acetate.,increase,no risk
Ruxolitinib,Hydrocortisone butyrate,The metabolism of Ruxolitinib can be increased when combined with Hydrocortisone butyrate.,increase,no risk
Ruxolitinib,Hydrocortisone succinate,The metabolism of Ruxolitinib can be increased when combined with Hydrocortisone succinate.,increase,no risk
Ruxolitinib,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of Ruxolitinib which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ruxolitinib,Hydromorphone,Hydromorphone may decrease the excretion rate of Ruxolitinib which could result in a higher serum level.,decrease,no risk
Ruxolitinib,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Ruxolitinib which could result in a higher serum level.,decrease,no risk
Ruxolitinib,Hydroxychloroquine,The risk or severity of adverse effects can be increased when Hydroxychloroquine is combined with Ruxolitinib.,increase,risk
Ruxolitinib,Hydroxyethyl Starch,Ruxolitinib may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Ruxolitinib,Hydroxyurea,The risk or severity of adverse effects can be increased when Hydroxyurea is combined with Ruxolitinib.,increase,risk
Ruxolitinib,Janssen COVID-19 Vaccine,The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Ruxolitinib.,decrease,no risk
Ruxolitinib,Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated),The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Ruxolitinib.,decrease,no risk
Ruxolitinib,Kanamycin,Ruxolitinib may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Ruxolitinib,Ketamine,Ketamine may decrease the excretion rate of Ruxolitinib which could result in a higher serum level.,decrease,no risk
Ruxolitinib,Ketazolam,The serum concentration of Ruxolitinib can be increased when it is combined with Ketazolam.,increase,no risk
Ruxolitinib,Ketoconazole,The metabolism of Ruxolitinib can be decreased when combined with Ketoconazole.,decrease,no risk
Ruxolitinib,Ketoprofen,Ketoprofen may decrease the excretion rate of Ruxolitinib which could result in a higher serum level.,decrease,no risk
Ruxolitinib,Ketorolac,Ketorolac may decrease the excretion rate of Ruxolitinib which could result in a higher serum level.,decrease,no risk
Ruxolitinib,N-acetyltyrosine,Ruxolitinib may decrease the excretion rate of N-acetyltyrosine which could result in a higher serum level.,decrease,no risk
Ruxolitinib,Nabilone,The metabolism of Ruxolitinib can be decreased when combined with Nabilone.,decrease,no risk
Ruxolitinib,Nabumetone,Nabumetone may decrease the excretion rate of Ruxolitinib which could result in a higher serum level.,decrease,no risk
Ruxolitinib,Nadolol,Ruxolitinib may increase the bradycardic activities of Nadolol.,increase,no risk
Ruxolitinib,Nadroparin,The risk or severity of bleeding can be increased when Nadroparin is combined with Ruxolitinib.,increase,risk
Ruxolitinib,Nafcillin,The metabolism of Ruxolitinib can be increased when combined with Nafcillin.,increase,no risk
Ruxolitinib,Naldemedine,Ruxolitinib may decrease the excretion rate of Naldemedine which could result in a higher serum level.,decrease,no risk
Ruxolitinib,Nalmefene,Nalmefene may decrease the excretion rate of Ruxolitinib which could result in a higher serum level.,decrease,no risk
Ruxolitinib,Naloxone,Naloxone may decrease the excretion rate of Ruxolitinib which could result in a higher serum level.,decrease,no risk
Ruxolitinib,Naproxen,Naproxen may decrease the excretion rate of Ruxolitinib which could result in a higher serum level.,decrease,no risk
Ruxolitinib,Natalizumab,The risk or severity of immunosuppression can be increased when Ruxolitinib is combined with Natalizumab.,increase,risk
Ruxolitinib,Nateglinide,Nateglinide may decrease the excretion rate of Ruxolitinib which could result in a higher serum level.,decrease,no risk
Ruxolitinib,Nebivolol,Ruxolitinib may increase the bradycardic activities of Nebivolol.,increase,no risk
Ruxolitinib,Nedaplatin,Ruxolitinib may decrease the excretion rate of Nedaplatin which could result in a higher serum level.,decrease,no risk
Ruxolitinib,Nedocromil,Nedocromil may decrease the excretion rate of Ruxolitinib which could result in a higher serum level.,decrease,no risk
Ruxolitinib,Nefazodone,The metabolism of Ruxolitinib can be decreased when combined with Nefazodone.,decrease,no risk
Ruxolitinib,Nelarabine,The risk or severity of adverse effects can be increased when Nelarabine is combined with Ruxolitinib.,increase,risk
Ruxolitinib,Nelfinavir,The metabolism of Ruxolitinib can be decreased when combined with Nelfinavir.,decrease,no risk
Ruxolitinib,Neomycin,Ruxolitinib may decrease the excretion rate of Neomycin which could result in a higher serum level.,decrease,no risk
Ruxolitinib,Netilmicin,Ruxolitinib may decrease the excretion rate of Netilmicin which could result in a higher serum level.,decrease,no risk
Ruxolitinib,Netupitant,The metabolism of Ruxolitinib can be decreased when combined with Netupitant.,decrease,no risk
Ruxolitinib,Nevirapine,The metabolism of Ruxolitinib can be decreased when combined with Nevirapine.,decrease,no risk
Ruxolitinib,Niacin,The serum concentration of Ruxolitinib can be increased when it is combined with Niacin.,increase,no risk
Ruxolitinib,Nicardipine,Ruxolitinib may increase the bradycardic activities of Nicardipine.,increase,no risk
Ruxolitinib,Niclosamide,The metabolism of Ruxolitinib can be decreased when combined with Niclosamide.,decrease,no risk
Ruxolitinib,Nicorandil,Ruxolitinib may decrease the excretion rate of Nicorandil which could result in a higher serum level.,decrease,no risk
Ruxolitinib,Nifedipine,Ruxolitinib may increase the bradycardic activities of Nifedipine.,increase,no risk
Ruxolitinib,Nilotinib,The metabolism of Ruxolitinib can be decreased when combined with Nilotinib.,decrease,no risk
Ruxolitinib,Nilutamide,The metabolism of Ruxolitinib can be decreased when combined with Nilutamide.,decrease,no risk
Ruxolitinib,Nilvadipine,Ruxolitinib may increase the bradycardic activities of Nilvadipine.,increase,no risk
Ruxolitinib,Nimesulide,Ruxolitinib may increase the bradycardic activities of Nimesulide.,increase,no risk
Ruxolitinib,Nimodipine,Ruxolitinib may increase the bradycardic activities of Nimodipine.,increase,no risk
Ruxolitinib,Nintedanib,The metabolism of Ruxolitinib can be decreased when combined with Nintedanib.,decrease,no risk
Ruxolitinib,Nirogacestat,The metabolism of Ruxolitinib can be increased when combined with Nirogacestat.,increase,no risk
Ruxolitinib,Nisoldipine,Ruxolitinib may increase the bradycardic activities of Nisoldipine.,increase,no risk
Ruxolitinib,Nitrendipine,Ruxolitinib may increase the bradycardic activities of Nitrendipine.,increase,no risk
Ruxolitinib,Nitric Oxide,Nitric Oxide may decrease the excretion rate of Ruxolitinib which could result in a higher serum level.,decrease,no risk
Ruxolitinib,Nitrofurantoin,Nitrofurantoin may decrease the excretion rate of Ruxolitinib which could result in a higher serum level.,decrease,no risk
Ruxolitinib,Nitroprusside,Nitroprusside may decrease the excretion rate of Ruxolitinib which could result in a higher serum level.,decrease,no risk
Ruxolitinib,Norethisterone,The metabolism of Ruxolitinib can be decreased when combined with Norethisterone.,decrease,no risk
Ruxolitinib,Norgestimate,The metabolism of Ruxolitinib can be increased when combined with Norgestimate.,increase,no risk
Ruxolitinib,Noscapine,The serum concentration of Ruxolitinib can be increased when it is combined with Noscapine.,increase,no risk
Ruxolitinib,Nuvaxovid,The therapeutic efficacy of Nuvaxovid can be decreased when used in combination with Ruxolitinib.,decrease,no risk
Ruxolitinib,Nylidrin,Ruxolitinib may increase the bradycardic activities of Nylidrin.,increase,no risk
Ruxolitinib,Obinutuzumab,The risk or severity of adverse effects can be increased when Ruxolitinib is combined with Obinutuzumab.,increase,risk
Ruxolitinib,Ocrelizumab,The risk or severity of adverse effects can be increased when Ruxolitinib is combined with Ocrelizumab.,increase,risk
Ruxolitinib,Octinoxate,Ruxolitinib may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Ruxolitinib,Octreotide,The serum concentration of Ruxolitinib can be increased when it is combined with Octreotide.,increase,no risk
Ruxolitinib,Ofatumumab,The risk or severity of adverse effects can be increased when Ofatumumab is combined with Ruxolitinib.,increase,risk
Ruxolitinib,Olanzapine,The metabolism of Ruxolitinib can be decreased when combined with Olanzapine.,decrease,no risk
Ruxolitinib,Olaparib,The metabolism of Ruxolitinib can be decreased when combined with Olaparib.,decrease,no risk
Ruxolitinib,Olodaterol,The metabolism of Olodaterol can be decreased when combined with Ruxolitinib.,decrease,no risk
Ruxolitinib,Olsalazine,Olsalazine may decrease the excretion rate of Ruxolitinib which could result in a higher serum level.,decrease,no risk
Ruxolitinib,Olutasidenib,The metabolism of Ruxolitinib can be increased when combined with Olutasidenib.,increase,no risk
Ruxolitinib,Omaveloxolone,The serum concentration of Ruxolitinib can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Ruxolitinib,Ondansetron,The metabolism of Ruxolitinib can be decreased when combined with Ondansetron.,decrease,no risk
Ruxolitinib,Opium,Ruxolitinib may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Ruxolitinib,Oritavancin,The metabolism of Ruxolitinib can be increased when combined with Oritavancin.,increase,no risk
Ruxolitinib,Orphenadrine,The metabolism of Ruxolitinib can be decreased when combined with Orphenadrine.,decrease,no risk
Ruxolitinib,Oseltamivir,Oseltamivir may decrease the excretion rate of Ruxolitinib which could result in a higher serum level.,decrease,no risk
Ruxolitinib,Osilodrostat,The metabolism of Ruxolitinib can be decreased when combined with Osilodrostat.,decrease,no risk
Ruxolitinib,Osimertinib,The metabolism of Ruxolitinib can be decreased when combined with Osimertinib.,decrease,no risk
Ruxolitinib,Ospemifene,The metabolism of Ruxolitinib can be decreased when combined with Ospemifene.,decrease,no risk
Ruxolitinib,Oxacillin,Oxacillin may decrease the excretion rate of Ruxolitinib which could result in a higher serum level.,decrease,no risk
Ruxolitinib,Oxaliplatin,The risk or severity of adverse effects can be increased when Oxaliplatin is combined with Ruxolitinib.,increase,risk
Ruxolitinib,Oxandrolone,The metabolism of Ruxolitinib can be decreased when combined with Oxandrolone.,decrease,no risk
Ruxolitinib,Oxaprozin,Oxaprozin may decrease the excretion rate of Ruxolitinib which could result in a higher serum level.,decrease,no risk
Ruxolitinib,Oxazepam,Oxazepam may decrease the excretion rate of Ruxolitinib which could result in a higher serum level.,decrease,no risk
Ruxolitinib,Oxcarbazepine,The metabolism of Ruxolitinib can be increased when combined with Oxcarbazepine.,increase,no risk
Ruxolitinib,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Ruxolitinib is combined with Oxetacaine.,increase,risk
Ruxolitinib,Oxprenolol,Ruxolitinib may increase the bradycardic activities of Oxprenolol.,increase,no risk
Ruxolitinib,Oxybenzone,Oxybenzone may decrease the excretion rate of Ruxolitinib which could result in a higher serum level.,decrease,no risk
Ruxolitinib,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Ruxolitinib is combined with Oxybuprocaine.,increase,risk
Ruxolitinib,Oxybutynin,The serum concentration of Ruxolitinib can be increased when it is combined with Oxybutynin.,increase,no risk
Ruxolitinib,Oxyphenbutazone,Oxyphenbutazone may decrease the excretion rate of Ruxolitinib which could result in a higher serum level.,decrease,no risk
Ruxolitinib,Oxyquinoline,Ruxolitinib may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Ruxolitinib,Ozanimod,The risk or severity of adverse effects can be increased when Ruxolitinib is combined with Ozanimod.,increase,risk
Ruxolitinib,Quetiapine,Quetiapine may decrease the excretion rate of Ruxolitinib which could result in a higher serum level.,decrease,no risk
Ruxolitinib,Quinethazone,Quinethazone may increase the excretion rate of Ruxolitinib which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ruxolitinib,Quinidine,The metabolism of Ruxolitinib can be decreased when combined with Quinidine.,decrease,no risk
Ruxolitinib,Quinine,The metabolism of Ruxolitinib can be increased when combined with Quinine.,increase,no risk
Ruxolitinib,Quinupristin,The metabolism of Ruxolitinib can be decreased when combined with Quinupristin.,decrease,no risk
Ruxolitinib,Ublituximab,The risk or severity of infection can be increased when Ublituximab is combined with Ruxolitinib.,increase,risk
Ruxolitinib,Upadacitinib,The risk or severity of adverse effects can be increased when Ruxolitinib is combined with Upadacitinib.,increase,risk
Ruxolitinib,Urokinase,The risk or severity of bleeding can be increased when Urokinase is combined with Ruxolitinib.,increase,risk
Ruxolitinib,Vaborbactam,Ruxolitinib may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Ruxolitinib,Vadadustat,The serum concentration of Ruxolitinib can be increased when it is combined with Vadadustat.,increase,no risk
Ruxolitinib,Valaciclovir,Valaciclovir may decrease the excretion rate of Ruxolitinib which could result in a higher serum level.,decrease,no risk
Ruxolitinib,Valbenazine,Ruxolitinib may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
Ruxolitinib,Valdecoxib,The metabolism of Ruxolitinib can be decreased when combined with Valdecoxib.,decrease,no risk
Ruxolitinib,Valganciclovir,Valganciclovir may decrease the excretion rate of Ruxolitinib which could result in a higher serum level.,decrease,no risk
Ruxolitinib,Valproic acid,The serum concentration of Ruxolitinib can be increased when it is combined with Valproic acid.,increase,no risk
Ruxolitinib,Valsartan,The metabolism of Ruxolitinib can be decreased when combined with Valsartan.,decrease,no risk
Ruxolitinib,Vancomycin,Ruxolitinib may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Ruxolitinib,Vardenafil,The metabolism of Ruxolitinib can be decreased when combined with Vardenafil.,decrease,no risk
Ruxolitinib,Varenicline,Varenicline may decrease the excretion rate of Ruxolitinib which could result in a higher serum level.,decrease,no risk
Ruxolitinib,Varicella zoster vaccine (live/attenuated),The risk or severity of infection can be increased when Varicella zoster vaccine (live/attenuated) is combined with Ruxolitinib.,increase,risk
Ruxolitinib,Varicella zoster vaccine (recombinant),The therapeutic efficacy of Varicella zoster vaccine (recombinant) can be decreased when used in combination with Ruxolitinib.,decrease,no risk
Ruxolitinib,Vedolizumab,The risk or severity of adverse effects can be increased when Ruxolitinib is combined with Vedolizumab.,increase,risk
Ruxolitinib,Vemurafenib,The metabolism of Ruxolitinib can be increased when combined with Vemurafenib.,increase,no risk
Ruxolitinib,Venetoclax,The metabolism of Ruxolitinib can be decreased when combined with Venetoclax.,decrease,no risk
Ruxolitinib,Venlafaxine,Venlafaxine may decrease the excretion rate of Ruxolitinib which could result in a higher serum level.,decrease,no risk
Ruxolitinib,Verapamil,Ruxolitinib may increase the bradycardic activities of Verapamil.,increase,no risk
Ruxolitinib,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Ruxolitinib.,decrease,no risk
Ruxolitinib,Vilanterol,The risk or severity of adverse effects can be increased when Ruxolitinib is combined with Vilanterol.,increase,risk
Ruxolitinib,Viloxazine,The metabolism of Ruxolitinib can be decreased when combined with Viloxazine.,decrease,no risk
Ruxolitinib,Vinblastine,The metabolism of Ruxolitinib can be increased when combined with Vinblastine.,increase,no risk
Ruxolitinib,Vincristine,The risk or severity of adverse effects can be increased when Vincristine is combined with Ruxolitinib.,increase,risk
Ruxolitinib,Vindesine,The risk or severity of adverse effects can be increased when Vindesine is combined with Ruxolitinib.,increase,risk
Ruxolitinib,Vinorelbine,The risk or severity of adverse effects can be increased when Vinorelbine is combined with Ruxolitinib.,increase,risk
Ruxolitinib,Vitamin E,The metabolism of Ruxolitinib can be increased when combined with Vitamin E.,increase,no risk
Ruxolitinib,Voclosporin,The risk or severity of adverse effects can be increased when Ruxolitinib is combined with Voclosporin.,increase,risk
Ruxolitinib,Vorapaxar,The metabolism of Ruxolitinib can be decreased when combined with Vorapaxar.,decrease,no risk
Ruxolitinib,Voriconazole,The metabolism of Ruxolitinib can be decreased when combined with Voriconazole.,decrease,no risk
Ruxolitinib,Vorinostat,The risk or severity of adverse effects can be increased when Vorinostat is combined with Ruxolitinib.,increase,risk
Ruxolitinib,Vortioxetine,Ruxolitinib may decrease the excretion rate of Vortioxetine which could result in a higher serum level.,decrease,no risk
Ruxolitinib,Voxelotor,The serum concentration of Ruxolitinib can be increased when it is combined with Voxelotor.,increase,no risk
Ruxolitinib,Warfarin,The metabolism of Ruxolitinib can be increased when combined with Warfarin.,increase,no risk
Ruxolitinib,Ximelagatran,The risk or severity of bleeding can be increased when Ximelagatran is combined with Ruxolitinib.,increase,risk
Ruxolitinib,Yellow fever vaccine,The risk or severity of infection can be increased when Yellow fever vaccine is combined with Ruxolitinib.,increase,risk
Ruxolitinib,Zafirlukast,The serum concentration of Ruxolitinib can be increased when it is combined with Zafirlukast.,increase,no risk
Ruxolitinib,Zaleplon,Zaleplon may decrease the excretion rate of Ruxolitinib which could result in a higher serum level.,decrease,no risk
Ruxolitinib,Zanamivir,Zanamivir may decrease the excretion rate of Ruxolitinib which could result in a higher serum level.,decrease,no risk
Ruxolitinib,Zidovudine,The risk or severity of adverse effects can be increased when Zidovudine is combined with Ruxolitinib.,increase,risk
Ruxolitinib,Zileuton,The metabolism of Ruxolitinib can be decreased when combined with Zileuton.,decrease,no risk
Ruxolitinib,Zimelidine,The metabolism of Ruxolitinib can be decreased when combined with Zimelidine.,decrease,no risk
Ruxolitinib,Ziprasidone,The metabolism of Ruxolitinib can be decreased when combined with Ziprasidone.,decrease,no risk
Ruxolitinib,Zolpidem,The metabolism of Ruxolitinib can be decreased when combined with Zolpidem.,decrease,no risk
Ruxolitinib,Zonisamide,Ruxolitinib may increase the bradycardic activities of Zonisamide.,increase,no risk
Ruxolitinib,Zopiclone,The metabolism of Ruxolitinib can be decreased when combined with Zopiclone.,decrease,no risk
Ruxolitinib,Zuclopenthixol,The metabolism of Ruxolitinib can be decreased when combined with Zuclopenthixol.,decrease,no risk
Fedratinib,Boceprevir,The serum concentration of Fedratinib can be increased when it is combined with Boceprevir.,increase,no risk
Fedratinib,Bortezomib,The serum concentration of Bortezomib can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Bosentan,The serum concentration of Fedratinib can be decreased when it is combined with Bosentan.,decrease,no risk
Fedratinib,Bosutinib,The serum concentration of Bosutinib can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Brentuximab vedotin,The serum concentration of Brentuximab vedotin can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Brexpiprazole,The serum concentration of Brexpiprazole can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Brigatinib,The serum concentration of Brigatinib can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Brincidofovir,The serum concentration of Brincidofovir can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Brinzolamide,The serum concentration of Brinzolamide can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Brivaracetam,The serum concentration of Brivaracetam can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Bromocriptine,The serum concentration of Bromocriptine can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Budesonide,The serum concentration of Budesonide can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Bupivacaine,The serum concentration of Bupivacaine can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Buprenorphine,The serum concentration of Buprenorphine can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Buspirone,The serum concentration of Buspirone can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Busulfan,The serum concentration of Busulfan can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Butacaine,The risk or severity of methemoglobinemia can be increased when Fedratinib is combined with Butacaine.,increase,risk
Fedratinib,Butamben,The risk or severity of methemoglobinemia can be increased when Fedratinib is combined with Butamben.,increase,risk
Fedratinib,Gadoxetic acid,The excretion of Gadoxetic acid can be decreased when combined with Fedratinib.,decrease,no risk
Fedratinib,Galantamine,The serum concentration of Galantamine can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Ganciclovir,Fedratinib may decrease the excretion rate of Ganciclovir which could result in a higher serum level.,decrease,no risk
Fedratinib,Gefitinib,The serum concentration of Gefitinib can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Gemcitabine,The serum concentration of Gemcitabine can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Gemfibrozil,The serum concentration of Gemfibrozil can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Gentamicin,Fedratinib may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Fedratinib,Gepirone,The serum concentration of Gepirone can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Gestrinone,The serum concentration of Gestrinone can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Gilteritinib,The serum concentration of Gilteritinib can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Glasdegib,The serum concentration of Glasdegib can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Glecaprevir,Fedratinib may decrease the excretion rate of Glecaprevir which could result in a higher serum level.,decrease,no risk
Fedratinib,Gliclazide,The serum concentration of Gliclazide can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Glimepiride,The therapeutic efficacy of Glimepiride can be increased when used in combination with Fedratinib.,increase,no risk
Fedratinib,Glipizide,The therapeutic efficacy of Glipizide can be increased when used in combination with Fedratinib.,increase,no risk
Fedratinib,Gliquidone,The therapeutic efficacy of Gliquidone can be increased when used in combination with Fedratinib.,increase,no risk
Fedratinib,Glofitamab,The serum concentration of Fedratinib can be increased when it is combined with Glofitamab.,increase,no risk
Fedratinib,Glyburide,The serum concentration of Glyburide can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Glymidine,The therapeutic efficacy of Glymidine can be increased when used in combination with Fedratinib.,increase,no risk
Fedratinib,Golimumab,The metabolism of Fedratinib can be increased when combined with Golimumab.,increase,no risk
Fedratinib,Granisetron,The serum concentration of Granisetron can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Grazoprevir,The serum concentration of Grazoprevir can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Grepafloxacin,The serum concentration of Grepafloxacin can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Guanfacine,The serum concentration of Guanfacine can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Guanidine,Fedratinib may decrease the excretion rate of Guanidine which could result in a higher serum level.,decrease,no risk
Fedratinib,Halcinonide,The serum concentration of Halcinonide can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Halofantrine,The serum concentration of Halofantrine can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Halothane,The serum concentration of Halothane can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Histamine,Fedratinib may decrease the excretion rate of Histamine which could result in a higher serum level.,decrease,no risk
Fedratinib,Hydrocodone,The serum concentration of Hydrocodone can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Hydrocortisone,The serum concentration of Hydrocortisone can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Hydrocortisone acetate,The serum concentration of Hydrocortisone acetate can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Hydrocortisone butyrate,The serum concentration of Hydrocortisone butyrate can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Hydrocortisone cypionate,The serum concentration of Hydrocortisone cypionate can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Hydrocortisone phosphate,The serum concentration of Hydrocortisone phosphate can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Hydrocortisone probutate,The serum concentration of Hydrocortisone probutate can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Hydrocortisone succinate,The serum concentration of Hydrocortisone succinate can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Hydrocortisone valerate,The serum concentration of Hydrocortisone valerate can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Hydroxychloroquine,The serum concentration of Hydroxychloroquine can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Hydroxyprogesterone caproate,The serum concentration of Hydroxyprogesterone caproate can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Hydroxyzine,The serum concentration of Hydroxyzine can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Ketamine,The serum concentration of Ketamine can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Ketazolam,The serum concentration of Ketazolam can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Ketoconazole,The serum concentration of Fedratinib can be increased when it is combined with Ketoconazole.,increase,no risk
Fedratinib,Ketoprofen,The risk or severity of adverse effects can be increased when Ketoprofen is combined with Fedratinib.,increase,risk
Fedratinib,Nabilone,The serum concentration of Nabilone can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Nadolol,The serum concentration of Nadolol can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Nafcillin,The serum concentration of Fedratinib can be decreased when it is combined with Nafcillin.,decrease,no risk
Fedratinib,Naloxegol,The serum concentration of Naloxegol can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Nateglinide,The serum concentration of Nateglinide can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Nebivolol,The serum concentration of Nebivolol can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Nefazodone,The serum concentration of Fedratinib can be increased when it is combined with Nefazodone.,increase,no risk
Fedratinib,Nelfinavir,The serum concentration of Fedratinib can be increased when it is combined with Nelfinavir.,increase,no risk
Fedratinib,Neratinib,The serum concentration of Neratinib can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Netupitant,The serum concentration of Netupitant can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Nevirapine,The serum concentration of Nevirapine can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Nicardipine,The serum concentration of Nicardipine can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Nicergoline,The serum concentration of Nicergoline can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Nicotine,The risk or severity of adverse effects can be increased when Fedratinib is combined with Nicotine.,increase,risk
Fedratinib,Nifedipine,The serum concentration of Nifedipine can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Nilotinib,The serum concentration of Fedratinib can be increased when it is combined with Nilotinib.,increase,no risk
Fedratinib,Nilutamide,The serum concentration of Nilutamide can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Nilvadipine,The serum concentration of Nilvadipine can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Nimesulide,The serum concentration of Nimesulide can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Nimodipine,The serum concentration of Nimodipine can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Nintedanib,The serum concentration of Nintedanib can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Nirmatrelvir,The serum concentration of Nirmatrelvir can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Nirogacestat,The serum concentration of Nirogacestat can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Nisoldipine,The serum concentration of Nisoldipine can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Nitrazepam,The serum concentration of Nitrazepam can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Nitrendipine,The serum concentration of Nitrendipine can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Nitrofurantoin,Fedratinib may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.,decrease,no risk
Fedratinib,Nomegestrol,The serum concentration of Nomegestrol can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Nomegestrol acetate,The serum concentration of Nomegestrol acetate can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Norelgestromin,The serum concentration of Norelgestromin can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Norepinephrine,Fedratinib may decrease the excretion rate of Norepinephrine which could result in a higher serum level.,decrease,no risk
Fedratinib,Norethisterone,The serum concentration of Norethisterone can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Norethynodrel,The serum concentration of Norethynodrel can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Norgestimate,The serum concentration of Norgestimate can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Norgestrel,The serum concentration of Norgestrel can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Nortriptyline,The serum concentration of Nortriptyline can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Nylidrin,The serum concentration of Nylidrin can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Olanzapine,The serum concentration of Olanzapine can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Olaparib,The serum concentration of Olaparib can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Oliceridine,The serum concentration of Oliceridine can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Olutasidenib,The serum concentration of Olutasidenib can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Omadacycline,The serum concentration of Omadacycline can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Omaveloxolone,The serum concentration of Omaveloxolone can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Ombitasvir,Fedratinib may decrease the excretion rate of Ombitasvir which could result in a higher serum level.,decrease,no risk
Fedratinib,Omeprazole,The serum concentration of Omeprazole can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Ondansetron,The serum concentration of Ondansetron can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Opium,The serum concentration of Opium can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Oritavancin,The metabolism of Fedratinib can be decreased when combined with Oritavancin.,decrease,no risk
Fedratinib,Orphenadrine,The serum concentration of Orphenadrine can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Osilodrostat,The serum concentration of Osilodrostat can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Osimertinib,The serum concentration of Osimertinib can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Ospemifene,The serum concentration of Ospemifene can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Ouabain,The excretion of Ouabain can be decreased when combined with Fedratinib.,decrease,no risk
Fedratinib,Oxaliplatin,Fedratinib may decrease the excretion rate of Oxaliplatin which could result in a higher serum level.,decrease,no risk
Fedratinib,Oxcarbazepine,The metabolism of Fedratinib can be decreased when combined with Oxcarbazepine.,decrease,no risk
Fedratinib,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Fedratinib is combined with Oxetacaine.,increase,risk
Fedratinib,Oxprenolol,The serum concentration of Oxprenolol can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Fedratinib is combined with Oxybuprocaine.,increase,risk
Fedratinib,Oxybutynin,The serum concentration of Oxybutynin can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Oxycodone,The serum concentration of Oxycodone can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Oxymorphone,The serum concentration of Oxymorphone can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Ozanimod,Fedratinib may decrease the excretion rate of Ozanimod which could result in a higher serum level.,decrease,no risk
Fedratinib,Quazepam,The serum concentration of Quazepam can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Quetiapine,The serum concentration of Quetiapine can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Quinidine,The serum concentration of Quinidine can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Quinine,The serum concentration of Quinine can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Quizartinib,The serum concentration of Quizartinib can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Ubrogepant,The serum concentration of Ubrogepant can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Udenafil,The serum concentration of Udenafil can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Ulipristal,The serum concentration of Ulipristal can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Umbralisib,The serum concentration of Fedratinib can be increased when it is combined with Umbralisib.,increase,no risk
Fedratinib,Umeclidinium,The serum concentration of Umeclidinium can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Upadacitinib,The serum concentration of Upadacitinib can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Vadadustat,The serum concentration of Fedratinib can be increased when it is combined with Vadadustat.,increase,no risk
Fedratinib,Valbenazine,The serum concentration of Valbenazine can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Valdecoxib,The serum concentration of Valdecoxib can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Valproic acid,The serum concentration of Valproic acid can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Valsartan,The excretion of Valsartan can be decreased when combined with Fedratinib.,decrease,no risk
Fedratinib,Vamorolone,The serum concentration of Vamorolone can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Vandetanib,The serum concentration of Vandetanib can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Vardenafil,The serum concentration of Vardenafil can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Varenicline,Fedratinib may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Fedratinib,Velpatasvir,The serum concentration of Velpatasvir can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Vemurafenib,The serum concentration of Fedratinib can be increased when it is combined with Vemurafenib.,increase,no risk
Fedratinib,Venetoclax,The serum concentration of Venetoclax can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Venlafaxine,The serum concentration of Venlafaxine can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Verapamil,The serum concentration of Verapamil can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Vernakalant,The serum concentration of Vernakalant can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Vilanterol,The serum concentration of Vilanterol can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Vilazodone,The serum concentration of Vilazodone can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Vildagliptin,The therapeutic efficacy of Vildagliptin can be increased when used in combination with Fedratinib.,increase,no risk
Fedratinib,Viloxazine,The metabolism of Fedratinib can be decreased when combined with Viloxazine.,decrease,no risk
Fedratinib,Vinblastine,The serum concentration of Vinblastine can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Vincristine,The serum concentration of Vincristine can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Vindesine,The serum concentration of Vindesine can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Vinflunine,The serum concentration of Vinflunine can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Vinorelbine,The serum concentration of Vinorelbine can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Vitamin D,The serum concentration of Vitamin D can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Vitamin E,The serum concentration of Vitamin E can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Voclosporin,The serum concentration of Voclosporin can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Vonoprazan,The serum concentration of Vonoprazan can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Vorapaxar,The serum concentration of Vorapaxar can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Voriconazole,The serum concentration of Fedratinib can be increased when it is combined with Voriconazole.,increase,no risk
Fedratinib,Vortioxetine,The serum concentration of Vortioxetine can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Voxelotor,The serum concentration of Voxelotor can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Voxilaprevir,The serum concentration of Voxilaprevir can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Warfarin,The serum concentration of Warfarin can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Yohimbine,The serum concentration of Yohimbine can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Zafirlukast,The metabolism of Fedratinib can be decreased when combined with Zafirlukast.,decrease,no risk
Fedratinib,Zaleplon,The serum concentration of Zaleplon can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Zanubrutinib,The serum concentration of Zanubrutinib can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Zavegepant,The serum concentration of Zavegepant can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Zidovudine,The serum concentration of Zidovudine can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Zileuton,The serum concentration of Zileuton can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Zimelidine,The metabolism of Fedratinib can be decreased when combined with Zimelidine.,decrease,no risk
Fedratinib,Ziprasidone,The serum concentration of Ziprasidone can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Zolpidem,The serum concentration of Zolpidem can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Zonisamide,The serum concentration of Zonisamide can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Zopiclone,The serum concentration of Zopiclone can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Zotepine,The serum concentration of Zotepine can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Zuclopenthixol,The serum concentration of Zuclopenthixol can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Zuranolone,The serum concentration of Zuranolone can be increased when it is combined with Fedratinib.,increase,no risk
Canakinumab,Bepridil,The metabolism of Bepridil can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Besilesomab,The risk or severity of adverse effects can be increased when Canakinumab is combined with Besilesomab.,increase,risk
Canakinumab,Betamethasone,The risk or severity of adverse effects can be increased when Betamethasone is combined with Canakinumab.,increase,risk
Canakinumab,Betaxolol,The metabolism of Betaxolol can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Bevacizumab,The risk or severity of adverse effects can be increased when Bevacizumab is combined with Canakinumab.,increase,risk
Canakinumab,Bexarotene,The metabolism of Bexarotene can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Bezlotoxumab,The risk or severity of adverse effects can be increased when Canakinumab is combined with Bezlotoxumab.,increase,risk
Canakinumab,Bicalutamide,The metabolism of Bicalutamide can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Bimekizumab,The risk or severity of adverse effects can be increased when Canakinumab is combined with Bimekizumab.,increase,risk
Canakinumab,Binimetinib,The metabolism of Binimetinib can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Bleomycin,The risk or severity of adverse effects can be increased when Bleomycin is combined with Canakinumab.,increase,risk
Canakinumab,Blinatumomab,The risk or severity of adverse effects can be increased when Canakinumab is combined with Blinatumomab.,increase,risk
Canakinumab,Boceprevir,The metabolism of Boceprevir can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,"Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated)","The therapeutic efficacy of Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated) can be decreased when used in combination with Canakinumab.",decrease,no risk
Canakinumab,Bortezomib,The metabolism of Bortezomib can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Bosentan,The metabolism of Bosentan can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Bosutinib,The metabolism of Bosutinib can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Brentuximab vedotin,The metabolism of Brentuximab vedotin can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Brexpiprazole,The metabolism of Brexpiprazole can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Brigatinib,The metabolism of Brigatinib can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Brivaracetam,The metabolism of Brivaracetam can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Brodalumab,The risk or severity of adverse effects can be increased when Canakinumab is combined with Brodalumab.,increase,risk
Canakinumab,Brolucizumab,The risk or severity of adverse effects can be increased when Canakinumab is combined with Brolucizumab.,increase,risk
Canakinumab,Bromazepam,The metabolism of Bromazepam can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Bromotheophylline,The metabolism of Bromotheophylline can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Brompheniramine,The metabolism of Brompheniramine can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Budesonide,The risk or severity of adverse effects can be increased when Budesonide is combined with Canakinumab.,increase,risk
Canakinumab,Bupivacaine,The metabolism of Bupivacaine can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Buprenorphine,The metabolism of Buprenorphine can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Bupropion,The metabolism of Bupropion can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Burosumab,The risk or severity of adverse effects can be increased when Canakinumab is combined with Burosumab.,increase,risk
Canakinumab,Buspirone,The metabolism of Buspirone can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Busulfan,The metabolism of Busulfan can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Galantamine,The metabolism of Galantamine can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Galcanezumab,The risk or severity of adverse effects can be increased when Canakinumab is combined with Galcanezumab.,increase,risk
Canakinumab,Gefitinib,The metabolism of Gefitinib can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Gemcitabine,The risk or severity of adverse effects can be increased when Gemcitabine is combined with Canakinumab.,increase,risk
Canakinumab,Gemtuzumab ozogamicin,The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Canakinumab.,increase,risk
Canakinumab,Gilteritinib,The metabolism of Gilteritinib can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Glasdegib,The metabolism of Glasdegib can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Glatiramer,The risk or severity of adverse effects can be increased when Glatiramer is combined with Canakinumab.,increase,risk
Canakinumab,Gliclazide,The metabolism of Gliclazide can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Glimepiride,The metabolism of Glimepiride can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Glipizide,The metabolism of Glipizide can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Gliquidone,The metabolism of Gliquidone can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Glofitamab,The risk or severity of adverse effects can be increased when Canakinumab is combined with Glofitamab.,increase,risk
Canakinumab,Glyburide,The metabolism of Glyburide can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Golimumab,The risk or severity of infection and neutropenia can be increased when Golimumab is combined with Canakinumab.,increase,risk
Canakinumab,Grepafloxacin,The metabolism of Grepafloxacin can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Guanabenz,The metabolism of Guanabenz can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Guselkumab,The risk or severity of adverse effects can be increased when Canakinumab is combined with Guselkumab.,increase,risk
Canakinumab,Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Canakinumab.,decrease,no risk
Canakinumab,Halofantrine,The metabolism of Halofantrine can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Haloperidol,The metabolism of Haloperidol can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Halothane,The metabolism of Halothane can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Hepatitis A Vaccine,The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Canakinumab.,decrease,no risk
Canakinumab,Hepatitis B immune globulin,The risk or severity of adverse effects can be increased when Hepatitis B immune globulin is combined with Canakinumab.,increase,risk
Canakinumab,Hepatitis B Vaccine (Recombinant),The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Canakinumab.,decrease,no risk
Canakinumab,Human adenovirus e serotype 4 strain cl-68578 antigen,The risk or severity of infection can be increased when Canakinumab is combined with Human adenovirus e serotype 4 strain cl-68578 antigen.,increase,risk
Canakinumab,Human cytomegalovirus immune globulin,The risk or severity of adverse effects can be increased when Canakinumab is combined with Human cytomegalovirus immune globulin.,increase,risk
Canakinumab,Human immunoglobulin G,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Canakinumab.,increase,risk
Canakinumab,Human Rho(D) immune globulin,The risk or severity of adverse effects can be increased when Canakinumab is combined with Human Rho(D) immune globulin.,increase,risk
Canakinumab,Human varicella-zoster immune globulin,The risk or severity of adverse effects can be increased when Canakinumab is combined with Human varicella-zoster immune globulin.,increase,risk
Canakinumab,Hydrocodone,The metabolism of Hydrocodone can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Hydrocortisone,The metabolism of Hydrocortisone can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Hydrocortisone acetate,The metabolism of Hydrocortisone acetate can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Hydrocortisone butyrate,The metabolism of Hydrocortisone butyrate can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Hydrocortisone cypionate,The metabolism of Hydrocortisone cypionate can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Hydrocortisone phosphate,The metabolism of Hydrocortisone phosphate can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Hydrocortisone succinate,The risk or severity of adverse effects can be increased when Canakinumab is combined with Hydrocortisone succinate.,increase,risk
Canakinumab,Hydromorphone,The metabolism of Hydromorphone can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Hydroxychloroquine,The metabolism of Hydroxychloroquine can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Hydroxyprogesterone caproate,The metabolism of Hydroxyprogesterone caproate can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Hydroxyurea,The risk or severity of adverse effects can be increased when Hydroxyurea is combined with Canakinumab.,increase,risk
Canakinumab,Hydroxyzine,The metabolism of Hydroxyzine can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Janssen COVID-19 Vaccine,The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Canakinumab.,decrease,no risk
Canakinumab,Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated),The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Canakinumab.,decrease,no risk
Canakinumab,Ketamine,The metabolism of Ketamine can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Ketorolac,The metabolism of Ketorolac can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Nabilone,The metabolism of Nabilone can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Nabumetone,The metabolism of Nabumetone can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Nadolol,The metabolism of Nadolol can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Naproxen,The metabolism of Naproxen can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Natalizumab,The risk or severity of immunosuppression can be increased when Canakinumab is combined with Natalizumab.,increase,risk
Canakinumab,Nateglinide,The metabolism of Nateglinide can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Nebivolol,The metabolism of Nebivolol can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Necitumumab,The risk or severity of adverse effects can be increased when Canakinumab is combined with Necitumumab.,increase,risk
Canakinumab,Nefazodone,The metabolism of Nefazodone can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Nelarabine,The risk or severity of adverse effects can be increased when Nelarabine is combined with Canakinumab.,increase,risk
Canakinumab,Nelfinavir,The metabolism of Nelfinavir can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Neratinib,The metabolism of Neratinib can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Netupitant,The metabolism of Netupitant can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Nevirapine,The metabolism of Nevirapine can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Nicardipine,The metabolism of Nicardipine can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Nicergoline,The metabolism of Nicergoline can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Niclosamide,The metabolism of Niclosamide can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Nicotine,The metabolism of Nicotine can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Nifedipine,The metabolism of Nifedipine can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Nilotinib,The metabolism of Nilotinib can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Nilutamide,The metabolism of Nilutamide can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Nilvadipine,The metabolism of Nilvadipine can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Nintedanib,The metabolism of Nintedanib can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Nirogacestat,The metabolism of Nirogacestat can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Nisoldipine,The metabolism of Nisoldipine can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Nitrendipine,The metabolism of Nitrendipine can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Nivolumab,The risk or severity of adverse effects can be increased when Canakinumab is combined with Nivolumab.,increase,risk
Canakinumab,Norethisterone,The metabolism of Norethisterone can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Norgestimate,The metabolism of Norgestimate can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Nortriptyline,The metabolism of Nortriptyline can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Nuvaxovid,The therapeutic efficacy of Nuvaxovid can be decreased when used in combination with Canakinumab.,decrease,no risk
Canakinumab,Obiltoxaximab,The risk or severity of adverse effects can be increased when Obiltoxaximab is combined with Canakinumab.,increase,risk
Canakinumab,Obinutuzumab,The risk or severity of adverse effects can be increased when Canakinumab is combined with Obinutuzumab.,increase,risk
Canakinumab,Ocrelizumab,The risk or severity of adverse effects can be increased when Canakinumab is combined with Ocrelizumab.,increase,risk
Canakinumab,Odesivimab,The risk or severity of adverse effects can be increased when Canakinumab is combined with Odesivimab.,increase,risk
Canakinumab,Ofatumumab,The risk or severity of adverse effects can be increased when Canakinumab is combined with Ofatumumab.,increase,risk
Canakinumab,Olanzapine,The metabolism of Olanzapine can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Olaparib,The metabolism of Olaparib can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Olaratumab,The risk or severity of adverse effects can be increased when Olaratumab is combined with Canakinumab.,increase,risk
Canakinumab,Oliceridine,The metabolism of Oliceridine can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Olodaterol,The metabolism of Olodaterol can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Omalizumab,The risk or severity of adverse effects can be increased when Omalizumab is combined with Canakinumab.,increase,risk
Canakinumab,Ombitasvir,The metabolism of Ombitasvir can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Omeprazole,The metabolism of Omeprazole can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Ondansetron,The metabolism of Ondansetron can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Opium,The metabolism of Opium can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Osilodrostat,The metabolism of Osilodrostat can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Osimertinib,The metabolism of Osimertinib can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Ospemifene,The metabolism of Ospemifene can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Oxaliplatin,The risk or severity of adverse effects can be increased when Oxaliplatin is combined with Canakinumab.,increase,risk
Canakinumab,Oxprenolol,The metabolism of Oxprenolol can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Oxtriphylline,The metabolism of Oxtriphylline can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Oxybutynin,The metabolism of Oxybutynin can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Oxycodone,The metabolism of Oxycodone can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Oxymorphone,The metabolism of Oxymorphone can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Ozanimod,The risk or severity of adverse effects can be increased when Canakinumab is combined with Ozanimod.,increase,risk
Canakinumab,Quetiapine,The metabolism of Quetiapine can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Quinestrol,Quinestrol may increase the thrombogenic activities of Canakinumab.,increase,no risk
Canakinumab,Quinidine,The metabolism of Quinidine can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Quinine,The metabolism of Quinine can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Quizartinib,The metabolism of Quizartinib can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Ublituximab,The risk or severity of infection can be increased when Ublituximab is combined with Canakinumab.,increase,risk
Canakinumab,Udenafil,The metabolism of Udenafil can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Umeclidinium,The metabolism of Umeclidinium can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Upadacitinib,The risk or severity of adverse effects can be increased when Canakinumab is combined with Upadacitinib.,increase,risk
Canakinumab,Ustekinumab,The risk or severity of adverse effects can be increased when Ustekinumab is combined with Canakinumab.,increase,risk
Canakinumab,Valbenazine,The metabolism of Valbenazine can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Valdecoxib,The metabolism of Valdecoxib can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Valproic acid,The metabolism of Valproic acid can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Valsartan,The metabolism of Valsartan can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Vandetanib,The metabolism of Vandetanib can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Vardenafil,The metabolism of Vardenafil can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Varicella zoster vaccine (live/attenuated),The risk or severity of infection can be increased when Canakinumab is combined with Varicella zoster vaccine (live/attenuated).,increase,risk
Canakinumab,Varicella zoster vaccine (recombinant),The therapeutic efficacy of Varicella zoster vaccine (recombinant) can be decreased when used in combination with Canakinumab.,decrease,no risk
Canakinumab,Vedolizumab,The risk or severity of adverse effects can be increased when Canakinumab is combined with Vedolizumab.,increase,risk
Canakinumab,Velpatasvir,The metabolism of Velpatasvir can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Vemurafenib,The metabolism of Vemurafenib can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Venetoclax,The metabolism of Venetoclax can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Venlafaxine,The metabolism of Venlafaxine can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Verapamil,The metabolism of Verapamil can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Vernakalant,The metabolism of Vernakalant can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Canakinumab.,decrease,no risk
Canakinumab,Vilanterol,The risk or severity of adverse effects can be increased when Canakinumab is combined with Vilanterol.,increase,risk
Canakinumab,Vilazodone,The metabolism of Vilazodone can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Vinblastine,The metabolism of Vinblastine can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Vincristine,The metabolism of Vincristine can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Vindesine,The metabolism of Vindesine can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Vinflunine,The metabolism of Vinflunine can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Vinorelbine,The metabolism of Vinorelbine can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Voclosporin,The risk or severity of adverse effects can be increased when Canakinumab is combined with Voclosporin.,increase,risk
Canakinumab,Vonoprazan,The metabolism of Vonoprazan can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Vorapaxar,The metabolism of Vorapaxar can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Voriconazole,The metabolism of Voriconazole can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Vorinostat,The risk or severity of adverse effects can be increased when Vorinostat is combined with Canakinumab.,increase,risk
Canakinumab,Vortioxetine,The metabolism of Vortioxetine can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Voxelotor,The metabolism of Voxelotor can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Voxilaprevir,The metabolism of Voxilaprevir can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Warfarin,The metabolism of Warfarin can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Ximelagatran,The metabolism of Ximelagatran can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Yellow fever vaccine,The risk or severity of infection can be increased when Canakinumab is combined with Yellow fever vaccine.,increase,risk
Canakinumab,Yohimbine,The metabolism of Yohimbine can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Zafirlukast,The metabolism of Zafirlukast can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Zaleplon,The metabolism of Zaleplon can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Zanubrutinib,The metabolism of Zanubrutinib can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Zidovudine,The metabolism of Zidovudine can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Zileuton,The metabolism of Zileuton can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Ziprasidone,The metabolism of Ziprasidone can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Zolmitriptan,The metabolism of Zolmitriptan can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Zolpidem,The metabolism of Zolpidem can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Zonisamide,The metabolism of Zonisamide can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Zopiclone,The metabolism of Zopiclone can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Zotepine,The metabolism of Zotepine can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Zuclopenthixol,The metabolism of Zuclopenthixol can be increased when combined with Canakinumab.,increase,no risk
Glycerol phenylbutyrate,Bumadizone,Bumadizone may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Glycerol phenylbutyrate,Bumetanide,Bumetanide may increase the excretion rate of Glycerol phenylbutyrate which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Glycerol phenylbutyrate,Bupivacaine,The metabolism of Bupivacaine can be decreased when combined with Glycerol phenylbutyrate.,decrease,no risk
Glycerol phenylbutyrate,Buprenorphine,The metabolism of Buprenorphine can be decreased when combined with Glycerol phenylbutyrate.,decrease,no risk
Glycerol phenylbutyrate,Bupropion,Bupropion may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Glycerol phenylbutyrate,Buspirone,The metabolism of Buspirone can be decreased when combined with Glycerol phenylbutyrate.,decrease,no risk
Glycerol phenylbutyrate,Busulfan,The metabolism of Busulfan can be increased when combined with Glycerol phenylbutyrate.,increase,no risk
Glycerol phenylbutyrate,Butabarbital,Butabarbital may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Glycerol phenylbutyrate,Gabapentin enacarbil,The metabolism of Fusidic acid can be decreased when combined with Glycerol phenylbutyrate.,decrease,no risk
Glycerol phenylbutyrate,Gadobenic acid,Gabapentin enacarbil may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Glycerol phenylbutyrate,Gadodiamide,Gadobenic acid may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Glycerol phenylbutyrate,Gadofosveset trisodium,Gadodiamide may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Glycerol phenylbutyrate,Gadopentetic acid,Gadofosveset trisodium may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Glycerol phenylbutyrate,Gadoteric acid,Gadopentetic acid may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Glycerol phenylbutyrate,Gadoteridol,Glycerol phenylbutyrate may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Glycerol phenylbutyrate,Galantamine,Gadoteridol may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Glycerol phenylbutyrate,Ganciclovir,The metabolism of Galantamine can be decreased when combined with Glycerol phenylbutyrate.,decrease,no risk
Glycerol phenylbutyrate,Gefitinib,Ganciclovir may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Glycerol phenylbutyrate,Gemcitabine,The metabolism of Gefitinib can be decreased when combined with Glycerol phenylbutyrate.,decrease,no risk
Glycerol phenylbutyrate,Gemfibrozil,Gemcitabine may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Glycerol phenylbutyrate,Gentamicin,Gemfibrozil may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Glycerol phenylbutyrate,Gestrinone,Glycerol phenylbutyrate may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Glycerol phenylbutyrate,Gilteritinib,The metabolism of Gestrinone can be increased when combined with Glycerol phenylbutyrate.,increase,no risk
Glycerol phenylbutyrate,Gimeracil,The metabolism of Gilteritinib can be increased when combined with Glycerol phenylbutyrate.,increase,no risk
Glycerol phenylbutyrate,Givosiran,Glycerol phenylbutyrate may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Glycerol phenylbutyrate,Glipizide,Givosiran may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Glycerol phenylbutyrate,Golodirsen,Glipizide may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Glycerol phenylbutyrate,Goserelin,Glycerol phenylbutyrate may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Glycerol phenylbutyrate,Guanethidine,Goserelin may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Glycerol phenylbutyrate,Guanfacine,Guanethidine may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Glycerol phenylbutyrate,Haloperidol,Guanfacine may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Glycerol phenylbutyrate,Hydralazine,The serum concentration of Haloperidol can be increased when it is combined with Glycerol phenylbutyrate.,increase,no risk
Glycerol phenylbutyrate,Hydrochlorothiazide,Hydralazine may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Glycerol phenylbutyrate,Hydrocodone,Hydrochlorothiazide may increase the excretion rate of Glycerol phenylbutyrate which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Glycerol phenylbutyrate,Hydrocortisone,The metabolism of Hydrocodone can be decreased when combined with Glycerol phenylbutyrate.,decrease,no risk
Glycerol phenylbutyrate,Hydrocortisone acetate,The therapeutic efficacy of Glycerol phenylbutyrate can be decreased when used in combination with Hydrocortisone.,decrease,no risk
Glycerol phenylbutyrate,Hydrocortisone butyrate,The therapeutic efficacy of Glycerol phenylbutyrate can be decreased when used in combination with Hydrocortisone acetate.,decrease,no risk
Glycerol phenylbutyrate,Hydrocortisone cypionate,The therapeutic efficacy of Glycerol phenylbutyrate can be decreased when used in combination with Hydrocortisone butyrate.,decrease,no risk
Glycerol phenylbutyrate,Hydrocortisone succinate,The therapeutic efficacy of Glycerol phenylbutyrate can be decreased when used in combination with Hydrocortisone cypionate.,decrease,no risk
Glycerol phenylbutyrate,Hydroflumethiazide,The therapeutic efficacy of Glycerol phenylbutyrate can be decreased when used in combination with Hydrocortisone succinate.,decrease,no risk
Glycerol phenylbutyrate,Hydromorphone,Hydroflumethiazide may increase the excretion rate of Glycerol phenylbutyrate which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Glycerol phenylbutyrate,Hydroxocobalamin,Hydromorphone may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Glycerol phenylbutyrate,Hydroxychloroquine,Hydroxocobalamin may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Glycerol phenylbutyrate,Hydroxyethyl Starch,The metabolism of Hydroxychloroquine can be decreased when combined with Glycerol phenylbutyrate.,decrease,no risk
Glycerol phenylbutyrate,Hydroxyprogesterone caproate,Glycerol phenylbutyrate may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Glycerol phenylbutyrate,Kanamycin,The metabolism of Ixazomib can be increased when combined with Glycerol phenylbutyrate.,increase,no risk
Glycerol phenylbutyrate,Ketamine,Glycerol phenylbutyrate may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Glycerol phenylbutyrate,Ketazolam,Ketamine may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Glycerol phenylbutyrate,Ketoprofen,Ketazolam may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Glycerol phenylbutyrate,Ketorolac,Ketoprofen may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Glycerol phenylbutyrate,N-acetyltyrosine,Mycophenolic acid may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Glycerol phenylbutyrate,Nabumetone,Glycerol phenylbutyrate may decrease the excretion rate of N-acetyltyrosine which could result in a higher serum level.,decrease,no risk
Glycerol phenylbutyrate,Nadolol,Nabumetone may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Glycerol phenylbutyrate,Naldemedine,The metabolism of Nadolol can be decreased when combined with Glycerol phenylbutyrate.,decrease,no risk
Glycerol phenylbutyrate,Nalmefene,Glycerol phenylbutyrate may decrease the excretion rate of Naldemedine which could result in a higher serum level.,decrease,no risk
Glycerol phenylbutyrate,Naloxone,Nalmefene may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Glycerol phenylbutyrate,Naproxen,Naloxone may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Glycerol phenylbutyrate,Nateglinide,Naproxen may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Glycerol phenylbutyrate,Nebivolol,The metabolism of Nateglinide can be decreased when combined with Glycerol phenylbutyrate.,decrease,no risk
Glycerol phenylbutyrate,Nedaplatin,The metabolism of Nebivolol can be decreased when combined with Glycerol phenylbutyrate.,decrease,no risk
Glycerol phenylbutyrate,Nedocromil,Glycerol phenylbutyrate may decrease the excretion rate of Nedaplatin which could result in a higher serum level.,decrease,no risk
Glycerol phenylbutyrate,Nefazodone,Nedocromil may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Glycerol phenylbutyrate,Neomycin,The metabolism of Nefazodone can be decreased when combined with Glycerol phenylbutyrate.,decrease,no risk
Glycerol phenylbutyrate,Neratinib,Glycerol phenylbutyrate may decrease the excretion rate of Neomycin which could result in a higher serum level.,decrease,no risk
Glycerol phenylbutyrate,Netilmicin,The metabolism of Neratinib can be increased when combined with Glycerol phenylbutyrate.,increase,no risk
Glycerol phenylbutyrate,Netupitant,Glycerol phenylbutyrate may decrease the excretion rate of Netilmicin which could result in a higher serum level.,decrease,no risk
Glycerol phenylbutyrate,Nevirapine,The metabolism of Netupitant can be decreased when combined with Glycerol phenylbutyrate.,decrease,no risk
Glycerol phenylbutyrate,Nicergoline,The metabolism of Nevirapine can be decreased when combined with Glycerol phenylbutyrate.,decrease,no risk
Glycerol phenylbutyrate,Nicorandil,The metabolism of Nicergoline can be decreased when combined with Glycerol phenylbutyrate.,decrease,no risk
Glycerol phenylbutyrate,Nifedipine,Glycerol phenylbutyrate may decrease the excretion rate of Nicorandil which could result in a higher serum level.,decrease,no risk
Glycerol phenylbutyrate,Nilotinib,The metabolism of Nifedipine can be decreased when combined with Glycerol phenylbutyrate.,decrease,no risk
Glycerol phenylbutyrate,Nilutamide,The metabolism of Nilotinib can be increased when combined with Glycerol phenylbutyrate.,increase,no risk
Glycerol phenylbutyrate,Nimesulide,Nilutamide may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Glycerol phenylbutyrate,Nintedanib,Nimesulide may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Glycerol phenylbutyrate,Nirogacestat,The metabolism of Nintedanib can be increased when combined with Glycerol phenylbutyrate.,increase,no risk
Glycerol phenylbutyrate,Nisoldipine,The metabolism of Nirogacestat can be decreased when combined with Glycerol phenylbutyrate.,decrease,no risk
Glycerol phenylbutyrate,Nitric Oxide,Nisoldipine may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Glycerol phenylbutyrate,Nitrofurantoin,Nitric Oxide may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Glycerol phenylbutyrate,Nitroprusside,Nitrofurantoin may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Glycerol phenylbutyrate,Nomegestrol,Nitroprusside may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Glycerol phenylbutyrate,Nomegestrol acetate,The metabolism of Nomegestrol can be increased when combined with Glycerol phenylbutyrate.,increase,no risk
Glycerol phenylbutyrate,Norelgestromin,The metabolism of Nomegestrol acetate can be increased when combined with Glycerol phenylbutyrate.,increase,no risk
Glycerol phenylbutyrate,Norethisterone,The metabolism of Norelgestromin can be increased when combined with Glycerol phenylbutyrate.,increase,no risk
Glycerol phenylbutyrate,Norethynodrel,The metabolism of Norethisterone can be increased when combined with Glycerol phenylbutyrate.,increase,no risk
Glycerol phenylbutyrate,Norgestimate,The metabolism of Norethynodrel can be increased when combined with Glycerol phenylbutyrate.,increase,no risk
Glycerol phenylbutyrate,Norgestrel,The metabolism of Norgestimate can be increased when combined with Glycerol phenylbutyrate.,increase,no risk
Glycerol phenylbutyrate,Nortriptyline,The metabolism of Norgestrel can be increased when combined with Glycerol phenylbutyrate.,increase,no risk
Glycerol phenylbutyrate,Octinoxate,The metabolism of Nortriptyline can be increased when combined with Glycerol phenylbutyrate.,increase,no risk
Glycerol phenylbutyrate,Olanzapine,Glycerol phenylbutyrate may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Glycerol phenylbutyrate,Olaparib,The metabolism of Olanzapine can be decreased when combined with Glycerol phenylbutyrate.,decrease,no risk
Glycerol phenylbutyrate,Oliceridine,The metabolism of Olaparib can be increased when combined with Glycerol phenylbutyrate.,increase,no risk
Glycerol phenylbutyrate,Olsalazine,The serum concentration of Oliceridine can be increased when it is combined with Glycerol phenylbutyrate.,increase,no risk
Glycerol phenylbutyrate,Ondansetron,Olsalazine may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Glycerol phenylbutyrate,Opium,The metabolism of Ondansetron can be decreased when combined with Glycerol phenylbutyrate.,decrease,no risk
Glycerol phenylbutyrate,Oseltamivir,The metabolism of Opium can be decreased when combined with Glycerol phenylbutyrate.,decrease,no risk
Glycerol phenylbutyrate,Osimertinib,Oseltamivir may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Glycerol phenylbutyrate,Oxacillin,The metabolism of Osimertinib can be increased when combined with Glycerol phenylbutyrate.,increase,no risk
Glycerol phenylbutyrate,Oxaprozin,Oxacillin may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Glycerol phenylbutyrate,Oxazepam,Oxaprozin may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Glycerol phenylbutyrate,Oxprenolol,Oxazepam may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Glycerol phenylbutyrate,Oxybenzone,The metabolism of Oxprenolol can be decreased when combined with Glycerol phenylbutyrate.,decrease,no risk
Glycerol phenylbutyrate,Oxycodone,Oxybenzone may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Glycerol phenylbutyrate,Oxymorphone,The metabolism of Oxycodone can be decreased when combined with Glycerol phenylbutyrate.,decrease,no risk
Glycerol phenylbutyrate,Oxyphenbutazone,The metabolism of Oxymorphone can be decreased when combined with Glycerol phenylbutyrate.,decrease,no risk
Glycerol phenylbutyrate,Oxyquinoline,Oxyphenbutazone may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Glycerol phenylbutyrate,Quetiapine,Pyridoxine may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Glycerol phenylbutyrate,Quinethazone,The metabolism of Quetiapine can be decreased when combined with Glycerol phenylbutyrate.,decrease,no risk
Glycerol phenylbutyrate,Quinidine,Quinethazone may increase the excretion rate of Glycerol phenylbutyrate which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Glycerol phenylbutyrate,Quinine,The metabolism of Quinidine can be increased when combined with Glycerol phenylbutyrate.,increase,no risk
Glycerol phenylbutyrate,Ubrogepant,Glycerol phenylbutyrate may decrease the excretion rate of Tropisetron which could result in a higher serum level.,decrease,no risk
Glycerol phenylbutyrate,Ulipristal,The serum concentration of Ubrogepant can be decreased when it is combined with Glycerol phenylbutyrate.,decrease,no risk
Glycerol phenylbutyrate,Umeclidinium,The metabolism of Ulipristal can be increased when combined with Glycerol phenylbutyrate.,increase,no risk
Glycerol phenylbutyrate,Vaborbactam,The metabolism of Umeclidinium can be decreased when combined with Glycerol phenylbutyrate.,decrease,no risk
Glycerol phenylbutyrate,Valaciclovir,Glycerol phenylbutyrate may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Glycerol phenylbutyrate,Valbenazine,Valaciclovir may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Glycerol phenylbutyrate,Valdecoxib,The serum concentration of Valbenazine can be increased when it is combined with Glycerol phenylbutyrate.,increase,no risk
Glycerol phenylbutyrate,Valganciclovir,Valdecoxib may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Glycerol phenylbutyrate,Valproic acid,Valganciclovir may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Glycerol phenylbutyrate,Vamorolone,The therapeutic efficacy of Glycerol phenylbutyrate can be decreased when used in combination with Valproic acid.,decrease,no risk
Glycerol phenylbutyrate,Vancomycin,The therapeutic efficacy of Glycerol phenylbutyrate can be decreased when used in combination with Vamorolone.,decrease,no risk
Glycerol phenylbutyrate,Vandetanib,Glycerol phenylbutyrate may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Glycerol phenylbutyrate,Varenicline,The metabolism of Vandetanib can be increased when combined with Glycerol phenylbutyrate.,increase,no risk
Glycerol phenylbutyrate,Vemurafenib,Varenicline may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Glycerol phenylbutyrate,Venetoclax,The metabolism of Vemurafenib can be increased when combined with Glycerol phenylbutyrate.,increase,no risk
Glycerol phenylbutyrate,Venlafaxine,The metabolism of Venetoclax can be increased when combined with Glycerol phenylbutyrate.,increase,no risk
Glycerol phenylbutyrate,Verapamil,The metabolism of Venlafaxine can be decreased when combined with Glycerol phenylbutyrate.,decrease,no risk
Glycerol phenylbutyrate,Vernakalant,Verapamil may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Glycerol phenylbutyrate,Vilanterol,The metabolism of Vernakalant can be decreased when combined with Glycerol phenylbutyrate.,decrease,no risk
Glycerol phenylbutyrate,Vilazodone,Glycerol phenylbutyrate may decrease the excretion rate of Vilanterol which could result in a higher serum level.,decrease,no risk
Glycerol phenylbutyrate,Viloxazine,The metabolism of Vilazodone can be decreased when combined with Glycerol phenylbutyrate.,decrease,no risk
Glycerol phenylbutyrate,Vinblastine,Glycerol phenylbutyrate may decrease the excretion rate of Viloxazine which could result in a higher serum level.,decrease,no risk
Glycerol phenylbutyrate,Vincristine,The metabolism of Vinblastine can be increased when combined with Glycerol phenylbutyrate.,increase,no risk
Glycerol phenylbutyrate,Vindesine,The metabolism of Vincristine can be increased when combined with Glycerol phenylbutyrate.,increase,no risk
Glycerol phenylbutyrate,Vinflunine,The metabolism of Vindesine can be increased when combined with Glycerol phenylbutyrate.,increase,no risk
Glycerol phenylbutyrate,Vinorelbine,The metabolism of Vinflunine can be increased when combined with Glycerol phenylbutyrate.,increase,no risk
Glycerol phenylbutyrate,Vorapaxar,The metabolism of Vinorelbine can be increased when combined with Glycerol phenylbutyrate.,increase,no risk
Glycerol phenylbutyrate,Vortioxetine,The metabolism of Vorapaxar can be increased when combined with Glycerol phenylbutyrate.,increase,no risk
Glycerol phenylbutyrate,Warfarin,The metabolism of Vortioxetine can be decreased when combined with Glycerol phenylbutyrate.,decrease,no risk
Glycerol phenylbutyrate,Yohimbine,The metabolism of Warfarin can be increased when combined with Glycerol phenylbutyrate.,increase,no risk
Glycerol phenylbutyrate,Zaleplon,The metabolism of Yohimbine can be decreased when combined with Glycerol phenylbutyrate.,decrease,no risk
Glycerol phenylbutyrate,Zanamivir,Zaleplon may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Glycerol phenylbutyrate,Zanubrutinib,Zanamivir may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Glycerol phenylbutyrate,Ziprasidone,The metabolism of Zanubrutinib can be increased when combined with Glycerol phenylbutyrate.,increase,no risk
Glycerol phenylbutyrate,Zolpidem,The metabolism of Ziprasidone can be increased when combined with Glycerol phenylbutyrate.,increase,no risk
Glycerol phenylbutyrate,Zonisamide,The metabolism of Zolpidem can be decreased when combined with Glycerol phenylbutyrate.,decrease,no risk
Glycerol phenylbutyrate,Zuclopenthixol,Zonisamide may increase the excretion rate of Glycerol phenylbutyrate which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Glycerol phenylbutyrate,Zuranolone,The metabolism of Zuclopenthixol can be decreased when combined with Glycerol phenylbutyrate.,decrease,no risk
Paclitaxel trevatide,Benzocaine,The risk or severity of methemoglobinemia can be increased when Paclitaxel trevatide is combined with Benzocaine.,increase,risk
Paclitaxel trevatide,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Paclitaxel trevatide is combined with Benzyl alcohol.,increase,risk
Paclitaxel trevatide,Bevacizumab,The risk or severity of cardiotoxicity can be increased when Bevacizumab is combined with Paclitaxel trevatide.,increase,risk
Paclitaxel trevatide,Bleomycin,The risk or severity of cardiotoxicity can be increased when Bleomycin is combined with Paclitaxel trevatide.,increase,risk
Paclitaxel trevatide,Bortezomib,The risk or severity of cardiotoxicity can be increased when Bortezomib is combined with Paclitaxel trevatide.,increase,risk
Paclitaxel trevatide,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Paclitaxel trevatide is combined with Bupivacaine.,increase,risk
Paclitaxel trevatide,Busulfan,The risk or severity of cardiotoxicity can be increased when Busulfan is combined with Paclitaxel trevatide.,increase,risk
Paclitaxel trevatide,Butacaine,The risk or severity of methemoglobinemia can be increased when Paclitaxel trevatide is combined with Butacaine.,increase,risk
Paclitaxel trevatide,Butamben,The risk or severity of methemoglobinemia can be increased when Paclitaxel trevatide is combined with Butamben.,increase,risk
Paclitaxel trevatide,Nelarabine,The risk or severity of adverse effects can be increased when Nelarabine is combined with Paclitaxel trevatide.,increase,risk
Paclitaxel trevatide,Ouabain,Ouabain may decrease the cardiotoxic activities of Paclitaxel trevatide.,decrease,no risk
Paclitaxel trevatide,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Paclitaxel trevatide is combined with Oxetacaine.,increase,risk
Paclitaxel trevatide,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Paclitaxel trevatide is combined with Oxybuprocaine.,increase,risk
Paclitaxel trevatide,Vinblastine,The risk or severity of cardiotoxicity can be increased when Vinblastine is combined with Paclitaxel trevatide.,increase,risk
Paclitaxel trevatide,Vincristine,The risk or severity of cardiotoxicity can be increased when Vincristine is combined with Paclitaxel trevatide.,increase,risk
Paclitaxel trevatide,Vindesine,The risk or severity of cardiotoxicity can be increased when Vindesine is combined with Paclitaxel trevatide.,increase,risk
Paclitaxel trevatide,Vinorelbine,The risk or severity of cardiotoxicity can be increased when Vinorelbine is combined with Paclitaxel trevatide.,increase,risk
Noscapine,Gepirone,The serum concentration of Gepirone can be increased when it is combined with Noscapine.,increase,no risk
Noscapine,Gilteritinib,The metabolism of Gilteritinib can be decreased when combined with Noscapine.,decrease,no risk
Noscapine,Gliclazide,The metabolism of Gliclazide can be decreased when combined with Noscapine.,decrease,no risk
Noscapine,Glimepiride,The metabolism of Glimepiride can be decreased when combined with Noscapine.,decrease,no risk
Noscapine,Glipizide,The metabolism of Glipizide can be decreased when combined with Noscapine.,decrease,no risk
Noscapine,Gliquidone,The metabolism of Gliquidone can be decreased when combined with Noscapine.,decrease,no risk
Noscapine,Glyburide,The metabolism of Glyburide can be decreased when combined with Noscapine.,decrease,no risk
Noscapine,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Noscapine.,increase,no risk
Noscapine,Halothane,The metabolism of Halothane can be decreased when combined with Noscapine.,decrease,no risk
Noscapine,Hydromorphone,The metabolism of Hydromorphone can be decreased when combined with Noscapine.,decrease,no risk
Noscapine,Ketamine,The metabolism of Ketamine can be decreased when combined with Noscapine.,decrease,no risk
Noscapine,Ketorolac,The metabolism of Ketorolac can be decreased when combined with Noscapine.,decrease,no risk
Noscapine,Nabilone,The metabolism of Nabilone can be decreased when combined with Noscapine.,decrease,no risk
Noscapine,Nabumetone,The metabolism of Nabumetone can be decreased when combined with Noscapine.,decrease,no risk
Noscapine,Naproxen,The metabolism of Naproxen can be decreased when combined with Noscapine.,decrease,no risk
Noscapine,Nateglinide,The metabolism of Nateglinide can be decreased when combined with Noscapine.,decrease,no risk
Noscapine,Neratinib,The serum concentration of Neratinib can be increased when it is combined with Noscapine.,increase,no risk
Noscapine,Netupitant,The metabolism of Netupitant can be decreased when combined with Noscapine.,decrease,no risk
Noscapine,Nevirapine,The metabolism of Nevirapine can be decreased when combined with Noscapine.,decrease,no risk
Noscapine,Niclosamide,The metabolism of Niclosamide can be decreased when combined with Noscapine.,decrease,no risk
Noscapine,Nilotinib,The serum concentration of Nilotinib can be increased when it is combined with Noscapine.,increase,no risk
Noscapine,Nintedanib,The metabolism of Nintedanib can be decreased when combined with Noscapine.,decrease,no risk
Noscapine,Nirogacestat,The metabolism of Nirogacestat can be decreased when combined with Noscapine.,decrease,no risk
Noscapine,Norethisterone,The metabolism of Norethisterone can be decreased when combined with Noscapine.,decrease,no risk
Noscapine,Norgestimate,The metabolism of Norgestimate can be decreased when combined with Noscapine.,decrease,no risk
Noscapine,Nortriptyline,The serum concentration of Nortriptyline can be increased when it is combined with Noscapine.,increase,no risk
Noscapine,Olaparib,The serum concentration of Olaparib can be increased when it is combined with Noscapine.,increase,no risk
Noscapine,Olodaterol,The metabolism of Olodaterol can be decreased when combined with Noscapine.,decrease,no risk
Noscapine,Ondansetron,The metabolism of Ondansetron can be decreased when combined with Noscapine.,decrease,no risk
Noscapine,Osimertinib,The serum concentration of Osimertinib can be increased when it is combined with Noscapine.,increase,no risk
Noscapine,Ospemifene,The metabolism of Ospemifene can be decreased when combined with Noscapine.,decrease,no risk
Noscapine,Quinidine,The serum concentration of Quinidine can be increased when it is combined with Noscapine.,increase,no risk
Noscapine,Quinine,The metabolism of Quinine can be decreased when combined with Noscapine.,decrease,no risk
Noscapine,Valdecoxib,The metabolism of Valdecoxib can be decreased when combined with Noscapine.,decrease,no risk
Noscapine,Valproic acid,The metabolism of Valproic acid can be decreased when combined with Noscapine.,decrease,no risk
Noscapine,Valsartan,The metabolism of Valsartan can be decreased when combined with Noscapine.,decrease,no risk
Noscapine,Vandetanib,The serum concentration of Vandetanib can be increased when it is combined with Noscapine.,increase,no risk
Noscapine,Vardenafil,The metabolism of Vardenafil can be decreased when combined with Noscapine.,decrease,no risk
Noscapine,Vemurafenib,The serum concentration of Vemurafenib can be increased when it is combined with Noscapine.,increase,no risk
Noscapine,Venetoclax,The serum concentration of Venetoclax can be increased when it is combined with Noscapine.,increase,no risk
Noscapine,Vinblastine,The serum concentration of Vinblastine can be increased when it is combined with Noscapine.,increase,no risk
Noscapine,Vincristine,The serum concentration of Vincristine can be increased when it is combined with Noscapine.,increase,no risk
Noscapine,Vindesine,The serum concentration of Vindesine can be increased when it is combined with Noscapine.,increase,no risk
Noscapine,Vinflunine,The serum concentration of Vinflunine can be increased when it is combined with Noscapine.,increase,no risk
Noscapine,Vinorelbine,The serum concentration of Vinorelbine can be increased when it is combined with Noscapine.,increase,no risk
Noscapine,Vorapaxar,The metabolism of Vorapaxar can be decreased when combined with Noscapine.,decrease,no risk
Noscapine,Voriconazole,The metabolism of Voriconazole can be decreased when combined with Noscapine.,decrease,no risk
Noscapine,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Noscapine.,decrease,no risk
Noscapine,Voxelotor,The serum concentration of Voxelotor can be increased when it is combined with Noscapine.,increase,no risk
Noscapine,Warfarin,The serum concentration of Warfarin can be increased when it is combined with Noscapine.,increase,no risk
Noscapine,Ximelagatran,The metabolism of Ximelagatran can be decreased when combined with Noscapine.,decrease,no risk
Noscapine,Zafirlukast,The metabolism of Zafirlukast can be decreased when combined with Noscapine.,decrease,no risk
Noscapine,Zanubrutinib,The serum concentration of Zanubrutinib can be increased when it is combined with Noscapine.,increase,no risk
Noscapine,Zidovudine,The metabolism of Zidovudine can be decreased when combined with Noscapine.,decrease,no risk
Noscapine,Zileuton,The metabolism of Zileuton can be decreased when combined with Noscapine.,decrease,no risk
Noscapine,Ziprasidone,The metabolism of Ziprasidone can be decreased when combined with Noscapine.,decrease,no risk
Noscapine,Zolpidem,The metabolism of Zolpidem can be decreased when combined with Noscapine.,decrease,no risk
Noscapine,Zopiclone,The metabolism of Zopiclone can be decreased when combined with Noscapine.,decrease,no risk
Noscapine,Zuclopenthixol,The metabolism of Zuclopenthixol can be decreased when combined with Noscapine.,decrease,no risk
Romidepsin,Buprenorphine,The metabolism of Romidepsin can be decreased when combined with Buprenorphine.,decrease,no risk
Romidepsin,Bupropion,The metabolism of Romidepsin can be decreased when combined with Bupropion.,decrease,no risk
Romidepsin,Buserelin,The risk or severity of QTc prolongation can be increased when Buserelin is combined with Romidepsin.,increase,risk
Romidepsin,Buspirone,The metabolism of Romidepsin can be decreased when combined with Buspirone.,decrease,no risk
Romidepsin,Butacaine,The risk or severity of methemoglobinemia can be increased when Romidepsin is combined with Butacaine.,increase,risk
Romidepsin,Butalbital,The metabolism of Romidepsin can be increased when combined with Butalbital.,increase,no risk
Romidepsin,Butamben,The risk or severity of methemoglobinemia can be increased when Romidepsin is combined with Butamben.,increase,risk
Romidepsin,Butriptyline,The risk or severity of QTc prolongation can be increased when Butriptyline is combined with Romidepsin.,increase,risk
Romidepsin,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Gadobenic acid is combined with Romidepsin.,increase,risk
Romidepsin,Galantamine,The risk or severity of QTc prolongation can be increased when Galantamine is combined with Romidepsin.,increase,risk
Romidepsin,Gatifloxacin,The risk or severity of QTc prolongation can be increased when Gatifloxacin is combined with Romidepsin.,increase,risk
Romidepsin,Gefitinib,The metabolism of Romidepsin can be decreased when combined with Gefitinib.,decrease,no risk
Romidepsin,Gemcitabine,The serum concentration of Romidepsin can be increased when it is combined with Gemcitabine.,increase,no risk
Romidepsin,Gemfibrozil,The excretion of Romidepsin can be decreased when combined with Gemfibrozil.,decrease,no risk
Romidepsin,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Gemifloxacin is combined with Romidepsin.,increase,risk
Romidepsin,Gepirone,The risk or severity of QTc prolongation can be increased when Gepirone is combined with Romidepsin.,increase,risk
Romidepsin,Gilteritinib,The risk or severity of QTc prolongation can be increased when Gilteritinib is combined with Romidepsin.,increase,risk
Romidepsin,Ginkgo biloba,The metabolism of Romidepsin can be decreased when combined with Ginkgo biloba.,decrease,no risk
Romidepsin,Glasdegib,The risk or severity of QTc prolongation can be increased when Romidepsin is combined with Glasdegib.,increase,risk
Romidepsin,Glecaprevir,The serum concentration of Romidepsin can be increased when it is combined with Glecaprevir.,increase,no risk
Romidepsin,Glofitamab,The serum concentration of Romidepsin can be increased when it is combined with Glofitamab.,increase,no risk
Romidepsin,Glyburide,The metabolism of Romidepsin can be decreased when combined with Glyburide.,decrease,no risk
Romidepsin,Glycerol phenylbutyrate,The metabolism of Romidepsin can be increased when combined with Glycerol phenylbutyrate.,increase,no risk
Romidepsin,Golimumab,The metabolism of Romidepsin can be increased when combined with Golimumab.,increase,no risk
Romidepsin,Goserelin,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Romidepsin.,increase,risk
Romidepsin,Granisetron,The risk or severity of QTc prolongation can be increased when Granisetron is combined with Romidepsin.,increase,risk
Romidepsin,Grapefruit,The serum concentration of Romidepsin can be increased when it is combined with Grapefruit.,increase,no risk
Romidepsin,Grazoprevir,The serum concentration of Romidepsin can be increased when it is combined with Grazoprevir.,increase,no risk
Romidepsin,Grepafloxacin,The risk or severity of QTc prolongation can be increased when Grepafloxacin is combined with Romidepsin.,increase,risk
Romidepsin,Griseofulvin,The metabolism of Romidepsin can be increased when combined with Griseofulvin.,increase,no risk
Romidepsin,Halofantrine,The risk or severity of QTc prolongation can be increased when Halofantrine is combined with Romidepsin.,increase,risk
Romidepsin,Haloperidol,The risk or severity of QTc prolongation can be increased when Romidepsin is combined with Haloperidol.,increase,risk
Romidepsin,Halothane,The metabolism of Romidepsin can be decreased when combined with Halothane.,decrease,no risk
Romidepsin,Histrelin,The risk or severity of QTc prolongation can be increased when Histrelin is combined with Romidepsin.,increase,risk
Romidepsin,Hydralazine,The serum concentration of Romidepsin can be increased when it is combined with Hydralazine.,increase,no risk
Romidepsin,Hydrochlorothiazide,The risk or severity of QTc prolongation can be increased when Hydrochlorothiazide is combined with Romidepsin.,increase,risk
Romidepsin,Hydrocodone,The metabolism of Romidepsin can be decreased when combined with Hydrocodone.,decrease,no risk
Romidepsin,Hydrocortamate,The metabolism of Romidepsin can be increased when combined with Hydrocortamate.,increase,no risk
Romidepsin,Hydrocortisone,The metabolism of Romidepsin can be increased when combined with Hydrocortisone.,increase,no risk
Romidepsin,Hydrocortisone acetate,The metabolism of Romidepsin can be increased when combined with Hydrocortisone acetate.,increase,no risk
Romidepsin,Hydrocortisone butyrate,The metabolism of Romidepsin can be increased when combined with Hydrocortisone butyrate.,increase,no risk
Romidepsin,Hydrocortisone cypionate,The metabolism of Hydrocortisone cypionate can be decreased when combined with Romidepsin.,decrease,no risk
Romidepsin,Hydrocortisone phosphate,The metabolism of Hydrocortisone phosphate can be decreased when combined with Romidepsin.,decrease,no risk
Romidepsin,Hydrocortisone succinate,The metabolism of Romidepsin can be increased when combined with Hydrocortisone succinate.,increase,no risk
Romidepsin,Hydroxychloroquine,The risk or severity of QTc prolongation can be increased when Hydroxychloroquine is combined with Romidepsin.,increase,risk
Romidepsin,Hydroxyprogesterone caproate,The metabolism of Hydroxyprogesterone caproate can be decreased when combined with Romidepsin.,decrease,no risk
Romidepsin,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Romidepsin is combined with Hydroxyzine.,increase,risk
Romidepsin,Hyoscyamine,The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Romidepsin.,increase,risk
Romidepsin,Ketamine,The metabolism of Romidepsin can be decreased when combined with Ketamine.,decrease,no risk
Romidepsin,Ketazolam,The serum concentration of Romidepsin can be increased when it is combined with Ketazolam.,increase,no risk
Romidepsin,Ketoconazole,The metabolism of Romidepsin can be decreased when combined with Ketoconazole.,decrease,no risk
Romidepsin,Nafcillin,The metabolism of Romidepsin can be increased when combined with Nafcillin.,increase,no risk
Romidepsin,Nalidixic acid,The risk or severity of QTc prolongation can be increased when Nalidixic acid is combined with Romidepsin.,increase,risk
Romidepsin,Nateglinide,The metabolism of Romidepsin can be decreased when combined with Nateglinide.,decrease,no risk
Romidepsin,Nefazodone,The metabolism of Romidepsin can be decreased when combined with Nefazodone.,decrease,no risk
Romidepsin,Nelfinavir,The metabolism of Romidepsin can be decreased when combined with Nelfinavir.,decrease,no risk
Romidepsin,Neratinib,The serum concentration of Romidepsin can be increased when it is combined with Neratinib.,increase,no risk
Romidepsin,Netupitant,The serum concentration of Romidepsin can be increased when it is combined with Netupitant.,increase,no risk
Romidepsin,Nevirapine,The metabolism of Romidepsin can be increased when combined with Nevirapine.,increase,no risk
Romidepsin,Niacin,The serum concentration of Romidepsin can be increased when it is combined with Niacin.,increase,no risk
Romidepsin,Nicardipine,The metabolism of Romidepsin can be decreased when combined with Nicardipine.,decrease,no risk
Romidepsin,Nicotine,The metabolism of Romidepsin can be decreased when combined with Nicotine.,decrease,no risk
Romidepsin,Nifedipine,The risk or severity of QTc prolongation can be increased when Nifedipine is combined with Romidepsin.,increase,risk
Romidepsin,Nilotinib,The metabolism of Romidepsin can be decreased when combined with Nilotinib.,decrease,no risk
Romidepsin,Nilvadipine,The metabolism of Romidepsin can be decreased when combined with Nilvadipine.,decrease,no risk
Romidepsin,Nimodipine,The risk or severity of QTc prolongation can be increased when Nimodipine is combined with Romidepsin.,increase,risk
Romidepsin,Nintedanib,The metabolism of Romidepsin can be decreased when combined with Nintedanib.,decrease,no risk
Romidepsin,Nirogacestat,The serum concentration of Romidepsin can be increased when it is combined with Nirogacestat.,increase,no risk
Romidepsin,Nisoldipine,The metabolism of Romidepsin can be decreased when combined with Nisoldipine.,decrease,no risk
Romidepsin,Nitrendipine,The risk or severity of QTc prolongation can be increased when Nitrendipine is combined with Romidepsin.,increase,risk
Romidepsin,Norethisterone,The metabolism of Romidepsin can be decreased when combined with Norethisterone.,decrease,no risk
Romidepsin,Norfloxacin,The risk or severity of QTc prolongation can be increased when Norfloxacin is combined with Romidepsin.,increase,risk
Romidepsin,Norgestimate,The serum concentration of Romidepsin can be increased when it is combined with Norgestimate.,increase,no risk
Romidepsin,Nortriptyline,The risk or severity of QTc prolongation can be increased when Nortriptyline is combined with Romidepsin.,increase,risk
Romidepsin,Noscapine,The serum concentration of Romidepsin can be increased when it is combined with Noscapine.,increase,no risk
Romidepsin,Novobiocin,The excretion of Romidepsin can be decreased when combined with Novobiocin.,decrease,no risk
Romidepsin,Nystatin,The excretion of Romidepsin can be decreased when combined with Nystatin.,decrease,no risk
Romidepsin,Octreotide,The serum concentration of Romidepsin can be increased when it is combined with Octreotide.,increase,no risk
Romidepsin,Ofloxacin,The risk or severity of QTc prolongation can be increased when Ofloxacin is combined with Romidepsin.,increase,risk
Romidepsin,Olanzapine,The risk or severity of QTc prolongation can be increased when Olanzapine is combined with Romidepsin.,increase,risk
Romidepsin,Olaparib,The metabolism of Romidepsin can be decreased when combined with Olaparib.,decrease,no risk
Romidepsin,Olodaterol,The risk or severity of QTc prolongation can be increased when Olodaterol is combined with Romidepsin.,increase,risk
Romidepsin,Olutasidenib,The metabolism of Romidepsin can be increased when combined with Olutasidenib.,increase,no risk
Romidepsin,Omadacycline,The serum concentration of Romidepsin can be increased when it is combined with Omadacycline.,increase,no risk
Romidepsin,Omaveloxolone,The serum concentration of Romidepsin can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Romidepsin,Ombitasvir,The serum concentration of Romidepsin can be increased when it is combined with Ombitasvir.,increase,no risk
Romidepsin,Ondansetron,The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Romidepsin.,increase,risk
Romidepsin,Oritavancin,The metabolism of Romidepsin can be increased when combined with Oritavancin.,increase,no risk
Romidepsin,Orphenadrine,The metabolism of Romidepsin can be decreased when combined with Orphenadrine.,decrease,no risk
Romidepsin,Osilodrostat,The metabolism of Romidepsin can be decreased when combined with Osilodrostat.,decrease,no risk
Romidepsin,Osimertinib,The metabolism of Romidepsin can be decreased when combined with Osimertinib.,decrease,no risk
Romidepsin,Ospemifene,The metabolism of Romidepsin can be decreased when combined with Ospemifene.,decrease,no risk
Romidepsin,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Romidepsin.,increase,risk
Romidepsin,Oxatomide,The risk or severity of QTc prolongation can be increased when Oxatomide is combined with Romidepsin.,increase,risk
Romidepsin,Oxcarbazepine,The metabolism of Romidepsin can be increased when combined with Oxcarbazepine.,increase,no risk
Romidepsin,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Romidepsin is combined with Oxetacaine.,increase,risk
Romidepsin,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Romidepsin is combined with Oxybuprocaine.,increase,risk
Romidepsin,Oxybutynin,The serum concentration of Romidepsin can be increased when it is combined with Oxybutynin.,increase,no risk
Romidepsin,Oxycodone,The metabolism of Romidepsin can be decreased when combined with Oxycodone.,decrease,no risk
Romidepsin,Oxytocin,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Romidepsin.,increase,risk
Romidepsin,Quetiapine,The risk or severity of QTc prolongation can be increased when Quetiapine is combined with Romidepsin.,increase,risk
Romidepsin,Quinidine,The serum concentration of Romidepsin can be increased when it is combined with Quinidine.,increase,no risk
Romidepsin,Quinine,The serum concentration of Romidepsin can be increased when it is combined with Quinine.,increase,no risk
Romidepsin,Quinupristin,The metabolism of Romidepsin can be decreased when combined with Quinupristin.,decrease,no risk
Romidepsin,Quizartinib,The risk or severity of QTc prolongation can be increased when Romidepsin is combined with Quizartinib.,increase,risk
Romidepsin,Ubrogepant,The serum concentration of Romidepsin can be increased when it is combined with Ubrogepant.,increase,no risk
Romidepsin,Udenafil,The metabolism of Udenafil can be decreased when combined with Romidepsin.,decrease,no risk
Romidepsin,Umbralisib,The serum concentration of Romidepsin can be increased when it is combined with Umbralisib.,increase,no risk
Romidepsin,Umeclidinium,The serum concentration of Romidepsin can be increased when it is combined with Umeclidinium.,increase,no risk
Romidepsin,Vadadustat,The serum concentration of Romidepsin can be decreased when it is combined with Vadadustat.,decrease,no risk
Romidepsin,Valbenazine,The metabolism of Valbenazine can be decreased when combined with Romidepsin.,decrease,no risk
Romidepsin,Valproic acid,The serum concentration of Romidepsin can be increased when it is combined with Valproic acid.,increase,no risk
Romidepsin,Vandetanib,The serum concentration of Romidepsin can be increased when it is combined with Vandetanib.,increase,no risk
Romidepsin,Vardenafil,The serum concentration of Romidepsin can be increased when it is combined with Vardenafil.,increase,no risk
Romidepsin,Velpatasvir,The serum concentration of Romidepsin can be increased when it is combined with Velpatasvir.,increase,no risk
Romidepsin,Vemurafenib,The serum concentration of Romidepsin can be increased when it is combined with Vemurafenib.,increase,no risk
Romidepsin,Venetoclax,The serum concentration of Romidepsin can be increased when it is combined with Venetoclax.,increase,no risk
Romidepsin,Verapamil,The serum concentration of Romidepsin can be increased when it is combined with Verapamil.,increase,no risk
Romidepsin,Vernakalant,The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Romidepsin.,increase,risk
Romidepsin,Vilanterol,The risk or severity of QTc prolongation and ventricular arrhythmias can be increased when Vilanterol is combined with Romidepsin.,increase,risk
Romidepsin,Viloxazine,The metabolism of Romidepsin can be decreased when combined with Viloxazine.,decrease,no risk
Romidepsin,Vinblastine,The metabolism of Romidepsin can be increased when combined with Vinblastine.,increase,no risk
Romidepsin,Vincristine,The metabolism of Vincristine can be decreased when combined with Romidepsin.,decrease,no risk
Romidepsin,Vinflunine,The serum concentration of Vinflunine can be increased when it is combined with Romidepsin.,increase,no risk
Romidepsin,Vitamin E,The metabolism of Romidepsin can be increased when combined with Vitamin E.,increase,no risk
Romidepsin,Voclosporin,The serum concentration of Romidepsin can be increased when it is combined with Voclosporin.,increase,no risk
Romidepsin,Vonoprazan,The metabolism of Vonoprazan can be decreased when combined with Romidepsin.,decrease,no risk
Romidepsin,Vorapaxar,The serum concentration of Romidepsin can be increased when it is combined with Vorapaxar.,increase,no risk
Romidepsin,Voriconazole,The metabolism of Romidepsin can be decreased when combined with Voriconazole.,decrease,no risk
Romidepsin,Vorinostat,The risk or severity of gastrointestinal bleeding and thrombocytopenia can be increased when Romidepsin is combined with Vorinostat.,increase,risk
Romidepsin,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Romidepsin.,decrease,no risk
Romidepsin,Voxelotor,The serum concentration of Romidepsin can be increased when it is combined with Voxelotor.,increase,no risk
Romidepsin,Voxilaprevir,The serum concentration of Romidepsin can be increased when it is combined with Voxilaprevir.,increase,no risk
Romidepsin,Warfarin,Romidepsin may increase the anticoagulant activities of Warfarin.,increase,no risk
Romidepsin,Zafirlukast,The serum concentration of Romidepsin can be increased when it is combined with Zafirlukast.,increase,no risk
Romidepsin,Zaleplon,The metabolism of Romidepsin can be decreased when combined with Zaleplon.,decrease,no risk
Romidepsin,Zanubrutinib,The metabolism of Zanubrutinib can be decreased when combined with Romidepsin.,decrease,no risk
Romidepsin,Zimelidine,The metabolism of Romidepsin can be decreased when combined with Zimelidine.,decrease,no risk
Romidepsin,Ziprasidone,The risk or severity of QTc prolongation can be increased when Romidepsin is combined with Ziprasidone.,increase,risk
Romidepsin,Zonisamide,The serum concentration of Romidepsin can be increased when it is combined with Zonisamide.,increase,no risk
Romidepsin,Zuclopenthixol,The risk or severity of QTc prolongation can be increased when Zuclopenthixol is combined with Romidepsin.,increase,risk
IMO-2055,Benzocaine,The risk or severity of methemoglobinemia can be increased when IMO-2055 is combined with Benzocaine.,increase,risk
IMO-2055,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when IMO-2055 is combined with Benzyl alcohol.,increase,risk
IMO-2055,Bupivacaine,The risk or severity of methemoglobinemia can be increased when IMO-2055 is combined with Bupivacaine.,increase,risk
IMO-2055,Butacaine,The risk or severity of methemoglobinemia can be increased when IMO-2055 is combined with Butacaine.,increase,risk
IMO-2055,Butamben,The risk or severity of methemoglobinemia can be increased when IMO-2055 is combined with Butamben.,increase,risk
IMO-2055,Nelarabine,The risk or severity of adverse effects can be increased when Nelarabine is combined with IMO-2055.,increase,risk
IMO-2055,Oxetacaine,The risk or severity of methemoglobinemia can be increased when IMO-2055 is combined with Oxetacaine.,increase,risk
IMO-2055,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when IMO-2055 is combined with Oxybuprocaine.,increase,risk
Ipilimumab,Bumadizone,Bumadizone may decrease the excretion rate of Ipilimumab which could result in a higher serum level.,decrease,no risk
Ipilimumab,Bumetanide,Bumetanide may increase the excretion rate of Ipilimumab which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ipilimumab,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Ipilimumab is combined with Bupivacaine.,increase,risk
Ipilimumab,Bupropion,Bupropion may decrease the excretion rate of Ipilimumab which could result in a higher serum level.,decrease,no risk
Ipilimumab,Burosumab,The risk or severity of adverse effects can be increased when Ipilimumab is combined with Burosumab.,increase,risk
Ipilimumab,Buspirone,Buspirone may decrease the excretion rate of Ipilimumab which could result in a higher serum level.,decrease,no risk
Ipilimumab,Butabarbital,Butabarbital may decrease the excretion rate of Ipilimumab which could result in a higher serum level.,decrease,no risk
Ipilimumab,Butacaine,The risk or severity of methemoglobinemia can be increased when Ipilimumab is combined with Butacaine.,increase,risk
Ipilimumab,Butamben,The risk or severity of methemoglobinemia can be increased when Ipilimumab is combined with Butamben.,increase,risk
Ipilimumab,Gabapentin enacarbil,Ipilimumab may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Ipilimumab,Gadobenic acid,Gadobenic acid may decrease the excretion rate of Ipilimumab which could result in a higher serum level.,decrease,no risk
Ipilimumab,Gadodiamide,Gadodiamide may decrease the excretion rate of Ipilimumab which could result in a higher serum level.,decrease,no risk
Ipilimumab,Gadofosveset trisodium,Ipilimumab may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Ipilimumab,Gadopentetic acid,Gadopentetic acid may decrease the excretion rate of Ipilimumab which could result in a higher serum level.,decrease,no risk
Ipilimumab,Gadoteric acid,Ipilimumab may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Ipilimumab,Gadoteridol,Gadoteridol may decrease the excretion rate of Ipilimumab which could result in a higher serum level.,decrease,no risk
Ipilimumab,Galcanezumab,The risk or severity of adverse effects can be increased when Ipilimumab is combined with Galcanezumab.,increase,risk
Ipilimumab,Ganciclovir,Ganciclovir may decrease the excretion rate of Ipilimumab which could result in a higher serum level.,decrease,no risk
Ipilimumab,Gemcitabine,Gemcitabine may decrease the excretion rate of Ipilimumab which could result in a higher serum level.,decrease,no risk
Ipilimumab,Gemfibrozil,Gemfibrozil may decrease the excretion rate of Ipilimumab which could result in a higher serum level.,decrease,no risk
Ipilimumab,Gemtuzumab ozogamicin,The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Ipilimumab.,increase,risk
Ipilimumab,Gentamicin,Ipilimumab may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Ipilimumab,Gimeracil,Ipilimumab may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Ipilimumab,Givosiran,Givosiran may decrease the excretion rate of Ipilimumab which could result in a higher serum level.,decrease,no risk
Ipilimumab,Glipizide,Glipizide may decrease the excretion rate of Ipilimumab which could result in a higher serum level.,decrease,no risk
Ipilimumab,Glofitamab,The risk or severity of adverse effects can be increased when Ipilimumab is combined with Glofitamab.,increase,risk
Ipilimumab,Glycerol phenylbutyrate,Ipilimumab may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Ipilimumab,Golimumab,The risk or severity of adverse effects can be increased when Ipilimumab is combined with Golimumab.,increase,risk
Ipilimumab,Golodirsen,Ipilimumab may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Ipilimumab,Goserelin,Goserelin may decrease the excretion rate of Ipilimumab which could result in a higher serum level.,decrease,no risk
Ipilimumab,Guanethidine,Guanethidine may decrease the excretion rate of Ipilimumab which could result in a higher serum level.,decrease,no risk
Ipilimumab,Guanfacine,Guanfacine may decrease the excretion rate of Ipilimumab which could result in a higher serum level.,decrease,no risk
Ipilimumab,Guselkumab,The risk or severity of adverse effects can be increased when Ipilimumab is combined with Guselkumab.,increase,risk
Ipilimumab,Haloperidol,Haloperidol may decrease the excretion rate of Ipilimumab which could result in a higher serum level.,decrease,no risk
Ipilimumab,Hepatitis B immune globulin,The risk or severity of adverse effects can be increased when Hepatitis B immune globulin is combined with Ipilimumab.,increase,risk
Ipilimumab,Human cytomegalovirus immune globulin,The risk or severity of adverse effects can be increased when Ipilimumab is combined with Human cytomegalovirus immune globulin.,increase,risk
Ipilimumab,Human immunoglobulin G,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Ipilimumab.,increase,risk
Ipilimumab,Human Rho(D) immune globulin,The risk or severity of adverse effects can be increased when Ipilimumab is combined with Human Rho(D) immune globulin.,increase,risk
Ipilimumab,Human varicella-zoster immune globulin,The risk or severity of adverse effects can be increased when Ipilimumab is combined with Human varicella-zoster immune globulin.,increase,risk
Ipilimumab,Hydralazine,Hydralazine may decrease the excretion rate of Ipilimumab which could result in a higher serum level.,decrease,no risk
Ipilimumab,Hydrochlorothiazide,Hydrochlorothiazide may increase the excretion rate of Ipilimumab which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ipilimumab,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of Ipilimumab which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ipilimumab,Hydromorphone,Hydromorphone may decrease the excretion rate of Ipilimumab which could result in a higher serum level.,decrease,no risk
Ipilimumab,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Ipilimumab which could result in a higher serum level.,decrease,no risk
Ipilimumab,Hydroxyethyl Starch,Ipilimumab may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Ipilimumab,Kanamycin,Ipilimumab may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Ipilimumab,Ketamine,Ketamine may decrease the excretion rate of Ipilimumab which could result in a higher serum level.,decrease,no risk
Ipilimumab,Ketazolam,Ketazolam may decrease the excretion rate of Ipilimumab which could result in a higher serum level.,decrease,no risk
Ipilimumab,Ketoprofen,Ketoprofen may decrease the excretion rate of Ipilimumab which could result in a higher serum level.,decrease,no risk
Ipilimumab,Ketorolac,Ketorolac may decrease the excretion rate of Ipilimumab which could result in a higher serum level.,decrease,no risk
Ipilimumab,N-acetyltyrosine,Ipilimumab may decrease the excretion rate of N-acetyltyrosine which could result in a higher serum level.,decrease,no risk
Ipilimumab,Nabumetone,Nabumetone may decrease the excretion rate of Ipilimumab which could result in a higher serum level.,decrease,no risk
Ipilimumab,Nadolol,Nadolol may decrease the excretion rate of Ipilimumab which could result in a higher serum level.,decrease,no risk
Ipilimumab,Naldemedine,Ipilimumab may decrease the excretion rate of Naldemedine which could result in a higher serum level.,decrease,no risk
Ipilimumab,Nalmefene,Ipilimumab may decrease the excretion rate of Nalmefene which could result in a higher serum level.,decrease,no risk
Ipilimumab,Naloxone,Naloxone may decrease the excretion rate of Ipilimumab which could result in a higher serum level.,decrease,no risk
Ipilimumab,Naproxen,Naproxen may decrease the excretion rate of Ipilimumab which could result in a higher serum level.,decrease,no risk
Ipilimumab,Natalizumab,The risk or severity of adverse effects can be increased when Natalizumab is combined with Ipilimumab.,increase,risk
Ipilimumab,Nateglinide,Nateglinide may decrease the excretion rate of Ipilimumab which could result in a higher serum level.,decrease,no risk
Ipilimumab,Necitumumab,The risk or severity of adverse effects can be increased when Ipilimumab is combined with Necitumumab.,increase,risk
Ipilimumab,Nedaplatin,Ipilimumab may decrease the excretion rate of Nedaplatin which could result in a higher serum level.,decrease,no risk
Ipilimumab,Nedocromil,Nedocromil may decrease the excretion rate of Ipilimumab which could result in a higher serum level.,decrease,no risk
Ipilimumab,Nefazodone,Nefazodone may decrease the excretion rate of Ipilimumab which could result in a higher serum level.,decrease,no risk
Ipilimumab,Neomycin,Ipilimumab may decrease the excretion rate of Neomycin which could result in a higher serum level.,decrease,no risk
Ipilimumab,Netilmicin,Ipilimumab may decrease the excretion rate of Netilmicin which could result in a higher serum level.,decrease,no risk
Ipilimumab,Nicorandil,Ipilimumab may decrease the excretion rate of Nicorandil which could result in a higher serum level.,decrease,no risk
Ipilimumab,Nifedipine,Nifedipine may decrease the excretion rate of Ipilimumab which could result in a higher serum level.,decrease,no risk
Ipilimumab,Nilutamide,Nilutamide may decrease the excretion rate of Ipilimumab which could result in a higher serum level.,decrease,no risk
Ipilimumab,Nimesulide,Nimesulide may decrease the excretion rate of Ipilimumab which could result in a higher serum level.,decrease,no risk
Ipilimumab,Nisoldipine,Nisoldipine may decrease the excretion rate of Ipilimumab which could result in a higher serum level.,decrease,no risk
Ipilimumab,Nitric Oxide,Nitric Oxide may decrease the excretion rate of Ipilimumab which could result in a higher serum level.,decrease,no risk
Ipilimumab,Nitrofurantoin,Nitrofurantoin may decrease the excretion rate of Ipilimumab which could result in a higher serum level.,decrease,no risk
Ipilimumab,Nitroprusside,Nitroprusside may decrease the excretion rate of Ipilimumab which could result in a higher serum level.,decrease,no risk
Ipilimumab,Nivolumab,The risk or severity of adverse effects can be increased when Ipilimumab is combined with Nivolumab.,increase,risk
Ipilimumab,Obiltoxaximab,The risk or severity of adverse effects can be increased when Obiltoxaximab is combined with Ipilimumab.,increase,risk
Ipilimumab,Obinutuzumab,The risk or severity of adverse effects can be increased when Ipilimumab is combined with Obinutuzumab.,increase,risk
Ipilimumab,Ocrelizumab,The risk or severity of adverse effects can be increased when Ipilimumab is combined with Ocrelizumab.,increase,risk
Ipilimumab,Octinoxate,Ipilimumab may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Ipilimumab,Odesivimab,The risk or severity of adverse effects can be increased when Ipilimumab is combined with Odesivimab.,increase,risk
Ipilimumab,Ofatumumab,The risk or severity of adverse effects can be increased when Ipilimumab is combined with Ofatumumab.,increase,risk
Ipilimumab,Olaratumab,The risk or severity of adverse effects can be increased when Olaratumab is combined with Ipilimumab.,increase,risk
Ipilimumab,Olsalazine,Olsalazine may decrease the excretion rate of Ipilimumab which could result in a higher serum level.,decrease,no risk
Ipilimumab,Omalizumab,The risk or severity of adverse effects can be increased when Omalizumab is combined with Ipilimumab.,increase,risk
Ipilimumab,Opium,Ipilimumab may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Ipilimumab,Oseltamivir,Oseltamivir may decrease the excretion rate of Ipilimumab which could result in a higher serum level.,decrease,no risk
Ipilimumab,Oxacillin,Oxacillin may decrease the excretion rate of Ipilimumab which could result in a higher serum level.,decrease,no risk
Ipilimumab,Oxaprozin,Oxaprozin may decrease the excretion rate of Ipilimumab which could result in a higher serum level.,decrease,no risk
Ipilimumab,Oxazepam,Oxazepam may decrease the excretion rate of Ipilimumab which could result in a higher serum level.,decrease,no risk
Ipilimumab,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Ipilimumab is combined with Oxetacaine.,increase,risk
Ipilimumab,Oxybenzone,Oxybenzone may decrease the excretion rate of Ipilimumab which could result in a higher serum level.,decrease,no risk
Ipilimumab,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Ipilimumab is combined with Oxybuprocaine.,increase,risk
Ipilimumab,Oxyphenbutazone,Oxyphenbutazone may decrease the excretion rate of Ipilimumab which could result in a higher serum level.,decrease,no risk
Ipilimumab,Oxyquinoline,Ipilimumab may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Ipilimumab,Quetiapine,Quetiapine may decrease the excretion rate of Ipilimumab which could result in a higher serum level.,decrease,no risk
Ipilimumab,Quinestrol,Quinestrol may increase the thrombogenic activities of Ipilimumab.,increase,no risk
Ipilimumab,Quinethazone,Quinethazone may increase the excretion rate of Ipilimumab which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ipilimumab,Quinidine,Ipilimumab may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Ipilimumab,Ublituximab,The risk or severity of adverse effects can be increased when Ipilimumab is combined with Ublituximab.,increase,risk
Ipilimumab,Ustekinumab,The risk or severity of adverse effects can be increased when Ustekinumab is combined with Ipilimumab.,increase,risk
Ipilimumab,Vaborbactam,Ipilimumab may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Ipilimumab,Valaciclovir,Valaciclovir may decrease the excretion rate of Ipilimumab which could result in a higher serum level.,decrease,no risk
Ipilimumab,Valbenazine,Ipilimumab may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
Ipilimumab,Valdecoxib,Valdecoxib may decrease the excretion rate of Ipilimumab which could result in a higher serum level.,decrease,no risk
Ipilimumab,Valganciclovir,Valganciclovir may decrease the excretion rate of Ipilimumab which could result in a higher serum level.,decrease,no risk
Ipilimumab,Vancomycin,Ipilimumab may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Ipilimumab,Varenicline,Varenicline may decrease the excretion rate of Ipilimumab which could result in a higher serum level.,decrease,no risk
Ipilimumab,Vedolizumab,The risk or severity of adverse effects can be increased when Ipilimumab is combined with Vedolizumab.,increase,risk
Ipilimumab,Vemurafenib,Ipilimumab may increase the hepatotoxic activities of Vemurafenib.,increase,no risk
Ipilimumab,Venlafaxine,Venlafaxine may decrease the excretion rate of Ipilimumab which could result in a higher serum level.,decrease,no risk
Ipilimumab,Verapamil,Verapamil may decrease the excretion rate of Ipilimumab which could result in a higher serum level.,decrease,no risk
Ipilimumab,Vilanterol,Ipilimumab may decrease the excretion rate of Vilanterol which could result in a higher serum level.,decrease,no risk
Ipilimumab,Viloxazine,Ipilimumab may decrease the excretion rate of Viloxazine which could result in a higher serum level.,decrease,no risk
Ipilimumab,Vortioxetine,Ipilimumab may decrease the excretion rate of Vortioxetine which could result in a higher serum level.,decrease,no risk
Ipilimumab,Warfarin,Ipilimumab may decrease the excretion rate of Warfarin which could result in a higher serum level.,decrease,no risk
Ipilimumab,Zaleplon,Zaleplon may decrease the excretion rate of Ipilimumab which could result in a higher serum level.,decrease,no risk
Ipilimumab,Zanamivir,Zanamivir may decrease the excretion rate of Ipilimumab which could result in a higher serum level.,decrease,no risk
Ipilimumab,Zonisamide,Zonisamide may increase the excretion rate of Ipilimumab which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Solabegron,Gallamine triethiodide,The risk or severity of Tachycardia can be increased when Gallamine triethiodide is combined with Solabegron.,increase,risk
Solabegron,Glycopyrronium,The risk or severity of Tachycardia can be increased when Glycopyrronium is combined with Solabegron.,increase,risk
Solabegron,Guanabenz,Solabegron may decrease the antihypertensive activities of Guanabenz.,decrease,no risk
Solabegron,Guanadrel,Solabegron may decrease the antihypertensive activities of Guanadrel.,decrease,no risk
Solabegron,Guanethidine,Solabegron may decrease the antihypertensive activities of Guanethidine.,decrease,no risk
Solabegron,Guanfacine,Solabegron may decrease the antihypertensive activities of Guanfacine.,decrease,no risk
Solabegron,Guanoxan,Solabegron may decrease the antihypertensive activities of Guanoxan.,decrease,no risk
Solabegron,Halothane,The risk or severity of hypertension can be increased when Halothane is combined with Solabegron.,increase,risk
Solabegron,Hexocyclium,The risk or severity of Tachycardia can be increased when Solabegron is combined with Hexocyclium.,increase,risk
Solabegron,Homatropine methylbromide,The risk or severity of Tachycardia can be increased when Homatropine methylbromide is combined with Solabegron.,increase,risk
Solabegron,Hydralazine,Solabegron may decrease the antihypertensive activities of Hydralazine.,decrease,no risk
Solabegron,Hydrochlorothiazide,Solabegron may decrease the antihypertensive activities of Hydrochlorothiazide.,decrease,no risk
Solabegron,Hydroflumethiazide,Solabegron may decrease the antihypertensive activities of Hydroflumethiazide.,decrease,no risk
Solabegron,Hyoscyamine,The risk or severity of Tachycardia can be increased when Hyoscyamine is combined with Solabegron.,increase,risk
Solabegron,Ketamine,The risk or severity of Tachycardia can be increased when Ketamine is combined with Solabegron.,increase,risk
Solabegron,Ketoprofen,The risk or severity of hypertension can be increased when Ketoprofen is combined with Solabegron.,increase,risk
Solabegron,Ketorolac,The risk or severity of hypertension can be increased when Ketorolac is combined with Solabegron.,increase,risk
Solabegron,Nabilone,The risk or severity of Tachycardia can be increased when Nabilone is combined with Solabegron.,increase,risk
Solabegron,Nabumetone,The risk or severity of hypertension can be increased when Nabumetone is combined with Solabegron.,increase,risk
Solabegron,Nadolol,The therapeutic efficacy of Solabegron can be decreased when used in combination with Nadolol.,decrease,no risk
Solabegron,Naphazoline,The risk or severity of hypertension can be increased when Solabegron is combined with Naphazoline.,increase,risk
Solabegron,Naproxen,The risk or severity of hypertension can be increased when Naproxen is combined with Solabegron.,increase,risk
Solabegron,Naratriptan,The risk or severity of hypertension can be increased when Naratriptan is combined with Solabegron.,increase,risk
Solabegron,Naxitamab,The risk or severity of hypertension can be increased when Solabegron is combined with Naxitamab.,increase,risk
Solabegron,Nebivolol,The therapeutic efficacy of Solabegron can be decreased when used in combination with Nebivolol.,decrease,no risk
Solabegron,Nefazodone,Nefazodone may increase the tachycardic activities of Solabegron.,increase,no risk
Solabegron,Nialamide,The risk or severity of hypertension can be increased when Nialamide is combined with Solabegron.,increase,risk
Solabegron,Nicardipine,The therapeutic efficacy of Solabegron can be decreased when used in combination with Nicardipine.,decrease,no risk
Solabegron,Nicergoline,Nicergoline may increase the hypertensive and vasoconstricting activities of Solabegron.,increase,no risk
Solabegron,Nicorandil,Solabegron may decrease the antihypertensive activities of Nicorandil.,decrease,no risk
Solabegron,Nicotine,The risk or severity of Tachycardia can be increased when Nicotine is combined with Solabegron.,increase,risk
Solabegron,Nilvadipine,Solabegron may decrease the antihypertensive activities of Nilvadipine.,decrease,no risk
Solabegron,Nimesulide,The risk or severity of hypertension can be increased when Nimesulide is combined with Solabegron.,increase,risk
Solabegron,Nimodipine,Solabegron may decrease the antihypertensive activities of Nimodipine.,decrease,no risk
Solabegron,Nisoldipine,Solabegron may decrease the antihypertensive activities of Nisoldipine.,decrease,no risk
Solabegron,Nitrendipine,Solabegron may decrease the antihypertensive activities of Nitrendipine.,decrease,no risk
Solabegron,Nitroglycerin,Solabegron may decrease the antihypertensive activities of Nitroglycerin.,decrease,no risk
Solabegron,Nitroprusside,Solabegron may decrease the antihypertensive activities of Nitroprusside.,decrease,no risk
Solabegron,Nitrous oxide,The risk or severity of hypertension can be increased when Solabegron is combined with Nitrous oxide.,increase,risk
Solabegron,Norepinephrine,The risk or severity of hypertension can be increased when Norepinephrine is combined with Solabegron.,increase,risk
Solabegron,Nortriptyline,The therapeutic efficacy of Solabegron can be decreased when used in combination with Nortriptyline.,decrease,no risk
Solabegron,Nylidrin,The risk or severity of hypertension can be increased when Nylidrin is combined with Solabegron.,increase,risk
Solabegron,Olanzapine,The therapeutic efficacy of Solabegron can be decreased when used in combination with Olanzapine.,decrease,no risk
Solabegron,Olmesartan,Solabegron may decrease the antihypertensive activities of Olmesartan.,decrease,no risk
Solabegron,Olodaterol,The risk or severity of hypertension can be increased when Solabegron is combined with Olodaterol.,increase,risk
Solabegron,Orciprenaline,The risk or severity of hypertension can be increased when Orciprenaline is combined with Solabegron.,increase,risk
Solabegron,Orphenadrine,The risk or severity of Tachycardia can be increased when Orphenadrine is combined with Solabegron.,increase,risk
Solabegron,Oxaprozin,The risk or severity of hypertension can be increased when Oxaprozin is combined with Solabegron.,increase,risk
Solabegron,Oxprenolol,The therapeutic efficacy of Solabegron can be decreased when used in combination with Oxprenolol.,decrease,no risk
Solabegron,Oxybutynin,The risk or severity of Tachycardia can be increased when Oxybutynin is combined with Solabegron.,increase,risk
Solabegron,Oxymetazoline,The risk or severity of hypertension can be increased when Oxymetazoline is combined with Solabegron.,increase,risk
Solabegron,Oxyphenbutazone,The risk or severity of hypertension can be increased when Oxyphenbutazone is combined with Solabegron.,increase,risk
Solabegron,Oxyphencyclimine,The risk or severity of Tachycardia can be increased when Oxyphencyclimine is combined with Solabegron.,increase,risk
Solabegron,Oxyphenonium,The risk or severity of Tachycardia can be increased when Oxyphenonium is combined with Solabegron.,increase,risk
Solabegron,Quetiapine,The therapeutic efficacy of Solabegron can be decreased when used in combination with Quetiapine.,decrease,no risk
Solabegron,Quinapril,Solabegron may decrease the antihypertensive activities of Quinapril.,decrease,no risk
Solabegron,Quinidine,The therapeutic efficacy of Solabegron can be decreased when used in combination with Quinidine.,decrease,no risk
Solabegron,Quinupramine,The risk or severity of hypertension can be increased when Quinupramine is combined with Solabegron.,increase,risk
Solabegron,Umeclidinium,The risk or severity of Tachycardia can be increased when Solabegron is combined with Umeclidinium.,increase,risk
Solabegron,Valdecoxib,The risk or severity of hypertension can be increased when Valdecoxib is combined with Solabegron.,increase,risk
Solabegron,Valsartan,Solabegron may decrease the antihypertensive activities of Valsartan.,decrease,no risk
Solabegron,Venlafaxine,Venlafaxine may increase the tachycardic activities of Solabegron.,increase,no risk
Solabegron,Verapamil,The therapeutic efficacy of Solabegron can be decreased when used in combination with Verapamil.,decrease,no risk
Solabegron,Vibegron,Solabegron may increase the smooth muscle relaxing activities of Vibegron.,increase,no risk
Solabegron,Vilanterol,The risk or severity of hypertension can be increased when Solabegron is combined with Vilanterol.,increase,risk
Solabegron,Vilazodone,The risk or severity of hypertension can be increased when Solabegron is combined with Vilazodone.,increase,risk
Solabegron,Vortioxetine,The risk or severity of hypertension can be increased when Solabegron is combined with Vortioxetine.,increase,risk
Solabegron,Xamoterol,The risk or severity of hypertension can be increased when Solabegron is combined with Xamoterol.,increase,risk
Solabegron,Xylometazoline,The risk or severity of hypertension can be increased when Solabegron is combined with Xylometazoline.,increase,risk
Solabegron,Yohimbine,The risk or severity of hypertension can be increased when Yohimbine is combined with Solabegron.,increase,risk
Solabegron,Ziprasidone,The therapeutic efficacy of Solabegron can be decreased when used in combination with Ziprasidone.,decrease,no risk
Solabegron,Zofenopril,Solabegron may decrease the antihypertensive activities of Zofenopril.,decrease,no risk
Solabegron,Zolmitriptan,The risk or severity of hypertension can be increased when Zolmitriptan is combined with Solabegron.,increase,risk
Solabegron,Zuclopenthixol,The therapeutic efficacy of Solabegron can be decreased when used in combination with Zuclopenthixol.,decrease,no risk
Zosuquidar,Ubrogepant,The serum concentration of Ubrogepant can be increased when it is combined with Zosuquidar.,increase,no risk
Zosuquidar,Umeclidinium,The serum concentration of Umeclidinium can be increased when it is combined with Zosuquidar.,increase,no risk
Zosuquidar,Vardenafil,The serum concentration of Vardenafil can be increased when it is combined with Zosuquidar.,increase,no risk
Zosuquidar,Velpatasvir,The serum concentration of Velpatasvir can be increased when it is combined with Zosuquidar.,increase,no risk
Zosuquidar,Vemurafenib,The serum concentration of Vemurafenib can be increased when it is combined with Zosuquidar.,increase,no risk
Zosuquidar,Venetoclax,The serum concentration of Venetoclax can be increased when it is combined with Zosuquidar.,increase,no risk
Zosuquidar,Verapamil,The serum concentration of Verapamil can be increased when it is combined with Zosuquidar.,increase,no risk
Zosuquidar,Vinblastine,The serum concentration of Vinblastine can be increased when it is combined with Zosuquidar.,increase,no risk
Zosuquidar,Vincristine,The excretion of Vincristine can be decreased when combined with Zosuquidar.,decrease,no risk
Zosuquidar,Vinflunine,The serum concentration of Vinflunine can be increased when it is combined with Zosuquidar.,increase,no risk
Zosuquidar,Voclosporin,The serum concentration of Voclosporin can be increased when it is combined with Zosuquidar.,increase,no risk
Zosuquidar,Voxilaprevir,The serum concentration of Voxilaprevir can be increased when it is combined with Zosuquidar.,increase,no risk
Nimotuzumab,Human varicella-zoster immune globulin,The risk or severity of adverse effects can be increased when Nimotuzumab is combined with Human varicella-zoster immune globulin.,increase,risk
Nimotuzumab,Natalizumab,The risk or severity of adverse effects can be increased when Natalizumab is combined with Nimotuzumab.,increase,risk
Nimotuzumab,Necitumumab,The risk or severity of adverse effects can be increased when Nimotuzumab is combined with Necitumumab.,increase,risk
Nimotuzumab,Nivolumab,The risk or severity of adverse effects can be increased when Nimotuzumab is combined with Nivolumab.,increase,risk
Nimotuzumab,Obiltoxaximab,The risk or severity of adverse effects can be increased when Obiltoxaximab is combined with Nimotuzumab.,increase,risk
Nimotuzumab,Obinutuzumab,The risk or severity of adverse effects can be increased when Nimotuzumab is combined with Obinutuzumab.,increase,risk
Nimotuzumab,Ocrelizumab,The risk or severity of adverse effects can be increased when Nimotuzumab is combined with Ocrelizumab.,increase,risk
Nimotuzumab,Odesivimab,The risk or severity of adverse effects can be increased when Nimotuzumab is combined with Odesivimab.,increase,risk
Nimotuzumab,Ofatumumab,The risk or severity of adverse effects can be increased when Nimotuzumab is combined with Ofatumumab.,increase,risk
Nimotuzumab,Olaratumab,The risk or severity of adverse effects can be increased when Olaratumab is combined with Nimotuzumab.,increase,risk
Nimotuzumab,Omalizumab,The risk or severity of adverse effects can be increased when Omalizumab is combined with Nimotuzumab.,increase,risk
Nimotuzumab,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Nimotuzumab is combined with Oxetacaine.,increase,risk
Nimotuzumab,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Nimotuzumab is combined with Oxybuprocaine.,increase,risk
Nimotuzumab,Quinestrol,Quinestrol may increase the thrombogenic activities of Nimotuzumab.,increase,no risk
Nimotuzumab,Ublituximab,The risk or severity of adverse effects can be increased when Nimotuzumab is combined with Ublituximab.,increase,risk
Nimotuzumab,Ustekinumab,The risk or severity of adverse effects can be increased when Ustekinumab is combined with Nimotuzumab.,increase,risk
Nimotuzumab,Vedolizumab,The risk or severity of adverse effects can be increased when Nimotuzumab is combined with Vedolizumab.,increase,risk
Pixantrone,Benzocaine,The risk or severity of methemoglobinemia can be increased when Pixantrone is combined with Benzocaine.,increase,risk
Pixantrone,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Pixantrone is combined with Benzyl alcohol.,increase,risk
Pixantrone,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Pixantrone is combined with Bupivacaine.,increase,risk
Pixantrone,Butacaine,The risk or severity of methemoglobinemia can be increased when Pixantrone is combined with Butacaine.,increase,risk
Pixantrone,Butamben,The risk or severity of methemoglobinemia can be increased when Pixantrone is combined with Butamben.,increase,risk
Pixantrone,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Pixantrone is combined with Oxetacaine.,increase,risk
Pixantrone,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Pixantrone is combined with Oxybuprocaine.,increase,risk
Elocalcitol,Vamorolone,The therapeutic efficacy of Elocalcitol can be decreased when used in combination with Vamorolone.,decrease,no risk
Elocalcitol,Vitamin D,The risk or severity of adverse effects can be increased when Elocalcitol is combined with Vitamin D.,increase,risk
Seliciclib,Benzocaine,The risk or severity of methemoglobinemia can be increased when Seliciclib is combined with Benzocaine.,increase,risk
Seliciclib,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Seliciclib is combined with Benzyl alcohol.,increase,risk
Seliciclib,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Seliciclib is combined with Bupivacaine.,increase,risk
Seliciclib,Butacaine,The risk or severity of methemoglobinemia can be increased when Seliciclib is combined with Butacaine.,increase,risk
Seliciclib,Butamben,The risk or severity of methemoglobinemia can be increased when Seliciclib is combined with Butamben.,increase,risk
Seliciclib,Nelarabine,The risk or severity of adverse effects can be increased when Nelarabine is combined with Seliciclib.,increase,risk
Seliciclib,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Seliciclib is combined with Oxetacaine.,increase,risk
Seliciclib,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Seliciclib is combined with Oxybuprocaine.,increase,risk
Icatibant,Gabapentin enacarbil,Icatibant may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Icatibant,Gadobenic acid,Gadobenic acid may decrease the excretion rate of Icatibant which could result in a higher serum level.,decrease,no risk
Icatibant,Gadodiamide,Gadodiamide may decrease the excretion rate of Icatibant which could result in a higher serum level.,decrease,no risk
Icatibant,Gadofosveset trisodium,Icatibant may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Icatibant,Gadopentetic acid,Gadopentetic acid may decrease the excretion rate of Icatibant which could result in a higher serum level.,decrease,no risk
Icatibant,Gadoteric acid,Icatibant may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Icatibant,Gadoteridol,Gadoteridol may decrease the excretion rate of Icatibant which could result in a higher serum level.,decrease,no risk
Icatibant,Ganciclovir,Ganciclovir may decrease the excretion rate of Icatibant which could result in a higher serum level.,decrease,no risk
Icatibant,Gemcitabine,Gemcitabine may decrease the excretion rate of Icatibant which could result in a higher serum level.,decrease,no risk
Icatibant,Gemfibrozil,Gemfibrozil may decrease the excretion rate of Icatibant which could result in a higher serum level.,decrease,no risk
Icatibant,Gentamicin,Icatibant may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Icatibant,Gimeracil,Icatibant may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Icatibant,Givosiran,Givosiran may decrease the excretion rate of Icatibant which could result in a higher serum level.,decrease,no risk
Icatibant,Glipizide,Glipizide may decrease the excretion rate of Icatibant which could result in a higher serum level.,decrease,no risk
Icatibant,Glycerol phenylbutyrate,Icatibant may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Icatibant,Golodirsen,Icatibant may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Icatibant,Goserelin,Goserelin may decrease the excretion rate of Icatibant which could result in a higher serum level.,decrease,no risk
Icatibant,Guanethidine,Guanethidine may decrease the excretion rate of Icatibant which could result in a higher serum level.,decrease,no risk
Icatibant,Guanfacine,Guanfacine may decrease the excretion rate of Icatibant which could result in a higher serum level.,decrease,no risk
Icatibant,Haloperidol,Haloperidol may decrease the excretion rate of Icatibant which could result in a higher serum level.,decrease,no risk
Icatibant,Hydralazine,Hydralazine may decrease the excretion rate of Icatibant which could result in a higher serum level.,decrease,no risk
Icatibant,Hydrochlorothiazide,Hydrochlorothiazide may increase the excretion rate of Icatibant which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Icatibant,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of Icatibant which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Icatibant,Hydromorphone,Hydromorphone may decrease the excretion rate of Icatibant which could result in a higher serum level.,decrease,no risk
Icatibant,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Icatibant which could result in a higher serum level.,decrease,no risk
Icatibant,Hydroxyethyl Starch,Icatibant may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Icatibant,Kanamycin,Icatibant may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Icatibant,Ketamine,Ketamine may decrease the excretion rate of Icatibant which could result in a higher serum level.,decrease,no risk
Icatibant,Ketazolam,Ketazolam may decrease the excretion rate of Icatibant which could result in a higher serum level.,decrease,no risk
Icatibant,Ketoprofen,Ketoprofen may decrease the excretion rate of Icatibant which could result in a higher serum level.,decrease,no risk
Icatibant,Ketorolac,Ketorolac may decrease the excretion rate of Icatibant which could result in a higher serum level.,decrease,no risk
Icatibant,N-acetyltyrosine,Icatibant may decrease the excretion rate of N-acetyltyrosine which could result in a higher serum level.,decrease,no risk
Icatibant,Nabumetone,Nabumetone may decrease the excretion rate of Icatibant which could result in a higher serum level.,decrease,no risk
Icatibant,Nadolol,Nadolol may decrease the excretion rate of Icatibant which could result in a higher serum level.,decrease,no risk
Icatibant,Naldemedine,Icatibant may decrease the excretion rate of Naldemedine which could result in a higher serum level.,decrease,no risk
Icatibant,Nalmefene,Icatibant may decrease the excretion rate of Nalmefene which could result in a higher serum level.,decrease,no risk
Icatibant,Naloxone,Naloxone may decrease the excretion rate of Icatibant which could result in a higher serum level.,decrease,no risk
Icatibant,Naproxen,Naproxen may decrease the excretion rate of Icatibant which could result in a higher serum level.,decrease,no risk
Icatibant,Nateglinide,Nateglinide may decrease the excretion rate of Icatibant which could result in a higher serum level.,decrease,no risk
Icatibant,Nedaplatin,Icatibant may decrease the excretion rate of Nedaplatin which could result in a higher serum level.,decrease,no risk
Icatibant,Nedocromil,Nedocromil may decrease the excretion rate of Icatibant which could result in a higher serum level.,decrease,no risk
Icatibant,Nefazodone,Nefazodone may decrease the excretion rate of Icatibant which could result in a higher serum level.,decrease,no risk
Icatibant,Neomycin,Icatibant may decrease the excretion rate of Neomycin which could result in a higher serum level.,decrease,no risk
Icatibant,Netilmicin,Icatibant may decrease the excretion rate of Netilmicin which could result in a higher serum level.,decrease,no risk
Icatibant,Nicorandil,Icatibant may decrease the excretion rate of Nicorandil which could result in a higher serum level.,decrease,no risk
Icatibant,Nifedipine,Nifedipine may decrease the excretion rate of Icatibant which could result in a higher serum level.,decrease,no risk
Icatibant,Nilutamide,Nilutamide may decrease the excretion rate of Icatibant which could result in a higher serum level.,decrease,no risk
Icatibant,Nimesulide,Nimesulide may decrease the excretion rate of Icatibant which could result in a higher serum level.,decrease,no risk
Icatibant,Nisoldipine,Nisoldipine may decrease the excretion rate of Icatibant which could result in a higher serum level.,decrease,no risk
Icatibant,Nitric Oxide,Nitric Oxide may decrease the excretion rate of Icatibant which could result in a higher serum level.,decrease,no risk
Icatibant,Nitrofurantoin,Nitrofurantoin may decrease the excretion rate of Icatibant which could result in a higher serum level.,decrease,no risk
Icatibant,Nitroprusside,Nitroprusside may decrease the excretion rate of Icatibant which could result in a higher serum level.,decrease,no risk
Icatibant,Octinoxate,Icatibant may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Icatibant,Olsalazine,Olsalazine may decrease the excretion rate of Icatibant which could result in a higher serum level.,decrease,no risk
Icatibant,Opium,Icatibant may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Icatibant,Oseltamivir,Oseltamivir may decrease the excretion rate of Icatibant which could result in a higher serum level.,decrease,no risk
Icatibant,Oxacillin,Oxacillin may decrease the excretion rate of Icatibant which could result in a higher serum level.,decrease,no risk
Icatibant,Oxaprozin,Oxaprozin may decrease the excretion rate of Icatibant which could result in a higher serum level.,decrease,no risk
Icatibant,Oxazepam,Oxazepam may decrease the excretion rate of Icatibant which could result in a higher serum level.,decrease,no risk
Icatibant,Oxybenzone,Oxybenzone may decrease the excretion rate of Icatibant which could result in a higher serum level.,decrease,no risk
Icatibant,Oxyphenbutazone,Oxyphenbutazone may decrease the excretion rate of Icatibant which could result in a higher serum level.,decrease,no risk
Icatibant,Oxyquinoline,Icatibant may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Icatibant,Quetiapine,Quetiapine may decrease the excretion rate of Icatibant which could result in a higher serum level.,decrease,no risk
Icatibant,Quinapril,Icatibant may decrease the antihypertensive activities of Quinapril.,decrease,no risk
Icatibant,Quinethazone,Quinethazone may increase the excretion rate of Icatibant which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Icatibant,Quinidine,Icatibant may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Icatibant,Urokinase,The risk or severity of angioedema can be increased when Urokinase is combined with Icatibant.,increase,risk
Icatibant,Vaborbactam,Icatibant may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Icatibant,Valaciclovir,Valaciclovir may decrease the excretion rate of Icatibant which could result in a higher serum level.,decrease,no risk
Icatibant,Valbenazine,Icatibant may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
Icatibant,Valdecoxib,Valdecoxib may decrease the excretion rate of Icatibant which could result in a higher serum level.,decrease,no risk
Icatibant,Valganciclovir,Valganciclovir may decrease the excretion rate of Icatibant which could result in a higher serum level.,decrease,no risk
Icatibant,Valsartan,The risk or severity of angioedema can be increased when Valsartan is combined with Icatibant.,increase,risk
Icatibant,Vancomycin,Icatibant may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Icatibant,Varenicline,Varenicline may decrease the excretion rate of Icatibant which could result in a higher serum level.,decrease,no risk
Icatibant,Venlafaxine,Venlafaxine may decrease the excretion rate of Icatibant which could result in a higher serum level.,decrease,no risk
Icatibant,Verapamil,Verapamil may decrease the excretion rate of Icatibant which could result in a higher serum level.,decrease,no risk
Icatibant,Vilanterol,Icatibant may decrease the excretion rate of Vilanterol which could result in a higher serum level.,decrease,no risk
Icatibant,Vildagliptin,The risk or severity of angioedema can be increased when Vildagliptin is combined with Icatibant.,increase,risk
Icatibant,Viloxazine,Icatibant may decrease the excretion rate of Viloxazine which could result in a higher serum level.,decrease,no risk
Icatibant,Vortioxetine,Icatibant may decrease the excretion rate of Vortioxetine which could result in a higher serum level.,decrease,no risk
Icatibant,Warfarin,Icatibant may decrease the excretion rate of Warfarin which could result in a higher serum level.,decrease,no risk
Icatibant,Zaleplon,Zaleplon may decrease the excretion rate of Icatibant which could result in a higher serum level.,decrease,no risk
Icatibant,Zanamivir,Zanamivir may decrease the excretion rate of Icatibant which could result in a higher serum level.,decrease,no risk
Icatibant,Zofenopril,Icatibant may decrease the antihypertensive activities of Zofenopril.,decrease,no risk
Icatibant,Zonisamide,Zonisamide may increase the excretion rate of Icatibant which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Alovudine,Bacillus calmette-guerin substrain connaught live antigen,The therapeutic efficacy of Bacillus calmette-guerin substrain connaught live antigen can be decreased when used in combination with Alovudine.,decrease,no risk
Alovudine,Bacillus calmette-guerin substrain russian BCG-I live antigen,The therapeutic efficacy of Bacillus calmette-guerin substrain russian BCG-I live antigen can be decreased when used in combination with Alovudine.,decrease,no risk
Alovudine,Bacillus calmette-guerin substrain tice live antigen,The therapeutic efficacy of Bacillus calmette-guerin substrain tice live antigen can be decreased when used in combination with Alovudine.,decrease,no risk
Alovudine,BCG vaccine,The therapeutic efficacy of BCG vaccine can be decreased when used in combination with Alovudine.,decrease,no risk
Alovudine,Human adenovirus e serotype 4 strain cl-68578 antigen,The therapeutic efficacy of Human adenovirus e serotype 4 strain cl-68578 antigen can be decreased when used in combination with Alovudine.,decrease,no risk
Alovudine,Varicella zoster vaccine (live/attenuated),The therapeutic efficacy of Varicella zoster vaccine (live/attenuated) can be decreased when used in combination with Alovudine.,decrease,no risk
Alovudine,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Alovudine.,decrease,no risk
Alovudine,Yellow fever vaccine,The therapeutic efficacy of Yellow fever vaccine can be decreased when used in combination with Alovudine.,decrease,no risk
Atrasentan,Quinidine,The excretion of Atrasentan can be decreased when combined with Quinidine.,decrease,no risk
Atrasentan,Quinine,The excretion of Atrasentan can be decreased when combined with Quinine.,decrease,no risk
Atrasentan,Valsartan,The excretion of Atrasentan can be decreased when combined with Valsartan.,decrease,no risk
Atrasentan,Velpatasvir,The excretion of Atrasentan can be decreased when combined with Velpatasvir.,decrease,no risk
Atrasentan,Venetoclax,The excretion of Atrasentan can be decreased when combined with Venetoclax.,decrease,no risk
Atrasentan,Vinblastine,The excretion of Atrasentan can be decreased when combined with Vinblastine.,decrease,no risk
Atrasentan,Vincristine,The excretion of Atrasentan can be decreased when combined with Vincristine.,decrease,no risk
Atrasentan,Voxilaprevir,The excretion of Atrasentan can be decreased when combined with Voxilaprevir.,decrease,no risk
Tedisamil,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Gadobenic acid is combined with Tedisamil.,increase,risk
Tedisamil,Galantamine,The risk or severity of QTc prolongation can be increased when Galantamine is combined with Tedisamil.,increase,risk
Tedisamil,Gatifloxacin,The risk or severity of QTc prolongation can be increased when Gatifloxacin is combined with Tedisamil.,increase,risk
Tedisamil,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Gemifloxacin is combined with Tedisamil.,increase,risk
Tedisamil,Gepirone,The risk or severity of QTc prolongation can be increased when Gepirone is combined with Tedisamil.,increase,risk
Tedisamil,Gilteritinib,The risk or severity of QTc prolongation can be increased when Tedisamil is combined with Gilteritinib.,increase,risk
Tedisamil,Glasdegib,The risk or severity of QTc prolongation can be increased when Tedisamil is combined with Glasdegib.,increase,risk
Tedisamil,Goserelin,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Tedisamil.,increase,risk
Tedisamil,Granisetron,The risk or severity of QTc prolongation can be increased when Granisetron is combined with Tedisamil.,increase,risk
Tedisamil,Grepafloxacin,The risk or severity of QTc prolongation can be increased when Tedisamil is combined with Grepafloxacin.,increase,risk
Tedisamil,Halofantrine,The risk or severity of QTc prolongation can be increased when Tedisamil is combined with Halofantrine.,increase,risk
Tedisamil,Haloperidol,The risk or severity of QTc prolongation can be increased when Tedisamil is combined with Haloperidol.,increase,risk
Tedisamil,Histrelin,The risk or severity of QTc prolongation can be increased when Histrelin is combined with Tedisamil.,increase,risk
Tedisamil,Hydrochlorothiazide,The risk or severity of QTc prolongation can be increased when Hydrochlorothiazide is combined with Tedisamil.,increase,risk
Tedisamil,Hydroxychloroquine,The risk or severity of QTc prolongation can be increased when Hydroxychloroquine is combined with Tedisamil.,increase,risk
Tedisamil,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Tedisamil is combined with Hydroxyzine.,increase,risk
Tedisamil,Hyoscyamine,Hyoscyamine may increase the arrhythmogenic activities of Tedisamil.,increase,no risk
Tedisamil,Ketoconazole,The risk or severity of QTc prolongation can be increased when Ketoconazole is combined with Tedisamil.,increase,risk
Tedisamil,Nadolol,Nadolol may increase the arrhythmogenic activities of Tedisamil.,increase,no risk
Tedisamil,Nalidixic acid,The risk or severity of QTc prolongation can be increased when Nalidixic acid is combined with Tedisamil.,increase,risk
Tedisamil,Nebivolol,Nebivolol may increase the arrhythmogenic activities of Tedisamil.,increase,no risk
Tedisamil,Nelfinavir,The risk or severity of QTc prolongation can be increased when Nelfinavir is combined with Tedisamil.,increase,risk
Tedisamil,Nicardipine,Nicardipine may increase the arrhythmogenic activities of Tedisamil.,increase,no risk
Tedisamil,Nicorandil,Tedisamil may increase the arrhythmogenic activities of Nicorandil.,increase,no risk
Tedisamil,Nifedipine,Nifedipine may increase the arrhythmogenic activities of Tedisamil.,increase,no risk
Tedisamil,Nilotinib,The risk or severity of QTc prolongation can be increased when Tedisamil is combined with Nilotinib.,increase,risk
Tedisamil,Nilvadipine,Tedisamil may increase the arrhythmogenic activities of Nilvadipine.,increase,no risk
Tedisamil,Nimesulide,Nimesulide may increase the arrhythmogenic activities of Tedisamil.,increase,no risk
Tedisamil,Nimodipine,Nimodipine may increase the arrhythmogenic activities of Tedisamil.,increase,no risk
Tedisamil,Nisoldipine,Nisoldipine may increase the arrhythmogenic activities of Tedisamil.,increase,no risk
Tedisamil,Nitrendipine,Nitrendipine may increase the arrhythmogenic activities of Tedisamil.,increase,no risk
Tedisamil,Norfloxacin,The risk or severity of QTc prolongation can be increased when Norfloxacin is combined with Tedisamil.,increase,risk
Tedisamil,Nortriptyline,The risk or severity of QTc prolongation can be increased when Nortriptyline is combined with Tedisamil.,increase,risk
Tedisamil,Nylidrin,Nylidrin may increase the arrhythmogenic activities of Tedisamil.,increase,no risk
Tedisamil,Octreotide,The risk or severity of QTc prolongation can be increased when Octreotide is combined with Tedisamil.,increase,risk
Tedisamil,Ofloxacin,The risk or severity of QTc prolongation can be increased when Ofloxacin is combined with Tedisamil.,increase,risk
Tedisamil,Olanzapine,The risk or severity of QTc prolongation can be increased when Olanzapine is combined with Tedisamil.,increase,risk
Tedisamil,Olodaterol,The risk or severity of QTc prolongation can be increased when Olodaterol is combined with Tedisamil.,increase,risk
Tedisamil,Ondansetron,The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Tedisamil.,increase,risk
Tedisamil,Orphenadrine,The risk or severity of QTc prolongation can be increased when Orphenadrine is combined with Tedisamil.,increase,risk
Tedisamil,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Tedisamil.,increase,risk
Tedisamil,Oxatomide,The risk or severity of QTc prolongation can be increased when Tedisamil is combined with Oxatomide.,increase,risk
Tedisamil,Oxprenolol,Oxprenolol may increase the arrhythmogenic activities of Tedisamil.,increase,no risk
Tedisamil,Oxytocin,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Tedisamil.,increase,risk
Tedisamil,Quetiapine,The risk or severity of QTc prolongation can be increased when Quetiapine is combined with Tedisamil.,increase,risk
Tedisamil,Quinidine,Quinidine may increase the arrhythmogenic activities of Tedisamil.,increase,no risk
Tedisamil,Quinine,The risk or severity of QTc prolongation can be increased when Tedisamil is combined with Quinine.,increase,risk
Tedisamil,Quizartinib,The risk or severity of QTc prolongation can be increased when Tedisamil is combined with Quizartinib.,increase,risk
Tedisamil,Valproic acid,The risk or severity of QTc prolongation can be increased when Tedisamil is combined with Valproic acid.,increase,risk
Tedisamil,Vandetanib,The risk or severity of QTc prolongation can be increased when Tedisamil is combined with Vandetanib.,increase,risk
Tedisamil,Vardenafil,The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Tedisamil.,increase,risk
Tedisamil,Vemurafenib,The risk or severity of QTc prolongation can be increased when Tedisamil is combined with Vemurafenib.,increase,risk
Tedisamil,Verapamil,Verapamil may increase the arrhythmogenic activities of Tedisamil.,increase,no risk
Tedisamil,Vernakalant,Tedisamil may increase the arrhythmogenic activities of Vernakalant.,increase,no risk
Tedisamil,Vilanterol,The risk or severity of QTc prolongation and ventricular arrhythmias can be increased when Vilanterol is combined with Tedisamil.,increase,risk
Tedisamil,Voriconazole,The risk or severity of QTc prolongation can be increased when Voriconazole is combined with Tedisamil.,increase,risk
Tedisamil,Vorinostat,The risk or severity of QTc prolongation can be increased when Vorinostat is combined with Tedisamil.,increase,risk
Tedisamil,Xylometazoline,Tedisamil may increase the arrhythmogenic activities of Xylometazoline.,increase,no risk
Tedisamil,Ziconotide,Tedisamil may increase the arrhythmogenic activities of Ziconotide.,increase,no risk
Tedisamil,Ziprasidone,The risk or severity of QTc prolongation can be increased when Tedisamil is combined with Ziprasidone.,increase,risk
Tedisamil,Zonisamide,Zonisamide may increase the arrhythmogenic activities of Tedisamil.,increase,no risk
Tedisamil,Zuclopenthixol,The risk or severity of QTc prolongation can be increased when Tedisamil is combined with Zuclopenthixol.,increase,risk
Rufinamide,Gabapentin,The risk or severity of adverse effects can be increased when Rufinamide is combined with Gabapentin.,increase,risk
Rufinamide,Gabapentin enacarbil,The risk or severity of adverse effects can be increased when Rufinamide is combined with Gabapentin enacarbil.,increase,risk
Rufinamide,Gallamine triethiodide,The risk or severity of adverse effects can be increased when Rufinamide is combined with Gallamine triethiodide.,increase,risk
Rufinamide,Gamolenic acid,The therapeutic efficacy of Rufinamide can be decreased when used in combination with Gamolenic acid.,decrease,no risk
Rufinamide,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Rufinamide is combined with Ganaxolone.",increase,risk
Rufinamide,Ganciclovir,The therapeutic efficacy of Rufinamide can be decreased when used in combination with Ganciclovir.,decrease,no risk
Rufinamide,Gepirone,The risk or severity of adverse effects can be increased when Rufinamide is combined with Gepirone.,increase,risk
Rufinamide,Gestrinone,The metabolism of Gestrinone can be increased when combined with Rufinamide.,increase,no risk
Rufinamide,Gilteritinib,The metabolism of Gilteritinib can be increased when combined with Rufinamide.,increase,no risk
Rufinamide,Glutethimide,The risk or severity of adverse effects can be increased when Rufinamide is combined with Glutethimide.,increase,risk
Rufinamide,Granisetron,The risk or severity of adverse effects can be increased when Rufinamide is combined with Granisetron.,increase,risk
Rufinamide,Guanfacine,The risk or severity of adverse effects can be increased when Rufinamide is combined with Guanfacine.,increase,risk
Rufinamide,Halazepam,The risk or severity of adverse effects can be increased when Rufinamide is combined with Halazepam.,increase,risk
Rufinamide,Halofantrine,The therapeutic efficacy of Rufinamide can be decreased when used in combination with Halofantrine.,decrease,no risk
Rufinamide,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Rufinamide.,increase,risk
Rufinamide,Halothane,The risk or severity of adverse effects can be increased when Rufinamide is combined with Halothane.,increase,risk
Rufinamide,Hexafluronium,The risk or severity of adverse effects can be increased when Rufinamide is combined with Hexafluronium.,increase,risk
Rufinamide,Hydrocodone,Rufinamide may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Rufinamide,Hydromorphone,The risk or severity of adverse effects can be increased when Rufinamide is combined with Hydromorphone.,increase,risk
Rufinamide,Hydroxychloroquine,The therapeutic efficacy of Rufinamide can be decreased when used in combination with Hydroxychloroquine.,decrease,no risk
Rufinamide,Hydroxyprogesterone caproate,The metabolism of Hydroxyprogesterone caproate can be increased when combined with Rufinamide.,increase,no risk
Rufinamide,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Rufinamide.,increase,no risk
Rufinamide,Ketamine,The risk or severity of adverse effects can be increased when Rufinamide is combined with Ketamine.,increase,risk
Rufinamide,Ketazolam,The risk or severity of adverse effects can be increased when Rufinamide is combined with Ketazolam.,increase,risk
Rufinamide,Nabilone,Nabilone may increase the central nervous system depressant (CNS depressant) activities of Rufinamide.,increase,no risk
Rufinamide,Nalbuphine,The risk or severity of adverse effects can be increased when Rufinamide is combined with Nalbuphine.,increase,risk
Rufinamide,Nalidixic acid,The therapeutic efficacy of Rufinamide can be decreased when used in combination with Nalidixic acid.,decrease,no risk
Rufinamide,Naratriptan,The risk or severity of adverse effects can be increased when Rufinamide is combined with Naratriptan.,increase,risk
Rufinamide,Nefazodone,The risk or severity of adverse effects can be increased when Rufinamide is combined with Nefazodone.,increase,risk
Rufinamide,Neratinib,The metabolism of Neratinib can be increased when combined with Rufinamide.,increase,no risk
Rufinamide,Netupitant,The metabolism of Netupitant can be increased when combined with Rufinamide.,increase,no risk
Rufinamide,Nialamide,The risk or severity of adverse effects can be increased when Rufinamide is combined with Nialamide.,increase,risk
Rufinamide,Nilotinib,The metabolism of Nilotinib can be increased when combined with Rufinamide.,increase,no risk
Rufinamide,Nilvadipine,The metabolism of Nilvadipine can be decreased when combined with Rufinamide.,decrease,no risk
Rufinamide,Nintedanib,The metabolism of Nintedanib can be increased when combined with Rufinamide.,increase,no risk
Rufinamide,Nitrazepam,The risk or severity of adverse effects can be increased when Rufinamide is combined with Nitrazepam.,increase,risk
Rufinamide,Nitrous oxide,The risk or severity of adverse effects can be increased when Rufinamide is combined with Nitrous oxide.,increase,risk
Rufinamide,Nomegestrol,The metabolism of Nomegestrol can be increased when combined with Rufinamide.,increase,no risk
Rufinamide,Nomegestrol acetate,The metabolism of Nomegestrol acetate can be increased when combined with Rufinamide.,increase,no risk
Rufinamide,Nomifensine,The risk or severity of adverse effects can be increased when Rufinamide is combined with Nomifensine.,increase,risk
Rufinamide,Nonoxynol-9,The metabolism of Nonoxynol-9 can be increased when combined with Rufinamide.,increase,no risk
Rufinamide,Norelgestromin,The metabolism of Norelgestromin can be increased when combined with Rufinamide.,increase,no risk
Rufinamide,Norethisterone,The metabolism of Norethisterone can be increased when combined with Rufinamide.,increase,no risk
Rufinamide,Norethynodrel,The metabolism of Norethynodrel can be increased when combined with Rufinamide.,increase,no risk
Rufinamide,Norgestimate,The metabolism of Norgestimate can be increased when combined with Rufinamide.,increase,no risk
Rufinamide,Norgestrel,The metabolism of Norgestrel can be increased when combined with Rufinamide.,increase,no risk
Rufinamide,Normethadone,The risk or severity of adverse effects can be increased when Rufinamide is combined with Normethadone.,increase,risk
Rufinamide,Nortriptyline,The risk or severity of adverse effects can be increased when Rufinamide is combined with Nortriptyline.,increase,risk
Rufinamide,Olanzapine,The risk or severity of adverse effects can be increased when Rufinamide is combined with Olanzapine.,increase,risk
Rufinamide,Olaparib,The metabolism of Olaparib can be increased when combined with Rufinamide.,increase,no risk
Rufinamide,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Rufinamide is combined with Oliceridine.",increase,risk
Rufinamide,Ondansetron,The risk or severity of adverse effects can be increased when Rufinamide is combined with Ondansetron.,increase,risk
Rufinamide,Opium,The risk or severity of adverse effects can be increased when Rufinamide is combined with Opium.,increase,risk
Rufinamide,Orlistat,Orlistat can cause a decrease in the absorption of Rufinamide resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Rufinamide,Orphenadrine,Rufinamide may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Rufinamide,Osimertinib,The metabolism of Osimertinib can be increased when combined with Rufinamide.,increase,no risk
Rufinamide,Oxazepam,The risk or severity of adverse effects can be increased when Rufinamide is combined with Oxazepam.,increase,risk
Rufinamide,Oxcarbazepine,The risk or severity of adverse effects can be increased when Rufinamide is combined with Oxcarbazepine.,increase,risk
Rufinamide,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Rufinamide is combined with Oxetacaine.,increase,risk
Rufinamide,Oxitriptan,The risk or severity of adverse effects can be increased when Rufinamide is combined with Oxitriptan.,increase,risk
Rufinamide,Oxprenolol,The risk or severity of adverse effects can be increased when Rufinamide is combined with Oxprenolol.,increase,risk
Rufinamide,Oxtriphylline,Rufinamide may increase the excretion rate of Oxtriphylline which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Rufinamide,Oxybuprocaine,The risk or severity of adverse effects can be increased when Rufinamide is combined with Oxybuprocaine.,increase,risk
Rufinamide,Oxycodone,The risk or severity of adverse effects can be increased when Rufinamide is combined with Oxycodone.,increase,risk
Rufinamide,Oxymorphone,The risk or severity of adverse effects can be increased when Rufinamide is combined with Oxymorphone.,increase,risk
Rufinamide,Quazepam,The risk or severity of adverse effects can be increased when Rufinamide is combined with Quazepam.,increase,risk
Rufinamide,Quetiapine,The risk or severity of adverse effects can be increased when Rufinamide is combined with Quetiapine.,increase,risk
Rufinamide,Quinidine,The metabolism of Quinidine can be increased when combined with Rufinamide.,increase,no risk
Rufinamide,Quinine,The risk or severity of adverse effects can be increased when Rufinamide is combined with Quinine.,increase,risk
Rufinamide,Quinupramine,The risk or severity of adverse effects can be increased when Rufinamide is combined with Quinupramine.,increase,risk
Rufinamide,Ubrogepant,The serum concentration of Ubrogepant can be decreased when it is combined with Rufinamide.,decrease,no risk
Rufinamide,Ulipristal,The metabolism of Ulipristal can be increased when combined with Rufinamide.,increase,no risk
Rufinamide,Urethane,The risk or severity of adverse effects can be increased when Rufinamide is combined with Urethane.,increase,risk
Rufinamide,Valganciclovir,The therapeutic efficacy of Rufinamide can be decreased when used in combination with Valganciclovir.,decrease,no risk
Rufinamide,Valproic acid,The serum concentration of Rufinamide can be increased when it is combined with Valproic acid.,increase,no risk
Rufinamide,Vandetanib,The metabolism of Vandetanib can be increased when combined with Rufinamide.,increase,no risk
Rufinamide,Vecuronium,The risk or severity of adverse effects can be increased when Rufinamide is combined with Vecuronium.,increase,risk
Rufinamide,Vemurafenib,The metabolism of Vemurafenib can be increased when combined with Rufinamide.,increase,no risk
Rufinamide,Venetoclax,The metabolism of Venetoclax can be increased when combined with Rufinamide.,increase,no risk
Rufinamide,Venlafaxine,The risk or severity of adverse effects can be increased when Rufinamide is combined with Venlafaxine.,increase,risk
Rufinamide,Vigabatrin,The risk or severity of adverse effects can be increased when Rufinamide is combined with Vigabatrin.,increase,risk
Rufinamide,Vilazodone,The risk or severity of adverse effects can be increased when Rufinamide is combined with Vilazodone.,increase,risk
Rufinamide,Viloxazine,The risk or severity of adverse effects can be increased when Rufinamide is combined with Viloxazine.,increase,risk
Rufinamide,Vinblastine,The metabolism of Vinblastine can be increased when combined with Rufinamide.,increase,no risk
Rufinamide,Vincristine,The metabolism of Vincristine can be increased when combined with Rufinamide.,increase,no risk
Rufinamide,Vindesine,The metabolism of Vindesine can be increased when combined with Rufinamide.,increase,no risk
Rufinamide,Vinflunine,The metabolism of Vinflunine can be increased when combined with Rufinamide.,increase,no risk
Rufinamide,Vinorelbine,The metabolism of Vinorelbine can be increased when combined with Rufinamide.,increase,no risk
Rufinamide,Vorapaxar,The metabolism of Vorapaxar can be increased when combined with Rufinamide.,increase,no risk
Rufinamide,Vortioxetine,The risk or severity of adverse effects can be increased when Rufinamide is combined with Vortioxetine.,increase,risk
Rufinamide,Warfarin,The metabolism of Warfarin can be increased when combined with Rufinamide.,increase,no risk
Rufinamide,Yohimbine,The risk or severity of adverse effects can be increased when Rufinamide is combined with Yohimbine.,increase,risk
Rufinamide,Zaleplon,The risk or severity of adverse effects can be increased when Rufinamide is combined with Zaleplon.,increase,risk
Rufinamide,Zanubrutinib,The metabolism of Zanubrutinib can be increased when combined with Rufinamide.,increase,no risk
Rufinamide,Ziconotide,The risk or severity of CNS depression can be increased when Rufinamide is combined with Ziconotide.,increase,risk
Rufinamide,Zimelidine,The risk or severity of adverse effects can be increased when Rufinamide is combined with Zimelidine.,increase,risk
Rufinamide,Ziprasidone,The risk or severity of adverse effects can be increased when Rufinamide is combined with Ziprasidone.,increase,risk
Rufinamide,Zolmitriptan,The risk or severity of adverse effects can be increased when Rufinamide is combined with Zolmitriptan.,increase,risk
Rufinamide,Zolpidem,Rufinamide may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Rufinamide,Zonisamide,The risk or severity of adverse effects can be increased when Rufinamide is combined with Zonisamide.,increase,risk
Rufinamide,Zopiclone,The risk or severity of adverse effects can be increased when Rufinamide is combined with Zopiclone.,increase,risk
Rufinamide,Zotepine,The risk or severity of adverse effects can be increased when Rufinamide is combined with Zotepine.,increase,risk
Rufinamide,Zuclopenthixol,The risk or severity of adverse effects can be increased when Rufinamide is combined with Zuclopenthixol.,increase,risk
Rufinamide,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Rufinamide.,increase,risk
Lasofoxifene,Ospemifene,The risk or severity of adverse effects can be increased when Lasofoxifene is combined with Ospemifene.,increase,risk
Alogliptin,Bexagliflozin,Bexagliflozin may increase the hypoglycemic activities of Alogliptin.,increase,no risk
Alogliptin,Bicisate,Alogliptin may decrease the excretion rate of Bicisate which could result in a higher serum level.,decrease,no risk
Alogliptin,Bimekizumab,The metabolism of Alogliptin can be increased when combined with Bimekizumab.,increase,no risk
Alogliptin,Biperiden,The metabolism of Alogliptin can be decreased when combined with Biperiden.,decrease,no risk
Alogliptin,Bismuth subgallate,Alogliptin may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Alogliptin,Bismuth subsalicylate,Bismuth subsalicylate may increase the hypoglycemic activities of Alogliptin.,increase,no risk
Alogliptin,Bisoprolol,The therapeutic efficacy of Alogliptin can be increased when used in combination with Bisoprolol.,increase,no risk
Alogliptin,Bisoxatin,Alogliptin may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,decrease,no risk
Alogliptin,Bleomycin,Bleomycin may decrease the excretion rate of Alogliptin which could result in a higher serum level.,decrease,no risk
Alogliptin,Boceprevir,The metabolism of Alogliptin can be decreased when combined with Boceprevir.,decrease,no risk
Alogliptin,Bortezomib,The metabolism of Alogliptin can be decreased when combined with Bortezomib.,decrease,no risk
Alogliptin,Bosentan,The therapeutic efficacy of Alogliptin can be increased when used in combination with Bosentan.,increase,no risk
Alogliptin,Brexpiprazole,The therapeutic efficacy of Alogliptin can be decreased when used in combination with Brexpiprazole.,decrease,no risk
Alogliptin,Brivaracetam,Brivaracetam may decrease the excretion rate of Alogliptin which could result in a higher serum level.,decrease,no risk
Alogliptin,Bromazepam,Bromazepam may decrease the excretion rate of Alogliptin which could result in a higher serum level.,decrease,no risk
Alogliptin,Bromocriptine,The risk or severity of hypoglycemia can be increased when Bromocriptine is combined with Alogliptin.,increase,risk
Alogliptin,Bromotheophylline,Bromotheophylline may increase the excretion rate of Alogliptin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Alogliptin,Budesonide,The risk or severity of hyperglycemia can be increased when Budesonide is combined with Alogliptin.,increase,risk
Alogliptin,Bumadizone,Bumadizone may decrease the excretion rate of Alogliptin which could result in a higher serum level.,decrease,no risk
Alogliptin,Bumetanide,The therapeutic efficacy of Alogliptin can be decreased when used in combination with Bumetanide.,decrease,no risk
Alogliptin,Bupivacaine,The metabolism of Alogliptin can be decreased when combined with Bupivacaine.,decrease,no risk
Alogliptin,Buprenorphine,The metabolism of Alogliptin can be decreased when combined with Buprenorphine.,decrease,no risk
Alogliptin,Bupropion,The metabolism of Alogliptin can be decreased when combined with Bupropion.,decrease,no risk
Alogliptin,Buserelin,The therapeutic efficacy of Alogliptin can be decreased when used in combination with Buserelin.,decrease,no risk
Alogliptin,Buspirone,Buspirone may decrease the excretion rate of Alogliptin which could result in a higher serum level.,decrease,no risk
Alogliptin,Butabarbital,Butabarbital may decrease the excretion rate of Alogliptin which could result in a higher serum level.,decrease,no risk
Alogliptin,Butriptyline,Butriptyline may decrease the hypoglycemic activities of Alogliptin.,decrease,no risk
Alogliptin,Gabapentin enacarbil,The metabolism of Alogliptin can be decreased when combined with Fusidic acid.,decrease,no risk
Alogliptin,Gadobenic acid,Alogliptin may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Alogliptin,Gadodiamide,Gadobenic acid may decrease the excretion rate of Alogliptin which could result in a higher serum level.,decrease,no risk
Alogliptin,Gadofosveset trisodium,Gadodiamide may decrease the excretion rate of Alogliptin which could result in a higher serum level.,decrease,no risk
Alogliptin,Gadopentetic acid,Alogliptin may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Alogliptin,Gadoteric acid,Gadopentetic acid may decrease the excretion rate of Alogliptin which could result in a higher serum level.,decrease,no risk
Alogliptin,Gadoteridol,Alogliptin may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Alogliptin,Galantamine,Gadoteridol may decrease the excretion rate of Alogliptin which could result in a higher serum level.,decrease,no risk
Alogliptin,Ganciclovir,The metabolism of Alogliptin can be decreased when combined with Galantamine.,decrease,no risk
Alogliptin,Gatifloxacin,Ganciclovir may decrease the excretion rate of Alogliptin which could result in a higher serum level.,decrease,no risk
Alogliptin,Gefapixant,The therapeutic efficacy of Alogliptin can be increased when used in combination with Gatifloxacin.,increase,no risk
Alogliptin,Gefitinib,The therapeutic efficacy of Alogliptin can be increased when used in combination with Gefapixant.,increase,no risk
Alogliptin,Gemcitabine,The metabolism of Alogliptin can be decreased when combined with Gefitinib.,decrease,no risk
Alogliptin,Gemfibrozil,Gemcitabine may decrease the excretion rate of Alogliptin which could result in a higher serum level.,decrease,no risk
Alogliptin,Gemifloxacin,Gemfibrozil may decrease the excretion rate of Alogliptin which could result in a higher serum level.,decrease,no risk
Alogliptin,Gentamicin,The therapeutic efficacy of Alogliptin can be increased when used in combination with Gemifloxacin.,increase,no risk
Alogliptin,Gimeracil,Alogliptin may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Alogliptin,Givosiran,Alogliptin may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Alogliptin,Gliclazide,The serum concentration of Alogliptin can be increased when it is combined with Givosiran.,increase,no risk
Alogliptin,Glimepiride,Alogliptin may increase the hypoglycemic activities of Gliclazide.,increase,no risk
Alogliptin,Glipizide,Alogliptin may increase the hypoglycemic activities of Glimepiride.,increase,no risk
Alogliptin,Gliquidone,Alogliptin may increase the hypoglycemic activities of Glipizide.,increase,no risk
Alogliptin,Glofitamab,Alogliptin may increase the hypoglycemic activities of Gliquidone.,increase,no risk
Alogliptin,Glyburide,The serum concentration of Alogliptin can be increased when it is combined with Glofitamab.,increase,no risk
Alogliptin,Glycerol phenylbutyrate,Alogliptin may increase the hypoglycemic activities of Glyburide.,increase,no risk
Alogliptin,Glymidine,The metabolism of Alogliptin can be decreased when combined with Glycerol phenylbutyrate.,decrease,no risk
Alogliptin,Golimumab,The therapeutic efficacy of Alogliptin can be increased when used in combination with Glymidine.,increase,no risk
Alogliptin,Golodirsen,The metabolism of Alogliptin can be increased when combined with Golimumab.,increase,no risk
Alogliptin,Goserelin,Alogliptin may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Alogliptin,Grepafloxacin,The therapeutic efficacy of Alogliptin can be decreased when used in combination with Goserelin.,decrease,no risk
Alogliptin,Guanethidine,The therapeutic efficacy of Alogliptin can be increased when used in combination with Grepafloxacin.,increase,no risk
Alogliptin,Guanfacine,Guanethidine may decrease the excretion rate of Alogliptin which could result in a higher serum level.,decrease,no risk
Alogliptin,Halcinonide,Guanfacine may decrease the excretion rate of Alogliptin which could result in a higher serum level.,decrease,no risk
Alogliptin,Halofantrine,The risk or severity of hyperglycemia can be increased when Halcinonide is combined with Alogliptin.,increase,risk
Alogliptin,Haloperidol,The metabolism of Alogliptin can be decreased when combined with Halofantrine.,decrease,no risk
Alogliptin,Histrelin,The serum concentration of Haloperidol can be increased when it is combined with Alogliptin.,increase,no risk
Alogliptin,Hydralazine,The therapeutic efficacy of Alogliptin can be decreased when used in combination with Histrelin.,decrease,no risk
Alogliptin,Hydrochlorothiazide,Hydralazine may decrease the excretion rate of Alogliptin which could result in a higher serum level.,decrease,no risk
Alogliptin,Hydrocortisone,The therapeutic efficacy of Alogliptin can be decreased when used in combination with Hydrochlorothiazide.,decrease,no risk
Alogliptin,Hydrocortisone acetate,The risk or severity of hyperglycemia can be increased when Hydrocortisone is combined with Alogliptin.,increase,risk
Alogliptin,Hydrocortisone butyrate,The risk or severity of hyperglycemia can be increased when Hydrocortisone acetate is combined with Alogliptin.,increase,risk
Alogliptin,Hydrocortisone cypionate,The risk or severity of hyperglycemia can be increased when Hydrocortisone butyrate is combined with Alogliptin.,increase,risk
Alogliptin,Hydrocortisone probutate,The risk or severity of hyperglycemia can be increased when Hydrocortisone cypionate is combined with Alogliptin.,increase,risk
Alogliptin,Hydrocortisone succinate,The risk or severity of hyperglycemia can be increased when Hydrocortisone probutate is combined with Alogliptin.,increase,risk
Alogliptin,Hydrocortisone valerate,The risk or severity of hyperglycemia can be increased when Hydrocortisone succinate is combined with Alogliptin.,increase,risk
Alogliptin,Hydroflumethiazide,The risk or severity of hyperglycemia can be increased when Hydrocortisone valerate is combined with Alogliptin.,increase,risk
Alogliptin,Hydromorphone,The therapeutic efficacy of Alogliptin can be decreased when used in combination with Hydroflumethiazide.,decrease,no risk
Alogliptin,Hydroxocobalamin,Hydromorphone may decrease the excretion rate of Alogliptin which could result in a higher serum level.,decrease,no risk
Alogliptin,Hydroxychloroquine,Hydroxocobalamin may decrease the excretion rate of Alogliptin which could result in a higher serum level.,decrease,no risk
Alogliptin,Hydroxyethyl Starch,The therapeutic efficacy of Alogliptin can be increased when used in combination with Hydroxychloroquine.,increase,no risk
Alogliptin,Hydroxyprogesterone caproate,Alogliptin may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Alogliptin,Hydroxyzine,The therapeutic efficacy of Alogliptin can be decreased when used in combination with Hydroxyprogesterone caproate.,decrease,no risk
Alogliptin,Kanamycin,Alogliptin may decrease the excretion rate of Ixazomib which could result in a higher serum level.,decrease,no risk
Alogliptin,Ketamine,Alogliptin may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Alogliptin,Ketazolam,Ketamine may decrease the excretion rate of Alogliptin which could result in a higher serum level.,decrease,no risk
Alogliptin,Ketoconazole,Ketazolam may decrease the excretion rate of Alogliptin which could result in a higher serum level.,decrease,no risk
Alogliptin,Ketoprofen,The metabolism of Alogliptin can be decreased when combined with Ketoconazole.,decrease,no risk
Alogliptin,Ketorolac,Ketoprofen may decrease the excretion rate of Alogliptin which could result in a higher serum level.,decrease,no risk
Alogliptin,Ketotifen,Ketorolac may decrease the excretion rate of Alogliptin which could result in a higher serum level.,decrease,no risk
Alogliptin,N-acetyltyrosine,Mycophenolic acid may decrease the excretion rate of Alogliptin which could result in a higher serum level.,decrease,no risk
Alogliptin,Nabumetone,Alogliptin may decrease the excretion rate of N-acetyltyrosine which could result in a higher serum level.,decrease,no risk
Alogliptin,Nadolol,Nabumetone may decrease the excretion rate of Alogliptin which could result in a higher serum level.,decrease,no risk
Alogliptin,Naldemedine,The therapeutic efficacy of Alogliptin can be increased when used in combination with Nadolol.,increase,no risk
Alogliptin,Nalidixic acid,Alogliptin may decrease the excretion rate of Naldemedine which could result in a higher serum level.,decrease,no risk
Alogliptin,Nalmefene,The therapeutic efficacy of Alogliptin can be increased when used in combination with Nalidixic acid.,increase,no risk
Alogliptin,Naloxone,Alogliptin may decrease the excretion rate of Nalmefene which could result in a higher serum level.,decrease,no risk
Alogliptin,Nandrolone decanoate,Naloxone may decrease the excretion rate of Alogliptin which could result in a higher serum level.,decrease,no risk
Alogliptin,Nandrolone phenpropionate,Nandrolone decanoate may increase the hypoglycemic activities of Alogliptin.,increase,no risk
Alogliptin,Naproxen,Nandrolone phenpropionate may increase the hypoglycemic activities of Alogliptin.,increase,no risk
Alogliptin,Nateglinide,Naproxen may decrease the excretion rate of Alogliptin which could result in a higher serum level.,decrease,no risk
Alogliptin,Nebivolol,The risk or severity of hypoglycemia can be increased when Nateglinide is combined with Alogliptin.,increase,risk
Alogliptin,Nedaplatin,The therapeutic efficacy of Alogliptin can be increased when used in combination with Nebivolol.,increase,no risk
Alogliptin,Nedocromil,Alogliptin may decrease the excretion rate of Nedaplatin which could result in a higher serum level.,decrease,no risk
Alogliptin,Nefazodone,Nedocromil may decrease the excretion rate of Alogliptin which could result in a higher serum level.,decrease,no risk
Alogliptin,Nelfinavir,The metabolism of Alogliptin can be decreased when combined with Nefazodone.,decrease,no risk
Alogliptin,Neomycin,The metabolism of Alogliptin can be decreased when combined with Nelfinavir.,decrease,no risk
Alogliptin,Netilmicin,Alogliptin may decrease the excretion rate of Neomycin which could result in a higher serum level.,decrease,no risk
Alogliptin,Netupitant,Alogliptin may decrease the excretion rate of Netilmicin which could result in a higher serum level.,decrease,no risk
Alogliptin,Nevirapine,The metabolism of Alogliptin can be decreased when combined with Netupitant.,decrease,no risk
Alogliptin,Niacin,The metabolism of Alogliptin can be decreased when combined with Nevirapine.,decrease,no risk
Alogliptin,Nialamide,The therapeutic efficacy of Alogliptin can be decreased when used in combination with Niacin.,decrease,no risk
Alogliptin,Nicardipine,Nialamide may increase the hypoglycemic activities of Alogliptin.,increase,no risk
Alogliptin,Nicergoline,The metabolism of Alogliptin can be decreased when combined with Nicardipine.,decrease,no risk
Alogliptin,Nicorandil,The metabolism of Alogliptin can be decreased when combined with Nicergoline.,decrease,no risk
Alogliptin,Nifedipine,Alogliptin may decrease the excretion rate of Nicorandil which could result in a higher serum level.,decrease,no risk
Alogliptin,Nilotinib,The risk or severity of hypoglycemia can be increased when Nifedipine is combined with Alogliptin.,increase,risk
Alogliptin,Nilutamide,The metabolism of Alogliptin can be decreased when combined with Nilotinib.,decrease,no risk
Alogliptin,Nilvadipine,Nilutamide may decrease the excretion rate of Alogliptin which could result in a higher serum level.,decrease,no risk
Alogliptin,Nimesulide,The metabolism of Alogliptin can be decreased when combined with Nilvadipine.,decrease,no risk
Alogliptin,Nimodipine,The risk or severity of hypoglycemia can be increased when Nimesulide is combined with Alogliptin.,increase,risk
Alogliptin,Nirogacestat,The risk or severity of hypoglycemia can be increased when Nimodipine is combined with Alogliptin.,increase,risk
Alogliptin,Nisoldipine,The metabolism of Nirogacestat can be decreased when combined with Alogliptin.,decrease,no risk
Alogliptin,Nitrendipine,The risk or severity of hypoglycemia can be increased when Nisoldipine is combined with Alogliptin.,increase,risk
Alogliptin,Nitric Oxide,The risk or severity of hypoglycemia can be increased when Nitrendipine is combined with Alogliptin.,increase,risk
Alogliptin,Nitrofurantoin,Nitric Oxide may decrease the excretion rate of Alogliptin which could result in a higher serum level.,decrease,no risk
Alogliptin,Nitroprusside,Nitrofurantoin may decrease the excretion rate of Alogliptin which could result in a higher serum level.,decrease,no risk
Alogliptin,Norethisterone,Nitroprusside may decrease the excretion rate of Alogliptin which could result in a higher serum level.,decrease,no risk
Alogliptin,Norfloxacin,The therapeutic efficacy of Alogliptin can be decreased when used in combination with Norethisterone.,decrease,no risk
Alogliptin,Norgestimate,The therapeutic efficacy of Alogliptin can be increased when used in combination with Norfloxacin.,increase,no risk
Alogliptin,Nortriptyline,The therapeutic efficacy of Alogliptin can be decreased when used in combination with Norgestimate.,decrease,no risk
Alogliptin,Nylidrin,The metabolism of Nortriptyline can be decreased when combined with Alogliptin.,decrease,no risk
Alogliptin,Octinoxate,The risk or severity of hypoglycemia can be increased when Nylidrin is combined with Alogliptin.,increase,risk
Alogliptin,Octreotide,Alogliptin may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Alogliptin,Ofloxacin,The therapeutic efficacy of Alogliptin can be decreased when used in combination with Octreotide.,decrease,no risk
Alogliptin,Olanzapine,The therapeutic efficacy of Alogliptin can be increased when used in combination with Ofloxacin.,increase,no risk
Alogliptin,Oliceridine,The therapeutic efficacy of Alogliptin can be decreased when used in combination with Olanzapine.,decrease,no risk
Alogliptin,Olsalazine,The metabolism of Oliceridine can be decreased when combined with Alogliptin.,decrease,no risk
Alogliptin,Omaveloxolone,Olsalazine may increase the hypoglycemic activities of Alogliptin.,increase,no risk
Alogliptin,Ondansetron,The serum concentration of Alogliptin can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Alogliptin,Opium,The metabolism of Alogliptin can be decreased when combined with Ondansetron.,decrease,no risk
Alogliptin,Oritavancin,Alogliptin may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Alogliptin,Orphenadrine,The metabolism of Alogliptin can be decreased when combined with Oritavancin.,decrease,no risk
Alogliptin,Oseltamivir,The metabolism of Alogliptin can be decreased when combined with Orphenadrine.,decrease,no risk
Alogliptin,Osilodrostat,Oseltamivir may decrease the excretion rate of Alogliptin which could result in a higher serum level.,decrease,no risk
Alogliptin,Ospemifene,The metabolism of Alogliptin can be decreased when combined with Osilodrostat.,decrease,no risk
Alogliptin,Oxacillin,The metabolism of Alogliptin can be decreased when combined with Ospemifene.,decrease,no risk
Alogliptin,Oxamniquine,Oxacillin may decrease the excretion rate of Alogliptin which could result in a higher serum level.,decrease,no risk
Alogliptin,Oxandrolone,The metabolism of Alogliptin can be decreased when combined with Oxamniquine.,decrease,no risk
Alogliptin,Oxaprozin,Oxandrolone may increase the hypoglycemic activities of Alogliptin.,increase,no risk
Alogliptin,Oxazepam,Oxaprozin may decrease the excretion rate of Alogliptin which could result in a higher serum level.,decrease,no risk
Alogliptin,Oxprenolol,Oxazepam may decrease the excretion rate of Alogliptin which could result in a higher serum level.,decrease,no risk
Alogliptin,Oxybenzone,The therapeutic efficacy of Alogliptin can be increased when used in combination with Oxprenolol.,increase,no risk
Alogliptin,Oxybutynin,Oxybenzone may decrease the excretion rate of Alogliptin which could result in a higher serum level.,decrease,no risk
Alogliptin,Oxycodone,The metabolism of Alogliptin can be decreased when combined with Oxybutynin.,decrease,no risk
Alogliptin,Oxymetholone,The metabolism of Alogliptin can be decreased when combined with Oxycodone.,decrease,no risk
Alogliptin,Oxymorphone,Oxymetholone may increase the hypoglycemic activities of Alogliptin.,increase,no risk
Alogliptin,Oxyphenbutazone,The metabolism of Alogliptin can be decreased when combined with Oxymorphone.,decrease,no risk
Alogliptin,Oxyquinoline,Oxyphenbutazone may decrease the excretion rate of Alogliptin which could result in a higher serum level.,decrease,no risk
Alogliptin,Quetiapine,Pyridoxine may decrease the excretion rate of Alogliptin which could result in a higher serum level.,decrease,no risk
Alogliptin,Quinapril,The therapeutic efficacy of Alogliptin can be decreased when used in combination with Quetiapine.,decrease,no risk
Alogliptin,Quinethazone,The risk or severity of angioedema can be increased when Alogliptin is combined with Quinapril.,increase,risk
Alogliptin,Quinidine,The therapeutic efficacy of Alogliptin can be decreased when used in combination with Quinethazone.,decrease,no risk
Alogliptin,Quinine,The metabolism of Alogliptin can be decreased when combined with Quinidine.,decrease,no risk
Alogliptin,Quinupramine,The metabolism of Alogliptin can be decreased when combined with Quinine.,decrease,no risk
Tapentadol,Gabapentin,Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Gabapentin.,increase,no risk
Tapentadol,Gabapentin enacarbil,Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Gabapentin enacarbil.,increase,no risk
Tapentadol,Gallamine triethiodide,Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Gallamine triethiodide.,increase,no risk
Tapentadol,Ganaxolone,Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Ganaxolone.,increase,no risk
Tapentadol,Gepirone,Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Gepirone.,increase,no risk
Tapentadol,Gilteritinib,The therapeutic efficacy of Tapentadol can be decreased when used in combination with Gilteritinib.,decrease,no risk
Tapentadol,Gluconic Acid,The therapeutic efficacy of Gluconic Acid can be decreased when used in combination with Tapentadol.,decrease,no risk
Tapentadol,Glutethimide,Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Glutethimide.,increase,no risk
Tapentadol,Glycerin,The therapeutic efficacy of Glycerin can be decreased when used in combination with Tapentadol.,decrease,no risk
Tapentadol,Glycopyrronium,The risk or severity of urinary retention and constipation can be increased when Glycopyrronium is combined with Tapentadol.,increase,risk
Tapentadol,Granisetron,Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Granisetron.,increase,no risk
Tapentadol,Guanfacine,Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Guanfacine.,increase,no risk
Tapentadol,Halazepam,Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Halazepam.,increase,no risk
Tapentadol,Haloperidol,Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Haloperidol.,increase,no risk
Tapentadol,Halothane,Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Halothane.,increase,no risk
Tapentadol,Hexafluronium,Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Hexafluronium.,increase,no risk
Tapentadol,Hexocyclium,The risk or severity of urinary retention and constipation can be increased when Hexocyclium is combined with Tapentadol.,increase,risk
Tapentadol,Homatropine,The risk or severity of urinary retention and constipation can be increased when Homatropine is combined with Tapentadol.,increase,risk
Tapentadol,Homatropine methylbromide,The risk or severity of urinary retention and constipation can be increased when Homatropine methylbromide is combined with Tapentadol.,increase,risk
Tapentadol,Hydrochlorothiazide,The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with Tapentadol.,decrease,no risk
Tapentadol,Hydrocodone,Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Tapentadol,Hydroflumethiazide,The therapeutic efficacy of Hydroflumethiazide can be decreased when used in combination with Tapentadol.,decrease,no risk
Tapentadol,Hydromorphone,Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Hydromorphone.,increase,no risk
Tapentadol,Hydroxyamphetamine,The risk or severity of serotonin syndrome can be increased when Hydroxyamphetamine is combined with Tapentadol.,increase,risk
Tapentadol,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Tapentadol.,increase,no risk
Tapentadol,Hyoscyamine,The risk or severity of urinary retention and constipation can be increased when Hyoscyamine is combined with Tapentadol.,increase,risk
Tapentadol,Ketamine,Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Ketamine.,increase,no risk
Tapentadol,Ketazolam,Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Ketazolam.,increase,no risk
Tapentadol,Nabilone,Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Nabilone.,increase,no risk
Tapentadol,Nalbuphine,The therapeutic efficacy of Tapentadol can be decreased when used in combination with Nalbuphine.,decrease,no risk
Tapentadol,Naldemedine,The therapeutic efficacy of Tapentadol can be decreased when used in combination with Naldemedine.,decrease,no risk
Tapentadol,Nalmefene,The therapeutic efficacy of Tapentadol can be decreased when used in combination with Nalmefene.,decrease,no risk
Tapentadol,Naloxegol,The risk or severity of adverse effects can be increased when Tapentadol is combined with Naloxegol.,increase,risk
Tapentadol,Naloxone,The therapeutic efficacy of Tapentadol can be decreased when used in combination with Naloxone.,decrease,no risk
Tapentadol,Naltrexone,The risk or severity of serotonin syndrome can be increased when Naltrexone is combined with Tapentadol.,increase,risk
Tapentadol,Naphazoline,Naphazoline may increase the central nervous system depressant (CNS depressant) activities of Tapentadol.,increase,no risk
Tapentadol,Naratriptan,Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Naratriptan.,increase,no risk
Tapentadol,Nefazodone,Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Nefazodone.,increase,no risk
Tapentadol,Nialamide,The risk or severity of serotonin syndrome can be increased when Nialamide is combined with Tapentadol.,increase,risk
Tapentadol,Nicardipine,The risk or severity of urinary retention and constipation can be increased when Nicardipine is combined with Tapentadol.,increase,risk
Tapentadol,Nitrazepam,Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Nitrazepam.,increase,no risk
Tapentadol,Nitrous oxide,Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Nitrous oxide.,increase,no risk
Tapentadol,Nomifensine,Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Nomifensine.,increase,no risk
Tapentadol,Normethadone,Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Normethadone.,increase,no risk
Tapentadol,Nortriptyline,Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Nortriptyline.,increase,no risk
Tapentadol,Olanzapine,Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Olanzapine.,increase,no risk
Tapentadol,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Tapentadol is combined with Oliceridine.",increase,risk
Tapentadol,Ondansetron,Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Ondansetron.,increase,no risk
Tapentadol,Opium,Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Opium.,increase,no risk
Tapentadol,Orphenadrine,Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Tapentadol,Oxazepam,Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Oxazepam.,increase,no risk
Tapentadol,Oxcarbazepine,Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Oxcarbazepine.,increase,no risk
Tapentadol,Oxitriptan,Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Oxitriptan.,increase,no risk
Tapentadol,Oxprenolol,Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Oxprenolol.,increase,no risk
Tapentadol,Oxybuprocaine,Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Oxybuprocaine.,increase,no risk
Tapentadol,Oxybutynin,The risk or severity of urinary retention and constipation can be increased when Oxybutynin is combined with Tapentadol.,increase,risk
Tapentadol,Oxycodone,Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Oxycodone.,increase,no risk
Tapentadol,Oxymorphone,Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Oxymorphone.,increase,no risk
Tapentadol,Oxyphencyclimine,The risk or severity of urinary retention and constipation can be increased when Oxyphencyclimine is combined with Tapentadol.,increase,risk
Tapentadol,Oxyphenisatin acetate,The therapeutic efficacy of Oxyphenisatin acetate can be decreased when used in combination with Tapentadol.,decrease,no risk
Tapentadol,Oxyphenonium,The risk or severity of urinary retention and constipation can be increased when Oxyphenonium is combined with Tapentadol.,increase,risk
Tapentadol,Quazepam,Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Quazepam.,increase,no risk
Tapentadol,Quetiapine,Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Quetiapine.,increase,no risk
Tapentadol,Quinethazone,The therapeutic efficacy of Quinethazone can be decreased when used in combination with Tapentadol.,decrease,no risk
Tapentadol,Quinidine,The risk or severity of urinary retention and constipation can be increased when Quinidine is combined with Tapentadol.,increase,risk
Tapentadol,Quinine,Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Quinine.,increase,no risk
Tapentadol,Quinupramine,Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Quinupramine.,increase,no risk
Tapentadol,Umeclidinium,The risk or severity of urinary retention and constipation can be increased when Umeclidinium is combined with Tapentadol.,increase,risk
Tapentadol,Urethane,Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Urethane.,increase,no risk
Tapentadol,Valproate bismuth,The risk or severity of serotonin syndrome can be increased when Valproate bismuth is combined with Tapentadol.,increase,risk
Tapentadol,Valproic acid,Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Valproic acid.,increase,no risk
Tapentadol,Vecuronium,Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Vecuronium.,increase,no risk
Tapentadol,Venlafaxine,Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Venlafaxine.,increase,no risk
Tapentadol,Vigabatrin,Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Vigabatrin.,increase,no risk
Tapentadol,Vilazodone,Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Vilazodone.,increase,no risk
Tapentadol,Viloxazine,Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Viloxazine.,increase,no risk
Tapentadol,Vortioxetine,Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Vortioxetine.,increase,no risk
Tapentadol,Warfarin,The risk or severity of adverse effects can be increased when Tapentadol is combined with Warfarin.,increase,risk
Tapentadol,Yohimbine,Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Yohimbine.,increase,no risk
Tapentadol,Zaleplon,Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Zaleplon.,increase,no risk
Tapentadol,Ziconotide,Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Ziconotide.,increase,no risk
Tapentadol,Zimelidine,Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Zimelidine.,increase,no risk
Tapentadol,Ziprasidone,Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Ziprasidone.,increase,no risk
Tapentadol,Zolmitriptan,Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Zolmitriptan.,increase,no risk
Tapentadol,Zolpidem,Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Tapentadol,Zonisamide,Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Zonisamide.,increase,no risk
Tapentadol,Zopiclone,Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Zopiclone.,increase,no risk
Tapentadol,Zotepine,Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Zotepine.,increase,no risk
Tapentadol,Zuclopenthixol,Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Zuclopenthixol.,increase,no risk
Tapentadol,Zuranolone,Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Zuranolone.,increase,no risk
Hyaluronidase (human recombinant),Quinestrol,The therapeutic efficacy of Hyaluronidase (human recombinant) can be decreased when used in combination with Quinestrol.,decrease,no risk
Hyaluronidase (human recombinant),Ziprasidone,The therapeutic efficacy of Hyaluronidase (human recombinant) can be decreased when used in combination with Ziprasidone.,decrease,no risk
Hyaluronidase (human recombinant),Zuclopenthixol,The therapeutic efficacy of Hyaluronidase (human recombinant) can be decreased when used in combination with Zuclopenthixol.,decrease,no risk
Sugammadex,Bemiparin,The risk or severity of bleeding and hemorrhage can be increased when Bemiparin is combined with Sugammadex.,increase,risk
Sugammadex,Betrixaban,The risk or severity of bleeding and hemorrhage can be increased when Betrixaban is combined with Sugammadex.,increase,risk
Sugammadex,Bivalirudin,The risk or severity of bleeding and hemorrhage can be increased when Bivalirudin is combined with Sugammadex.,increase,risk
Sugammadex,Gestrinone,The serum concentration of Gestrinone can be decreased when it is combined with Sugammadex.,decrease,no risk
Sugammadex,Heparin,The risk or severity of bleeding and hemorrhage can be increased when Heparin is combined with Sugammadex.,increase,risk
Sugammadex,Hydroxyprogesterone caproate,The serum concentration of Hydroxyprogesterone caproate can be decreased when it is combined with Sugammadex.,decrease,no risk
Sugammadex,Nadroparin,The risk or severity of bleeding and hemorrhage can be increased when Nadroparin is combined with Sugammadex.,increase,risk
Sugammadex,Nomegestrol acetate,The serum concentration of Nomegestrol acetate can be decreased when it is combined with Sugammadex.,decrease,no risk
Sugammadex,Norethisterone,The serum concentration of Norethisterone can be decreased when it is combined with Sugammadex.,decrease,no risk
Sugammadex,Norethynodrel,The serum concentration of Norethynodrel can be decreased when it is combined with Sugammadex.,decrease,no risk
Sugammadex,Norgestimate,The serum concentration of Norgestimate can be decreased when it is combined with Sugammadex.,decrease,no risk
Sugammadex,Norgestrel,The serum concentration of Norgestrel can be decreased when it is combined with Sugammadex.,decrease,no risk
Sugammadex,Urokinase,The risk or severity of bleeding and hemorrhage can be increased when Urokinase is combined with Sugammadex.,increase,risk
Sugammadex,Vorapaxar,The risk or severity of bleeding and hemorrhage can be increased when Vorapaxar is combined with Sugammadex.,increase,risk
Sugammadex,Warfarin,The risk or severity of bleeding and hemorrhage can be increased when Warfarin is combined with Sugammadex.,increase,risk
Sugammadex,Ximelagatran,The risk or severity of bleeding and hemorrhage can be increased when Ximelagatran is combined with Sugammadex.,increase,risk
Silodosin,Gemcitabine,The serum concentration of Gemcitabine can be increased when it is combined with Silodosin.,increase,no risk
Silodosin,Gilteritinib,The serum concentration of Gilteritinib can be increased when it is combined with Silodosin.,increase,no risk
Silodosin,Glasdegib,The excretion of Silodosin can be decreased when combined with Glasdegib.,decrease,no risk
Silodosin,Glecaprevir,The excretion of Silodosin can be decreased when combined with Glecaprevir.,decrease,no risk
Silodosin,Glofitamab,The serum concentration of Silodosin can be increased when it is combined with Glofitamab.,increase,no risk
Silodosin,Grazoprevir,The serum concentration of Grazoprevir can be increased when it is combined with Silodosin.,increase,no risk
Silodosin,Guanabenz,The risk or severity of orthostatic hypotension and dizziness can be increased when Guanabenz is combined with Silodosin.,increase,risk
Silodosin,Guanadrel,The risk or severity of orthostatic hypotension and dizziness can be increased when Guanadrel is combined with Silodosin.,increase,risk
Silodosin,Guanethidine,The risk or severity of orthostatic hypotension and dizziness can be increased when Guanethidine is combined with Silodosin.,increase,risk
Silodosin,Guanfacine,The risk or severity of orthostatic hypotension and dizziness can be increased when Guanfacine is combined with Silodosin.,increase,risk
Silodosin,Guanoxan,The risk or severity of orthostatic hypotension and dizziness can be increased when Guanoxan is combined with Silodosin.,increase,risk
Silodosin,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Silodosin.,increase,no risk
Silodosin,Hydralazine,The risk or severity of orthostatic hypotension and dizziness can be increased when Hydralazine is combined with Silodosin.,increase,risk
Silodosin,Hydrochlorothiazide,The risk or severity of orthostatic hypotension and dizziness can be increased when Hydrochlorothiazide is combined with Silodosin.,increase,risk
Silodosin,Hydroflumethiazide,The risk or severity of orthostatic hypotension and dizziness can be increased when Hydroflumethiazide is combined with Silodosin.,increase,risk
Silodosin,Ketoconazole,The excretion of Silodosin can be decreased when combined with Ketoconazole.,decrease,no risk
Silodosin,Nadolol,The risk or severity of orthostatic hypotension and dizziness can be increased when Nadolol is combined with Silodosin.,increase,risk
Silodosin,Naphazoline,The therapeutic efficacy of Naphazoline can be decreased when used in combination with Silodosin.,decrease,no risk
Silodosin,Nebivolol,The risk or severity of orthostatic hypotension and dizziness can be increased when Nebivolol is combined with Silodosin.,increase,risk
Silodosin,Nefazodone,The metabolism of Silodosin can be decreased when combined with Nefazodone.,decrease,no risk
Silodosin,Nelfinavir,The metabolism of Silodosin can be decreased when combined with Nelfinavir.,decrease,no risk
Prasugrel,Benoxaprofen,The risk or severity of bleeding and hemorrhage can be increased when Benoxaprofen is combined with Prasugrel.,increase,risk
Prasugrel,Benserazide,Prasugrel may decrease the excretion rate of Benserazide which could result in a higher serum level.,decrease,no risk
Prasugrel,Benzatropine,Benzatropine may decrease the excretion rate of Prasugrel which could result in a higher serum level.,decrease,no risk
Prasugrel,Benznidazole,Prasugrel may decrease the excretion rate of Benznidazole which could result in a higher serum level.,decrease,no risk
Prasugrel,Benzocaine,The metabolism of Prasugrel can be decreased when combined with Benzocaine.,decrease,no risk
Prasugrel,Benzphetamine,The metabolism of Prasugrel can be decreased when combined with Benzphetamine.,decrease,no risk
Prasugrel,Benzthiazide,Benzthiazide may increase the excretion rate of Prasugrel which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Prasugrel,Benzydamine,The risk or severity of bleeding and hemorrhage can be increased when Benzydamine is combined with Prasugrel.,increase,risk
Prasugrel,Bepotastine,Bepotastine may decrease the excretion rate of Prasugrel which could result in a higher serum level.,decrease,no risk
Prasugrel,Beroctocog alfa,The therapeutic efficacy of Beroctocog alfa can be decreased when used in combination with Prasugrel.,decrease,no risk
Prasugrel,Betamethasone,The metabolism of Prasugrel can be increased when combined with Betamethasone.,increase,no risk
Prasugrel,Betrixaban,The risk or severity of bleeding can be increased when Prasugrel is combined with Betrixaban.,increase,risk
Prasugrel,Bexarotene,The risk or severity of bleeding can be increased when Prasugrel is combined with Bexarotene.,increase,risk
Prasugrel,Bicisate,Prasugrel may decrease the excretion rate of Bicisate which could result in a higher serum level.,decrease,no risk
Prasugrel,Bimekizumab,The metabolism of Prasugrel can be increased when combined with Bimekizumab.,increase,no risk
Prasugrel,Bismuth subgallate,Prasugrel may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Prasugrel,Bismuth subsalicylate,The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Prasugrel.,increase,risk
Prasugrel,Bisoprolol,Bisoprolol may decrease the excretion rate of Prasugrel which could result in a higher serum level.,decrease,no risk
Prasugrel,Bisoxatin,Prasugrel may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,decrease,no risk
Prasugrel,Bivalirudin,The risk or severity of bleeding can be increased when Prasugrel is combined with Bivalirudin.,increase,risk
Prasugrel,Bleomycin,Bleomycin may decrease the excretion rate of Prasugrel which could result in a higher serum level.,decrease,no risk
Prasugrel,Blinatumomab,The risk or severity of bleeding can be increased when Prasugrel is combined with Blinatumomab.,increase,risk
Prasugrel,Bortezomib,The risk or severity of bleeding can be increased when Prasugrel is combined with Bortezomib.,increase,risk
Prasugrel,Bosentan,The metabolism of Prasugrel can be increased when combined with Bosentan.,increase,no risk
Prasugrel,Bosutinib,The risk or severity of bleeding can be increased when Prasugrel is combined with Bosutinib.,increase,risk
Prasugrel,Brivaracetam,The metabolism of Prasugrel can be decreased when combined with Brivaracetam.,decrease,no risk
Prasugrel,Bromazepam,Bromazepam may decrease the excretion rate of Prasugrel which could result in a higher serum level.,decrease,no risk
Prasugrel,Bromotheophylline,Bromotheophylline may increase the excretion rate of Prasugrel which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Prasugrel,Brompheniramine,The metabolism of Prasugrel can be decreased when combined with Brompheniramine.,decrease,no risk
Prasugrel,Budesonide,Budesonide may decrease the excretion rate of Prasugrel which could result in a higher serum level.,decrease,no risk
Prasugrel,Bumadizone,The risk or severity of bleeding and hemorrhage can be increased when Bumadizone is combined with Prasugrel.,increase,risk
Prasugrel,Bumetanide,Bumetanide may increase the excretion rate of Prasugrel which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Prasugrel,Buprenorphine,The metabolism of Prasugrel can be decreased when combined with Buprenorphine.,decrease,no risk
Prasugrel,Bupropion,The metabolism of Prasugrel can be decreased when combined with Bupropion.,decrease,no risk
Prasugrel,Buspirone,Buspirone may decrease the excretion rate of Prasugrel which could result in a higher serum level.,decrease,no risk
Prasugrel,Busulfan,The risk or severity of bleeding can be increased when Prasugrel is combined with Busulfan.,increase,risk
Prasugrel,Butabarbital,Butabarbital may decrease the excretion rate of Prasugrel which could result in a higher serum level.,decrease,no risk
Prasugrel,Gabapentin enacarbil,Prasugrel may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Prasugrel,Gadobenic acid,Gadobenic acid may decrease the excretion rate of Prasugrel which could result in a higher serum level.,decrease,no risk
Prasugrel,Gadodiamide,Gadodiamide may decrease the excretion rate of Prasugrel which could result in a higher serum level.,decrease,no risk
Prasugrel,Gadofosveset trisodium,Prasugrel may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Prasugrel,Gadopentetic acid,Gadopentetic acid may decrease the excretion rate of Prasugrel which could result in a higher serum level.,decrease,no risk
Prasugrel,Gadoteric acid,Prasugrel may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Prasugrel,Gadoteridol,Gadoteridol may decrease the excretion rate of Prasugrel which could result in a higher serum level.,decrease,no risk
Prasugrel,Ganciclovir,Ganciclovir may decrease the excretion rate of Prasugrel which could result in a higher serum level.,decrease,no risk
Prasugrel,Gemcitabine,The risk or severity of bleeding can be increased when Prasugrel is combined with Gemcitabine.,increase,risk
Prasugrel,Gemfibrozil,The metabolism of Prasugrel can be decreased when combined with Gemfibrozil.,decrease,no risk
Prasugrel,Gemtuzumab ozogamicin,The risk or severity of bleeding can be increased when Prasugrel is combined with Gemtuzumab ozogamicin.,increase,risk
Prasugrel,Gentamicin,Prasugrel may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Prasugrel,Gestrinone,The risk or severity of adverse effects can be increased when Gestrinone is combined with Prasugrel.,increase,risk
Prasugrel,Gimeracil,Prasugrel may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Prasugrel,Ginkgo biloba,Ginkgo biloba may increase the anticoagulant activities of Prasugrel.,increase,no risk
Prasugrel,Givosiran,Givosiran may decrease the excretion rate of Prasugrel which could result in a higher serum level.,decrease,no risk
Prasugrel,Gliclazide,The metabolism of Prasugrel can be decreased when combined with Gliclazide.,decrease,no risk
Prasugrel,Glimepiride,The metabolism of Prasugrel can be decreased when combined with Glimepiride.,decrease,no risk
Prasugrel,Glipizide,Glipizide may decrease the excretion rate of Prasugrel which could result in a higher serum level.,decrease,no risk
Prasugrel,Gliquidone,The metabolism of Prasugrel can be decreased when combined with Gliquidone.,decrease,no risk
Prasugrel,Glofitamab,The serum concentration of Prasugrel can be increased when it is combined with Glofitamab.,increase,no risk
Prasugrel,Glucosamine,Glucosamine may increase the antiplatelet activities of Prasugrel.,increase,no risk
Prasugrel,Glyburide,The metabolism of Prasugrel can be decreased when combined with Glyburide.,decrease,no risk
Prasugrel,Glycerol phenylbutyrate,Prasugrel may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Prasugrel,Glycol salicylate,The risk or severity of bleeding and hemorrhage can be increased when Glycol salicylate is combined with Prasugrel.,increase,risk
Prasugrel,Golimumab,The metabolism of Prasugrel can be increased when combined with Golimumab.,increase,no risk
Prasugrel,Golodirsen,Prasugrel may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Prasugrel,Goserelin,Goserelin may decrease the excretion rate of Prasugrel which could result in a higher serum level.,decrease,no risk
Prasugrel,Guanethidine,Guanethidine may decrease the excretion rate of Prasugrel which could result in a higher serum level.,decrease,no risk
Prasugrel,Guanfacine,Guanfacine may decrease the excretion rate of Prasugrel which could result in a higher serum level.,decrease,no risk
Prasugrel,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Prasugrel.,increase,no risk
Prasugrel,Halothane,The metabolism of Prasugrel can be decreased when combined with Halothane.,decrease,no risk
Prasugrel,Hemin,Hemin may increase the anticoagulant activities of Prasugrel.,increase,no risk
Prasugrel,Heparin,The risk or severity of bleeding can be increased when Prasugrel is combined with Heparin.,increase,risk
Prasugrel,Hydralazine,Hydralazine may decrease the excretion rate of Prasugrel which could result in a higher serum level.,decrease,no risk
Prasugrel,Hydrochlorothiazide,Hydrochlorothiazide may increase the excretion rate of Prasugrel which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Prasugrel,Hydrocodone,The metabolism of Prasugrel can be decreased when combined with Hydrocodone.,decrease,no risk
Prasugrel,Hydrocortisone,The metabolism of Prasugrel can be increased when combined with Hydrocortisone.,increase,no risk
Prasugrel,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of Prasugrel which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Prasugrel,Hydromorphone,Hydromorphone may decrease the excretion rate of Prasugrel which could result in a higher serum level.,decrease,no risk
Prasugrel,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Prasugrel which could result in a higher serum level.,decrease,no risk
Prasugrel,Hydroxyethyl Starch,Prasugrel may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Prasugrel,Hydroxyprogesterone caproate,The therapeutic efficacy of Prasugrel can be decreased when used in combination with Hydroxyprogesterone caproate.,decrease,no risk
Prasugrel,Hydroxyurea,The risk or severity of bleeding can be increased when Prasugrel is combined with Hydroxyurea.,increase,risk
Prasugrel,Kanamycin,Prasugrel may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Prasugrel,Ketamine,The metabolism of Prasugrel can be decreased when combined with Ketamine.,decrease,no risk
Prasugrel,Ketazolam,Ketazolam may decrease the excretion rate of Prasugrel which could result in a higher serum level.,decrease,no risk
Prasugrel,Ketoconazole,The metabolism of Prasugrel can be decreased when combined with Ketoconazole.,decrease,no risk
Prasugrel,Ketoprofen,The risk or severity of bleeding and hemorrhage can be increased when Ketoprofen is combined with Prasugrel.,increase,risk
Prasugrel,Ketorolac,The risk or severity of bleeding and hemorrhage can be increased when Ketorolac is combined with Prasugrel.,increase,risk
Eltrombopag,Gadoxetic acid,The excretion of Gadoxetic acid can be decreased when combined with Eltrombopag.,decrease,no risk
Eltrombopag,Gatifloxacin,The metabolism of Eltrombopag can be decreased when combined with Gatifloxacin.,decrease,no risk
Eltrombopag,Gefitinib,Eltrombopag may decrease the excretion rate of Gefitinib which could result in a higher serum level.,decrease,no risk
Eltrombopag,Gemfibrozil,The metabolism of Eltrombopag can be decreased when combined with Gemfibrozil.,decrease,no risk
Eltrombopag,Gemifloxacin,The metabolism of Eltrombopag can be decreased when combined with Gemifloxacin.,decrease,no risk
Eltrombopag,Givosiran,The serum concentration of Eltrombopag can be increased when it is combined with Givosiran.,increase,no risk
Eltrombopag,Glasdegib,The metabolism of Glasdegib can be decreased when combined with Eltrombopag.,decrease,no risk
Eltrombopag,Glecaprevir,Eltrombopag may decrease the excretion rate of Glecaprevir which could result in a higher serum level.,decrease,no risk
Eltrombopag,Glipizide,The metabolism of Glipizide can be decreased when combined with Eltrombopag.,decrease,no risk
Eltrombopag,Glofitamab,The serum concentration of Eltrombopag can be increased when it is combined with Glofitamab.,increase,no risk
Eltrombopag,Glyburide,Eltrombopag may decrease the excretion rate of Glyburide which could result in a higher serum level.,decrease,no risk
Eltrombopag,Golimumab,The metabolism of Eltrombopag can be increased when combined with Golimumab.,increase,no risk
Eltrombopag,Grazoprevir,The excretion of Grazoprevir can be decreased when combined with Eltrombopag.,decrease,no risk
Eltrombopag,Grepafloxacin,The metabolism of Eltrombopag can be decreased when combined with Grepafloxacin.,decrease,no risk
Eltrombopag,Guanabenz,The metabolism of Eltrombopag can be decreased when combined with Guanabenz.,decrease,no risk
Eltrombopag,Halofantrine,The metabolism of Halofantrine can be decreased when combined with Eltrombopag.,decrease,no risk
Eltrombopag,Haloperidol,The metabolism of Eltrombopag can be decreased when combined with Haloperidol.,decrease,no risk
Eltrombopag,Hydrocortisone,The metabolism of Eltrombopag can be increased when combined with Hydrocortisone.,increase,no risk
Eltrombopag,Hydromorphone,The metabolism of Hydromorphone can be decreased when combined with Eltrombopag.,decrease,no risk
Eltrombopag,Hydrotalcite,Hydrotalcite can cause a decrease in the absorption of Eltrombopag resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Eltrombopag,Hydroxychloroquine,The metabolism of Hydroxychloroquine can be decreased when combined with Eltrombopag.,decrease,no risk
Eltrombopag,Kaolin,Kaolin can cause a decrease in the absorption of Eltrombopag resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Eltrombopag,Ketamine,The metabolism of Ketamine can be decreased when combined with Eltrombopag.,decrease,no risk
Eltrombopag,Ketoconazole,The metabolism of Eltrombopag can be decreased when combined with Ketoconazole.,decrease,no risk
Eltrombopag,Ketoprofen,The metabolism of Ketoprofen can be decreased when combined with Eltrombopag.,decrease,no risk
Eltrombopag,Ketorolac,The metabolism of Ketorolac can be decreased when combined with Eltrombopag.,decrease,no risk
Eltrombopag,Nabumetone,The metabolism of Eltrombopag can be decreased when combined with Nabumetone.,decrease,no risk
Eltrombopag,Nafcillin,The metabolism of Eltrombopag can be increased when combined with Nafcillin.,increase,no risk
Eltrombopag,Naldemedine,The metabolism of Naldemedine can be decreased when combined with Eltrombopag.,decrease,no risk
Eltrombopag,Nalidixic acid,The metabolism of Eltrombopag can be decreased when combined with Nalidixic acid.,decrease,no risk
Eltrombopag,Nalmefene,The metabolism of Nalmefene can be decreased when combined with Eltrombopag.,decrease,no risk
Eltrombopag,Naloxone,The metabolism of Naloxone can be decreased when combined with Eltrombopag.,decrease,no risk
Eltrombopag,Naltrexone,The metabolism of Naltrexone can be decreased when combined with Eltrombopag.,decrease,no risk
Eltrombopag,Naproxen,The metabolism of Naproxen can be decreased when combined with Eltrombopag.,decrease,no risk
Eltrombopag,Nateglinide,The metabolism of Nateglinide can be decreased when combined with Eltrombopag.,decrease,no risk
Eltrombopag,Nelfinavir,The metabolism of Eltrombopag can be increased when combined with Nelfinavir.,increase,no risk
Eltrombopag,Nevirapine,The metabolism of Eltrombopag can be decreased when combined with Nevirapine.,decrease,no risk
Eltrombopag,Nicardipine,The metabolism of Eltrombopag can be decreased when combined with Nicardipine.,decrease,no risk
Eltrombopag,Niclosamide,The metabolism of Eltrombopag can be decreased when combined with Niclosamide.,decrease,no risk
Eltrombopag,Nifedipine,The metabolism of Eltrombopag can be decreased when combined with Nifedipine.,decrease,no risk
Eltrombopag,Nilotinib,Eltrombopag may decrease the excretion rate of Nilotinib which could result in a higher serum level.,decrease,no risk
Eltrombopag,Nilutamide,The metabolism of Eltrombopag can be decreased when combined with Nilutamide.,decrease,no risk
Eltrombopag,Nilvadipine,The metabolism of Eltrombopag can be decreased when combined with Nilvadipine.,decrease,no risk
Eltrombopag,Nintedanib,The metabolism of Nintedanib can be decreased when combined with Eltrombopag.,decrease,no risk
Eltrombopag,Nirogacestat,The metabolism of Eltrombopag can be increased when combined with Nirogacestat.,increase,no risk
Eltrombopag,Nitrofurantoin,Eltrombopag may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.,decrease,no risk
Eltrombopag,Norfloxacin,The metabolism of Eltrombopag can be decreased when combined with Norfloxacin.,decrease,no risk
Eltrombopag,Norgestimate,The metabolism of Norgestimate can be decreased when combined with Eltrombopag.,decrease,no risk
Eltrombopag,Obeticholic acid,The metabolism of Eltrombopag can be decreased when combined with Obeticholic acid.,decrease,no risk
Eltrombopag,Olanzapine,The metabolism of Eltrombopag can be decreased when combined with Olanzapine.,decrease,no risk
Eltrombopag,Olodaterol,The metabolism of Olodaterol can be decreased when combined with Eltrombopag.,decrease,no risk
Eltrombopag,Omaveloxolone,The serum concentration of Eltrombopag can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Eltrombopag,Ombitasvir,The metabolism of Ombitasvir can be decreased when combined with Eltrombopag.,decrease,no risk
Eltrombopag,Ondansetron,The metabolism of Eltrombopag can be decreased when combined with Ondansetron.,decrease,no risk
Eltrombopag,Orphenadrine,The metabolism of Eltrombopag can be decreased when combined with Orphenadrine.,decrease,no risk
Eltrombopag,Osilodrostat,The metabolism of Eltrombopag can be decreased when combined with Osilodrostat.,decrease,no risk
Eltrombopag,Osimertinib,The serum concentration of Eltrombopag can be decreased when it is combined with Osimertinib.,decrease,no risk
Eltrombopag,Ouabain,The excretion of Ouabain can be decreased when combined with Eltrombopag.,decrease,no risk
Eltrombopag,Oxaliplatin,Eltrombopag may decrease the excretion rate of Oxaliplatin which could result in a higher serum level.,decrease,no risk
Eltrombopag,Oxazepam,The metabolism of Oxazepam can be decreased when combined with Eltrombopag.,decrease,no risk
Eltrombopag,Oxtriphylline,The metabolism of Eltrombopag can be decreased when combined with Oxtriphylline.,decrease,no risk
Eltrombopag,Oxybutynin,The metabolism of Eltrombopag can be decreased when combined with Oxybutynin.,decrease,no risk
Eltrombopag,Ozanimod,Eltrombopag may decrease the excretion rate of Ozanimod which could result in a higher serum level.,decrease,no risk
Eltrombopag,Quinidine,The metabolism of Eltrombopag can be decreased when combined with Quinidine.,decrease,no risk
Eltrombopag,Quinine,The metabolism of Eltrombopag can be decreased when combined with Quinine.,decrease,no risk
Eltrombopag,Quizartinib,The metabolism of Eltrombopag can be decreased when combined with Quizartinib.,decrease,no risk
Eltrombopag,Ubrogepant,The serum concentration of Ubrogepant can be increased when it is combined with Eltrombopag.,increase,no risk
Eltrombopag,Vadadustat,The serum concentration of Eltrombopag can be increased when it is combined with Vadadustat.,increase,no risk
Eltrombopag,Valdecoxib,The metabolism of Valdecoxib can be decreased when combined with Eltrombopag.,decrease,no risk
Eltrombopag,Valproic acid,The metabolism of Valproic acid can be decreased when combined with Eltrombopag.,decrease,no risk
Eltrombopag,Valsartan,The excretion of Valsartan can be decreased when combined with Eltrombopag.,decrease,no risk
Eltrombopag,Velpatasvir,The metabolism of Velpatasvir can be decreased when combined with Eltrombopag.,decrease,no risk
Eltrombopag,Vemurafenib,The serum concentration of Eltrombopag can be increased when it is combined with Vemurafenib.,increase,no risk
Eltrombopag,Venetoclax,Eltrombopag may decrease the excretion rate of Venetoclax which could result in a higher serum level.,decrease,no risk
Eltrombopag,Verapamil,The metabolism of Eltrombopag can be decreased when combined with Verapamil.,decrease,no risk
Eltrombopag,Vericiguat,The metabolism of Vericiguat can be decreased when combined with Eltrombopag.,decrease,no risk
Eltrombopag,Viloxazine,The metabolism of Eltrombopag can be decreased when combined with Viloxazine.,decrease,no risk
Eltrombopag,Vincristine,Eltrombopag may decrease the excretion rate of Vincristine which could result in a higher serum level.,decrease,no risk
Eltrombopag,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Eltrombopag.,decrease,no risk
Eltrombopag,Voxilaprevir,The metabolism of Voxilaprevir can be decreased when combined with Eltrombopag.,decrease,no risk
Eltrombopag,Warfarin,The metabolism of Eltrombopag can be decreased when combined with Warfarin.,decrease,no risk
Eltrombopag,Zidovudine,The metabolism of Eltrombopag can be increased when combined with Zidovudine.,increase,no risk
Eltrombopag,Zileuton,The metabolism of Eltrombopag can be decreased when combined with Zileuton.,decrease,no risk
Eltrombopag,Zinc,Zinc can cause a decrease in the absorption of Eltrombopag resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Eltrombopag,Zinc acetate,Zinc acetate can cause a decrease in the absorption of Eltrombopag resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Eltrombopag,Zinc ascorbate,Zinc ascorbate can cause a decrease in the absorption of Eltrombopag resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Eltrombopag,Zinc chloride,Zinc chloride can cause a decrease in the absorption of Eltrombopag resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Eltrombopag,Zinc gluconate,Zinc gluconate can cause a decrease in the absorption of Eltrombopag resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Eltrombopag,Zinc oxide,Zinc oxide can cause a decrease in the absorption of Eltrombopag resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Eltrombopag,Zinc sulfate,Zinc sulfate can cause a decrease in the absorption of Eltrombopag resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Eltrombopag,"Zinc sulfate, unspecified form","Zinc sulfate, unspecified form can cause a decrease in the absorption of Eltrombopag resulting in a reduced serum concentration and potentially a decrease in efficacy.",decrease,no risk
Eltrombopag,Zolmitriptan,The metabolism of Eltrombopag can be decreased when combined with Zolmitriptan.,decrease,no risk
Eltrombopag,Zolpidem,The metabolism of Eltrombopag can be decreased when combined with Zolpidem.,decrease,no risk
Eltrombopag,Zonisamide,The metabolism of Zonisamide can be decreased when combined with Eltrombopag.,decrease,no risk
Eltrombopag,Zopiclone,The metabolism of Zopiclone can be decreased when combined with Eltrombopag.,decrease,no risk
Eltrombopag,Zotepine,The metabolism of Zotepine can be decreased when combined with Eltrombopag.,decrease,no risk
Doripenem,Gabapentin enacarbil,Doripenem may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Doripenem,Gadobenic acid,Gadobenic acid may decrease the excretion rate of Doripenem which could result in a higher serum level.,decrease,no risk
Doripenem,Gadodiamide,Gadodiamide may decrease the excretion rate of Doripenem which could result in a higher serum level.,decrease,no risk
Doripenem,Gadofosveset trisodium,Doripenem may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Doripenem,Gadopentetic acid,Gadopentetic acid may decrease the excretion rate of Doripenem which could result in a higher serum level.,decrease,no risk
Doripenem,Gadoteric acid,Doripenem may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Doripenem,Gadoteridol,Gadoteridol may decrease the excretion rate of Doripenem which could result in a higher serum level.,decrease,no risk
Doripenem,Ganciclovir,The excretion of Doripenem can be decreased when combined with Ganciclovir.,decrease,no risk
Doripenem,Gemcitabine,Gemcitabine may decrease the excretion rate of Doripenem which could result in a higher serum level.,decrease,no risk
Doripenem,Gemfibrozil,The excretion of Doripenem can be decreased when combined with Gemfibrozil.,decrease,no risk
Doripenem,Gentamicin,Doripenem may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Doripenem,Gimeracil,Doripenem may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Doripenem,Givosiran,Givosiran may decrease the excretion rate of Doripenem which could result in a higher serum level.,decrease,no risk
Doripenem,Glipizide,Glipizide may decrease the excretion rate of Doripenem which could result in a higher serum level.,decrease,no risk
Doripenem,Glycerol phenylbutyrate,Doripenem may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Doripenem,Golodirsen,Doripenem may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Doripenem,Goserelin,Goserelin may decrease the excretion rate of Doripenem which could result in a higher serum level.,decrease,no risk
Doripenem,Guanethidine,Guanethidine may decrease the excretion rate of Doripenem which could result in a higher serum level.,decrease,no risk
Doripenem,Guanfacine,Guanfacine may decrease the excretion rate of Doripenem which could result in a higher serum level.,decrease,no risk
Doripenem,Guanidine,The excretion of Doripenem can be decreased when combined with Guanidine.,decrease,no risk
Doripenem,Haloperidol,Haloperidol may decrease the excretion rate of Doripenem which could result in a higher serum level.,decrease,no risk
Doripenem,Hydralazine,Hydralazine may decrease the excretion rate of Doripenem which could result in a higher serum level.,decrease,no risk
Doripenem,Hydrochlorothiazide,Hydrochlorothiazide may increase the excretion rate of Doripenem which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Doripenem,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of Doripenem which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Doripenem,Hydromorphone,Hydromorphone may decrease the excretion rate of Doripenem which could result in a higher serum level.,decrease,no risk
Doripenem,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Doripenem which could result in a higher serum level.,decrease,no risk
Doripenem,Hydroxyethyl Starch,Doripenem may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Doripenem,Kanamycin,Doripenem may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Doripenem,Ketamine,Ketamine may decrease the excretion rate of Doripenem which could result in a higher serum level.,decrease,no risk
Doripenem,Ketazolam,Ketazolam may decrease the excretion rate of Doripenem which could result in a higher serum level.,decrease,no risk
Doripenem,Ketoprofen,The excretion of Doripenem can be decreased when combined with Ketoprofen.,decrease,no risk
Doripenem,Ketorolac,Ketorolac may decrease the excretion rate of Doripenem which could result in a higher serum level.,decrease,no risk
Doripenem,N-acetyltyrosine,Doripenem may decrease the excretion rate of N-acetyltyrosine which could result in a higher serum level.,decrease,no risk
Doripenem,Nabumetone,Nabumetone may decrease the excretion rate of Doripenem which could result in a higher serum level.,decrease,no risk
Doripenem,Nadolol,Nadolol may decrease the excretion rate of Doripenem which could result in a higher serum level.,decrease,no risk
Doripenem,Naldemedine,Doripenem may decrease the excretion rate of Naldemedine which could result in a higher serum level.,decrease,no risk
Doripenem,Nalmefene,Doripenem may decrease the excretion rate of Nalmefene which could result in a higher serum level.,decrease,no risk
Doripenem,Naloxone,Naloxone may decrease the excretion rate of Doripenem which could result in a higher serum level.,decrease,no risk
Doripenem,Naproxen,Naproxen may decrease the excretion rate of Doripenem which could result in a higher serum level.,decrease,no risk
Doripenem,Nateglinide,Nateglinide may decrease the excretion rate of Doripenem which could result in a higher serum level.,decrease,no risk
Doripenem,Nedaplatin,Doripenem may decrease the excretion rate of Nedaplatin which could result in a higher serum level.,decrease,no risk
Doripenem,Nedocromil,Nedocromil may decrease the excretion rate of Doripenem which could result in a higher serum level.,decrease,no risk
Doripenem,Nefazodone,Nefazodone may decrease the excretion rate of Doripenem which could result in a higher serum level.,decrease,no risk
Doripenem,Neomycin,Doripenem may decrease the excretion rate of Neomycin which could result in a higher serum level.,decrease,no risk
Doripenem,Netilmicin,Doripenem may decrease the excretion rate of Netilmicin which could result in a higher serum level.,decrease,no risk
Doripenem,Nicorandil,Doripenem may decrease the excretion rate of Nicorandil which could result in a higher serum level.,decrease,no risk
Doripenem,Nifedipine,Nifedipine may decrease the excretion rate of Doripenem which could result in a higher serum level.,decrease,no risk
Doripenem,Nilutamide,Nilutamide may decrease the excretion rate of Doripenem which could result in a higher serum level.,decrease,no risk
Doripenem,Nimesulide,Nimesulide may decrease the excretion rate of Doripenem which could result in a higher serum level.,decrease,no risk
Doripenem,Nisoldipine,Nisoldipine may decrease the excretion rate of Doripenem which could result in a higher serum level.,decrease,no risk
Doripenem,Nitric Oxide,Nitric Oxide may decrease the excretion rate of Doripenem which could result in a higher serum level.,decrease,no risk
Doripenem,Nitrofurantoin,Nitrofurantoin may decrease the excretion rate of Doripenem which could result in a higher serum level.,decrease,no risk
Doripenem,Nitroprusside,Nitroprusside may decrease the excretion rate of Doripenem which could result in a higher serum level.,decrease,no risk
Doripenem,Novobiocin,The excretion of Doripenem can be decreased when combined with Novobiocin.,decrease,no risk
Doripenem,Octinoxate,Doripenem may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Doripenem,Olsalazine,Olsalazine may decrease the excretion rate of Doripenem which could result in a higher serum level.,decrease,no risk
Doripenem,Opium,Doripenem may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Doripenem,Oseltamivir,Oseltamivir may decrease the excretion rate of Doripenem which could result in a higher serum level.,decrease,no risk
Doripenem,Ouabain,The excretion of Doripenem can be decreased when combined with Ouabain.,decrease,no risk
Doripenem,Oxacillin,Oxacillin may decrease the excretion rate of Doripenem which could result in a higher serum level.,decrease,no risk
Doripenem,Oxaprozin,Oxaprozin may decrease the excretion rate of Doripenem which could result in a higher serum level.,decrease,no risk
Doripenem,Oxazepam,Oxazepam may decrease the excretion rate of Doripenem which could result in a higher serum level.,decrease,no risk
Doripenem,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Doripenem is combined with Oxetacaine.,increase,risk
Doripenem,Oxybenzone,Oxybenzone may decrease the excretion rate of Doripenem which could result in a higher serum level.,decrease,no risk
Doripenem,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Doripenem is combined with Oxybuprocaine.,increase,risk
Doripenem,Oxyphenbutazone,Oxyphenbutazone may decrease the excretion rate of Doripenem which could result in a higher serum level.,decrease,no risk
Doripenem,Oxyquinoline,Doripenem may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Doripenem,Oxytetracycline,The excretion of Doripenem can be decreased when combined with Oxytetracycline.,decrease,no risk
Doripenem,Quetiapine,Quetiapine may decrease the excretion rate of Doripenem which could result in a higher serum level.,decrease,no risk
Doripenem,Quinethazone,Quinethazone may increase the excretion rate of Doripenem which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Doripenem,Quinidine,Doripenem may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Doripenem,Vaborbactam,Doripenem may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Doripenem,Vadadustat,The serum concentration of Doripenem can be increased when it is combined with Vadadustat.,increase,no risk
Doripenem,Valaciclovir,Valaciclovir may decrease the excretion rate of Doripenem which could result in a higher serum level.,decrease,no risk
Doripenem,Valbenazine,Doripenem may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
Doripenem,Valdecoxib,Valdecoxib may decrease the excretion rate of Doripenem which could result in a higher serum level.,decrease,no risk
Doripenem,Valganciclovir,Valganciclovir may decrease the excretion rate of Doripenem which could result in a higher serum level.,decrease,no risk
Doripenem,Valproic acid,The serum concentration of Valproic acid can be decreased when it is combined with Doripenem.,decrease,no risk
Doripenem,Vancomycin,Doripenem may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Doripenem,Varenicline,Varenicline may decrease the excretion rate of Doripenem which could result in a higher serum level.,decrease,no risk
Doripenem,Venlafaxine,Venlafaxine may decrease the excretion rate of Doripenem which could result in a higher serum level.,decrease,no risk
Doripenem,Verapamil,Verapamil may decrease the excretion rate of Doripenem which could result in a higher serum level.,decrease,no risk
Doripenem,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Doripenem.,decrease,no risk
Doripenem,Vilanterol,Doripenem may decrease the excretion rate of Vilanterol which could result in a higher serum level.,decrease,no risk
Doripenem,Viloxazine,Doripenem may decrease the excretion rate of Viloxazine which could result in a higher serum level.,decrease,no risk
Doripenem,Vortioxetine,Doripenem may decrease the excretion rate of Vortioxetine which could result in a higher serum level.,decrease,no risk
Doripenem,Warfarin,Doripenem may decrease the excretion rate of Warfarin which could result in a higher serum level.,decrease,no risk
Doripenem,Zaleplon,Zaleplon may decrease the excretion rate of Doripenem which could result in a higher serum level.,decrease,no risk
Doripenem,Zanamivir,Zanamivir may decrease the excretion rate of Doripenem which could result in a higher serum level.,decrease,no risk
Doripenem,Zidovudine,The excretion of Doripenem can be decreased when combined with Zidovudine.,decrease,no risk
Doripenem,Zonisamide,Zonisamide may increase the excretion rate of Doripenem which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tolvaptan,Betamethasone phosphate,The metabolism of Tolvaptan can be increased when combined with Betamethasone phosphate.,increase,no risk
Tolvaptan,Betaxolol,The risk or severity of hyperkalemia can be increased when Betaxolol is combined with Tolvaptan.,increase,risk
Tolvaptan,Betrixaban,The serum concentration of Tolvaptan can be increased when it is combined with Betrixaban.,increase,no risk
Tolvaptan,Bexarotene,The metabolism of Tolvaptan can be increased when combined with Bexarotene.,increase,no risk
Tolvaptan,Bicalutamide,The metabolism of Tolvaptan can be decreased when combined with Bicalutamide.,decrease,no risk
Tolvaptan,Bicisate,Tolvaptan may increase the excretion rate of Bicisate which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tolvaptan,Bifonazole,The metabolism of Tolvaptan can be decreased when combined with Bifonazole.,decrease,no risk
Tolvaptan,Bimekizumab,The metabolism of Tolvaptan can be increased when combined with Bimekizumab.,increase,no risk
Tolvaptan,Binimetinib,The serum concentration of Binimetinib can be increased when it is combined with Tolvaptan.,increase,no risk
Tolvaptan,Bisacodyl,The risk or severity of dehydration can be increased when Tolvaptan is combined with Bisacodyl.,increase,risk
Tolvaptan,Bismuth subgallate,Tolvaptan may increase the excretion rate of Bismuth subgallate which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tolvaptan,Bisoprolol,Tolvaptan may increase the excretion rate of Bisoprolol which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tolvaptan,Bisoxatin,The risk or severity of dehydration can be increased when Tolvaptan is combined with Bisoxatin.,increase,risk
Tolvaptan,Bleomycin,Tolvaptan may increase the excretion rate of Bleomycin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tolvaptan,Boceprevir,The metabolism of Tolvaptan can be decreased when combined with Boceprevir.,decrease,no risk
Tolvaptan,Bortezomib,The serum concentration of Tolvaptan can be increased when it is combined with Bortezomib.,increase,no risk
Tolvaptan,Bosentan,The metabolism of Tolvaptan can be increased when combined with Bosentan.,increase,no risk
Tolvaptan,Bosutinib,The metabolism of Tolvaptan can be decreased when combined with Bosutinib.,decrease,no risk
Tolvaptan,Brentuximab vedotin,The serum concentration of Tolvaptan can be increased when it is combined with Brentuximab vedotin.,increase,no risk
Tolvaptan,Brivaracetam,Tolvaptan may increase the excretion rate of Brivaracetam which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tolvaptan,Bromazepam,Tolvaptan may increase the excretion rate of Bromazepam which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tolvaptan,Budesonide,The metabolism of Tolvaptan can be increased when combined with Budesonide.,increase,no risk
Tolvaptan,Bumadizone,The risk or severity of hyperkalemia can be increased when Tolvaptan is combined with Bumadizone.,increase,risk
Tolvaptan,Bumetanide,Tolvaptan may increase the excretion rate of Bumetanide which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tolvaptan,Buprenorphine,The metabolism of Tolvaptan can be decreased when combined with Buprenorphine.,decrease,no risk
Tolvaptan,Bupropion,Tolvaptan may increase the excretion rate of Bupropion which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tolvaptan,Buspirone,Tolvaptan may increase the excretion rate of Buspirone which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tolvaptan,Butabarbital,Tolvaptan may increase the excretion rate of Butabarbital which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tolvaptan,Butalbital,The metabolism of Tolvaptan can be increased when combined with Butalbital.,increase,no risk
Tolvaptan,Butorphanol,The therapeutic efficacy of Tolvaptan can be decreased when used in combination with Butorphanol.,decrease,no risk
Tolvaptan,Gabapentin enacarbil,Tolvaptan may increase the excretion rate of Gabapentin enacarbil which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tolvaptan,Gadobenic acid,Tolvaptan may increase the excretion rate of Gadobenic acid which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tolvaptan,Gadodiamide,Tolvaptan may increase the excretion rate of Gadodiamide which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tolvaptan,Gadofosveset trisodium,Tolvaptan may increase the excretion rate of Gadofosveset trisodium which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tolvaptan,Gadopentetic acid,Tolvaptan may increase the excretion rate of Gadopentetic acid which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tolvaptan,Gadoteric acid,Tolvaptan may increase the excretion rate of Gadoteric acid which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tolvaptan,Gadoteridol,Tolvaptan may increase the excretion rate of Gadoteridol which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tolvaptan,Ganciclovir,Tolvaptan may increase the excretion rate of Ganciclovir which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tolvaptan,Gemcitabine,Tolvaptan may increase the excretion rate of Gemcitabine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tolvaptan,Gemfibrozil,Tolvaptan may increase the excretion rate of Gemfibrozil which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tolvaptan,Gilteritinib,The metabolism of Tolvaptan can be decreased when combined with Gilteritinib.,decrease,no risk
Tolvaptan,Gimeracil,Tolvaptan may increase the excretion rate of Gimeracil which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tolvaptan,Ginkgo biloba,The metabolism of Tolvaptan can be decreased when combined with Ginkgo biloba.,decrease,no risk
Tolvaptan,Glasdegib,The serum concentration of Tolvaptan can be increased when it is combined with Glasdegib.,increase,no risk
Tolvaptan,Glecaprevir,The serum concentration of Tolvaptan can be increased when it is combined with Glecaprevir.,increase,no risk
Tolvaptan,Glipizide,Tolvaptan may increase the excretion rate of Glipizide which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tolvaptan,Glofitamab,The serum concentration of Tolvaptan can be increased when it is combined with Glofitamab.,increase,no risk
Tolvaptan,Gluconic Acid,The risk or severity of dehydration can be increased when Tolvaptan is combined with Gluconic Acid.,increase,risk
Tolvaptan,Glyburide,The metabolism of Tolvaptan can be decreased when combined with Glyburide.,decrease,no risk
Tolvaptan,Glycerin,The risk or severity of dehydration can be increased when Tolvaptan is combined with Glycerin.,increase,risk
Tolvaptan,Glycerol phenylbutyrate,The metabolism of Tolvaptan can be increased when combined with Glycerol phenylbutyrate.,increase,no risk
Tolvaptan,Golimumab,The metabolism of Tolvaptan can be increased when combined with Golimumab.,increase,no risk
Tolvaptan,Golodirsen,Tolvaptan may increase the excretion rate of Golodirsen which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tolvaptan,Goserelin,Tolvaptan may increase the excretion rate of Goserelin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tolvaptan,Grapefruit,The serum concentration of Tolvaptan can be increased when it is combined with Grapefruit.,increase,no risk
Tolvaptan,Grazoprevir,The serum concentration of Tolvaptan can be increased when it is combined with Grazoprevir.,increase,no risk
Tolvaptan,Griseofulvin,The metabolism of Tolvaptan can be increased when combined with Griseofulvin.,increase,no risk
Tolvaptan,Guanethidine,Tolvaptan may increase the excretion rate of Guanethidine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tolvaptan,Guanfacine,Tolvaptan may increase the excretion rate of Guanfacine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tolvaptan,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Tolvaptan.,increase,no risk
Tolvaptan,Heparin,The risk or severity of hyperkalemia can be increased when Heparin is combined with Tolvaptan.,increase,risk
Tolvaptan,Hydralazine,The serum concentration of Tolvaptan can be increased when it is combined with Hydralazine.,increase,no risk
Tolvaptan,Hydrocodone,The therapeutic efficacy of Tolvaptan can be decreased when used in combination with Hydrocodone.,decrease,no risk
Tolvaptan,Hydrocortamate,The metabolism of Tolvaptan can be increased when combined with Hydrocortamate.,increase,no risk
Tolvaptan,Hydrocortisone,The metabolism of Tolvaptan can be increased when combined with Hydrocortisone.,increase,no risk
Tolvaptan,Hydrocortisone acetate,The metabolism of Tolvaptan can be increased when combined with Hydrocortisone acetate.,increase,no risk
Tolvaptan,Hydrocortisone butyrate,The metabolism of Tolvaptan can be increased when combined with Hydrocortisone butyrate.,increase,no risk
Tolvaptan,Hydrocortisone succinate,The metabolism of Tolvaptan can be increased when combined with Hydrocortisone succinate.,increase,no risk
Tolvaptan,Hydromorphone,Tolvaptan may increase the excretion rate of Hydromorphone which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tolvaptan,Hydroxocobalamin,Tolvaptan may increase the excretion rate of Hydroxocobalamin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tolvaptan,Hydroxyethyl Starch,Tolvaptan may increase the excretion rate of Hydroxyethyl Starch which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tolvaptan,Ketamine,Tolvaptan may increase the excretion rate of Ketamine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tolvaptan,Ketazolam,The serum concentration of Tolvaptan can be increased when it is combined with Ketazolam.,increase,no risk
Tolvaptan,Ketoconazole,The metabolism of Tolvaptan can be decreased when combined with Ketoconazole.,decrease,no risk
Tolvaptan,Ketoprofen,Tolvaptan may increase the excretion rate of Ketoprofen which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tolvaptan,Ketorolac,The risk or severity of hyperkalemia can be increased when Ketorolac is combined with Tolvaptan.,increase,risk
Tolvaptan,N-acetyltyrosine,Tolvaptan may increase the excretion rate of N-acetyltyrosine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tolvaptan,Nabumetone,The risk or severity of hyperkalemia can be increased when Nabumetone is combined with Tolvaptan.,increase,risk
Tolvaptan,Nadolol,Tolvaptan may increase the excretion rate of Nadolol which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tolvaptan,Nadroparin,The risk or severity of hyperkalemia can be increased when Tolvaptan is combined with Nadroparin.,increase,risk
Tolvaptan,Nafcillin,The metabolism of Tolvaptan can be increased when combined with Nafcillin.,increase,no risk
Tolvaptan,Nalbuphine,The therapeutic efficacy of Tolvaptan can be decreased when used in combination with Nalbuphine.,decrease,no risk
Tolvaptan,Naldemedine,Tolvaptan may increase the excretion rate of Naldemedine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tolvaptan,Nalmefene,Tolvaptan may increase the excretion rate of Nalmefene which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tolvaptan,Naloxegol,The therapeutic efficacy of Tolvaptan can be decreased when used in combination with Naloxegol.,decrease,no risk
Tolvaptan,Naloxone,Tolvaptan may increase the excretion rate of Naloxone which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tolvaptan,Naltrexone,The therapeutic efficacy of Tolvaptan can be decreased when used in combination with Naltrexone.,decrease,no risk
Tolvaptan,Naproxen,The risk or severity of hyperkalemia can be increased when Naproxen is combined with Tolvaptan.,increase,risk
Tolvaptan,Nateglinide,Tolvaptan may increase the excretion rate of Nateglinide which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tolvaptan,Nebivolol,The risk or severity of hyperkalemia can be increased when Nebivolol is combined with Tolvaptan.,increase,risk
Tolvaptan,Nedaplatin,Tolvaptan may increase the excretion rate of Nedaplatin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tolvaptan,Nedocromil,Tolvaptan may increase the excretion rate of Nedocromil which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tolvaptan,Nefazodone,The metabolism of Tolvaptan can be decreased when combined with Nefazodone.,decrease,no risk
Tolvaptan,Nelfinavir,The metabolism of Tolvaptan can be decreased when combined with Nelfinavir.,decrease,no risk
Tolvaptan,Neratinib,The serum concentration of Tolvaptan can be increased when it is combined with Neratinib.,increase,no risk
Tolvaptan,Netupitant,The serum concentration of Tolvaptan can be increased when it is combined with Netupitant.,increase,no risk
Tolvaptan,Niacin,The serum concentration of Tolvaptan can be increased when it is combined with Niacin.,increase,no risk
Tolvaptan,Nicardipine,The metabolism of Tolvaptan can be decreased when combined with Nicardipine.,decrease,no risk
Tolvaptan,Nicorandil,Tolvaptan may increase the excretion rate of Nicorandil which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tolvaptan,Nifedipine,Tolvaptan may increase the excretion rate of Nifedipine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tolvaptan,Nilotinib,The metabolism of Tolvaptan can be decreased when combined with Nilotinib.,decrease,no risk
Tolvaptan,Nilutamide,Tolvaptan may increase the excretion rate of Nilutamide which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tolvaptan,Nilvadipine,The metabolism of Tolvaptan can be decreased when combined with Nilvadipine.,decrease,no risk
Tolvaptan,Nimesulide,The risk or severity of hyperkalemia can be increased when Nimesulide is combined with Tolvaptan.,increase,risk
Tolvaptan,Nimodipine,The risk or severity of hyperkalemia can be increased when Nimodipine is combined with Tolvaptan.,increase,risk
Tolvaptan,Nintedanib,The metabolism of Tolvaptan can be decreased when combined with Nintedanib.,decrease,no risk
Tolvaptan,Nirogacestat,The serum concentration of Tolvaptan can be increased when it is combined with Nirogacestat.,increase,no risk
Tolvaptan,Nisoldipine,Tolvaptan may increase the excretion rate of Nisoldipine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tolvaptan,Nitrendipine,The risk or severity of hyperkalemia can be increased when Nitrendipine is combined with Tolvaptan.,increase,risk
Tolvaptan,Nitric Oxide,Tolvaptan may increase the excretion rate of Nitric Oxide which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tolvaptan,Nitrofurantoin,Tolvaptan may increase the excretion rate of Nitrofurantoin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tolvaptan,Nitroprusside,Tolvaptan may increase the excretion rate of Nitroprusside which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tolvaptan,Norepinephrine,The risk or severity of Cardiac Arrhythmia can be increased when Norepinephrine is combined with Tolvaptan.,increase,risk
Tolvaptan,Norethisterone,The metabolism of Tolvaptan can be decreased when combined with Norethisterone.,decrease,no risk
Tolvaptan,Norgestimate,The serum concentration of Tolvaptan can be increased when it is combined with Norgestimate.,increase,no risk
Tolvaptan,Normethadone,The therapeutic efficacy of Tolvaptan can be decreased when used in combination with Normethadone.,decrease,no risk
Tolvaptan,Nortriptyline,The serum concentration of Nortriptyline can be increased when it is combined with Tolvaptan.,increase,no risk
Tolvaptan,Noscapine,The serum concentration of Tolvaptan can be increased when it is combined with Noscapine.,increase,no risk
Tolvaptan,Nylidrin,The risk or severity of hyperkalemia can be increased when Nylidrin is combined with Tolvaptan.,increase,risk
Tolvaptan,Octinoxate,Tolvaptan may increase the excretion rate of Octinoxate which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tolvaptan,Octreotide,The serum concentration of Tolvaptan can be increased when it is combined with Octreotide.,increase,no risk
Tolvaptan,Olaparib,The metabolism of Tolvaptan can be decreased when combined with Olaparib.,decrease,no risk
Tolvaptan,Oliceridine,The therapeutic efficacy of Tolvaptan can be decreased when used in combination with Oliceridine.,decrease,no risk
Tolvaptan,Olmesartan,The risk or severity of hyperkalemia can be increased when Tolvaptan is combined with Olmesartan.,increase,risk
Tolvaptan,Olutasidenib,The therapeutic efficacy of Tolvaptan can be decreased when used in combination with Olutasidenib.,decrease,no risk
Tolvaptan,Omadacycline,The serum concentration of Tolvaptan can be increased when it is combined with Omadacycline.,increase,no risk
Tolvaptan,Omaveloxolone,The serum concentration of Tolvaptan can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Tolvaptan,Ombitasvir,The serum concentration of Tolvaptan can be increased when it is combined with Ombitasvir.,increase,no risk
Tolvaptan,Opium,Tolvaptan may increase the excretion rate of Opium which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tolvaptan,Oritavancin,The metabolism of Tolvaptan can be increased when combined with Oritavancin.,increase,no risk
Tolvaptan,Orphenadrine,The metabolism of Tolvaptan can be decreased when combined with Orphenadrine.,decrease,no risk
Tolvaptan,Oseltamivir,Tolvaptan may increase the excretion rate of Oseltamivir which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tolvaptan,Osilodrostat,The metabolism of Tolvaptan can be decreased when combined with Osilodrostat.,decrease,no risk
Tolvaptan,Osimertinib,The metabolism of Tolvaptan can be decreased when combined with Osimertinib.,decrease,no risk
Tolvaptan,Oxacillin,Tolvaptan may increase the excretion rate of Oxacillin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tolvaptan,Oxaprozin,Tolvaptan may increase the excretion rate of Oxaprozin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tolvaptan,Oxazepam,Tolvaptan may increase the excretion rate of Oxazepam which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tolvaptan,Oxcarbazepine,The metabolism of Tolvaptan can be increased when combined with Oxcarbazepine.,increase,no risk
Tolvaptan,Oxprenolol,The risk or severity of hyperkalemia can be increased when Oxprenolol is combined with Tolvaptan.,increase,risk
Tolvaptan,Oxybenzone,Tolvaptan may increase the excretion rate of Oxybenzone which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tolvaptan,Oxybutynin,The serum concentration of Tolvaptan can be increased when it is combined with Oxybutynin.,increase,no risk
Tolvaptan,Oxycodone,The therapeutic efficacy of Tolvaptan can be decreased when used in combination with Oxycodone.,decrease,no risk
Tolvaptan,Oxymorphone,The therapeutic efficacy of Tolvaptan can be decreased when used in combination with Oxymorphone.,decrease,no risk
Tolvaptan,Oxyphenbutazone,The risk or severity of hyperkalemia can be increased when Oxyphenbutazone is combined with Tolvaptan.,increase,risk
Tolvaptan,Oxyphenisatin acetate,The risk or severity of dehydration can be increased when Tolvaptan is combined with Oxyphenisatin acetate.,increase,risk
Tolvaptan,Oxyquinoline,Tolvaptan may increase the excretion rate of Oxyquinoline which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tolvaptan,Quetiapine,Tolvaptan may increase the excretion rate of Quetiapine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tolvaptan,Quinapril,Tolvaptan may increase the hyperkalemic activities of Quinapril.,increase,no risk
Tolvaptan,Quinidine,The serum concentration of Tolvaptan can be increased when it is combined with Quinidine.,increase,no risk
Tolvaptan,Quinine,The serum concentration of Tolvaptan can be increased when it is combined with Quinine.,increase,no risk
Tolvaptan,Quinupristin,The metabolism of Tolvaptan can be decreased when combined with Quinupristin.,decrease,no risk
Tolvaptan,Quizartinib,The serum concentration of Tolvaptan can be increased when it is combined with Quizartinib.,increase,no risk
Tolvaptan,Ubrogepant,The serum concentration of Tolvaptan can be increased when it is combined with Ubrogepant.,increase,no risk
Tolvaptan,Umbralisib,The serum concentration of Tolvaptan can be increased when it is combined with Umbralisib.,increase,no risk
Tolvaptan,Umeclidinium,The serum concentration of Tolvaptan can be increased when it is combined with Umeclidinium.,increase,no risk
Tolvaptan,Vaborbactam,Tolvaptan may increase the excretion rate of Vaborbactam which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tolvaptan,Vadadustat,The serum concentration of Tolvaptan can be increased when it is combined with Vadadustat.,increase,no risk
Tolvaptan,Valaciclovir,Tolvaptan may increase the excretion rate of Valaciclovir which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tolvaptan,Valbenazine,Tolvaptan may increase the excretion rate of Valbenazine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tolvaptan,Valdecoxib,The risk or severity of hyperkalemia can be increased when Valdecoxib is combined with Tolvaptan.,increase,risk
Tolvaptan,Valganciclovir,Tolvaptan may increase the excretion rate of Valganciclovir which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tolvaptan,Valproic acid,The serum concentration of Tolvaptan can be increased when it is combined with Valproic acid.,increase,no risk
Tolvaptan,Valsartan,The risk or severity of hyperkalemia can be increased when Tolvaptan is combined with Valsartan.,increase,risk
Tolvaptan,Vancomycin,Tolvaptan may increase the excretion rate of Vancomycin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tolvaptan,Vandetanib,The serum concentration of Tolvaptan can be increased when it is combined with Vandetanib.,increase,no risk
Tolvaptan,Vardenafil,The serum concentration of Tolvaptan can be increased when it is combined with Vardenafil.,increase,no risk
Tolvaptan,Varenicline,Tolvaptan may increase the excretion rate of Varenicline which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tolvaptan,Velpatasvir,The serum concentration of Tolvaptan can be increased when it is combined with Velpatasvir.,increase,no risk
Tolvaptan,Vemurafenib,The serum concentration of Tolvaptan can be increased when it is combined with Vemurafenib.,increase,no risk
Tolvaptan,Venetoclax,The serum concentration of Tolvaptan can be increased when it is combined with Venetoclax.,increase,no risk
Tolvaptan,Venlafaxine,Tolvaptan may increase the excretion rate of Venlafaxine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tolvaptan,Verapamil,The serum concentration of Tolvaptan can be increased when it is combined with Verapamil.,increase,no risk
Tolvaptan,Vilanterol,Tolvaptan may increase the excretion rate of Vilanterol which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tolvaptan,Viloxazine,The metabolism of Tolvaptan can be decreased when combined with Viloxazine.,decrease,no risk
Tolvaptan,Vinblastine,The metabolism of Tolvaptan can be increased when combined with Vinblastine.,increase,no risk
Tolvaptan,Vincristine,The serum concentration of Tolvaptan can be increased when it is combined with Vincristine.,increase,no risk
Tolvaptan,Vinflunine,The serum concentration of Vinflunine can be increased when it is combined with Tolvaptan.,increase,no risk
Tolvaptan,Vitamin E,The metabolism of Tolvaptan can be increased when combined with Vitamin E.,increase,no risk
Tolvaptan,Voclosporin,The serum concentration of Tolvaptan can be increased when it is combined with Voclosporin.,increase,no risk
Tolvaptan,Vorapaxar,The serum concentration of Tolvaptan can be increased when it is combined with Vorapaxar.,increase,no risk
Tolvaptan,Voriconazole,The serum concentration of Tolvaptan can be increased when it is combined with Voriconazole.,increase,no risk
Tolvaptan,Vortioxetine,Tolvaptan may increase the excretion rate of Vortioxetine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tolvaptan,Voxelotor,The serum concentration of Tolvaptan can be increased when it is combined with Voxelotor.,increase,no risk
Tolvaptan,Voxilaprevir,The serum concentration of Tolvaptan can be increased when it is combined with Voxilaprevir.,increase,no risk
Tolvaptan,Warfarin,The metabolism of Tolvaptan can be increased when combined with Warfarin.,increase,no risk
Tolvaptan,Zafirlukast,The serum concentration of Tolvaptan can be increased when it is combined with Zafirlukast.,increase,no risk
Tolvaptan,Zaleplon,Tolvaptan may increase the excretion rate of Zaleplon which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tolvaptan,Zanamivir,Tolvaptan may increase the excretion rate of Zanamivir which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tolvaptan,Ziconotide,The risk or severity of CNS depression can be increased when Tolvaptan is combined with Ziconotide.,increase,risk
Tolvaptan,Zimelidine,The metabolism of Tolvaptan can be decreased when combined with Zimelidine.,decrease,no risk
Tolvaptan,Ziprasidone,The metabolism of Tolvaptan can be decreased when combined with Ziprasidone.,decrease,no risk
Tolvaptan,Zofenopril,Tolvaptan may increase the hyperkalemic activities of Zofenopril.,increase,no risk
Tolvaptan,Zonisamide,The serum concentration of Tolvaptan can be increased when it is combined with Zonisamide.,increase,no risk
Tolvaptan,Zuclopenthixol,The metabolism of Tolvaptan can be decreased when combined with Zuclopenthixol.,decrease,no risk
Regadenoson,Bromotheophylline,Bromotheophylline may decrease effectiveness of Regadenoson as a diagnostic agent.,decrease,no risk
Regadenoson,Oxtriphylline,Oxtriphylline may decrease effectiveness of Regadenoson as a diagnostic agent.,decrease,no risk
Ferumoxytol,Gatifloxacin,Ferumoxytol can cause a decrease in the absorption of Gatifloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Ferumoxytol,Gemifloxacin,Ferumoxytol can cause a decrease in the absorption of Gemifloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Ferumoxytol,Grepafloxacin,Ferumoxytol can cause a decrease in the absorption of Grepafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Ferumoxytol,Nalidixic acid,Ferumoxytol can cause a decrease in the absorption of Nalidixic acid resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Ferumoxytol,Norfloxacin,Ferumoxytol can cause a decrease in the absorption of Norfloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Ferumoxytol,Ofloxacin,Ferumoxytol can cause a decrease in the absorption of Ofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Ferumoxytol,Omeprazole,The absorption of Ferumoxytol can be decreased when combined with Omeprazole.,decrease,no risk
Asenapine,Bethanidine,The therapeutic efficacy of Bethanidine can be decreased when used in combination with Asenapine.,decrease,no risk
Asenapine,Bexagliflozin,The therapeutic efficacy of Bexagliflozin can be decreased when used in combination with Asenapine.,decrease,no risk
Asenapine,Bifonazole,Asenapine can cause a decrease in the absorption of Bifonazole resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Asenapine,Bilastine,The risk or severity of QTc prolongation can be increased when Bilastine is combined with Asenapine.,increase,risk
Asenapine,Bimekizumab,The metabolism of Asenapine can be increased when combined with Bimekizumab.,increase,no risk
Asenapine,Binimetinib,The metabolism of Binimetinib can be decreased when combined with Asenapine.,decrease,no risk
Asenapine,Biperiden,The therapeutic efficacy of Biperiden can be decreased when used in combination with Asenapine.,decrease,no risk
Asenapine,Bismuth subcitrate potassium,Asenapine may increase the neurotoxic activities of Bismuth subcitrate potassium.,increase,no risk
Asenapine,Bismuth subgallate,Asenapine may increase the neurotoxic activities of Bismuth subgallate.,increase,no risk
Asenapine,Bismuth subnitrate,Asenapine may increase the neurotoxic activities of Bismuth subnitrate.,increase,no risk
Asenapine,Bisoprolol,Bisoprolol may increase the orthostatic hypotensive activities of Asenapine.,increase,no risk
Asenapine,Boceprevir,The metabolism of Asenapine can be decreased when combined with Boceprevir.,decrease,no risk
Asenapine,Bortezomib,The risk or severity of QTc prolongation can be increased when Bortezomib is combined with Asenapine.,increase,risk
Asenapine,Bosentan,Asenapine may decrease the antihypertensive activities of Bosentan.,decrease,no risk
Asenapine,Bosutinib,Asenapine can cause a decrease in the absorption of Bosutinib resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Asenapine,Botulinum toxin type A,The risk or severity of CNS depression can be increased when Botulinum toxin type A is combined with Asenapine.,increase,risk
Asenapine,Botulinum toxin type B,The risk or severity of CNS depression can be increased when Botulinum toxin type B is combined with Asenapine.,increase,risk
Asenapine,Bretylium,The risk or severity of QTc prolongation can be increased when Bretylium is combined with Asenapine.,increase,risk
Asenapine,Brexanolone,The risk or severity of CNS depression can be increased when Asenapine is combined with Brexanolone.,increase,risk
Asenapine,Brexpiprazole,"Asenapine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Brexpiprazole.",increase,no risk
Asenapine,Brimonidine,Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Asenapine.,increase,no risk
Asenapine,Brivaracetam,The risk or severity of CNS depression can be increased when Brivaracetam is combined with Asenapine.,increase,risk
Asenapine,Bromazepam,The risk or severity of CNS depression can be increased when Bromazepam is combined with Asenapine.,increase,risk
Asenapine,Bromocriptine,"Bromocriptine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Asenapine.",increase,no risk
Asenapine,Bromotheophylline,The metabolism of Bromotheophylline can be decreased when combined with Asenapine.,decrease,no risk
Asenapine,Bromperidol,The risk or severity of CNS depression can be increased when Asenapine is combined with Bromperidol.,increase,risk
Asenapine,Brompheniramine,The risk or severity of QTc prolongation can be increased when Brompheniramine is combined with Asenapine.,increase,risk
Asenapine,Buclizine,The risk or severity of QTc prolongation can be increased when Buclizine is combined with Asenapine.,increase,risk
Asenapine,Budesonide,Asenapine can cause a decrease in the absorption of Budesonide resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Asenapine,Bumadizone,The risk or severity of hypertension can be increased when Asenapine is combined with Bumadizone.,increase,risk
Asenapine,Bupivacaine,The risk or severity of CNS depression can be increased when Bupivacaine is combined with Asenapine.,increase,risk
Asenapine,Buprenorphine,Asenapine may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Asenapine,Bupropion,The risk or severity of CNS depression can be increased when Bupropion is combined with Asenapine.,increase,risk
Asenapine,Buserelin,The risk or severity of QTc prolongation can be increased when Buserelin is combined with Asenapine.,increase,risk
Asenapine,Buspirone,The risk or severity of CNS depression can be increased when Buspirone is combined with Asenapine.,increase,risk
Asenapine,Butabarbital,The risk or severity of CNS depression can be increased when Butabarbital is combined with Asenapine.,increase,risk
Asenapine,Butalbital,The risk or severity of CNS depression can be increased when Butalbital is combined with Asenapine.,increase,risk
Asenapine,Butaperazine,The risk or severity of CNS depression can be increased when Asenapine is combined with Butaperazine.,increase,risk
Asenapine,Butobarbital,The risk or severity of CNS depression can be increased when Butobarbital is combined with Asenapine.,increase,risk
Asenapine,Butorphanol,The risk or severity of CNS depression can be increased when Butorphanol is combined with Asenapine.,increase,risk
Asenapine,Butriptyline,The risk or severity of QTc prolongation can be increased when Butriptyline is combined with Asenapine.,increase,risk
Asenapine,Gabapentin,The risk or severity of CNS depression can be increased when Gabapentin is combined with Asenapine.,increase,risk
Asenapine,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Asenapine is combined with Gabapentin enacarbil.,increase,risk
Asenapine,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Gadobenic acid is combined with Asenapine.,increase,risk
Asenapine,Galantamine,The risk or severity of QTc prolongation can be increased when Galantamine is combined with Asenapine.,increase,risk
Asenapine,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with Asenapine.,increase,risk
Asenapine,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Asenapine is combined with Ganaxolone.",increase,risk
Asenapine,Gatifloxacin,The risk or severity of QTc prolongation can be increased when Gatifloxacin is combined with Asenapine.,increase,risk
Asenapine,Gefitinib,Asenapine can cause a decrease in the absorption of Gefitinib resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Asenapine,Gemfibrozil,The metabolism of Asenapine can be decreased when combined with Gemfibrozil.,decrease,no risk
Asenapine,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Gemifloxacin is combined with Asenapine.,increase,risk
Asenapine,Gepirone,The risk or severity of QTc prolongation can be increased when Gepirone is combined with Asenapine.,increase,risk
Asenapine,Gilteritinib,The therapeutic efficacy of Asenapine can be decreased when used in combination with Gilteritinib.,decrease,no risk
Asenapine,Givosiran,The serum concentration of Asenapine can be increased when it is combined with Givosiran.,increase,no risk
Asenapine,Glasdegib,The risk or severity of QTc prolongation can be increased when Asenapine is combined with Glasdegib.,increase,risk
Asenapine,Gliclazide,The therapeutic efficacy of Gliclazide can be decreased when used in combination with Asenapine.,decrease,no risk
Asenapine,Glimepiride,The therapeutic efficacy of Glimepiride can be decreased when used in combination with Asenapine.,decrease,no risk
Asenapine,Glipizide,The therapeutic efficacy of Glipizide can be decreased when used in combination with Asenapine.,decrease,no risk
Asenapine,Gliquidone,The therapeutic efficacy of Gliquidone can be decreased when used in combination with Asenapine.,decrease,no risk
Asenapine,Glofitamab,The serum concentration of Asenapine can be increased when it is combined with Glofitamab.,increase,no risk
Asenapine,Glutethimide,The risk or severity of CNS depression can be increased when Glutethimide is combined with Asenapine.,increase,risk
Asenapine,Glyburide,The therapeutic efficacy of Glyburide can be decreased when used in combination with Asenapine.,decrease,no risk
Asenapine,Glymidine,The therapeutic efficacy of Glymidine can be decreased when used in combination with Asenapine.,decrease,no risk
Asenapine,Golimumab,The metabolism of Asenapine can be increased when combined with Golimumab.,increase,no risk
Asenapine,Goserelin,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Asenapine.,increase,risk
Asenapine,Granisetron,The risk or severity of QTc prolongation can be increased when Granisetron is combined with Asenapine.,increase,risk
Asenapine,Grepafloxacin,The risk or severity of QTc prolongation can be increased when Grepafloxacin is combined with Asenapine.,increase,risk
Asenapine,Guanabenz,The therapeutic efficacy of Guanabenz can be decreased when used in combination with Asenapine.,decrease,no risk
Asenapine,Guanadrel,Asenapine may decrease the antihypertensive activities of Guanadrel.,decrease,no risk
Asenapine,Guanethidine,Asenapine may decrease the antihypertensive activities of Guanethidine.,decrease,no risk
Asenapine,Guanfacine,The therapeutic efficacy of Guanfacine can be decreased when used in combination with Asenapine.,decrease,no risk
Asenapine,Guanoxan,Asenapine may decrease the antihypertensive activities of Guanoxan.,decrease,no risk
Asenapine,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with Asenapine.,increase,risk
Asenapine,Halofantrine,The risk or severity of QTc prolongation can be increased when Halofantrine is combined with Asenapine.,increase,risk
Asenapine,Haloperidol,The risk or severity of QTc prolongation can be increased when Asenapine is combined with Haloperidol.,increase,risk
Asenapine,Halothane,The risk or severity of CNS depression can be increased when Halothane is combined with Asenapine.,increase,risk
Asenapine,Hexafluronium,The risk or severity of CNS depression can be increased when Hexafluronium is combined with Asenapine.,increase,risk
Asenapine,Histrelin,The risk or severity of QTc prolongation can be increased when Histrelin is combined with Asenapine.,increase,risk
Asenapine,Hydralazine,Asenapine may decrease the antihypertensive activities of Hydralazine.,decrease,no risk
Asenapine,Hydrochlorothiazide,The risk or severity of QTc prolongation can be increased when Hydrochlorothiazide is combined with Asenapine.,increase,risk
Asenapine,Hydrocodone,Asenapine may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Asenapine,Hydroflumethiazide,Asenapine may decrease the antihypertensive activities of Hydroflumethiazide.,decrease,no risk
Asenapine,Hydromorphone,The risk or severity of CNS depression can be increased when Hydromorphone is combined with Asenapine.,increase,risk
Asenapine,Hydroxychloroquine,The risk or severity of QTc prolongation can be increased when Hydroxychloroquine is combined with Asenapine.,increase,risk
Asenapine,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Asenapine is combined with Hydroxyzine.,increase,risk
Asenapine,Hyoscyamine,Asenapine may increase the anticholinergic activities of Hyoscyamine.,increase,no risk
Asenapine,Ketamine,The risk or severity of CNS depression can be increased when Ketamine is combined with Asenapine.,increase,risk
Asenapine,Ketazolam,The risk or severity of CNS depression can be increased when Ketazolam is combined with Asenapine.,increase,risk
Asenapine,Ketoconazole,Asenapine can cause a decrease in the absorption of Ketoconazole resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Asenapine,Ketoprofen,The risk or severity of hypertension can be increased when Ketoprofen is combined with Asenapine.,increase,risk
Asenapine,Ketorolac,The risk or severity of hypertension can be increased when Ketorolac is combined with Asenapine.,increase,risk
Asenapine,Nabilone,Nabilone may increase the central nervous system depressant (CNS depressant) activities of Asenapine.,increase,no risk
Asenapine,Nabumetone,The metabolism of Asenapine can be decreased when combined with Nabumetone.,decrease,no risk
Asenapine,Nadolol,Nadolol may increase the orthostatic hypotensive activities of Asenapine.,increase,no risk
Asenapine,Nafcillin,The metabolism of Asenapine can be increased when combined with Nafcillin.,increase,no risk
Asenapine,Nalbuphine,The risk or severity of CNS depression can be increased when Nalbuphine is combined with Asenapine.,increase,risk
Asenapine,Nalidixic acid,The risk or severity of QTc prolongation can be increased when Nalidixic acid is combined with Asenapine.,increase,risk
Asenapine,Naltrexone,The risk or severity of serotonin syndrome can be increased when Naltrexone is combined with Asenapine.,increase,risk
Asenapine,Naphazoline,The therapeutic efficacy of Naphazoline can be decreased when used in combination with Asenapine.,decrease,no risk
Asenapine,Naproxen,The metabolism of Asenapine can be decreased when combined with Naproxen.,decrease,no risk
Asenapine,Naratriptan,The risk or severity of adverse effects can be increased when Naratriptan is combined with Asenapine.,increase,risk
Asenapine,Nateglinide,The therapeutic efficacy of Nateglinide can be decreased when used in combination with Asenapine.,decrease,no risk
Asenapine,Naxitamab,The risk or severity of hypertension can be increased when Asenapine is combined with Naxitamab.,increase,risk
Asenapine,Nebivolol,The therapeutic efficacy of Nebivolol can be decreased when used in combination with Asenapine.,decrease,no risk
Asenapine,Nefazodone,The metabolism of Asenapine can be decreased when combined with Nefazodone.,decrease,no risk
Asenapine,Nelfinavir,Asenapine can cause a decrease in the absorption of Nelfinavir resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Asenapine,Neomycin,Neomycin may increase the neurotoxic activities of Asenapine.,increase,no risk
Asenapine,Netupitant,The metabolism of Asenapine can be decreased when combined with Netupitant.,decrease,no risk
Asenapine,Nevirapine,The metabolism of Asenapine can be decreased when combined with Nevirapine.,decrease,no risk
Asenapine,Nialamide,The risk or severity of CNS depression can be increased when Nialamide is combined with Asenapine.,increase,risk
Asenapine,Nicardipine,"Nicardipine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Asenapine.",increase,no risk
Asenapine,Nicergoline,"Nicergoline may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Asenapine.",increase,no risk
Asenapine,Niclosamide,The metabolism of Asenapine can be decreased when combined with Niclosamide.,decrease,no risk
Asenapine,Nicorandil,Asenapine may decrease the antihypertensive activities of Nicorandil.,decrease,no risk
Asenapine,Nifedipine,The risk or severity of QTc prolongation can be increased when Nifedipine is combined with Asenapine.,increase,risk
Asenapine,Nilotinib,Asenapine can cause a decrease in the absorption of Nilotinib resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Asenapine,Nilvadipine,The risk or severity of QTc prolongation can be increased when Nilvadipine is combined with Asenapine.,increase,risk
Asenapine,Nimesulide,The risk or severity of hypertension can be increased when Nimesulide is combined with Asenapine.,increase,risk
Asenapine,Nimodipine,The risk or severity of QTc prolongation can be increased when Nimodipine is combined with Asenapine.,increase,risk
Asenapine,Nisoldipine,Asenapine may decrease the antihypertensive activities of Nisoldipine.,decrease,no risk
Asenapine,Nitrazepam,The risk or severity of CNS depression can be increased when Nitrazepam is combined with Asenapine.,increase,risk
Asenapine,Nitrendipine,The risk or severity of QTc prolongation can be increased when Nitrendipine is combined with Asenapine.,increase,risk
Asenapine,Nitroglycerin,Asenapine may decrease the antihypertensive activities of Nitroglycerin.,decrease,no risk
Asenapine,Nitroprusside,Asenapine may decrease the antihypertensive activities of Nitroprusside.,decrease,no risk
Asenapine,Nitrous oxide,The risk or severity of CNS depression can be increased when Asenapine is combined with Nitrous oxide.,increase,risk
Asenapine,Nomifensine,The risk or severity of CNS depression can be increased when Nomifensine is combined with Asenapine.,increase,risk
Asenapine,Norepinephrine,The therapeutic efficacy of Norepinephrine can be decreased when used in combination with Asenapine.,decrease,no risk
Asenapine,Norfloxacin,The risk or severity of QTc prolongation can be increased when Norfloxacin is combined with Asenapine.,increase,risk
Asenapine,Normethadone,The risk or severity of CNS depression can be increased when Asenapine is combined with Normethadone.,increase,risk
Asenapine,Nortriptyline,The serum concentration of Nortriptyline can be increased when it is combined with Asenapine.,increase,no risk
Asenapine,Nylidrin,The therapeutic efficacy of Nylidrin can be decreased when used in combination with Asenapine.,decrease,no risk
Asenapine,Obeticholic acid,The metabolism of Asenapine can be decreased when combined with Obeticholic acid.,decrease,no risk
Asenapine,Octreotide,The risk or severity of QTc prolongation can be increased when Octreotide is combined with Asenapine.,increase,risk
Asenapine,Ofloxacin,The risk or severity of QTc prolongation can be increased when Ofloxacin is combined with Asenapine.,increase,risk
Asenapine,Olanzapine,"Olanzapine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Asenapine.",increase,no risk
Asenapine,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Asenapine is combined with Oliceridine.",increase,risk
Asenapine,Olmesartan,Asenapine may decrease the antihypertensive activities of Olmesartan.,decrease,no risk
Asenapine,Olodaterol,The therapeutic efficacy of Olodaterol can be decreased when used in combination with Asenapine.,decrease,no risk
Asenapine,Omaveloxolone,The serum concentration of Asenapine can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Asenapine,Ondansetron,The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Asenapine.,increase,risk
Asenapine,Opicapone,The therapeutic efficacy of Opicapone can be decreased when used in combination with Asenapine.,decrease,no risk
Asenapine,Opium,The risk or severity of CNS depression can be increased when Asenapine is combined with Opium.,increase,risk
Asenapine,Orciprenaline,The therapeutic efficacy of Orciprenaline can be decreased when used in combination with Asenapine.,decrease,no risk
Asenapine,Orphenadrine,Asenapine may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Asenapine,Osilodrostat,The metabolism of Asenapine can be decreased when combined with Osilodrostat.,decrease,no risk
Asenapine,Osimertinib,The serum concentration of Asenapine can be decreased when it is combined with Osimertinib.,decrease,no risk
Asenapine,Oteseconazole,Asenapine can cause a decrease in the absorption of Oteseconazole resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Asenapine,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Asenapine.,increase,risk
Asenapine,Oxaprozin,The risk or severity of hypertension can be increased when Oxaprozin is combined with Asenapine.,increase,risk
Asenapine,Oxatomide,The risk or severity of QTc prolongation can be increased when Oxatomide is combined with Asenapine.,increase,risk
Asenapine,Oxazepam,The risk or severity of CNS depression can be increased when Oxazepam is combined with Asenapine.,increase,risk
Asenapine,Oxcarbazepine,The risk or severity of CNS depression can be increased when Oxcarbazepine is combined with Asenapine.,increase,risk
Asenapine,Oxitriptan,The risk or severity of CNS depression can be increased when Oxitriptan is combined with Asenapine.,increase,risk
Asenapine,Oxprenolol,Oxprenolol may increase the orthostatic hypotensive activities of Asenapine.,increase,no risk
Asenapine,Oxtriphylline,The metabolism of Asenapine can be decreased when combined with Oxtriphylline.,decrease,no risk
Asenapine,Oxybuprocaine,The risk or severity of CNS depression can be increased when Oxybuprocaine is combined with Asenapine.,increase,risk
Asenapine,Oxycodone,The risk or severity of CNS depression can be increased when Oxycodone is combined with Asenapine.,increase,risk
Asenapine,Oxymetazoline,The therapeutic efficacy of Oxymetazoline can be decreased when used in combination with Asenapine.,decrease,no risk
Asenapine,Oxymorphone,The risk or severity of CNS depression can be increased when Oxymorphone is combined with Asenapine.,increase,risk
Asenapine,Oxyphenbutazone,The risk or severity of hypertension can be increased when Oxyphenbutazone is combined with Asenapine.,increase,risk
Asenapine,Oxytocin,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Asenapine.,increase,risk
Asenapine,Quazepam,The risk or severity of CNS depression can be increased when Quazepam is combined with Asenapine.,increase,risk
Asenapine,Quetiapine,"Quetiapine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Asenapine.",increase,no risk
Asenapine,Quinagolide,The therapeutic efficacy of Quinagolide can be decreased when used in combination with Asenapine.,decrease,no risk
Asenapine,Quinapril,Asenapine may decrease the antihypertensive activities of Quinapril.,decrease,no risk
Asenapine,Quinidine,"Quinidine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Asenapine.",increase,no risk
Asenapine,Quinine,The risk or severity of QTc prolongation can be increased when Quinine is combined with Asenapine.,increase,risk
Asenapine,Quinupramine,The risk or severity of CNS depression can be increased when Asenapine is combined with Quinupramine.,increase,risk
Asenapine,Quizartinib,The risk or severity of QTc prolongation can be increased when Asenapine is combined with Quizartinib.,increase,risk
Asenapine,Udenafil,The risk or severity of hypotension and syncope can be increased when Udenafil is combined with Asenapine.,increase,risk
Asenapine,Urethane,The risk or severity of CNS depression can be increased when Urethane is combined with Asenapine.,increase,risk
Asenapine,Vadadustat,The serum concentration of Asenapine can be increased when it is combined with Vadadustat.,increase,no risk
Asenapine,Valdecoxib,The risk or severity of hypertension can be increased when Valdecoxib is combined with Asenapine.,increase,risk
Asenapine,Valproate bismuth,The risk or severity of serotonin syndrome can be increased when Asenapine is combined with Valproate bismuth.,increase,risk
Asenapine,Valproic acid,The risk or severity of QTc prolongation can be increased when Valproic acid is combined with Asenapine.,increase,risk
Asenapine,Valsartan,Asenapine may decrease the antihypertensive activities of Valsartan.,decrease,no risk
Asenapine,Vandetanib,The risk or severity of QTc prolongation can be increased when Vandetanib is combined with Asenapine.,increase,risk
Asenapine,Vardenafil,The risk or severity of hypotension and syncope can be increased when Vardenafil is combined with Asenapine.,increase,risk
Asenapine,Vecuronium,The risk or severity of CNS depression can be increased when Vecuronium is combined with Asenapine.,increase,risk
Asenapine,Vemurafenib,The risk or severity of QTc prolongation can be increased when Vemurafenib is combined with Asenapine.,increase,risk
Asenapine,Venetoclax,The metabolism of Asenapine can be decreased when combined with Venetoclax.,decrease,no risk
Asenapine,Venlafaxine,The risk or severity of serotonin syndrome can be increased when Asenapine is combined with Venlafaxine.,increase,risk
Asenapine,Verapamil,The metabolism of Asenapine can be decreased when combined with Verapamil.,decrease,no risk
Asenapine,Vernakalant,The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Asenapine.,increase,risk
Asenapine,Vibegron,The therapeutic efficacy of Vibegron can be decreased when used in combination with Asenapine.,decrease,no risk
Asenapine,Vigabatrin,The risk or severity of CNS depression can be increased when Vigabatrin is combined with Asenapine.,increase,risk
Asenapine,Vilanterol,The risk or severity of QTc prolongation and ventricular arrhythmias can be increased when Vilanterol is combined with Asenapine.,increase,risk
Asenapine,Vilazodone,The risk or severity of adverse effects can be increased when Vilazodone is combined with Asenapine.,increase,risk
Asenapine,Vildagliptin,The therapeutic efficacy of Vildagliptin can be decreased when used in combination with Asenapine.,decrease,no risk
Asenapine,Viloxazine,The metabolism of Asenapine can be decreased when combined with Viloxazine.,decrease,no risk
Asenapine,Vincristine,Vincristine may increase the neurotoxic activities of Asenapine.,increase,no risk
Asenapine,Vinorelbine,Vinorelbine may increase the neurotoxic activities of Asenapine.,increase,no risk
Asenapine,Viomycin,Asenapine may increase the neurotoxic activities of Viomycin.,increase,no risk
Asenapine,Voriconazole,The metabolism of Asenapine can be decreased when combined with Voriconazole.,decrease,no risk
Asenapine,Vorinostat,The risk or severity of QTc prolongation can be increased when Vorinostat is combined with Asenapine.,increase,risk
Asenapine,Vortioxetine,The risk or severity of adverse effects can be increased when Vortioxetine is combined with Asenapine.,increase,risk
Asenapine,Voxilaprevir,The metabolism of Voxilaprevir can be decreased when combined with Asenapine.,decrease,no risk
Asenapine,Warfarin,The metabolism of Asenapine can be decreased when combined with Warfarin.,decrease,no risk
Asenapine,Xamoterol,The therapeutic efficacy of Xamoterol can be decreased when used in combination with Asenapine.,decrease,no risk
Asenapine,Xylometazoline,The therapeutic efficacy of Xylometazoline can be decreased when used in combination with Asenapine.,decrease,no risk
Asenapine,Yohimbine,The risk or severity of CNS depression can be increased when Yohimbine is combined with Asenapine.,increase,risk
Asenapine,Zaleplon,The risk or severity of CNS depression can be increased when Zaleplon is combined with Asenapine.,increase,risk
Asenapine,Ziconotide,The risk or severity of CNS depression can be increased when Asenapine is combined with Ziconotide.,increase,risk
Asenapine,Zileuton,The metabolism of Asenapine can be decreased when combined with Zileuton.,decrease,no risk
Asenapine,Zimelidine,The risk or severity of adverse effects can be increased when Asenapine is combined with Zimelidine.,increase,risk
Asenapine,Ziprasidone,The risk or severity of QTc prolongation can be increased when Asenapine is combined with Ziprasidone.,increase,risk
Asenapine,Zofenopril,Asenapine may decrease the antihypertensive activities of Zofenopril.,decrease,no risk
Asenapine,Zolmitriptan,The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Asenapine.,increase,risk
Asenapine,Zolpidem,Asenapine may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Asenapine,Zonisamide,The risk or severity of QTc prolongation can be increased when Zonisamide is combined with Asenapine.,increase,risk
Asenapine,Zopiclone,The risk or severity of adverse effects can be increased when Asenapine is combined with Zopiclone.,increase,risk
Asenapine,Zotepine,The risk or severity of CNS depression can be increased when Asenapine is combined with Zotepine.,increase,risk
Asenapine,Zuclopenthixol,"Zuclopenthixol may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Asenapine.",increase,no risk
Asenapine,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Asenapine.,increase,risk
Vernakalant,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Gadobenic acid.,increase,risk
Vernakalant,Galantamine,The risk or severity of QTc prolongation can be increased when Galantamine is combined with Vernakalant.,increase,risk
Vernakalant,Gatifloxacin,The risk or severity of QTc prolongation can be increased when Gatifloxacin is combined with Vernakalant.,increase,risk
Vernakalant,Gefitinib,The metabolism of Vernakalant can be decreased when combined with Gefitinib.,decrease,no risk
Vernakalant,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Gemifloxacin.,increase,risk
Vernakalant,Gepirone,The risk or severity of QTc prolongation can be increased when Gepirone is combined with Vernakalant.,increase,risk
Vernakalant,Gilteritinib,The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Gilteritinib.,increase,risk
Vernakalant,Givosiran,The serum concentration of Vernakalant can be increased when it is combined with Givosiran.,increase,no risk
Vernakalant,Glasdegib,The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Glasdegib.,increase,risk
Vernakalant,Glycerol phenylbutyrate,The metabolism of Vernakalant can be decreased when combined with Glycerol phenylbutyrate.,decrease,no risk
Vernakalant,Golimumab,The metabolism of Vernakalant can be increased when combined with Golimumab.,increase,no risk
Vernakalant,Goserelin,The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Goserelin.,increase,risk
Vernakalant,Granisetron,The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Granisetron.,increase,risk
Vernakalant,Grepafloxacin,The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Grepafloxacin.,increase,risk
Vernakalant,Halofantrine,The metabolism of Vernakalant can be decreased when combined with Halofantrine.,decrease,no risk
Vernakalant,Haloperidol,The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Haloperidol.,increase,risk
Vernakalant,Histrelin,The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Histrelin.,increase,risk
Vernakalant,Hydrochlorothiazide,The risk or severity of QTc prolongation can be increased when Hydrochlorothiazide is combined with Vernakalant.,increase,risk
Vernakalant,Hydroxychloroquine,The metabolism of Vernakalant can be decreased when combined with Hydroxychloroquine.,decrease,no risk
Vernakalant,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Hydroxyzine.,increase,risk
Vernakalant,Hyoscyamine,Hyoscyamine may increase the arrhythmogenic activities of Vernakalant.,increase,no risk
Vernakalant,Ketoconazole,The metabolism of Vernakalant can be decreased when combined with Ketoconazole.,decrease,no risk
Vernakalant,Nadolol,Nadolol may increase the arrhythmogenic activities of Vernakalant.,increase,no risk
Vernakalant,Nalidixic acid,The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Nalidixic acid.,increase,risk
Vernakalant,Nateglinide,The metabolism of Vernakalant can be decreased when combined with Nateglinide.,decrease,no risk
Vernakalant,Nebivolol,Nebivolol may increase the arrhythmogenic activities of Vernakalant.,increase,no risk
Vernakalant,Nefazodone,The metabolism of Vernakalant can be decreased when combined with Nefazodone.,decrease,no risk
Vernakalant,Nelfinavir,The risk or severity of QTc prolongation can be increased when Nelfinavir is combined with Vernakalant.,increase,risk
Vernakalant,Netupitant,The metabolism of Netupitant can be decreased when combined with Vernakalant.,decrease,no risk
Vernakalant,Nevirapine,The metabolism of Vernakalant can be decreased when combined with Nevirapine.,decrease,no risk
Vernakalant,Niacin,The metabolism of Vernakalant can be decreased when combined with Niacin.,decrease,no risk
Vernakalant,Nicardipine,Nicardipine may increase the arrhythmogenic activities of Vernakalant.,increase,no risk
Vernakalant,Nicergoline,The metabolism of Vernakalant can be decreased when combined with Nicergoline.,decrease,no risk
Vernakalant,Nicorandil,Vernakalant may increase the arrhythmogenic activities of Nicorandil.,increase,no risk
Vernakalant,Nifedipine,Nifedipine may increase the arrhythmogenic activities of Vernakalant.,increase,no risk
Vernakalant,Nilotinib,The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Nilotinib.,increase,risk
Vernakalant,Nilvadipine,Vernakalant may increase the arrhythmogenic activities of Nilvadipine.,increase,no risk
Vernakalant,Nimesulide,Nimesulide may increase the arrhythmogenic activities of Vernakalant.,increase,no risk
Vernakalant,Nimodipine,Nimodipine may increase the arrhythmogenic activities of Vernakalant.,increase,no risk
Vernakalant,Nirogacestat,The metabolism of Nirogacestat can be decreased when combined with Vernakalant.,decrease,no risk
Vernakalant,Nisoldipine,Nisoldipine may increase the arrhythmogenic activities of Vernakalant.,increase,no risk
Vernakalant,Nitrendipine,Nitrendipine may increase the arrhythmogenic activities of Vernakalant.,increase,no risk
Vernakalant,Norfloxacin,The risk or severity of QTc prolongation can be increased when Norfloxacin is combined with Vernakalant.,increase,risk
Vernakalant,Nortriptyline,The metabolism of Nortriptyline can be decreased when combined with Vernakalant.,decrease,no risk
Vernakalant,Nylidrin,Nylidrin may increase the arrhythmogenic activities of Vernakalant.,increase,no risk
Vernakalant,Octreotide,The risk or severity of QTc prolongation can be increased when Octreotide is combined with Vernakalant.,increase,risk
Vernakalant,Ofloxacin,The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Ofloxacin.,increase,risk
Vernakalant,Olanzapine,The risk or severity of QTc prolongation can be increased when Olanzapine is combined with Vernakalant.,increase,risk
Vernakalant,Oliceridine,The metabolism of Oliceridine can be decreased when combined with Vernakalant.,decrease,no risk
Vernakalant,Olodaterol,The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Olodaterol.,increase,risk
Vernakalant,Ondansetron,The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Ondansetron.,increase,risk
Vernakalant,Opium,The metabolism of Opium can be decreased when combined with Vernakalant.,decrease,no risk
Vernakalant,Oritavancin,The metabolism of Vernakalant can be decreased when combined with Oritavancin.,decrease,no risk
Vernakalant,Orphenadrine,The metabolism of Vernakalant can be decreased when combined with Orphenadrine.,decrease,no risk
Vernakalant,Osilodrostat,The metabolism of Vernakalant can be decreased when combined with Osilodrostat.,decrease,no risk
Vernakalant,Ospemifene,The metabolism of Vernakalant can be decreased when combined with Ospemifene.,decrease,no risk
Vernakalant,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Vernakalant.,increase,risk
Vernakalant,Oxamniquine,The metabolism of Vernakalant can be decreased when combined with Oxamniquine.,decrease,no risk
Vernakalant,Oxatomide,The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Oxatomide.,increase,risk
Vernakalant,Oxprenolol,Oxprenolol may increase the arrhythmogenic activities of Vernakalant.,increase,no risk
Vernakalant,Oxybutynin,The metabolism of Vernakalant can be decreased when combined with Oxybutynin.,decrease,no risk
Vernakalant,Oxycodone,The metabolism of Vernakalant can be decreased when combined with Oxycodone.,decrease,no risk
Vernakalant,Oxymorphone,The metabolism of Vernakalant can be decreased when combined with Oxymorphone.,decrease,no risk
Vernakalant,Oxytocin,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Vernakalant.,increase,risk
Vernakalant,Quetiapine,The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Quetiapine.,increase,risk
Vernakalant,Quinidine,Quinidine may increase the arrhythmogenic activities of Vernakalant.,increase,no risk
Vernakalant,Quinine,The metabolism of Vernakalant can be decreased when combined with Quinine.,decrease,no risk
Vernakalant,Quizartinib,The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Quizartinib.,increase,risk
Vernakalant,Umeclidinium,The metabolism of Umeclidinium can be decreased when combined with Vernakalant.,decrease,no risk
Vernakalant,Valbenazine,The metabolism of Valbenazine can be decreased when combined with Vernakalant.,decrease,no risk
Vernakalant,Valproic acid,The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Valproic acid.,increase,risk
Vernakalant,Vandetanib,The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Vandetanib.,increase,risk
Vernakalant,Vardenafil,The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Vernakalant.,increase,risk
Vernakalant,Vemurafenib,The risk or severity of QTc prolongation can be increased when Vemurafenib is combined with Vernakalant.,increase,risk
Vernakalant,Venlafaxine,The metabolism of Vernakalant can be decreased when combined with Venlafaxine.,decrease,no risk
Vernakalant,Verapamil,Verapamil may increase the arrhythmogenic activities of Vernakalant.,increase,no risk
Vernakalant,Vilanterol,The risk or severity of QTc prolongation and ventricular arrhythmias can be increased when Vilanterol is combined with Vernakalant.,increase,risk
Vernakalant,Vilazodone,The metabolism of Vernakalant can be decreased when combined with Vilazodone.,decrease,no risk
Vernakalant,Viloxazine,The metabolism of Vernakalant can be decreased when combined with Viloxazine.,decrease,no risk
Vernakalant,Vinblastine,The metabolism of Vernakalant can be decreased when combined with Vinblastine.,decrease,no risk
Vernakalant,Vinorelbine,The metabolism of Vernakalant can be decreased when combined with Vinorelbine.,decrease,no risk
Vernakalant,Voriconazole,The risk or severity of QTc prolongation can be increased when Voriconazole is combined with Vernakalant.,increase,risk
Vernakalant,Vorinostat,The risk or severity of QTc prolongation can be increased when Vorinostat is combined with Vernakalant.,increase,risk
Vernakalant,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Vernakalant.,decrease,no risk
Vernakalant,Xylometazoline,Vernakalant may increase the arrhythmogenic activities of Xylometazoline.,increase,no risk
Vernakalant,Yohimbine,The metabolism of Vernakalant can be decreased when combined with Yohimbine.,decrease,no risk
Vernakalant,Ziconotide,Vernakalant may increase the arrhythmogenic activities of Ziconotide.,increase,no risk
Vernakalant,Ziprasidone,The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Ziprasidone.,increase,risk
Vernakalant,Zolpidem,The metabolism of Vernakalant can be decreased when combined with Zolpidem.,decrease,no risk
Vernakalant,Zonisamide,Zonisamide may increase the arrhythmogenic activities of Vernakalant.,increase,no risk
Vernakalant,Zuclopenthixol,The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Zuclopenthixol.,increase,risk
Lacosamide,Galantamine,"The risk or severity of ventricular arrhythmias, bradycardia, and heart block can be increased when Galantamine is combined with Lacosamide.",increase,risk
Lacosamide,Gamolenic acid,The therapeutic efficacy of Lacosamide can be decreased when used in combination with Gamolenic acid.,decrease,no risk
Lacosamide,Ganciclovir,The therapeutic efficacy of Lacosamide can be decreased when used in combination with Ganciclovir.,decrease,no risk
Lacosamide,Gemfibrozil,The metabolism of Lacosamide can be decreased when combined with Gemfibrozil.,decrease,no risk
Lacosamide,Gestrinone,The metabolism of Gestrinone can be increased when combined with Lacosamide.,increase,no risk
Lacosamide,Gilteritinib,The metabolism of Gilteritinib can be decreased when combined with Lacosamide.,decrease,no risk
Lacosamide,Ginkgo biloba,The metabolism of Lacosamide can be decreased when combined with Ginkgo biloba.,decrease,no risk
Lacosamide,Glecaprevir,The metabolism of Lacosamide can be decreased when combined with Glecaprevir.,decrease,no risk
Lacosamide,Gliclazide,The metabolism of Lacosamide can be decreased when combined with Gliclazide.,decrease,no risk
Lacosamide,Glimepiride,The metabolism of Lacosamide can be decreased when combined with Glimepiride.,decrease,no risk
Lacosamide,Glipizide,The metabolism of Lacosamide can be decreased when combined with Glipizide.,decrease,no risk
Lacosamide,Gliquidone,The metabolism of Lacosamide can be decreased when combined with Gliquidone.,decrease,no risk
Lacosamide,Glofitamab,The serum concentration of Lacosamide can be increased when it is combined with Glofitamab.,increase,no risk
Lacosamide,Glyburide,The metabolism of Lacosamide can be decreased when combined with Glyburide.,decrease,no risk
Lacosamide,Glycerol phenylbutyrate,The metabolism of Lacosamide can be increased when combined with Glycerol phenylbutyrate.,increase,no risk
Lacosamide,Golimumab,The metabolism of Lacosamide can be increased when combined with Golimumab.,increase,no risk
Lacosamide,Grapefruit,The metabolism of Lacosamide can be decreased when combined with Grapefruit.,decrease,no risk
Lacosamide,Griseofulvin,The metabolism of Lacosamide can be increased when combined with Griseofulvin.,increase,no risk
Lacosamide,Guanfacine,"The risk or severity of ventricular arrhythmias, bradycardia, and heart block can be increased when Guanfacine is combined with Lacosamide.",increase,risk
Lacosamide,Halofantrine,The therapeutic efficacy of Lacosamide can be decreased when used in combination with Halofantrine.,decrease,no risk
Lacosamide,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Lacosamide.,increase,no risk
Lacosamide,Halothane,The metabolism of Lacosamide can be decreased when combined with Halothane.,decrease,no risk
Lacosamide,Hydralazine,The metabolism of Lacosamide can be decreased when combined with Hydralazine.,decrease,no risk
Lacosamide,Hydrocortamate,The metabolism of Lacosamide can be increased when combined with Hydrocortamate.,increase,no risk
Lacosamide,Hydrocortisone,The metabolism of Lacosamide can be increased when combined with Hydrocortisone.,increase,no risk
Lacosamide,Hydrocortisone acetate,The metabolism of Lacosamide can be increased when combined with Hydrocortisone acetate.,increase,no risk
Lacosamide,Hydrocortisone butyrate,The metabolism of Lacosamide can be increased when combined with Hydrocortisone butyrate.,increase,no risk
Lacosamide,Hydrocortisone succinate,The metabolism of Lacosamide can be increased when combined with Hydrocortisone succinate.,increase,no risk
Lacosamide,Hydromorphone,The metabolism of Lacosamide can be decreased when combined with Hydromorphone.,decrease,no risk
Lacosamide,Hydroxychloroquine,The therapeutic efficacy of Lacosamide can be decreased when used in combination with Hydroxychloroquine.,decrease,no risk
Lacosamide,Hydroxyprogesterone caproate,The metabolism of Hydroxyprogesterone caproate can be increased when combined with Lacosamide.,increase,no risk
Lacosamide,Ketamine,The metabolism of Lacosamide can be decreased when combined with Ketamine.,decrease,no risk
Lacosamide,Ketazolam,The metabolism of Lacosamide can be decreased when combined with Ketazolam.,decrease,no risk
Lacosamide,Ketoconazole,The metabolism of Lacosamide can be decreased when combined with Ketoconazole.,decrease,no risk
Lacosamide,Ketorolac,The metabolism of Lacosamide can be decreased when combined with Ketorolac.,decrease,no risk
Lacosamide,Nabilone,The metabolism of Lacosamide can be decreased when combined with Nabilone.,decrease,no risk
Lacosamide,Nabumetone,The metabolism of Lacosamide can be decreased when combined with Nabumetone.,decrease,no risk
Lacosamide,Nadolol,"The risk or severity of ventricular arrhythmias, bradycardia, and heart block can be increased when Nadolol is combined with Lacosamide.",increase,risk
Lacosamide,Nafcillin,The metabolism of Lacosamide can be increased when combined with Nafcillin.,increase,no risk
Lacosamide,Nalidixic acid,The therapeutic efficacy of Lacosamide can be decreased when used in combination with Nalidixic acid.,decrease,no risk
Lacosamide,Naproxen,The metabolism of Lacosamide can be decreased when combined with Naproxen.,decrease,no risk
Lacosamide,Nateglinide,The metabolism of Lacosamide can be decreased when combined with Nateglinide.,decrease,no risk
Lacosamide,Nebivolol,"The risk or severity of ventricular arrhythmias, bradycardia, and heart block can be increased when Nebivolol is combined with Lacosamide.",increase,risk
Lacosamide,Nefazodone,The metabolism of Lacosamide can be decreased when combined with Nefazodone.,decrease,no risk
Lacosamide,Nelfinavir,The metabolism of Lacosamide can be decreased when combined with Nelfinavir.,decrease,no risk
Lacosamide,Neratinib,The metabolism of Neratinib can be decreased when combined with Lacosamide.,decrease,no risk
Lacosamide,Netupitant,The metabolism of Lacosamide can be decreased when combined with Netupitant.,decrease,no risk
Lacosamide,Nevirapine,The metabolism of Lacosamide can be decreased when combined with Nevirapine.,decrease,no risk
Lacosamide,Niacin,The metabolism of Lacosamide can be decreased when combined with Niacin.,decrease,no risk
Lacosamide,Nialamide,The therapeutic efficacy of Lacosamide can be decreased when used in combination with Nialamide.,decrease,no risk
Lacosamide,Nicardipine,The metabolism of Lacosamide can be decreased when combined with Nicardipine.,decrease,no risk
Lacosamide,Niclosamide,The metabolism of Niclosamide can be decreased when combined with Lacosamide.,decrease,no risk
Lacosamide,Nifedipine,"The risk or severity of ventricular arrhythmias, bradycardia, and heart block can be increased when Nifedipine is combined with Lacosamide.",increase,risk
Lacosamide,Nilotinib,The metabolism of Lacosamide can be decreased when combined with Nilotinib.,decrease,no risk
Lacosamide,Nilutamide,The metabolism of Lacosamide can be decreased when combined with Nilutamide.,decrease,no risk
Lacosamide,Nilvadipine,"The risk or severity of ventricular arrhythmias, bradycardia, and heart block can be increased when Nilvadipine is combined with Lacosamide.",increase,risk
Lacosamide,Nimesulide,"The risk or severity of ventricular arrhythmias, bradycardia, and heart block can be increased when Nimesulide is combined with Lacosamide.",increase,risk
Lacosamide,Nimodipine,"The risk or severity of ventricular arrhythmias, bradycardia, and heart block can be increased when Nimodipine is combined with Lacosamide.",increase,risk
Lacosamide,Nintedanib,The metabolism of Nintedanib can be decreased when combined with Lacosamide.,decrease,no risk
Lacosamide,Nirogacestat,The metabolism of Nirogacestat can be decreased when combined with Lacosamide.,decrease,no risk
Lacosamide,Nisoldipine,"The risk or severity of ventricular arrhythmias, bradycardia, and heart block can be increased when Nisoldipine is combined with Lacosamide.",increase,risk
Lacosamide,Nitrendipine,"The risk or severity of ventricular arrhythmias, bradycardia, and heart block can be increased when Nitrendipine is combined with Lacosamide.",increase,risk
Lacosamide,Nomegestrol,The metabolism of Nomegestrol can be increased when combined with Lacosamide.,increase,no risk
Lacosamide,Nomegestrol acetate,The metabolism of Nomegestrol acetate can be increased when combined with Lacosamide.,increase,no risk
Lacosamide,Nonoxynol-9,The metabolism of Nonoxynol-9 can be increased when combined with Lacosamide.,increase,no risk
Lacosamide,Norelgestromin,The metabolism of Norelgestromin can be increased when combined with Lacosamide.,increase,no risk
Lacosamide,Norethisterone,The metabolism of Norethisterone can be increased when combined with Lacosamide.,increase,no risk
Lacosamide,Norethynodrel,The metabolism of Norethynodrel can be increased when combined with Lacosamide.,increase,no risk
Lacosamide,Norgestimate,The metabolism of Norgestimate can be increased when combined with Lacosamide.,increase,no risk
Lacosamide,Norgestrel,The metabolism of Norgestrel can be increased when combined with Lacosamide.,increase,no risk
Lacosamide,Nortriptyline,The metabolism of Nortriptyline can be decreased when combined with Lacosamide.,decrease,no risk
Lacosamide,Noscapine,The metabolism of Lacosamide can be decreased when combined with Noscapine.,decrease,no risk
Lacosamide,Nylidrin,"The risk or severity of ventricular arrhythmias, bradycardia, and heart block can be increased when Nylidrin is combined with Lacosamide.",increase,risk
Lacosamide,Octreotide,The serum concentration of the active metabolites of Octreotide can be increased when Octreotide is used in combination with Lacosamide.,increase,no risk
Lacosamide,Olanzapine,The metabolism of Lacosamide can be decreased when combined with Olanzapine.,decrease,no risk
Lacosamide,Olaparib,The metabolism of Olaparib can be decreased when combined with Lacosamide.,decrease,no risk
Lacosamide,Olodaterol,The metabolism of Olodaterol can be decreased when combined with Lacosamide.,decrease,no risk
Lacosamide,Olutasidenib,The metabolism of Lacosamide can be increased when combined with Olutasidenib.,increase,no risk
Lacosamide,Omaveloxolone,The serum concentration of Lacosamide can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Lacosamide,Omeprazole,The metabolism of Lacosamide can be decreased when combined with Omeprazole.,decrease,no risk
Lacosamide,Ondansetron,The metabolism of Lacosamide can be decreased when combined with Ondansetron.,decrease,no risk
Lacosamide,Oritavancin,The metabolism of Lacosamide can be increased when combined with Oritavancin.,increase,no risk
Lacosamide,Orlistat,Orlistat can cause a decrease in the absorption of Lacosamide resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Lacosamide,Orphenadrine,The metabolism of Lacosamide can be decreased when combined with Orphenadrine.,decrease,no risk
Lacosamide,Osilodrostat,The metabolism of Lacosamide can be decreased when combined with Osilodrostat.,decrease,no risk
Lacosamide,Osimertinib,The metabolism of Osimertinib can be decreased when combined with Lacosamide.,decrease,no risk
Lacosamide,Ospemifene,The metabolism of Lacosamide can be decreased when combined with Ospemifene.,decrease,no risk
Lacosamide,Oxandrolone,The metabolism of Lacosamide can be decreased when combined with Oxandrolone.,decrease,no risk
Lacosamide,Oxcarbazepine,The metabolism of Lacosamide can be increased when combined with Oxcarbazepine.,increase,no risk
Lacosamide,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Lacosamide is combined with Oxetacaine.,increase,risk
Lacosamide,Oxprenolol,"The risk or severity of ventricular arrhythmias, bradycardia, and heart block can be increased when Oxprenolol is combined with Lacosamide.",increase,risk
Lacosamide,Oxtriphylline,Lacosamide may increase the excretion rate of Oxtriphylline which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Lacosamide,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Lacosamide is combined with Oxybuprocaine.,increase,risk
Lacosamide,Oxybutynin,The metabolism of Lacosamide can be decreased when combined with Oxybutynin.,decrease,no risk
Lacosamide,Quinidine,The metabolism of Quinidine can be decreased when combined with Lacosamide.,decrease,no risk
Lacosamide,Quinine,The metabolism of Lacosamide can be increased when combined with Quinine.,increase,no risk
Lacosamide,Quinupramine,The therapeutic efficacy of Lacosamide can be decreased when used in combination with Quinupramine.,decrease,no risk
Lacosamide,Quinupristin,The metabolism of Lacosamide can be decreased when combined with Quinupristin.,decrease,no risk
Lacosamide,Ulipristal,The metabolism of Ulipristal can be increased when combined with Lacosamide.,increase,no risk
Lacosamide,Vadadustat,The serum concentration of Lacosamide can be increased when it is combined with Vadadustat.,increase,no risk
Lacosamide,Valdecoxib,The metabolism of Lacosamide can be decreased when combined with Valdecoxib.,decrease,no risk
Lacosamide,Valganciclovir,The therapeutic efficacy of Lacosamide can be decreased when used in combination with Valganciclovir.,decrease,no risk
Lacosamide,Valproic acid,The metabolism of Lacosamide can be decreased when combined with Valproic acid.,decrease,no risk
Lacosamide,Valsartan,The metabolism of Lacosamide can be decreased when combined with Valsartan.,decrease,no risk
Lacosamide,Vandetanib,The metabolism of Vandetanib can be decreased when combined with Lacosamide.,decrease,no risk
Lacosamide,Vardenafil,The metabolism of Lacosamide can be decreased when combined with Vardenafil.,decrease,no risk
Lacosamide,Vemurafenib,The metabolism of Vemurafenib can be decreased when combined with Lacosamide.,decrease,no risk
Lacosamide,Venetoclax,The metabolism of Venetoclax can be decreased when combined with Lacosamide.,decrease,no risk
Lacosamide,Venlafaxine,The therapeutic efficacy of Lacosamide can be decreased when used in combination with Venlafaxine.,decrease,no risk
Lacosamide,Verapamil,"The risk or severity of ventricular arrhythmias, bradycardia, and heart block can be increased when Verapamil is combined with Lacosamide.",increase,risk
Lacosamide,Vilazodone,The metabolism of Vilazodone can be decreased when combined with Lacosamide.,decrease,no risk
Lacosamide,Viloxazine,The metabolism of Lacosamide can be decreased when combined with Viloxazine.,decrease,no risk
Lacosamide,Vinblastine,The metabolism of Vinblastine can be decreased when combined with Lacosamide.,decrease,no risk
Lacosamide,Vincristine,The metabolism of Vincristine can be decreased when combined with Lacosamide.,decrease,no risk
Lacosamide,Vindesine,The metabolism of Vindesine can be decreased when combined with Lacosamide.,decrease,no risk
Lacosamide,Vinflunine,The metabolism of Vinflunine can be decreased when combined with Lacosamide.,decrease,no risk
Lacosamide,Vinorelbine,The metabolism of Vinorelbine can be decreased when combined with Lacosamide.,decrease,no risk
Lacosamide,Vitamin E,The metabolism of Lacosamide can be increased when combined with Vitamin E.,increase,no risk
Lacosamide,Vonoprazan,The metabolism of Lacosamide can be decreased when combined with Vonoprazan.,decrease,no risk
Lacosamide,Vorapaxar,The metabolism of Vorapaxar can be decreased when combined with Lacosamide.,decrease,no risk
Lacosamide,Voriconazole,The metabolism of Lacosamide can be decreased when combined with Voriconazole.,decrease,no risk
Lacosamide,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Lacosamide.,decrease,no risk
Lacosamide,Voxelotor,The metabolism of Voxelotor can be decreased when combined with Lacosamide.,decrease,no risk
Lacosamide,Warfarin,The metabolism of Warfarin can be decreased when combined with Lacosamide.,decrease,no risk
Lacosamide,Ximelagatran,The metabolism of Lacosamide can be decreased when combined with Ximelagatran.,decrease,no risk
Lacosamide,Zafirlukast,The metabolism of Lacosamide can be decreased when combined with Zafirlukast.,decrease,no risk
Lacosamide,Zanubrutinib,The metabolism of Zanubrutinib can be decreased when combined with Lacosamide.,decrease,no risk
Lacosamide,Ziconotide,The risk or severity of CNS depression can be increased when Lacosamide is combined with Ziconotide.,increase,risk
Lacosamide,Zidovudine,The metabolism of Lacosamide can be decreased when combined with Zidovudine.,decrease,no risk
Lacosamide,Zileuton,The metabolism of Lacosamide can be decreased when combined with Zileuton.,decrease,no risk
Lacosamide,Zimelidine,The metabolism of Lacosamide can be decreased when combined with Zimelidine.,decrease,no risk
Lacosamide,Ziprasidone,The metabolism of Lacosamide can be decreased when combined with Ziprasidone.,decrease,no risk
Lacosamide,Zolpidem,The metabolism of Lacosamide can be decreased when combined with Zolpidem.,decrease,no risk
Lacosamide,Zonisamide,"The risk or severity of ventricular arrhythmias, bradycardia, and heart block can be increased when Zonisamide is combined with Lacosamide.",increase,risk
Lacosamide,Zopiclone,The metabolism of Lacosamide can be decreased when combined with Zopiclone.,decrease,no risk
Lacosamide,Zuclopenthixol,The metabolism of Lacosamide can be decreased when combined with Zuclopenthixol.,decrease,no risk
Dalbavancin,BCG vaccine,The therapeutic efficacy of BCG vaccine can be decreased when used in combination with Dalbavancin.,decrease,no risk
Dalbavancin,Benzocaine,The risk or severity of methemoglobinemia can be increased when Dalbavancin is combined with Benzocaine.,increase,risk
Dalbavancin,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Dalbavancin is combined with Benzyl alcohol.,increase,risk
Dalbavancin,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Dalbavancin is combined with Bupivacaine.,increase,risk
Dalbavancin,Butacaine,The risk or severity of methemoglobinemia can be increased when Dalbavancin is combined with Butacaine.,increase,risk
Dalbavancin,Butamben,The risk or severity of methemoglobinemia can be increased when Dalbavancin is combined with Butamben.,increase,risk
Dalbavancin,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Dalbavancin is combined with Oxetacaine.,increase,risk
Dalbavancin,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Dalbavancin is combined with Oxybuprocaine.,increase,risk
Dalbavancin,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Dalbavancin.,decrease,no risk
Dalbavancin,Warfarin,The risk or severity of bleeding can be increased when Dalbavancin is combined with Warfarin.,increase,risk
Rivaroxaban,Belinostat,The serum concentration of Rivaroxaban can be increased when it is combined with Belinostat.,increase,no risk
Rivaroxaban,Belumosudil,Belumosudil may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.,decrease,no risk
Rivaroxaban,Bemiparin,Bemiparin may increase the anticoagulant activities of Rivaroxaban.,increase,no risk
Rivaroxaban,Bendamustine,The serum concentration of Bendamustine can be increased when it is combined with Rivaroxaban.,increase,no risk
Rivaroxaban,Bendroflumethiazide,Bendroflumethiazide may increase the excretion rate of Rivaroxaban which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Rivaroxaban,Benorilate,The risk or severity of bleeding and hemorrhage can be increased when Benorilate is combined with Rivaroxaban.,increase,risk
Rivaroxaban,Benoxaprofen,The risk or severity of bleeding and hemorrhage can be increased when Benoxaprofen is combined with Rivaroxaban.,increase,risk
Rivaroxaban,Benserazide,Rivaroxaban may decrease the excretion rate of Benserazide which could result in a higher serum level.,decrease,no risk
Rivaroxaban,Benzatropine,Benzatropine may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.,decrease,no risk
Rivaroxaban,Benznidazole,Rivaroxaban may decrease the excretion rate of Benznidazole which could result in a higher serum level.,decrease,no risk
Rivaroxaban,Benzthiazide,Benzthiazide may increase the excretion rate of Rivaroxaban which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Rivaroxaban,Benzydamine,The risk or severity of bleeding and hemorrhage can be increased when Benzydamine is combined with Rivaroxaban.,increase,risk
Rivaroxaban,Bepotastine,Bepotastine may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.,decrease,no risk
Rivaroxaban,Beroctocog alfa,The therapeutic efficacy of Beroctocog alfa can be decreased when used in combination with Rivaroxaban.,decrease,no risk
Rivaroxaban,Berotralstat,The metabolism of Rivaroxaban can be decreased when combined with Berotralstat.,decrease,no risk
Rivaroxaban,Betamethasone,The metabolism of Rivaroxaban can be increased when combined with Betamethasone.,increase,no risk
Rivaroxaban,Betamethasone phosphate,The metabolism of Rivaroxaban can be increased when combined with Betamethasone phosphate.,increase,no risk
Rivaroxaban,Betrixaban,Betrixaban may increase the anticoagulant activities of Rivaroxaban.,increase,no risk
Rivaroxaban,Bexarotene,The risk or severity of bleeding can be increased when Rivaroxaban is combined with Bexarotene.,increase,risk
Rivaroxaban,Bicisate,Rivaroxaban may decrease the excretion rate of Bicisate which could result in a higher serum level.,decrease,no risk
Rivaroxaban,Bimekizumab,The metabolism of Rivaroxaban can be increased when combined with Bimekizumab.,increase,no risk
Rivaroxaban,Binimetinib,The serum concentration of Binimetinib can be increased when it is combined with Rivaroxaban.,increase,no risk
Rivaroxaban,Bismuth subgallate,Rivaroxaban may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Rivaroxaban,Bismuth subsalicylate,The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Rivaroxaban.,increase,risk
Rivaroxaban,Bisoprolol,The serum concentration of Rivaroxaban can be increased when it is combined with Bisoprolol.,increase,no risk
Rivaroxaban,Bisoxatin,Rivaroxaban may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,decrease,no risk
Rivaroxaban,Bivalirudin,Bivalirudin may increase the anticoagulant activities of Rivaroxaban.,increase,no risk
Rivaroxaban,Bleomycin,Bleomycin may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.,decrease,no risk
Rivaroxaban,Blinatumomab,The risk or severity of bleeding can be increased when Rivaroxaban is combined with Blinatumomab.,increase,risk
Rivaroxaban,Boceprevir,The metabolism of Rivaroxaban can be decreased when combined with Boceprevir.,decrease,no risk
Rivaroxaban,Bortezomib,The serum concentration of Bortezomib can be increased when it is combined with Rivaroxaban.,increase,no risk
Rivaroxaban,Bosutinib,The serum concentration of Bosutinib can be increased when it is combined with Rivaroxaban.,increase,no risk
Rivaroxaban,Brentuximab vedotin,The serum concentration of Brentuximab vedotin can be increased when it is combined with Rivaroxaban.,increase,no risk
Rivaroxaban,Brigatinib,Brigatinib may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.,decrease,no risk
Rivaroxaban,Brivaracetam,Brivaracetam may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.,decrease,no risk
Rivaroxaban,Bromazepam,Bromazepam may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.,decrease,no risk
Rivaroxaban,Bromotheophylline,Bromotheophylline may increase the excretion rate of Rivaroxaban which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Rivaroxaban,Budesonide,The metabolism of Rivaroxaban can be increased when combined with Budesonide.,increase,no risk
Rivaroxaban,Bumadizone,The risk or severity of bleeding and hemorrhage can be increased when Bumadizone is combined with Rivaroxaban.,increase,risk
Rivaroxaban,Bumetanide,Bumetanide may increase the excretion rate of Rivaroxaban which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Rivaroxaban,Buprenorphine,Buprenorphine may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.,decrease,no risk
Rivaroxaban,Bupropion,Bupropion may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.,decrease,no risk
Rivaroxaban,Buspirone,Buspirone may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.,decrease,no risk
Rivaroxaban,Busulfan,The risk or severity of bleeding can be increased when Rivaroxaban is combined with Busulfan.,increase,risk
Rivaroxaban,Butabarbital,Butabarbital may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.,decrease,no risk
Nalmefene,Gabapentin enacarbil,Nalmefene may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Nalmefene,Gadobenic acid,Gadobenic acid may decrease the excretion rate of Nalmefene which could result in a higher serum level.,decrease,no risk
Nalmefene,Gadodiamide,Gadodiamide may decrease the excretion rate of Nalmefene which could result in a higher serum level.,decrease,no risk
Nalmefene,Gadofosveset trisodium,Nalmefene may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Nalmefene,Gadopentetic acid,Gadopentetic acid may decrease the excretion rate of Nalmefene which could result in a higher serum level.,decrease,no risk
Nalmefene,Gadoteric acid,Nalmefene may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Nalmefene,Gadoteridol,Gadoteridol may decrease the excretion rate of Nalmefene which could result in a higher serum level.,decrease,no risk
Nalmefene,Ganciclovir,Ganciclovir may decrease the excretion rate of Nalmefene which could result in a higher serum level.,decrease,no risk
Nalmefene,Gemcitabine,Gemcitabine may decrease the excretion rate of Nalmefene which could result in a higher serum level.,decrease,no risk
Nalmefene,Gemfibrozil,Gemfibrozil may decrease the excretion rate of Nalmefene which could result in a higher serum level.,decrease,no risk
Nalmefene,Gentamicin,Nalmefene may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Nalmefene,Gimeracil,Nalmefene may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Nalmefene,Givosiran,Givosiran may decrease the excretion rate of Nalmefene which could result in a higher serum level.,decrease,no risk
Nalmefene,Glipizide,Glipizide may decrease the excretion rate of Nalmefene which could result in a higher serum level.,decrease,no risk
Nalmefene,Glycerol phenylbutyrate,Nalmefene may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Nalmefene,Golodirsen,Nalmefene may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Nalmefene,Goserelin,Goserelin may decrease the excretion rate of Nalmefene which could result in a higher serum level.,decrease,no risk
Nalmefene,Guanethidine,Guanethidine may decrease the excretion rate of Nalmefene which could result in a higher serum level.,decrease,no risk
Nalmefene,Guanfacine,Guanfacine may decrease the excretion rate of Nalmefene which could result in a higher serum level.,decrease,no risk
Nalmefene,Haloperidol,Haloperidol may decrease the excretion rate of Nalmefene which could result in a higher serum level.,decrease,no risk
Nalmefene,Hydralazine,Hydralazine may decrease the excretion rate of Nalmefene which could result in a higher serum level.,decrease,no risk
Nalmefene,Hydrochlorothiazide,Hydrochlorothiazide may increase the excretion rate of Nalmefene which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Nalmefene,Hydrocodone,The therapeutic efficacy of Hydrocodone can be decreased when used in combination with Nalmefene.,decrease,no risk
Nalmefene,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of Nalmefene which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Nalmefene,Hydromorphone,The therapeutic efficacy of Hydromorphone can be decreased when used in combination with Nalmefene.,decrease,no risk
Nalmefene,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Nalmefene which could result in a higher serum level.,decrease,no risk
Nalmefene,Hydroxyethyl Starch,Nalmefene may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Nalmefene,Kanamycin,Nalmefene may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Nalmefene,Ketamine,Ketamine may decrease the excretion rate of Nalmefene which could result in a higher serum level.,decrease,no risk
Nalmefene,Ketazolam,Ketazolam may decrease the excretion rate of Nalmefene which could result in a higher serum level.,decrease,no risk
Nalmefene,Ketoconazole,The metabolism of Nalmefene can be decreased when combined with Ketoconazole.,decrease,no risk
Nalmefene,Ketoprofen,Ketoprofen may decrease the excretion rate of Nalmefene which could result in a higher serum level.,decrease,no risk
Nalmefene,Ketorolac,Ketorolac may decrease the excretion rate of Nalmefene which could result in a higher serum level.,decrease,no risk
Nalmefene,N-acetyltyrosine,Nalmefene may decrease the excretion rate of N-acetyltyrosine which could result in a higher serum level.,decrease,no risk
Nalmefene,Nabumetone,Nabumetone may decrease the excretion rate of Nalmefene which could result in a higher serum level.,decrease,no risk
Nalmefene,Nadolol,Nadolol may decrease the excretion rate of Nalmefene which could result in a higher serum level.,decrease,no risk
Nalmefene,Nalbuphine,The therapeutic efficacy of Nalbuphine can be decreased when used in combination with Nalmefene.,decrease,no risk
Nalmefene,Naldemedine,Nalmefene may decrease the excretion rate of Naldemedine which could result in a higher serum level.,decrease,no risk
Nalmefene,Naloxegol,Nalmefene may increase the opioid antagonism activities of Naloxegol.,increase,no risk
Nalmefene,Naloxone,Naloxone may decrease the excretion rate of Nalmefene which could result in a higher serum level.,decrease,no risk
Nalmefene,Naltrexone,The therapeutic efficacy of Naltrexone can be decreased when used in combination with Nalmefene.,decrease,no risk
Nalmefene,Naproxen,Naproxen may decrease the excretion rate of Nalmefene which could result in a higher serum level.,decrease,no risk
Nalmefene,Nateglinide,Nateglinide may decrease the excretion rate of Nalmefene which could result in a higher serum level.,decrease,no risk
Nalmefene,Nedaplatin,Nalmefene may decrease the excretion rate of Nedaplatin which could result in a higher serum level.,decrease,no risk
Nalmefene,Nedocromil,Nedocromil may decrease the excretion rate of Nalmefene which could result in a higher serum level.,decrease,no risk
Nalmefene,Nefazodone,Nefazodone may decrease the excretion rate of Nalmefene which could result in a higher serum level.,decrease,no risk
Nalmefene,Neomycin,Nalmefene may decrease the excretion rate of Neomycin which could result in a higher serum level.,decrease,no risk
Nalmefene,Netilmicin,Nalmefene may decrease the excretion rate of Netilmicin which could result in a higher serum level.,decrease,no risk
Nalmefene,Nicorandil,Nalmefene may decrease the excretion rate of Nicorandil which could result in a higher serum level.,decrease,no risk
Nalmefene,Nifedipine,Nifedipine may decrease the excretion rate of Nalmefene which could result in a higher serum level.,decrease,no risk
Nalmefene,Nilutamide,Nilutamide may decrease the excretion rate of Nalmefene which could result in a higher serum level.,decrease,no risk
Nalmefene,Nimesulide,Nimesulide may decrease the excretion rate of Nalmefene which could result in a higher serum level.,decrease,no risk
Nalmefene,Nisoldipine,Nisoldipine may decrease the excretion rate of Nalmefene which could result in a higher serum level.,decrease,no risk
Nalmefene,Nitric Oxide,Nitric Oxide may decrease the excretion rate of Nalmefene which could result in a higher serum level.,decrease,no risk
Nalmefene,Nitrofurantoin,Nitrofurantoin may decrease the excretion rate of Nalmefene which could result in a higher serum level.,decrease,no risk
Nalmefene,Nitroprusside,Nitroprusside may decrease the excretion rate of Nalmefene which could result in a higher serum level.,decrease,no risk
Nalmefene,Normethadone,The therapeutic efficacy of Normethadone can be decreased when used in combination with Nalmefene.,decrease,no risk
Nalmefene,Octinoxate,Nalmefene may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Nalmefene,Oliceridine,The therapeutic efficacy of Oliceridine can be decreased when used in combination with Nalmefene.,decrease,no risk
Nalmefene,Olsalazine,Olsalazine may decrease the excretion rate of Nalmefene which could result in a higher serum level.,decrease,no risk
Nalmefene,Opium,The therapeutic efficacy of Opium can be decreased when used in combination with Nalmefene.,decrease,no risk
Nalmefene,Oseltamivir,Oseltamivir may decrease the excretion rate of Nalmefene which could result in a higher serum level.,decrease,no risk
Nalmefene,Oxacillin,Oxacillin may decrease the excretion rate of Nalmefene which could result in a higher serum level.,decrease,no risk
Nalmefene,Oxaprozin,Oxaprozin may decrease the excretion rate of Nalmefene which could result in a higher serum level.,decrease,no risk
Nalmefene,Oxazepam,Oxazepam may decrease the excretion rate of Nalmefene which could result in a higher serum level.,decrease,no risk
Nalmefene,Oxybenzone,Oxybenzone may decrease the excretion rate of Nalmefene which could result in a higher serum level.,decrease,no risk
Nalmefene,Oxycodone,The therapeutic efficacy of Oxycodone can be decreased when used in combination with Nalmefene.,decrease,no risk
Nalmefene,Oxymorphone,The therapeutic efficacy of Oxymorphone can be decreased when used in combination with Nalmefene.,decrease,no risk
Nalmefene,Oxyphenbutazone,Oxyphenbutazone may decrease the excretion rate of Nalmefene which could result in a higher serum level.,decrease,no risk
Nalmefene,Oxyquinoline,Nalmefene may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Nalmefene,Quetiapine,Quetiapine may decrease the excretion rate of Nalmefene which could result in a higher serum level.,decrease,no risk
Nalmefene,Quinethazone,Quinethazone may increase the excretion rate of Nalmefene which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Nalmefene,Quinidine,Nalmefene may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Nalmefene,Vaborbactam,Nalmefene may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Nalmefene,Valaciclovir,Valaciclovir may decrease the excretion rate of Nalmefene which could result in a higher serum level.,decrease,no risk
Nalmefene,Valbenazine,Nalmefene may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
Nalmefene,Valdecoxib,Valdecoxib may decrease the excretion rate of Nalmefene which could result in a higher serum level.,decrease,no risk
Nalmefene,Valganciclovir,Valganciclovir may decrease the excretion rate of Nalmefene which could result in a higher serum level.,decrease,no risk
Nalmefene,Vancomycin,Nalmefene may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Nalmefene,Varenicline,Varenicline may decrease the excretion rate of Nalmefene which could result in a higher serum level.,decrease,no risk
Nalmefene,Venlafaxine,Venlafaxine may decrease the excretion rate of Nalmefene which could result in a higher serum level.,decrease,no risk
Nalmefene,Verapamil,Verapamil may decrease the excretion rate of Nalmefene which could result in a higher serum level.,decrease,no risk
Nalmefene,Vilanterol,Nalmefene may decrease the excretion rate of Vilanterol which could result in a higher serum level.,decrease,no risk
Nalmefene,Viloxazine,Nalmefene may decrease the excretion rate of Viloxazine which could result in a higher serum level.,decrease,no risk
Nalmefene,Vortioxetine,Nalmefene may decrease the excretion rate of Vortioxetine which could result in a higher serum level.,decrease,no risk
Nalmefene,Warfarin,Nalmefene may decrease the excretion rate of Warfarin which could result in a higher serum level.,decrease,no risk
Nalmefene,Zaleplon,Zaleplon may decrease the excretion rate of Nalmefene which could result in a higher serum level.,decrease,no risk
Nalmefene,Zanamivir,Zanamivir may decrease the excretion rate of Nalmefene which could result in a higher serum level.,decrease,no risk
Nalmefene,Zonisamide,Zonisamide may increase the excretion rate of Nalmefene which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ridaforolimus,Gepirone,The serum concentration of Gepirone can be increased when it is combined with Ridaforolimus.,increase,no risk
Ridaforolimus,Gilteritinib,The metabolism of Gilteritinib can be decreased when combined with Ridaforolimus.,decrease,no risk
Ridaforolimus,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Ridaforolimus.,increase,no risk
Ridaforolimus,Hydrocortisone,The serum concentration of Hydrocortisone can be increased when it is combined with Ridaforolimus.,increase,no risk
Ridaforolimus,Nelarabine,The risk or severity of adverse effects can be increased when Nelarabine is combined with Ridaforolimus.,increase,risk
Ridaforolimus,Neratinib,The serum concentration of Neratinib can be increased when it is combined with Ridaforolimus.,increase,no risk
Ridaforolimus,Netupitant,The metabolism of Netupitant can be decreased when combined with Ridaforolimus.,decrease,no risk
Ridaforolimus,Nicergoline,The serum concentration of Nicergoline can be increased when it is combined with Ridaforolimus.,increase,no risk
Ridaforolimus,Nilotinib,The serum concentration of Nilotinib can be increased when it is combined with Ridaforolimus.,increase,no risk
Ridaforolimus,Nintedanib,The metabolism of Nintedanib can be decreased when combined with Ridaforolimus.,decrease,no risk
Ridaforolimus,Norethisterone,The metabolism of Norethisterone can be decreased when combined with Ridaforolimus.,decrease,no risk
Ridaforolimus,Nortriptyline,The serum concentration of Nortriptyline can be increased when it is combined with Ridaforolimus.,increase,no risk
Ridaforolimus,Olaparib,The serum concentration of Olaparib can be increased when it is combined with Ridaforolimus.,increase,no risk
Ridaforolimus,Osimertinib,The serum concentration of Osimertinib can be increased when it is combined with Ridaforolimus.,increase,no risk
Ridaforolimus,Ouabain,The serum concentration of Ouabain can be increased when it is combined with Ridaforolimus.,increase,no risk
Ridaforolimus,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Ridaforolimus is combined with Oxetacaine.,increase,risk
Ridaforolimus,Oxtriphylline,The metabolism of Oxtriphylline can be decreased when combined with Ridaforolimus.,decrease,no risk
Ridaforolimus,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Ridaforolimus is combined with Oxybuprocaine.,increase,risk
Ridaforolimus,Quinidine,The serum concentration of Quinidine can be increased when it is combined with Ridaforolimus.,increase,no risk
Ridaforolimus,Quinine,The serum concentration of Quinine can be increased when it is combined with Ridaforolimus.,increase,no risk
Ridaforolimus,Vandetanib,The serum concentration of Vandetanib can be increased when it is combined with Ridaforolimus.,increase,no risk
Ridaforolimus,Vardenafil,The metabolism of Vardenafil can be decreased when combined with Ridaforolimus.,decrease,no risk
Ridaforolimus,Vemurafenib,The serum concentration of Vemurafenib can be increased when it is combined with Ridaforolimus.,increase,no risk
Ridaforolimus,Venetoclax,The serum concentration of Venetoclax can be increased when it is combined with Ridaforolimus.,increase,no risk
Ridaforolimus,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Ridaforolimus.,decrease,no risk
Ridaforolimus,Vinblastine,The serum concentration of Vinblastine can be increased when it is combined with Ridaforolimus.,increase,no risk
Ridaforolimus,Vincristine,The serum concentration of Vincristine can be increased when it is combined with Ridaforolimus.,increase,no risk
Ridaforolimus,Vindesine,The serum concentration of Vindesine can be increased when it is combined with Ridaforolimus.,increase,no risk
Ridaforolimus,Vinflunine,The serum concentration of Vinflunine can be increased when it is combined with Ridaforolimus.,increase,no risk
Ridaforolimus,Vinorelbine,The serum concentration of Vinorelbine can be increased when it is combined with Ridaforolimus.,increase,no risk
Ridaforolimus,Vorapaxar,The metabolism of Vorapaxar can be decreased when combined with Ridaforolimus.,decrease,no risk
Ridaforolimus,Voxelotor,The serum concentration of Voxelotor can be increased when it is combined with Ridaforolimus.,increase,no risk
Ridaforolimus,Warfarin,The serum concentration of Warfarin can be increased when it is combined with Ridaforolimus.,increase,no risk
Ridaforolimus,Zanubrutinib,The serum concentration of Zanubrutinib can be increased when it is combined with Ridaforolimus.,increase,no risk
Ridaforolimus,Ziprasidone,The metabolism of Ziprasidone can be decreased when combined with Ridaforolimus.,decrease,no risk
Ridaforolimus,Zopiclone,The metabolism of Zopiclone can be decreased when combined with Ridaforolimus.,decrease,no risk
Ridaforolimus,Zuclopenthixol,The metabolism of Zuclopenthixol can be decreased when combined with Ridaforolimus.,decrease,no risk
Maribavir,Ganciclovir,The therapeutic efficacy of Ganciclovir can be decreased when used in combination with Maribavir.,decrease,no risk
Maribavir,Gefitinib,Maribavir may decrease the excretion rate of Gefitinib which could result in a higher serum level.,decrease,no risk
Maribavir,Gemcitabine,The serum concentration of Gemcitabine can be increased when it is combined with Maribavir.,increase,no risk
Maribavir,Gilteritinib,The serum concentration of Gilteritinib can be increased when it is combined with Maribavir.,increase,no risk
Maribavir,Glasdegib,Maribavir may decrease the excretion rate of Glasdegib which could result in a higher serum level.,decrease,no risk
Maribavir,Glecaprevir,Maribavir may decrease the excretion rate of Glecaprevir which could result in a higher serum level.,decrease,no risk
Maribavir,Glofitamab,The serum concentration of Maribavir can be increased when it is combined with Glofitamab.,increase,no risk
Maribavir,Glyburide,Maribavir may decrease the excretion rate of Glyburide which could result in a higher serum level.,decrease,no risk
Maribavir,Grazoprevir,The serum concentration of Grazoprevir can be increased when it is combined with Maribavir.,increase,no risk
Maribavir,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Maribavir.,increase,no risk
Maribavir,Human adenovirus e serotype 4 strain cl-68578 antigen,The therapeutic efficacy of Human adenovirus e serotype 4 strain cl-68578 antigen can be decreased when used in combination with Maribavir.,decrease,no risk
Maribavir,Ketoconazole,The metabolism of Maribavir can be decreased when combined with Ketoconazole.,decrease,no risk
Maribavir,Naloxegol,The serum concentration of Naloxegol can be increased when it is combined with Maribavir.,increase,no risk
Maribavir,Nefazodone,The metabolism of Maribavir can be decreased when combined with Nefazodone.,decrease,no risk
Maribavir,Nelfinavir,The metabolism of Maribavir can be decreased when combined with Nelfinavir.,decrease,no risk
Maribavir,Netupitant,The metabolism of Maribavir can be decreased when combined with Netupitant.,decrease,no risk
Maribavir,Nicardipine,The metabolism of Maribavir can be decreased when combined with Nicardipine.,decrease,no risk
Maribavir,Nilotinib,The metabolism of Maribavir can be decreased when combined with Nilotinib.,decrease,no risk
Maribavir,Nilvadipine,The metabolism of Maribavir can be decreased when combined with Nilvadipine.,decrease,no risk
Maribavir,Nintedanib,The serum concentration of Nintedanib can be increased when it is combined with Maribavir.,increase,no risk
Maribavir,Nirogacestat,The serum concentration of Nirogacestat can be increased when it is combined with Maribavir.,increase,no risk
Maribavir,Nitrofurantoin,Maribavir may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.,decrease,no risk
Maribavir,Nortriptyline,The serum concentration of Nortriptyline can be increased when it is combined with Maribavir.,increase,no risk
Maribavir,Omadacycline,The serum concentration of Omadacycline can be increased when it is combined with Maribavir.,increase,no risk
Maribavir,Omaveloxolone,The serum concentration of Maribavir can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Maribavir,Ombitasvir,Maribavir may decrease the excretion rate of Ombitasvir which could result in a higher serum level.,decrease,no risk
Maribavir,Osimertinib,The serum concentration of Osimertinib can be increased when it is combined with Maribavir.,increase,no risk
Maribavir,Oxaliplatin,Maribavir may decrease the excretion rate of Oxaliplatin which could result in a higher serum level.,decrease,no risk
Maribavir,Ozanimod,Maribavir may decrease the excretion rate of Ozanimod which could result in a higher serum level.,decrease,no risk
Maribavir,Quinidine,The serum concentration of Quinidine can be increased when it is combined with Maribavir.,increase,no risk
Maribavir,Quinine,The serum concentration of Quinine can be increased when it is combined with Maribavir.,increase,no risk
Maribavir,Quizartinib,The serum concentration of Quizartinib can be increased when it is combined with Maribavir.,increase,no risk
Maribavir,Ubrogepant,The serum concentration of Ubrogepant can be increased when it is combined with Maribavir.,increase,no risk
Maribavir,Umeclidinium,The serum concentration of Umeclidinium can be increased when it is combined with Maribavir.,increase,no risk
Maribavir,Vadadustat,The serum concentration of Maribavir can be increased when it is combined with Vadadustat.,increase,no risk
Maribavir,Valganciclovir,The therapeutic efficacy of Valganciclovir can be decreased when used in combination with Maribavir.,decrease,no risk
Maribavir,Vardenafil,The serum concentration of Vardenafil can be increased when it is combined with Maribavir.,increase,no risk
Maribavir,Varicella zoster vaccine (live/attenuated),The therapeutic efficacy of Varicella zoster vaccine (live/attenuated) can be decreased when used in combination with Maribavir.,decrease,no risk
Maribavir,Velpatasvir,Maribavir may decrease the excretion rate of Velpatasvir which could result in a higher serum level.,decrease,no risk
Maribavir,Vemurafenib,The serum concentration of Vemurafenib can be increased when it is combined with Maribavir.,increase,no risk
Maribavir,Venetoclax,The serum concentration of Venetoclax can be increased when it is combined with Maribavir.,increase,no risk
Maribavir,Verapamil,The metabolism of Maribavir can be decreased when combined with Verapamil.,decrease,no risk
Maribavir,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Maribavir.,decrease,no risk
Maribavir,Viloxazine,The metabolism of Maribavir can be decreased when combined with Viloxazine.,decrease,no risk
Maribavir,Vinblastine,The serum concentration of Vinblastine can be increased when it is combined with Maribavir.,increase,no risk
Maribavir,Vincristine,The excretion of Vincristine can be decreased when combined with Maribavir.,decrease,no risk
Maribavir,Vinflunine,The serum concentration of Vinflunine can be increased when it is combined with Maribavir.,increase,no risk
Maribavir,Voclosporin,The serum concentration of Voclosporin can be increased when it is combined with Maribavir.,increase,no risk
Maribavir,Voriconazole,The metabolism of Maribavir can be decreased when combined with Voriconazole.,decrease,no risk
Maribavir,Voxilaprevir,Maribavir may decrease the excretion rate of Voxilaprevir which could result in a higher serum level.,decrease,no risk
Vadimezan,Gatifloxacin,The metabolism of Vadimezan can be decreased when combined with Gatifloxacin.,decrease,no risk
Vadimezan,Gemfibrozil,The metabolism of Vadimezan can be decreased when combined with Gemfibrozil.,decrease,no risk
Vadimezan,Gemifloxacin,The metabolism of Vadimezan can be decreased when combined with Gemifloxacin.,decrease,no risk
Vadimezan,Givosiran,The serum concentration of Vadimezan can be increased when it is combined with Givosiran.,increase,no risk
Vadimezan,Glofitamab,The serum concentration of Vadimezan can be increased when it is combined with Glofitamab.,increase,no risk
Vadimezan,Golimumab,The metabolism of Vadimezan can be increased when combined with Golimumab.,increase,no risk
Vadimezan,Grepafloxacin,The metabolism of Vadimezan can be decreased when combined with Grepafloxacin.,decrease,no risk
Vadimezan,Guanabenz,The metabolism of Vadimezan can be decreased when combined with Guanabenz.,decrease,no risk
Vadimezan,Haloperidol,The metabolism of Vadimezan can be decreased when combined with Haloperidol.,decrease,no risk
Vadimezan,Ketoconazole,The metabolism of Vadimezan can be decreased when combined with Ketoconazole.,decrease,no risk
Vadimezan,Nabumetone,The metabolism of Vadimezan can be decreased when combined with Nabumetone.,decrease,no risk
Vadimezan,Nafcillin,The metabolism of Vadimezan can be increased when combined with Nafcillin.,increase,no risk
Vadimezan,Nalidixic acid,The metabolism of Vadimezan can be decreased when combined with Nalidixic acid.,decrease,no risk
Vadimezan,Naproxen,The metabolism of Vadimezan can be decreased when combined with Naproxen.,decrease,no risk
Vadimezan,Nelarabine,The risk or severity of adverse effects can be increased when Nelarabine is combined with Vadimezan.,increase,risk
Vadimezan,Nevirapine,The metabolism of Vadimezan can be decreased when combined with Nevirapine.,decrease,no risk
Vadimezan,Niclosamide,The metabolism of Vadimezan can be decreased when combined with Niclosamide.,decrease,no risk
Vadimezan,Nifedipine,The metabolism of Vadimezan can be decreased when combined with Nifedipine.,decrease,no risk
Vadimezan,Norfloxacin,The metabolism of Vadimezan can be decreased when combined with Norfloxacin.,decrease,no risk
Vadimezan,Obeticholic acid,The metabolism of Vadimezan can be decreased when combined with Obeticholic acid.,decrease,no risk
Vadimezan,Olanzapine,The metabolism of Vadimezan can be decreased when combined with Olanzapine.,decrease,no risk
Vadimezan,Ondansetron,The metabolism of Vadimezan can be decreased when combined with Ondansetron.,decrease,no risk
Vadimezan,Orphenadrine,The metabolism of Vadimezan can be decreased when combined with Orphenadrine.,decrease,no risk
Vadimezan,Osilodrostat,The metabolism of Vadimezan can be decreased when combined with Osilodrostat.,decrease,no risk
Vadimezan,Osimertinib,The serum concentration of Vadimezan can be decreased when it is combined with Osimertinib.,decrease,no risk
Vadimezan,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Vadimezan is combined with Oxetacaine.,increase,risk
Vadimezan,Oxtriphylline,The metabolism of Vadimezan can be decreased when combined with Oxtriphylline.,decrease,no risk
Vadimezan,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Vadimezan is combined with Oxybuprocaine.,increase,risk
Vadimezan,Quinidine,The metabolism of Vadimezan can be decreased when combined with Quinidine.,decrease,no risk
Vadimezan,Quinine,The metabolism of Vadimezan can be decreased when combined with Quinine.,decrease,no risk
Vadimezan,Valproic acid,The metabolism of Vadimezan can be decreased when combined with Valproic acid.,decrease,no risk
Vadimezan,Vemurafenib,The serum concentration of Vadimezan can be increased when it is combined with Vemurafenib.,increase,no risk
Vadimezan,Verapamil,The metabolism of Vadimezan can be decreased when combined with Verapamil.,decrease,no risk
Vadimezan,Viloxazine,The metabolism of Vadimezan can be decreased when combined with Viloxazine.,decrease,no risk
Vadimezan,Voxilaprevir,The metabolism of Voxilaprevir can be decreased when combined with Vadimezan.,decrease,no risk
Vadimezan,Warfarin,The metabolism of Vadimezan can be decreased when combined with Warfarin.,decrease,no risk
Vadimezan,Zileuton,The metabolism of Vadimezan can be decreased when combined with Zileuton.,decrease,no risk
Vadimezan,Zolmitriptan,The metabolism of Vadimezan can be decreased when combined with Zolmitriptan.,decrease,no risk
Vadimezan,Zolpidem,The metabolism of Vadimezan can be decreased when combined with Zolpidem.,decrease,no risk
Vadimezan,Zotepine,The metabolism of Zotepine can be decreased when combined with Vadimezan.,decrease,no risk
Elvucitabine,Bacillus calmette-guerin substrain connaught live antigen,The therapeutic efficacy of Bacillus calmette-guerin substrain connaught live antigen can be decreased when used in combination with Elvucitabine.,decrease,no risk
Elvucitabine,Bacillus calmette-guerin substrain russian BCG-I live antigen,The therapeutic efficacy of Bacillus calmette-guerin substrain russian BCG-I live antigen can be decreased when used in combination with Elvucitabine.,decrease,no risk
Elvucitabine,Bacillus calmette-guerin substrain tice live antigen,The therapeutic efficacy of Bacillus calmette-guerin substrain tice live antigen can be decreased when used in combination with Elvucitabine.,decrease,no risk
Elvucitabine,BCG vaccine,The therapeutic efficacy of BCG vaccine can be decreased when used in combination with Elvucitabine.,decrease,no risk
Elvucitabine,Human adenovirus e serotype 4 strain cl-68578 antigen,The therapeutic efficacy of Human adenovirus e serotype 4 strain cl-68578 antigen can be decreased when used in combination with Elvucitabine.,decrease,no risk
Elvucitabine,Varicella zoster vaccine (live/attenuated),The therapeutic efficacy of Varicella zoster vaccine (live/attenuated) can be decreased when used in combination with Elvucitabine.,decrease,no risk
Elvucitabine,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Elvucitabine.,decrease,no risk
Elvucitabine,Yellow fever vaccine,The therapeutic efficacy of Yellow fever vaccine can be decreased when used in combination with Elvucitabine.,decrease,no risk
Avanafil,Bioallethrin,The serum concentration of Avanafil can be increased when it is combined with Bioallethrin.,increase,no risk
Avanafil,Bisoprolol,The serum concentration of Avanafil can be increased when it is combined with Bisoprolol.,increase,no risk
Avanafil,Boceprevir,The metabolism of Avanafil can be decreased when combined with Boceprevir.,decrease,no risk
Avanafil,Bortezomib,The serum concentration of Avanafil can be increased when it is combined with Bortezomib.,increase,no risk
Avanafil,Bosentan,The serum concentration of Avanafil can be increased when it is combined with Bosentan.,increase,no risk
Avanafil,Bosutinib,The serum concentration of Avanafil can be increased when it is combined with Bosutinib.,increase,no risk
Avanafil,Brentuximab vedotin,The serum concentration of Avanafil can be increased when it is combined with Brentuximab vedotin.,increase,no risk
Avanafil,Bretylium,Bretylium may increase the hypotensive activities of Avanafil.,increase,no risk
Avanafil,Brexpiprazole,Brexpiprazole may increase the hypotensive activities of Avanafil.,increase,no risk
Avanafil,Brigatinib,The serum concentration of Avanafil can be increased when it is combined with Brigatinib.,increase,no risk
Avanafil,Brimonidine,The risk or severity of hypotension can be increased when Avanafil is combined with Brimonidine.,increase,risk
Avanafil,Brinzolamide,The serum concentration of Avanafil can be increased when it is combined with Brinzolamide.,increase,no risk
Avanafil,Brivaracetam,The serum concentration of Avanafil can be increased when it is combined with Brivaracetam.,increase,no risk
Avanafil,Bromocriptine,Bromocriptine may increase the hypotensive activities of Avanafil.,increase,no risk
Avanafil,Budesonide,The serum concentration of Avanafil can be increased when it is combined with Budesonide.,increase,no risk
Avanafil,Bumetanide,The risk or severity of hypotension can be increased when Avanafil is combined with Bumetanide.,increase,risk
Avanafil,Bupivacaine,The serum concentration of Avanafil can be increased when it is combined with Bupivacaine.,increase,no risk
Avanafil,Buprenorphine,The serum concentration of Avanafil can be increased when it is combined with Buprenorphine.,increase,no risk
Avanafil,Bupropion,The metabolism of Avanafil can be decreased when combined with Bupropion.,decrease,no risk
Avanafil,Buspirone,The serum concentration of Avanafil can be increased when it is combined with Buspirone.,increase,no risk
Avanafil,Busulfan,The serum concentration of Avanafil can be increased when it is combined with Busulfan.,increase,no risk
Tariquidar,Ubrogepant,The serum concentration of Ubrogepant can be increased when it is combined with Tariquidar.,increase,no risk
Tariquidar,Umeclidinium,The serum concentration of Umeclidinium can be increased when it is combined with Tariquidar.,increase,no risk
Tariquidar,Vardenafil,The serum concentration of Vardenafil can be increased when it is combined with Tariquidar.,increase,no risk
Tariquidar,Velpatasvir,The serum concentration of Velpatasvir can be increased when it is combined with Tariquidar.,increase,no risk
Tariquidar,Vemurafenib,The serum concentration of Vemurafenib can be increased when it is combined with Tariquidar.,increase,no risk
Tariquidar,Venetoclax,The serum concentration of Venetoclax can be increased when it is combined with Tariquidar.,increase,no risk
Tariquidar,Verapamil,The serum concentration of Verapamil can be increased when it is combined with Tariquidar.,increase,no risk
Tariquidar,Vinblastine,The serum concentration of Vinblastine can be increased when it is combined with Tariquidar.,increase,no risk
Tariquidar,Vincristine,The excretion of Vincristine can be decreased when combined with Tariquidar.,decrease,no risk
Tariquidar,Vinflunine,The serum concentration of Vinflunine can be increased when it is combined with Tariquidar.,increase,no risk
Tariquidar,Voclosporin,The serum concentration of Voclosporin can be increased when it is combined with Tariquidar.,increase,no risk
Tariquidar,Voxilaprevir,The serum concentration of Voxilaprevir can be increased when it is combined with Tariquidar.,increase,no risk
Clenoliximab,Natalizumab,The risk or severity of adverse effects can be increased when Natalizumab is combined with Clenoliximab.,increase,risk
Clenoliximab,Necitumumab,The risk or severity of adverse effects can be increased when Clenoliximab is combined with Necitumumab.,increase,risk
Clenoliximab,Nivolumab,The risk or severity of adverse effects can be increased when Clenoliximab is combined with Nivolumab.,increase,risk
Clenoliximab,Obiltoxaximab,The risk or severity of adverse effects can be increased when Obiltoxaximab is combined with Clenoliximab.,increase,risk
Clenoliximab,Obinutuzumab,The risk or severity of adverse effects can be increased when Clenoliximab is combined with Obinutuzumab.,increase,risk
Clenoliximab,Ocrelizumab,The risk or severity of adverse effects can be increased when Clenoliximab is combined with Ocrelizumab.,increase,risk
Clenoliximab,Odesivimab,The risk or severity of adverse effects can be increased when Clenoliximab is combined with Odesivimab.,increase,risk
Clenoliximab,Ofatumumab,The risk or severity of adverse effects can be increased when Clenoliximab is combined with Ofatumumab.,increase,risk
Clenoliximab,Olaratumab,The risk or severity of adverse effects can be increased when Olaratumab is combined with Clenoliximab.,increase,risk
Clenoliximab,Omalizumab,The risk or severity of adverse effects can be increased when Omalizumab is combined with Clenoliximab.,increase,risk
Clenoliximab,Quinestrol,Quinestrol may increase the thrombogenic activities of Clenoliximab.,increase,no risk
Clenoliximab,Ublituximab,The risk or severity of adverse effects can be increased when Clenoliximab is combined with Ublituximab.,increase,risk
Clenoliximab,Ustekinumab,The risk or severity of adverse effects can be increased when Ustekinumab is combined with Clenoliximab.,increase,risk
Clenoliximab,Vedolizumab,The risk or severity of adverse effects can be increased when Clenoliximab is combined with Vedolizumab.,increase,risk
Eflornithine,Benzocaine,The risk or severity of methemoglobinemia can be increased when Eflornithine is combined with Benzocaine.,increase,risk
Eflornithine,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Eflornithine is combined with Benzyl alcohol.,increase,risk
Eflornithine,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Eflornithine is combined with Bupivacaine.,increase,risk
Eflornithine,Butacaine,The risk or severity of methemoglobinemia can be increased when Eflornithine is combined with Butacaine.,increase,risk
Eflornithine,Butamben,The risk or severity of methemoglobinemia can be increased when Eflornithine is combined with Butamben.,increase,risk
Eflornithine,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Eflornithine is combined with Oxetacaine.,increase,risk
Eflornithine,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Eflornithine is combined with Oxybuprocaine.,increase,risk
Lanoteplase,Benazepril,The risk or severity of angioedema can be increased when Benazepril is combined with Lanoteplase.,increase,risk
Lanoteplase,Hydrogen peroxide,The therapeutic efficacy of Hydrogen peroxide can be decreased when used in combination with Lanoteplase.,decrease,no risk
Lanoteplase,Quinapril,The risk or severity of angioedema can be increased when Quinapril is combined with Lanoteplase.,increase,risk
Lanoteplase,Urokinase,The risk or severity of angioedema can be increased when Urokinase is combined with Lanoteplase.,increase,risk
Lanoteplase,Valsartan,The risk or severity of angioedema can be increased when Valsartan is combined with Lanoteplase.,increase,risk
Lanoteplase,Vildagliptin,The risk or severity of angioedema can be increased when Vildagliptin is combined with Lanoteplase.,increase,risk
Lanoteplase,Zofenopril,The risk or severity of angioedema can be increased when Lanoteplase is combined with Zofenopril.,increase,risk
Exisulind,Benzocaine,The risk or severity of methemoglobinemia can be increased when Exisulind is combined with Benzocaine.,increase,risk
Exisulind,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Exisulind is combined with Benzyl alcohol.,increase,risk
Exisulind,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Exisulind is combined with Bupivacaine.,increase,risk
Exisulind,Butacaine,The risk or severity of methemoglobinemia can be increased when Exisulind is combined with Butacaine.,increase,risk
Exisulind,Butamben,The risk or severity of methemoglobinemia can be increased when Exisulind is combined with Butamben.,increase,risk
Exisulind,Nelarabine,The risk or severity of adverse effects can be increased when Nelarabine is combined with Exisulind.,increase,risk
Exisulind,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Exisulind is combined with Oxetacaine.,increase,risk
Exisulind,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Exisulind is combined with Oxybuprocaine.,increase,risk
Fluasterone,Beclomethasone dipropionate,The risk or severity of edema formation can be increased when Fluasterone is combined with Beclomethasone dipropionate.,increase,risk
Fluasterone,Betamethasone,The risk or severity of edema formation can be increased when Fluasterone is combined with Betamethasone.,increase,risk
Fluasterone,Betamethasone phosphate,The risk or severity of edema formation can be increased when Fluasterone is combined with Betamethasone phosphate.,increase,risk
Fluasterone,Budesonide,The risk or severity of edema formation can be increased when Fluasterone is combined with Budesonide.,increase,risk
Fluasterone,Hydrocortisone,The risk or severity of edema formation can be increased when Fluasterone is combined with Fluticasone propionate.,increase,risk
Fluasterone,Hydrocortisone acetate,The risk or severity of edema formation can be increased when Fluasterone is combined with Hydrocortisone.,increase,risk
Fluasterone,Hydrocortisone butyrate,The risk or severity of edema formation can be increased when Fluasterone is combined with Hydrocortisone acetate.,increase,risk
Fluasterone,Hydrocortisone cypionate,The risk or severity of edema formation can be increased when Fluasterone is combined with Hydrocortisone butyrate.,increase,risk
Fluasterone,Hydrocortisone succinate,The risk or severity of edema formation can be increased when Fluasterone is combined with Hydrocortisone cypionate.,increase,risk
Fluasterone,Vamorolone,The risk or severity of edema formation can be increased when Fluasterone is combined with Trilostane.,increase,risk
Dersalazine,Gliclazide,Dersalazine may increase the hypoglycemic activities of Gliclazide.,increase,no risk
Dersalazine,Glimepiride,Dersalazine may increase the hypoglycemic activities of Glimepiride.,increase,no risk
Dersalazine,Glipizide,Dersalazine may increase the hypoglycemic activities of Glipizide.,increase,no risk
Dersalazine,Gliquidone,Dersalazine may increase the hypoglycemic activities of Gliquidone.,increase,no risk
Dersalazine,Glyburide,Dersalazine may increase the hypoglycemic activities of Glyburide.,increase,no risk
Dersalazine,Glymidine,Dersalazine may increase the hypoglycemic activities of Glymidine.,increase,no risk
Dersalazine,Heparin,The risk or severity of bleeding can be increased when Dersalazine is combined with Heparin.,increase,risk
Dersalazine,Hyaluronidase,The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Dersalazine.,decrease,no risk
Dersalazine,Hyaluronidase (human recombinant),The therapeutic efficacy of Hyaluronidase (human recombinant) can be decreased when used in combination with Dersalazine.,decrease,no risk
Dersalazine,Hyaluronidase (ovine),The therapeutic efficacy of Hyaluronidase (ovine) can be decreased when used in combination with Dersalazine.,decrease,no risk
Dersalazine,Hydrocortisone,The serum concentration of Dersalazine can be decreased when it is combined with Hydrocortisone.,decrease,no risk
Dersalazine,Ketoprofen,The risk or severity of bleeding and gastrointestinal bleeding can be increased when Dersalazine is combined with Ketoprofen.,increase,risk
Dersalazine,Ketorolac,The therapeutic efficacy of Dersalazine can be decreased when used in combination with Ketorolac.,decrease,no risk
Dersalazine,Nabumetone,The therapeutic efficacy of Dersalazine can be decreased when used in combination with Nabumetone.,decrease,no risk
Dersalazine,Nadroparin,The risk or severity of bleeding can be increased when Dersalazine is combined with Nadroparin.,increase,risk
Dersalazine,Naproxen,The therapeutic efficacy of Dersalazine can be decreased when used in combination with Naproxen.,decrease,no risk
Dersalazine,Nateglinide,Dersalazine may increase the hypoglycemic activities of Nateglinide.,increase,no risk
Dersalazine,Nepafenac,The therapeutic efficacy of Dersalazine can be decreased when used in combination with Nepafenac.,decrease,no risk
Dersalazine,Nimesulide,The risk or severity of bleeding can be increased when Nimesulide is combined with Dersalazine.,increase,risk
Dersalazine,Olsalazine,"The risk or severity of bleeding, nephrotoxicity, and gastrointestinal bleeding can be increased when Olsalazine is combined with Dersalazine.",increase,risk
Dersalazine,Ouabain,The serum concentration of Ouabain can be decreased when it is combined with Dersalazine.,decrease,no risk
Dersalazine,Oxaprozin,The therapeutic efficacy of Dersalazine can be decreased when used in combination with Oxaprozin.,decrease,no risk
Dersalazine,Quinapril,The risk or severity of renal failure can be increased when Dersalazine is combined with Quinapril.,increase,risk
Dersalazine,Quinine,Dersalazine may increase the hypoglycemic activities of Quinine.,increase,no risk
Dersalazine,Urokinase,The risk or severity of bleeding can be increased when Dersalazine is combined with Urokinase.,increase,risk
Dersalazine,Valproic acid,The serum concentration of Valproic acid can be increased when it is combined with Dersalazine.,increase,no risk
Dersalazine,Varicella zoster vaccine (live/attenuated),The risk or severity of adverse effects can be increased when Dersalazine is combined with Varicella zoster vaccine (live/attenuated).,increase,risk
Dersalazine,Verapamil,The risk or severity of bleeding can be increased when Verapamil is combined with Dersalazine.,increase,risk
Dersalazine,Vildagliptin,Dersalazine may increase the hypoglycemic activities of Vildagliptin.,increase,no risk
Dersalazine,Vorapaxar,The risk or severity of bleeding can be increased when Dersalazine is combined with Vorapaxar.,increase,risk
Dersalazine,Warfarin,Dersalazine may increase the anticoagulant activities of Warfarin.,increase,no risk
Dersalazine,Ximelagatran,The risk or severity of bleeding can be increased when Dersalazine is combined with Ximelagatran.,increase,risk
Dersalazine,Zofenopril,The risk or severity of renal failure can be increased when Dersalazine is combined with Zofenopril.,increase,risk
Dersalazine,Zonisamide,The risk or severity of adverse effects can be increased when Dersalazine is combined with Zonisamide.,increase,risk
Incadronic acid,Gentamicin,The risk or severity of nephrotoxicity and hypocalcemia can be increased when Gentamicin is combined with Incadronic acid.,increase,risk
Incadronic acid,Givosiran,The risk or severity of nephrotoxicity and hypocalcemia can be increased when Givosiran is combined with Incadronic acid.,increase,risk
Incadronic acid,Glycol salicylate,The risk or severity of gastrointestinal bleeding can be increased when Glycol salicylate is combined with Incadronic acid.,increase,risk
Incadronic acid,Human calcitonin,The risk or severity of hypocalcemia can be increased when Human calcitonin is combined with Incadronic acid.,increase,risk
Incadronic acid,Hydrochlorothiazide,The risk or severity of nephrotoxicity and hypocalcemia can be increased when Hydrochlorothiazide is combined with Incadronic acid.,increase,risk
Incadronic acid,Hydrotalcite,The serum concentration of Incadronic acid can be decreased when it is combined with Hydrotalcite.,decrease,no risk
Incadronic acid,Kanamycin,The risk or severity of nephrotoxicity and hypocalcemia can be increased when Kanamycin is combined with Incadronic acid.,increase,risk
Incadronic acid,Ketoprofen,The risk or severity of gastrointestinal bleeding can be increased when Ketoprofen is combined with Incadronic acid.,increase,risk
Incadronic acid,Ketorolac,The risk or severity of gastrointestinal bleeding can be increased when Ketorolac is combined with Incadronic acid.,increase,risk
Incadronic acid,Nabumetone,The risk or severity of gastrointestinal bleeding can be increased when Nabumetone is combined with Incadronic acid.,increase,risk
Incadronic acid,Naproxen,The risk or severity of gastrointestinal bleeding can be increased when Naproxen is combined with Incadronic acid.,increase,risk
Incadronic acid,Neomycin,The risk or severity of nephrotoxicity and hypocalcemia can be increased when Neomycin is combined with Incadronic acid.,increase,risk
Incadronic acid,Netilmicin,The risk or severity of nephrotoxicity and hypocalcemia can be increased when Netilmicin is combined with Incadronic acid.,increase,risk
Incadronic acid,Nimesulide,The risk or severity of gastrointestinal bleeding can be increased when Nimesulide is combined with Incadronic acid.,increase,risk
Incadronic acid,Nitroprusside,Nitroprusside can cause a decrease in the absorption of Incadronic acid resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Incadronic acid,Olsalazine,The risk or severity of nephrotoxicity and hypocalcemia can be increased when Olsalazine is combined with Incadronic acid.,increase,risk
Incadronic acid,Omeprazole,The therapeutic efficacy of Incadronic acid can be decreased when used in combination with Omeprazole.,decrease,no risk
Incadronic acid,Oxaprozin,The risk or severity of gastrointestinal bleeding can be increased when Oxaprozin is combined with Incadronic acid.,increase,risk
Incadronic acid,Oxyphenbutazone,The risk or severity of gastrointestinal bleeding can be increased when Oxyphenbutazone is combined with Incadronic acid.,increase,risk
Incadronic acid,Valaciclovir,The risk or severity of nephrotoxicity and hypocalcemia can be increased when Valaciclovir is combined with Incadronic acid.,increase,risk
Incadronic acid,Valdecoxib,The risk or severity of gastrointestinal bleeding can be increased when Valdecoxib is combined with Incadronic acid.,increase,risk
Incadronic acid,Vancomycin,The risk or severity of nephrotoxicity and hypocalcemia can be increased when Vancomycin is combined with Incadronic acid.,increase,risk
Incadronic acid,Zoledronic acid,The risk or severity of adverse effects can be increased when Zoledronic acid is combined with Incadronic acid.,increase,risk
Hexaminolevulinate,BCG vaccine,BCG vaccine may decrease effectiveness of Hexaminolevulinate as a diagnostic agent.,decrease,no risk
Hexaminolevulinate,Verteporfin,Hexaminolevulinate may increase the photosensitizing activities of Verteporfin.,increase,no risk
Droxidopa,Bisoxatin,Droxidopa may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,decrease,no risk
Droxidopa,Bleomycin,Bleomycin may decrease the excretion rate of Droxidopa which could result in a higher serum level.,decrease,no risk
Droxidopa,Bosentan,Droxidopa may decrease the antihypertensive activities of Bosentan.,decrease,no risk
Droxidopa,Bretylium,Droxidopa may decrease the antihypertensive activities of Bretylium.,decrease,no risk
Droxidopa,Brexpiprazole,Brexpiprazole may increase the hypertensive activities of Droxidopa.,increase,no risk
Droxidopa,Brivaracetam,Brivaracetam may decrease the excretion rate of Droxidopa which could result in a higher serum level.,decrease,no risk
Droxidopa,Bromazepam,Bromazepam may decrease the excretion rate of Droxidopa which could result in a higher serum level.,decrease,no risk
Droxidopa,Bromocriptine,Bromocriptine may increase the hypertensive and vasoconstricting activities of Droxidopa.,increase,no risk
Droxidopa,Bromotheophylline,Bromotheophylline may increase the excretion rate of Droxidopa which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Droxidopa,Brompheniramine,The therapeutic efficacy of Droxidopa can be increased when used in combination with Brompheniramine.,increase,no risk
Droxidopa,Buclizine,The therapeutic efficacy of Droxidopa can be increased when used in combination with Buclizine.,increase,no risk
Droxidopa,Budesonide,The risk or severity of hypokalemia can be increased when Budesonide is combined with Droxidopa.,increase,risk
Droxidopa,Bumadizone,The risk or severity of hypertension can be increased when Droxidopa is combined with Bumadizone.,increase,risk
Droxidopa,Bumetanide,The risk or severity of hypokalemia can be increased when Droxidopa is combined with Bumetanide.,increase,risk
Droxidopa,Bupropion,Bupropion may decrease the excretion rate of Droxidopa which could result in a higher serum level.,decrease,no risk
Droxidopa,Buspirone,The risk or severity of hypertension can be increased when Buspirone is combined with Droxidopa.,increase,risk
Droxidopa,Butabarbital,Butabarbital may decrease the excretion rate of Droxidopa which could result in a higher serum level.,decrease,no risk
Droxidopa,Butriptyline,Butriptyline may increase the vasopressor activities of Droxidopa.,increase,no risk
Droxidopa,Butylscopolamine,The risk or severity of Tachycardia can be increased when Droxidopa is combined with Butylscopolamine.,increase,risk
Droxidopa,Gabapentin enacarbil,The risk or severity of hypokalemia can be increased when Droxidopa is combined with Furosemide.,increase,risk
Droxidopa,Gadobenic acid,Droxidopa may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Droxidopa,Gadodiamide,Gadobenic acid may decrease the excretion rate of Droxidopa which could result in a higher serum level.,decrease,no risk
Droxidopa,Gadofosveset trisodium,Gadodiamide may decrease the excretion rate of Droxidopa which could result in a higher serum level.,decrease,no risk
Droxidopa,Gadopentetic acid,Droxidopa may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Droxidopa,Gadoteric acid,Gadopentetic acid may decrease the excretion rate of Droxidopa which could result in a higher serum level.,decrease,no risk
Droxidopa,Gadoteridol,Droxidopa may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Droxidopa,Gallamine triethiodide,Gadoteridol may decrease the excretion rate of Droxidopa which could result in a higher serum level.,decrease,no risk
Droxidopa,Ganciclovir,The risk or severity of Tachycardia can be increased when Gallamine triethiodide is combined with Droxidopa.,increase,risk
Droxidopa,Gemcitabine,Ganciclovir may decrease the excretion rate of Droxidopa which could result in a higher serum level.,decrease,no risk
Droxidopa,Gemfibrozil,Gemcitabine may decrease the excretion rate of Droxidopa which could result in a higher serum level.,decrease,no risk
Droxidopa,Gentamicin,Gemfibrozil may decrease the excretion rate of Droxidopa which could result in a higher serum level.,decrease,no risk
Droxidopa,Gimeracil,Droxidopa may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Droxidopa,Givosiran,Droxidopa may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Droxidopa,Glipizide,Givosiran may decrease the excretion rate of Droxidopa which could result in a higher serum level.,decrease,no risk
Droxidopa,Glycerol phenylbutyrate,Glipizide may decrease the excretion rate of Droxidopa which could result in a higher serum level.,decrease,no risk
Droxidopa,Glycopyrronium,Droxidopa may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Droxidopa,Golodirsen,The risk or severity of Tachycardia can be increased when Glycopyrronium is combined with Droxidopa.,increase,risk
Droxidopa,Goserelin,Droxidopa may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Droxidopa,Guanabenz,Goserelin may decrease the excretion rate of Droxidopa which could result in a higher serum level.,decrease,no risk
Droxidopa,Guanadrel,Droxidopa may decrease the antihypertensive activities of Guanabenz.,decrease,no risk
Droxidopa,Guanethidine,Droxidopa may decrease the antihypertensive activities of Guanadrel.,decrease,no risk
Droxidopa,Guanfacine,Droxidopa may decrease the antihypertensive activities of Guanethidine.,decrease,no risk
Droxidopa,Guanoxan,Droxidopa may decrease the antihypertensive activities of Guanfacine.,decrease,no risk
Droxidopa,Haloperidol,Droxidopa may decrease the antihypertensive activities of Guanoxan.,decrease,no risk
Droxidopa,Halothane,Haloperidol may decrease the excretion rate of Droxidopa which could result in a higher serum level.,decrease,no risk
Droxidopa,Hexocyclium,The risk or severity of hypertension can be increased when Halothane is combined with Droxidopa.,increase,risk
Droxidopa,Homatropine methylbromide,The risk or severity of Tachycardia can be increased when Droxidopa is combined with Hexocyclium.,increase,risk
Droxidopa,Hydralazine,The risk or severity of Tachycardia can be increased when Homatropine methylbromide is combined with Droxidopa.,increase,risk
Droxidopa,Hydrochlorothiazide,Droxidopa may decrease the antihypertensive activities of Hydralazine.,decrease,no risk
Droxidopa,Hydrocortisone,The risk or severity of hypokalemia can be increased when Droxidopa is combined with Hydrochlorothiazide.,increase,risk
Droxidopa,Hydrocortisone acetate,The risk or severity of hypokalemia can be increased when Hydrocortisone is combined with Droxidopa.,increase,risk
Droxidopa,Hydrocortisone butyrate,The risk or severity of hypokalemia can be increased when Hydrocortisone acetate is combined with Droxidopa.,increase,risk
Droxidopa,Hydrocortisone cypionate,The risk or severity of hypokalemia can be increased when Hydrocortisone butyrate is combined with Droxidopa.,increase,risk
Droxidopa,Hydrocortisone succinate,The risk or severity of hypokalemia can be increased when Hydrocortisone cypionate is combined with Droxidopa.,increase,risk
Droxidopa,Hydroflumethiazide,The risk or severity of hypokalemia can be increased when Hydrocortisone succinate is combined with Droxidopa.,increase,risk
Droxidopa,Hydromorphone,The risk or severity of hypokalemia can be increased when Droxidopa is combined with Hydroflumethiazide.,increase,risk
Droxidopa,Hydroxocobalamin,Hydromorphone may decrease the excretion rate of Droxidopa which could result in a higher serum level.,decrease,no risk
Droxidopa,Hydroxyethyl Starch,Hydroxocobalamin may decrease the excretion rate of Droxidopa which could result in a higher serum level.,decrease,no risk
Droxidopa,Hyoscyamine,Droxidopa may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Droxidopa,Kanamycin,Droxidopa may decrease the excretion rate of Ixazomib which could result in a higher serum level.,decrease,no risk
Droxidopa,Ketamine,Droxidopa may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Droxidopa,Ketazolam,Ketamine may decrease the excretion rate of Droxidopa which could result in a higher serum level.,decrease,no risk
Droxidopa,Ketoprofen,Ketazolam may decrease the excretion rate of Droxidopa which could result in a higher serum level.,decrease,no risk
Droxidopa,Ketorolac,The risk or severity of hypertension can be increased when Ketoprofen is combined with Droxidopa.,increase,risk
Droxidopa,Ketotifen,The risk or severity of hypertension can be increased when Ketorolac is combined with Droxidopa.,increase,risk
Droxidopa,N-acetyltyrosine,Mycophenolic acid may decrease the excretion rate of Droxidopa which could result in a higher serum level.,decrease,no risk
Droxidopa,Nabilone,Droxidopa may decrease the excretion rate of N-acetyltyrosine which could result in a higher serum level.,decrease,no risk
Droxidopa,Nabumetone,The risk or severity of Tachycardia can be increased when Nabilone is combined with Droxidopa.,increase,risk
Droxidopa,Nadolol,The risk or severity of hypertension can be increased when Nabumetone is combined with Droxidopa.,increase,risk
Droxidopa,Naldemedine,Nadolol may decrease the bronchodilatory activities of Droxidopa.,decrease,no risk
Droxidopa,Nalmefene,Droxidopa may decrease the excretion rate of Naldemedine which could result in a higher serum level.,decrease,no risk
Droxidopa,Naloxone,Nalmefene may decrease the excretion rate of Droxidopa which could result in a higher serum level.,decrease,no risk
Droxidopa,Naphazoline,Naloxone may decrease the excretion rate of Droxidopa which could result in a higher serum level.,decrease,no risk
Droxidopa,Naproxen,The therapeutic efficacy of Naphazoline can be increased when used in combination with Droxidopa.,increase,no risk
Droxidopa,Naratriptan,The risk or severity of hypertension can be increased when Naproxen is combined with Droxidopa.,increase,risk
Droxidopa,Nateglinide,Naratriptan may increase the hypertensive activities of Droxidopa.,increase,no risk
Droxidopa,Naxitamab,Nateglinide may decrease the excretion rate of Droxidopa which could result in a higher serum level.,decrease,no risk
Droxidopa,Nebivolol,The risk or severity of hypertension can be increased when Droxidopa is combined with Naxitamab.,increase,risk
Droxidopa,Nedaplatin,The therapeutic efficacy of Droxidopa can be decreased when used in combination with Nebivolol.,decrease,no risk
Droxidopa,Nedocromil,Droxidopa may decrease the excretion rate of Nedaplatin which could result in a higher serum level.,decrease,no risk
Droxidopa,Nefazodone,Nedocromil may decrease the excretion rate of Droxidopa which could result in a higher serum level.,decrease,no risk
Droxidopa,Neomycin,Nefazodone may increase the tachycardic activities of Droxidopa.,increase,no risk
Droxidopa,Netilmicin,Droxidopa may decrease the excretion rate of Neomycin which could result in a higher serum level.,decrease,no risk
Droxidopa,Nialamide,Droxidopa may decrease the excretion rate of Netilmicin which could result in a higher serum level.,decrease,no risk
Droxidopa,Nicardipine,Nialamide may increase the hypertensive activities of Droxidopa.,increase,no risk
Droxidopa,Nicergoline,The therapeutic efficacy of Droxidopa can be decreased when used in combination with Nicardipine.,decrease,no risk
Droxidopa,Nicorandil,Nicergoline may increase the hypertensive and vasoconstricting activities of Droxidopa.,increase,no risk
Droxidopa,Nicotine,Droxidopa may decrease the antihypertensive activities of Nicorandil.,decrease,no risk
Droxidopa,Nifedipine,The risk or severity of Tachycardia can be increased when Nicotine is combined with Droxidopa.,increase,risk
Droxidopa,Nilutamide,Nifedipine may decrease the excretion rate of Droxidopa which could result in a higher serum level.,decrease,no risk
Droxidopa,Nilvadipine,Nilutamide may decrease the excretion rate of Droxidopa which could result in a higher serum level.,decrease,no risk
Droxidopa,Nimesulide,Droxidopa may decrease the antihypertensive activities of Nilvadipine.,decrease,no risk
Droxidopa,Nimodipine,The risk or severity of hypertension can be increased when Nimesulide is combined with Droxidopa.,increase,risk
Droxidopa,Nisoldipine,Droxidopa may decrease the antihypertensive activities of Nimodipine.,decrease,no risk
Droxidopa,Nitrendipine,Droxidopa may decrease the antihypertensive activities of Nisoldipine.,decrease,no risk
Droxidopa,Nitric Oxide,Droxidopa may decrease the antihypertensive activities of Nitrendipine.,decrease,no risk
Droxidopa,Nitrofurantoin,Nitric Oxide may decrease the excretion rate of Droxidopa which could result in a higher serum level.,decrease,no risk
Droxidopa,Nitroglycerin,Nitrofurantoin may decrease the excretion rate of Droxidopa which could result in a higher serum level.,decrease,no risk
Droxidopa,Nitroprusside,Droxidopa may decrease the antihypertensive activities of Nitroglycerin.,decrease,no risk
Droxidopa,Nitrous oxide,Droxidopa may decrease the antihypertensive activities of Nitroprusside.,decrease,no risk
Droxidopa,Norepinephrine,The risk or severity of hypertension can be increased when Droxidopa is combined with Nitrous oxide.,increase,risk
Droxidopa,Nortriptyline,The therapeutic efficacy of Norepinephrine can be increased when used in combination with Droxidopa.,increase,no risk
Droxidopa,Nylidrin,Nortriptyline may increase the vasopressor activities of Droxidopa.,increase,no risk
Droxidopa,Octinoxate,The therapeutic efficacy of Nylidrin can be increased when used in combination with Droxidopa.,increase,no risk
Droxidopa,Olanzapine,Droxidopa may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Droxidopa,Olmesartan,The therapeutic efficacy of Droxidopa can be decreased when used in combination with Olanzapine.,decrease,no risk
Droxidopa,Olodaterol,Droxidopa may decrease the antihypertensive activities of Olmesartan.,decrease,no risk
Droxidopa,Olsalazine,The risk or severity of adverse effects can be increased when Droxidopa is combined with Olodaterol.,increase,risk
Droxidopa,Opium,Olsalazine may decrease the excretion rate of Droxidopa which could result in a higher serum level.,decrease,no risk
Droxidopa,Orciprenaline,Droxidopa may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Droxidopa,Orphenadrine,The therapeutic efficacy of Orciprenaline can be increased when used in combination with Droxidopa.,increase,no risk
Droxidopa,Oseltamivir,The risk or severity of Tachycardia can be increased when Orphenadrine is combined with Droxidopa.,increase,risk
Droxidopa,Ouabain,Oseltamivir may decrease the excretion rate of Droxidopa which could result in a higher serum level.,decrease,no risk
Droxidopa,Oxacillin,The risk or severity of Cardiac Arrhythmia can be increased when Droxidopa is combined with Ouabain.,increase,risk
Droxidopa,Oxaprozin,Oxacillin may decrease the excretion rate of Droxidopa which could result in a higher serum level.,decrease,no risk
Droxidopa,Oxatomide,The risk or severity of hypertension can be increased when Oxaprozin is combined with Droxidopa.,increase,risk
Droxidopa,Oxazepam,The therapeutic efficacy of Droxidopa can be increased when used in combination with Oxatomide.,increase,no risk
Droxidopa,Oxprenolol,Oxazepam may decrease the excretion rate of Droxidopa which could result in a higher serum level.,decrease,no risk
Droxidopa,Oxtriphylline,Oxprenolol may decrease the bronchodilatory activities of Droxidopa.,decrease,no risk
Droxidopa,Oxybenzone,The risk or severity of hypokalemia can be increased when Oxtriphylline is combined with Droxidopa.,increase,risk
Droxidopa,Oxybutynin,Oxybenzone may decrease the excretion rate of Droxidopa which could result in a higher serum level.,decrease,no risk
Droxidopa,Oxymetazoline,The risk or severity of Tachycardia can be increased when Oxybutynin is combined with Droxidopa.,increase,risk
Droxidopa,Oxyphenbutazone,Droxidopa may increase the hypertensive and vasoconstricting activities of Oxymetazoline.,increase,no risk
Droxidopa,Oxyphencyclimine,The risk or severity of hypertension can be increased when Oxyphenbutazone is combined with Droxidopa.,increase,risk
Droxidopa,Oxyphenonium,The risk or severity of Tachycardia can be increased when Oxyphencyclimine is combined with Droxidopa.,increase,risk
Droxidopa,Oxyquinoline,The risk or severity of Tachycardia can be increased when Oxyphenonium is combined with Droxidopa.,increase,risk
Droxidopa,Quetiapine,Pyridoxine may decrease the excretion rate of Droxidopa which could result in a higher serum level.,decrease,no risk
Droxidopa,Quinapril,The therapeutic efficacy of Droxidopa can be decreased when used in combination with Quetiapine.,decrease,no risk
Droxidopa,Quinethazone,Droxidopa may decrease the antihypertensive activities of Quinapril.,decrease,no risk
Droxidopa,Quinidine,Quinethazone may increase the excretion rate of Droxidopa which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Droxidopa,Quinupramine,Droxidopa may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Droxidopa,Umeclidinium,The risk or severity of Tachycardia can be increased when Trospium is combined with Droxidopa.,increase,risk
Droxidopa,Vaborbactam,The risk or severity of Tachycardia can be increased when Droxidopa is combined with Umeclidinium.,increase,risk
Droxidopa,Valaciclovir,Droxidopa may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Droxidopa,Valbenazine,Valaciclovir may decrease the excretion rate of Droxidopa which could result in a higher serum level.,decrease,no risk
Droxidopa,Valdecoxib,Droxidopa may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
Droxidopa,Valganciclovir,The risk or severity of hypertension can be increased when Valdecoxib is combined with Droxidopa.,increase,risk
Droxidopa,Valsartan,Valganciclovir may decrease the excretion rate of Droxidopa which could result in a higher serum level.,decrease,no risk
Droxidopa,Vamorolone,Droxidopa may decrease the antihypertensive activities of Valsartan.,decrease,no risk
Droxidopa,Vancomycin,The risk or severity of hypokalemia can be increased when Vamorolone is combined with Droxidopa.,increase,risk
Droxidopa,Varenicline,Droxidopa may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Droxidopa,Vasopressin,Varenicline may decrease the excretion rate of Droxidopa which could result in a higher serum level.,decrease,no risk
Droxidopa,Venlafaxine,Vasopressin may increase the hypertensive activities of Droxidopa.,increase,no risk
Droxidopa,Verapamil,Venlafaxine may increase the tachycardic activities of Droxidopa.,increase,no risk
Droxidopa,Vilanterol,Verapamil may decrease the hypertensive activities of Droxidopa.,decrease,no risk
Droxidopa,Vilazodone,The risk or severity of adverse effects can be increased when Droxidopa is combined with Vilanterol.,increase,risk
Droxidopa,Viloxazine,Vilazodone may increase the hypertensive activities of Droxidopa.,increase,no risk
Droxidopa,Vortioxetine,Droxidopa may decrease the excretion rate of Viloxazine which could result in a higher serum level.,decrease,no risk
Droxidopa,Warfarin,Vortioxetine may increase the hypertensive activities of Droxidopa.,increase,no risk
Droxidopa,Xamoterol,Droxidopa may decrease the excretion rate of Warfarin which could result in a higher serum level.,decrease,no risk
Droxidopa,Xylometazoline,The risk or severity of hypertension can be increased when Droxidopa is combined with Xamoterol.,increase,risk
Droxidopa,Yohimbine,The risk or severity of hypertension can be increased when Droxidopa is combined with Xylometazoline.,increase,risk
Droxidopa,Zaleplon,Yohimbine may decrease the hypertensive activities of Droxidopa.,decrease,no risk
Droxidopa,Zanamivir,Zaleplon may decrease the excretion rate of Droxidopa which could result in a higher serum level.,decrease,no risk
Droxidopa,Ziprasidone,Zanamivir may decrease the excretion rate of Droxidopa which could result in a higher serum level.,decrease,no risk
Droxidopa,Zofenopril,Ziprasidone may increase the hypertensive activities of Droxidopa.,increase,no risk
Droxidopa,Zolmitriptan,Droxidopa may decrease the antihypertensive activities of Zofenopril.,decrease,no risk
Droxidopa,Zonisamide,Zolmitriptan may increase the hypertensive activities of Droxidopa.,increase,no risk
Droxidopa,Zuclopenthixol,Zonisamide may increase the excretion rate of Droxidopa which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Amrubicin,Benzocaine,The risk or severity of methemoglobinemia can be increased when Amrubicin is combined with Benzocaine.,increase,risk
Amrubicin,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Amrubicin is combined with Benzyl alcohol.,increase,risk
Amrubicin,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Amrubicin is combined with Bupivacaine.,increase,risk
Amrubicin,Butacaine,The risk or severity of methemoglobinemia can be increased when Amrubicin is combined with Butacaine.,increase,risk
Amrubicin,Butamben,The risk or severity of methemoglobinemia can be increased when Amrubicin is combined with Butamben.,increase,risk
Amrubicin,Nelarabine,The risk or severity of adverse effects can be increased when Nelarabine is combined with Amrubicin.,increase,risk
Amrubicin,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Amrubicin is combined with Oxetacaine.,increase,risk
Amrubicin,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Amrubicin is combined with Oxybuprocaine.,increase,risk
Tolperisone,Gabapentin,The risk or severity of CNS depression can be increased when Gabapentin is combined with Tolperisone.,increase,risk
Tolperisone,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Tolperisone is combined with Gabapentin enacarbil.,increase,risk
Tolperisone,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with Tolperisone.,increase,risk
Tolperisone,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Tolperisone is combined with Ganaxolone.",increase,risk
Tolperisone,Gepirone,The risk or severity of CNS depression can be increased when Tolperisone is combined with Gepirone.,increase,risk
Tolperisone,Glutethimide,The risk or severity of CNS depression can be increased when Glutethimide is combined with Tolperisone.,increase,risk
Tolperisone,Granisetron,The risk or severity of CNS depression can be increased when Granisetron is combined with Tolperisone.,increase,risk
Tolperisone,Guanfacine,The risk or severity of CNS depression can be increased when Guanfacine is combined with Tolperisone.,increase,risk
Tolperisone,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with Tolperisone.,increase,risk
Tolperisone,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Tolperisone.,increase,risk
Tolperisone,Halothane,The risk or severity of CNS depression can be increased when Halothane is combined with Tolperisone.,increase,risk
Tolperisone,Hexafluronium,The risk or severity of CNS depression can be increased when Hexafluronium is combined with Tolperisone.,increase,risk
Tolperisone,Hydrocodone,Tolperisone may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Tolperisone,Hydromorphone,The risk or severity of CNS depression can be increased when Hydromorphone is combined with Tolperisone.,increase,risk
Tolperisone,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Tolperisone.,increase,no risk
Tolperisone,Ketamine,The risk or severity of CNS depression can be increased when Ketamine is combined with Tolperisone.,increase,risk
Tolperisone,Ketazolam,The risk or severity of CNS depression can be increased when Ketazolam is combined with Tolperisone.,increase,risk
Tolperisone,Nabilone,Nabilone may increase the central nervous system depressant (CNS depressant) activities of Tolperisone.,increase,no risk
Tolperisone,Nalbuphine,The risk or severity of CNS depression can be increased when Nalbuphine is combined with Tolperisone.,increase,risk
Tolperisone,Naloxegol,The risk or severity of respiratory depression can be increased when Naloxegol is combined with Tolperisone.,increase,risk
Tolperisone,Naltrexone,The risk or severity of respiratory depression can be increased when Naltrexone is combined with Tolperisone.,increase,risk
Tolperisone,Naratriptan,The risk or severity of CNS depression can be increased when Naratriptan is combined with Tolperisone.,increase,risk
Tolperisone,Nefazodone,The risk or severity of adverse effects can be increased when Tolperisone is combined with Nefazodone.,increase,risk
Tolperisone,Nialamide,The risk or severity of CNS depression can be increased when Nialamide is combined with Tolperisone.,increase,risk
Tolperisone,Nitrazepam,The risk or severity of CNS depression can be increased when Nitrazepam is combined with Tolperisone.,increase,risk
Tolperisone,Nitrous oxide,The risk or severity of CNS depression can be increased when Tolperisone is combined with Nitrous oxide.,increase,risk
Tolperisone,Nomifensine,The risk or severity of CNS depression can be increased when Nomifensine is combined with Tolperisone.,increase,risk
Tolperisone,Normethadone,The risk or severity of CNS depression can be increased when Tolperisone is combined with Normethadone.,increase,risk
Tolperisone,Nortriptyline,The risk or severity of CNS depression can be increased when Nortriptyline is combined with Tolperisone.,increase,risk
Tolperisone,Olanzapine,The risk or severity of CNS depression can be increased when Olanzapine is combined with Tolperisone.,increase,risk
Tolperisone,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Tolperisone is combined with Oliceridine.",increase,risk
Tolperisone,Ondansetron,The risk or severity of CNS depression can be increased when Ondansetron is combined with Tolperisone.,increase,risk
Tolperisone,Opium,The risk or severity of CNS depression can be increased when Tolperisone is combined with Opium.,increase,risk
Tolperisone,Orphenadrine,Tolperisone may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Tolperisone,Oxazepam,The risk or severity of CNS depression can be increased when Oxazepam is combined with Tolperisone.,increase,risk
Tolperisone,Oxcarbazepine,The risk or severity of CNS depression can be increased when Oxcarbazepine is combined with Tolperisone.,increase,risk
Tolperisone,Oxitriptan,The risk or severity of CNS depression can be increased when Oxitriptan is combined with Tolperisone.,increase,risk
Tolperisone,Oxprenolol,The risk or severity of CNS depression can be increased when Oxprenolol is combined with Tolperisone.,increase,risk
Tolperisone,Oxybuprocaine,The risk or severity of CNS depression can be increased when Oxybuprocaine is combined with Tolperisone.,increase,risk
Tolperisone,Oxycodone,The risk or severity of CNS depression can be increased when Oxycodone is combined with Tolperisone.,increase,risk
Tolperisone,Oxymorphone,The risk or severity of CNS depression can be increased when Oxymorphone is combined with Tolperisone.,increase,risk
Tolperisone,Quazepam,The risk or severity of CNS depression can be increased when Quazepam is combined with Tolperisone.,increase,risk
Tolperisone,Quetiapine,The risk or severity of CNS depression can be increased when Quetiapine is combined with Tolperisone.,increase,risk
Tolperisone,Quinine,The risk or severity of CNS depression can be increased when Quinine is combined with Tolperisone.,increase,risk
Tolperisone,Quinupramine,The risk or severity of CNS depression can be increased when Tolperisone is combined with Quinupramine.,increase,risk
Tolperisone,Urethane,The risk or severity of CNS depression can be increased when Urethane is combined with Tolperisone.,increase,risk
Tolperisone,Valproic acid,The risk or severity of CNS depression can be increased when Valproic acid is combined with Tolperisone.,increase,risk
Tolperisone,Vecuronium,The risk or severity of CNS depression can be increased when Vecuronium is combined with Tolperisone.,increase,risk
Tolperisone,Venlafaxine,The risk or severity of CNS depression can be increased when Venlafaxine is combined with Tolperisone.,increase,risk
Tolperisone,Vigabatrin,The risk or severity of CNS depression can be increased when Vigabatrin is combined with Tolperisone.,increase,risk
Tolperisone,Vilazodone,The risk or severity of CNS depression can be increased when Tolperisone is combined with Vilazodone.,increase,risk
Tolperisone,Viloxazine,The risk or severity of CNS depression can be increased when Tolperisone is combined with Viloxazine.,increase,risk
Tolperisone,Vortioxetine,The risk or severity of CNS depression can be increased when Tolperisone is combined with Vortioxetine.,increase,risk
Tolperisone,Yohimbine,The risk or severity of CNS depression can be increased when Yohimbine is combined with Tolperisone.,increase,risk
Tolperisone,Zaleplon,The risk or severity of CNS depression can be increased when Zaleplon is combined with Tolperisone.,increase,risk
Tolperisone,Ziconotide,The risk or severity of CNS depression can be increased when Tolperisone is combined with Ziconotide.,increase,risk
Tolperisone,Zimelidine,The risk or severity of adverse effects can be increased when Tolperisone is combined with Zimelidine.,increase,risk
Tolperisone,Ziprasidone,The risk or severity of adverse effects can be increased when Tolperisone is combined with Ziprasidone.,increase,risk
Tolperisone,Zolmitriptan,The risk or severity of CNS depression can be increased when Zolmitriptan is combined with Tolperisone.,increase,risk
Tolperisone,Zolpidem,Tolperisone may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Tolperisone,Zonisamide,The risk or severity of CNS depression can be increased when Zonisamide is combined with Tolperisone.,increase,risk
Tolperisone,Zopiclone,The risk or severity of adverse effects can be increased when Tolperisone is combined with Zopiclone.,increase,risk
Tolperisone,Zotepine,The risk or severity of CNS depression can be increased when Tolperisone is combined with Zotepine.,increase,risk
Tolperisone,Zuclopenthixol,The risk or severity of CNS depression can be increased when Zuclopenthixol is combined with Tolperisone.,increase,risk
Tolperisone,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Tolperisone.,increase,risk
Udenafil,Gefitinib,The metabolism of Udenafil can be decreased when combined with Gefitinib.,decrease,no risk
Udenafil,Gliclazide,The therapeutic efficacy of Gliclazide can be increased when used in combination with Udenafil.,increase,no risk
Udenafil,Glimepiride,The therapeutic efficacy of Glimepiride can be increased when used in combination with Udenafil.,increase,no risk
Udenafil,Glipizide,The therapeutic efficacy of Glipizide can be increased when used in combination with Udenafil.,increase,no risk
Udenafil,Gliquidone,The therapeutic efficacy of Gliquidone can be increased when used in combination with Udenafil.,increase,no risk
Udenafil,Glofitamab,The serum concentration of Udenafil can be increased when it is combined with Glofitamab.,increase,no risk
Udenafil,Glyburide,The therapeutic efficacy of Glyburide can be increased when used in combination with Udenafil.,increase,no risk
Udenafil,Glymidine,The therapeutic efficacy of Glymidine can be increased when used in combination with Udenafil.,increase,no risk
Udenafil,Golimumab,The metabolism of Udenafil can be increased when combined with Golimumab.,increase,no risk
Udenafil,Guanabenz,Udenafil may increase the antihypertensive activities of Guanabenz.,increase,no risk
Udenafil,Guanadrel,Udenafil may increase the antihypertensive activities of Guanadrel.,increase,no risk
Udenafil,Guanethidine,Udenafil may increase the antihypertensive activities of Guanethidine.,increase,no risk
Udenafil,Guanfacine,Udenafil may increase the antihypertensive activities of Guanfacine.,increase,no risk
Udenafil,Guanoxan,Udenafil may increase the antihypertensive activities of Guanoxan.,increase,no risk
Udenafil,Halofantrine,The metabolism of Udenafil can be decreased when combined with Halofantrine.,decrease,no risk
Udenafil,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Udenafil.,increase,no risk
Udenafil,Halothane,The risk or severity of hypotension can be increased when Udenafil is combined with Halothane.,increase,risk
Udenafil,Hydralazine,Udenafil may increase the antihypertensive activities of Hydralazine.,increase,no risk
Udenafil,Hydrochlorothiazide,Udenafil may increase the antihypertensive activities of Hydrochlorothiazide.,increase,no risk
Udenafil,Hydrocortisone,The metabolism of Udenafil can be decreased when combined with Hydrocortisone.,decrease,no risk
Udenafil,Hydrocortisone acetate,The metabolism of Hydrocortisone acetate can be decreased when combined with Udenafil.,decrease,no risk
Udenafil,Hydrocortisone butyrate,The metabolism of Hydrocortisone butyrate can be decreased when combined with Udenafil.,decrease,no risk
Udenafil,Hydrocortisone cypionate,The metabolism of Hydrocortisone cypionate can be decreased when combined with Udenafil.,decrease,no risk
Udenafil,Hydrocortisone phosphate,The metabolism of Hydrocortisone phosphate can be decreased when combined with Udenafil.,decrease,no risk
Udenafil,Hydroflumethiazide,Udenafil may increase the antihypertensive activities of Hydroflumethiazide.,increase,no risk
Udenafil,Hydroxyprogesterone caproate,The metabolism of Hydroxyprogesterone caproate can be decreased when combined with Udenafil.,decrease,no risk
Udenafil,Hydroxyzine,The metabolism of Udenafil can be decreased when combined with Hydroxyzine.,decrease,no risk
Udenafil,Ketoconazole,The metabolism of Udenafil can be decreased when combined with Ketoconazole.,decrease,no risk
Udenafil,Ketoprofen,The risk or severity of adverse effects can be increased when Ketoprofen is combined with Udenafil.,increase,risk
Udenafil,Nabilone,The risk or severity of hypotension can be increased when Udenafil is combined with Nabilone.,increase,risk
Udenafil,Nadolol,Udenafil may increase the antihypertensive activities of Nadolol.,increase,no risk
Udenafil,Nateglinide,The therapeutic efficacy of Nateglinide can be increased when used in combination with Udenafil.,increase,no risk
Udenafil,Nebivolol,Udenafil may increase the antihypertensive activities of Nebivolol.,increase,no risk
Udenafil,Nefazodone,The metabolism of Udenafil can be decreased when combined with Nefazodone.,decrease,no risk
Udenafil,Nelfinavir,The metabolism of Udenafil can be decreased when combined with Nelfinavir.,decrease,no risk
Udenafil,Nesiritide,The risk or severity of hypotension can be increased when Udenafil is combined with Nesiritide.,increase,risk
Udenafil,Netupitant,The metabolism of Udenafil can be decreased when combined with Netupitant.,decrease,no risk
Udenafil,Nevirapine,The metabolism of Udenafil can be decreased when combined with Nevirapine.,decrease,no risk
Udenafil,Nicardipine,The risk or severity of hypotension and syncope can be increased when Udenafil is combined with Nicardipine.,increase,risk
Udenafil,Nicergoline,The risk or severity of hypotension and syncope can be increased when Udenafil is combined with Nicergoline.,increase,risk
Udenafil,Nicorandil,Udenafil may increase the hypotensive activities of Nicorandil.,increase,no risk
Udenafil,Nicotine,The risk or severity of adverse effects can be increased when Udenafil is combined with Nicotine.,increase,risk
Udenafil,Nifedipine,The risk or severity of hypotension can be increased when Udenafil is combined with Nifedipine.,increase,risk
Udenafil,Nilotinib,The metabolism of Udenafil can be decreased when combined with Nilotinib.,decrease,no risk
Udenafil,Nilvadipine,The metabolism of Udenafil can be decreased when combined with Nilvadipine.,decrease,no risk
Udenafil,Nimodipine,Udenafil may increase the antihypertensive activities of Nimodipine.,increase,no risk
Udenafil,Nisoldipine,Udenafil may increase the antihypertensive activities of Nisoldipine.,increase,no risk
Udenafil,Nitrendipine,Udenafil may increase the antihypertensive activities of Nitrendipine.,increase,no risk
Udenafil,Nitric Oxide,The risk or severity of hypotension can be increased when Udenafil is combined with Nitric Oxide.,increase,risk
Udenafil,Nitroglycerin,The risk or severity of hypotension can be increased when Udenafil is combined with Nitroglycerin.,increase,risk
Udenafil,Nitroprusside,Udenafil may increase the antihypertensive activities of Nitroprusside.,increase,no risk
Udenafil,Nitrous acid,The risk or severity of hypotension can be increased when Udenafil is combined with Nitrous acid.,increase,risk
Udenafil,Norethisterone,The metabolism of Udenafil can be decreased when combined with Norethisterone.,decrease,no risk
Udenafil,Nortriptyline,The risk or severity of hypotension and syncope can be increased when Udenafil is combined with Nortriptyline.,increase,risk
Udenafil,Obinutuzumab,The risk or severity of hypotension can be increased when Udenafil is combined with Obinutuzumab.,increase,risk
Udenafil,Olanzapine,The risk or severity of hypotension and syncope can be increased when Udenafil is combined with Olanzapine.,increase,risk
Udenafil,Olaparib,The metabolism of Olaparib can be decreased when combined with Udenafil.,decrease,no risk
Udenafil,Olmesartan,Udenafil may increase the antihypertensive activities of Olmesartan.,increase,no risk
Udenafil,Omaveloxolone,The serum concentration of Udenafil can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Udenafil,Ondansetron,The metabolism of Udenafil can be decreased when combined with Ondansetron.,decrease,no risk
Udenafil,Opicapone,The risk or severity of hypotension can be increased when Udenafil is combined with Opicapone.,increase,risk
Udenafil,Osilodrostat,The metabolism of Udenafil can be decreased when combined with Osilodrostat.,decrease,no risk
Udenafil,Oxcarbazepine,The metabolism of Udenafil can be increased when combined with Oxcarbazepine.,increase,no risk
Udenafil,Oxprenolol,Udenafil may increase the antihypertensive activities of Oxprenolol.,increase,no risk
Udenafil,Oxybutynin,The metabolism of Udenafil can be decreased when combined with Oxybutynin.,decrease,no risk
Udenafil,Oxycodone,The metabolism of Udenafil can be decreased when combined with Oxycodone.,decrease,no risk
Udenafil,Quetiapine,The risk or severity of hypotension and syncope can be increased when Udenafil is combined with Quetiapine.,increase,risk
Udenafil,Quinapril,Udenafil may increase the antihypertensive activities of Quinapril.,increase,no risk
Udenafil,Quinidine,The risk or severity of hypotension and syncope can be increased when Udenafil is combined with Quinidine.,increase,risk
Udenafil,Quinine,The therapeutic efficacy of Quinine can be increased when used in combination with Udenafil.,increase,no risk
Udenafil,Quizartinib,The metabolism of Quizartinib can be decreased when combined with Udenafil.,decrease,no risk
Udenafil,Vadadustat,The serum concentration of Udenafil can be increased when it is combined with Vadadustat.,increase,no risk
Udenafil,Valbenazine,The metabolism of Valbenazine can be decreased when combined with Udenafil.,decrease,no risk
Udenafil,Valsartan,Udenafil may increase the antihypertensive activities of Valsartan.,increase,no risk
Udenafil,Vardenafil,The risk or severity of adverse effects can be increased when Vardenafil is combined with Udenafil.,increase,risk
Udenafil,Venetoclax,The metabolism of Udenafil can be decreased when combined with Venetoclax.,decrease,no risk
Udenafil,Verapamil,The metabolism of Udenafil can be decreased when combined with Verapamil.,decrease,no risk
Udenafil,Vericiguat,The risk or severity of hypotension can be increased when Udenafil is combined with Vericiguat.,increase,risk
Udenafil,Vildagliptin,The therapeutic efficacy of Vildagliptin can be increased when used in combination with Udenafil.,increase,no risk
Udenafil,Viloxazine,The metabolism of Udenafil can be decreased when combined with Viloxazine.,decrease,no risk
Udenafil,Vincristine,The metabolism of Vincristine can be decreased when combined with Udenafil.,decrease,no risk
Udenafil,Vonoprazan,The metabolism of Vonoprazan can be decreased when combined with Udenafil.,decrease,no risk
Udenafil,Voriconazole,The metabolism of Udenafil can be decreased when combined with Voriconazole.,decrease,no risk
Udenafil,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Udenafil.,decrease,no risk
Udenafil,Zaleplon,The metabolism of Udenafil can be decreased when combined with Zaleplon.,decrease,no risk
Udenafil,Zimelidine,The metabolism of Udenafil can be decreased when combined with Zimelidine.,decrease,no risk
Udenafil,Ziprasidone,The risk or severity of hypotension and syncope can be increased when Udenafil is combined with Ziprasidone.,increase,risk
Udenafil,Zofenopril,Udenafil may increase the antihypertensive activities of Zofenopril.,increase,no risk
Udenafil,Zonisamide,The metabolism of Udenafil can be decreased when combined with Zonisamide.,decrease,no risk
Udenafil,Zuclopenthixol,The risk or severity of hypotension and syncope can be increased when Udenafil is combined with Zuclopenthixol.,increase,risk
Sitaxentan,Brivaracetam,The metabolism of Brivaracetam can be decreased when combined with Sitaxentan.,decrease,no risk
Sitaxentan,Bromocriptine,Bromocriptine may decrease the antihypertensive activities of Sitaxentan.,decrease,no risk
Sitaxentan,Bumadizone,The therapeutic efficacy of Sitaxentan can be decreased when used in combination with Bumadizone.,decrease,no risk
Sitaxentan,Bumetanide,Bumetanide may increase the hypotensive activities of Sitaxentan.,increase,no risk
Sitaxentan,Bupivacaine,Bupivacaine may increase the hypotensive activities of Sitaxentan.,increase,no risk
Sitaxentan,Buprenorphine,The metabolism of Buprenorphine can be decreased when combined with Sitaxentan.,decrease,no risk
Sitaxentan,Bupropion,The metabolism of Bupropion can be decreased when combined with Sitaxentan.,decrease,no risk
Sitaxentan,Buspirone,Buspirone may decrease the antihypertensive activities of Sitaxentan.,decrease,no risk
Sitaxentan,Busulfan,The serum concentration of Busulfan can be increased when it is combined with Sitaxentan.,increase,no risk
Sitaxentan,Butriptyline,Butriptyline may decrease the antihypertensive activities of Sitaxentan.,decrease,no risk
Sitaxentan,Gemfibrozil,The metabolism of Sitaxentan can be decreased when combined with Gemfibrozil.,decrease,no risk
Sitaxentan,Gepirone,The serum concentration of Gepirone can be increased when it is combined with Sitaxentan.,increase,no risk
Sitaxentan,Gilteritinib,The metabolism of Gilteritinib can be decreased when combined with Sitaxentan.,decrease,no risk
Sitaxentan,Ginkgo biloba,The metabolism of Sitaxentan can be decreased when combined with Ginkgo biloba.,decrease,no risk
Sitaxentan,Gliclazide,The metabolism of Gliclazide can be decreased when combined with Sitaxentan.,decrease,no risk
Sitaxentan,Glimepiride,The metabolism of Glimepiride can be decreased when combined with Sitaxentan.,decrease,no risk
Sitaxentan,Glipizide,The metabolism of Glipizide can be decreased when combined with Sitaxentan.,decrease,no risk
Sitaxentan,Gliquidone,The metabolism of Gliquidone can be decreased when combined with Sitaxentan.,decrease,no risk
Sitaxentan,Glofitamab,The serum concentration of Sitaxentan can be increased when it is combined with Glofitamab.,increase,no risk
Sitaxentan,Glyburide,The metabolism of Glyburide can be decreased when combined with Sitaxentan.,decrease,no risk
Sitaxentan,Glycol salicylate,The therapeutic efficacy of Sitaxentan can be decreased when used in combination with Glycol salicylate.,decrease,no risk
Sitaxentan,Golimumab,The metabolism of Sitaxentan can be increased when combined with Golimumab.,increase,no risk
Sitaxentan,Guanabenz,Guanabenz may decrease the antihypertensive activities of Sitaxentan.,decrease,no risk
Sitaxentan,Guanadrel,Guanadrel may increase the hypotensive activities of Sitaxentan.,increase,no risk
Sitaxentan,Guanethidine,Guanethidine may increase the hypotensive activities of Sitaxentan.,increase,no risk
Sitaxentan,Guanfacine,Guanfacine may decrease the antihypertensive activities of Sitaxentan.,decrease,no risk
Sitaxentan,Guanoxan,Sitaxentan may increase the hypotensive activities of Guanoxan.,increase,no risk
Sitaxentan,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Sitaxentan.,increase,no risk
Sitaxentan,Halothane,The metabolism of Halothane can be decreased when combined with Sitaxentan.,decrease,no risk
Sitaxentan,Hydralazine,Hydralazine may increase the hypotensive activities of Sitaxentan.,increase,no risk
Sitaxentan,Hydrochlorothiazide,The therapeutic efficacy of Sitaxentan can be increased when used in combination with Hydrochlorothiazide.,increase,no risk
Sitaxentan,Hydroflumethiazide,The therapeutic efficacy of Sitaxentan can be increased when used in combination with Hydroflumethiazide.,increase,no risk
Sitaxentan,Hydromorphone,The metabolism of Hydromorphone can be decreased when combined with Sitaxentan.,decrease,no risk
Sitaxentan,Ketamine,The metabolism of Ketamine can be decreased when combined with Sitaxentan.,decrease,no risk
Sitaxentan,Ketoprofen,The therapeutic efficacy of Sitaxentan can be decreased when used in combination with Ketoprofen.,decrease,no risk
Sitaxentan,Ketorolac,The therapeutic efficacy of Sitaxentan can be decreased when used in combination with Ketorolac.,decrease,no risk
Sitaxentan,Nabilone,The metabolism of Nabilone can be decreased when combined with Sitaxentan.,decrease,no risk
Sitaxentan,Nabumetone,The therapeutic efficacy of Sitaxentan can be decreased when used in combination with Nabumetone.,decrease,no risk
Sitaxentan,Nadolol,Nadolol may increase the hypotensive activities of Sitaxentan.,increase,no risk
Sitaxentan,Naphazoline,Naphazoline may decrease the antihypertensive activities of Sitaxentan.,decrease,no risk
Sitaxentan,Naproxen,The therapeutic efficacy of Sitaxentan can be decreased when used in combination with Naproxen.,decrease,no risk
Sitaxentan,Naratriptan,Naratriptan may decrease the antihypertensive activities of Sitaxentan.,decrease,no risk
Sitaxentan,Nateglinide,The metabolism of Nateglinide can be decreased when combined with Sitaxentan.,decrease,no risk
Sitaxentan,Naxitamab,Naxitamab may decrease the antihypertensive activities of Sitaxentan.,decrease,no risk
Sitaxentan,Nebivolol,The metabolism of Nebivolol can be decreased when combined with Sitaxentan.,decrease,no risk
Sitaxentan,Nefazodone,Nefazodone may decrease the antihypertensive activities of Sitaxentan.,decrease,no risk
Sitaxentan,Neratinib,The serum concentration of Neratinib can be increased when it is combined with Sitaxentan.,increase,no risk
Sitaxentan,Nesiritide,Nesiritide may increase the hypotensive activities of Sitaxentan.,increase,no risk
Sitaxentan,Netupitant,The metabolism of Netupitant can be decreased when combined with Sitaxentan.,decrease,no risk
Sitaxentan,Nevirapine,The metabolism of Nevirapine can be decreased when combined with Sitaxentan.,decrease,no risk
Sitaxentan,Nialamide,Nialamide may increase the hypotensive activities of Sitaxentan.,increase,no risk
Sitaxentan,Nicardipine,The metabolism of Sitaxentan can be decreased when combined with Nicardipine.,decrease,no risk
Sitaxentan,Nicergoline,Nicergoline may decrease the antihypertensive activities of Sitaxentan.,decrease,no risk
Sitaxentan,Niclosamide,The metabolism of Niclosamide can be decreased when combined with Sitaxentan.,decrease,no risk
Sitaxentan,Nicorandil,Sitaxentan may increase the hypotensive activities of Nicorandil.,increase,no risk
Sitaxentan,Nifedipine,Nifedipine may increase the hypotensive activities of Sitaxentan.,increase,no risk
Sitaxentan,Nilotinib,The serum concentration of Nilotinib can be increased when it is combined with Sitaxentan.,increase,no risk
Sitaxentan,Nilutamide,The metabolism of Nilutamide can be decreased when combined with Sitaxentan.,decrease,no risk
Sitaxentan,Nilvadipine,Sitaxentan may increase the hypotensive activities of Nilvadipine.,increase,no risk
Sitaxentan,Nimesulide,The therapeutic efficacy of Sitaxentan can be decreased when used in combination with Nimesulide.,decrease,no risk
Sitaxentan,Nimodipine,Nimodipine may increase the hypotensive activities of Sitaxentan.,increase,no risk
Sitaxentan,Nintedanib,The metabolism of Nintedanib can be decreased when combined with Sitaxentan.,decrease,no risk
Sitaxentan,Nirogacestat,The metabolism of Nirogacestat can be decreased when combined with Sitaxentan.,decrease,no risk
Sitaxentan,Nisoldipine,Nisoldipine may increase the hypotensive activities of Sitaxentan.,increase,no risk
Sitaxentan,Nitrendipine,Nitrendipine may increase the hypotensive activities of Sitaxentan.,increase,no risk
Sitaxentan,Nitric Oxide,Nitric Oxide may increase the hypotensive activities of Sitaxentan.,increase,no risk
Sitaxentan,Nitroglycerin,Nitroglycerin may increase the hypotensive activities of Sitaxentan.,increase,no risk
Sitaxentan,Nitroprusside,Nitroprusside may increase the hypotensive activities of Sitaxentan.,increase,no risk
Sitaxentan,Nitrous acid,Nitrous acid may increase the hypotensive activities of Sitaxentan.,increase,no risk
Sitaxentan,Nitrous oxide,Nitrous oxide may decrease the antihypertensive activities of Sitaxentan.,decrease,no risk
Sitaxentan,Norepinephrine,Norepinephrine may decrease the antihypertensive activities of Sitaxentan.,decrease,no risk
Sitaxentan,Norethisterone,The metabolism of Norethisterone can be decreased when combined with Sitaxentan.,decrease,no risk
Sitaxentan,Norgestimate,The metabolism of Norgestimate can be decreased when combined with Sitaxentan.,decrease,no risk
Sitaxentan,Nortriptyline,The serum concentration of Nortriptyline can be increased when it is combined with Sitaxentan.,increase,no risk
Sitaxentan,Noscapine,The metabolism of Sitaxentan can be decreased when combined with Noscapine.,decrease,no risk
Sitaxentan,Nylidrin,Nylidrin may decrease the antihypertensive activities of Sitaxentan.,decrease,no risk
Sitaxentan,Obinutuzumab,Sitaxentan may increase the hypotensive activities of Obinutuzumab.,increase,no risk
Sitaxentan,Olanzapine,The metabolism of Sitaxentan can be decreased when combined with Olanzapine.,decrease,no risk
Sitaxentan,Olaparib,The serum concentration of Olaparib can be increased when it is combined with Sitaxentan.,increase,no risk
Sitaxentan,Olmesartan,Olmesartan may increase the hypotensive activities of Sitaxentan.,increase,no risk
Sitaxentan,Olodaterol,The metabolism of Olodaterol can be decreased when combined with Sitaxentan.,decrease,no risk
Sitaxentan,Omeprazole,The metabolism of Omeprazole can be decreased when combined with Sitaxentan.,decrease,no risk
Sitaxentan,Ondansetron,The metabolism of Ondansetron can be decreased when combined with Sitaxentan.,decrease,no risk
Sitaxentan,Opicapone,Opicapone may increase the hypotensive activities of Sitaxentan.,increase,no risk
Sitaxentan,Orciprenaline,Orciprenaline may decrease the antihypertensive activities of Sitaxentan.,decrease,no risk
Sitaxentan,Oritavancin,The metabolism of Sitaxentan can be decreased when combined with Oritavancin.,decrease,no risk
Sitaxentan,Osimertinib,The serum concentration of Osimertinib can be increased when it is combined with Sitaxentan.,increase,no risk
Sitaxentan,Ospemifene,The metabolism of Ospemifene can be decreased when combined with Sitaxentan.,decrease,no risk
Sitaxentan,Oxandrolone,The metabolism of Sitaxentan can be decreased when combined with Oxandrolone.,decrease,no risk
Sitaxentan,Oxaprozin,The therapeutic efficacy of Sitaxentan can be decreased when used in combination with Oxaprozin.,decrease,no risk
Sitaxentan,Oxprenolol,Oxprenolol may increase the hypotensive activities of Sitaxentan.,increase,no risk
Sitaxentan,Oxymetazoline,The therapeutic efficacy of Sitaxentan can be decreased when used in combination with Oxymetazoline.,decrease,no risk
Sitaxentan,Oxyphenbutazone,The therapeutic efficacy of Sitaxentan can be decreased when used in combination with Oxyphenbutazone.,decrease,no risk
Sitaxentan,Quetiapine,Quetiapine may increase the hypotensive activities of Sitaxentan.,increase,no risk
Sitaxentan,Quinapril,Quinapril may increase the hypotensive activities of Sitaxentan.,increase,no risk
Sitaxentan,Quinidine,The serum concentration of Quinidine can be increased when it is combined with Sitaxentan.,increase,no risk
Sitaxentan,Quinine,The metabolism of Quinine can be decreased when combined with Sitaxentan.,decrease,no risk
Sitaxentan,Quinupramine,Quinupramine may decrease the antihypertensive activities of Sitaxentan.,decrease,no risk
Sitaxentan,Udenafil,Udenafil may increase the antihypertensive activities of Sitaxentan.,increase,no risk
Sitaxentan,Unoprostone,Sitaxentan may increase the hypotensive activities of Unoprostone.,increase,no risk
Sitaxentan,Vadadustat,The metabolism of Sitaxentan can be decreased when combined with Vadadustat.,decrease,no risk
Sitaxentan,Valdecoxib,The therapeutic efficacy of Sitaxentan can be decreased when used in combination with Valdecoxib.,decrease,no risk
Sitaxentan,Valproic acid,The metabolism of Sitaxentan can be decreased when combined with Valproic acid.,decrease,no risk
Sitaxentan,Valsartan,The metabolism of Sitaxentan can be decreased when combined with Valsartan.,decrease,no risk
Sitaxentan,Vandetanib,The serum concentration of Vandetanib can be increased when it is combined with Sitaxentan.,increase,no risk
Sitaxentan,Vardenafil,The metabolism of Vardenafil can be decreased when combined with Sitaxentan.,decrease,no risk
Sitaxentan,Vemurafenib,The serum concentration of Vemurafenib can be increased when it is combined with Sitaxentan.,increase,no risk
Sitaxentan,Venetoclax,The serum concentration of Venetoclax can be increased when it is combined with Sitaxentan.,increase,no risk
Sitaxentan,Verapamil,Verapamil may increase the hypotensive activities of Sitaxentan.,increase,no risk
Sitaxentan,Vericiguat,Vericiguat may increase the hypotensive activities of Sitaxentan.,increase,no risk
Sitaxentan,Vilanterol,Vilanterol may decrease the antihypertensive activities of Sitaxentan.,decrease,no risk
Sitaxentan,Vilazodone,The metabolism of Vilazodone can be decreased when combined with Sitaxentan.,decrease,no risk
Sitaxentan,Vinblastine,The serum concentration of Vinblastine can be increased when it is combined with Sitaxentan.,increase,no risk
Sitaxentan,Vincristine,The serum concentration of Vincristine can be increased when it is combined with Sitaxentan.,increase,no risk
Sitaxentan,Vindesine,The serum concentration of Vindesine can be increased when it is combined with Sitaxentan.,increase,no risk
Sitaxentan,Vinflunine,The serum concentration of Vinflunine can be increased when it is combined with Sitaxentan.,increase,no risk
Sitaxentan,Vinorelbine,The serum concentration of Vinorelbine can be increased when it is combined with Sitaxentan.,increase,no risk
Sitaxentan,Vorapaxar,The metabolism of Vorapaxar can be decreased when combined with Sitaxentan.,decrease,no risk
Sitaxentan,Voriconazole,The metabolism of Voriconazole can be decreased when combined with Sitaxentan.,decrease,no risk
Sitaxentan,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Sitaxentan.,decrease,no risk
Sitaxentan,Voxelotor,The serum concentration of Voxelotor can be increased when it is combined with Sitaxentan.,increase,no risk
Sitaxentan,Warfarin,The serum concentration of Warfarin can be increased when it is combined with Sitaxentan.,increase,no risk
Sitaxentan,Xamoterol,Xamoterol may decrease the antihypertensive activities of Sitaxentan.,decrease,no risk
Sitaxentan,Ximelagatran,The metabolism of Ximelagatran can be decreased when combined with Sitaxentan.,decrease,no risk
Sitaxentan,Xylometazoline,Xylometazoline may decrease the antihypertensive activities of Sitaxentan.,decrease,no risk
Sitaxentan,Yohimbine,Yohimbine may decrease the antihypertensive activities of Sitaxentan.,decrease,no risk
Sitaxentan,Zafirlukast,The metabolism of Sitaxentan can be decreased when combined with Zafirlukast.,decrease,no risk
Sitaxentan,Zanubrutinib,The serum concentration of Zanubrutinib can be increased when it is combined with Sitaxentan.,increase,no risk
Sitaxentan,Zidovudine,The metabolism of Zidovudine can be decreased when combined with Sitaxentan.,decrease,no risk
Sitaxentan,Zileuton,The metabolism of Zileuton can be decreased when combined with Sitaxentan.,decrease,no risk
Sitaxentan,Ziprasidone,Ziprasidone may increase the antihypertensive activities of Sitaxentan.,increase,no risk
Sitaxentan,Zofenopril,Sitaxentan may increase the hypotensive activities of Zofenopril.,increase,no risk
Sitaxentan,Zolmitriptan,Zolmitriptan may decrease the antihypertensive activities of Sitaxentan.,decrease,no risk
Sitaxentan,Zolpidem,The metabolism of Zolpidem can be decreased when combined with Sitaxentan.,decrease,no risk
Sitaxentan,Zonisamide,The metabolism of Zonisamide can be decreased when combined with Sitaxentan.,decrease,no risk
Sitaxentan,Zopiclone,The metabolism of Zopiclone can be decreased when combined with Sitaxentan.,decrease,no risk
Sitaxentan,Zuclopenthixol,The metabolism of Zuclopenthixol can be decreased when combined with Sitaxentan.,decrease,no risk
Sulodexide,Gemcitabine,The risk or severity of bleeding can be increased when Sulodexide is combined with Gemcitabine.,increase,risk
Sulodexide,Gemtuzumab ozogamicin,The risk or severity of bleeding can be increased when Sulodexide is combined with Gemtuzumab ozogamicin.,increase,risk
Sulodexide,Gentamicin,The therapeutic efficacy of Gentamicin can be decreased when used in combination with Sulodexide.,decrease,no risk
Sulodexide,Gestrinone,The risk or severity of adverse effects can be increased when Gestrinone is combined with Sulodexide.,increase,risk
Sulodexide,Ginkgo biloba,Ginkgo biloba may increase the anticoagulant activities of Sulodexide.,increase,no risk
Sulodexide,Glycol salicylate,The risk or severity of bleeding and hemorrhage can be increased when Glycol salicylate is combined with Sulodexide.,increase,risk
Sulodexide,Hemin,Hemin may increase the anticoagulant activities of Sulodexide.,increase,no risk
Sulodexide,Heparin,The risk or severity of bleeding can be increased when Heparin is combined with Sulodexide.,increase,risk
Sulodexide,Hydrochlorothiazide,The therapeutic efficacy of Sulodexide can be decreased when used in combination with Hydrochlorothiazide.,decrease,no risk
Sulodexide,Hydroflumethiazide,The therapeutic efficacy of Sulodexide can be decreased when used in combination with Hydroflumethiazide.,decrease,no risk
Sulodexide,Hydroxyprogesterone caproate,The therapeutic efficacy of Sulodexide can be decreased when used in combination with Hydroxyprogesterone caproate.,decrease,no risk
Sulodexide,Hydroxyurea,The risk or severity of bleeding can be increased when Sulodexide is combined with Hydroxyurea.,increase,risk
Sulodexide,Kanamycin,The therapeutic efficacy of Kanamycin can be decreased when used in combination with Sulodexide.,decrease,no risk
Sulodexide,Ketoconazole,The risk or severity of hyperkalemia can be increased when Ketoconazole is combined with Sulodexide.,increase,risk
Sulodexide,Ketoprofen,The risk or severity of bleeding and hemorrhage can be increased when Ketoprofen is combined with Sulodexide.,increase,risk
Sulodexide,Ketorolac,The risk or severity of bleeding and hemorrhage can be increased when Ketorolac is combined with Sulodexide.,increase,risk
Sulodexide,Nabumetone,The risk or severity of bleeding and hemorrhage can be increased when Nabumetone is combined with Sulodexide.,increase,risk
Sulodexide,Nadolol,The risk or severity of hyperkalemia can be increased when Nadolol is combined with Sulodexide.,increase,risk
Sulodexide,Nadroparin,The risk or severity of bleeding can be increased when Sulodexide is combined with Nadroparin.,increase,risk
Sulodexide,Naproxen,The risk or severity of bleeding and hemorrhage can be increased when Naproxen is combined with Sulodexide.,increase,risk
Sulodexide,Nebivolol,The risk or severity of hyperkalemia can be increased when Nebivolol is combined with Sulodexide.,increase,risk
Sulodexide,Nefazodone,The risk or severity of hemorrhage can be increased when Nefazodone is combined with Sulodexide.,increase,risk
Sulodexide,Nelarabine,The risk or severity of bleeding can be increased when Sulodexide is combined with Nelarabine.,increase,risk
Sulodexide,Neomycin,The therapeutic efficacy of Neomycin can be decreased when used in combination with Sulodexide.,decrease,no risk
Sulodexide,Netilmicin,The therapeutic efficacy of Netilmicin can be decreased when used in combination with Sulodexide.,decrease,no risk
Sulodexide,Nialamide,The risk or severity of bleeding and hemorrhage can be increased when Nialamide is combined with Sulodexide.,increase,risk
Sulodexide,Nicardipine,The risk or severity of hyperkalemia can be increased when Nicardipine is combined with Sulodexide.,increase,risk
Sulodexide,Nicorandil,The risk or severity of hyperkalemia can be increased when Sulodexide is combined with Nicorandil.,increase,risk
Sulodexide,Nifedipine,The risk or severity of hyperkalemia can be increased when Nifedipine is combined with Sulodexide.,increase,risk
Sulodexide,Nilotinib,The risk or severity of bleeding can be increased when Sulodexide is combined with Nilotinib.,increase,risk
Sulodexide,Nilvadipine,The risk or severity of hyperkalemia can be increased when Sulodexide is combined with Nilvadipine.,increase,risk
Sulodexide,Nimesulide,The risk or severity of bleeding and hemorrhage can be increased when Nimesulide is combined with Sulodexide.,increase,risk
Sulodexide,Nimodipine,The risk or severity of hyperkalemia can be increased when Nimodipine is combined with Sulodexide.,increase,risk
Sulodexide,Nintedanib,The risk or severity of bleeding can be increased when Nintedanib is combined with Sulodexide.,increase,risk
Sulodexide,Nisoldipine,The risk or severity of hyperkalemia can be increased when Nisoldipine is combined with Sulodexide.,increase,risk
Sulodexide,Nitrendipine,The risk or severity of hyperkalemia can be increased when Nitrendipine is combined with Sulodexide.,increase,risk
Sulodexide,Nitrofurantoin,The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Sulodexide.,increase,risk
Sulodexide,Nomegestrol,The therapeutic efficacy of Sulodexide can be decreased when used in combination with Nomegestrol.,decrease,no risk
Sulodexide,Nomegestrol acetate,The risk or severity of adverse effects can be increased when Nomegestrol acetate is combined with Sulodexide.,increase,risk
Sulodexide,Nonacog beta pegol,The therapeutic efficacy of Nonacog beta pegol can be decreased when used in combination with Sulodexide.,decrease,no risk
Sulodexide,Norelgestromin,The therapeutic efficacy of Sulodexide can be decreased when used in combination with Norelgestromin.,decrease,no risk
Sulodexide,Norethisterone,The risk or severity of adverse effects can be increased when Norethisterone is combined with Sulodexide.,increase,risk
Sulodexide,Norethynodrel,The risk or severity of adverse effects can be increased when Norethynodrel is combined with Sulodexide.,increase,risk
Sulodexide,Norgestimate,The risk or severity of adverse effects can be increased when Norgestimate is combined with Sulodexide.,increase,risk
Sulodexide,Norgestrel,The risk or severity of adverse effects can be increased when Norgestrel is combined with Sulodexide.,increase,risk
Sulodexide,Nylidrin,The risk or severity of hyperkalemia can be increased when Nylidrin is combined with Sulodexide.,increase,risk
Sulodexide,Obeticholic acid,The risk or severity of bleeding and bruising can be increased when Sulodexide is combined with Obeticholic acid.,increase,risk
Sulodexide,Obinutuzumab,The risk or severity of bleeding and hemorrhage can be increased when Sulodexide is combined with Obinutuzumab.,increase,risk
Sulodexide,Olaparib,The risk or severity of bleeding can be increased when Sulodexide is combined with Olaparib.,increase,risk
Sulodexide,Olive oil,The therapeutic efficacy of Sulodexide can be decreased when used in combination with Olive oil.,decrease,no risk
Sulodexide,Olmesartan,The risk or severity of hyperkalemia can be increased when Sulodexide is combined with Olmesartan.,increase,risk
Sulodexide,Olsalazine,The risk or severity of bleeding can be increased when Sulodexide is combined with Olsalazine.,increase,risk
Sulodexide,Omacetaxine mepesuccinate,The risk or severity of bleeding can be increased when Sulodexide is combined with Omacetaxine mepesuccinate.,increase,risk
Sulodexide,Omega-3 fatty acids,Omega-3 fatty acids may increase the anticoagulant activities of Sulodexide.,increase,no risk
Sulodexide,Omega-3-acid ethyl esters,The risk or severity of bleeding can be increased when Omega-3-acid ethyl esters is combined with Sulodexide.,increase,risk
Sulodexide,Omega-3-carboxylic acids,The therapeutic efficacy of Sulodexide can be increased when used in combination with Omega-3-carboxylic acids.,increase,no risk
Sulodexide,Oritavancin,The therapeutic efficacy of Sulodexide can be decreased when used in combination with Oritavancin.,decrease,no risk
Sulodexide,Oxaliplatin,The risk or severity of hemorrhage can be increased when Oxaliplatin is combined with Sulodexide.,increase,risk
Sulodexide,Oxaprozin,The risk or severity of bleeding and hemorrhage can be increased when Oxaprozin is combined with Sulodexide.,increase,risk
Sulodexide,Oxprenolol,The risk or severity of hyperkalemia can be increased when Oxprenolol is combined with Sulodexide.,increase,risk
Sulodexide,Oxyphenbutazone,The risk or severity of bleeding and hemorrhage can be increased when Oxyphenbutazone is combined with Sulodexide.,increase,risk
Sulodexide,Quinapril,The risk or severity of hyperkalemia can be increased when Quinapril is combined with Sulodexide.,increase,risk
Sulodexide,Quinestrol,Quinestrol may decrease the anticoagulant activities of Sulodexide.,decrease,no risk
Sulodexide,Quinidine,The therapeutic efficacy of Sulodexide can be increased when used in combination with Quinidine.,increase,no risk
Sulodexide,Quinine,The therapeutic efficacy of Sulodexide can be increased when used in combination with Quinine.,increase,no risk
Sulodexide,Ulipristal,The therapeutic efficacy of Sulodexide can be decreased when used in combination with Ulipristal.,decrease,no risk
Sulodexide,Urokinase,Urokinase may increase the anticoagulant activities of Sulodexide.,increase,no risk
Sulodexide,Ursodeoxycholic acid,The risk or severity of bleeding and bruising can be increased when Sulodexide is combined with Ursodeoxycholic acid.,increase,risk
Sulodexide,Valdecoxib,The risk or severity of bleeding and hemorrhage can be increased when Valdecoxib is combined with Sulodexide.,increase,risk
Sulodexide,Valsartan,The risk or severity of hyperkalemia can be increased when Sulodexide is combined with Valsartan.,increase,risk
Sulodexide,Vasopressin,The therapeutic efficacy of Vasopressin can be decreased when used in combination with Sulodexide.,decrease,no risk
Sulodexide,Venlafaxine,The risk or severity of bleeding can be increased when Sulodexide is combined with Venlafaxine.,increase,risk
Sulodexide,Vinblastine,The risk or severity of bleeding can be increased when Sulodexide is combined with Vinblastine.,increase,risk
Sulodexide,Vindesine,The risk or severity of bleeding can be increased when Sulodexide is combined with Vindesine.,increase,risk
Sulodexide,Vinorelbine,The risk or severity of bleeding can be increased when Sulodexide is combined with Vinorelbine.,increase,risk
Sulodexide,Vitamin E,Vitamin E may increase the anticoagulant activities of Sulodexide.,increase,no risk
Sulodexide,Von Willebrand factor human,The therapeutic efficacy of Von Willebrand factor human can be decreased when used in combination with Sulodexide.,decrease,no risk
Sulodexide,Vorapaxar,The risk or severity of bleeding and hemorrhage can be increased when Vorapaxar is combined with Sulodexide.,increase,risk
Sulodexide,Vorinostat,The risk or severity of bleeding can be increased when Sulodexide is combined with Vorinostat.,increase,risk
Sulodexide,Warfarin,The risk or severity of bleeding can be increased when Warfarin is combined with Sulodexide.,increase,risk
Sulodexide,Ximelagatran,The risk or severity of bleeding can be increased when Ximelagatran is combined with Sulodexide.,increase,risk
Sulodexide,Zidovudine,The risk or severity of bleeding can be increased when Sulodexide is combined with Zidovudine.,increase,risk
Sulodexide,Zimelidine,The risk or severity of hemorrhage can be increased when Zimelidine is combined with Sulodexide.,increase,risk
Sulodexide,Zofenopril,The risk or severity of hyperkalemia can be increased when Zofenopril is combined with Sulodexide.,increase,risk
Sulodexide,Zonisamide,The risk or severity of hyperkalemia can be increased when Zonisamide is combined with Sulodexide.,increase,risk
Maxacalcitol,Nelarabine,The risk or severity of adverse effects can be increased when Nelarabine is combined with Maxacalcitol.,increase,risk
Maxacalcitol,Orlistat,Orlistat can cause a decrease in the absorption of Maxacalcitol resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Maxacalcitol,Ouabain,The risk or severity of ventricular arrhythmias and Cardiac Arrhythmia can be increased when Maxacalcitol is combined with Ouabain.,increase,risk
Maxacalcitol,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Maxacalcitol is combined with Oxetacaine.,increase,risk
Maxacalcitol,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Maxacalcitol is combined with Oxybuprocaine.,increase,risk
Maxacalcitol,Quinethazone,The risk or severity of hypokalemia can be increased when Maxacalcitol is combined with Quinethazone.,increase,risk
Maxacalcitol,Vamorolone,The therapeutic efficacy of Maxacalcitol can be decreased when used in combination with Vamorolone.,decrease,no risk
Maxacalcitol,Vitamin D,The risk or severity of adverse effects can be increased when Maxacalcitol is combined with Vitamin D.,increase,risk
Tocilizumab,Benzyl alcohol,The metabolism of Benzyl alcohol can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Bepridil,The metabolism of Bepridil can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Besilesomab,The risk or severity of adverse effects can be increased when Tocilizumab is combined with Besilesomab.,increase,risk
Tocilizumab,Betamethasone,The risk or severity of adverse effects can be increased when Betamethasone is combined with Tocilizumab.,increase,risk
Tocilizumab,Betaxolol,The metabolism of Betaxolol can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Bevacizumab,The risk or severity of adverse effects can be increased when Bevacizumab is combined with Tocilizumab.,increase,risk
Tocilizumab,Bexarotene,The metabolism of Bexarotene can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Bezlotoxumab,The risk or severity of adverse effects can be increased when Tocilizumab is combined with Bezlotoxumab.,increase,risk
Tocilizumab,Bicalutamide,The metabolism of Bicalutamide can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Bimekizumab,The risk or severity of adverse effects can be increased when Tocilizumab is combined with Bimekizumab.,increase,risk
Tocilizumab,Binimetinib,The metabolism of Binimetinib can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Bleomycin,The risk or severity of adverse effects can be increased when Bleomycin is combined with Tocilizumab.,increase,risk
Tocilizumab,Blinatumomab,The risk or severity of adverse effects can be increased when Tocilizumab is combined with Blinatumomab.,increase,risk
Tocilizumab,Boceprevir,The metabolism of Boceprevir can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,"Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated)","The therapeutic efficacy of Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated) can be decreased when used in combination with Tocilizumab.",decrease,no risk
Tocilizumab,Bortezomib,The metabolism of Bortezomib can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Bosentan,The metabolism of Bosentan can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Bosutinib,The metabolism of Bosutinib can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Brentuximab vedotin,The metabolism of Brentuximab vedotin can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Brexpiprazole,The metabolism of Brexpiprazole can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Brigatinib,The metabolism of Brigatinib can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Brivaracetam,The metabolism of Brivaracetam can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Brodalumab,The risk or severity of adverse effects can be increased when Tocilizumab is combined with Brodalumab.,increase,risk
Tocilizumab,Brolucizumab,The risk or severity of adverse effects can be increased when Tocilizumab is combined with Brolucizumab.,increase,risk
Tocilizumab,Bromazepam,The metabolism of Bromazepam can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Bromotheophylline,The metabolism of Bromotheophylline can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Brompheniramine,The metabolism of Brompheniramine can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Budesonide,The risk or severity of adverse effects can be increased when Budesonide is combined with Tocilizumab.,increase,risk
Tocilizumab,Bupivacaine,The metabolism of Bupivacaine can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Buprenorphine,The metabolism of Buprenorphine can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Bupropion,The metabolism of Bupropion can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Burosumab,The risk or severity of adverse effects can be increased when Tocilizumab is combined with Burosumab.,increase,risk
Tocilizumab,Buspirone,The metabolism of Buspirone can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Busulfan,The metabolism of Busulfan can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Galantamine,The metabolism of Galantamine can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Galcanezumab,The risk or severity of adverse effects can be increased when Tocilizumab is combined with Galcanezumab.,increase,risk
Tocilizumab,Gefitinib,The metabolism of Gefitinib can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Gemcitabine,The risk or severity of adverse effects can be increased when Gemcitabine is combined with Tocilizumab.,increase,risk
Tocilizumab,Gemtuzumab ozogamicin,The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Tocilizumab.,increase,risk
Tocilizumab,Gestrinone,The metabolism of Gestrinone can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Gilteritinib,The metabolism of Gilteritinib can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Glasdegib,The metabolism of Glasdegib can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Glatiramer,The risk or severity of adverse effects can be increased when Glatiramer is combined with Tocilizumab.,increase,risk
Tocilizumab,Gliclazide,The metabolism of Gliclazide can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Glimepiride,The metabolism of Glimepiride can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Glipizide,The metabolism of Glipizide can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Gliquidone,The metabolism of Gliquidone can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Glofitamab,The risk or severity of adverse effects can be increased when Tocilizumab is combined with Glofitamab.,increase,risk
Tocilizumab,Glyburide,The metabolism of Glyburide can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Golimumab,Tocilizumab may increase the immunosuppressive activities of Golimumab.,increase,no risk
Tocilizumab,Grepafloxacin,The metabolism of Grepafloxacin can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Guanabenz,The metabolism of Guanabenz can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Guselkumab,The risk or severity of adverse effects can be increased when Tocilizumab is combined with Guselkumab.,increase,risk
Tocilizumab,Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Tocilizumab.,decrease,no risk
Tocilizumab,Halofantrine,The metabolism of Halofantrine can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Haloperidol,The metabolism of Haloperidol can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Halothane,The metabolism of Halothane can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Hepatitis A Vaccine,The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Tocilizumab.,decrease,no risk
Tocilizumab,Hepatitis B immune globulin,The risk or severity of adverse effects can be increased when Hepatitis B immune globulin is combined with Tocilizumab.,increase,risk
Tocilizumab,Hepatitis B Vaccine (Recombinant),The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Tocilizumab.,decrease,no risk
Tocilizumab,Human adenovirus e serotype 4 strain cl-68578 antigen,The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Tocilizumab.,increase,risk
Tocilizumab,Human cytomegalovirus immune globulin,The risk or severity of adverse effects can be increased when Tocilizumab is combined with Human cytomegalovirus immune globulin.,increase,risk
Tocilizumab,Human immunoglobulin G,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Tocilizumab.,increase,risk
Tocilizumab,Human Rho(D) immune globulin,The risk or severity of adverse effects can be increased when Tocilizumab is combined with Human Rho(D) immune globulin.,increase,risk
Tocilizumab,Human varicella-zoster immune globulin,The risk or severity of adverse effects can be increased when Tocilizumab is combined with Human varicella-zoster immune globulin.,increase,risk
Tocilizumab,Hydrocodone,The metabolism of Hydrocodone can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Hydrocortisone,The metabolism of Hydrocortisone can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Hydrocortisone acetate,The metabolism of Hydrocortisone acetate can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Hydrocortisone butyrate,The metabolism of Hydrocortisone butyrate can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Hydrocortisone cypionate,The metabolism of Hydrocortisone cypionate can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Hydrocortisone phosphate,The metabolism of Hydrocortisone phosphate can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Hydrocortisone succinate,The risk or severity of adverse effects can be increased when Tocilizumab is combined with Hydrocortisone succinate.,increase,risk
Tocilizumab,Hydromorphone,The metabolism of Hydromorphone can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Hydroxychloroquine,The metabolism of Hydroxychloroquine can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Hydroxyprogesterone caproate,The metabolism of Hydroxyprogesterone caproate can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Hydroxyurea,The risk or severity of adverse effects can be increased when Hydroxyurea is combined with Tocilizumab.,increase,risk
Tocilizumab,Hydroxyzine,The metabolism of Hydroxyzine can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Janssen COVID-19 Vaccine,The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Tocilizumab.,decrease,no risk
Tocilizumab,Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated),The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Tocilizumab.,decrease,no risk
Tocilizumab,Ketamine,The metabolism of Ketamine can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Ketorolac,The metabolism of Ketorolac can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Nabilone,The metabolism of Nabilone can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Nabumetone,The metabolism of Nabumetone can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Nadolol,The metabolism of Nadolol can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Naproxen,The metabolism of Naproxen can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Natalizumab,The risk or severity of immunosuppression can be increased when Tocilizumab is combined with Natalizumab.,increase,risk
Tocilizumab,Nateglinide,The metabolism of Nateglinide can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Nebivolol,The metabolism of Nebivolol can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Necitumumab,The risk or severity of adverse effects can be increased when Tocilizumab is combined with Necitumumab.,increase,risk
Tocilizumab,Nefazodone,The metabolism of Nefazodone can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Nelarabine,The risk or severity of adverse effects can be increased when Nelarabine is combined with Tocilizumab.,increase,risk
Tocilizumab,Nelfinavir,The metabolism of Nelfinavir can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Neratinib,The metabolism of Neratinib can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Netupitant,The metabolism of Netupitant can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Nevirapine,The metabolism of Nevirapine can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Nicardipine,The metabolism of Nicardipine can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Nicergoline,The metabolism of Nicergoline can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Niclosamide,The metabolism of Niclosamide can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Nicotine,The metabolism of Nicotine can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Nifedipine,The metabolism of Nifedipine can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Nilotinib,The metabolism of Nilotinib can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Nilutamide,The metabolism of Nilutamide can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Nilvadipine,The metabolism of Nilvadipine can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Nintedanib,The metabolism of Nintedanib can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Nirogacestat,The metabolism of Nirogacestat can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Nisoldipine,The metabolism of Nisoldipine can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Nitrendipine,The metabolism of Nitrendipine can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Nivolumab,The risk or severity of adverse effects can be increased when Tocilizumab is combined with Nivolumab.,increase,risk
Tocilizumab,Nomegestrol,The metabolism of Nomegestrol can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Nomegestrol acetate,The metabolism of Nomegestrol acetate can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Norelgestromin,The metabolism of Norelgestromin can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Norethisterone,The metabolism of Norethisterone can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Norethynodrel,The metabolism of Norethynodrel can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Norgestimate,The metabolism of Norgestimate can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Norgestrel,The metabolism of Norgestrel can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Nortriptyline,The metabolism of Nortriptyline can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Nuvaxovid,The therapeutic efficacy of Nuvaxovid can be decreased when used in combination with Tocilizumab.,decrease,no risk
Tocilizumab,Obiltoxaximab,The risk or severity of adverse effects can be increased when Obiltoxaximab is combined with Tocilizumab.,increase,risk
Tocilizumab,Obinutuzumab,The risk or severity of adverse effects can be increased when Tocilizumab is combined with Obinutuzumab.,increase,risk
Tocilizumab,Ocrelizumab,Ocrelizumab may increase the immunosuppressive activities of Tocilizumab.,increase,no risk
Tocilizumab,Odesivimab,The risk or severity of adverse effects can be increased when Tocilizumab is combined with Odesivimab.,increase,risk
Tocilizumab,Ofatumumab,The risk or severity of adverse effects can be increased when Tocilizumab is combined with Ofatumumab.,increase,risk
Tocilizumab,Olanzapine,The metabolism of Olanzapine can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Olaparib,The metabolism of Olaparib can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Olaratumab,The risk or severity of adverse effects can be increased when Olaratumab is combined with Tocilizumab.,increase,risk
Tocilizumab,Oliceridine,The serum concentration of Oliceridine can be decreased when it is combined with Tocilizumab.,decrease,no risk
Tocilizumab,Olodaterol,The metabolism of Olodaterol can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Omalizumab,The risk or severity of adverse effects can be increased when Omalizumab is combined with Tocilizumab.,increase,risk
Tocilizumab,Ombitasvir,The metabolism of Ombitasvir can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Omeprazole,The metabolism of Omeprazole can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Ondansetron,The metabolism of Ondansetron can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Opium,The metabolism of Opium can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Osilodrostat,The metabolism of Osilodrostat can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Osimertinib,The metabolism of Osimertinib can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Ospemifene,The metabolism of Ospemifene can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Oxaliplatin,The risk or severity of adverse effects can be increased when Oxaliplatin is combined with Tocilizumab.,increase,risk
Tocilizumab,Oxprenolol,The metabolism of Oxprenolol can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Oxtriphylline,The metabolism of Oxtriphylline can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Oxybutynin,The metabolism of Oxybutynin can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Oxycodone,The metabolism of Oxycodone can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Oxymorphone,The metabolism of Oxymorphone can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Ozanimod,The risk or severity of adverse effects can be increased when Tocilizumab is combined with Ozanimod.,increase,risk
Tocilizumab,Quetiapine,The metabolism of Quetiapine can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Quinestrol,Quinestrol may increase the thrombogenic activities of Tocilizumab.,increase,no risk
Tocilizumab,Quinidine,The metabolism of Quinidine can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Quinine,The metabolism of Quinine can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Quizartinib,The metabolism of Quizartinib can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Ublituximab,The risk or severity of infection can be increased when Ublituximab is combined with Tocilizumab.,increase,risk
Tocilizumab,Ubrogepant,The serum concentration of Ubrogepant can be decreased when it is combined with Tocilizumab.,decrease,no risk
Tocilizumab,Udenafil,The metabolism of Udenafil can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Ulipristal,The metabolism of Ulipristal can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Umeclidinium,The metabolism of Umeclidinium can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Upadacitinib,The risk or severity of adverse effects can be increased when Tocilizumab is combined with Upadacitinib.,increase,risk
Tocilizumab,Ustekinumab,The risk or severity of adverse effects can be increased when Ustekinumab is combined with Tocilizumab.,increase,risk
Tocilizumab,Valbenazine,The metabolism of Valbenazine can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Valdecoxib,The metabolism of Valdecoxib can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Valproic acid,The metabolism of Valproic acid can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Valsartan,The metabolism of Valsartan can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Vandetanib,The metabolism of Vandetanib can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Vardenafil,The metabolism of Vardenafil can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Varicella zoster vaccine (live/attenuated),The risk or severity of infection can be increased when Varicella zoster vaccine (live/attenuated) is combined with Tocilizumab.,increase,risk
Tocilizumab,Varicella zoster vaccine (recombinant),The therapeutic efficacy of Varicella zoster vaccine (recombinant) can be decreased when used in combination with Tocilizumab.,decrease,no risk
Tocilizumab,Vedolizumab,The risk or severity of adverse effects can be increased when Tocilizumab is combined with Vedolizumab.,increase,risk
Tocilizumab,Velpatasvir,The metabolism of Velpatasvir can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Vemurafenib,The metabolism of Vemurafenib can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Venetoclax,The metabolism of Venetoclax can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Venlafaxine,The metabolism of Venlafaxine can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Verapamil,The metabolism of Verapamil can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Vernakalant,The metabolism of Vernakalant can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Tocilizumab.,decrease,no risk
Tocilizumab,Vilanterol,The risk or severity of adverse effects can be increased when Tocilizumab is combined with Vilanterol.,increase,risk
Tocilizumab,Vilazodone,The metabolism of Vilazodone can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Vinblastine,The metabolism of Vinblastine can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Vincristine,The metabolism of Vincristine can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Vindesine,The metabolism of Vindesine can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Vinflunine,The metabolism of Vinflunine can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Vinorelbine,The metabolism of Vinorelbine can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Voclosporin,The risk or severity of adverse effects can be increased when Tocilizumab is combined with Voclosporin.,increase,risk
Tocilizumab,Vonoprazan,The metabolism of Vonoprazan can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Vorapaxar,The metabolism of Vorapaxar can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Voriconazole,The metabolism of Voriconazole can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Vorinostat,The risk or severity of adverse effects can be increased when Vorinostat is combined with Tocilizumab.,increase,risk
Tocilizumab,Vortioxetine,The metabolism of Vortioxetine can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Voxelotor,The metabolism of Voxelotor can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Voxilaprevir,The metabolism of Voxilaprevir can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Warfarin,The metabolism of Warfarin can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Ximelagatran,The metabolism of Ximelagatran can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Yellow fever vaccine,The risk or severity of infection can be increased when Yellow fever vaccine is combined with Tocilizumab.,increase,risk
Tocilizumab,Yohimbine,The metabolism of Yohimbine can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Zafirlukast,The metabolism of Zafirlukast can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Zaleplon,The metabolism of Zaleplon can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Zanubrutinib,The metabolism of Zanubrutinib can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Zidovudine,The metabolism of Zidovudine can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Zileuton,The metabolism of Zileuton can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Ziprasidone,The metabolism of Ziprasidone can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Zolmitriptan,The metabolism of Zolmitriptan can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Zolpidem,The metabolism of Zolpidem can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Zonisamide,The metabolism of Zonisamide can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Zopiclone,The metabolism of Zopiclone can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Zotepine,The metabolism of Zotepine can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Zuclopenthixol,The metabolism of Zuclopenthixol can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Zuranolone,The serum concentration of Zuranolone can be decreased when it is combined with Tocilizumab.,decrease,no risk
Alvimopan,Benzhydrocodone,The risk or severity of adverse effects can be increased when Benzhydrocodone is combined with Alvimopan.,increase,risk
Alvimopan,Buprenorphine,The risk or severity of adverse effects can be increased when Buprenorphine is combined with Alvimopan.,increase,risk
Alvimopan,Butorphanol,The risk or severity of adverse effects can be increased when Butorphanol is combined with Alvimopan.,increase,risk
Alvimopan,Hydrocodone,The risk or severity of adverse effects can be increased when Hydrocodone is combined with Alvimopan.,increase,risk
Alvimopan,Hydromorphone,The risk or severity of adverse effects can be increased when Hydromorphone is combined with Alvimopan.,increase,risk
Alvimopan,Nalbuphine,The risk or severity of adverse effects can be increased when Nalbuphine is combined with Alvimopan.,increase,risk
Alvimopan,Naloxegol,Alvimopan may increase the opioid antagonism activities of Naloxegol.,increase,no risk
Alvimopan,Naltrexone,The risk or severity of adverse effects can be increased when Naltrexone is combined with Alvimopan.,increase,risk
Alvimopan,Normethadone,The risk or severity of adverse effects can be increased when Normethadone is combined with Alvimopan.,increase,risk
Alvimopan,Oliceridine,The risk or severity of adverse effects can be increased when Oliceridine is combined with Alvimopan.,increase,risk
Alvimopan,Opium,The risk or severity of adverse effects can be increased when Opium is combined with Alvimopan.,increase,risk
Alvimopan,Oxycodone,The risk or severity of adverse effects can be increased when Oxycodone is combined with Alvimopan.,increase,risk
Alvimopan,Oxymorphone,The risk or severity of adverse effects can be increased when Oxymorphone is combined with Alvimopan.,increase,risk
Methoxy polyethylene glycol-epoetin beta,Gefitinib,The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol-epoetin beta is combined with Gefitinib.,increase,risk
Methoxy polyethylene glycol-epoetin beta,Gemcitabine,The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol-epoetin beta is combined with Gemcitabine.,increase,risk
Methoxy polyethylene glycol-epoetin beta,Gemtuzumab ozogamicin,The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol-epoetin beta is combined with Gemtuzumab ozogamicin.,increase,risk
Methoxy polyethylene glycol-epoetin beta,Gilteritinib,The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol-epoetin beta is combined with Gilteritinib.,increase,risk
Methoxy polyethylene glycol-epoetin beta,Glasdegib,The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol-epoetin beta is combined with Glasdegib.,increase,risk
Methoxy polyethylene glycol-epoetin beta,Goserelin,The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol-epoetin beta is combined with Goserelin.,increase,risk
Methoxy polyethylene glycol-epoetin beta,Hydroxyprogesterone caproate,The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol-epoetin beta is combined with Hydroxyprogesterone caproate.,increase,risk
Methoxy polyethylene glycol-epoetin beta,Hydroxyurea,The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol-epoetin beta is combined with Hydroxyurea.,increase,risk
Methoxy polyethylene glycol-epoetin beta,Nandrolone decanoate,The therapeutic efficacy of Methoxy polyethylene glycol-epoetin beta can be increased when used in combination with Nandrolone decanoate.,increase,no risk
Methoxy polyethylene glycol-epoetin beta,Nandrolone phenpropionate,The therapeutic efficacy of Methoxy polyethylene glycol-epoetin beta can be increased when used in combination with Nandrolone phenpropionate.,increase,no risk
Methoxy polyethylene glycol-epoetin beta,Naxitamab,The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol-epoetin beta is combined with Naxitamab.,increase,risk
Methoxy polyethylene glycol-epoetin beta,Necitumumab,The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol-epoetin beta is combined with Necitumumab.,increase,risk
Methoxy polyethylene glycol-epoetin beta,Nedaplatin,The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol-epoetin beta is combined with Nedaplatin.,increase,risk
Methoxy polyethylene glycol-epoetin beta,Nelarabine,The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol-epoetin beta is combined with Nelarabine.,increase,risk
Methoxy polyethylene glycol-epoetin beta,Neratinib,The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol-epoetin beta is combined with Neratinib.,increase,risk
Methoxy polyethylene glycol-epoetin beta,Nilotinib,The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol-epoetin beta is combined with Nilotinib.,increase,risk
Methoxy polyethylene glycol-epoetin beta,Nilutamide,The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol-epoetin beta is combined with Nilutamide.,increase,risk
Methoxy polyethylene glycol-epoetin beta,Nintedanib,The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol-epoetin beta is combined with Nintedanib.,increase,risk
Methoxy polyethylene glycol-epoetin beta,Niraparib,The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol-epoetin beta is combined with Niraparib.,increase,risk
Methoxy polyethylene glycol-epoetin beta,Nivolumab,The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol-epoetin beta is combined with Nivolumab.,increase,risk
Methoxy polyethylene glycol-epoetin beta,Nonacog beta pegol,The therapeutic efficacy of Nonacog beta pegol can be decreased when used in combination with Methoxy polyethylene glycol-epoetin beta.,decrease,no risk
Methoxy polyethylene glycol-epoetin beta,Obinutuzumab,The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol-epoetin beta is combined with Obinutuzumab.,increase,risk
Methoxy polyethylene glycol-epoetin beta,Octreotide,The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol-epoetin beta is combined with Octreotide.,increase,risk
Methoxy polyethylene glycol-epoetin beta,Ofatumumab,The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol-epoetin beta is combined with Ofatumumab.,increase,risk
Methoxy polyethylene glycol-epoetin beta,Olaparib,The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol-epoetin beta is combined with Olaparib.,increase,risk
Methoxy polyethylene glycol-epoetin beta,Olaratumab,The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol-epoetin beta is combined with Olaratumab.,increase,risk
Methoxy polyethylene glycol-epoetin beta,Olutasidenib,The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol-epoetin beta is combined with Olutasidenib.,increase,risk
Methoxy polyethylene glycol-epoetin beta,Omacetaxine mepesuccinate,The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol-epoetin beta is combined with Omacetaxine mepesuccinate.,increase,risk
Methoxy polyethylene glycol-epoetin beta,Osimertinib,The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol-epoetin beta is combined with Osimertinib.,increase,risk
Methoxy polyethylene glycol-epoetin beta,Oxaliplatin,The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol-epoetin beta is combined with Oxaliplatin.,increase,risk
Methoxy polyethylene glycol-epoetin beta,Quizartinib,The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol-epoetin beta is combined with Quizartinib.,increase,risk
Methoxy polyethylene glycol-epoetin beta,Umbralisib,The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol-epoetin beta is combined with Umbralisib.,increase,risk
Methoxy polyethylene glycol-epoetin beta,Uracil mustard,The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol-epoetin beta is combined with Uracil mustard.,increase,risk
Methoxy polyethylene glycol-epoetin beta,Urethane,The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol-epoetin beta is combined with Urethane.,increase,risk
Methoxy polyethylene glycol-epoetin beta,Valproic acid,The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol-epoetin beta is combined with Valproic acid.,increase,risk
Methoxy polyethylene glycol-epoetin beta,Valrubicin,The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol-epoetin beta is combined with Valrubicin.,increase,risk
Methoxy polyethylene glycol-epoetin beta,Vandetanib,The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol-epoetin beta is combined with Vandetanib.,increase,risk
Methoxy polyethylene glycol-epoetin beta,Vemurafenib,The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol-epoetin beta is combined with Vemurafenib.,increase,risk
Methoxy polyethylene glycol-epoetin beta,Venetoclax,The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol-epoetin beta is combined with Venetoclax.,increase,risk
Methoxy polyethylene glycol-epoetin beta,Vinblastine,The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol-epoetin beta is combined with Vinblastine.,increase,risk
Methoxy polyethylene glycol-epoetin beta,Vincristine,The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol-epoetin beta is combined with Vincristine.,increase,risk
Methoxy polyethylene glycol-epoetin beta,Vindesine,The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol-epoetin beta is combined with Vindesine.,increase,risk
Methoxy polyethylene glycol-epoetin beta,Vinflunine,The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol-epoetin beta is combined with Vinflunine.,increase,risk
Methoxy polyethylene glycol-epoetin beta,Vinorelbine,The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol-epoetin beta is combined with Vinorelbine.,increase,risk
Methoxy polyethylene glycol-epoetin beta,Vismodegib,The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol-epoetin beta is combined with Vismodegib.,increase,risk
Methoxy polyethylene glycol-epoetin beta,Vorinostat,The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol-epoetin beta is combined with Vorinostat.,increase,risk
Methoxy polyethylene glycol-epoetin beta,Zanubrutinib,The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol-epoetin beta is combined with Zanubrutinib.,increase,risk
Levocetirizine,Benzyl alcohol,The risk or severity of CNS depression can be increased when Levocetirizine is combined with Benzyl alcohol.,increase,risk
Levocetirizine,Benzylpenicilloyl polylysine,Levocetirizine may decrease effectiveness of Benzylpenicilloyl polylysine as a diagnostic agent.,decrease,no risk
Levocetirizine,Bepotastine,Bepotastine may decrease the excretion rate of Levocetirizine which could result in a higher serum level.,decrease,no risk
Levocetirizine,Bepridil,The risk or severity of QTc prolongation can be increased when Levocetirizine is combined with Bepridil.,increase,risk
Levocetirizine,Berotralstat,The metabolism of Levocetirizine can be decreased when combined with Berotralstat.,decrease,no risk
Levocetirizine,Betahistine,The therapeutic efficacy of Betahistine can be decreased when used in combination with Levocetirizine.,decrease,no risk
Levocetirizine,Bicisate,Levocetirizine may decrease the excretion rate of Bicisate which could result in a higher serum level.,decrease,no risk
Levocetirizine,Bilastine,The risk or severity of QTc prolongation can be increased when Levocetirizine is combined with Bilastine.,increase,risk
Levocetirizine,Biperiden,Biperiden may increase the anticholinergic activities of Levocetirizine.,increase,no risk
Levocetirizine,Bismuth subgallate,Levocetirizine may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Levocetirizine,Bisoprolol,Bisoprolol may decrease the excretion rate of Levocetirizine which could result in a higher serum level.,decrease,no risk
Levocetirizine,Bisoxatin,Levocetirizine may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,decrease,no risk
Levocetirizine,Bleomycin,Bleomycin may decrease the excretion rate of Levocetirizine which could result in a higher serum level.,decrease,no risk
Levocetirizine,Boceprevir,The metabolism of Levocetirizine can be decreased when combined with Boceprevir.,decrease,no risk
Levocetirizine,Bortezomib,The risk or severity of QTc prolongation can be increased when Bortezomib is combined with Levocetirizine.,increase,risk
Levocetirizine,Botulinum toxin type A,The risk or severity of CNS depression can be increased when Botulinum toxin type A is combined with Levocetirizine.,increase,risk
Levocetirizine,Botulinum toxin type B,The risk or severity of CNS depression can be increased when Botulinum toxin type B is combined with Levocetirizine.,increase,risk
Levocetirizine,Bretylium,The risk or severity of QTc prolongation can be increased when Bretylium is combined with Levocetirizine.,increase,risk
Levocetirizine,Brexanolone,The risk or severity of CNS depression can be increased when Levocetirizine is combined with Brexanolone.,increase,risk
Levocetirizine,Brexpiprazole,The risk or severity of CNS depression can be increased when Levocetirizine is combined with Brexpiprazole.,increase,risk
Levocetirizine,Brimonidine,Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Levocetirizine.,increase,no risk
Levocetirizine,Brivaracetam,The risk or severity of CNS depression can be increased when Brivaracetam is combined with Levocetirizine.,increase,risk
Levocetirizine,Bromazepam,The risk or severity of CNS depression can be increased when Bromazepam is combined with Levocetirizine.,increase,risk
Levocetirizine,Bromocriptine,The risk or severity of CNS depression can be increased when Bromocriptine is combined with Levocetirizine.,increase,risk
Levocetirizine,Bromotheophylline,Bromotheophylline may increase the excretion rate of Levocetirizine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Levocetirizine,Bromperidol,The risk or severity of CNS depression can be increased when Levocetirizine is combined with Bromperidol.,increase,risk
Levocetirizine,Brompheniramine,The risk or severity of CNS depression can be increased when Brompheniramine is combined with Levocetirizine.,increase,risk
Levocetirizine,Buclizine,The risk or severity of QTc prolongation can be increased when Buclizine is combined with Levocetirizine.,increase,risk
Levocetirizine,Budesonide,Budesonide may decrease the excretion rate of Levocetirizine which could result in a higher serum level.,decrease,no risk
Levocetirizine,Bumadizone,Bumadizone may decrease the excretion rate of Levocetirizine which could result in a higher serum level.,decrease,no risk
Levocetirizine,Bumetanide,Bumetanide may increase the excretion rate of Levocetirizine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Levocetirizine,Bupivacaine,The risk or severity of CNS depression can be increased when Bupivacaine is combined with Levocetirizine.,increase,risk
Levocetirizine,Buprenorphine,Levocetirizine may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Levocetirizine,Bupropion,The risk or severity of CNS depression can be increased when Bupropion is combined with Levocetirizine.,increase,risk
Levocetirizine,Buserelin,The risk or severity of QTc prolongation can be increased when Levocetirizine is combined with Buserelin.,increase,risk
Levocetirizine,Buspirone,The risk or severity of CNS depression can be increased when Buspirone is combined with Levocetirizine.,increase,risk
Levocetirizine,Butabarbital,The risk or severity of CNS depression can be increased when Butabarbital is combined with Levocetirizine.,increase,risk
Levocetirizine,Butalbital,The risk or severity of CNS depression can be increased when Butalbital is combined with Levocetirizine.,increase,risk
Levocetirizine,Butaperazine,The risk or severity of CNS depression can be increased when Levocetirizine is combined with Butaperazine.,increase,risk
Levocetirizine,Butobarbital,The risk or severity of CNS depression can be increased when Butobarbital is combined with Levocetirizine.,increase,risk
Levocetirizine,Butorphanol,The risk or severity of CNS depression can be increased when Butorphanol is combined with Levocetirizine.,increase,risk
Levocetirizine,Butriptyline,The risk or severity of CNS depression can be increased when Levocetirizine is combined with Butriptyline.,increase,risk
Levocetirizine,Butylscopolamine,Butylscopolamine may increase the anticholinergic activities of Levocetirizine.,increase,no risk
Levocetirizine,Gabapentin,The risk or severity of CNS depression can be increased when Gabapentin is combined with Levocetirizine.,increase,risk
Levocetirizine,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Levocetirizine is combined with Gabapentin enacarbil.,increase,risk
Levocetirizine,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Levocetirizine is combined with Gadobenic acid.,increase,risk
Levocetirizine,Gadodiamide,Gadodiamide may decrease the excretion rate of Levocetirizine which could result in a higher serum level.,decrease,no risk
Levocetirizine,Gadofosveset trisodium,Levocetirizine may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Levocetirizine,Gadopentetic acid,Gadopentetic acid may decrease the excretion rate of Levocetirizine which could result in a higher serum level.,decrease,no risk
Levocetirizine,Gadoteric acid,Levocetirizine may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Levocetirizine,Gadoteridol,Gadoteridol may decrease the excretion rate of Levocetirizine which could result in a higher serum level.,decrease,no risk
Levocetirizine,Galantamine,The risk or severity of QTc prolongation can be increased when Galantamine is combined with Levocetirizine.,increase,risk
Levocetirizine,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with Levocetirizine.,increase,risk
Levocetirizine,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Levocetirizine is combined with Ganaxolone.",increase,risk
Levocetirizine,Ganciclovir,Ganciclovir may decrease the excretion rate of Levocetirizine which could result in a higher serum level.,decrease,no risk
Levocetirizine,Gatifloxacin,The risk or severity of QTc prolongation can be increased when Gatifloxacin is combined with Levocetirizine.,increase,risk
Levocetirizine,Gemcitabine,Gemcitabine may decrease the excretion rate of Levocetirizine which could result in a higher serum level.,decrease,no risk
Levocetirizine,Gemfibrozil,Gemfibrozil may decrease the excretion rate of Levocetirizine which could result in a higher serum level.,decrease,no risk
Levocetirizine,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Levocetirizine is combined with Gemifloxacin.,increase,risk
Levocetirizine,Gentamicin,Levocetirizine may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Levocetirizine,Gepirone,The risk or severity of QTc prolongation can be increased when Gepirone is combined with Levocetirizine.,increase,risk
Levocetirizine,Gilteritinib,The risk or severity of QTc prolongation can be increased when Levocetirizine is combined with Gilteritinib.,increase,risk
Levocetirizine,Gimeracil,Levocetirizine may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Levocetirizine,Givosiran,Givosiran may decrease the excretion rate of Levocetirizine which could result in a higher serum level.,decrease,no risk
Levocetirizine,Glasdegib,The risk or severity of QTc prolongation can be increased when Levocetirizine is combined with Glasdegib.,increase,risk
Levocetirizine,Glipizide,Glipizide may decrease the excretion rate of Levocetirizine which could result in a higher serum level.,decrease,no risk
Levocetirizine,Glofitamab,The serum concentration of Levocetirizine can be increased when it is combined with Glofitamab.,increase,no risk
Levocetirizine,Glutethimide,The risk or severity of CNS depression can be increased when Glutethimide is combined with Levocetirizine.,increase,risk
Levocetirizine,Glycerol phenylbutyrate,Levocetirizine may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Levocetirizine,Glycopyrronium,Glycopyrronium may increase the anticholinergic activities of Levocetirizine.,increase,no risk
Levocetirizine,Golodirsen,Levocetirizine may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Levocetirizine,Goserelin,The risk or severity of QTc prolongation can be increased when Levocetirizine is combined with Goserelin.,increase,risk
Levocetirizine,Granisetron,The risk or severity of CNS depression can be increased when Granisetron is combined with Levocetirizine.,increase,risk
Levocetirizine,Grepafloxacin,The risk or severity of QTc prolongation can be increased when Levocetirizine is combined with Grepafloxacin.,increase,risk
Levocetirizine,Guanethidine,Guanethidine may decrease the excretion rate of Levocetirizine which could result in a higher serum level.,decrease,no risk
Levocetirizine,Guanfacine,The risk or severity of CNS depression can be increased when Guanfacine is combined with Levocetirizine.,increase,risk
Levocetirizine,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with Levocetirizine.,increase,risk
Levocetirizine,Halofantrine,The risk or severity of QTc prolongation can be increased when Levocetirizine is combined with Halofantrine.,increase,risk
Levocetirizine,Haloperidol,The risk or severity of QTc prolongation can be increased when Levocetirizine is combined with Haloperidol.,increase,risk
Levocetirizine,Halothane,The risk or severity of CNS depression can be increased when Halothane is combined with Levocetirizine.,increase,risk
Levocetirizine,Hexafluronium,The risk or severity of CNS depression can be increased when Hexafluronium is combined with Levocetirizine.,increase,risk
Levocetirizine,Hexocyclium,Hexocyclium may increase the anticholinergic activities of Levocetirizine.,increase,no risk
Levocetirizine,Histrelin,The risk or severity of QTc prolongation can be increased when Levocetirizine is combined with Histrelin.,increase,risk
Levocetirizine,Homatropine methylbromide,Homatropine methylbromide may increase the anticholinergic activities of Levocetirizine.,increase,no risk
Levocetirizine,Hydralazine,Hydralazine may decrease the excretion rate of Levocetirizine which could result in a higher serum level.,decrease,no risk
Levocetirizine,Hydrochlorothiazide,Hydrochlorothiazide may increase the excretion rate of Levocetirizine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Levocetirizine,Hydrocodone,Levocetirizine may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
